Citrus Sinensis ID: 006528
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 641 | 2.2.26 [Sep-21-2011] | |||||||
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.889 | 0.931 | 0.512 | 1e-162 | |
| Q8S8Y8 | 567 | Probable serine/threonine | yes | no | 0.599 | 0.677 | 0.624 | 1e-145 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.600 | 0.691 | 0.617 | 1e-142 | |
| Q944Q0 | 563 | Serine/threonine-protein | no | no | 0.617 | 0.703 | 0.615 | 1e-134 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.595 | 0.729 | 0.624 | 1e-129 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.597 | 0.544 | 0.544 | 1e-126 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.595 | 0.542 | 0.546 | 1e-126 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.616 | 0.564 | 0.513 | 1e-122 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.558 | 0.693 | 0.535 | 1e-121 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.594 | 0.613 | 0.536 | 1e-119 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 571 bits (1471), Expect = e-162, Method: Compositional matrix adjust.
Identities = 321/626 (51%), Positives = 405/626 (64%), Gaps = 56/626 (8%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKAFDE GIEVAWS+V+ID+V+Q P +L++LYSEVHLLKSLK +NV+KFY WVDD+K
Sbjct: 39 VYKAFDEVEGIEVAWSQVEIDEVMQSPDNLERLYSEVHLLKSLKHENVMKFYNYWVDDQK 98
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KT+N+ITELFTSG+LRQYR+KH VD+K IKNWARQ+L GL YLH+H PPIIHRDLKCDN
Sbjct: 99 KTINVITELFTSGSLRQYRQKHPRVDLKAIKNWARQVLRGLDYLHTHQPPIIHRDLKCDN 158
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGNHGEVKIGDLGLA M P A+SVIGTPEFMAPELY+E Y+ELVDIYSFGMC+LE
Sbjct: 159 IFVNGNHGEVKIGDLGLATVMLTPRAKSVIGTPEFMAPELYDENYDELVDIYSFGMCMLE 218
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
M T EYPYSEC N AQIFKKV+ G+KPA+LAK+ + Q K FI+KCLVPASERLSAK+LL+
Sbjct: 219 MFTLEYPYSECTNAAQIFKKVSKGVKPAALAKITNIQAKQFIDKCLVPASERLSAKELLQ 278
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 314
DPFL +N + K P K + + + MD+D++ + + STC ++ G PH
Sbjct: 279 DPFLCSDNSS--VLVGTKFPSSLPKSVDVSLEAL-HMDVDTN-ESMCTSTCKRNDLGGPH 334
Query: 315 CPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGE 374
VLEF R +KN E +L G K DD SVSL LRIAD G RNIHFLFYLDSDTA+SVA E
Sbjct: 335 RSVLEFTRTNKNTELKLTGEKLDDNSVSLVLRIADLCGHARNIHFLFYLDSDTAMSVAAE 394
Query: 375 MVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPS 434
MVEQL+LAD DV FIA+FID LI+ L+PG + D A+ S +G + S
Sbjct: 395 MVEQLELADCDVTFIADFIDLLIVNLVPGQQLMND-----AVMSTSSESKMGESEHVITS 449
Query: 435 PWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQG-ENLHDNAGGGGISSPSLAKLEDQ 493
PSE +V G + + +P+ ++L + GG
Sbjct: 450 QQH------PSELTHDYVLVEGMMHSKEANASPSDYIDSLLNATNLGG------------ 491
Query: 494 ESQSSVASDIFVD-DTSTKNDKASEFSDYSTDRSYKDL--NGYVSELELGDLCYDECKLQ 550
SS SDI V D S+K+ S+Y D Y+ L Y +LG C+
Sbjct: 492 -PNSSEGSDISVQLDGSSKS-----LSEYGVDE-YRTLECGAYKGTDKLG------CR-- 536
Query: 551 GNYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVDELKMEIDAIEAQY 610
S + ++Q + S + + +S+T ++ D L E+ IEAQY
Sbjct: 537 HPLSNGSSNFAIFQMDQASHHSELVIGASVSIT----------ENRDVLNGELGLIEAQY 586
Query: 611 EHWFQELSKMKEEALEASRKRWMAKK 636
E WF+EL++M+EEALE +RK+W+ K
Sbjct: 587 EQWFRELTRMREEALEGARKKWLPDK 612
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 514 bits (1325), Expect = e-145, Method: Compositional matrix adjust.
Identities = 253/405 (62%), Positives = 307/405 (75%), Gaps = 21/405 (5%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKAFDE GIEVAW++V+IDDVLQ P L++LYSEV LLKSLK +N+++FY SW+DDK
Sbjct: 42 VYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKN 101
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KTVN+ITELFTSG+LR YRKKH+ V++K +KNWARQIL GL YLH PPIIHRDLKCDN
Sbjct: 102 KTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDN 161
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IF+NGNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LE
Sbjct: 162 IFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLE 221
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTF+YPY ECKN AQI+KKV+SGIKPASL++V DP++K FIEKCL+PASERLSAK+LL
Sbjct: 222 MVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLL 281
Query: 255 DPFLQVENQKEPICDPLKLP-----------IQSLKMLRLPMSGPS---SMDIDSDYKQL 300
DPFLQ+ + +PL LP + L P + PS S+D+D D
Sbjct: 282 DPFLQLNGLT--MNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDS--- 336
Query: 301 SLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFL 360
+L T S+N C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFL
Sbjct: 337 NLPIVTFSDNSGSRC--IEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFL 394
Query: 361 FYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 405
FY + DTA V+ EMVEQL+L D +V FIAE ID L++ ++P WK
Sbjct: 395 FYQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWK 439
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 249/403 (61%), Positives = 306/403 (75%), Gaps = 18/403 (4%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
+K FDE GIEVAW++V+IDD+LQ P L++LYSEV LLKSLK N+++FY SW+DDK
Sbjct: 42 VFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKN 101
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KTVN+ITELFTSG+LRQYRKKH+ V++K +K WARQIL GL YLHS +PPIIHRD+KCDN
Sbjct: 102 KTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDN 161
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IF+NGNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LE
Sbjct: 162 IFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLE 221
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTFEYPY EC+N AQI+KKV+SGIKPASL+KV DP++ FIEKCL+PASERLSA++LL
Sbjct: 222 MVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLL 281
Query: 255 DPFLQVE----NQKEPICDPLKLPIQSLKMLRLPMS-GPS-------SMDIDSDYKQLSL 302
D FL V N P+ D + +P + R MS GP SM++D D +L
Sbjct: 282 DSFLNVNGLVMNNPLPLPD-IVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDN---NL 337
Query: 303 STCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFY 362
SNN +C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLF+
Sbjct: 338 PIVISSNNSGTNC--IEVRRAKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFF 395
Query: 363 LDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 405
+ DTA +V+ EMVEQL+L D +V FIAE ID L++ L+P WK
Sbjct: 396 QEGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNWK 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 248/403 (61%), Positives = 300/403 (74%), Gaps = 7/403 (1%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKAFDE GIEVAW+ V I+DV+Q+PG L++LYSEVHLLK+LK +N++K + SWVD+K
Sbjct: 43 VYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKN 102
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KT+NMITELFTSG+LR YRKKH+ VD K IKNWARQIL GL YLHS NPP+IHRDLKCDN
Sbjct: 103 KTINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDN 162
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGN GEVKIGDLGLA +QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LE
Sbjct: 163 IFVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLE 222
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVT EYPY+EC+N AQI+KKVTS IKP SL KV+DPQ++ FIEKCL+PAS R +A +L K
Sbjct: 223 MVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSK 282
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 314
DPFL + K+ L S K +R P MD+D + + SN P
Sbjct: 283 DPFLARDGGKDSAL--LASSSTSSKYVRPPQLEHLPMDVDHNENK-----SVSSNEDYPW 335
Query: 315 CPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGE 374
+E QR+ +N EFRLRG ++DD + S+ LRIAD SG+ R +HF FYL+SDTA ++A E
Sbjct: 336 SQTIELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEE 395
Query: 375 MVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALS 417
MVE+L L +V IA+ ID IM+LL S+ +S L+
Sbjct: 396 MVEELHLTSQEVVVIADMIDDFIMQLLSDRTSSHHNQNSPRLT 438
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1193), Expect = e-129, Method: Compositional matrix adjust.
Identities = 243/389 (62%), Positives = 288/389 (74%), Gaps = 7/389 (1%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKAFDE GIEVAW+ + I+DVLQ+PG L +LYSEVHLL SLK DN++K + SWVDD
Sbjct: 30 VYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVDDHN 89
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
K++NMITELFTSG+L YRKKH+ VD K I NWARQIL GL YLHS PP+IHRDLKCDN
Sbjct: 90 KSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDN 149
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGN G+VKIGDLGLA MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LE
Sbjct: 150 IFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLE 209
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVT EYPY EC+N AQI+KKVTSGIKP SL+KV+DPQ+K FIEKCL+PA R +A +LLK
Sbjct: 210 MVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLK 269
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 314
D L V+ K+ + K P MD++ K S+S C+ S S
Sbjct: 270 DQLLAVDGAKDSTLTASS--NTTFKPAMPPQCEYRPMDVEYK-KNTSVSICS-SAKSSQE 325
Query: 315 CPVL---EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSV 371
C +L E QR+ ++ EF+L G + DD + S+ LRIA SSG+ R + F F L +DTA +V
Sbjct: 326 CALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLKTDTARAV 385
Query: 372 AGEMVEQLDLADHDVAFIAEFIDYLIMKL 400
GEMVE+LDL+ H+V IAE ID LIMKL
Sbjct: 386 TGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-126, Method: Compositional matrix adjust.
Identities = 225/413 (54%), Positives = 285/413 (69%), Gaps = 30/413 (7%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y+AFDE+ G+EVAW++VK+ D LQ P DL++LY E+HLLK+LK N++KFY SWVD +
Sbjct: 41 VYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSR 100
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ +N ITE+FTSG LRQYR+KH V+I +K+W RQIL GL+YLHSH+PPIIHRDLKCDN
Sbjct: 101 RNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDN 160
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGN GEVKIGDLGLA +++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LE
Sbjct: 161 IFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLE 220
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTFEYPYSEC +P QI+KKV SG KP +L KV DP ++ F+EKCL AS RLSA++LLK
Sbjct: 221 MVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLK 280
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLP-----------MSGPSSMDIDSDYKQLSLS 303
DPFLQV++ + P + LR P MS S ID D
Sbjct: 281 DPFLQVDDL---VFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRW 337
Query: 304 TCTESN---------NGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRV 354
C + + NG P+ N + ++G K++D S+ L LRIAD+ G V
Sbjct: 338 DCEDDDIKADGIDLFNGHEDEPL-------GNVDITIKGRKSEDGSIFLRLRIADNDGHV 390
Query: 355 RNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPS 407
RNI+F F +++DTALSVA EMV +LD+ DH+V IAE ID + L+P W+P
Sbjct: 391 RNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPG 443
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-126, Method: Compositional matrix adjust.
Identities = 225/412 (54%), Positives = 285/412 (69%), Gaps = 30/412 (7%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y+AFDE+ G+EVAW++VK+ D LQ P DL++LY E+HLLK+LK N++KFY SWVD +
Sbjct: 41 VYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSR 100
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ +N ITE+FTSG LRQYR+KH V+I +K+W RQIL GL+YLHSH+PPIIHRDLKCDN
Sbjct: 101 RNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDN 160
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGN GEVKIGDLGLA +++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LE
Sbjct: 161 IFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLE 220
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTFEYPYSEC +P QI+KKV SG KP +L KV DP ++ F+EKCL AS RLSA++LLK
Sbjct: 221 MVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLK 280
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLP-----------MSGPSSMDIDSDYKQLSLS 303
DPFLQV++ + P + LR P MS S ID D
Sbjct: 281 DPFLQVDDL---VFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRW 337
Query: 304 TCTESN---------NGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRV 354
C + + NG P+ N + ++G K++D S+ L LRIAD+ G V
Sbjct: 338 DCEDDDIKADGIDLFNGHEDEPL-------GNVDITIKGRKSEDGSIFLRLRIADNDGHV 390
Query: 355 RNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKP 406
RNI+F F +++DTALSVA EMV +LD+ DH+V IAE ID + L+P W+P
Sbjct: 391 RNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRP 442
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1126), Expect = e-122, Method: Compositional matrix adjust.
Identities = 224/436 (51%), Positives = 288/436 (66%), Gaps = 41/436 (9%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y+AFDE+ GIEVAW++VK+ D LQ P DL++LY E+HLLK+LK N++KFY SWVD
Sbjct: 38 VYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTAN 97
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ +N +TELFTSG LRQYR +HK V+I+ +K+W RQIL GL YLHSH+PP+IHRDLKCDN
Sbjct: 98 RNINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDN 157
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGN GEVKIGDLGLA +++ A +GTPEFMAPE+YEE YNELVDIYSFGMCILE
Sbjct: 158 IFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILE 217
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTF+YPYSEC +PAQI+KKV SG KP +L KV DP++K FIEKCL S R+SA++LL
Sbjct: 218 MVTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLD 277
Query: 255 DPFLQVEN-------------------QKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDS 295
DPFL++++ Q + D P S + R +G + S
Sbjct: 278 DPFLRIDDGEFDLRSVDMEDSVGPLYRQPHHLPDYYNYPSNSSSLNRQYSNGNYPSNSSS 337
Query: 296 DYKQLS--LSTCTESNNGSPHCPVLEFQRMH-------KNN------------EFRLRGT 334
+Q S ++ E NG + P E + H +NN + ++G
Sbjct: 338 LNRQYSNGYNSHHEYQNGWAYNPA-ETEETHGIELFESRNNDDQEEEKKSGNVDITIKGK 396
Query: 335 KNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFID 394
+ DD + L LRIAD GRVRNI+F F +++DTALSVA EMV +LD+ DH V IA ID
Sbjct: 397 RRDDGGLFLRLRIADKEGRVRNIYFPFDIETDTALSVATEMVAELDMDDHGVTKIANMID 456
Query: 395 YLIMKLLPGWKPSYDY 410
I L+P W+P ++
Sbjct: 457 GEISSLVPSWRPGPEF 472
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1117), Expect = e-121, Method: Compositional matrix adjust.
Identities = 212/396 (53%), Positives = 274/396 (69%), Gaps = 38/396 (9%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ Y+AFD+ GIEVAW++VK+DD DL +LYSEVHLLK+LK +++KFY SW+D +
Sbjct: 35 EVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQ 94
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
T+N+ITE+FTSGNLRQYRKKHK VD++ +K W+RQIL GLVYLHSH+PP+IHRDLKCD
Sbjct: 95 HMTINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCD 154
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCI 192
NIF+NGN GEVKIGDLGLA + + +A SVIGTPEFMAPELYEE+YN LVDIY+FGMC+
Sbjct: 155 NIFINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCL 214
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDL 252
LE+VTFEYPYSEC N AQI++KVTSGIKPA+L V DPQ++ FIEKC+ S+RLSAK+L
Sbjct: 215 LELVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKEL 274
Query: 253 LKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGS 312
L DPFL+ YK+ + + + NG
Sbjct: 275 LDDPFLKC------------------------------------YKENTENVSSHKENGY 298
Query: 313 PHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVA 372
+++ + + G + D ++ L LRI DS G++RNIHF F +++DT+ SVA
Sbjct: 299 NGNGIVDKLSDSEVGLLTVEGQRKDLNTIFLKLRITDSKGQIRNIHFPFNIETDTSFSVA 358
Query: 373 GEMVEQLDLA-DHDVAFIAEFIDYLIMKLLPGWKPS 407
EMVE+LDL D D++ IA+ ID I +P W PS
Sbjct: 359 IEMVEELDLTDDQDISTIAKMIDTEIHSHIPDWTPS 394
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1099), Expect = e-119, Method: Compositional matrix adjust.
Identities = 214/399 (53%), Positives = 278/399 (69%), Gaps = 18/399 (4%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKAFD+ G+EVAW+++K+ D+L+ DL++L SEV LLK+LK N++KFY SW+D K
Sbjct: 43 YKAFDQLEGLEVAWNQIKVGDILRNNDDLERLRSEVRLLKTLKHKNIIKFYNSWLDKKNN 102
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+N ITE+FTSG LRQYR KHK VD++ +K W+RQIL GLVYLHSH+PP+IHRDLKCDNI
Sbjct: 103 NINFITEVFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNI 162
Query: 136 FVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
FVNGN GEVKIGDLGLA + +A S+IGTPEFMAPELY+EEYNELVDIY+FGMC+LE
Sbjct: 163 FVNGNQGEVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLE 222
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
+VTFEYPY EC N AQI+KKV+ G KP+SLAK+ DP+++ FIEKC+ AS+RLSA++LL
Sbjct: 223 LVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLM 282
Query: 255 DPFLQVENQKEPICDPLKLPIQS-LKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSP 313
DPFL+ + +K + P+QS K S SSM D S++ + + +
Sbjct: 283 DPFLRDDGEK------IFYPLQSNTKASDGAGSSNSSMGYKYDRDASSMAIREHTGSFAE 336
Query: 314 HCPVLEFQRMHKNNE--------FRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDS 365
P + +H + + D ++ L LRIADS+G +NIHF F +++
Sbjct: 337 EHPSDRY--IHSTMDPQAAAGRIITVESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEA 394
Query: 366 DTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGW 404
DT++SVA EMV QLDL D DV IAE ID I +P W
Sbjct: 395 DTSISVATEMVVQLDLTDQDVTAIAEMIDAEIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 641 | ||||||
| 255564615 | 693 | kinase, putative [Ricinus communis] gi|2 | 0.970 | 0.897 | 0.652 | 0.0 | |
| 351721887 | 710 | with no lysine kinase 6 [Glycine max] gi | 0.957 | 0.864 | 0.622 | 0.0 | |
| 356560001 | 723 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.957 | 0.849 | 0.621 | 0.0 | |
| 449433018 | 663 | PREDICTED: probable serine/threonine-pro | 0.968 | 0.936 | 0.654 | 0.0 | |
| 225470964 | 625 | PREDICTED: probable serine/threonine-pro | 0.907 | 0.931 | 0.628 | 0.0 | |
| 449478217 | 713 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.943 | 0.848 | 0.643 | 0.0 | |
| 297745505 | 591 | unnamed protein product [Vitis vinifera] | 0.786 | 0.852 | 0.577 | 0.0 | |
| 356571256 | 581 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.887 | 0.979 | 0.549 | 1e-180 | |
| 359474135 | 645 | PREDICTED: serine/threonine-protein kina | 0.921 | 0.916 | 0.551 | 1e-172 | |
| 224127975 | 425 | predicted protein [Populus trichocarpa] | 0.609 | 0.92 | 0.772 | 1e-170 |
| >gi|255564615|ref|XP_002523302.1| kinase, putative [Ricinus communis] gi|223537390|gb|EEF39018.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/636 (65%), Positives = 489/636 (76%), Gaps = 14/636 (2%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YK FDE GIEVAW++V+I DVL+ P DL+KL+SEVHLL+SLK +N+++ SWVDDKKK
Sbjct: 56 YKGFDEVDGIEVAWNQVRIADVLRSPKDLEKLHSEVHLLRSLKHENIMELCNSWVDDKKK 115
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
T+NMITELFTSGNLRQYRKKHKNVD+K IKNWARQIL GLVYLH HNPPIIHRDLKCDNI
Sbjct: 116 TINMITELFTSGNLRQYRKKHKNVDMKAIKNWARQILQGLVYLHGHNPPIIHRDLKCDNI 175
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 195
FVNG++G VKIGDLGLAI MQQPTA SVIGTPEFMA ELYEEEYNEL+DIYSFGMC+LEM
Sbjct: 176 FVNGHNGVVKIGDLGLAIIMQQPTATSVIGTPEFMATELYEEEYNELIDIYSFGMCMLEM 235
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 255
VTFEYPYSEC+NPAQI+KKVTSGIKPASL V+DPQ+K FI KCLVPASERLSAK+LLKD
Sbjct: 236 VTFEYPYSECRNPAQIYKKVTSGIKPASLGNVSDPQVKEFILKCLVPASERLSAKELLKD 295
Query: 256 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 315
PFLQ +N EP+ DPL LP Q K SGP SMDID+DYKQ+S STCT SNN
Sbjct: 296 PFLQPQNLVEPVRDPLLLPNQYPKSSSATKSGPLSMDIDADYKQISSSTCTGSNNEGTRF 355
Query: 316 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 375
PV E+QR HKN F+L+G ++DD SVSLTLRIADSSGRV NIHFLFYLDSDTALSVA EM
Sbjct: 356 PVPEYQREHKNKVFKLKGKESDDNSVSLTLRIADSSGRVWNIHFLFYLDSDTALSVASEM 415
Query: 376 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 435
V+QL+LADHDVAFIAEFID+LIMKL PGWK S +YS + SFY+ S L N S P
Sbjct: 416 VDQLELADHDVAFIAEFIDHLIMKLSPGWKLSSNYSLNELTSFYTASAALEN---SVACP 472
Query: 436 WDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAKL 490
WD++ V S+ V+Q+ +SG T P + A N +DN G SSPS +
Sbjct: 473 WDSVLTTVLSQPAVEQEALSGMTTTPPEGSLQADDFNYNDNRDGAVFHINYHSSPSFGYM 532
Query: 491 EDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQ 550
EDQ+SQ+S S+I V+D S+K+D+ SE DY+TD + K LNGY SE EL D Y KL+
Sbjct: 533 EDQDSQTSGVSEILVEDVSSKDDRISELPDYNTDGNCKYLNGYTSEPELRD-SYSLRKLE 591
Query: 551 GNYSEDGEDILLYQFVKNSKLTFPNLSTV----LSLTSSYSSLSLTGKDVD-ELKMEIDA 605
N S GE I + + K S+ FP LS +SS SSL L GK +D ELK+E+DA
Sbjct: 592 RNDSGVGECIPMNENAKVSETPFPKLSGAPNDMSMTSSSSSSLYLVGKSMDTELKLELDA 651
Query: 606 IEAQYEHWFQELSKMKEEALEASRKRWMAKKRLPVN 641
IEAQY++WF++LS+ +EEALE+++KRW AKK+LPV+
Sbjct: 652 IEAQYQNWFRDLSRRREEALESTKKRWTAKKKLPVH 687
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721887|ref|NP_001235945.1| with no lysine kinase 6 [Glycine max] gi|225348641|gb|ACN87282.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/628 (62%), Positives = 468/628 (74%), Gaps = 14/628 (2%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y+ FDE GIEVAW++VKID ++ DL KLYSEV+LLKSLK +N++KFY SW+DDKKK
Sbjct: 89 YRGFDEVDGIEVAWNQVKIDGLMHSVDDLAKLYSEVNLLKSLKHENIIKFYDSWIDDKKK 148
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
TVNMITELFTSGNLRQYRKKHK V++K IK WARQILHGLVYLHSH PPIIHRDLKCDNI
Sbjct: 149 TVNMITELFTSGNLRQYRKKHKYVEMKAIKGWARQILHGLVYLHSHKPPIIHRDLKCDNI 208
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 195
FVNGN GEVKIGDLGLAI MQQPTA+SVIGTPEFMAPELYEE Y ELVDIYSFGMCILEM
Sbjct: 209 FVNGNQGEVKIGDLGLAIVMQQPTAQSVIGTPEFMAPELYEEAYTELVDIYSFGMCILEM 268
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 255
VT EYPYSEC+NPAQIFKKVTSGIKPASL KV+DPQ+K FIEKCLVPASERLSA +LLKD
Sbjct: 269 VTLEYPYSECQNPAQIFKKVTSGIKPASLNKVSDPQLKDFIEKCLVPASERLSADELLKD 328
Query: 256 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 315
PFLQVEN K+PI PL+ P ++L+ SG SMD+DSDYK S+S +ESN +PHC
Sbjct: 329 PFLQVENPKDPILYPLQPPSRTLRAYSFK-SGSLSMDMDSDYKPFSMSIYSESNQENPHC 387
Query: 316 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 375
P+ E QR +KNN+FRL+GTKND SVSLTLRIAD+ GRVRNIHFLFY D+DTA+SVA EM
Sbjct: 388 PIFEVQRTYKNNKFRLKGTKNDVNSVSLTLRIADTCGRVRNIHFLFYPDTDTAVSVATEM 447
Query: 376 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 435
VE L+LADHDV FIAE IDYLIMKLLP WKPS D+ S G LS Y + +G+T P
Sbjct: 448 VEHLELADHDVDFIAELIDYLIMKLLPWWKPSPDHCSCGELSPYCTNI---DGQTLMAWP 504
Query: 436 WDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGG----GGISSPSLAKLE 491
W ++ +PSE V+ QD SG P +D ++ ++ A G +S SL KLE
Sbjct: 505 WGSVSTSIPSELVIGQDGFSGSDTTPKEDFVVSENSSVSKIANNATFEGDCNSSSLVKLE 564
Query: 492 DQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQG 551
D+ SQ S AS++ +++TS KND + +D S EL D+ +++CKLQ
Sbjct: 565 DRYSQGSRASEMIIENTSMKNDNCHDSND-----DLSSKCFSSSMSELRDVYFEDCKLQQ 619
Query: 552 NYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDAIEAQY 610
GE +++ +F KNS V +L SS S +S T +D+D LK ++D IEA Y
Sbjct: 620 TEYCVGEGVVINEFPKNSGSVLGTSINVENLASSCSYVSSTEEDIDLGLKFKLDEIEAHY 679
Query: 611 EHWFQELSKMKEEALEASRKRWMAKKRL 638
+HW EL++M EALE++R+RWMAKK+L
Sbjct: 680 QHWIDELNEMMLEALESTRRRWMAKKKL 707
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560001|ref|XP_003548284.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/631 (62%), Positives = 471/631 (74%), Gaps = 17/631 (2%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y+ FDE GIEVAW++VKID ++ DL KLYSEV+LLKSLK +N++KFY SW+DDK+K
Sbjct: 103 YRGFDEVDGIEVAWNQVKIDGLMHSVDDLAKLYSEVNLLKSLKHENIIKFYDSWIDDKQK 162
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
TVNMITELFTSGNLR YRKKHK V++K IK WARQILHGLVYLHSH PPIIHRDLKCDNI
Sbjct: 163 TVNMITELFTSGNLRLYRKKHKYVEMKAIKGWARQILHGLVYLHSHRPPIIHRDLKCDNI 222
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 195
FVNGN GEVKIGDLGLA+ MQQPTA+SVIGTPEFMAPELYEE Y ELVDIYSFGMCILEM
Sbjct: 223 FVNGNQGEVKIGDLGLAVVMQQPTAQSVIGTPEFMAPELYEEAYTELVDIYSFGMCILEM 282
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 255
VT EYPYSECKNPAQIFKKVTSGIKPASL KV+DPQ+K FIEKCLVPASERLSA++LLKD
Sbjct: 283 VTLEYPYSECKNPAQIFKKVTSGIKPASLNKVSDPQLKEFIEKCLVPASERLSAEELLKD 342
Query: 256 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 315
PFLQVEN K+PI PL+ P ++L+ SG SMD+DSD K S+S C+ESN +PHC
Sbjct: 343 PFLQVENPKDPILYPLQPPSRTLRAYSFK-SGSLSMDMDSDCKPFSMSICSESNQENPHC 401
Query: 316 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 375
PV E QR + +EFRL+GTKNDD SVSLTLRIAD+ GRVRNIHFLFYLD+DTA+SVA EM
Sbjct: 402 PVFEVQRTNNKHEFRLKGTKNDDNSVSLTLRIADTCGRVRNIHFLFYLDTDTAVSVATEM 461
Query: 376 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 435
VE L+LADHDV FIAE IDYLIMKLLP WKPS D+ S G LS YS + I G P
Sbjct: 462 VEHLELADHDVDFIAELIDYLIMKLLPWWKPSPDHFSCGELSPYSTN-IDGQW------P 514
Query: 436 WDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGG----GGISSPSLAKLE 491
W ++ +PSE + QD SG P +D ++ ++ N G +S SL KLE
Sbjct: 515 WGSVLTSIPSELAIDQDGFSGSDTTPKEDFVASEKSSVSKNDSNATFEGDCNSSSLVKLE 574
Query: 492 DQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQG 551
D+ SQ S AS++ V++TS KND D + D S + L+ +SELE+G +++CKLQ
Sbjct: 575 DRYSQGSRASEMIVENTSMKNDNC---HDSNADVSSESLSNSMSELEIGGAYFEDCKLQP 631
Query: 552 NYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVD--ELKMEIDAIEAQ 609
GE +++ +F KNS V + T+S S +S T +D+ EL+ ++D IEA
Sbjct: 632 AEYCSGEGVVINEFPKNSGSVLGTSINVENPTNSCSYVSSTEEDIIDLELQFKLDEIEAH 691
Query: 610 YEHWFQELSKMKEEALEASRKRWMAKKRLPV 640
Y+HW EL KM EAL+++R+ W+AKK+L V
Sbjct: 692 YQHWIDELKKMMLEALDSTRRSWVAKKKLAV 722
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433018|ref|XP_004134295.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/634 (65%), Positives = 480/634 (75%), Gaps = 13/634 (2%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKAFDE GIEVAW++V+ID LQ P DL+KLYSEVHLLKSLK +N++KFY SWVDDKK
Sbjct: 31 VYKAFDEVDGIEVAWNQVRIDGFLQSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKK 90
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KTVNMITELFTSG+LRQYRKKHK+VD+K IKNWARQIL GLVYLHSH+PPIIHRDLK DN
Sbjct: 91 KTVNMITELFTSGSLRQYRKKHKHVDMKAIKNWARQILRGLVYLHSHDPPIIHRDLKGDN 150
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IF+NGNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVD+YSFGMC+LE
Sbjct: 151 IFINGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDVYSFGMCMLE 210
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTFEYPYSECKNPAQIF+KVTSGIKPASLAKV+DP+ FI KCLVP ERLSAK+LLK
Sbjct: 211 MVTFEYPYSECKNPAQIFRKVTSGIKPASLAKVSDPRTMEFINKCLVPVHERLSAKELLK 270
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 314
D FLQVEN KE +PL+L Q K + LP SGP SMDID D K SLST ESN+GSP
Sbjct: 271 DSFLQVENPKESARNPLQLSNQVSKSINLPKSGPISMDIDIDQKIHSLSTYAESNSGSPR 330
Query: 315 CPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGE 374
PV+EFQ M+KNNEFRLRG KNDD SV+LTLRIADS+GRVRNIHF FYLDSDTALSVA E
Sbjct: 331 FPVVEFQTMNKNNEFRLRGNKNDDNSVALTLRIADSNGRVRNIHFTFYLDSDTALSVAAE 390
Query: 375 MVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPS 434
M EQL+L +HDV FIAEFID+LI KL+P WKP YSS+G LS +S P L + K+S S
Sbjct: 391 MAEQLELINHDVDFIAEFIDFLITKLIPEWKPLSVYSSNGELSLFSAPPFLKSAKSSIGS 450
Query: 435 PWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAK 489
W ++ G + +V QD+ SG +D ++ + + G I SSPSLA
Sbjct: 451 AWGSILTG-SHDGLVAQDISSGLGCGTQKDCLQSEEDGWTTDISAGHIFDTCPSSPSLAN 509
Query: 490 LEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCY-DECK 548
ED S +S A ++ VDD STK+ K + S+ D S K + ++ELE Y E K
Sbjct: 510 FEDLNSHASFALELLVDDCSTKSAKVFDCSN--IDGSSKGSSWSIAELEHHGSSYVVEDK 567
Query: 549 LQGNYSEDGEDILLYQFVKNSKLTFP---NLSTVLSLTSSYSSLSLTGKDVD-ELKMEID 604
Q N + G + F KNS ++ P S V+SLTSS SSLSLT KD+D ELKMEID
Sbjct: 568 FQRNVGDVGIFTPMDYFAKNSVVSMPAPSEASNVMSLTSSCSSLSLTDKDLDAELKMEID 627
Query: 605 AIEAQYEHWFQELSKMKEEALEASRKRWMAKKRL 638
AIE Y F ELS+M+EEALEA+R+RW+AKK+L
Sbjct: 628 AIETHYRQLFDELSRMREEALEATRRRWIAKKKL 661
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/633 (62%), Positives = 464/633 (73%), Gaps = 51/633 (8%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKAFDE GIE+AW++VKIDDVL+ P DL+KLYSEVHLLKSLK +N++KFY SWVDDKK
Sbjct: 36 VYKAFDEVDGIEIAWNQVKIDDVLRSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKK 95
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KTVNMITELFTSG+LRQYRKKHKNVD+K IKNWARQ+L GLVYLHSHNPPIIHRDLKCDN
Sbjct: 96 KTVNMITELFTSGSLRQYRKKHKNVDMKAIKNWARQVLRGLVYLHSHNPPIIHRDLKCDN 155
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LE
Sbjct: 156 IFVNGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLE 215
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTFEYPY+ECKNPAQI+KKVTSGIKPASL KV D QIK FI KCL PASERL AK+LLK
Sbjct: 216 MVTFEYPYNECKNPAQIYKKVTSGIKPASLCKVTDLQIKEFIVKCLAPASERLPAKELLK 275
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 314
DPF Q EN KEPI PL+LP +S K + L SGP SMDID D+ QLS ST TE NNGSP
Sbjct: 276 DPFFQSENPKEPIRVPLQLPSRSPKSIILSKSGPFSMDIDPDHPQLSSSTSTE-NNGSPD 334
Query: 315 CPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGE 374
PVLEFQRM+K++EFRLR K +D S+SLTLR DS G V+NIHF F LD+DT SV GE
Sbjct: 335 FPVLEFQRMYKSSEFRLRAKKINDNSISLTLRTVDSYGPVKNIHFPFSLDTDTVHSVVGE 394
Query: 375 MVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPS 434
MVEQL+LA+H+VAFIA+FIDY+IM+LLPGWKP D GA S + P+LGNG
Sbjct: 395 MVEQLELAEHEVAFIADFIDYVIMRLLPGWKPPRDDPLGGARSPNAEPPVLGNG------ 448
Query: 435 PWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDN--AGGGGISSPSLAKLED 492
N HD + G G SSP+LA ED
Sbjct: 449 -------------------------------------NNHDCTISHGDGNSSPNLANAED 471
Query: 493 QESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLN-GYVSELELGDLCYDECKLQG 551
Q+S +S D S KNDK F DY+ +YK N G+ SE E D +++ KLQ
Sbjct: 472 QDSLASAGLVTLTVDASKKNDKTVGFGDYNIGGNYKGSNGGHASEQESRDPYHEDYKLQR 531
Query: 552 NYSEDGEDILLYQFVKNSKLTFPNLSTVLSL-TSSYSSLSLTGKDVDE---LKMEIDAIE 607
N S E + +F K++ L+F +LS + ++ + + S SL+ D+D+ LK E+DAI+
Sbjct: 532 NNSSIEEFTPMNKFQKSTVLSFDDLSGLSNVRSLTCSCSSLSLADIDQDPGLKQELDAID 591
Query: 608 AQYEHWFQELSKMKEEALEASRKRWMAKKRLPV 640
QY+HWFQELS+M+ EALEA++KRWM KK+L V
Sbjct: 592 LQYQHWFQELSRMRVEALEATKKRWMTKKKLAV 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449478217|ref|XP_004155253.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1852), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/634 (64%), Positives = 470/634 (74%), Gaps = 29/634 (4%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKAFDE GIEVAW++V+ID LQ P DL+KLYSEVHLLKSLK +N++KFY SWVDDKK
Sbjct: 97 VYKAFDEVDGIEVAWNQVRIDGFLQSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKK 156
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KTVNMITELFTSG+LRQYRKKHK+VD+K IKNWARQIL GLVYLHSH+PPIIHRDLK DN
Sbjct: 157 KTVNMITELFTSGSLRQYRKKHKHVDMKAIKNWARQILRGLVYLHSHDPPIIHRDLKGDN 216
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IF+NGNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVD+YSFGMC+LE
Sbjct: 217 IFINGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDVYSFGMCMLE 276
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTFEYPYSECKNPAQIF+KVTSGIKPASLAKV+DP+ FI KCLVP ERLSAK+LLK
Sbjct: 277 MVTFEYPYSECKNPAQIFRKVTSGIKPASLAKVSDPRTMEFINKCLVPVHERLSAKELLK 336
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 314
D FLQVEN KE +PL+L Q K + LP SGP SMDID D K SLST ESN+GSP
Sbjct: 337 DSFLQVENPKESARNPLQLSNQVSKSINLPKSGPISMDIDIDQKIHSLSTYAESNSGSPR 396
Query: 315 CPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGE 374
PV+EFQ M+KNNEFRLRG KNDD SV+LTLRIADS+GRVRNIHF YLDSDTALSVA E
Sbjct: 397 FPVVEFQTMNKNNEFRLRGNKNDDNSVALTLRIADSNGRVRNIHFTXYLDSDTALSVAAE 456
Query: 375 MVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPS 434
M EQL+L +HDV FIAEFID+LI KL+P WKP YSS+G L S
Sbjct: 457 MAEQLELINHDVDFIAEFIDFLITKLIPEWKPLSVYSSNGELR----------------S 500
Query: 435 PWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAK 489
W ++ G + +V QD+ SG +D ++ + + G I SSPSLA
Sbjct: 501 AWGSILTG-SHDGLVAQDISSGLGCGTQKDCLQSEEDGWTTDISAGHIFDTCPSSPSLAN 559
Query: 490 LEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCY-DECK 548
ED S +S A ++ VDD STK+ K + S+ D S K + ++ELE Y E K
Sbjct: 560 FEDLNSHASFALELLVDDCSTKSAKVFDCSN--IDGSSKGSSWSIAELEHHGSSYVVEDK 617
Query: 549 LQGNYSEDGEDILLYQFVKNSKLTFP---NLSTVLSLTSSYSSLSLTGKDVD-ELKMEID 604
Q N + G + F KNS ++ P S V+SLTSS SSLSLT KD+D ELKMEID
Sbjct: 618 FQRNVGDVGIFTPMDYFAKNSVVSMPAPSEASNVMSLTSSCSSLSLTDKDLDAELKMEID 677
Query: 605 AIEAQYEHWFQELSKMKEEALEASRKRWMAKKRL 638
AIE Y F ELS+M+EEALEA+R+RW+AKK+L
Sbjct: 678 AIETHYRQLFDELSRMREEALEATRRRWIAKKKL 711
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745505|emb|CBI40585.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1660), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/627 (57%), Positives = 413/627 (65%), Gaps = 123/627 (19%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKAFDE GIE+AW++VKIDDVL+ P DL+KLYSEVHLLKSLK +N++KFY SWVDDKK
Sbjct: 44 VYKAFDEVDGIEIAWNQVKIDDVLRSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKK 103
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KTVNMITELFTSG+LRQYRKKHKNVD+K IKNWARQ+L GLVYLHSHNPPIIHRDLKCDN
Sbjct: 104 KTVNMITELFTSGSLRQYRKKHKNVDMKAIKNWARQVLRGLVYLHSHNPPIIHRDLKCDN 163
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LE
Sbjct: 164 IFVNGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLE 223
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTFEYPY+ECKNPAQI+KKVTSGIKPASL KV D QIK FI KCL PASERL AK+LLK
Sbjct: 224 MVTFEYPYNECKNPAQIYKKVTSGIKPASLCKVTDLQIKEFIVKCLAPASERLPAKELLK 283
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 314
DPF Q EN KEPI R+P+ P
Sbjct: 284 DPFFQSENPKEPI--------------RVPL--------------------------HPD 303
Query: 315 CPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGE 374
PVLEFQRM+K++EFRLR K +D S+SLTLR DS G V+NIHF F LD+DT SV GE
Sbjct: 304 FPVLEFQRMYKSSEFRLRAKKINDNSISLTLRTVDSYGPVKNIHFPFSLDTDTVHSVVGE 363
Query: 375 MVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPS 434
MVEQL+LA+H+VAFIA+FIDY+IM+LLPGWKP D GA S + P+LGNG
Sbjct: 364 MVEQLELAEHEVAFIADFIDYVIMRLLPGWKPPRDDPLGGARSPNAEPPVLGNG------ 417
Query: 435 PWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDN--AGGGGISSPSLAKLED 492
N HD + G G SSP+LA ED
Sbjct: 418 -------------------------------------NNHDCTISHGDGNSSPNLANAED 440
Query: 493 QESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLN-GYVSELELGDLCYDECKLQG 551
Q+S +S D S KNDK F DY+ +YK N G+ SE E D +++ KLQ
Sbjct: 441 QDSLASAGLVTLTVDASKKNDKTVGFGDYNIGGNYKGSNGGHASEQESRDPYHEDYKLQR 500
Query: 552 NYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVDELKMEIDAIEAQYE 611
N S +D P LK E+DAI+ QY+
Sbjct: 501 NNSNIDQD--------------PG-----------------------LKQELDAIDLQYQ 523
Query: 612 HWFQELSKMKEEALEASRKRWMAKKRL 638
HWFQELS+M+ EALEA++KRWM KK+L
Sbjct: 524 HWFQELSRMRVEALEATKKRWMTKKKL 550
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356571256|ref|XP_003553795.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like, partial [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1646), Expect = e-180, Method: Compositional matrix adjust.
Identities = 347/631 (54%), Positives = 431/631 (68%), Gaps = 62/631 (9%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
+YK FDE VAW++V+ID++ Q DL KLYSEV+LLKSLK +N++KF+ SW+D KK
Sbjct: 3 SYKGFDE-----VAWNQVRIDELQQSVDDLAKLYSEVNLLKSLKHENIIKFFNSWIDGKK 57
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KT+N+I EL T GNLRQY K+H+ VD+K IK+WA+QIL GLVYLHSHNPPIIH+DLKCDN
Sbjct: 58 KTINIIIELCTLGNLRQYCKRHRYVDMKAIKDWAKQILQGLVYLHSHNPPIIHKDLKCDN 117
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGNHGEVKIGDLGLAI MQQPTA SVIGT EFMAP+LYEEEYNELVD+YSFGMC+LE
Sbjct: 118 IFVNGNHGEVKIGDLGLAIFMQQPTAXSVIGTLEFMAPKLYEEEYNELVDVYSFGMCLLE 177
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
MVTF+YPYSEC NPAQI+KKVTSGI+PASL KVNDPQIK FI+KCLV S+RLS K+LLK
Sbjct: 178 MVTFQYPYSECNNPAQIYKKVTSGIEPASLEKVNDPQIKEFIKKCLVSTSKRLSTKELLK 237
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCT-ESNNGSP 313
DPFLQVE+ K+ I D L L +SLK++ L MS SMD+D DY+ +SLSTC ESN +P
Sbjct: 238 DPFLQVESPKQSILDHLHLSNKSLKVINLSMSDKLSMDLDVDYQFISLSTCVDESNQENP 297
Query: 314 HCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAG 373
HC +L+ QR +KNN FRL+GTKN D SVS LRIA + NIHFLFYL++D A+SVA
Sbjct: 298 HCSILKVQRTYKNNXFRLKGTKNGDKSVSFILRIAK---FMWNIHFLFYLETDIAISVAS 354
Query: 374 EMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTP 433
EM E L+L ++DVAFI E IDYLIM+L+ GWKPS+DYSS+G LS SP L + +TS
Sbjct: 355 EMAENLELENNDVAFIVELIDYLIMELVLGWKPSFDYSSNGGLSQCDGSPTLIDNQTSIS 414
Query: 434 SPWDAMGAGVPSEFVVKQD--VVSGPTRNPSQDLAP-AQGENLHDNAGGGGIS-SPSLAK 489
PW A VPSE V+ QD T+ S P + N+ D G+S S S K
Sbjct: 415 FPWVRALASVPSELVLDQDNCFRFNTTKKESLTTTPKSYIFNVVDKDTLEGLSCSTSEIK 474
Query: 490 LEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSE-LELGDLCYDECK 548
L D F Y + N VS+ +E+ +L +
Sbjct: 475 LGDM-----------------------HFEGYKLHTT----NCNVSKSIEINELSKNSHH 507
Query: 549 LQGNYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDAIE 607
+ + E + I S T++ SSLSLT K++D ELK ++ IE
Sbjct: 508 MTSTFCETPDHI--------------------SFTNNCSSLSLTHKNIDFELKFNVEEIE 547
Query: 608 AQYEHWFQELSKMKEEALEASRKRWMAKKRL 638
+QY+H QEL +M+ +ALEA K+W+AKK++
Sbjct: 548 SQYQHLSQELLRMRSKALEAVEKKWIAKKKM 578
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1576), Expect = e-172, Method: Compositional matrix adjust.
Identities = 351/636 (55%), Positives = 436/636 (68%), Gaps = 45/636 (7%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKAFDE GIEVAW +V+I+D+LQ P L++LYSEVHLLKSLK DN++KFY SWVDD
Sbjct: 37 VYKAFDEVDGIEVAWGQVEIEDLLQSPQQLERLYSEVHLLKSLKHDNIIKFYNSWVDDTN 96
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KT+N+ITELFTSG+LRQYRKKHKNVD+K IKNWA+QIL GL YLHSHNPPIIHRDLKCDN
Sbjct: 97 KTINLITELFTSGSLRQYRKKHKNVDLKAIKNWAKQILRGLHYLHSHNPPIIHRDLKCDN 156
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGN+GEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE
Sbjct: 157 IFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 216
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
+VT EYPY+ECKNPAQI+KKV+SGIKPASL KV+DPQ+K FIEKCLVPAS RLSA++LLK
Sbjct: 217 LVTCEYPYNECKNPAQIYKKVSSGIKPASLGKVSDPQVKQFIEKCLVPASLRLSAQELLK 276
Query: 255 DPFLQVENQKEPICDPLKL--PIQSL----KMLRLPMSGPSSMDIDSDYKQLSLSTCTES 308
D F EN KEP+ + + + +QS ++ LP MD+D +YK+LS+ST +S
Sbjct: 277 DAFFATENSKEPVYNHMHVDDSLQSSNFMPNLMNLPKPELQPMDMDPNYKKLSVSTHMKS 336
Query: 309 NNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTA 368
+G+PH L+F+R +KNN F+LRG K DD S+S+TL IAD GR +NIHF FYLDSDTA
Sbjct: 337 ISGTPHFRALQFERFNKNNLFKLRGEKIDDNSISMTLHIADPCGRAKNIHFAFYLDSDTA 396
Query: 369 LSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNG 428
LS+AGEMVEQLDL + DVA IAE ID +I +L+P WKP+++ GA S S +L NG
Sbjct: 397 LSIAGEMVEQLDLYNEDVAVIAELIDVMISELVPTWKPAFESMLCGANSSCEDSLVLHNG 456
Query: 429 KTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGISSPSLA 488
TS P D+ A S+ V + ++S Q + G+S+
Sbjct: 457 GTSLRHPSDSGSAKGTSD-AVTEHLISLSANGEEQSTV---------ESALSGMST---- 502
Query: 489 KLEDQESQSSVASDIFVDDTSTKNDKASEFSD---YSTDRSYKDLNGYVSELELGDLCYD 545
+D + +S A+DI +D+ E SD ++ DR D +
Sbjct: 503 --KDDATVASDANDI--KSLECPDDECYEASDRCCFNGDRQVLDHER-----------HK 547
Query: 546 ECKLQGNYSEDGEDILLYQFVKN---SKLTFPNLSTVLSLTSSYSSLSLTGKD-VDELKM 601
E + GN GE + + F K+ S + + + SS SLSL KD DELK+
Sbjct: 548 EGRYNGNI---GEPVAMNGFTKDWEISCIESCSGMSNSLSLSSICSLSLADKDPSDELKL 604
Query: 602 EIDAIEAQYEHWFQELSKMKEEALEASRKRWMAKKR 637
E+D I+ QY FQEL +M+EEA+E ++ RW+ K R
Sbjct: 605 EVDTIDTQYHQCFQELLRMREEAIEKAKNRWITKSR 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127975|ref|XP_002320210.1| predicted protein [Populus trichocarpa] gi|222860983|gb|EEE98525.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1558), Expect = e-170, Method: Compositional matrix adjust.
Identities = 303/392 (77%), Positives = 337/392 (85%), Gaps = 1/392 (0%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y+AFDE GIEVAW++V+IDDVL+ P D +KLYSEV+LL+SL+ +N++KF SWVDDK
Sbjct: 34 VYRAFDEVDGIEVAWNQVRIDDVLRSPEDFEKLYSEVYLLRSLRHENIIKFSNSWVDDKN 93
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KT+NMITELFTSGNLRQYR+KH+N+DIK IKNWARQIL GLVYLH H+PPIIHRDLKCDN
Sbjct: 94 KTINMITELFTSGNLRQYRRKHRNIDIKAIKNWARQILRGLVYLHGHSPPIIHRDLKCDN 153
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
IFVNGNHGEVKIGDLGLAI MQ PTA+SVIGTPEFMAPELYEEEYNELVDIYSFGMCILE
Sbjct: 154 IFVNGNHGEVKIGDLGLAIVMQNPTAKSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 213
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
+VT YPYSEC+N AQI+KKVTSGIKPASL V + QIK FIEKCL+PASERLSAK+LLK
Sbjct: 214 LVTCNYPYSECRNAAQIYKKVTSGIKPASLKTVGNTQIKEFIEKCLLPASERLSAKELLK 273
Query: 255 DPFLQVENQ-KEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSP 313
PFLQ+E E ICDPL +P Q L LP SGP MD+D D KQLS STCT SNNGSP
Sbjct: 274 HPFLQLEIPILEQICDPLPVPDQFPISLSLPKSGPLFMDMDIDEKQLSESTCTGSNNGSP 333
Query: 314 HCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAG 373
PVLE+QR HKNNEF L+G KNDD S SLTLRI+D GRVRNIHF+FYLDSDTA+SVA
Sbjct: 334 KSPVLEYQRAHKNNEFGLKGMKNDDNSASLTLRISDLGGRVRNIHFIFYLDSDTAISVAS 393
Query: 374 EMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 405
EMVEQL+LADHDVAFIAE ID LI+KLLPGWK
Sbjct: 394 EMVEQLELADHDVAFIAELIDSLIVKLLPGWK 425
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 641 | ||||||
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.658 | 0.749 | 0.591 | 2.4e-138 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.602 | 0.680 | 0.630 | 5.2e-136 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.599 | 0.689 | 0.619 | 7.6e-133 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.594 | 0.727 | 0.623 | 5.3e-132 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.385 | 0.352 | 0.672 | 2.6e-113 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.383 | 0.476 | 0.688 | 7e-113 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.606 | 0.790 | 0.518 | 1.8e-103 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.488 | 0.570 | 0.534 | 6.7e-100 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.379 | 0.425 | 0.643 | 4.2e-96 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.393 | 0.802 | 0.572 | 1.3e-77 |
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1261 (449.0 bits), Expect = 2.4e-138, Sum P(2) = 2.4e-138
Identities = 255/431 (59%), Positives = 312/431 (72%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKAFDE GIEVAW+ V I+DV+Q+PG L++LYSEVHLLK+LK +N++K + SWVD+K K
Sbjct: 44 YKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNK 103
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
T+NMITELFTSG+LR YRKKH+ VD K IKNWARQIL GL YLHS NPP+IHRDLKCDNI
Sbjct: 104 TINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNI 163
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 195
FVNGN GEVKIGDLGLA +QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEM
Sbjct: 164 FVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 223
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 255
VT EYPY+EC+N AQI+KKVTS IKP SL KV+DPQ++ FIEKCL+PAS R +A +L KD
Sbjct: 224 VTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKD 283
Query: 256 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 315
PFL + K+ L S K +R P MD+D + + S+S SN P
Sbjct: 284 PFLARDGGKDSAL--LASSSTSSKYVRPPQLEHLPMDVDHNENK-SVS----SNEDYPWS 336
Query: 316 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 375
+E QR+ +N EFRLRG ++DD + S+ LRIAD SG+ R +HF FYL+SDTA ++A EM
Sbjct: 337 QTIELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEM 396
Query: 376 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 435
VE+L L +V IA+ ID IM+LL S+ +S L+ N +T
Sbjct: 397 VEELHLTSQEVVVIADMIDDFIMQLLSDRTSSHHNQNSPRLTHEDHEA--ANQQTVNSKD 454
Query: 436 WDAMGAGVPSE 446
+A G + S+
Sbjct: 455 EEAAGQSMKSD 465
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 5.2e-136, Sum P(2) = 5.2e-136
Identities = 253/401 (63%), Positives = 308/401 (76%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKAFDE GIEVAW++V+IDDVLQ P L++LYSEV LLKSLK +N+++FY SW+DDK K
Sbjct: 43 YKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNK 102
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
TVN+ITELFTSG+LR YRKKH+ V++K +KNWARQIL GL YLH PPIIHRDLKCDNI
Sbjct: 103 TVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNI 162
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 195
F+NGNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 255
VTF+YPY ECKN AQI+KKV+SGIKPASL++V DP++K FIEKCL+PASERLSAK+LL D
Sbjct: 223 VTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLD 282
Query: 256 PFLQVE----NQKEPICDPLKLPIQSLKMLRLPMS-GP------SSMDIDSDYKQLSLST 304
PFLQ+ N P+ D + +P + R MS GP ++ ID D + +L
Sbjct: 283 PFLQLNGLTMNNPLPLPD-IVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLD-EDSNLPI 340
Query: 305 CTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLD 364
T S+N C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLFY +
Sbjct: 341 VTFSDNSGSRC--IEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQE 398
Query: 365 SDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 405
DTA V+ EMVEQL+L D +V FIAE ID L++ ++P WK
Sbjct: 399 GDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWK 439
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1256 (447.2 bits), Expect = 7.6e-133, Sum P(2) = 7.6e-133
Identities = 249/402 (61%), Positives = 306/402 (76%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+K FDE GIEVAW++V+IDD+LQ P L++LYSEV LLKSLK N+++FY SW+DDK K
Sbjct: 43 FKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNK 102
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
TVN+ITELFTSG+LRQYRKKH+ V++K +K WARQIL GL YLHS +PPIIHRD+KCDNI
Sbjct: 103 TVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNI 162
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 195
F+NGNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 255
VTFEYPY EC+N AQI+KKV+SGIKPASL+KV DP++ FIEKCL+PASERLSA++LL D
Sbjct: 223 VTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLD 282
Query: 256 PFLQVE----NQKEPICDPLKLPIQSLKMLRLPMS-GPS-------SMDIDSDYKQLSLS 303
FL V N P+ D + +P + R MS GP SM++D D +L
Sbjct: 283 SFLNVNGLVMNNPLPLPD-IVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDN---NLP 338
Query: 304 TCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYL 363
SNN +C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLF+
Sbjct: 339 IVISSNNSGTNC--IEVRRAKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQ 396
Query: 364 DSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 405
+ DTA +V+ EMVEQL+L D +V FIAE ID L++ L+P WK
Sbjct: 397 EGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNWK 438
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1213 (432.1 bits), Expect = 5.3e-132, Sum P(2) = 5.3e-132
Identities = 242/388 (62%), Positives = 289/388 (74%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKAFDE GIEVAW+ + I+DVLQ+PG L +LYSEVHLL SLK DN++K + SWVDD K
Sbjct: 31 YKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVDDHNK 90
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
++NMITELFTSG+L YRKKH+ VD K I NWARQIL GL YLHS PP+IHRDLKCDNI
Sbjct: 91 SINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNI 150
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 195
FVNGN G+VKIGDLGLA MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEM
Sbjct: 151 FVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 210
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 255
VT EYPY EC+N AQI+KKVTSGIKP SL+KV+DPQ+K FIEKCL+PA R +A +LLKD
Sbjct: 211 VTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKD 270
Query: 256 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 315
L V+ K+ + K P MD++ K S+S C+ + + S C
Sbjct: 271 QLLAVDGAKDSTLTASSNT--TFKPAMPPQCEYRPMDVEYK-KNTSVSICSSAKS-SQEC 326
Query: 316 PVL---EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVA 372
+L E QR+ ++ EF+L G + DD + S+ LRIA SSG+ R + F F L +DTA +V
Sbjct: 327 ALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLKTDTARAVT 386
Query: 373 GEMVEQLDLADHDVAFIAEFIDYLIMKL 400
GEMVE+LDL+ H+V IAE ID LIMKL
Sbjct: 387 GEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 924 (330.3 bits), Expect = 2.6e-113, Sum P(2) = 2.6e-113
Identities = 166/247 (67%), Positives = 205/247 (82%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y+AFDE+ GIEVAW++VK+ D LQ P DL++LY E+HLLK+LK N++KFY SWVD +
Sbjct: 39 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+N +TELFTSG LRQYR +HK V+I+ +K+W RQIL GL YLHSH+PP+IHRDLKCDNI
Sbjct: 99 NINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNI 158
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 195
FVNGN GEVKIGDLGLA +++ A +GTPEFMAPE+YEE YNELVDIYSFGMCILEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 255
VTF+YPYSEC +PAQI+KKV SG KP +L KV DP++K FIEKCL S R+SA++LL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDD 278
Query: 256 PFLQVEN 262
PFL++++
Sbjct: 279 PFLRIDD 285
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 948 (338.8 bits), Expect = 7.0e-113, Sum P(2) = 7.0e-113
Identities = 170/247 (68%), Positives = 209/247 (84%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ Y+AFD+ GIEVAW++VK+DD DL +LYSEVHLLK+LK +++KFY SW+D +
Sbjct: 35 EVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQ 94
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
T+N+ITE+FTSGNLRQYRKKHK VD++ +K W+RQIL GLVYLHSH+PP+IHRDLKCD
Sbjct: 95 HMTINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCD 154
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCI 192
NIF+NGN GEVKIGDLGLA + + +A SVIGTPEFMAPELYEE+YN LVDIY+FGMC+
Sbjct: 155 NIFINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCL 214
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDL 252
LE+VTFEYPYSEC N AQI++KVTSGIKPA+L V DPQ++ FIEKC+ S+RLSAK+L
Sbjct: 215 LELVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKEL 274
Query: 253 LKDPFLQ 259
L DPFL+
Sbjct: 275 LDDPFLK 281
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 1.8e-103, P = 1.8e-103
Identities = 208/401 (51%), Positives = 269/401 (67%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y+ FDE+ GIEVAW++VK+ D LQ P +L++LY E+HLLK+LK +++KFY SWVD +
Sbjct: 40 YRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNR 99
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+N +TE+FTSG LRQYR KHK V+I+ +KNW RQIL GL YLH+H+PP+IHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNI 159
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 195
F+NGN GEVKIGDLGLA +Q A +GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEM
Sbjct: 160 FINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEM 219
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 255
VTF+YPYSEC +PAQI+K+V SG KP L KV DP+++GFIEKCL S RLSA +LL D
Sbjct: 220 VTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDD 279
Query: 256 PFLQV-ENQKEPICDPLKLPIQSLKMLRLPMSGPS-SMDIDSDYKQLSLSTCTESNNGSP 313
FL + E+ + L ++ LR P S S Y Q + S
Sbjct: 280 HFLCIDESDMRRVESEKGLIDEAGTPLRHSYHIPHYSNGYYSLYNQNQWDYNGDETVESH 339
Query: 314 HCPVLEFQRMHKNNE---------FRLRGTKNDD-TSVSLTLRIADSSGRVRNIHFLFYL 363
+LEFQ E ++G + D+ + L L+ + G VRNI+F F +
Sbjct: 340 EIDLLEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDI 399
Query: 364 DSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGW 404
++DTA+SVA EMVE+L++ D DV IA ID I L+P W
Sbjct: 400 ETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNW 440
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 6.7e-100, Sum P(2) = 6.7e-100
Identities = 170/318 (53%), Positives = 226/318 (71%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKAFD+ G+EVAW++VK+++V + P LQ+LYSEVHLLK+L ++++++ SW+D ++
Sbjct: 40 YKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRR 99
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
T N ITELFTSG LR+YR+K++ VDI+ IK+WARQIL+GL YLH H+PP+IHRDLKCDNI
Sbjct: 100 TFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNI 159
Query: 136 FVNGNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
FVNG+ G+VKIGDLGLA ++ A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LE
Sbjct: 160 FVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLE 219
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
M+T EYPYSEC NPAQI+KKVTSG P S + + + F+ KCL S RL AK+LL
Sbjct: 220 MLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLA 279
Query: 255 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDS--DYKQLSLSTCTESNNGS 312
DPFL ++++ + +LP Q L + L +G + S D + + + T N
Sbjct: 280 DPFLAATDERD-LAPLFRLP-QQLAIQNLAANGTVVEHLPSTTDPTRTTDMSITGKMNSE 337
Query: 313 PHCPVLEFQRMHKNNEFR 330
H L+ Q + + R
Sbjct: 338 DHTIFLQVQILDGDGHMR 355
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 4.2e-96, Sum P(2) = 4.2e-96
Identities = 157/244 (64%), Positives = 196/244 (80%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA DE GIEVAWS+VK+ +VL+ DLQ+LYSEVHLL +L ++++FY SW+D
Sbjct: 34 YKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSEVHLLSTLNHKSIIRFYTSWIDVHNH 93
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
T+N ITELFTSG LRQY+ K+ +DI+ IK+WARQIL GLVYLH H+PP+IHRDLKCDNI
Sbjct: 94 TLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNI 153
Query: 136 FVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 194
FVNG+ G+VKIGDLGLA ++ +A S+IGTPEFMAPELYEE YNEL+D+YSFGMC LE
Sbjct: 154 FVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLE 213
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
M+T E+PYSEC +PAQI+KKV G P + +V D + + FI KCLV AS+R+SAK+LL+
Sbjct: 214 MITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQ 273
Query: 255 DPFL 258
DPFL
Sbjct: 274 DPFL 277
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 781 (280.0 bits), Expect = 1.3e-77, P = 1.3e-77
Identities = 146/255 (57%), Positives = 192/255 (75%)
Query: 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 63
L+ S + V Y+AFD+ GIEVAW++VK+ P ++LYSEV LLK+LK+ N++
Sbjct: 36 LLGSGAVKKV--YRAFDQEEGIEVAWNQVKLRCFSDDPAMTERLYSEVRLLKNLKNSNII 93
Query: 64 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 123
YK W D++ T+N ITE+ TSGNLR+YRKKH++V ++ +K W++QIL GL YLH+H+P
Sbjct: 94 TLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHVSMRALKKWSKQILKGLDYLHTHDP 153
Query: 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPELYEEEYNEL 182
IIHRDL C NIFVNGN G+VKIGDLGLA I + A S++GTPEFMAPELYEE Y E+
Sbjct: 154 CIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHLAHSILGTPEFMAPELYEENYTEM 213
Query: 183 VDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 242
VDIYS+GMC+LE+V+ E PYSEC + A+I+K+V+ G+KP +L KVNDP+ K FIEKC+
Sbjct: 214 VDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGLKPEALNKVNDPEAKAFIEKCIAQ 273
Query: 243 ASERLSAKDLLKDPF 257
R SA +LL DPF
Sbjct: 274 PRARPSAAELLCDPF 288
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5127 | 0.8892 | 0.9313 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 641 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-58 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-49 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-44 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-43 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-35 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-32 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-32 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-31 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 4e-60
Identities = 83/248 (33%), Positives = 131/248 (52%), Gaps = 14/248 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y A D+ G VA +K+ ++ D +++ E+ +LK LK N+V+ Y + D+ K
Sbjct: 16 YLARDKKTGKLVA---IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDK- 71
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ ++ E G+L KK + + + RQIL L YLHS I+HRDLK +NI
Sbjct: 72 -LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENI 128
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 193
++ G VK+ D GLA + + +GTPE+MAPE L + Y + VDI+S G IL
Sbjct: 129 LLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VIL 186
Query: 194 -EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASERLSAK 250
E++T + P+ ++FKK+ P + + P+ K I K LV +RL+A+
Sbjct: 187 YELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAE 246
Query: 251 DLLKDPFL 258
+ L+ PF
Sbjct: 247 EALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 2e-58
Identities = 91/250 (36%), Positives = 136/250 (54%), Gaps = 13/250 (5%)
Query: 16 YKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y A D+ G +A VK ++ +L+ L E+ +L SL+ N+V++Y S D++K
Sbjct: 17 YLALDKDTGELMA---VKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
T+N+ E + G+L KK + VI+ + RQIL GL YLHS+ I+HRD+K N
Sbjct: 74 NTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGAN 131
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFG 189
I V+ + G VK+ D G A + SV GTP +MAPE+ EEY DI+S G
Sbjct: 132 ILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLG 190
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
++EM T + P+SE NP K+ S +P + + + K F+ KCL +R +
Sbjct: 191 CTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
Query: 249 AKDLLKDPFL 258
A +LL+ PFL
Sbjct: 251 ADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-50
Identities = 75/252 (29%), Positives = 122/252 (48%), Gaps = 16/252 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA + G VA +K + Q E+ +L+ L N+V+ ++ D
Sbjct: 16 YKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH- 72
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ ++ E G+L Y + + K A QIL GL YLHS+ IIHRDLK +NI
Sbjct: 73 -LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENI 129
Query: 136 FVNGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMC 191
++ +G VKI D GLA + + + +GTP +MAPE L Y VD++S G+
Sbjct: 130 LLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 192 ILEMVTFEYPYSECKNPAQ--IFKKVTSGIKPASLAKVNDPQI--KGFIEKCLVP-ASER 246
+ E++T + P+S Q + +++ K + K I+KCL S+R
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
Query: 247 LSAKDLLKDPFL 258
+A+++L+ P+
Sbjct: 249 PTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 1e-49
Identities = 71/247 (28%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y A D+ G +VA +KI L++L E+ +LK L N+VK Y + D+
Sbjct: 10 YLARDKKTGKKVA---IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN-- 64
Query: 76 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ ++ E G+L+ ++ + I QIL GL YLHS+ IIHRDLK +N
Sbjct: 65 HLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPEN 122
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGM 190
I ++ ++G+VK+ D GL+ + ++++GTP +MAPE+ Y+E DI+S G+
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 249
+ E+ P++K I K L +R SA
Sbjct: 183 ILYEL----------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 250 KDLLKDP 256
K++L+
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 84/253 (33%), Positives = 136/253 (53%), Gaps = 23/253 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA D G EVA ++++ + + + +E+ ++K K N+V +Y S++
Sbjct: 36 YKATDRATGKEVAIKKMRLRK-----QNKELIINEILIMKDCKHPNIVDYYDSYLVGD-- 88
Query: 76 TVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
+ ++ E G+L Q + I + R++L GL YLHS N +IHRD+K
Sbjct: 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLEYLHSQN--VIHRDIK 143
Query: 132 CDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 188
DNI ++ + G VK+ D G A + ++ SV+GTP +MAPE+ + ++Y VDI+S
Sbjct: 144 SDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202
Query: 189 GMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 246
G+ +EM E PY + P + +F T GI P + P+ K F+ KCLV +R
Sbjct: 203 GIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261
Query: 247 LSAKDLLKDPFLQ 259
SA++LL+ PFL+
Sbjct: 262 PSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-44
Identities = 82/249 (32%), Positives = 133/249 (53%), Gaps = 19/249 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA + G EVA +K+ L+ +K+ +E+ +LK K N+VK+Y S++ +
Sbjct: 17 YKARHKRTGKEVA---IKVIK-LESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE- 71
Query: 76 TVNMITELFTSGNLRQYRKKHKNV----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
+ ++ E + G+L+ K I + +++L GL YLHS+ IIHRD+K
Sbjct: 72 -LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV---CKELLKGLEYLHSNG--IIHRDIK 125
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE-LYEEEYNELVDIYSFG 189
NI + + GEVK+ D GL+ + AR +++GTP +MAPE + + Y+ DI+S G
Sbjct: 126 AANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLG 184
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RLS 248
+ +E+ + PYSE +FK T+G + + K F++KCL E R +
Sbjct: 185 ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244
Query: 249 AKDLLKDPF 257
A+ LLK PF
Sbjct: 245 AEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 6e-43
Identities = 83/251 (33%), Positives = 131/251 (52%), Gaps = 17/251 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y+ + G A V + D Q +++L E+ LL L+ N+V++ + ++
Sbjct: 17 YEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ + EL G+L + KK+ + VI+ + RQIL GL YLH N +HRD+K N
Sbjct: 77 --LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGAN 132
Query: 135 IFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMC 191
I V+ N G VK+ D G+A ++ A+S G+P +MAPE+ ++ Y DI+S G
Sbjct: 133 ILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---SLAKVNDPQIKGFIEKCL-VPASERL 247
+LEM T + P+S+ + A +FK S P L+ + K FI KCL S R
Sbjct: 192 VLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFILKCLQRDPSLRP 247
Query: 248 SAKDLLKDPFL 258
+A +LL+ PF+
Sbjct: 248 TAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 4e-41
Identities = 69/224 (30%), Positives = 121/224 (54%), Gaps = 15/224 (6%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI- 101
+ + +EV +LK L N++K+Y+S+ + K + ++ E G+L Q KK K
Sbjct: 42 EREDALNEVKILKKLNHPNIIKYYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKEGKP 99
Query: 102 ---KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158
+ I +W Q+ L YLHS I+HRD+K NIF+ N G VK+GD G++ +
Sbjct: 100 FPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156
Query: 159 T--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 215
A++V+GTP +++PEL + + YN DI+S G + E+ T ++P+ E +N ++ K+
Sbjct: 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKI 215
Query: 216 TSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 258
G P ++ + +++ + L ER S +L+ PF+
Sbjct: 216 LKGQYPPIPSQYSS-ELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 74/251 (29%), Positives = 129/251 (51%), Gaps = 15/251 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YK + G A ++ +D + ++L E+ L+S + VVK Y ++ K+
Sbjct: 18 YKVRHKPTGKIYALKKIHVDGDEEF---RKQLLRELKTLRSCESPYVVKCYGAF--YKEG 72
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDN 134
++++ E G+L KK + V+ ARQIL GL YLH+ + IIHRD+K N
Sbjct: 73 EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSN 130
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 191
+ +N GEVKI D G++ ++ + +GT +M+PE + E Y+ DI+S G+
Sbjct: 131 LLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 192 ILEMVTFEYPYS--ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
+LE ++P+ + ++ + + G P+ A+ P+ + FI CL +R S
Sbjct: 190 LLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249
Query: 249 AKDLLKDPFLQ 259
A +LL+ PF++
Sbjct: 250 AAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 7e-36
Identities = 81/250 (32%), Positives = 132/250 (52%), Gaps = 14/250 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y +D G E+A +V D D + ++ L E+ LLK+L+ + +V++Y DD+
Sbjct: 19 YLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET 78
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
++ M E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 LSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGAN 134
Query: 135 IFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 188
I + G VK+GD G + I +SV GTP +M+PE+ E Y D++S
Sbjct: 135 ILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV 193
Query: 189 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERL 247
G ++EM+T + P++E + A IFK T P + V P + F+ + V A +R
Sbjct: 194 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRTFVENAKKRP 252
Query: 248 SAKDLLKDPF 257
SA++LL+ F
Sbjct: 253 SAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 80/228 (35%), Positives = 128/228 (56%), Gaps = 19/228 (8%)
Query: 44 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV 103
++++ E+ +L+ LK N+VK+Y V +K V + E + G L + + + +D V
Sbjct: 43 IKEIADEMKVLELLKHPNLVKYYGVEVHREK--VYIFMEYCSGGTLEELLEHGRILDEHV 100
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 161
I+ + Q+L GL YLHSH I+HRD+K NIF++ N G +K+GD G A+ ++ T
Sbjct: 101 IRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMG 157
Query: 162 ----SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 213
S+ GTP +MAPE+ + + DI+S G +LEM T + P+SE N QI
Sbjct: 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF 217
Query: 214 KVTSGIKPASLAKVN-DPQIKGFIEKCLV--PASERLSAKDLLKDPFL 258
V +G KP + P+ K F+++CL P +R +A +LL+ PF+
Sbjct: 218 HVGAGHKPPIPDSLQLSPEGKDFLDRCLESDP-KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 78/247 (31%), Positives = 127/247 (51%), Gaps = 13/247 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YK + G VA ++ ++ + + L+ + E+ LLK+LK N+VK+ S
Sbjct: 17 YKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKHPNIVKYIGSIET--SD 72
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
++ +I E +G+LRQ KK ++ + Q+L GL YLH +IHRD+K NI
Sbjct: 73 SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANI 130
Query: 136 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 192
+ G VK+ D G+A + SV+GTP +MAPE+ E + DI+S G +
Sbjct: 131 LTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTV 189
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 251
+E++T PY + A +F+ V P L + P++K F+ +C + R +AK
Sbjct: 190 IELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQKDPNLRPTAKQ 247
Query: 252 LLKDPFL 258
LLK P++
Sbjct: 248 LLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 84/256 (32%), Positives = 127/256 (49%), Gaps = 32/256 (12%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA + G VA V ++ DLQ++ E+ +LK +VK+Y S+ K
Sbjct: 20 YKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYF--KNT 71
Query: 76 TVNMITELFTSGN----LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
+ ++ E +G+ ++ K +I I Q L GL YLHS+ IHRD+K
Sbjct: 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI---LYQTLKGLEYLHSNK--KIHRDIK 126
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSF 188
NI +N G+ K+ D G++ + A+ +VIGTP +MAPE+ +E YN DI+S
Sbjct: 127 AGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSL 185
Query: 189 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PASLAKVND--PQIKGFIEKCLV-P 242
G+ +EM + PYS+ IF I P +L+ P+ F++KCLV
Sbjct: 186 GITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFNDFVKKCLVKD 240
Query: 243 ASERLSAKDLLKDPFL 258
ER SA LL+ PF+
Sbjct: 241 PEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 82/252 (32%), Positives = 137/252 (54%), Gaps = 11/252 (4%)
Query: 16 YKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y +D G E+A +V+ D + + ++ L E+ LLK+L+ + +V++Y D +
Sbjct: 19 YLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
KT+ + E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGAN 136
Query: 135 IFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 188
I + + G VK+GD G + I M RSV GTP +M+PE+ E Y D++S
Sbjct: 137 ILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195
Query: 189 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLS 248
G ++EM+T + P++E + A IFK T P + +++ + F+ V A R S
Sbjct: 196 GCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLGCIFVEARHRPS 254
Query: 249 AKDLLKDPFLQV 260
A++LL+ PF Q+
Sbjct: 255 AEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 69/225 (30%), Positives = 121/225 (53%), Gaps = 14/225 (6%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVD 100
Q+L SEV++L+ LK N+V++Y +D +T+ ++ E G+L ++ +K+ K ++
Sbjct: 44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE 103
Query: 101 IKVIKNWARQILHGLVYLHSHNPP---IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157
+ I Q+L L H+ + P ++HRDLK NIF++ N+ VK+GD GLA +
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGH 162
Query: 158 PT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 214
+ A++ +GTP +M+PE L Y+E DI+S G I E+ P+ +N Q+ K
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASK 221
Query: 215 VTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 258
+ G + ++ I+ L V +R S ++LL+ P +
Sbjct: 222 IKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 82/278 (29%), Positives = 134/278 (48%), Gaps = 28/278 (10%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ YKA D+ VA +K+ D+ + +++ + E+ L + + K+Y S++
Sbjct: 16 EVYKAIDKRTNQVVA---IKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS 72
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
K + M E G+ K K +D I R++L GL YLH IHRD+K
Sbjct: 73 KLWIIM--EYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGK--IHRDIKAA 127
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY-EEEYNELVDIYSFGM 190
NI ++ G+VK+ D G++ + ++ + +GTP +MAPE+ + Y+E DI+S G+
Sbjct: 128 NILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGI 186
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVN-DPQIKGFIEKCLV--PAS 244
+E+ E P S+ +P +V I P SL K F+ CL P
Sbjct: 187 TAIELAKGEPPLSD-LHPM----RVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPK- 240
Query: 245 ERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
ER SAK+LLK F ++ K+ L L I+ +K +
Sbjct: 241 ERPSAKELLKHKF--IKKAKKT--SYLTLLIERIKKWK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 80/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 16 YKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y +D G E+A +V+ D + + ++ L E+ LLK+L + +V++Y D +
Sbjct: 19 YLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+T+++ E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGAN 136
Query: 135 IFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 188
I + + G VK+GD G + I + +SV GTP +M+PE+ E Y DI+S
Sbjct: 137 ILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSV 195
Query: 189 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLS 248
G ++EM+T + P++E + A IFK T P V+D + F+++ V A R S
Sbjct: 196 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFLKRIFVEAKLRPS 254
Query: 249 AKDLLKDPFLQ 259
A +LL+ F+
Sbjct: 255 ADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 48/279 (17%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA D+ G VA ++++D+ + G E+ LLK LK N+VK ++K
Sbjct: 16 YKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK- 72
Query: 76 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ ++ E + +L++Y K+ + +IK+ Q+L GL Y HSH I+HRDLK N
Sbjct: 73 -LYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQN 128
Query: 135 IFVNGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSF 188
I +N + G +K+ D GLA I ++ T V T + APE+ + Y+ VDI+S
Sbjct: 129 ILINRD-GVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSKHYSTAVDIWSV 185
Query: 189 GMCILEMVTF--------------------------EYP-YSECKNPAQIFKKVTSGIKP 221
G EM+T +P ++ + F K
Sbjct: 186 GCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP-PKDL 244
Query: 222 ASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFL 258
+ DP+ + K L PA +R+SAK+ LK P+
Sbjct: 245 EKVLPRLDPEGIDLLSKMLQYNPA-KRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 81/251 (32%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 14 DTYKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
+ Y +D G E+A +V D D + ++ L E+ LLK+L+ D +V++Y D
Sbjct: 17 EVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
++K +++ E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K
Sbjct: 77 EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKG 134
Query: 133 DNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIY 186
NI + + G VK+GD G + I M +SV GTP +M+PE+ E Y D++
Sbjct: 135 ANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVW 193
Query: 187 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASER 246
S ++EM+T + P++E + A IFK T KP V+D + F+++ V R
Sbjct: 194 SVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRDFLKQIFVEEKRR 252
Query: 247 LSAKDLLKDPF 257
+A+ LL+ PF
Sbjct: 253 PTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 71/235 (30%), Positives = 123/235 (52%), Gaps = 14/235 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA G VA +V+I +++ Q E+ LLK L NV+K+ S++++ +
Sbjct: 19 YKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE- 76
Query: 76 TVNMITELFTSGNLRQ----YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
+N++ EL +G+L + ++K+ + + + I + Q+ L ++HS I+HRD+K
Sbjct: 77 -LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIK 133
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSF 188
N+F+ G VK+GDLGL T A S++GTP +M+PE ++E YN DI+S
Sbjct: 134 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 189 GMCILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 242
G + EM + P Y + N + KK+ P A +++ + +C+ P
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 73/243 (30%), Positives = 116/243 (47%), Gaps = 24/243 (9%)
Query: 32 VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR- 90
+K D+ + + +L EV + NVVK+Y S+V + + M + G+L
Sbjct: 31 IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM--PYLSGGSLLD 88
Query: 91 --QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 148
+ +D +I +++L GL YLHS+ IHRD+K NI + G G VKI D
Sbjct: 89 IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILL-GEDGSVKIAD 145
Query: 149 LGLAIAMQQPTARS------VIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEY 200
G++ ++ R+ +GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T
Sbjct: 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
Query: 201 PYSECKNPAQIFKKVTSGIKPASL-----AKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 254
PYS+ P ++ P SL K + I CL S+R +A++LLK
Sbjct: 206 PYSKYP-PMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
Query: 255 DPF 257
F
Sbjct: 264 HKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 66/255 (25%), Positives = 115/255 (45%), Gaps = 32/255 (12%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
T K + +EVA +K D Q +++ E +++ L N+VK +++
Sbjct: 19 TLKGKGDGKEVEVAVKTLKEDASEQ---QIEEFLREARIMRKLDHPNIVKLL-GVCTEEE 74
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKC 132
+ ++ E G+L Y +K++ ++ + ++A QI G+ YL S N IHRDL
Sbjct: 75 PLM-IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAA 131
Query: 133 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE---FMAPE-LYEEEYNELVDIYSF 188
N V N VKI D GL+ + V G +MAPE L E ++ D++SF
Sbjct: 132 RNCLVGENLV-VKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSF 190
Query: 189 GMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-------PASLAKVNDPQIKGFIEKCL 240
G+ + E+ T E PY N A++ + + G + P L K+ + +C
Sbjct: 191 GVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPPELYKL--------MLQCW 241
Query: 241 VP-ASERLSAKDLLK 254
+R + +L++
Sbjct: 242 AEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 58/215 (26%), Positives = 110/215 (51%), Gaps = 15/215 (6%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 109
E ++L + +VK + ++ ++K + ++ E G L + K + + +A
Sbjct: 43 ERNILSRINHPFIVKLHYAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAA 100
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP 167
+I+ L YLHS II+RDLK +NI ++ G +K+ D GLA ++ + + GTP
Sbjct: 101 EIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 168 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 226
E++APE L + Y + VD +S G+ + EM+T + P+ ++ +I++K+ P +
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPE 214
Query: 227 VNDPQIKGFIEKCLVP-ASERL---SAKDLLKDPF 257
P+ + I L ++RL A+++ PF
Sbjct: 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 66/215 (30%), Positives = 118/215 (54%), Gaps = 13/215 (6%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 109
E +L L ++++Y+S++D K +N++ E +G+L + K + + + W
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGK--LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRF 106
Query: 110 --QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIG 165
QIL GL +LHS I+HRD+K N+F++ VKIGDLG+A + T A +++G
Sbjct: 107 FIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVG 163
Query: 166 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 224
TP +++PEL E++ YNE D+++ G+ + E T ++P+ + N + K+ G+ P
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFPPVS 222
Query: 225 AKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 258
+ Q+ I++CL +R LL++P L
Sbjct: 223 QMYS-QQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 72/228 (31%), Positives = 123/228 (53%), Gaps = 20/228 (8%)
Query: 43 DLQK------LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH 96
DL+K L++EV +++ + N+V+ Y S++ + V M E G L H
Sbjct: 53 DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM--EFLEGGALTDI-VTH 109
Query: 97 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 154
++ + I +L L +LH+ +IHRD+K D+I + + G VK+ D G ++
Sbjct: 110 TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVS 166
Query: 155 MQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 213
+ P +S++GTP +MAPE+ Y VDI+S G+ ++EMV E PY + P Q K
Sbjct: 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMK 225
Query: 214 KVTSGIKPAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258
++ + P L KV+ P+++ F+++ LV ++R +A +LL PFL
Sbjct: 226 RIRDNLPPKLKNLHKVS-PRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 82/230 (35%), Positives = 117/230 (50%), Gaps = 23/230 (10%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 101
+Q L+ E+ L LK N+V++ S D + + E G+L R K +
Sbjct: 48 YVQPLHEEIALHSYLKHRNIVQYLGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKD 105
Query: 102 K--VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQ 157
I + +QIL GL YLH + I+HRD+K DN+ VN G VKI D G + +A
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163
Query: 158 PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIFK 213
P + GT ++MAPE+ ++ Y DI+S G I+EM T + P+ E P A +FK
Sbjct: 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK 223
Query: 214 ----KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 258
K+ I P SL+ + K FI +C P +R SA DLL+DPFL
Sbjct: 224 VGMFKIHPEI-PESLSA----EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 64/257 (24%), Positives = 108/257 (42%), Gaps = 37/257 (14%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGD---LQKLYSEVHLLKSLKDDNVVKFYKSWVD 71
K +EVA VK L+ +++ E +++ L NVVK
Sbjct: 19 KLKGKGGKKKVEVA---VK---TLKEDASEQQIEEFLREARIMRKLDHPNVVKLL-GVCT 71
Query: 72 DKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130
+++ ++ E G+L Y RK + + + ++A QI G+ YL S N IHRDL
Sbjct: 72 EEEPLY-IVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN--FIHRDL 128
Query: 131 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE---FMAPE-LYEEEYNELVDIY 186
N V N VKI D GL+ + G +MAPE L E ++ D++
Sbjct: 129 AARNCLVGENLV-VKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVW 187
Query: 187 SFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-------PASLAKVNDPQIKGFIEK 238
SFG+ + E+ T E PY N ++ + + +G + P L + + +
Sbjct: 188 SFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPELYDL--------MLQ 238
Query: 239 CLVP-ASERLSAKDLLK 254
C +R + +L++
Sbjct: 239 CWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 40/227 (17%)
Query: 61 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 120
++K Y ++ D++ + + E +G L QY +K+ ++D K + +A +IL L YLHS
Sbjct: 63 GIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 121 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----------------------QQP 158
IIHRDLK +NI ++ + +KI D G A + +
Sbjct: 121 KG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 159 TARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVT 216
S +GT E+++PEL E+ + D+++ G CI+ +M+T + P+ N F+K+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNEYLTFQKIL 235
Query: 217 SGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKD----LLKDPF 257
S P K IEK LV P +RL + L PF
Sbjct: 236 KL--EYSFPPNFPPDAKDLIEKLLVLDP-QDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
T K E +VA +K + + ++ E ++K L N+V+ V +
Sbjct: 19 TLKGDGEGTETKVAVKTLKEGASEE---EREEFLEEASIMKKLSHPNIVRLLG--VCTQG 73
Query: 75 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ + ++TE G+L + +KH + +K + A QI G+ YL S N +HRDL
Sbjct: 74 EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDLAAR 131
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF-----MAPELYEE-EYNELVDIYS 187
N V N VKI D GL+ + MAPE ++ ++ D++S
Sbjct: 132 NCLVTEN-LVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWS 189
Query: 188 FGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
FG+ + E+ T E PY N ++ + + G
Sbjct: 190 FGVLLWEIFTLGEQPYPGMSN-EEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 13/215 (6%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKN-VDIKVIK 105
E+ +L S+ N++ + ++++D K + M E G+L + RKK + + + I
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVM--EYAPFGDLSKAISKRKKKRKLIPEQEIW 106
Query: 106 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 165
Q+L GL LH I+HRDLK NI + N VKIGDLG++ +++ A++ IG
Sbjct: 107 RIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKNMAKTQIG 163
Query: 166 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 224
TP +MAPE+++ Y+ DI+S G + EM TF P+ E ++ + KV G P +
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPP-I 221
Query: 225 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 258
+ ++ FI L R + +L P +
Sbjct: 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 78/256 (30%), Positives = 122/256 (47%), Gaps = 23/256 (8%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
D YKA D G VA +K++ PGD + + E+ +LK + N+V ++ S++
Sbjct: 18 DVYKARDIATGELVAIKVIKLE-----PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR 72
Query: 73 KKKTVNMITELFTSGNLRQ-YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
K + M E G+L+ Y+ + I R+ L GL YLH IHRD+K
Sbjct: 73 DKLWIVM--EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIK 128
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE----YNELVDI 185
NI + G+VK+ D G++ + A+ S IGTP +MAPE+ E Y+ DI
Sbjct: 129 GANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187
Query: 186 YSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVN--DPQIKGFIEKCLVP 242
++ G+ +E+ + P + +P + +F S P L P FI+KCL
Sbjct: 188 WALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTK 246
Query: 243 A-SERLSAKDLLKDPF 257
+R +A LL+ PF
Sbjct: 247 DPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 75/234 (32%), Positives = 117/234 (50%), Gaps = 24/234 (10%)
Query: 35 DDVLQLPGDLQKLYSEVHLLKSLKDD---NVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 91
DDV D+Q+ EV LL L+ N+ K+Y S++ + +I E G++R
Sbjct: 41 DDV----SDIQR---EVALLSQLRQSQPPNITKYYGSYLKGP--RLWIIMEYAEGGSVRT 91
Query: 92 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151
K + K I R++L L Y+H +IHRD+K NI V N G VK+ D G+
Sbjct: 92 LMKAGP-IAEKYISVIIREVLVALKYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGV 147
Query: 152 AIAMQQPTAR--SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKN 207
A + Q +++ + +GTP +MAPE+ E Y+ DI+S G+ I EM T PYS+ +
Sbjct: 148 AALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VD 206
Query: 208 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQ 259
+ + P ++ F+ CL P ERLSA++LLK +++
Sbjct: 207 AFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPK-ERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 68/232 (29%), Positives = 117/232 (50%), Gaps = 19/232 (8%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWA 108
E+ +L K N+V Y+++ + K ++ E G L + + + I+
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVC 109
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 166
RQ+L L +LHSH +IHRDLK NI + G+VK+ D G++ + + + IGT
Sbjct: 110 RQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGT 166
Query: 167 PEFMAPELYEEE------YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 220
P +MAPE+ E Y+ DI+S G+ ++E+ E P+ E NP ++ K+ +
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKS-E 224
Query: 221 PASLAKVN--DPQIKGFIEKCLVPASE-RLSAKDLLKDPFLQVENQKEPICD 269
P +L + + F++ CLV + R +A +LLK PF+ ++ + I D
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKD 276
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 8e-27
Identities = 70/310 (22%), Positives = 115/310 (37%), Gaps = 33/310 (10%)
Query: 44 LQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH---KNV 99
+++ E+ +L SL N+VK Y + D+ + ++ E G+L KK +
Sbjct: 41 VERFLREIQILASLNHPPNIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPL 98
Query: 100 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM---- 155
QIL L YLHS IIHRD+K +NI ++ + VK+ D GLA +
Sbjct: 99 SESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156
Query: 156 ----QQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPY---SE 204
+ +GTP +MAPE+ + DI+S G+ + E++T P+
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 205 CKNPAQIFKKVTSGIKPASLAKVN-------DPQIKGFIEKCLVP-ASERLSAKDLLKDP 256
+Q K + P+ + ++ ++K L RLS+ L
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 257 FLQVENQKE--PICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 314
L KE L++ P ++S S +SN
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
Query: 315 CPVLEFQRMH 324
P H
Sbjct: 337 APNGVSSSPH 346
|
Length = 384 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 14/222 (6%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 104
+ L E+ L+ L ++++ + +D N+ E G++ K+ VI
Sbjct: 48 EALRKEIRLMARLNHPHIIRMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVI 105
Query: 105 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-- 162
N+ Q+L GL YLH + IIHRD+K N+ ++ ++I D G A + +
Sbjct: 106 INYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 163 ----VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYS--ECKNPAQIFKKV 215
++GT FMAPE L E+Y D++S G I+EM T + P++ + N + K+
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223
Query: 216 TSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDP 256
S S+ + P ++ +CL + +R +++LLK P
Sbjct: 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 72/225 (32%), Positives = 122/225 (54%), Gaps = 17/225 (7%)
Query: 44 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV 103
L L E+ LLK L+ +N+V++ S +D +N+ E G++ + + +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETL 107
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------IAMQ 156
++N+ RQIL GL YLH+ IIHRD+K NI V+ N G +KI D G++ ++ +
Sbjct: 108 VRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTK 164
Query: 157 QPTAR-SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 214
AR S+ G+ +MAPE+ ++ Y DI+S G ++EM+T ++P+ +C IF K
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-K 223
Query: 215 VTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 258
+ P + ++ + F+EK ++R +A +LLK PFL
Sbjct: 224 IGENASPEIPSNISS-EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 74/245 (30%), Positives = 120/245 (48%), Gaps = 19/245 (7%)
Query: 27 VAWSRVKID--DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84
+A +V++D +VL + +KL EV LLKSLK N+V++ + +DD T+++ E
Sbjct: 27 IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTISIFMEFV 84
Query: 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 144
G++ + + V + +QIL G+ YLH++ ++HRD+K +N+ + N G +
Sbjct: 85 PGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GII 141
Query: 145 KIGDLGLA--IAM------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEM 195
K+ D G A +A +S+ GTP +MAPE+ E Y DI+S G + EM
Sbjct: 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 253
T + P + A +F + + L F+ CL ER SA LL
Sbjct: 202 ATGKPPLASMDRLAAMF-YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260
Query: 254 KDPFL 258
+ FL
Sbjct: 261 RHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 53/230 (23%), Positives = 96/230 (41%), Gaps = 23/230 (10%)
Query: 41 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-- 98
+ + E ++K L NVV+ +++ ++ E G+L Y +K +
Sbjct: 37 EEERKDFLKEARVMKKLGHPNVVRLL-GVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVF 94
Query: 99 -------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151
+ +K + ++A QI G+ YL S +HRDL N V G VKI D GL
Sbjct: 95 PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFGL 151
Query: 152 AIAMQQPT-ARSVIGTPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSEC 205
+ + R G +MAPE L + + D++SFG+ + E+ T PY
Sbjct: 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211
Query: 206 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 254
N ++ + + G + D ++ + C +R + +L++
Sbjct: 212 SN-EEVLEYLRKGYRLPKPEYCPD-ELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 70/241 (29%), Positives = 127/241 (52%), Gaps = 14/241 (5%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ Y+A G+ VA +V+I D++ E+ LLK L NV+K+Y S+++D
Sbjct: 17 EVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKYYASFIEDN 75
Query: 74 KKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
+ +N++ EL +G+L + ++K+ + + K + + Q+ L ++HS ++HRD
Sbjct: 76 E--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRD 131
Query: 130 LKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIY 186
+K N+F+ G VK+GDLGL + + A S++GTP +M+PE ++E YN DI+
Sbjct: 132 IKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 190
Query: 187 SFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE 245
S G + EM + P Y + N + KK+ P + +++ + C+ P E
Sbjct: 191 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPE 250
Query: 246 R 246
+
Sbjct: 251 K 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 62/236 (26%), Positives = 122/236 (51%), Gaps = 16/236 (6%)
Query: 31 RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR 90
R++I++ +Q +++ E+ +L +V FY ++ ++ +++ E G+L
Sbjct: 35 RLEINEAIQ-----KQILRELDILHKCNSPYIVGFYGAFYNNG--DISICMEYMDGGSLD 87
Query: 91 QYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 149
+ K+ + +++ A +L GL YLH IIHRD+K NI VN + G++K+ D
Sbjct: 88 KILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVN-SRGQIKLCDF 145
Query: 150 GLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSEC--- 205
G++ + A++ +GT +MAPE + +Y+ DI+S G+ ++E+ T +PY
Sbjct: 146 GVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP 205
Query: 206 -KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
++ + + + P + P + F+ CL+ ER S K+LL+ PF++
Sbjct: 206 PDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 66/240 (27%), Positives = 126/240 (52%), Gaps = 19/240 (7%)
Query: 43 DLQK-LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHK 97
DLQK + E+ + KS K +VK+Y +++D+ ++ + E G+L ++ +K+
Sbjct: 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG 100
Query: 98 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157
+ KV+ A +L GL YLHS IIHRD+K NI + G+VK+ D G++ +
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN 157
Query: 158 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY-SECKNPAQIFKKV 215
A + GT +MAPE + + Y+ D++S G+ +LE+ +P+ E + P + +
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217
Query: 216 TSGIKPASLAKVNDP--------QIKGFIEKCL-VPASERLSAKDLLKDPFLQVENQKEP 266
+ + + ++P + K FI++CL + R + D+L+ P+++ + +K+
Sbjct: 218 SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 104
++ +E +L + VVK Y S+ K + ++ E G+L + ++D V
Sbjct: 38 DQVLTERDILSQAQSPYVVKLYYSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVA 95
Query: 105 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL--------AIAMQ 156
+ + +I+ L YLHS+ IIHRDLK DNI ++ N G +K+ D GL I +
Sbjct: 96 RIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLN 152
Query: 157 QPTARS--VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 213
++GTP+++APE + + +++ VD +S G + E + P+ + P +IF+
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQ 211
Query: 214 KVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RL---SAKDLLKDPFL 258
+ +G + I K LVP E RL S +++ PF
Sbjct: 212 NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 73/218 (33%), Positives = 120/218 (55%), Gaps = 14/218 (6%)
Query: 47 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 106
L++EV +++ + +NVV+ Y S++ + V M E G L H ++ + I
Sbjct: 64 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM--EFLEGGALTDI-VTHTRMNEEQIAA 120
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 164
+L L LH+ +IHRD+K D+I + + G VK+ D G ++ + P +S++
Sbjct: 121 VCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLV 177
Query: 165 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-- 221
GTP +MAPEL Y VDI+S G+ ++EMV E PY + P + K + + P
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKL 236
Query: 222 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258
+L KV+ P +KGF+++ LV ++R +A +LLK PFL
Sbjct: 237 KNLHKVS-PSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 16/223 (7%)
Query: 47 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 106
++SE +L+ +VK Y+++ D KK + M+ E G L + D +
Sbjct: 40 IFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARF 97
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-ARSVIG 165
+ ++ YLH+ II+RDLK +N+ ++ N G VK+ D G A ++ + G
Sbjct: 98 YIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCG 154
Query: 166 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPAS 223
TPE++APE+ + Y+ VD +S G+ + E++T P+ E +P +I+ + G
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE 214
Query: 224 LAKVNDPQIKGFIEK--CLVPASERL-----SAKDLLKDPFLQ 259
D K I++ P ERL KD+ K +
Sbjct: 215 FPNYIDKAAKDLIKQLLRRNPE-ERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT---SGNLRQYRKKHKNVDIKVIKN 106
E+ LL+ L+ N+V+ + K ++ M+ E +G L K IK
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKC 104
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS---- 162
+ +Q+L GL YLHS+ I+HRD+K NI +N N G +K+ D GLA + +
Sbjct: 105 YMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 163 VIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 197
VI T + PEL Y VD++S G CIL E+
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 64/217 (29%), Positives = 115/217 (52%), Gaps = 11/217 (5%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDIK 102
+E +LK L N++++Y+++++DK + M E G L +Y +K N +D
Sbjct: 44 LAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM--EYAPGGTLAEYIQKRCNSLLDED 101
Query: 103 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTAR 161
I ++ QIL L ++H+ I+HRDLK NI ++ + VKIGD G++ I + A
Sbjct: 102 TILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159
Query: 162 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 220
+V+GTP +++PEL E + YN+ DI++ G + E+ + + + PA + K+ SG
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL-KIMSG-T 217
Query: 221 PASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDP 256
A ++ P ++ I L + S+R ++ P
Sbjct: 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 72/217 (33%), Positives = 115/217 (52%), Gaps = 12/217 (5%)
Query: 47 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 106
L++EV +++ + NVV+ YKS++ ++ V M E G L + + ++ + I
Sbjct: 65 LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM--EFLQGGALTDIVSQTR-LNEEQIAT 121
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 164
+L L YLHS +IHRD+K D+I + + G VK+ D G I+ P +S++
Sbjct: 122 VCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLV 178
Query: 165 GTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-A 222
GTP +MAPE+ Y VDI+S G+ ++EMV E PY +P Q K++ P
Sbjct: 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKL 237
Query: 223 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258
A P ++ F+E+ L ER +A++LL PFL
Sbjct: 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-23
Identities = 68/220 (30%), Positives = 119/220 (54%), Gaps = 14/220 (6%)
Query: 47 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 106
L++EV +++ +NVV Y S++ + V M E G L H ++ + I
Sbjct: 66 LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM--EFLEGGALTDI-VTHTRMNEEQIAT 122
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 164
+L L YLH+ +IHRD+K D+I + + G +K+ D G ++ + P +S++
Sbjct: 123 VCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLV 179
Query: 165 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-- 221
GTP +MAPE+ Y VDI+S G+ ++EM+ E PY + P Q +++ + P
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRV 238
Query: 222 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260
KV+ ++GF++ LV S+R +A++LL+ PFL++
Sbjct: 239 KDSHKVSS-VLRGFLDLMLVREPSQRATAQELLQHPFLKL 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 8e-23
Identities = 65/237 (27%), Positives = 123/237 (51%), Gaps = 14/237 (5%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ Y+A VA +V+I +++ Q E+ LLK L NV+K+ S+++D
Sbjct: 17 EVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKYLDSFIEDN 75
Query: 74 KKTVNMITELFTSGNLRQ----YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
+ +N++ EL +G+L Q ++K+ + + + + + Q+ + ++HS ++HRD
Sbjct: 76 E--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRD 131
Query: 130 LKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIY 186
+K N+F+ G VK+GDLGL + + A S++GTP +M+PE ++E YN DI+
Sbjct: 132 IKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 190
Query: 187 SFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 242
S G + EM + P Y + N + +K+ P + +++ + C+ P
Sbjct: 191 SLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 47 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 106
L SE+ LK L N+V++ + ++ +++ E G++ + + + ++++
Sbjct: 55 LRSEIETLKDLDHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL----AIAMQQPTARS 162
+ Q+L GL YLHS I+HRDLK DN+ V+ + G KI D G+ S
Sbjct: 113 FTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMS 169
Query: 163 VIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK----KV 215
+ G+ +MAPE Y + Y+ VDI+S G +LEM P+S+ + A +FK +
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS 229
Query: 216 TSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPF 257
I P ++ + + R +A++LL+ PF
Sbjct: 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 78/250 (31%), Positives = 128/250 (51%), Gaps = 16/250 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y A D G EVA ++ + Q +L + +E+ +++ K N+V + S++ +
Sbjct: 36 YTAIDVATGQEVAIKQMNLQQ--QPKKEL--IINEILVMRENKHPNIVNYLDSYLVGDEL 91
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
V M E G+L + +D I R+ L L +LHS+ +IHRD+K DNI
Sbjct: 92 WVVM--EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 146
Query: 136 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 192
+ G G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 193 LEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAK 250
+EMV E PY +NP + ++ T+G + + F+ +CL + +R SAK
Sbjct: 206 IEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK 264
Query: 251 DLLKDPFLQV 260
+LL+ PFL++
Sbjct: 265 ELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 79/250 (31%), Positives = 130/250 (52%), Gaps = 16/250 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ A D G EVA ++ LQ + + +E+ ++K LK+ N+V F S++ +
Sbjct: 36 FTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
V M E G+L + +D I R+ L L +LH++ +IHRD+K DN+
Sbjct: 92 FVVM--EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNV 146
Query: 136 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 192
+ G G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 193 LEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAK 250
+EMV E PY +NP + ++ T+G + P + F+ +CL + +R SAK
Sbjct: 206 IEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAK 264
Query: 251 DLLKDPFLQV 260
+LL+ PFL++
Sbjct: 265 ELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ--YRKKHKNVDIKVIKNW 107
E+ +L L+ N++ +Y ++DD + M E G L R+K + + +++ +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIG 165
QI+ + Y+H I+HRD+K NIF+ G +K+GD G++ + A +V+G
Sbjct: 107 LFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVG 163
Query: 166 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 224
TP +M+PEL + +YN DI++ G + E++T + + + NP + K+ G
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNY---- 218
Query: 225 AKVNDPQIKGFIE---KCL-VPASERLSAKDLLKDPFL 258
V I L +R +A ++L P L
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 16/222 (7%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 104
+ + +E +L+ L +V + S+ D++ + ++ +L G+LR + + + +
Sbjct: 45 RNVLNERRILQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQV 102
Query: 105 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTARSV 163
K W +I+ L YLHS IIHRD+K DNI ++ G V I D +A + S
Sbjct: 103 KFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTST 159
Query: 164 IGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGI 219
GTP +MAPE+ + Y+ VD +S G+ E + + PY S K+ T+ +
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV 219
Query: 220 K-PASLAKVNDPQIKGFIEKCLVPASERLS--AKDLLKDPFL 258
PA+ + I +E +RL KDL P+
Sbjct: 220 LYPATWSTEAIDAINKLLE---RDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 72/323 (22%)
Query: 17 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK-- 74
A D+ G +VA KI +V D +++ E+ LL+ L+ +N++
Sbjct: 18 SAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75
Query: 75 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
V ++TEL + +L + K + + I+ + QIL GL YLHS N +IHRDLK
Sbjct: 76 FNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPS 132
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APE--LYEEEYNE 181
NI VN N ++KI D GLA + F+ APE L Y +
Sbjct: 133 NILVNSN-CDLKICDFGLARGVDPDED-----EKGFLTEYVVTRWYRAPELLLSSSRYTK 186
Query: 182 LVDIYSFGMCIL-EMVT----F----------------------EYPYSECKNPAQIFKK 214
+DI+S G CI E++T F + + + A+ + K
Sbjct: 187 AIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK-ARNYLK 244
Query: 215 VTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKEPI 267
L+K+ P+ +EK LV P +R++A + L P+L + + EP+
Sbjct: 245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK-KRITADEALAHPYLAQLHDPEDEPV 303
Query: 268 CDPL---------KLPIQSLKML 281
P +L + LK L
Sbjct: 304 AKPPFDFDFFDDDELTEEELKEL 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 72/270 (26%), Positives = 127/270 (47%), Gaps = 44/270 (16%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK-LYSEVHLLKSLKD-DNVVKFYKSWVDDK 73
YKA + G VA +KI D++ D ++ + E ++L+ + N+ FY +++ K
Sbjct: 23 YKARHKKTGQLVA---IKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFI--K 74
Query: 74 KKTVN------MITELFTSGNLRQYRKKHKNVDIKVIKNW----ARQILHGLVYLHSHNP 123
K ++ EL G++ K + ++ + W R+ L GL YLH +
Sbjct: 75 KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK- 133
Query: 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPEL------Y 175
+IHRD+K NI + N EVK+ D G++ + R + IGTP +MAPE+
Sbjct: 134 -VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQP 191
Query: 176 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA----QIFKKVTSGIKPASL--AKVND 229
+ Y+ D++S G+ +E+ + P + +P +I + +K K ND
Sbjct: 192 DASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPRNPPPTLKSPENWSKKFND 250
Query: 230 PQIKGFIEKCLVP-ASERLSAKDLLKDPFL 258
FI +CL+ +R ++LL+ PF+
Sbjct: 251 -----FISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 12/215 (5%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDIKVIKNW 107
E LL LK N+V + +SW + + + ++ G+L K+ K + + W
Sbjct: 49 EAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVIG 165
QI L YLH + I+HRDLK N+F+ + +K+GDLG+A + Q A ++IG
Sbjct: 108 FVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIG 164
Query: 166 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 224
TP +M+PEL+ + YN D+++ G C+ EM T ++ ++ + +++ + + P +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--M 222
Query: 225 AKVNDPQIKGFIEKCLVPASE-RLSAKDLLKDPFL 258
K P++ I L E R S K +L+ P++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 14/216 (6%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK--VIKNW 107
EV LL +K N+V F+ S+ ++ + + M E G+L + + + V I +W
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVM--EYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIG 165
QI GL H H+ I+HRD+K NIF++ N K+GD G+A + A + +G
Sbjct: 107 FVQISLGLK--HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 166 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IKPAS 223
TP +++PE+ + YN DI+S G + E+ T ++P+ E N Q+ K+ G P S
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYFAPIS 223
Query: 224 LAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 258
D ++ I + V +R S +LK PFL
Sbjct: 224 PNFSRD--LRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 74/261 (28%), Positives = 110/261 (42%), Gaps = 58/261 (22%)
Query: 45 QKLYS--------EVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK 95
+K YS EV L+ L + N+VK + + + + + E + GNL Q K
Sbjct: 34 KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKD 90
Query: 96 HKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153
K VI++ QIL GL ++H H HRDLK +N+ V+G VKI D GLA
Sbjct: 91 RKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAR 147
Query: 154 AMQ-QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTFE--YP-YSECK 206
++ +P + T + APE L Y+ VDI++ G CI+ E+ T +P SE
Sbjct: 148 EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALG-CIMAELYTLRPLFPGSSEID 206
Query: 207 NPAQIFKKVT-----------SGIKPASLAKVNDPQIKG----------------FIEKC 239
Q++K + G K AS PQ I+
Sbjct: 207 ---QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDM 263
Query: 240 LV--PASERLSAKDLLKDPFL 258
L P +R +A L+ P+
Sbjct: 264 LRWDPK-KRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 73/231 (31%), Positives = 120/231 (51%), Gaps = 12/231 (5%)
Query: 32 VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 91
+KI D+ + +++ + E+ +L V K+Y S++ D K + +I E G+
Sbjct: 34 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALD 91
Query: 92 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151
+ +D I R+IL GL YLHS IHRD+K N+ ++ HGEVK+ D G+
Sbjct: 92 LLEPGP-LDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGV 147
Query: 152 A--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNP 208
A + Q + +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P+SE +P
Sbjct: 148 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HP 206
Query: 209 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 258
++ + P + P +K F+E CL S R +AK+LLK F+
Sbjct: 207 MKVLFLIPKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 55/173 (31%), Positives = 97/173 (56%), Gaps = 12/173 (6%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 108
+E +L+S++ +V Y S+ DD + ++ E G L + +K V + +A
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYA 107
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
Q++ L YLHS + I++RDLK +N+ + + G +KI D G A ++ T ++ GTPE
Sbjct: 108 AQVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRT-YTLCGTPE 163
Query: 169 FMAPELYEEE-YNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSG 218
++APE+ + Y + VD ++ G+ I EM+ YP + + NP QI++K+ G
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDD--NPIQIYEKILEG 213
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 78/254 (30%), Positives = 129/254 (50%), Gaps = 24/254 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y A D G EVA ++ LQ + + +E+ +++ K+ N+V + S++ +
Sbjct: 36 YTAIDIATGQEVAIKQMN----LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
V M E G+L + +D I R+ L L +LHS+ +IHRD+K DNI
Sbjct: 92 WVVM--EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNI 146
Query: 136 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 192
+ G G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ-----IKGFIEKCL-VPASER 246
+EMV E PY +NP + + + P ++ +P+ + F+ +CL + R
Sbjct: 206 IEMVEGEPPYLN-ENPLRALYLIATNGTP----ELQNPERLSAVFRDFLNRCLEMDVDRR 260
Query: 247 LSAKDLLKDPFLQV 260
SAK+LL+ PFL++
Sbjct: 261 GSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 57/225 (25%), Positives = 113/225 (50%), Gaps = 21/225 (9%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 109
E+ ++ + +V FY +++++ + M E G+L + KK + ++++ A
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAV 110
Query: 110 QILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
++ GL YL++ H I+HRD+K NI VN G++K+ D G++ + A + +GT
Sbjct: 111 AVVEGLTYLYNVHR--IMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTST 167
Query: 169 FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-------- 219
+M+PE + +Y D++S G+ I+E+ ++P++ N + GI
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIV 226
Query: 220 --KPASLAKVNDPQI-KGFIEKCLV-PASERLSAKDLLK-DPFLQ 259
P L + P+ + F++ CL+ +ER + + L PF+Q
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 67/255 (26%), Positives = 124/255 (48%), Gaps = 20/255 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA+ +A + +D ++L +++ SE+ +L ++ FY ++ + +
Sbjct: 18 YKAYHLLTRRILAVKVIPLDITVELQ---KQIMSELEILYKCDSPYIIGFYGAFFVENR- 73
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+++ TE G+L YRK + V+ A ++ GL YL S I+HRD+K N+
Sbjct: 74 -ISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNM 126
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 194
VN G+VK+ D G++ + A++ +GT +MAPE + E+Y D++S G+ +E
Sbjct: 127 LVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185
Query: 195 MVTFEYPYSEC-KN-----PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERL 247
+ +PY + KN P Q+ + + P + FI +C+ ER
Sbjct: 186 LALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERP 245
Query: 248 SAKDLLKDPFLQVEN 262
+ ++L+ PF+ N
Sbjct: 246 APENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 21/224 (9%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF---TSGNLRQYRKKHKNVDI 101
Q + EV L+ L+ N +++ ++ ++ T ++ E S L ++K + V+I
Sbjct: 60 QDIIKEVRFLQQLRHPNTIEYKGCYL--REHTAWLVMEYCLGSASDILEVHKKPLQEVEI 117
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
I L GL YLHSH IHRD+K NI + G VK+ D G A ++ P A
Sbjct: 118 AAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSA-SLVSP-AN 169
Query: 162 SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 217
S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + ++ +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 218 GIKPASLAKVNDPQ-IKGFIEKCLV-PASERLSAKDLLKDPFLQ 259
+L+ + + F++ CL +R S+++LLK F+
Sbjct: 230 --DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 57/176 (32%), Positives = 98/176 (55%), Gaps = 13/176 (7%)
Query: 47 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIK 105
L E+ +L++L +N+VK+ +D + +I E SG+L++Y ++KN +++K
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 106 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TAR 161
+A QI G+ YL S +HRDL N+ V + +VKIGD GL A++ T +
Sbjct: 113 KYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 162 SVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 215
+ +P F APE L + ++ D++SFG+ + E++T Y SE +P +F K+
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT--YCDSES-SPMTLFLKM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 77/284 (27%), Positives = 118/284 (41%), Gaps = 53/284 (18%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL----YSEVHLLKSLKD---DNVVKFYK- 67
YKA D G VA +V++ P + + E+ LLK L+ N+V+
Sbjct: 16 YKARDLNTGRFVALKKVRV------PLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDV 69
Query: 68 --SWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNP 123
D++ + ++ E +L Y K + + IK+ RQ+L G+ +LHSH
Sbjct: 70 CHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR- 127
Query: 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNE 181
I+HRDLK NI V + G+VKI D GLA I + SV+ T + APE L + Y
Sbjct: 128 -IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYAT 185
Query: 182 LVDIYSFGMCIL-EMVTFE---YPYSECKNPAQIFKKV---------------------T 216
VD++S G CI E+ SE +IF +
Sbjct: 186 PVDMWSVG-CIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSY 244
Query: 217 SGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFL 258
+ S + ++K L P R+SA + L+ P+
Sbjct: 245 TPRSFKSFVPEICEEGLDLLKKMLTFNPHK-RISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 16/217 (7%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIK 105
E LL L +VKF+ S+++ + +ITE +L + + K + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLE--RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC 109
Query: 106 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSV 163
W Q+L G+ Y+H I+HRDLK NIF+ N +KIGD G++ + A +
Sbjct: 110 EWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTF 165
Query: 164 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 222
GTP +M+PE L + Y+ DI+S G + EM + + E +N + ++ G P
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP- 223
Query: 223 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 258
SL + Q+ ++ L S R SA ++L++PF+
Sbjct: 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 70/246 (28%), Positives = 110/246 (44%), Gaps = 44/246 (17%)
Query: 54 LKSLKDDN---VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQ 110
LK L + N +V FY ++ D + ++ M E G+L Q KK + ++ +
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIA 107
Query: 111 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM 170
+L GL YL I+HRD+K NI VN GE+K+ D G++ + A S +GT +M
Sbjct: 108 VLRGLTYLRE-KHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYM 165
Query: 171 APE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--SECKNPAQIFKKVTSGIK------- 220
+PE L Y DI+S G+ ++EM YP + K +F + S +
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225
Query: 221 --------PASLA-------KVNDP-----------QIKGFIEKCLVP-ASERLSAKDLL 253
P +A VN+P + + F++KCL ER K+L
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285
Query: 254 KDPFLQ 259
K PF++
Sbjct: 286 KHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 54/182 (29%), Positives = 92/182 (50%), Gaps = 9/182 (4%)
Query: 90 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 149
++ K + ++ A I+ L YLHS +IHRD+K N+ +N +G+VK+ D
Sbjct: 91 KKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLIN-RNGQVKLCDF 148
Query: 150 GLAIAMQQPTARSV-IGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTFEYPYS 203
G++ + A+++ G +MAPE E Y+ D++S G+ ++E+ T +PY
Sbjct: 149 GISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
Query: 204 ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVEN 262
K P Q K+V P A+ P+ + F+ KCL ER + +LL+ PF ++
Sbjct: 209 SWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268
Query: 263 QK 264
K
Sbjct: 269 SK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 57/166 (34%), Positives = 89/166 (53%), Gaps = 20/166 (12%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ-----YRKKHKNVDIKVI 104
E+ LL+ LK +NVV + +++ K+V ++ + + +L Q + K ++ ++
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 105 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAIAMQQP--- 158
K+ QIL+G+ YLHS+ ++HRDLK NI V G G VKIGDLGLA P
Sbjct: 111 KSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 159 --TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFE 199
V+ T + APEL Y + +DI++ G CI E++T E
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 57/172 (33%), Positives = 91/172 (52%), Gaps = 16/172 (9%)
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 161
I+ +Q L L YLH + IIHRDLK NI + G++K+ D G++ + R
Sbjct: 105 IRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRD 161
Query: 162 SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 215
S IGTP +MAPE+ + Y+ D++S G+ ++EM E P+ E NP ++ K+
Sbjct: 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKI 220
Query: 216 TSGIKPASLAKVN--DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 264
+P +LA+ + + K F++KCL R + LL+ PF+ V + K
Sbjct: 221 AKS-EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 4e-19
Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 24/254 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y A D G EVA ++ LQ + + +E+ +++ K+ N+V + S++ +
Sbjct: 37 YTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
V M E G+L + +D I R+ L L +LHS+ +IHRD+K DNI
Sbjct: 93 WVVM--EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 136 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 192
+ G G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 148 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ-----IKGFIEKCL-VPASER 246
+EM+ E PY +NP + + + P ++ +P+ + F+ +CL + +R
Sbjct: 207 IEMIEGEPPYLN-ENPLRALYLIATNGTP----ELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 247 LSAKDLLKDPFLQV 260
SAK+LL+ FL++
Sbjct: 262 GSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 63/229 (27%), Positives = 117/229 (51%), Gaps = 15/229 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ D + A + I +V++L Q +++E +LK + +++ + + D +
Sbjct: 18 HLVRDRISEHYYALKVMAIPEVIRLK-QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-- 74
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ M+ E G L Y + +A +I+ L YLHS I++RDLK +NI
Sbjct: 75 FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENI 132
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 194
++ G +K+ D G A ++ T ++ GTPE++APE+ + + +N+ VD ++ G+ I E
Sbjct: 133 LLD-KEGHIKLTDFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYE 190
Query: 195 MVTFEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLV 241
M+ P+ + NP I++K+ +G ++ P L D K I+K LV
Sbjct: 191 MLVGYPPFFD-DNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 69/232 (29%), Positives = 116/232 (50%), Gaps = 17/232 (7%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKV 103
Q + EV L+ LK N +++ ++ + + M L ++ +L + KK + V+I
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 125
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 163
I + A L GL YLHSHN +IHRD+K NI + G+VK+ D G A + P A S
Sbjct: 126 ITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSA-SKSSP-ANSF 177
Query: 164 IGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 219
+GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N +
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQND 236
Query: 220 KPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVENQKEPICD 269
P + +GF++ CL +P ER ++ +LL+ F++ + + D
Sbjct: 237 SPTLQSNEWTDSFRGFVDYCLQKIP-QERPASAELLRHDFVRRDRPARVLID 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 12/195 (6%)
Query: 60 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 119
V K Y + K + ++ E G+ K + K + +++ G+ LH
Sbjct: 57 PYVAKLY--YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH 114
Query: 120 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EE 178
IIHRD+K +N+ ++ G +K+ D GL+ + + +GTP+++APE
Sbjct: 115 QRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVG 169
Query: 179 YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFI 236
+++ D +S G I E + F YP + P +F + S P + + P+ I
Sbjct: 170 DDKMSDWWSLGCVIFEFL-FGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI 228
Query: 237 EKCLVP-ASERLSAK 250
+ L ++RL A
Sbjct: 229 NRLLCMDPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 74/254 (29%), Positives = 120/254 (47%), Gaps = 20/254 (7%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
D YKA + G A +K++ PG D + E+ ++K K N+V ++ S++
Sbjct: 24 DVYKARNVNTGELAAIKVIKLE-----PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
K + M E G+L+ + I +R+ L GL YLHS +HRD+K
Sbjct: 79 DKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--MHRDIKG 134
Query: 133 DNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE----YNELVDIY 186
NI + N G VK+ D G++ + A+ S IGTP +MAPE+ E YN+L DI+
Sbjct: 135 ANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIW 193
Query: 187 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA-KVN-DPQIKGFIEKCLVP-A 243
+ G+ +E+ + P + +F S +P L K+ F++ L
Sbjct: 194 AVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNP 253
Query: 244 SERLSAKDLLKDPF 257
+R +A+ LL+ PF
Sbjct: 254 KKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV--IKNW 107
E+ LL+ LK N++ + K +N++ E F +L + K K++ + IK++
Sbjct: 52 EIKLLQELKHPNIIGLLDVFG--HKSNINLVFE-FMETDLEKVIKD-KSIVLTPADIKSY 107
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SVI 164
L GL YLHS+ I+HRDLK +N+ + + G +K+ D GLA + P + V+
Sbjct: 108 MLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 165 GTPEFMAPELY--EEEYNELVDIYSFGMCIL 193
T + APEL Y VD++S G CI
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 9e-18
Identities = 71/249 (28%), Positives = 122/249 (48%), Gaps = 15/249 (6%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ YK D VA +KI D+ + +++ + E+ +L + ++Y S++
Sbjct: 19 EVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
K + +I E G+ K ++ I R+IL GL YLHS IHRD+K
Sbjct: 76 K--LWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSERK--IHRDIKAA 130
Query: 134 NIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGM 190
N+ ++ G+VK+ D G+A + Q + +GTP +MAPE+ ++ Y+ DI+S G+
Sbjct: 131 NVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGI 189
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RLSA 249
+E+ E P S+ +P ++ + P + + P K F+E CL R +A
Sbjct: 190 TAIELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEGQYSKP-FKEFVEACLNKDPRFRPTA 247
Query: 250 KDLLKDPFL 258
K+LLK F+
Sbjct: 248 KELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 71/249 (28%), Positives = 115/249 (46%), Gaps = 25/249 (10%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
D YKA + G A +K++ PGD + E+ ++K K N+V ++ S++
Sbjct: 24 DVYKARNLHTGELAAVKIIKLE-----PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+K + M E G+L+ + I R+ L GL YLHS +HRD+K
Sbjct: 79 EKLWICM--EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--MHRDIKG 134
Query: 133 DNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE----YNELVDIY 186
NI + ++G+VK+ D G+A + A+ S IGTP +MAPE+ E YN+L DI+
Sbjct: 135 ANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIW 193
Query: 187 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN--DPQIKGFIEKCLV--- 241
+ G+ +E+ + P + +F S +P L F++ L
Sbjct: 194 AVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNP 253
Query: 242 ---PASERL 247
P +ERL
Sbjct: 254 KKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 43/277 (15%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA D+ G VA ++K+ + G + E+ LLK L N++K V K
Sbjct: 16 YKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLLD--VFRHKG 71
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ ++ E + + + + + + +IK++ Q+L GL + HSH I+HRDLK +N+
Sbjct: 72 DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENL 129
Query: 136 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMC 191
+N G +K+ D GLA + T + APEL ++ Y+ VDI+S G C
Sbjct: 130 LINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVG-C 187
Query: 192 IL-EMVTFEYPYSECKN--------------PAQ-IFKKVTS-------------GIKPA 222
I E+++ P K+ P ++ K TS G+
Sbjct: 188 IFAELLSRR-PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLP 246
Query: 223 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258
L PQ + + L +R++A+ L P+
Sbjct: 247 KLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 46 KLYSEVHLLK-SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY----RKKHKNVD 100
+ SEV ++K L+ N+V++YK+++++ + + M +L L ++ ++K +
Sbjct: 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVM--DLIEGAPLGEHFNSLKEKKQRFT 111
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160
+ I N Q++ L YLH I+HRDL +NI + G +V I D GLA +QP +
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDFGLA-KQKQPES 168
Query: 161 R--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 217
+ SV+GT + PE+ + E Y E D+++FG + +M T + P+ N + K+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVE 227
Query: 218 GIKPASLAKVNDPQIKGFIEKCLVPASE 245
+ + + I CL P +E
Sbjct: 228 AVYEPLPEGMYSEDVTDVITSCLTPDAE 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 70/245 (28%), Positives = 121/245 (49%), Gaps = 27/245 (11%)
Query: 32 VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM-------ITELF 84
+KI D+ + +++ + E+ +L V K+Y S++ K + M +L
Sbjct: 34 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL 93
Query: 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 144
+G +++ I ++IL GL YLHS IHRD+K N+ ++ G+V
Sbjct: 94 RAGPFDEFQ----------IATMLKEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDV 140
Query: 145 KIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYP 201
K+ D G+A + Q + +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
Query: 202 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFLQV 260
S+ +P ++ + P +L K FI+ CL S R +AK+LLK F+ V
Sbjct: 201 NSD-MHPMRVLFLIPK-NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI-V 257
Query: 261 ENQKE 265
+N K+
Sbjct: 258 KNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 67/256 (26%), Positives = 124/256 (48%), Gaps = 25/256 (9%)
Query: 22 FAGIEVAWSRVKIDDVLQLPGDLQK-LYSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVN- 78
+ G V ++ V+ + GD ++ + E+++LK N+ +Y +++ ++
Sbjct: 23 YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82
Query: 79 ---MITELFTSGNLRQYRKKHKNVDIKVIKNW----ARQILHGLVYLHSHNPPIIHRDLK 131
++ E +G++ K K +K + W R+IL GL +LH H +IHRD+K
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIAYICREILRGLSHLHQHK--VIHRDIK 138
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY------EEEYNELV 183
N+ + N EVK+ D G++ + + R + IGTP +MAPE+ + Y+
Sbjct: 139 GQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 197
Query: 184 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA 243
D++S G+ +EM P + +P + + P +K + + FIE CLV
Sbjct: 198 DLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKN 256
Query: 244 -SERLSAKDLLKDPFL 258
S+R + + L+K PF+
Sbjct: 257 HSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 161
I+ RQ+L L YLHS IIHRDLK N+ + + G++K+ D G++ + R
Sbjct: 112 IQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRD 168
Query: 162 SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 215
S IGTP +MAPE + + Y+ DI+S G+ ++EM E P+ E NP ++ K+
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKI 227
Query: 216 TSGIKPASLAKVN-DPQIKGFIEKCLVPASE-RLSAKDLLKDPFLQVENQKEPI 267
P + + F++ L E R SA LL+ PF+ P+
Sbjct: 228 AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 24 GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK-KKTVNMITE 82
G +VA + Q D ++ E+ +L++L +N+VK YK + +++ +I E
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHENIVK-YKGVCEKPGGRSLRLIME 88
Query: 83 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141
SG+LR Y ++H+ +++K + ++ QI G+ YL S IHRDL NI V
Sbjct: 89 YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESED 146
Query: 142 GEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEM 195
VKI D GLA + + + +P F APE L +++ D++SFG+ + E+
Sbjct: 147 -LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205
Query: 196 VTFEYPYSECKNPAQIFK 213
F Y PA+ +
Sbjct: 206 --FTYGDPSQSPPAEFLR 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 16/189 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA D+ G VA +++++ + G E+ LLK L N+V+ + K
Sbjct: 16 YKARDKLTGEIVALKKIRLET--EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK- 72
Query: 76 TVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ ++ E F +L++Y +D +IK++ Q+L G+ Y HSH ++HRDLK
Sbjct: 73 -LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQ 128
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 189
N+ ++ G +K+ D GLA A P T + T + APE L +Y+ VDI+S G
Sbjct: 129 NLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG 187
Query: 190 MCIL-EMVT 197
CI EMV
Sbjct: 188 -CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 25 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84
I VA +K D + + D K E ++ SL +N+++ Y + M+TEL
Sbjct: 24 IPVAVKCLKSDKLSDIMDDFLK---EAAIMHSLDHENLIRLYGVVLTHPLM---MVTELA 77
Query: 85 TSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 142
G+L +K I + ++A QI +G+ YL S IHRDL NI + +
Sbjct: 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDD- 134
Query: 143 EVKIGDLGLAIAMQQ-------------PTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 188
+VKIGD GL A+ Q P A + APE L ++ D++ F
Sbjct: 135 KVKIGDFGLMRALPQNEDHYVMEEHLKVPFA--------WCAPESLRTRTFSHASDVWMF 186
Query: 189 GMCILEMVTF-EYPYSECKNPAQIFKKV 215
G+ + EM T+ E P++ + +QI KK+
Sbjct: 187 GVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 69/232 (29%), Positives = 114/232 (49%), Gaps = 17/232 (7%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKV 103
Q + EV L+ L+ N +++ ++ + + M L ++ +L + KK + V+I
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 163
+ + A L GL YLHSHN +IHRD+K NI ++ G VK+GD G A M A
Sbjct: 120 VTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXF 171
Query: 164 IGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 219
+GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNE 230
Query: 220 KPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVENQKEPICD 269
PA + + F++ CL +P +R +++ LLK F+ E I D
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIP-QDRPTSEVLLKHRFVLRERPPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 61/188 (32%), Positives = 94/188 (50%), Gaps = 14/188 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA ++ G VA ++++D + G E+ LLK L N+VK V +
Sbjct: 17 YKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVKLLD--VIHTEN 72
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKV--IKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ ++ E F +L+++ I + IK++ Q+L GL + HSH ++HRDLK
Sbjct: 73 KLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQ 129
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 189
N+ +N G +K+ D GLA A P T + T + APE L + Y+ VDI+S G
Sbjct: 130 NLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 188
Query: 190 MCILEMVT 197
EMVT
Sbjct: 189 CIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 81/290 (27%), Positives = 125/290 (43%), Gaps = 48/290 (16%)
Query: 18 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77
A D+ G VA KI P ++ Y E+ LLK L+ +N++ ++ + +
Sbjct: 29 ARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-PLEDI 85
Query: 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137
+TEL + R + ++ + I+ + QIL GL Y+HS ++HRDLK NI +
Sbjct: 86 YFVTELLGTDLHRLL--TSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILI 141
Query: 138 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEM 195
N N ++KI D GLA +Q P + T + APE L ++Y+ VDI+S G EM
Sbjct: 142 NEN-CDLKICDFGLA-RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
Query: 196 VTFEYPYSECKNPAQIFKKVTS--GIKP---------------------------ASLAK 226
+ + P K+ F +T G P + K
Sbjct: 200 LEGK-PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFK 258
Query: 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEPICDPLKLPI 275
DP +EK LV +R+SA + L P+L P DP P+
Sbjct: 259 NADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA------PYHDPTDEPV 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 10/184 (5%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VD 100
++ E LL +K N+V F +S+ D + M E G+L Q K +
Sbjct: 41 AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM--EYCDGGDLMQKIKLQRGKLFP 98
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160
I W Q+ G+ H H ++HRD+K NIF+ N G+VK+GD G A + P A
Sbjct: 99 EDTILQWFVQMCLGVQ--HIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA 155
Query: 161 RSV--IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 217
+ +GTP ++ PE++E YN DI+S G + E+ T ++P+ I K
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215
Query: 218 GIKP 221
KP
Sbjct: 216 SYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 41/99 (41%), Positives = 62/99 (62%), Gaps = 6/99 (6%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARSVI 164
+ QI+ GL +LH II+RDLK +N+ ++ N G V+I DLGLA+ ++ Q +
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 165 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPY 202
GTP FMAPEL + EEY+ VD ++ G+ + EM+ P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 53/177 (29%), Positives = 92/177 (51%), Gaps = 11/177 (6%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI--KVIKNW 107
EV +L ++K N+V++ +S+ ++ + ++ + G+L + + V I +W
Sbjct: 49 EVAVLSNMKHPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIG 165
QI L H H+ I+HRD+K NIF+ G +K+GD G+A + AR+ IG
Sbjct: 107 FVQICLALK--HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIG 163
Query: 166 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 221
TP +++PE+ E YN DI++ G + EM T ++ + E N + K+ G P
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVI 164
+A QI+ GL H H I++RDLK +N+ ++ +HG V+I DLGLA+ + +
Sbjct: 100 YAAQIICGL--EHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155
Query: 165 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP---YSECKNPAQIFKKVTSGIK 220
GTP +MAPE L E Y+ VD ++ G + EM+ P E ++ ++
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--M 213
Query: 221 PASLAKVNDPQIKGFIEKCLVP-ASERL-----SAKDLLKDPFLQ 259
P+ K E L +RL SA ++ + P +
Sbjct: 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 68/232 (29%), Positives = 117/232 (50%), Gaps = 17/232 (7%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKV 103
Q + EV L+ +K N +++ ++ + + M L ++ +L + KK + V+I
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 129
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 163
I + A L GL YLHSHN +IHRD+K NI + G+VK+ D G A ++ P A S
Sbjct: 130 ITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSA-SIASP-ANSF 181
Query: 164 IGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 219
+GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N +
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNE 240
Query: 220 KPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVENQKEPICD 269
P + + F++ CL +P +R ++++LLK F+ E + + D
Sbjct: 241 SPTLQSNEWSDYFRNFVDSCLQKIP-QDRPTSEELLKHMFVLRERPETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 62/188 (32%), Positives = 103/188 (54%), Gaps = 19/188 (10%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+KA + VA RV++DD + G E+ LLK LK N+V+ Y DKK
Sbjct: 17 FKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74
Query: 76 TVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
T ++ E + +L++Y + ++D +++K++ Q+L GL + HSHN ++HRDLK N
Sbjct: 75 T--LVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQN 129
Query: 135 IFVNGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSF 188
+ +N N GE+K+ D GLA I ++ +A V T + P+ + Y+ +D++S
Sbjct: 130 LLINKN-GELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTSIDMWSA 186
Query: 189 GMCIL-EM 195
G CI E+
Sbjct: 187 G-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 71/260 (27%), Positives = 123/260 (47%), Gaps = 29/260 (11%)
Query: 16 YKAFDEFAGIEVAWS--RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
YK G+ +A R+++D+ ++ E+ +L +V FY ++
Sbjct: 18 YKVLHRPTGVTMAMKEIRLELDE-----SKFNQIIMELDILHKAVSPYIVDFYGAFF--I 70
Query: 74 KKTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRD 129
+ V M E +G+L + + + V++ ++ GL +L HN IIHRD
Sbjct: 71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRD 128
Query: 130 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-------YNEL 182
+K N+ VNGN G+VK+ D G++ + A++ IG +MAPE + Y
Sbjct: 129 VKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ 187
Query: 183 VDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCL 240
D++S G+ ILEM YPY + A IF ++++ + P +L + F+ KCL
Sbjct: 188 SDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCL 246
Query: 241 --VPASERLSAKDLLKDPFL 258
+P + R + LL+ P+L
Sbjct: 247 NKIP-NRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 54/156 (34%), Positives = 87/156 (55%), Gaps = 14/156 (8%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 109
E+++LK+L +N+VK+ + K + +I E G+LR Y KH +++ + +A+
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQ 114
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA------RSV 163
QI G+ YLHS + IHRDL N+ ++ N VKIGD GLA A+ P R
Sbjct: 115 QICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PEGHEYYRVRED 169
Query: 164 IGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 197
+P F A E L E +++ D++SFG+ + E++T
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 50/249 (20%)
Query: 50 EVHLLKSLKDDNVVKF---YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 106
EV +L+ L+ +N+V ++ K + ++ E L + +++
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRR-----KGRLYLVFEYVERTLLELLEASPGGLPPDAVRS 104
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SV 163
+ Q+L + Y HSHN IIHRD+K +NI V+ G +K+ D G A A++ A
Sbjct: 105 YIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDY 161
Query: 164 IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFE--YP----------------- 201
+ T + APEL + Y + VD+++ G CI+ E++ E +P
Sbjct: 162 VATRWYRAPELLVGDTNYGKPVDVWAIG-CIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220
Query: 202 ------YSECKNPAQIFKKVTSGIKPASL-----AKVNDPQIKGFIEKCLVP-ASERLSA 249
NP +P SL KV+ P + F++ CL ERL+
Sbjct: 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL-DFLKACLRMDPKERLTC 279
Query: 250 KDLLKDPFL 258
+LL+ P+
Sbjct: 280 DELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 69/248 (27%), Positives = 122/248 (49%), Gaps = 32/248 (12%)
Query: 32 VKIDDVLQLPGDLQKLYSEVHLLKSLKDD-NVVKFYKSWV-------DDKKKTVNMITEL 83
+K+ DV + + +++ E+++LK N+ +Y +++ DD+ + ++ E
Sbjct: 46 IKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ---LWLVMEF 100
Query: 84 FTSGNLRQYRKKHKNVDIKVIKNW----ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139
+G++ K K +K ++W R+IL GL +LH+H +IHRD+K N+ +
Sbjct: 101 CGAGSVTDLVKNTKGNALK--EDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTE 156
Query: 140 NHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIYSFGMC 191
N EVK+ D G++ + + R + IGTP +MAPE+ + Y+ DI+S G+
Sbjct: 157 N-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGIT 215
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPAS-ERLSAK 250
+EM P + +P + + P +K + FIE CLV R S +
Sbjct: 216 AIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTE 274
Query: 251 DLLKDPFL 258
LLK PF+
Sbjct: 275 QLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 56/177 (31%), Positives = 90/177 (50%), Gaps = 15/177 (8%)
Query: 44 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIK 102
L+ E+ +LKSL+ DN+VK+ ++ + ++ E G+LR Y +KH+ +D +
Sbjct: 49 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR 108
Query: 103 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 162
+ +A QI G+ YL S +HRDL NI V + VKIGD GL + Q
Sbjct: 109 KLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYY 165
Query: 163 VIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSE-CKNPAQIF 212
+ P + APE L E +++ D++SFG+ + E+ T YS+ +P F
Sbjct: 166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNW 107
E ++K L+ +++ Y V ++ + ++TEL G+L +Y + + + + +
Sbjct: 51 EAQIMKKLRHPKLIQLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 165
A Q+ G+ YL + N IHRDL N+ V G + K+ D GLA I AR
Sbjct: 109 AAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAK 165
Query: 166 TP-EFMAPELYEEEYNELV---DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
P ++ APE YN D++SFG+ + E+VT+ PY N A++ ++V G
Sbjct: 166 FPIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 69/242 (28%), Positives = 110/242 (45%), Gaps = 29/242 (11%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 109
E+ +L+ + NVVK + + D + ++ E G+L + + + + AR
Sbjct: 122 EIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE----QFLADVAR 175
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---PTARSVIGT 166
QIL G+ YLH + I+HRD+K N+ +N VKI D G++ + Q P SV GT
Sbjct: 176 QILSGIAYLHRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV-GT 231
Query: 167 PEFMAPELYEEEYNELV------DIYSFGMCILE--MVTFEYPYSECKNPAQIFKKVTSG 218
+M+PE + N DI+S G+ ILE + F + + A + +
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS 291
Query: 219 IKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFL----QVENQKEPICDPLK 272
P + A + + + FI CL PA +R SA LL+ PF+ + Q P L
Sbjct: 292 QPPEAPATAS-REFRHFISCCLQREPA-KRWSAMQLLQHPFILRAQPGQGQGGPNLHQLL 349
Query: 273 LP 274
P
Sbjct: 350 PP 351
|
Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 41/244 (16%)
Query: 48 YSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIK 105
E+ L+ L N+++ + D K + ++ EL NL + K K + K +K
Sbjct: 45 LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVK 103
Query: 106 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSV 163
++ Q+L L ++H + I HRD+K +NI + + +K+ D G I + P
Sbjct: 104 SYMYQLLKSLDHMHRNG--IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYT-EY 158
Query: 164 IGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA-QIFK------- 213
I T + APE L + Y +DI++ G E+++ +P N QI K
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL-FPLFPGTNELDQIAKIHDVLGT 217
Query: 214 ---KVTSGIKPASLAKVNDPQIKGF-IEKCLVPAS----------------ERLSAKDLL 253
+V + + N P KG + K L AS ER++AK L
Sbjct: 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
Query: 254 KDPF 257
+ P+
Sbjct: 278 RHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 40/101 (39%), Positives = 57/101 (56%), Gaps = 8/101 (7%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSV 163
+A ++ GL YLH + I++RDLK DN+ ++ G VKI D GL + T+ +
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTS-TF 161
Query: 164 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYS 203
GTPEF+APE L E Y VD + G+ I EM+ E P+
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 49/162 (30%), Positives = 85/162 (52%), Gaps = 5/162 (3%)
Query: 41 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 100
P ++ E+ +L +V FY ++ D + ++ M E G+L Q K+ K +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIP 101
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160
+++ + +L GL YL + I+HRD+K NI VN + GE+K+ D G++ + A
Sbjct: 102 EEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 161 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP 201
S +GT +M+PE L Y+ DI+S G+ ++E+ YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 41/129 (31%), Positives = 72/129 (55%), Gaps = 6/129 (4%)
Query: 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139
+ E G+L + + D + +A +I+ GL +LH II+RDLK DN+ ++
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDK 131
Query: 140 NHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 196
+ G +KI D G+ + A + GTP+++APE+ + ++YNE VD +SFG+ + EM+
Sbjct: 132 D-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
Query: 197 TFEYPYSEC 205
+ P+
Sbjct: 191 IGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 68/191 (35%), Positives = 95/191 (49%), Gaps = 22/191 (11%)
Query: 17 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVDD 72
AFD G +VA K+ Q ++ Y E+ LLK + +NV+ F + +
Sbjct: 33 SAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ V ++T L + +L K K D I+ QIL GL Y+HS IIHRDLK
Sbjct: 91 DFQDVYLVTHLMGA-DLNNIVKCQKLSD-DHIQFLVYQILRGLKYIHSAG--IIHRDLKP 146
Query: 133 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG---TPEFMAPE--LYEEEYNELVDIYS 187
NI VN + E+KI D GLA + T + G T + APE L YN+ VDI+S
Sbjct: 147 SNIAVNEDC-ELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201
Query: 188 FGMCIL-EMVT 197
G CI+ E++T
Sbjct: 202 VG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 40/206 (19%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA D+ G VA +V++D+ + G E+ +L+ L N+V K V DK+
Sbjct: 24 YKARDKDTGELVALKKVRLDN--EKEGFPITAIREIKILRQLNHRNIVNL-KEIVTDKQD 80
Query: 76 TVNMITE-----------------LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 118
++ + L SG L + + H IK++ +Q+L GL Y
Sbjct: 81 ALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKSFMKQLLEGLNYC 132
Query: 119 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPEL 174
H N +HRD+KC NI +N N G++K+ D GLA +P VI T + PEL
Sbjct: 133 HKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPEL 188
Query: 175 Y--EEEYNELVDIYSFGMCIL-EMVT 197
EE Y +D++S G CIL E+ T
Sbjct: 189 LLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 51/154 (33%), Positives = 81/154 (52%), Gaps = 9/154 (5%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 109
E+ +LK L+ +N+V + V +KK + ++ E L K +D ++ +
Sbjct: 50 EIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP 167
QIL G+ + HSHN IIHRD+K +NI V+ + G VK+ D G A +A + T
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 168 EFMAPELY--EEEYNELVDIYSFGMCILEMVTFE 199
+ APEL + +Y VDI++ G + EM+T E
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 22/192 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YK + G VA + +D P + E+ L+K LK +N+V+ + D
Sbjct: 17 YKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVRLH-----DVIH 68
Query: 76 TVNMITELF--TSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130
T N + +F +L++Y H +D +K++ Q+L G+ + H + ++HRDL
Sbjct: 69 TENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDL 126
Query: 131 KCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIY 186
K N+ +N GE+K+ D GLA A P T + + T + AP+ L Y+ +DI+
Sbjct: 127 KPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIW 185
Query: 187 SFGMCIL-EMVT 197
S G CI+ EM+T
Sbjct: 186 SVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 8/197 (4%)
Query: 41 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 100
P ++ E+ +L +V FY ++ D + ++ M E G+L Q KK +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIP 101
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160
+++ + ++ GL YL + I+HRD+K NI VN + GE+K+ D G++ + A
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 161 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--SECKNPAQIFKKVTS 217
S +GT +M+PE L Y+ DI+S G+ ++EM YP + K +F
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVE 219
Query: 218 GIKPASLAKVNDPQIKG 234
G PA P+ G
Sbjct: 220 G-DPAESETSPRPRPPG 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 60/242 (24%), Positives = 106/242 (43%), Gaps = 40/242 (16%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 109
E+ +LK LK N+V + V +K+ ++++ E L + K + V +IK
Sbjct: 50 EIRMLKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTP 167
Q L + + H HN IHRD+K +NI + G++K+ D G A + P + T
Sbjct: 108 QTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 168 EFMAPELY--EEEYNELVDIYSFGMCILEMVTFE--YPYSE---------------CKNP 208
+ APEL + +Y VD+++ G E++T + +P
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224
Query: 209 AQIFK--KVTSGIK----------PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 255
QIF + G+ + ++ P + F++ CL +ERLS ++LL+
Sbjct: 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALS-FLKGCLQMDPTERLSCEELLEH 283
Query: 256 PF 257
P+
Sbjct: 284 PY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 1e-14
Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 32/234 (13%)
Query: 46 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL-RQYRKKHK---NVDI 101
+L EV++++ LK N+V++ +++ + + ++ E +G+L R +K +K ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 102 KVIKNWARQILHGLVYLHS-----HNPPIIHRDLKCDNIFV--------------NGNHG 142
I + RQ+LH L Y H+ + ++HRDLK NIF+ N +G
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 143 E--VKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMV 196
KIGD GL+ + + A S +GTP + +PEL E Y++ D+++ G I E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 197 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSA 249
+ + P+ + N +Q+ ++ G P K ++ I+ L + A ER SA
Sbjct: 238 SGKTPFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSA 289
|
Length = 1021 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 25 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84
+ VA +K DD+L+ D QK EV LK L+ +++ + V + V +ITEL
Sbjct: 31 VRVAIKILKSDDLLKQ-QDFQK---EVQALKRLRHKHLISLFA--VCSVGEPVYIITELM 84
Query: 85 TSGNLRQYRK--KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 142
G+L + + + + + + + + A Q+ G+ YL N IHRDL NI V G
Sbjct: 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV-GEDL 141
Query: 143 EVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 198
K+ D GLA +++ + ++ APE ++ D++SFG+ + EM T+
Sbjct: 142 VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG 201
Query: 199 EYPYSECKNPAQIFKKVTSG 218
+ PY N +++ ++T+G
Sbjct: 202 QVPY-PGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 164
+A +I+ GL +LH II+RDLK DN+ ++ G +KI D G+ T +
Sbjct: 101 YAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC 157
Query: 165 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 221
GTP+++APE L + Y VD ++ G+ + EM+ + P+ E + ++F+ + P
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYP 216
Query: 222 ASLAKVNDPQIKGFIEKCLVPASERLSA-----KDLLKDPF 257
L+K +K F+ K +RL +D+ PF
Sbjct: 217 RWLSKEAKSILKSFLTK---NPEKRLGCLPTGEQDIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 75 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
V +IT+L G L Y + HK N+ + + NW QI G+ YL ++HRDL
Sbjct: 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAAR 138
Query: 134 NIFVNG-NHGEVKIGDLGLAIAMQQPTARSVIGT----P-EFMAPE-LYEEEYNELVDIY 186
N+ V H VKI D GLA + + P ++MA E + Y D++
Sbjct: 139 NVLVKTPQH--VKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVW 195
Query: 187 SFGMCILEMVTF-EYPY 202
S+G+ + E++TF PY
Sbjct: 196 SYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 163
+K++ R +L G+ Y+H++ I+HRDLK N+ + G +KI D GLA + R
Sbjct: 101 VKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLY 157
Query: 164 ---IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EM 195
+ T + APEL +Y+ VD+++ G CI E+
Sbjct: 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVG-CIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 58/179 (32%), Positives = 82/179 (45%), Gaps = 44/179 (24%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVD------DKKKTVNMIT-----ELFTSGNLRQYRKKHKN 98
E+ +LK LK NVV V+ K+ +V M+T +L SG L +N
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDL--SGLL-------EN 107
Query: 99 VDIKV----IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI- 153
+K+ IK + Q+L G+ YLH ++ I+HRD+K NI ++ N G +KI D GLA
Sbjct: 108 PSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARP 164
Query: 154 ---AMQQPTARSVIGTPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 197
P GT ++ PEL E Y VDI+ G C+ EM T
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 48/283 (16%)
Query: 16 YKAFDEFAGIEVAW--SRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDD 72
YKA D+ G VA +R+++D+ P L+ E+ LL+ L + +V+ +
Sbjct: 18 YKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQMLSESIYIVRLLDVEHVE 73
Query: 73 KKKTVNMITELFT--SGNLRQY-----RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 125
+K + +F +L+++ R + + K IK++ Q+L G+ + H H +
Sbjct: 74 EKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--V 131
Query: 126 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV--IGTPEFMAPE--LYEEEYNE 181
+HRDLK N+ V+ G +KI DLGL A P I T + APE L Y+
Sbjct: 132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYST 191
Query: 182 LVDIYSFGMCILEMVTFEYPY---SECKNPAQIFK-------KVTSGI------------ 219
VDI+S G EM + + SE + IFK +V G+
Sbjct: 192 PVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQW 251
Query: 220 KPASLAKVN---DPQIKGFIEKCLV--PASERLSAKDLLKDPF 257
KP L++ P+ ++K L PA +R+SAK L P+
Sbjct: 252 KPQDLSRAVPDLSPEGLDLLQKMLRYDPA-KRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 111 ILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-VIGTPE 168
I+ L YL H +IHRD+K NI ++ + G VK+ D G++ + A++ G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 169 FMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA- 222
+MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++ K+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 223 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
+ P F++ CL +R ++LL+ PF++
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 52/233 (22%), Positives = 95/233 (40%), Gaps = 45/233 (19%)
Query: 62 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 121
+VK Y S+ D++ + ++ E G+L + + + + +++ L +H
Sbjct: 63 IVKLYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 122 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM-------------------------- 155
IHRD+K DNI + G +K+ D GL M
Sbjct: 121 G--FIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 156 ---QQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKN 207
+Q A S +GTP+++APE L Y D +S G+ + EM+ + +P YS+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPFYSD--T 234
Query: 208 PAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVPASERL-SAKDLLKDPF 257
+ + K+ + + P+ I + L +RL S +++ PF
Sbjct: 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
++ EL G L +Y KK + + + +K A Q+ G+ YL S + +HRDL N+ +
Sbjct: 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV 129
Query: 139 GNHGEVKIGDLGLAIAM----QQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 192
H + KI D G++ A+ A + P ++ APE + +++ D++S+G+ +
Sbjct: 130 NRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188
Query: 193 LEMVTF-EYPYSECKNPAQIFKKVTSG 218
E ++ PY E K ++ + SG
Sbjct: 189 WEAFSYGAKPYGEMKGA-EVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 44/137 (32%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 164
+A +I GL +LHS II+RDLK DN+ ++ G +KI D G+ T R+
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFC 162
Query: 165 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SGIKP 221
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ + ++ ++F+ + + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYP 221
Query: 222 ASLAKVNDPQIKGFIEK 238
SL+K KG + K
Sbjct: 222 KSLSKEAVSICKGLLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 109
E LL+++ +V++ + V M+ ++S K+ + + I +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPE 168
QIL GL YLH+ IIHRD+K +NIF+N + +V IGDLG A + P + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 169 FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNP 208
APE L ++YN DI+S G+ + EM+ YP + ++P
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 104
Q + E +L L +V S+ D+ + V + E G L + +K V
Sbjct: 63 QHVAQEKSILMELSHPFIVNMMCSFQDENR--VYFLLEFVVGGELFTHLRKAGRFPNDVA 120
Query: 105 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 164
K + +++ YLHS + II+RDLK +N+ ++ N G VK+ D G A + T ++
Sbjct: 121 KFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF-TLC 176
Query: 165 GTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 223
GTPE++APE+ + + + + VD ++ G+ + E + P+ + P +I++K+ +G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG----- 230
Query: 224 LAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQK 264
+ P A+DL+K LQ ++ K
Sbjct: 231 --------------RLKFPNWFDGRARDLVKG-LLQTDHTK 256
|
Length = 329 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 48/247 (19%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYR---KKHKNVDIKVIKN 106
E+ LLK L+ N+V + + + + +I E F S +L++Y K + +D +++K+
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESR--LYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKS 105
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARS 162
+ QIL G+++ HS ++HRDLK N+ ++ N G +K+ D GLA A P T
Sbjct: 106 YLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 163 VIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPY----SECKNPAQIFKKV- 215
V T + APE L Y+ VDI+S G EM T + P SE +IF+ +
Sbjct: 163 V--TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILG 219
Query: 216 --TSGIKP---------ASLAKVNDPQIKGF-----------IEKCLV--PASERLSAKD 251
T + P + K ++ +EK L+ PA +R+SAK
Sbjct: 220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA-KRISAKK 278
Query: 252 LLKDPFL 258
L P+
Sbjct: 279 ALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 54/167 (32%), Positives = 86/167 (51%), Gaps = 14/167 (8%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NW 107
E ++K L+ D +V+ Y V +++ + ++TE + G+L + K + +++ + +
Sbjct: 51 EAQIMKKLRHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 165
A QI G+ YL S N IHRDL NI V G + KI D GLA I + TAR
Sbjct: 109 AAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAK 165
Query: 166 TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNP 208
P ++ APE Y + D++SFG+ + E+VT+ PY N
Sbjct: 166 FPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 33 KIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV---KFYKSWVDDKKKTVNMITELFTSGNL 89
KI +P ++ E+ +L+ K DN++ + D K V ++ +L S +L
Sbjct: 37 KIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK-DVYVVMDLMES-DL 94
Query: 90 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 149
+ + + I+ + Q+L GL Y+HS N +IHRDLK N+ VN + E++IGD
Sbjct: 95 HHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDF 151
Query: 150 GLA-IAMQQPTARSV-----IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMV 196
G+A PT + T + APEL EY +D++S G CI EM+
Sbjct: 152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 26/189 (13%)
Query: 48 YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKV-- 103
+E ++K +VV+ V + T+ ++ EL G+L+ Y + + +
Sbjct: 57 LNEASVMKEFNCHHVVRLL-GVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLG 114
Query: 104 ------IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157
A +I G+ YL + +HRDL N V + VKIGD G+ + +
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMTRDIYE 171
Query: 158 -----PTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPA 209
+ ++ P +MAPE L + + D++SFG+ + EM T E PY N
Sbjct: 172 TDYYRKGGKGLL--PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-E 228
Query: 210 QIFKKVTSG 218
++ K V G
Sbjct: 229 EVLKFVIDG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 63/236 (26%), Positives = 116/236 (49%), Gaps = 30/236 (12%)
Query: 45 QKLYSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVN---MITELFTSGNL----RQYRKKH 96
+++ +E ++LK+L D NVVKFY + K + ++ EL G++ + + K+
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118
Query: 97 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156
+ ++ +I + L GL +LH IHRD+K +NI + G VK+ D G++ +
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLT 175
Query: 157 QPTAR--SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNP 208
R + +GTP +MAPE+ + Y+ D++S G+ +E+ + P ++ +P
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HP 234
Query: 209 AQIFKKVTSGIKPASLAKVNDPQI-----KGFIEKCLVPASE-RLSAKDLLKDPFL 258
+ K+ P ++ P++ FI KCL E R + DLL+ F+
Sbjct: 235 MRALFKIPRNPPP----TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 55/301 (18%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD---D 72
+ A D VA ++ + D P ++ E+ +++ L DN+VK Y+ D
Sbjct: 22 FSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD 77
Query: 73 KKKTVNMITELFTSGNLRQYRK-------KHKNVDIKVIKNWARQILHGLVYLHSHNPPI 125
+ V +TEL + +++Y + + + + + + Q+L GL Y+HS N +
Sbjct: 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--V 135
Query: 126 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-----VIGTPEFMAPE--LYEEE 178
+HRDLK N+F+N +KIGD GLA + + + T + +P L
Sbjct: 136 LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN 195
Query: 179 YNELVDIYSFGMCIL-EMVT------------------------FEYPYSECKNPAQIFK 213
Y + +D+++ G CI EM+T E +E N F
Sbjct: 196 YTKAIDMWAAG-CIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFV 254
Query: 214 KVTSGIKPASLAKV---NDPQIKGFIEKCLVPA-SERLSAKDLLKDPFLQVEN--QKEPI 267
+ G L + +P+ F+E+ L +RL+A++ L P++ + EP+
Sbjct: 255 RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPV 314
Query: 268 C 268
Sbjct: 315 S 315
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 125 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-IGTPEFMAPELYEEE----Y 179
IIHRD+K NI ++ +G +K+ D G++ + A++ G +MAPE + Y
Sbjct: 129 IIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187
Query: 180 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---IKPASLAKVNDPQIKGFI 236
+ D++S G+ + E+ T ++PY + + +V G I S + P FI
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247
Query: 237 EKCLVPASE-RLSAKDLLKDPFLQVENQKE 265
CL+ R K+LL+ PF++ ++
Sbjct: 248 NLCLIKDESKRPKYKELLEHPFIKDYEERN 277
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 54/188 (28%), Positives = 92/188 (48%), Gaps = 13/188 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA D +A +++++ + G E+ LLK ++ N+V+ V +K
Sbjct: 19 YKARDRVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQD--VVHSEK 74
Query: 76 TVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ ++ E + +L+++ + + ++IK + QIL G+ Y HSH ++HRDLK
Sbjct: 75 RLYLVFE-YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQ 131
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 189
N+ ++ +K+ D GLA A P T + T + APE L Y+ VDI+S G
Sbjct: 132 NLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG 191
Query: 190 MCILEMVT 197
EMV
Sbjct: 192 CIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 45/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 25 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84
I VA K P +K E ++++ ++VK ++ V ++ EL
Sbjct: 35 IAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHPHIVKLIGVITENP---VWIVMELA 88
Query: 85 TSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 143
G LR Y + +K +D+ + ++ Q+ L YL S +HRD+ N+ V+
Sbjct: 89 PLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDC- 145
Query: 144 VKIGDLGLAIAMQQPT--ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 198
VK+GD GL+ ++ + S P ++MAPE + + D++ FG+C+ E++
Sbjct: 146 VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 35/205 (17%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDV-LQLPGDLQK---------LYSEVHLLKSLKDDNVVKF 65
KA+D G VA +VKI ++ + D Q E+ ++ +K +N++
Sbjct: 26 EKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85
Query: 66 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 125
+V + +N++ ++ + +L++ + + +K QIL+GL LH
Sbjct: 86 VDVYV--EGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--F 140
Query: 126 IHRDLKCDNIFVNGNHGEVKIGDLGLA-----------IAMQQPTARSVIGTPE-----F 169
+HRDL NIF+N + G KI D GLA ++ + R T + +
Sbjct: 141 MHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199
Query: 170 MAPELY--EEEYNELVDIYSFGMCI 192
APEL E+Y+ VD++S G CI
Sbjct: 200 RAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 66/235 (28%), Positives = 114/235 (48%), Gaps = 26/235 (11%)
Query: 45 QKLYSEVHLLKSLKDD-NVVKFYKSWVDDKKKT---VNMITELFTSGNLRQYRKKHKNVD 100
+++ +E ++L+SL + NVVKFY + K + ++ EL G++ + K
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 101 IKVIKNWARQILHG--LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158
++ + IL+G L H HN IIHRD+K +NI + G VK+ D G++ +
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTST 181
Query: 159 TAR--SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 210
R + +GTP +MAPE+ Y+ Y+ D++S G+ +E+ + P + +P +
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVK 240
Query: 211 IFKKVTSGIKPASLAKVNDPQ-----IKGFIEKCLVPASE-RLSAKDLLKDPFLQ 259
K+ P L P+ FI +CL+ E R S LL+ PF++
Sbjct: 241 TLFKIPRNPPPTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 56/189 (29%), Positives = 95/189 (50%), Gaps = 15/189 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y+A D+ G VA ++K++ + P + L E+++L L+ N+V + V
Sbjct: 22 YRARDKKTGEIVALKKLKMEKEKEGFP--ITSL-REINILLKLQHPNIVTVKEVVVGSNL 78
Query: 75 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ M+ E + +L+ + K +K Q+L G+ +LH + I+HRDLK
Sbjct: 79 DKIYMVME-YVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTS 135
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFG 189
N+ +N N G +KI D GLA P ++ T + APEL +EY+ +D++S G
Sbjct: 136 NLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG 194
Query: 190 MCIL-EMVT 197
CI E++T
Sbjct: 195 -CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 22/188 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKID---DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
Y+A D +G VA +V++D D + + E+ LL +L+ N+V+ + V
Sbjct: 24 YRARDTTSGEIVALKKVRMDNERDGIPISS-----LREITLLLNLRHPNIVELKEVVVGK 78
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ ++ E + +L +K Q+L GL YLH + IIHRDLK
Sbjct: 79 HLDSIFLVME-YCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLK 135
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELY--EEEYNELVDI 185
N+ + G +KI D GLA P T + V T + APEL Y +D+
Sbjct: 136 VSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDM 192
Query: 186 YSFGMCIL 193
++ G CIL
Sbjct: 193 WAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 84/304 (27%), Positives = 131/304 (43%), Gaps = 51/304 (16%)
Query: 18 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 74
AFD G+ VA K+ Q ++ Y E+ LLK +K +NV+ + +
Sbjct: 36 AFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93
Query: 75 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
V ++T L +L K K D V + QIL GL Y+HS + IIHRDLK
Sbjct: 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHSAD--IIHRDLKPS 149
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG---TPEFMAPELYEE--EYNELVDIYSF 188
N+ VN + E+KI D GLA + T + G T + APE+ YN+ VDI+S
Sbjct: 150 NLAVNED-CELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 204
Query: 189 GMCILEMVTFE--YPYSECKNPAQIFKKVTSGIKPASLAKVN------------------ 228
G + E++T +P ++ + ++ ++ L K++
Sbjct: 205 GCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN 264
Query: 229 --------DPQIKGFIEKCLVPASE-RLSAKDLLKDP-FLQVEN-QKEPICDPLKLPIQS 277
+P +EK LV S+ R++A L F Q + EP+ DP +S
Sbjct: 265 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFES 324
Query: 278 LKML 281
+L
Sbjct: 325 RDLL 328
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 43/132 (32%), Positives = 74/132 (56%), Gaps = 6/132 (4%)
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
K+ + + E G+L + + D+ +A +I+ GL +LHS I++RDLK D
Sbjct: 68 KENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLD 125
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARS--VIGTPEFMAPE-LYEEEYNELVDIYSFGM 190
NI ++ + G +KI D G+ A++ GTP+++APE L ++YN VD +SFG+
Sbjct: 126 NILLDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGV 184
Query: 191 CILEMVTFEYPY 202
+ EM+ + P+
Sbjct: 185 LLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 40/129 (31%), Positives = 70/129 (54%), Gaps = 5/129 (3%)
Query: 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139
I +L G+L + +H K ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 140 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 197
HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 198 FEYPYSECK 206
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 37/102 (36%), Positives = 60/102 (58%), Gaps = 5/102 (4%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 165
+A +I GL LH I++RDLK +NI ++ ++G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163
Query: 166 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK 206
T +MAPE+ + E Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 41/140 (29%), Positives = 80/140 (57%), Gaps = 9/140 (6%)
Query: 72 DKKKTVNMITELFTSGNLRQ--YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
+ K + ++ L G+L+ Y + ++++ + +++ QI G+++LHS + I++RD
Sbjct: 63 ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRD 120
Query: 130 LKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYEEEYNELVDIY 186
+K +N+ ++ G ++ DLGLA+ ++ + + GT +MAPE L EE Y+ VD +
Sbjct: 121 MKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKEEPYSYPVDWF 178
Query: 187 SFGMCILEMVTFEYPYSECK 206
+ G I EMV P+ + K
Sbjct: 179 AMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 14/176 (7%)
Query: 41 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 98
PG + Q E +L+K+L+ D +V+ Y V K++ + +ITE G+L + K +
Sbjct: 40 PGTMSVQAFLEEANLMKTLQHDKLVRLYA--VVTKEEPIYIITEYMAKGSLLDFLKSDEG 97
Query: 99 VDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 154
+ + K +++ QI G+ Y+ N IHRDL+ N+ V+ KI D GLA I
Sbjct: 98 GKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIE 154
Query: 155 MQQPTARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKN 207
+ TAR P ++ APE + D++SFG+ + E+VT+ + PY N
Sbjct: 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--N 106
+E +L+K L+ +V+ Y ++ + +ITE +G+L + K + + + + K +
Sbjct: 50 AEANLMKQLQHPRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 164
A QI G+ ++ N IHRDL+ NI V+ KI D GLA I + TAR
Sbjct: 107 MAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGA 163
Query: 165 GTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 211
P ++ APE + + D++SFG+ + E+VT+ PY NP I
Sbjct: 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 21/194 (10%)
Query: 38 LQLPGDLQKLY--SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQ 91
+ L + Q Y SE+H L + +VK + + D K + +I E + G+L +Q
Sbjct: 101 VMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQ 158
Query: 92 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151
K+H + QI+ L +HS ++HRDLK NIF+ G +K+GD G
Sbjct: 159 RLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGF 215
Query: 152 AI----AMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK 206
+ ++ A S GTP ++APEL+E + Y++ D++S G+ + E++T P+ K
Sbjct: 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---K 272
Query: 207 NPAQ--IFKKVTSG 218
P+Q I ++V G
Sbjct: 273 GPSQREIMQQVLYG 286
|
Length = 478 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 56/204 (27%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 169
Q+L GL Y+HS N ++HRDLK N+ +N N ++KI D GL AR+ +F
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGL--------ARTTSEKGDF 164
Query: 170 M----------APELY--EEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKNPAQIFKK 214
M APEL EY +D++S G CI E++ + +P + + ++ +
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITE 223
Query: 215 VTSGIKPASLAKVNDPQIKGFI--------------------------EKCLV-PASERL 247
+ L + + + + +I EK LV S+R+
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283
Query: 248 SAKDLLKDPFLQV--ENQKEPICD 269
+ ++ L P+L + EP+C
Sbjct: 284 TVEEALAHPYLASLHDPSDEPVCQ 307
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 66/193 (34%), Positives = 95/193 (49%), Gaps = 22/193 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKI---DDVLQLPGDLQKLYSEVHLLKSLKD---DNVVKFYK-- 67
YKA D +G VA V++ +D L L EV LLK L+ N+V+
Sbjct: 17 YKARDPHSGHFVALKSVRVQTNEDGLPL-----STVREVALLKRLEAFDHPNIVRLMDVC 71
Query: 68 -SWVDDKKKTVNMITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPP 124
+ D++ V ++ E +LR Y K + + IK+ RQ L GL +LH++
Sbjct: 72 ATSRTDRETKVTLVFE-HVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC-- 128
Query: 125 IIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNEL 182
I+HRDLK +NI V + G+VK+ D GLA I Q V+ T + APE L + Y
Sbjct: 129 IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATP 187
Query: 183 VDIYSFGMCILEM 195
VD++S G EM
Sbjct: 188 VDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 41/132 (31%), Positives = 72/132 (54%), Gaps = 6/132 (4%)
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
K+ + + E G+L + + D+ +A +I+ GL +LHS II+RDLK D
Sbjct: 68 KEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLD 125
Query: 134 NIFVNGNHGEVKIGDLGLAI--AMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 190
N+ ++ + G +KI D G+ A + GTP+++APE+ + +Y VD +SFG+
Sbjct: 126 NVMLDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 191 CILEMVTFEYPY 202
+ EM+ + P+
Sbjct: 185 LLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 108
EV LLK+LK N+V + + ++ + ++ E S +L+QY N+ + +K +
Sbjct: 53 EVSLLKNLKHANIVTLHD--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGT 166
Q+L GL Y H I+HRDLK N+ +N GE+K+ D GLA A PT + + T
Sbjct: 110 FQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVT 166
Query: 167 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 197
+ P+ L EY+ +D++ G + EM T
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139
+ E G+L ++ + D + +A ++ L++LH H +I+RDLK DNI ++
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDA 131
Query: 140 NHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 196
G K+ D G+ + T + GTP+++APE L E EY VD ++ G+ + EM+
Sbjct: 132 E-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMM 190
Query: 197 TFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIEK 238
+ P+ E N +F+ + + P L+K +K F+ K
Sbjct: 191 AGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 108
EV LLK LK N+V + + +K++ ++ E + +L+QY N +++ +K +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFL 110
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGT 166
Q+L GL Y H ++HRDLK N+ +N GE+K+ D GLA A PT + + T
Sbjct: 111 FQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVT 167
Query: 167 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 197
+ P+ L +Y+ +D++ G EM T
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 13/189 (6%)
Query: 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139
I +L G+L + +H ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 140 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 197
HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 198 FEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERL-----SAK 250
P+ + K + ++T + L P+++ +E L + RL A+
Sbjct: 192 GHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 250
Query: 251 DLLKDPFLQ 259
++ + PF +
Sbjct: 251 EVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 108
E LLK LK N+V + + KKT+ ++ E + +L+QY + + ++ +
Sbjct: 53 EASLLKDLKHANIVTLHD--IIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFL 109
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGT 166
Q+L GL Y H ++HRDLK N+ ++ GE+K+ D GLA A P T + + T
Sbjct: 110 FQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVT 166
Query: 167 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 197
+ P+ L EY+ +D++ G EM T
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139
+ E G+L + +K + D + +A +I L++LH II+RDLK DN+ ++
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD- 130
Query: 140 NHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 196
+ G K+ D G+ T + GTP+++APE L E Y VD ++ G+ + EM+
Sbjct: 131 HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML 190
Query: 197 TFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIEK 238
P+ E +N +F+ + + + P L++ +K F+ K
Sbjct: 191 CGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 121 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEY 179
H IHRDLK +N F+ G +K+ D GL+ + A SV+G+P++MAPE L + Y
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGY 175
Query: 180 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK------ 233
+ VD +S G C+L +P P + ++ + + +DP+
Sbjct: 176 DFTVDYWSLG-CMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234
Query: 234 GFIEKCLVPASERL-SAKDLLKDPF 257
I K + S R S +D+ PF
Sbjct: 235 DLITKLINDPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 49/153 (32%), Positives = 78/153 (50%), Gaps = 11/153 (7%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 108
EV LLK LK N+V + + K++ ++ E + +L+QY N+ + +K +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFL 110
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGT 166
QIL GL Y H ++HRDLK N+ +N GE+K+ D GLA A PT + + T
Sbjct: 111 YQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVT 167
Query: 167 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 197
+ P+ L EY+ +D++ G EM +
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 11/188 (5%)
Query: 16 YKAFD-EFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+KA D + G VA RV++ + +P + + + L++ + NVV+ + +
Sbjct: 18 FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77
Query: 74 KKTVNMITELF--TSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
+T +F +L Y K V + IK+ Q+L GL +LHSH ++HRD
Sbjct: 78 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD 135
Query: 130 LKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYS 187
LK NI V + G++K+ D GLA I Q SV+ T + APE L + Y VD++S
Sbjct: 136 LKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS 194
Query: 188 FGMCILEM 195
G EM
Sbjct: 195 VGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 42 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT---SGNLRQYRKKHKN 98
G +E H+L+++ ++++ ++ T N T L +L Y +N
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYCYLAAKRN 178
Query: 99 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAM 155
+ I I R +L + YLH IIHRD+K +NIF+N + G+V +GD G A + +
Sbjct: 179 IAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDI 235
Query: 156 QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVT 197
GT APEL + Y VDI+S G+ + EM T
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 5e-11
Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 59/292 (20%)
Query: 33 KIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 91
KI D + D Q+ + E+ L+ L D N+VK + K + ++ E + +L
Sbjct: 39 KIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHA 97
Query: 92 YRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 149
+ + ++V + I Q+L L Y+HS N +IHRDLK NI +N + VK+ D
Sbjct: 98 VIRANILEDVHKRYI---MYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADF 151
Query: 150 GLA-------IAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTFE 199
GLA + P + T + APE L Y + VD++S G CIL EM+ +
Sbjct: 152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLGK 210
Query: 200 --YPYSECKNPAQIFKKVTSGIKPAS--------------LAKVNDPQIKG--------- 234
+P + N Q+ K + P++ L + K
Sbjct: 211 PLFPGTSTLN--QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKAS 268
Query: 235 -----FIEKCLV--PASERLSAKDLLKDPFLQ--VENQKEPICD-PLKLPIQ 276
++K LV P ++RL+A++ L+ P++ EP+ P+ +P+
Sbjct: 269 DDALDLLKKLLVFNP-NKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 41 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 98
PG + + E ++K L+ D +V+ Y ++ + ++TE + G+L + K +
Sbjct: 40 PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEG 96
Query: 99 VDIKV--IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 154
+K+ + + A Q+ G+ Y+ N IHRDL+ NI V G+ KI D GLA I
Sbjct: 97 RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIE 153
Query: 155 MQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQ 210
+ TAR P ++ APE LY + D++SFG+ + E+VT PY N +
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-RE 211
Query: 211 IFKKVTSGIK-------PASLAKV 227
+ ++V G + P SL ++
Sbjct: 212 VLEQVERGYRMPCPQDCPISLHEL 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 164
+ +I+ L YLHS + +++RD+K +N+ ++ G +KI D GL T ++
Sbjct: 100 YGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 165 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 202
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 164
+A +I L YLHS N II+RDLK +NI ++ + G V + D GL + T +
Sbjct: 101 YAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFC 157
Query: 165 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 223
GTPE++APE L ++ Y+ VD + G + EM+ + P ++ A+++ + + KP
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILN--KPLR 214
Query: 224 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 255
L + +E L ++RL AKD +
Sbjct: 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-11
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 24/114 (21%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----------PT 159
+I + Y+HS ++HRDLK DNI + G GEV I D G AI +
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 160 ARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY 202
++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 25/260 (9%)
Query: 18 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77
A D G +VA KI+DV + D ++ E+ LL+ L+ ++V+ + ++
Sbjct: 19 AIDTHTGEKVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76
Query: 78 N---MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
++ EL S +L Q K + ++ + + + Q+L L Y+H+ N + HRDLK N
Sbjct: 77 KDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKN 133
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSV-----IGTPEFMAPEL---YEEEYNELVDIY 186
I N + ++KI D GLA T ++ + T + APEL + +Y +DI+
Sbjct: 134 ILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192
Query: 187 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI----EKC 239
S G CI V P KN +T + P ++++V + + + ++ +K
Sbjct: 193 SIG-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQ 251
Query: 240 LVPASERLSAKDLLKDPFLQ 259
VP S++ D L L+
Sbjct: 252 PVPFSQKFPNADPLALRLLE 271
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 43/137 (31%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 164
+A +I GL +LHS II+RDLK DN+ ++ + G +KI D G+ T ++
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFC 162
Query: 165 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 221
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYP 221
Query: 222 ASLAKVNDPQIKGFIEK 238
S++K KG + K
Sbjct: 222 KSMSKEAVAICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 102
DL+ L E+ + L+ N++ + S++ D + + +++ L G+ K H +
Sbjct: 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAYGSCEDLLKTHFPEGLP 99
Query: 103 --VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQP 158
I + +L+ L Y+HS IHR +K +I ++G+ G+V + L +++M
Sbjct: 100 ELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGK 156
Query: 159 TARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSE 204
R V P+ ++PE+ ++ YNE DIYS G+ E+ P+ +
Sbjct: 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 53/206 (25%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 32 VKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWV-DDKKKTVN-----MITELF 84
VK+ D+ + D + +EV L + ++VK ++ + D + N ++ +
Sbjct: 62 VKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYA 121
Query: 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-------HSHNPPIIHRDLKCDNIFV 137
+G+LRQ K + ++ A GL+++ H H+ +IHRD+K NI +
Sbjct: 122 NAGDLRQEIKSRAKTNRTFREHEA-----GLLFIQVLLAVHHVHSKHMIHRDIKSANILL 176
Query: 138 NGNHGEVKIGDLGL----AIAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 192
N G VK+GD G A + R+ GTP ++APE++ + Y++ D++S G+ +
Sbjct: 177 CSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLL 235
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSG 218
E++T + P+ + +N ++ K +G
Sbjct: 236 YELLTLKRPF-DGENMEEVMHKTLAG 260
|
Length = 496 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 63/260 (24%)
Query: 50 EVHLLKSLKDDNVVKFY------KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV 103
E+ +L+ LK +NVV + + K + ++ E K+ +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----- 158
IK + +L+GL Y+H + I+HRD+K NI + + G +K+ D GLA A
Sbjct: 121 IKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKP 177
Query: 159 ---TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFEYP----------- 201
T R V T + PEL E +Y +D++ G CI+ EM T P
Sbjct: 178 NRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWT-RSPIMQGNTEQHQL 233
Query: 202 -----------------------YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238
+ + + P +KV +KP V DP I+K
Sbjct: 234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALDLIDK 289
Query: 239 CLV-PASERLSAKDLLKDPF 257
LV ++R+ A L F
Sbjct: 290 LLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 49/161 (30%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 164
+A +I L YLHS N I++RDLK +NI ++ + G + + D GL + T +
Sbjct: 101 YAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFC 157
Query: 165 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 223
GTPE++APE L+++ Y+ VD + G + EM+ + P +N A+++ + + KP
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN--KPLQ 214
Query: 224 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ 263
L + +E L ++RL A KD F++++N
Sbjct: 215 LKPNITNSARHLLEGLLQKDRTKRLGA----KDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 42/137 (30%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 164
+A +I GL +LH II+RDLK DN+ ++ + G +KI D G+ + T R+
Sbjct: 106 YAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFC 162
Query: 165 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 221
GTP+++APE+ + Y + VD +++G+ + EM+ + P+ + ++ ++F+ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYP 221
Query: 222 ASLAKVNDPQIKGFIEK 238
SL+K KG + K
Sbjct: 222 KSLSKEAVSICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 44 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDI 101
+++ E ++K +K N+V+ V ++ +ITE T GNL Y + V+
Sbjct: 46 VEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 103
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
V+ A QI + YL N IHRDL N V G + VK+ D GL+ M T
Sbjct: 104 VVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYT 160
Query: 162 SVIGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYP 201
+ G ++ APE L +++ D+++FG+ + E+ T+ YP
Sbjct: 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ------Q 157
+++ QIL GL Y+HS N ++HRDLK N+ VN + E+KI D GLA
Sbjct: 107 FQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENA 163
Query: 158 PTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL 193
+ T + APE L + Y + +D++S G CIL
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 11/130 (8%)
Query: 76 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
T+ ++T+L G L Y +HK N+ +++ NW QI G++YL ++HRDL N
Sbjct: 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARN 139
Query: 135 IFVNG-NHGEVKIGDLGLAIAMQ----QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 188
+ V NH VKI D GLA ++ + A ++MA E ++ ++ D++S+
Sbjct: 140 VLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSY 197
Query: 189 GMCILEMVTF 198
G+ I E++TF
Sbjct: 198 GVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 35/113 (30%), Positives = 65/113 (57%), Gaps = 9/113 (7%)
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSV--IG 165
+Q+L + Y+H +IHRD+K +NIF+N + G++ +GD G A+ ++ A +G
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY-PYSE-CKNPAQIFKKV 215
T +PE L + Y E+ DI+S G+ +L+M++ ++ P + P + K+
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383
|
Length = 501 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 36/98 (36%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 165
+A +IL GL LH N ++RDLK +NI ++ ++G ++I DLGLA+ + + + R +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY 202
T +MAPE L + Y D + G I EM+ + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 36/102 (35%), Positives = 61/102 (59%), Gaps = 5/102 (4%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 165
+A +I GL LH I++RDLK +NI ++ +HG ++I DLGLA+ + + T + +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 166 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK 206
T +MAPE+ + E Y D ++ G + EM+ + P+ + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 48/174 (27%), Positives = 88/174 (50%), Gaps = 8/174 (4%)
Query: 47 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 106
++SE +L + V Y S+ D+ + ++ E G + +++K V
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT 166
+A QI+ YL S N I++RDLK +N+ ++ + G +K+ D G A + T ++ GT
Sbjct: 136 YAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRT-YTLCGT 191
Query: 167 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 219
PE++APE L + + D ++ G+ I E++ P+ P I++K+ GI
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGI 244
|
Length = 340 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL-----FTSGNLRQYRKKHKNV 99
++ Y E+ LLK +K +NV+ + D +++ + F +L + KH+ +
Sbjct: 59 KRAYRELRLLKHMKHENVIGLLDVFTPDL--SLDRFHDFYLVMPFMGTDLGKL-MKHEKL 115
Query: 100 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159
I+ Q+L GL Y+H+ IIHRDLK N+ VN E+KI D GLA
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEM 172
Query: 160 ARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 197
V+ T + APE L Y + VDI+S G + EM+T
Sbjct: 173 TGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVD--DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW 107
E+ L+ + +N++K Y +D D +++I E T G LR+ K K++ K +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 108 ARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT 166
A GL L+ N P +++L + V N ++KI GL + P ++V
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTEN-YKLKIICHGLEKILSSPPFKNV--- 181
Query: 167 PEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 220
FM Y+ EY DIYS G+ + E+ T + P+ E +I+ + +
Sbjct: 182 -NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIYDLIINKNN 239
Query: 221 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 253
L +IK +E C + +R + K++L
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 53 LLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQIL 112
LLK+LK +V + S+ +K + + + G L + ++ + + +A ++
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEK--LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
Query: 113 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFM 170
+ YLHS N II+RDLK +NI ++ + G V + D GL +P T + GTPE++
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 171 APE-LYEEEYNELVDIYSFGMCILEMV 196
APE L +E Y+ VD + G + EM+
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 54/180 (30%), Positives = 92/180 (51%), Gaps = 15/180 (8%)
Query: 41 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 98
PG + + +E +++K+L+ D +VK + K+ + +ITE G+L + K +
Sbjct: 40 PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEG 96
Query: 99 VDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 154
+ K +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA I
Sbjct: 97 SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIE 153
Query: 155 MQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 211
+ TAR P ++ APE + + D++SFG+ ++E+VT+ PY NP I
Sbjct: 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 11/152 (7%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 108
E LLK LK N+V + + K+T+ ++ E + +L QY KH + + +K +
Sbjct: 53 EASLLKGLKHANIVLLHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFL 109
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGT 166
Q+L GL Y+H I+HRDLK N+ ++ + GE+K+ D GLA A P T + + T
Sbjct: 110 FQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 167 PEFMAPE--LYEEEYNELVDIYSFGMCILEMV 196
+ P+ L EY+ +D++ G +EM+
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 40/96 (41%), Positives = 56/96 (58%), Gaps = 12/96 (12%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSV----I 164
QIL GL Y+HS N ++HRDLK N+ +N N ++KI D GLA IA + +
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 165 GTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 197
T + APE L + Y + +DI+S G CIL EM++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 52/191 (27%), Positives = 95/191 (49%), Gaps = 24/191 (12%)
Query: 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141
ELFT R++ + + ++ + +I+ L +LH II+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTESE------VRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 142 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 195
G V + D GL+ +A ++ A S GT E+MAPE+ +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 196 VTFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RL---S 248
+T P++ E + ++I +++ P K + + FI+K L + RL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 249 AKDLLKDPFLQ 259
A ++ PF Q
Sbjct: 260 ADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 12/177 (6%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 108
E ++ L N+V+ Y V K++ + ++TE +G L Y ++ K + + +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP- 167
+ + YL S+ IHRDL N V G VK+ D GLA + S GT
Sbjct: 107 SDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 168 --EFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK 220
++ PE+++ ++ D++SFG+ + E+ + + PY N +++ + V++G +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYR 219
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 71/270 (26%), Positives = 116/270 (42%), Gaps = 52/270 (19%)
Query: 33 KIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD-------DKKKTVNMITELFT 85
K+ +V Q ++++ E+ +L K DNV+ S +D D + + ++TEL
Sbjct: 32 KMPNVFQNLVSCKRVFRELKMLCFFKHDNVL----SALDILQPPHIDPFEEIYVVTELMQ 87
Query: 86 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
S +L + + + +K + QIL GL YLHS I+HRD+K N+ VN N +K
Sbjct: 88 S-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLK 143
Query: 146 IGDLGLAIAMQQPTARSV---IGTPEFMAPELY--EEEYNELVDIYSFGMCI-------- 192
I D GLA + ++ + + T + APE+ Y VDI+S G CI
Sbjct: 144 ICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVG-CIFAELLGRR 202
Query: 193 -----------LEMVT-------FEYPYSECKNP-AQIFKKVTSGIKPASLAKVNDP--- 230
L+++T E S C+ A I + L ++
Sbjct: 203 ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATH 262
Query: 231 QIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259
+ + + LV +R+SA D L P+L
Sbjct: 263 EAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 21/175 (12%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE--------LFTSGNLRQYRKKHKNVDI 101
E+ LL+ LK NV+ K ++ + V ++ + + + KK +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQP 158
++K+ QIL G+ YLH++ ++HRDLK NI V G G VKI D+G A P
Sbjct: 108 SMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 159 TA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFEYPYSECK 206
V+ T + APEL Y + +DI++ G E++T E P C+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 23/179 (12%)
Query: 44 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------- 96
+ EV +L L D N+ + D + MI E +G+L Q+ +KH
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 97 ----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152
K++ + A QI G+ YL S N +HRDL N V N+ +KI D G++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY-TIKIADFGMS 177
Query: 153 IAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF--EYPYSE 204
+ V G +MA E + ++ D+++FG+ + E++T E PY
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL-------RQYRKKHKNVDIK 102
E+ LL+ LK NV+ K ++ + V ++ + + +L R + K V +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLP 106
Query: 103 --VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQ 157
++K+ QIL G+ YLH++ ++HRDLK NI V G G VKI D+G A
Sbjct: 107 RGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 158 PTA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFEYPYSECK 206
P V+ T + APEL Y + +DI++ G E++T E P C+
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 108
E LLK LK N+V + + K+T+ + E + +L QY +H + ++ +
Sbjct: 53 EASLLKGLKHANIVLLHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFM 109
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGT 166
Q+L GL Y+H + I+HRDLK N+ ++ GE+K+ D GLA A P T S + T
Sbjct: 110 FQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVT 166
Query: 167 PEFMAPE--LYEEEYNELVDIYSFGMCILEMV 196
+ P+ L +Y+ +DI+ G +EM+
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 35/121 (28%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
++T+ + G L + +K K + +++ L +LH ++ I++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 139 GNHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILE 194
G + + D GL+ A T + GT E++APE+ +E Y + VD +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 195 M 195
M
Sbjct: 190 M 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 31/206 (15%)
Query: 35 DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRK 94
D L D Q+ E LL +L+ +++VKFY D + M+ E G+L ++ +
Sbjct: 45 DPTLAARKDFQR---EAELLTNLQHEHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLR 99
Query: 95 KH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
H + + + + A QI G+VYL S + +HRDL N V
Sbjct: 100 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV- 156
Query: 139 GNHGEVKIGDLGLAIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCIL 193
G + VKIGD G++ + V G +M PE + ++ D++SFG+ +
Sbjct: 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216
Query: 194 EMVTF-EYPYSECKNPAQIFKKVTSG 218
E+ T+ + P+ + + ++ + +T G
Sbjct: 217 EIFTYGKQPWFQL-SNTEVIECITQG 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 49/167 (29%), Positives = 90/167 (53%), Gaps = 11/167 (6%)
Query: 53 LLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQIL 112
LLK++K +V + S+ +K + + + G L + ++ ++ + +A +I
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEK--LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 113 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL---AIAMQQPTARSVIGTPEF 169
L YLHS N I++RDLK +NI ++ + G V + D GL IA Q T + GTPE+
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEY 162
Query: 170 MAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 215
+APE + ++ Y+ VD + G + EM+ + P C++ A+++ +
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 38/135 (28%), Positives = 74/135 (54%), Gaps = 10/135 (7%)
Query: 76 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
++ ++T+L G+L + ++H+ ++D + + NW QI G+ YL H ++HR+L N
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARN 139
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTP-EFMAPE-LYEEEYNELVDIYSFG 189
I + + V+I D G+A + + S TP ++MA E + Y D++S+G
Sbjct: 140 ILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 190 MCILEMVTF-EYPYS 203
+ + EM+++ PY+
Sbjct: 199 VTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 45 QKLYSEVHLLKSLKDDNVVK----FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 100
++ Y E+ LLK +K +NV+ F + + V ++T L +L K K D
Sbjct: 59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSD 117
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160
+ ++ Q+L GL Y+HS IIHRDLK N+ VN + E++I D GLA
Sbjct: 118 -EHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLARQADDEMT 173
Query: 161 RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFE--YPYSECKNPAQIFKKVT 216
+ T + APE L YN+ VDI+S G + E++ + +P ++ + + +V
Sbjct: 174 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232
Query: 217 SGIKPASLAKVNDPQIKGFIE 237
P L K++ + +I+
Sbjct: 233 GTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 37/127 (29%), Positives = 68/127 (53%), Gaps = 6/127 (4%)
Query: 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
++ E G+L + ++ + + + + +A +I L +LH II+RDLK DN+ ++
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD 130
Query: 139 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 195
+ G +K+ D G+ P T + GTP ++APE+ EEY VD ++ G+ + EM
Sbjct: 131 AD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 196 VTFEYPY 202
+ P+
Sbjct: 190 MAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
D YK + EVA + P +K E +LK N+VK V
Sbjct: 10 DVYKGVLK-GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-- 63
Query: 74 KKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
K+ + ++ EL G+L + RKK + +K + + G+ YL S N IHRDL
Sbjct: 64 KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAA 121
Query: 133 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE----FMAPE-LYEEEYNELVDIYS 187
N V N+ +KI D G++ + G + + APE L Y D++S
Sbjct: 122 RNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWS 180
Query: 188 FGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
+G+ + E + + PY N Q +++ SG
Sbjct: 181 YGILLWETFSLGDTPYPGMSN-QQTRERIESG 211
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 41 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-- 96
PG + + E ++K L+ D +V Y ++ + ++TE G+L + K+
Sbjct: 40 PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDG 96
Query: 97 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 154
K + + + + A QI G+ Y+ N IHRDL+ NI V G++ KI D GLA I
Sbjct: 97 KYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIE 153
Query: 155 MQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 197
+ TAR P ++ APE LY + D++SFG+ + E+VT
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 45/177 (25%), Positives = 87/177 (49%), Gaps = 12/177 (6%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWA 108
E ++ L + +V+ Y V K++ + ++TE ++G L Y ++H K +
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP- 167
+ + G+ YL S IHRDL N V+ G VK+ D GL+ + S +G+
Sbjct: 107 KDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 168 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK 220
+ PE L +++ D+++FG+ + E+ + + PY N ++ +KV+ G++
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----QPTARSV 163
ARQ+L + Y+H IIHRD+K +N+ VNG ++ +GD G A + P +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 164 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 194
GT + APE L + Y VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 22/190 (11%)
Query: 46 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN------- 98
+ E HL+ + N+VK + ++ +I EL G+L Y + +
Sbjct: 45 EFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPL 102
Query: 99 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE----VKIGDLGLAIA 154
+ +K + + + G VYL + IHRDL N V+ + VKIGD GLA
Sbjct: 103 LTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160
Query: 155 MQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNP 208
+ + G +MAPE L + ++ D++SFG+ + E++T + PY N
Sbjct: 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN- 219
Query: 209 AQIFKKVTSG 218
++ + VT+G
Sbjct: 220 QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 108
E+ +LK++ ++ ++ K TV M+ + +L Y + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----QQPTARSVI 164
R++L L YLH IIHRD+K +NIF++ +GD G A + P
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 165 GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 195
GT E +PEL + Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 164
+ +I+ L YLHS I++RDLK +N+ ++ + G +KI D GL T ++
Sbjct: 100 YGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFC 156
Query: 165 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 202
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVIGTP 167
+I+ L YLHS + +++RDLK +N+ ++ + G +KI D GL T ++ GTP
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTP 159
Query: 168 EFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 202
E++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 9/138 (6%)
Query: 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
+ E G+L + ++ + + + + ++ +I L YLH II+RDLK DN+ ++
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD 130
Query: 139 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 195
+ G +K+ D G+ +P T + GTP ++APE+ E+Y VD ++ G+ + EM
Sbjct: 131 -SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 196 VTFEYPYS---ECKNPAQ 210
+ P+ NP Q
Sbjct: 190 MAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 164
+ +I+ L YLHS +++RDLK +N+ ++ + G +KI D GL T ++
Sbjct: 100 YGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFC 157
Query: 165 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 202
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 79 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 136
+ITE G+L + RK+ + ++ + +++ Q+ G+ +L S N IHRDL N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVL 173
Query: 137 VNGNHGEV-KIGDLGLAIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGM 190
+ HG++ KI D GLA + + V G ++MAPE ++ Y D++S+G+
Sbjct: 174 LT--HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231
Query: 191 CILEMVTF-EYPYSECKNPAQIFKKVTSGIKPAS 223
+ E+ + PY ++ +K + G + A
Sbjct: 232 LLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 46/135 (34%), Positives = 70/135 (51%), Gaps = 12/135 (8%)
Query: 76 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
TV +IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRDL N
Sbjct: 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARN 139
Query: 135 IFVNG-NHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE-LYEEEYNELVDIYSF 188
+ V H VKI D GLA + + + G P ++MA E + Y D++S+
Sbjct: 140 VLVKTPQH--VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 197
Query: 189 GMCILEMVTF-EYPY 202
G+ + E++TF PY
Sbjct: 198 GVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 32/87 (36%), Positives = 50/87 (57%), Gaps = 4/87 (4%)
Query: 119 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVIGTPEFMAPELYE 176
H H+ II+RDLK +NI ++ G +K+ D GL+ + A S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 177 EE-YNELVDIYSFGMCILEMVTFEYPY 202
+ + D +SFG+ + EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 23/173 (13%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-----------N 98
E+ ++ LKD N+++ + + MITE +G+L Q+ +H+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDP--LCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 99 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158
+ + A QI G+ YL S N +HRDL N V N+ +KI D G++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSG 183
Query: 159 -----TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF--EYPYSE 204
R+V+ + ++ D+++FG+ + E++T E PYS+
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWV-----DDKKKTVNMITELFTSGNLRQYRKKHKNV 99
++ Y E+ LLK ++ +NV+ + D+ + ++ + T +L++ +
Sbjct: 59 KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT--DLQKIMGHPLSE 116
Query: 100 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159
D ++ Q+L GL Y+HS IIHRDLK N+ VN + E+KI D GLA
Sbjct: 117 D--KVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLARHADAEM 171
Query: 160 ARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--KV 215
V+ T + APE L YN+ VDI+S G + EM+T + + Q+ + KV
Sbjct: 172 TGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230
Query: 216 TSGIKPASLAKVNDPQIKGFIE 237
T P + K+ D K +I+
Sbjct: 231 TGVPGPEFVQKLEDKAAKSYIK 252
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 43 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 101
DL L SE+ ++K + K N++ + D + +I E + GNLR+Y + + +
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGM 120
Query: 102 KVIKNWAR----------------QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
+ + AR Q+ G+ YL S IHRDL N+ V N+ +K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMK 177
Query: 146 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 198
I D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236
Query: 199 --EYPYSECKNPAQIFKKVTSGIKPAS 223
YP + ++ K+ KPA+
Sbjct: 237 GSPYPGIPVEELFKLLKEGHRMDKPAN 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 40/149 (26%), Positives = 78/149 (52%), Gaps = 14/149 (9%)
Query: 62 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 121
VV+ + ++ DDK + M+ E G+L + +V K K + +++ L +HS
Sbjct: 105 VVQLFCAFQDDKY--LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 161
Query: 122 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEEE 178
+IHRD+K DN+ ++ HG +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 179 -----YNELVDIYSFGMCILEMVTFEYPY 202
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 31/203 (15%)
Query: 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
+ E + G+L + ++ + + + + ++ +I L +LH II+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 139 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 195
G +K+ D G+ +P T + GTP ++APE L E+Y VD ++ G+ + EM
Sbjct: 131 AE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 196 VTFEYPY---SECKNPAQ---------IFKKVTSGIK-PASLAKVNDPQIKGFIEKCLVP 242
+ P+ NP Q I +K I+ P SL+ +KGF+ K P
Sbjct: 190 MAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---IRIPRSLSVKASSVLKGFLNK--DP 244
Query: 243 ASERLSAK------DLLKDPFLQ 259
ERL D+ PF +
Sbjct: 245 K-ERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 87 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 146
G+L KK + +K RQ++ L LH HN IIH D+K +N+ + + +
Sbjct: 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYL 151
Query: 147 GDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--- 202
D GL + P+ GT ++ +PE + Y+ D ++ G+ E++T ++P+
Sbjct: 152 CDYGLCKIIGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209
Query: 203 -SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA-SERLSA-KDLLKDPFLQ 259
E + + K+ K K F++ L + RL+ +++K PFL+
Sbjct: 210 EDEELDLESLLKRQQ---KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266
Query: 260 V 260
+
Sbjct: 267 I 267
|
Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 47/166 (28%), Positives = 83/166 (50%), Gaps = 16/166 (9%)
Query: 41 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 98
PG + + E ++K L+ + +V+ Y ++ + ++TE + G+L + K
Sbjct: 40 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMG 96
Query: 99 VDIKV--IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 154
+++ + + A QI G+ Y+ N +HRDL+ NI V G + K+ D GLA I
Sbjct: 97 KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIE 153
Query: 155 MQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 197
+ TAR P ++ APE LY + D++SFG+ + E+ T
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 32/185 (17%)
Query: 43 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----- 96
DL L SE+ ++K + K N++ + V + E GNLR + +
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV--VVEYAAHGNLRDFLRARRPPGE 115
Query: 97 -----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
+ + K + ++A Q+ G+ +L S IHRDL N+ V +H +K
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMK 172
Query: 146 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 198
I D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 173 IADFGLARDIHHIDYYRKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 231
Query: 199 --EYP 201
YP
Sbjct: 232 GSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 72/258 (27%), Positives = 115/258 (44%), Gaps = 19/258 (7%)
Query: 18 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 74
AFD GI VA K+ Q ++ Y E+ LLK + N++ + K
Sbjct: 40 AFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97
Query: 75 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ V ++ EL + NL Q H +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 98 FQDVYLVMELMDA-NLCQV--IHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 152
Query: 134 NIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 191
NI V + +KI D GLA A + T + APE + Y E VDI+S G
Sbjct: 153 NIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 211
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN--DPQIKGFIEKCLVPASERLSA 249
+ E+V + + Q + KV + S +N P ++ ++E P +S
Sbjct: 212 MGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMNRLQPTVRNYVEN--RPQYPGISF 268
Query: 250 KDLLKDPFLQVENQKEPI 267
++L D E++++ +
Sbjct: 269 EELFPDWIFPSESERDKL 286
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 23/175 (13%)
Query: 118 LHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM---QQPTARSVIGTPEFMAPE 173
+HS H +HRD+K +N+ ++ G +K+ D G A + + ++ +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 174 LYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPAS 223
+ Y D +S G+ EM+ P+ E A+ + + + +K
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPE 232
Query: 224 LAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL------QVENQKEPICDPLK 272
KV+ I+ L ERL + L PF + N P LK
Sbjct: 233 DPKVSS-DFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLK 286
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 165
+A ++ GL L I++RDLK +NI ++ + G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVG 163
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECK 206
T +MAPE + E+Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 104
Q E LL L+ ++V+FY V + + + M+ E G+L ++ + H D K++
Sbjct: 52 QDFQREAELLTVLQHQHIVRFYG--VCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKIL 108
Query: 105 KNW----------------ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 148
A QI G+VYL S + +HRDL N V G VKIGD
Sbjct: 109 AGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGD 165
Query: 149 LGLAIAMQQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYP 201
G++ + V G +M PE LY + E DI+SFG+ + E+ T+ + P
Sbjct: 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQP 224
Query: 202 YSECKNPAQI 211
+ + N I
Sbjct: 225 WYQLSNTEAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 29/179 (16%)
Query: 43 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK---- 97
DL L SE+ ++K + K N++ + D V I E + GNLR+Y + +
Sbjct: 66 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGM 123
Query: 98 ------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
+ K + + A Q+ G+ YL S IHRDL N+ V ++ +K
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMK 180
Query: 146 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 198
I D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 87 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 146
G L + ++ D+ + + ++L L LH N +I+RDLK +NI ++ G + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 147 GDLGLA-IAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYS 203
D GL + M+ + GTPE++APEL Y + VD ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 204 ECKNPAQIFKKV 215
+ +N ++++K+
Sbjct: 195 D-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 47/188 (25%), Positives = 94/188 (50%), Gaps = 19/188 (10%)
Query: 21 EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80
++ G +VA +K D Q +E ++ L+ N+V+ V++K + ++
Sbjct: 26 DYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIV 78
Query: 81 TELFTSGNLRQY-RKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
TE G+L Y R + ++V + ++ + + YL ++N +HRDL N+ V+
Sbjct: 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS 136
Query: 139 GNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 195
++ K+ D GL + Q T + + ++ APE L E++++ D++SFG+ + E+
Sbjct: 137 EDN-VAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEI 192
Query: 196 VTF-EYPY 202
+F PY
Sbjct: 193 YSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 26/196 (13%)
Query: 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141
ELFT + R+ K+ + ++ ++ +I+ L +LH II+RD+K +NI ++ N
Sbjct: 91 ELFTHLSQRERFKEQE------VQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN- 141
Query: 142 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 195
G V + D GL+ + A S GT E+MAP++ + +++ VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 196 VTFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL---- 247
+T P++ E + A+I +++ P + K I++ L+ +RL
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLGCGP 259
Query: 248 -SAKDLLKDPFLQVEN 262
A ++ K PF Q N
Sbjct: 260 SDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 17/190 (8%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 104
Q SE ++ N+++ V K K +ITE +G L +Y + H +
Sbjct: 51 QDFLSEASIMGQFSHHNIIRL--EGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSY 107
Query: 105 K--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 162
+ R I G+ YL N +HRDL NI VN N E K+ D GL+ ++ +
Sbjct: 108 QLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGT 164
Query: 163 VIGTP-----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
+ + APE + ++ D++SFG+ + E+++F E PY + N ++ K +
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAI 223
Query: 216 TSGIK-PASL 224
G + PA +
Sbjct: 224 NDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 24/199 (12%)
Query: 38 LQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK 97
L L +Q+++ E +L ++ VV + S+ + K+ + M+ E G+ K
Sbjct: 39 LILRNQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIG 96
Query: 98 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQ 156
+ + + + + + + L YLH++ I+HRDLK DN+ + + G +K+ D GL+ I +
Sbjct: 97 ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLM 153
Query: 157 QPTA----------------RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFE 199
T + V GTPE++APE + + Y + VD ++ G+ + E +
Sbjct: 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213
Query: 200 YPYSECKNPAQIFKKVTSG 218
P+ P ++F +V S
Sbjct: 214 VPFFG-DTPEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 14/100 (14%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGL--------AIAMQQPT 159
Q+L L +HN I+HRDLK NI V+ K+ D G+ + T
Sbjct: 87 QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 160 ARS-VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 197
+ V+GTP + APE L E D+Y++G+ LE +T
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 37/193 (19%)
Query: 41 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 100
+L+ L SE +LLK + +V+K Y + D + +I E G+LR + ++ + V
Sbjct: 44 SSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKVG 101
Query: 101 ------------------------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 136
+ + ++A QI G+ YL ++HRDL N+
Sbjct: 102 PSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVL 159
Query: 137 VNGNHGEVKIGDLGLAIAMQQPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMC 191
V ++KI D GL+ + + + RS P ++MA E L++ Y D++SFG+
Sbjct: 160 V-AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 218
Query: 192 ILEMVTF---EYP 201
+ E+VT YP
Sbjct: 219 LWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 76 TVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
TV ++T+L G L Y +++K+ + + + NW QI G+ YL ++HRDL N
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARN 139
Query: 135 IFV-NGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 188
+ V + NH VKI D GLA I + A ++MA E + + D++S+
Sbjct: 140 VLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197
Query: 189 GMCILEMVTF 198
G+ + E++TF
Sbjct: 198 GVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 28/191 (14%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--------------RKK 95
E LL + + +N+VKFY + M+ E G+L ++
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115
Query: 96 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155
+ + + A QI G+VYL S + +HRDL N V G VKIGD G++ +
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDV 172
Query: 156 QQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNP 208
V G +M PE +Y + E D++SFG+ + E+ T+ + P+ N
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN- 230
Query: 209 AQIFKKVTSGI 219
++ + +T G
Sbjct: 231 EEVIECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 47/189 (24%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 21 EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80
++ G +VA +K DD Q +E ++ +L+ N+V+ + + ++
Sbjct: 26 DYRGQKVAVKCLK-DDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN--PLYIV 78
Query: 81 TELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137
TE G+L Y R + + +A + G+ YL N +HRDL N+ V
Sbjct: 79 TEYMAKGSLVDYLRSRGRAVIT-LAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLV 135
Query: 138 NGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 194
+ K+ D GLA Q + + + ++ APE L E++++ D++SFG+ + E
Sbjct: 136 S-EDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 195 MVTF-EYPY 202
+ +F PY
Sbjct: 192 IYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 35/201 (17%)
Query: 118 LHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS--VIGTPEFMAPE 173
+HS H +HRD+K DN+ ++ N G +++ D G + M Q T +S +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 174 LYEE------EYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASL 224
+ + +Y D +S G+C+ EM+ E P+ S + +I P+ +
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
Query: 225 AKVNDPQIKGFIEKCLVPASERLSA---KDLLKDPFLQ------VENQKEPICDPLKLPI 275
V++ + K I++ + RL +D K F + + N + P + P
Sbjct: 234 TDVSE-EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSP- 291
Query: 276 QSLKMLRLPMSGPSSMDIDSD 296
S S+ D+D D
Sbjct: 292 ----------SDTSNFDVDDD 302
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 34/197 (17%)
Query: 121 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA-MQQPTARS--VIGTPEFMAPELYEE 177
H +HRD+K DNI ++ N G +++ D G + M+ T +S +GTP++++PE+ +
Sbjct: 119 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 178 ------EYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASLAKVN 228
+Y D +S G+C+ EM+ E P+ S + +I PA + V+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237
Query: 229 DPQIKGFIEKCLVPASERLSA---KDLLKDPFL------QVENQKEPICDPLKLPIQSLK 279
+ K I + + RL +D + PF + N + P + P +
Sbjct: 238 E-DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDT-- 294
Query: 280 MLRLPMSGPSSMDIDSD 296
S+ D+D D
Sbjct: 295 ---------SNFDVDDD 302
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 119 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL---AIAMQQPTARSVIGTPEFMAPE-L 174
H H II+RDLK +NI ++ G VK+ D GL +I T + GT E+MAPE L
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT-HTFCGTIEYMAPEIL 172
Query: 175 YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQI 232
+ + VD +S G + +M+T P++ +N + K+ G P L P+
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPYLT----PEA 227
Query: 233 KGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEPICDPLKLPIQ 276
+ ++K L S RL A ++ PF + N + + ++ P +
Sbjct: 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFK 277
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 25/193 (12%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-------- 96
+ + E LL +L+ +++VKFY V+ + M+ E G+L ++ + H
Sbjct: 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDP--LIMVFEYMKHGDLNKFLRAHGPDAVLMA 109
Query: 97 -----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151
+ + + A+QI G+VYL S + +HRDL N V G + VKIGD G+
Sbjct: 110 EGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGM 166
Query: 152 AIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSEC 205
+ + V G +M PE + ++ D++S G+ + E+ T+ + P+ +
Sbjct: 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
Query: 206 KNPAQIFKKVTSG 218
N ++ + +T G
Sbjct: 227 SN-NEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 44/192 (22%)
Query: 62 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 121
VVK + S+ D K+ + +I E G++ K + + + + + + + +H
Sbjct: 63 VVKMFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 122 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--------------PT-------- 159
IHRD+K DN+ ++ G VK+ D GL +++ P+
Sbjct: 121 G--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 160 ---------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYS 203
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPPF 236
Query: 204 ECKNPAQIFKKV 215
+ P + ++KV
Sbjct: 237 CSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 44/192 (22%)
Query: 62 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 121
VVK + S+ D K + +I E G++ K + + + + + + + +H
Sbjct: 63 VVKMFYSFQD--KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 122 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--------------PT-------- 159
IHRD+K DN+ ++ + G VK+ D GL +++ P+
Sbjct: 121 G--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 160 ---------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYS 203
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPPF 236
Query: 204 ECKNPAQIFKKV 215
+ P + +KKV
Sbjct: 237 CSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 59/190 (31%), Positives = 89/190 (46%), Gaps = 24/190 (12%)
Query: 18 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 74
A+D G VA K+ Q ++ Y E+ L+K + N++ + K
Sbjct: 35 AYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92
Query: 75 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ V ++ EL + NL Q ++D + + Q+L G+ +LHS IIHRDLK
Sbjct: 93 FQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 147
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYS 187
NI V + +KI D GLA + S + TP + APE + Y E VDI+S
Sbjct: 148 NIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 202
Query: 188 FGMCIL-EMV 196
G CI+ EM+
Sbjct: 203 VG-CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 31/183 (16%)
Query: 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141
E+FT R + + ++ ++ +I+ L +LH I++RD+K +NI ++ +
Sbjct: 91 EMFTHLYQRDNFSEDE------VRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 142 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMV 196
G V + D GL+ ++ ++ S GT E+MAPE+ + + + VD +S G+ I E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 197 TFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLL 253
T P++ E +++ +++ DP FI P ++ L K L
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILK----------CDPPFPSFIG----PEAQDLLHKLLR 247
Query: 254 KDP 256
KDP
Sbjct: 248 KDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 39/197 (19%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD--------- 100
EV +L LKD N+++ VD+ + MITE +G+L Q+ H D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDP--LCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 101 ----------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 150
+ + A QI G+ YL S N +HRDL N V N +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADFG 183
Query: 151 LAIAM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF--EYPY 202
++ + + R+V+ +MA E + ++ D+++FG+ + E++ E PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 203 SE------CKNPAQIFK 213
E +N + F+
Sbjct: 243 GELTDEQVIENAGEFFR 259
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 43 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--------- 92
DL L SE+ ++K + K N++ + D V + E + GNLR+Y
Sbjct: 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV--LVEYASKGNLREYLRARRPPGM 117
Query: 93 -------RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
+ + + K + + A Q+ G+ YL S IHRDL N+ V ++ +K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMK 174
Query: 146 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 198
I D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 233
Query: 199 --EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC--LVPASERLSAKDLLK 254
YP + ++ K+ KPA+ ++ + +C VP S+R + K L++
Sbjct: 234 GSPYPGIPVEELFKLLKEGHRMDKPANCTH----ELYMIMRECWHAVP-SQRPTFKQLVE 288
Query: 255 D 255
D
Sbjct: 289 D 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 45/191 (23%), Positives = 74/191 (38%), Gaps = 55/191 (28%)
Query: 121 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 155
H IHRD+K DNI ++ G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 156 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 194
Q+ A S++GTP ++APE+ Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 195 MVTFEYPYSECKNPAQIFKKVT---SGIKPASLAKVNDPQIKGFIEKCLVPASERL---S 248
M+ + P+ PA+ KV + + S AK++ + I + A +RL
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS-REASDLILRLCCGAEDRLGKNG 294
Query: 249 AKDLLKDPFLQ 259
A ++ PF +
Sbjct: 295 ADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 32/185 (17%)
Query: 43 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--------- 92
DL L SE+ L+K + K N++ + V I E GNLR++
Sbjct: 60 DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGP 117
Query: 93 -------RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
+ + + K + + A Q+ G+ YL S IHRDL N+ V ++ +K
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMK 174
Query: 146 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 198
I D GLA I + T+ + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG 233
Query: 199 --EYP 201
YP
Sbjct: 234 GSPYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 61 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLH 119
N+++ V K + V +ITE +G+L ++ R+ + + R I G+ YL
Sbjct: 66 NIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 120 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM--------- 170
N +HRDL NI VN ++ K+ D GL+ T
Sbjct: 124 EMN--YVHRDLAARNILVN-SNLVCKVSDFGLS-----RRLEDSEATYTTKGGKIPIRWT 175
Query: 171 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
APE + ++ D++SFG+ + E++++ E PY + N + K V G
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 22/185 (11%)
Query: 31 RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV----KFYKSWVDDKKKTV--NMITELF 84
+V I VLQ P Q E+ ++K+L N++ +Y +K + N++ E
Sbjct: 93 KVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI 149
Query: 85 ---TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141
++ Y + + + + ++K ++ Q+ L Y+HS I HRDLK N+ ++ N
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT 207
Query: 142 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 196
+K+ D G A +A Q+ S I + + APEL Y +D++S G I EM+
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSV--SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
Query: 197 TFEYP 201
YP
Sbjct: 266 -LGYP 269
|
Length = 440 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 39/153 (25%), Positives = 77/153 (50%), Gaps = 22/153 (14%)
Query: 62 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR----QILHGLVY 117
VV+ + ++ DD+ + M+ E G+L + V + WAR +++ L
Sbjct: 105 VVQLFYAFQDDR--YLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDA 157
Query: 118 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPEL 174
+HS IHRD+K DN+ ++ + G +K+ D G + M + + +GTP++++PE+
Sbjct: 158 IHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214
Query: 175 YEEE-----YNELVDIYSFGMCILEMVTFEYPY 202
+ + Y D +S G+ + EM+ + P+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---------RKKHKNVD 100
E+ + + L NVV+ + + MI E G+L+Q+ + K +
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQ 157
K QI G+ +L + +HRDL N V+ EVK+ L L+ +
Sbjct: 116 TKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEY 172
Query: 158 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 207
R+ + ++APE + E++++ D++SFG+ + E+ T E P+ +
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 58/190 (30%)
Query: 118 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL------------------------AI 153
+H IHRD+K DN+ ++ G +K+ D GL
Sbjct: 117 IHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 154 AMQQPT----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 196
+ +P A S +GTP+++APE++ + YN+ D +S G+ + EM+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 197 TFEYP--YSECKNPAQIFKKVTSGIKPASLAKVND----PQIKGFIEKCLVPASERL--- 247
YP S+ NP + ++K+ + + +L ++ P+ K I++ A RL
Sbjct: 234 V-GYPPFCSD--NPQETYRKIINWKE--TLQFPDEVPLSPEAKDLIKRLCCEAERRLGNN 288
Query: 248 SAKDLLKDPF 257
++ PF
Sbjct: 289 GVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
++ EL G L ++ +K+K+V K I Q+ G+ YL N +HRDL N+ +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 139 GNHGEVKIGDLGLAIAMQQP----TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 192
H KI D GL+ A+ A++ P ++ APE + +++ D++SFG+ +
Sbjct: 130 TQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 193 LEMVTF-EYPYSECK 206
E ++ + PY K
Sbjct: 189 WEAFSYGQKPYKGMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 19/133 (14%)
Query: 87 GNLRQYRKKHKNVDIKVIK--------NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
GNL+ + ++ + + + + A QI G+ YLH +IH+D+ N ++
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID 151
Query: 139 GNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCI 192
+VKI D L+ + P +G E +MA E L +EY+ D++SFG+ +
Sbjct: 152 -EELQVKITDNALSRDLF-PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209
Query: 193 LEMVTF-EYPYSE 204
E++T + PY E
Sbjct: 210 WELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 33/117 (28%), Positives = 59/117 (50%), Gaps = 17/117 (14%)
Query: 98 NVDIKVIKNWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153
N DI + WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G +
Sbjct: 136 NYDIP--EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCM 190
Query: 154 AMQ---QPTARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPY 202
M + +GTP++++PE+ + Y D +S G+ + EM+ + P+
Sbjct: 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 21 EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80
E+ G +VA +K D Q E ++ L N+V+ + + + ++
Sbjct: 26 EYTGQKVAVKNIKCDVTAQ------AFLEETAVMTKLHHKNLVRLLGVILHNG---LYIV 76
Query: 81 TELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
EL + GNL + + + VI+ ++ + G+ YL S ++HRDL NI V+
Sbjct: 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS 134
Query: 139 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 197
+ G K+ D GLA S + ++ APE L ++++ D++S+G+ + E+ +
Sbjct: 135 ED-GVAKVSDFGLARVGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
Query: 198 F-EYPYSECKNPAQIFKKVTSGIK 220
+ PY P K+V ++
Sbjct: 193 YGRAPY-----PKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 107
SE ++ N++ V K + V +ITE +G L + R+ + +
Sbjct: 54 SEASIMGQFDHPNIIHL--EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM 111
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----PTARSV 163
R I G+ YL N +HRDL NI VN N K+ D GL+ ++ PT S
Sbjct: 112 LRGIAAGMKYLSEMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 164 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 207
+G + APE + ++ D++S+G+ + E++++ E PY + N
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 37/149 (24%), Positives = 74/149 (49%), Gaps = 21/149 (14%)
Query: 126 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS--VIGTPEFMAPELYEE----- 177
+HRD+K DN+ ++ +G +++ D G + + T +S +GTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 178 -EYNELVDIYSFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIK----PASLAKVNDPQ 231
Y D +S G+C+ EM+ E P Y+E + + + K+ + + P + V++ +
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTDVSE-E 239
Query: 232 IKGFIEKCLVPASERL---SAKDLLKDPF 257
K I + + RL +D PF
Sbjct: 240 AKDLIRRLICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 43/175 (24%), Positives = 90/175 (51%), Gaps = 12/175 (6%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWA 108
E ++ L +V+ Y V ++K + ++TE +G L Y R++ + ++ +
Sbjct: 49 EAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 166
+ + G+ YL ++ IHRDL N V+ + G VK+ D G+ + + T+ S
Sbjct: 107 QDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKF 163
Query: 167 P-EFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 218
P ++ PE++ +Y+ D++SFG+ + E+ T + P+ E K+ ++ + ++ G
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDL 130
K K V ++TE +G+L + +KH + VI+ R I G+ YL +HRDL
Sbjct: 76 KSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDL 132
Query: 131 KCDNIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVD 184
NI VN N K+ D GL+ ++ T R + APE + ++ D
Sbjct: 133 AARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASD 191
Query: 185 IYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-PASL 224
++S+G+ + E++++ E PY E N + K + G + PA +
Sbjct: 192 VWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPM 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIAMQQPTARSVIGTP- 167
Q+ +G+ +L S N +HRDL N+ + G+ VKI D GLA + + + G+
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 168 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPA 222
++MAPE ++ Y L D++SFG+ + E+ T PY E Q + + G + A
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 223 SLAKVNDPQIKGFIEKC 239
A +D +I ++KC
Sbjct: 363 KPAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 27/56 (48%), Positives = 35/56 (62%), Gaps = 3/56 (5%)
Query: 100 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155
DI VIK RQ+L GL LH I+HRD+K +N+ V + G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 36/180 (20%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNV-- 99
Q+ E L+ L+ N+V V K++ M+ E G+L ++ H +V
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110
Query: 100 --DIKVIK---------NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 148
+ +K + A QI G+ YL SH+ +HRDL N V G VKI D
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISD 167
Query: 149 LGLA--------IAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTF 198
GL+ +Q ++S++ +M PE LY + E DI+SFG+ + E+ ++
Sbjct: 168 FGLSRDIYSADYYRVQ---SKSLLPV-RWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 20/162 (12%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVD 100
++ Y E+ L+K + N++ + K + V ++ EL + NL Q + +D
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LD 124
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160
+ + Q+L G+ +LHS IIHRDLK NI V + +KI D GLA +
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAG 177
Query: 161 RSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMV 196
S + TP + APE + Y E VDI+S G + EM+
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 20/162 (12%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVD 100
++ Y E+ L+K + N++ + K + V ++ EL + NL Q + +D
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME--LD 117
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160
+ + Q+L G+ +LHS IIHRDLK NI V + +KI D GLA +
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAG 170
Query: 161 RSVIGTP-----EFMAPE-LYEEEYNELVDIYSFGMCILEMV 196
S + TP + APE + Y E VDI+S G + EMV
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 20/156 (12%)
Query: 79 MITELFTSGNLRQY----RKKHKN------VDIKVIKNWARQILHGLVYLHSHNPPIIHR 128
+I EL T G+L+ Y R + +N +K + A +I G+ YL+++ +HR
Sbjct: 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHR 143
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELV 183
DL N V + VKIGD G+ + + G +M+PE L + +
Sbjct: 144 DLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 202
Query: 184 DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
D++SFG+ + E+ T E PY N Q+ + V G
Sbjct: 203 DVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 58/263 (22%), Positives = 91/263 (34%), Gaps = 68/263 (25%)
Query: 121 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 155
H IHRD+K DNI ++ + G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 156 ------------------------QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 190
Q+ A S++GTP ++APE L + Y +L D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVT---SGIKPASLAKVNDPQIKGFIEKCLVPASERL 247
+ EM+ + P+ P + KV + + K++ P+ I K A ERL
Sbjct: 237 ILFEMLVGQPPFL-APTPTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERL 294
Query: 248 ---SAKDLLKDPFLQ-------VENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDY 297
A D+ PF + Q P + P+ + P+ S + S
Sbjct: 295 GRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNF--DPVEEESPWNDASGD 352
Query: 298 KQLSLSTCTESNNGSPHCPVLEF 320
+ T N P EF
Sbjct: 353 STRTWDTLCSPNGKHPEHAFYEF 375
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 38/170 (22%), Positives = 61/170 (35%), Gaps = 25/170 (14%)
Query: 107 WA--RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 164
WA Q L L LH L + + + G +R
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLKLD---------GSVAFKTPEQSR--- 65
Query: 165 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-- 221
P FMAPE+ + Y E DIYS G+ + E + +E PY+E + + I + + +G+
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD 125
Query: 222 ----ASLAKVND-PQIKGFIEKCLVPAS-ERLSAKDLLKDPFLQVENQKE 265
++L V+ + F+ C R +A L E
Sbjct: 126 PRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLE 175
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 11/129 (8%)
Query: 99 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV-KIGDLGLAIAMQQ 157
+D + + +++ Q+ G+ +L S N IHRDL NI + HG + KI D GLA ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRN 266
Query: 158 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 211
+ V G ++MAPE ++ Y D++S+G+ + E+ + PY ++
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 212 FKKVTSGIK 220
+K + G +
Sbjct: 327 YKMIKEGYR 335
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 36/182 (19%)
Query: 42 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKN 98
G+ Q+ E L+ L N+V V +++ V M+ E G+L ++ R H +
Sbjct: 52 GEFQQ---EASLMAELHHPNIVCLLG--VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSD 106
Query: 99 V--------------DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 144
V D + A QI G+ YL SH +H+DL NI + G V
Sbjct: 107 VGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHV 163
Query: 145 KIGDLGLAIAMQ-------QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 196
KI DLGL+ + QP + I +M PE + +++ DI+SFG+ + E+
Sbjct: 164 KISDLGLSREIYSADYYRVQPKSLLPI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
Query: 197 TF 198
+F
Sbjct: 221 SF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 35/149 (23%), Positives = 84/149 (56%), Gaps = 12/149 (8%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 108
E+ +L++LK +N+V+ +++ ++ + ++ E + N+ + ++ N V + ++++
Sbjct: 50 ELKMLRTLKQENIVELKEAF--RRRGKLYLVFE-YVEKNMLELLEEMPNGVPPEKVRSYI 106
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS---VIG 165
Q++ + + H ++ I+HRD+K +N+ ++ N +K+ D G A + + + + +
Sbjct: 107 YQLIKAIHWCHKND--IVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVA 163
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCIL 193
T + +PE L Y + VD++S G CIL
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 79 MITELFTSGNLRQYRKKHKNV-----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
++ E G+L+ Y + ++ + V++ A ++ GL++LH + IH DL
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALR 129
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV------ 183
N + + VKIGD GLA+ T ++APEL E +L+
Sbjct: 130 NCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTK 188
Query: 184 --DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
+I+S G+ + E+ T + PY + + Q+ K+V
Sbjct: 189 KSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 30/79 (37%), Positives = 40/79 (50%), Gaps = 9/79 (11%)
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----- 156
K+I+ RQIL L LHS I+HRD+K NI + G KI DLG A ++
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 157 QPTARSVIGTPEFMAPELY 175
P + + P + APE Y
Sbjct: 313 IP--KEFLLDPRYAAPEQY 329
|
Length = 566 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 35/120 (29%), Positives = 61/120 (50%), Gaps = 11/120 (9%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIAMQQPTARSVIGTP- 167
Q+ G+ +L S N +HRDL N+ + G+ VKI D GLA + + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 168 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPA 222
++MAPE +++ Y L D++S+G+ + E+ + PY + + K+ SG + A
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWA 108
E ++ L +V+ Y V ++ + ++ E G L Y R + + +
Sbjct: 49 EAQVMMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP- 167
+ G+ YL S N +IHRDL N V G + VK+ D G+ + S GT
Sbjct: 107 LDVCEGMAYLESSN--VIHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 168 --EFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP 208
++ +PE++ +Y+ D++SFG+ + E+ +SE K P
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 42/197 (21%)
Query: 89 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 148
L Q R+ K + +V + +A ++L L YLH I++RDLK +NI ++ + G + + D
Sbjct: 91 LLQ-RQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHES-GHIMLSD 146
Query: 149 LGLA-----------------------------IAMQQPTAR--SVIGTPEFMAPELYEE 177
L+ ++P+ R S +GT E++APE+
Sbjct: 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206
Query: 178 E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA-KVNDP-QIKG 234
+ + VD ++ G+ + EM+ P+ + N + F + K + +
Sbjct: 207 DGHGSAVDWWTLGILLYEMLYGTTPF-KGSNRDETFSNILK--KEVTFPGSPPVSSSARD 263
Query: 235 FIEKCLVP-ASERLSAK 250
I K LV S+RL +K
Sbjct: 264 LIRKLLVKDPSKRLGSK 280
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 32/175 (18%)
Query: 87 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 146
L Q + +N + +++ A +I G+ ++H HN +H DL N F+ + VK+
Sbjct: 84 SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKV 140
Query: 147 GDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV--------DIYSFGMCILE 194
GD G+ + + T ++APEL E + L+ ++++ G+ + E
Sbjct: 141 GDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200
Query: 195 MVTFE---YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASER 246
+ FE PYS + ++ V + D Q+K F + +P SER
Sbjct: 201 L--FENAAQPYSHLSD-REVLNHV-----------IKDQQVKLFKPQLELPYSER 241
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 23/199 (11%)
Query: 22 FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81
+G A VK V + K E +SL+ N+++ + ++
Sbjct: 17 NSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL--LVM 74
Query: 82 ELFTSGNLRQYRKKHKNV-----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 136
E G+L+ Y + + D ++ A +I GL++LH +N IH DL N
Sbjct: 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCL 132
Query: 137 VNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV--------D 184
+ + VKIGD GL+ + T + ++APEL +E + L+ +
Sbjct: 133 LTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 185 IYSFGMCILEMVTF-EYPY 202
++S G+ I E+ PY
Sbjct: 192 VWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 32/132 (24%), Positives = 50/132 (37%), Gaps = 51/132 (38%)
Query: 121 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 155
H IHRD+K DNI ++ + G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 156 ------------------------QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 190
Q+ A S++GTP ++APE L Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 191 CILEMVTFEYPY 202
+ EM+ + P+
Sbjct: 237 ILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 27/108 (25%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 169
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229
Query: 170 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYP 201
MAPE ++++ Y D++SFG+ + E+ + YP
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 26/144 (18%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 169
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230
Query: 170 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
MAPE ++++ Y D++SFG+ + E+ + PY + + +++
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290
Query: 216 TSGIKPASLAKVNDPQIKGFIEKC 239
G + + + P+I + C
Sbjct: 291 KDGTRMRA-PENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 20/38 (52%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 115 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152
L YLH H IIHRDLK DN+ ++ N G +K+ D GL+
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 11/119 (9%)
Query: 87 GNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
G+LR + R + N +K + + Q+ G+ YL S +HRDL N ++ + VK
Sbjct: 82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESF-TVK 138
Query: 146 IGDLGLAIAMQQPTARSV-----IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 197
+ D GLA + SV P ++MA E L +++ D++SFG+ + E++T
Sbjct: 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 25/125 (20%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 169
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235
Query: 170 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
MAPE +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 216 TSGIK 220
G +
Sbjct: 296 KEGTR 300
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 34/160 (21%)
Query: 82 ELFTSGNLRQYRKKHKN-------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
EL G+L+ + ++++ + +K + AR + G YL ++ IHRD+ N
Sbjct: 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARN 146
Query: 135 IFVN--GNHGEVKIGDLGLAIAMQQPTARSVIGTP------------EFMAPELYEEE-Y 179
+ G KI D G+A R + ++M PE + + +
Sbjct: 147 CLLTCKGPGRVAKIADFGMA--------RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF 198
Query: 180 NELVDIYSFGMCILEMVTFEY-PYSECKNPAQIFKKVTSG 218
D++SFG+ + E+ + Y PY N ++ + VT G
Sbjct: 199 TSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 641 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.79 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.78 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.63 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.62 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.38 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.36 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.26 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.17 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.08 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.0 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.77 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.67 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.64 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.48 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.23 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.14 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.1 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.05 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.05 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.01 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.61 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.43 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.33 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.3 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.24 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.22 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.92 | |
| PLN02236 | 344 | choline kinase | 95.75 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.69 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.66 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.44 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.26 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.13 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.97 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.7 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.43 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.43 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.0 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.39 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.72 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.7 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 88.8 | |
| KOG4720 | 391 | consensus Ethanolamine kinase [Lipid transport and | 87.51 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 87.45 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 85.96 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 85.52 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-88 Score=734.30 Aligned_cols=403 Identities=59% Similarity=0.922 Sum_probs=347.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
|.-..+|+|+|+|||+|+|.++|.+|||+++++.++.+.+..+++|+.|+++|+.|+|||||+||++|++..+++++||+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44457999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
|+|++|+|++|++++++++.++++.|++|||+||.|||++.||||||||||+||||+|+.|.|||||+|||+.++...+.
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak 202 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK 202 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 162 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.++|||+|||||++++.|++.+|||||||||+||+|++|||++|.++++||+++++|++|..+.++.+|++++||++||.
T Consensus 203 svIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~ 282 (632)
T KOG0584|consen 203 SVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLA 282 (632)
T ss_pred eeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHcCcccccccCCCCcCCCCC----------CcchhhhhccCCCCC--CCCCcCCccccccccccccCCC
Q 006528 242 PASERLSAKDLLKDPFLQVENQKEPICDPLK----------LPIQSLKMLRLPMSG--PSSMDIDSDYKQLSLSTCTESN 309 (641)
Q Consensus 242 dP~~RpSa~eLL~Hpff~~~~~~~~~~~~~~----------~~~~~~~~~~~~~s~--~~~~~~d~~~~~~~~s~~~~~~ 309 (641)
..++||||.|||+||||+.+.... ...+.. ......+....+... ...+++..| .....+.++.
T Consensus 283 ~~~~R~sa~eLL~d~Ff~~d~g~~-~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D---~~e~v~~em~ 358 (632)
T KOG0584|consen 283 TKSERLSAKELLKDPFFDEDGGIV-ELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTD---ESEEVAQEMV 358 (632)
T ss_pred CchhccCHHHHhhChhhccccccc-cccchhhcccccccccccccchhhcCCcccccccceeecCCC---chhHHHHHHH
Confidence 999999999999999999875531 111100 111111111111111 011111111 0111111000
Q ss_pred CC--CCCCCchhhhhcccCcceeeccccCCCC-ceEEEEEecCCCCCcceeeeccccCCCCHHHHHHHHHHccccCCccH
Q 006528 310 NG--SPHCPVLEFQRMHKNNEFRLRGTKNDDT-SVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDV 386 (641)
Q Consensus 310 ~~--~~~~~~~e~~~~~~~~~~~~~g~~~~~~-~i~L~Lri~d~~~~~~~i~F~f~~~~DTa~~vA~EmV~~~~i~~~D~ 386 (641)
.. -......+..+...+..+.++|+.+++. .++|.|||+|..|+.|||+|||+++.|||.+||.|||+++.++++++
T Consensus 359 ~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~dq~v 438 (632)
T KOG0584|consen 359 EEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITDQPV 438 (632)
T ss_pred HhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcccch
Confidence 00 0111224455667788899999999876 99999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCC
Q 006528 387 AFIAEFIDYLIMKLLPGWKPSY 408 (641)
Q Consensus 387 ~~iA~~i~~~i~~l~~~~~~~~ 408 (641)
..||+|||.+|.+|+|.|+...
T Consensus 439 ~~ia~mid~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 439 VNIAEMIDGEISALVPNWKAST 460 (632)
T ss_pred hhHHHHHhchhhhcCCccCCCC
Confidence 9999999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-53 Score=438.06 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=232.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+.+..+|.|+.|+|||+.|+.|++.+|.|.|... ..+....++.+|+++|+.++|||||+||+.|..... .+.|+|
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~m 157 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICM 157 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeeh
Confidence 4577899999999999999999999999999543 357788899999999999999999999999998864 699999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
|||.+|+|.++++..++++|..+..++.+|++||.|||. ++ ||||||||+||||+. .|.|||||||.++.+-+..+
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNs-kGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNS-KGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeecc-CCCEEeccccccHHhhhhhc
Confidence 999999999999999999999999999999999999996 77 999999999999984 58999999999999888888
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCC----CCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSE----CKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~----~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
.+++||..|||||.+.+ .|+.++||||||+.++||++|++||.. ..+..+++..|..+.+|.......++++++|
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~F 314 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSF 314 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 99999999999998876 699999999999999999999999976 3567889999999877665555689999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
|..||+ ||.+||+++|||+|||++...
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999 899999999999999998544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-51 Score=425.74 Aligned_cols=256 Identities=24% Similarity=0.318 Sum_probs=223.0
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCCh---hhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLP---GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~---~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
+-..+|.|+||.|-+|..+.||+.||||+++........ .....+.+|+++|++|+|||||+++++|... .+.||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~--ds~Ym 253 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP--DSSYM 253 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--CceEE
Confidence 457899999999999999999999999999876643311 2344578999999999999999999998766 45899
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC--CCcEEEeecchhhhccC
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~--~G~VKL~DFGlA~~~~~ 157 (641)
||||+.||+|.+++..++.+.+..-+.+++||+.|+.|||++| |+||||||+|||++.+ .-.+||+|||+|+....
T Consensus 254 VlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred EEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 9999999999999999999999999999999999999999999 9999999999999743 23689999999998764
Q ss_pred -CCCccccCCCCCCCccccccc----CCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC--ccccCChH
Q 006528 158 -PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDP 230 (641)
Q Consensus 158 -~~~~~~~GTp~ymAPEvl~~~----y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~--~l~~~~~~ 230 (641)
...++.||||.|.|||++... |..++||||+||++|-+++|.+||++...+..+.++|.+|.... ..+...+.
T Consensus 332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISE 411 (475)
T ss_pred ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhH
Confidence 356789999999999998642 56699999999999999999999998777777889999986643 34455578
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 231 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 231 ~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
++++||.+||. ||++|||++|+|+||||+...
T Consensus 412 ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999998 999999999999999998543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=422.69 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=220.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
.+...+|.|+.++||+|++..+++.||||++.++++. ..+..+.+|++.|+.++||||+++|.+|+.+ ..+|+||
T Consensus 29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~--~~LWvVm 103 (516)
T KOG0582|consen 29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVVD--SELWVVM 103 (516)
T ss_pred eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEec--ceeEEee
Confidence 3567899999999999999999999999999999864 3478899999999999999999999999987 4599999
Q ss_pred ccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 82 ELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
.||.+|++.++++.. ..++|..|..+++++|+||.|||.+| .||||||+.||||+ .+|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCceeeeeecccC
Confidence 999999999999874 45999999999999999999999999 99999999999998 5589999999987554321
Q ss_pred ----CC-ccccCCCCCCCccccc---ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-------CCc
Q 006528 159 ----TA-RSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-------PAS 223 (641)
Q Consensus 159 ----~~-~~~~GTp~ymAPEvl~---~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~-------~~~ 223 (641)
.. .+++|||+|||||++. .+|+.|+|||||||++.||++|..||.+......+..+++...+ +..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d 260 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD 260 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence 12 5679999999999954 36999999999999999999999999986555556555555433 122
Q ss_pred cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccCCC
Q 006528 224 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 224 l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~~ 265 (641)
..+..+..++.||..||+ ||.+||||++||+|+||+......
T Consensus 261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 233446789999999999 899999999999999998776554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=430.41 Aligned_cols=247 Identities=32% Similarity=0.475 Sum_probs=224.2
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
..+|.|+|++||.+.+..+|+.||+|+|.+..+ ..+...+++.+||++.++|+|||||+||++|.+. .++|||.|+|
T Consensus 24 ~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs--~nVYivLELC 100 (592)
T KOG0575|consen 24 RFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS--NNVYIVLELC 100 (592)
T ss_pred eeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC--CceEEEEEec
Confidence 468999999999999999999999999987654 4567899999999999999999999999999876 4599999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~~~ 162 (641)
..|+|..++++.+.++|..++.+++||+.||.|||+++ |||||||..|+|++.+ -.|||||||||+.+... ...+
T Consensus 101 ~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 101 HRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred CCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEecccceeeeecCcccccce
Confidence 99999999999999999999999999999999999999 9999999999999855 49999999999887643 4567
Q ss_pred ccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.||||.|.|||++. .+++..+||||+||+||-|++|++||.. .+..+.+.+|..... .++...+.++++||.++|.
T Consensus 178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCHHHHHHHHHHhc
Confidence 89999999999886 4699999999999999999999999986 668889999987543 3455778899999999999
Q ss_pred -CCCCCCCHHHHHcCccccc
Q 006528 242 -PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 242 -dP~~RpSa~eLL~Hpff~~ 260 (641)
+|.+|||++++|.|+||..
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred CCcccCCCHHHHhcCHhhhC
Confidence 8999999999999999943
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=411.74 Aligned_cols=266 Identities=24% Similarity=0.405 Sum_probs=237.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++++.+|.|+||+||+++.+.||+.+|.|++++..... ..+......|..+|..++||+||+++.+|.+..+ +|||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k--LylV 103 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK--LYLV 103 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe--EEEE
Confidence 578999999999999999999999999999998877543 3567889999999999999999999999988754 9999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--C
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--P 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~ 158 (641)
+||+.||.|+.+|++.+.|++..++.|+.+|+.||.|||+.| ||||||||+|||++ .+|+|+|+|||+++.... .
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCC
Confidence 999999999999999999999999999999999999999999 99999999999998 679999999999985432 3
Q ss_pred CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHH
Q 006528 159 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
...++|||++|||||++. .+|+..+|+||||+++|||++|.+||.. .+...++++|..+.. ...+...+.++++||.
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEARDLLK 258 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHHHHHHH
Confidence 556789999999999775 5799999999999999999999999987 677888899988762 3345667899999999
Q ss_pred HhcC-CCCCCC----CHHHHHcCcccccccCCCCcCCCCCCc
Q 006528 238 KCLV-PASERL----SAKDLLKDPFLQVENQKEPICDPLKLP 274 (641)
Q Consensus 238 kcL~-dP~~Rp----Sa~eLL~Hpff~~~~~~~~~~~~~~~~ 274 (641)
++|. +|.+|. .+.++-+||||...+|+......+.+|
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~Pp 300 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPP 300 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCC
Confidence 9999 899996 699999999999999987655444443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=403.02 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=224.4
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+...+|+|+|++||+|.++.+|.+||||.|.+..+ .++..+.+..||.+|+.++|||||.++++.... +.+|||||
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~~i~lVME 89 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--DFIYLVME 89 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--CeEEEEEE
Confidence 45679999999999999999999999999988764 467788899999999999999999999987665 57999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC-C----CcEEEeecchhhhccC
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-H----GEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~-~----G~VKL~DFGlA~~~~~ 157 (641)
||.||+|.+|+++++.+++..++.++.||+.||++||+++ ||||||||+|||++.. . -.+||+|||+|+.+..
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999 9999999999999753 1 3589999999998875
Q ss_pred C-CCccccCCCCCCCcccc-cccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCccccCChHHHHH
Q 006528 158 P-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIKG 234 (641)
Q Consensus 158 ~-~~~~~~GTp~ymAPEvl-~~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~-~~~l~~~~~~~l~~ 234 (641)
. ...+.||+|.|||||++ .++|+.|+|+||+|+++|+|++|+.||.. .++.+++..+..+.. ...++...++...+
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~ 246 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSNPLRE 246 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccCchhh
Confidence 4 46678999999999988 57899999999999999999999999987 567788878877644 33445555666778
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 235 FIEKCLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
++...|. +|..|.+..+-+.|+|+......
T Consensus 247 Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~ 277 (429)
T KOG0595|consen 247 LLISLLQRNPKDRISFEDFFDHPFLAANPQD 277 (429)
T ss_pred hhhHHHhcCccccCchHHhhhhhhcccCccc
Confidence 8888887 89999999999999999766533
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=398.86 Aligned_cols=253 Identities=29% Similarity=0.473 Sum_probs=214.3
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
...+|+|+||+||++.+..+|...|||.+...+ .+. .+.+.+|+.+|++|+|||||++|+.........+++.|||
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 457899999999999999999999999998763 222 6779999999999999999999996333322478999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC-----
Q 006528 84 FTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----- 157 (641)
Q Consensus 84 ~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~----- 157 (641)
+++|+|.+++++.+ ++++..++.+.+||++||+|||++| |+||||||+|||++...|.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 99999999999987 7999999999999999999999999 999999999999985358999999999976652
Q ss_pred CCCccccCCCCCCCcccccccCC--cccccccccchhhhhhhccCCCCCC-CCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 158 PTARSVIGTPEFMAPELYEEEYN--ELVDIYSFGMCILEMVTFEYPYSEC-KNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~~y~--~ksDIwSlGiil~EmltG~~Pf~~~-~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
.....+.|||.|||||++...+. .++|||||||++.||+||..||.+. .....++...... ..+.++...++++++
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~ip~~ls~~a~~ 254 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPEIPDSLSDEAKD 254 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCCCCcccCHHHHH
Confidence 22446789999999998885433 4999999999999999999999873 3333344444444 334677778999999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccccC
Q 006528 235 FIEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
||.+|+. +|.+||||++||.|||++....
T Consensus 255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 255 FLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999 8999999999999999976543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=387.44 Aligned_cols=266 Identities=25% Similarity=0.415 Sum_probs=238.7
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+.+++.+|-|+||+|.+++++.+|..+|+|++++.++.. ..+.+....|..+|+.+.||++++++++|.+. ..++||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~lymv 122 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SNLYMV 122 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccC--CeEEEE
Confidence 357899999999999999999999999999999877643 46778899999999999999999999999876 469999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
|||.+||.|..++++.++|++..++.++.||+.||+|||+++ |++|||||+|||+| .+|.+||.|||+|+..... .
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-T 198 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-E
Confidence 999999999999999999999999999999999999999999 99999999999998 5689999999999887665 6
Q ss_pred ccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 161 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.+.||||.|+|||++. .+|+.++|+|+|||++|||+.|.+||.. .++.++|.+|..+.. .++...++++++||+++
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~L 275 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKL 275 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHH
Confidence 7889999999999776 5799999999999999999999999987 678999999999854 35677789999999999
Q ss_pred cC-CCCCC-----CCHHHHHcCcccccccCCCCcCCCCCCcch
Q 006528 240 LV-PASER-----LSAKDLLKDPFLQVENQKEPICDPLKLPIQ 276 (641)
Q Consensus 240 L~-dP~~R-----pSa~eLL~Hpff~~~~~~~~~~~~~~~~~~ 276 (641)
|+ |-++| ....++..||||....|.......+..|..
T Consensus 276 L~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~ 318 (355)
T KOG0616|consen 276 LQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFE 318 (355)
T ss_pred HhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCC
Confidence 98 88888 458899999999998887765555555543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=392.93 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=220.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+|+.++|+|+||+||++.+..+|..||+|.++.... .....+.+..|+.+|++|+|||||+||+.-+.+++.-+++||
T Consensus 22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 466789999999999999999999999999996654 457788999999999999999999999944445556689999
Q ss_pred ccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 82 ELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPP--IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 82 Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~--IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
|||.+|+|.+.++. ++.++++.+|+++.|++.||..+|+.-|. |+||||||.|||++ ..|.|||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhHh
Confidence 99999999999874 46799999999999999999999995444 99999999999998 5589999999999988
Q ss_pred cCC--CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHH
Q 006528 156 QQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 232 (641)
Q Consensus 156 ~~~--~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l 232 (641)
... .+.+++|||.||+||++. .+|+.++||||+||++|||+..+.||.+ .+..++.++|.++..++......+..+
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~l 257 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTDL 257 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhHH
Confidence 754 467889999999999775 5799999999999999999999999998 588999999999977766667888999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 233 KGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 233 ~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
+.+|..|+. ||..||+. +|+++.
T Consensus 258 ~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred HHHHHHHccCCcccCCCc-----chHHHH
Confidence 999999998 99999986 555543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=412.06 Aligned_cols=250 Identities=30% Similarity=0.505 Sum_probs=221.7
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
...++|+|+-|.||.|....++..||||++.+... ...+.+.+|+.+|+.++|+|||+|+++|... +.+|+|||
T Consensus 277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVVME 350 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVVME 350 (550)
T ss_pred chhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEEEe
Confidence 34689999999999999999999999999988763 2346789999999999999999999999887 45999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCC
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTA 160 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~~~ 160 (641)
|+.||+|.+.+... .++|.+|..+|+++|.||+|||.+| |||||||.+|||+. .+|.|||+|||++..+.. ..+
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeeeccccccCcc
Confidence 99999999988764 4999999999999999999999999 99999999999997 668999999999977643 356
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.+.+|||.|||||++.. .|++++||||||++++||+-|++||-.......++.....|.+....+...++++++|+.+|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 78899999999998875 69999999999999999999999998744445566666677777777788899999999999
Q ss_pred cC-CCCCCCCHHHHHcCccccccc
Q 006528 240 LV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
|+ |+.+|++|.|||+||||+...
T Consensus 507 L~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred hhcchhcCCCHHHHhcChhhhhcC
Confidence 99 999999999999999996443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=400.71 Aligned_cols=253 Identities=23% Similarity=0.452 Sum_probs=222.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCCh-hhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~-~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~l 79 (641)
++...+|.|+||+||.|.+..+|..||+|.+......... ...+.+.+|+.+++.++ ||||++++.++....+ +++
T Consensus 20 ~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~--~~i 97 (370)
T KOG0583|consen 20 ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK--IYI 97 (370)
T ss_pred eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe--EEE
Confidence 4678899999999999999999999999977665332122 44567789999999998 9999999998876644 999
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc--cC
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQ 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~--~~ 157 (641)
||||+.||+|.+++...+++.+..++.+++||+.|++|||++| |+||||||+|||++++.+.+||+|||++... ..
T Consensus 98 vmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred EEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 9999999999999999999999999999999999999999999 9999999999999966589999999999887 34
Q ss_pred CCCccccCCCCCCCcccccc-c-CC-cccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC-hHHHH
Q 006528 158 PTARSVIGTPEFMAPELYEE-E-YN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIK 233 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~-~-y~-~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~-~~~l~ 233 (641)
....+.+|||.|+|||++.+ . |+ .++||||+|++||.|++|.+||.+ .+...++.++..+... ++... +++++
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~--~p~~~~S~~~~ 252 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFK--IPSYLLSPEAR 252 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCcc--CCCCcCCHHHH
Confidence 56788999999999999975 4 64 789999999999999999999998 6677778888876543 34444 89999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 234 GFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.||.+||. +|.+|+++.+++.||||+..
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 99999999 89999999999999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=404.16 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=226.3
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+-..+|.|+|++||+|+++.++++||||++.+.-+. .+.....+..|-.+|.+| .||.|+++|..|.|+.+ +|||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii-ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s--LYFvL 153 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII-KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES--LYFVL 153 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHH-hhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc--eEEEE
Confidence 456799999999999999999999999998765443 345566788999999999 89999999999988855 99999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--- 158 (641)
||+++|+|.++|++.+.|++...+.++.||+.||+|||++| ||||||||+|||++++ |++||+|||.|+.+...
T Consensus 154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccccccCChhhcc
Confidence 99999999999999999999999999999999999999999 9999999999999854 89999999999866321
Q ss_pred ----------C--CccccCCCCCCCccccccc-CCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 006528 159 ----------T--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 225 (641)
Q Consensus 159 ----------~--~~~~~GTp~ymAPEvl~~~-y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~ 225 (641)
. +.+++||-.|.+||++... .+..+|||+|||++|+|+.|.+||.+ .|+-.++++|..- ...++
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l--~y~fp 307 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQAL--DYEFP 307 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHh--cccCC
Confidence 1 1458999999999998754 68899999999999999999999987 6788888988873 33456
Q ss_pred cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccCCCCc
Q 006528 226 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEPI 267 (641)
Q Consensus 226 ~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~~~~ 267 (641)
...++.+++||+++|+ ||++|+|+.+|.+||||...+|...+
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence 6667899999999999 99999999999999999999887643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=399.14 Aligned_cols=261 Identities=22% Similarity=0.376 Sum_probs=228.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+.+|..||+||||.||+|.-+.||..+|+|.+++.... ...+...+..|-.+|...++|+||++|.+|.+. .++|||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--~~LYLi 219 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--EYLYLI 219 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--CeeEEE
Confidence 45789999999999999999999999999999987754 457788999999999999999999999999876 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC---
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--- 157 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--- 157 (641)
|||++||++..+|.+.+.|++..++.|+.+++.|+..||++| +|||||||+|+||| ..|++||.||||+..+..
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhh
Confidence 999999999999999999999999999999999999999999 99999999999998 569999999999842210
Q ss_pred ----------------------CC------------------------CccccCCCCCCCcccccc-cCCcccccccccc
Q 006528 158 ----------------------PT------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGM 190 (641)
Q Consensus 158 ----------------------~~------------------------~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGi 190 (641)
+. ..+.+|||.|||||++.+ +|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 00 013579999999998865 6999999999999
Q ss_pred hhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--cCChHHHHHHHHHhcCCCCCCCC---HHHHHcCcccccccCCC
Q 006528 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQKE 265 (641)
Q Consensus 191 il~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~--~~~~~~l~~LI~kcL~dP~~RpS---a~eLL~Hpff~~~~~~~ 265 (641)
|||||+.|.+||.. .++.+.+++|......-.++ ...++++++||.+||.||.+|+. ++||.+||||+..+|..
T Consensus 377 ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcch
Confidence 99999999999987 67899999888765322222 23458999999999999999985 99999999999999987
Q ss_pred CcC
Q 006528 266 PIC 268 (641)
Q Consensus 266 ~~~ 268 (641)
...
T Consensus 456 l~~ 458 (550)
T KOG0605|consen 456 LRE 458 (550)
T ss_pred hhc
Confidence 543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=401.07 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=220.6
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
.+-.+|+|+||.||+|.|..+++.||+|++..+. ..++.+.+++|+.+|.+++++||.++|++|+.... +|++||
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~--LwiiMe 91 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK--LWIIME 91 (467)
T ss_pred cchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc--HHHHHH
Confidence 3467999999999999999999999999998775 56778899999999999999999999999998854 999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 160 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~ 160 (641)
||.||++.+.++....+++..+..++++++.||.|||.++ .+|||||+.|||+..+ |.|||+|||++..+... ..
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecceeeeeechhhcc
Confidence 9999999999998888899999999999999999999999 9999999999999855 89999999999776543 34
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.+++|||.|||||++.+ .|+.++||||||++++||++|++||.++.... .. .+.....|+.+....++.+++||..|
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-vl-flIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-VL-FLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-EE-EeccCCCCCccccccCHHHHHHHHHH
Confidence 68899999999998875 79999999999999999999999999865422 11 12233356666778899999999999
Q ss_pred cC-CCCCCCCHHHHHcCcccccc
Q 006528 240 LV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
|. +|..||+|.+||+|+|++..
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhc
Confidence 99 89999999999999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=391.69 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=213.3
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEEEEc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+.++|.|+||.||+|...++|..||||+++..-. + -+.-.-.+|++.|++|+ |||||++++++.+.+. .++||||
T Consensus 15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~--s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~fVfE 90 (538)
T KOG0661|consen 15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYFVFE 90 (538)
T ss_pred HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc--c-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEeeeHH
Confidence 5679999999999999999999999999875542 2 22233479999999998 9999999999887763 8999999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-C
Q 006528 83 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-A 160 (641)
Q Consensus 83 y~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~-~ 160 (641)
||.. +|+++++.+ +.|++..|+.|+.||++||+|+|.+| +.||||||+|||+.+. ..|||+|||+|+...... .
T Consensus 91 ~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 91 FMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred hhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccccccccccCCCc
Confidence 9986 999999864 56999999999999999999999999 9999999999999865 489999999999887554 4
Q ss_pred ccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-C-------------------
Q 006528 161 RSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------------- 218 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-g------------------- 218 (641)
..++.|.+|+|||++- +-|+.++|+|++||+++|+++.++-|.+....+|+++...- |
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 4578999999999764 45999999999999999999999999998888888775421 0
Q ss_pred CC----C---CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 219 IK----P---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 219 ~~----~---~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
.. + ..+....++++.+||.+||. ||.+||||.++|+||||+.....
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 00 0 11112246789999999999 99999999999999999876543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=376.48 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=215.6
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|+|+||+||+|.+..+|..||+|+++.... ........+.+|+.+|++++||||+++++++... ..+++||||+.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~ 78 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYAN 78 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCCC
Confidence 58999999999999999999999999986432 2234566788999999999999999999988665 56999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCccc
Q 006528 86 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARSV 163 (641)
Q Consensus 86 gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~~~~~~ 163 (641)
+|+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ ..|.+||+|||++..... ......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccce
Confidence 9999999998889999999999999999999999999 99999999999998 557999999999865322 233456
Q ss_pred cCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-
Q 006528 164 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 241 (641)
Q Consensus 164 ~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~- 241 (641)
+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...+...+..+.. .++...++++++||.+||.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHccC
Confidence 79999999998864 589999999999999999999999976 455666666655432 3445567899999999999
Q ss_pred CCCCCC-----CHHHHHcCcccccccCCCC
Q 006528 242 PASERL-----SAKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 242 dP~~Rp-----Sa~eLL~Hpff~~~~~~~~ 266 (641)
||.+|| ++.++++||||....+...
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~ 262 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASINWQDV 262 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 899999 8999999999987766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=383.83 Aligned_cols=243 Identities=30% Similarity=0.453 Sum_probs=208.8
Q ss_pred EEeCccCceEEEEEEEcCCCeE-EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIE-VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~-VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
..+|.|+||+||+|... |.. ||||.+..... .......+.+|+.+|++|+|||||+|+|++..... .+++||||
T Consensus 47 ~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtEy 121 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTEY 121 (362)
T ss_pred hhcccCCceeEEEEEeC--CceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEEe
Confidence 34899999999999976 556 99999987654 22337899999999999999999999998766532 58999999
Q ss_pred CCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 84 FTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 84 ~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
+++|+|++++.. ...++...+..|+.||++||.|||+++| ||||||||+|||++.+.-++||+|||+++..... .
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 999999999987 5789999999999999999999999996 9999999999999855339999999999876643 3
Q ss_pred CccccCCCCCCCcccccc---cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
.....||+.|||||++.+ .|+.++|||||||++|||+||+.||.+... .++...+..+...+.++...++.+..+|
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~l~ 279 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSSLM 279 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence 334789999999999985 399999999999999999999999998665 6666666555555556666889999999
Q ss_pred HHhcC-CCCCCCCHHHHHc
Q 006528 237 EKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~ 254 (641)
++||. +|.+||+..+++.
T Consensus 280 ~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 280 ERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHhCCCCCCcCCCHHHHHH
Confidence 99999 8999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=397.16 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=225.7
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
=+.+|.|+-|.|-+|.+.+||+.+|||.|.+.. ..+......+.+||-+|+.+.||||+++|++|... ..+|+|.||
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~--~~lylvlEy 93 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK--QHLYLVLEY 93 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeeccC--ceEEEEEEe
Confidence 357899999999999999999999999998764 23456677899999999999999999999999655 569999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc-cCCCCcc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM-QQPTARS 162 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~-~~~~~~~ 162 (641)
++||.|++|+..++++++..+..+++||+.|+.|||..+ |+||||||+|+|++.+ +.|||+|||.|..- ......+
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeecccCCccccc
Confidence 999999999999999999999999999999999999999 9999999999999855 56999999999654 3445678
Q ss_pred ccCCCCCCCcccccc-cC-CcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhc
Q 006528 163 VIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y-~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL 240 (641)
.||+|+|.|||++.+ .| +.++||||+|||||.|+||++||.+ +|...++.+|.+|... ++...++++++||.+||
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEAQDLLRRML 247 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHHHHHHHHHh
Confidence 899999999998875 46 5789999999999999999999997 7899999999999764 45677899999999999
Q ss_pred C-CCCCCCCHHHHHcCcccccccC
Q 006528 241 V-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 241 ~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
. ||++|.|.+|+++|||+..-..
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ccCccccccHHHHhhCchhhcCCC
Confidence 8 9999999999999999986543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=400.49 Aligned_cols=266 Identities=24% Similarity=0.396 Sum_probs=234.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~l 79 (641)
++.+..+|+|+||+|++|..+.+++.+|||.+++..+.. .++.+....|.+++... +||.++.+|.+|... .++++
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~~l~f 446 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--EHLFF 446 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccC--CeEEE
Confidence 578999999999999999999999999999999988765 47788999999999988 599999999999766 56999
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--C
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--Q 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~ 157 (641)
||||+.||++..++ ..+.|++..++.|+..|+.||.|||++| |||||||.+|||+| ..|.+||+|||+++... .
T Consensus 447 vmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCCC
Confidence 99999999955543 3467999999999999999999999999 99999999999998 55899999999997543 3
Q ss_pred CCCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 158 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
....++||||.|||||++.+ .|+.++|+|||||+||||++|+.||.+ ++.++++..|... ....+...+.++..++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEAIAIM 599 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHHHHHH
Confidence 45678999999999998875 699999999999999999999999998 6789999999874 3445677789999999
Q ss_pred HHhcC-CCCCCCC-----HHHHHcCcccccccCCCCcCCCCCCcch
Q 006528 237 EKCLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQ 276 (641)
Q Consensus 237 ~kcL~-dP~~RpS-----a~eLL~Hpff~~~~~~~~~~~~~~~~~~ 276 (641)
+++|. +|.+|+. +.+|.+||||+..+|.......+++|..
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~ 645 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFV 645 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCC
Confidence 99999 8999996 5899999999999998766655555543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=369.30 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=208.1
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
.+..+|.|+||+|||++++.||+.||||.+.-.+ ..+....-..+||++|++|+|||+|.+..+|. .+..+++|+|
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhLVFE 81 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHLVFE 81 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEEEee
Confidence 4678999999999999999999999999986543 34566677899999999999999999999774 4467999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 160 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~ 160 (641)
||...-|.++-..-..++.+.++.+++|++.|+.|+|+++ +|||||||+||||+ .+|.+||||||+|+.+..+ .-
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCCcchh
Confidence 9998555544344456999999999999999999999999 99999999999998 5689999999999988743 23
Q ss_pred ccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-------------------CC
Q 006528 161 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------------GI 219 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-------------------g~ 219 (641)
..++.|.+|+|||++-+ +|+..+|||++||++.||++|++-|.+.++-++++..... |.
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 45788999999997765 6999999999999999999999999998888888754422 10
Q ss_pred C------CC----ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 220 K------PA----SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 220 ~------~~----~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
. +. .++.. +..+.+|+++||. ||.+|++.++||.||||+
T Consensus 239 ~lP~~~~~epLe~k~p~~-s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKI-SNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred ecCCCCCccchhhhcccc-hHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 0 01 11111 3468899999999 999999999999999994
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=372.21 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=219.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+|++++||||+++++++.+. ..+++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 79 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLYML 79 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEEEE
Confidence 36788999999999999999999999999999765432 223456788999999999999999999987654 579999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
|||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~-~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR-T 155 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC-c
Confidence 999999999999999889999999999999999999999999 99999999999997 5589999999999766432 2
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...++.+++||.+|
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKL 232 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHHH
Confidence 34679999999998764 589999999999999999999999987 456777777776543 23445578999999999
Q ss_pred cC-CCCCCCC-----HHHHHcCcccccccCC
Q 006528 240 LV-PASERLS-----AKDLLKDPFLQVENQK 264 (641)
Q Consensus 240 L~-dP~~RpS-----a~eLL~Hpff~~~~~~ 264 (641)
|. ||.+||+ ++++++||||+...+.
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 99 8999995 9999999999865554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=377.41 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=220.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|+||+||+|.+..+|+.||+|.++..... .....+.+.+|+.+|++++||||+++++++.+. ..+++||
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 97 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLL 97 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEEEEE
Confidence 6788999999999999999999999999999865432 234467789999999999999999999988765 5699999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... ..
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~-~~ 173 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR-TF 173 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC-cc
Confidence 99999999999999889999999999999999999999999 99999999999998 5589999999999765432 23
Q ss_pred cccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhc
Q 006528 162 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL 240 (641)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .++.+.+..+..+..+ ++...++.+++||.+||
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRLK--FPNWFDGRARDLVKGLL 250 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCcC--CCCCCCHHHHHHHHHHh
Confidence 4679999999998764 589999999999999999999999986 4567777777776432 34556788999999999
Q ss_pred C-CCCCCCC-----HHHHHcCcccccccCCC
Q 006528 241 V-PASERLS-----AKDLLKDPFLQVENQKE 265 (641)
Q Consensus 241 ~-dP~~RpS-----a~eLL~Hpff~~~~~~~ 265 (641)
. ||.+||+ +++|+.||||....+..
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~ 281 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHGANWDK 281 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence 8 8999997 79999999998765543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=378.65 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=216.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||+||+|.+..+|..||+|.++..... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~lv 79 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYLI 79 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEEE
Confidence 46889999999999999999999999999999765432 234556788999999999999999999988765 469999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
|||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCccccccccc
Confidence 999999999999998889999999999999999999999999 99999999999997 45899999999986542110
Q ss_pred ------------------------------------CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCC
Q 006528 160 ------------------------------------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPY 202 (641)
Q Consensus 160 ------------------------------------~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf 202 (641)
....+||+.|+|||++. ..|+.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 12457999999999876 46899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCccc--cCChHHHHHHHHHhcCCC---CCCCCHHHHHcCcccccccCCCC
Q 006528 203 SECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPA---SERLSAKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 203 ~~~~~~~~i~~~i~~g~~~~~l~--~~~~~~l~~LI~kcL~dP---~~RpSa~eLL~Hpff~~~~~~~~ 266 (641)
.. .++...+..+........++ ...++++++||.+++.+| ..||+++||++||||+..++...
T Consensus 237 ~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~ 304 (363)
T cd05628 237 CS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHI 304 (363)
T ss_pred CC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHH
Confidence 86 45667777776543222222 124678999999977643 45789999999999998776554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=388.41 Aligned_cols=246 Identities=28% Similarity=0.435 Sum_probs=219.1
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
-.+|+|+||+||||+.+.+++.||+|.+.+.. ..+.++..+.+|+++++.|+|||||.++++|... ..+|+|+|||
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~--~~~~vVte~a 83 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETS--AHLWVVTEYA 83 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--ceEEEEehhh
Confidence 46899999999999999999999999987655 4667889999999999999999999999988554 5699999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~~~ 162 (641)
.| +|+.++...+.++++.++.++.|++.||.|||+++ |+|||+||.|||+. ..|.+|+||||+|+.+... ....
T Consensus 84 ~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 84 VG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccCceeeee
Confidence 87 99999999999999999999999999999999999 99999999999997 5589999999999887654 3456
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
..|||-|||||++++ .|+..+|.||+||++|||++|++||.. ..-.++.+.|... +..++...+..++.|++.+|.
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~gLL~ 236 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNFLQGLLI 236 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHHHHHHhh
Confidence 789999999998875 599999999999999999999999976 4566777787764 333445667899999999998
Q ss_pred -CCCCCCCHHHHHcCcccccc
Q 006528 242 -PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 242 -dP~~RpSa~eLL~Hpff~~~ 261 (641)
||.+|+++.+|+.|||.+..
T Consensus 237 kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 237 KDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred cChhhcccHHHHhcChHHhhh
Confidence 89999999999999998743
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=375.35 Aligned_cols=257 Identities=22% Similarity=0.394 Sum_probs=216.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|+||+||+|.+..+|..||+|++...... .......+.+|+.+|+.++||||+++++++.+. ..+++|
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv 79 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYLI 79 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEEE
Confidence 46889999999999999999999999999999865432 234556788999999999999999999988765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceecccccc
Confidence 999999999999998888999999999999999999999999 99999999999997 5589999999998643211
Q ss_pred --------------------------------------CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhcc
Q 006528 159 --------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFE 199 (641)
Q Consensus 159 --------------------------------------~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~ 199 (641)
.....+||+.|+|||++. ..|+.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 011346999999999876 46899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCccc--cCChHHHHHHHHHhcCCCCCCCC---HHHHHcCcccccccCC
Q 006528 200 YPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQK 264 (641)
Q Consensus 200 ~Pf~~~~~~~~i~~~i~~g~~~~~l~--~~~~~~l~~LI~kcL~dP~~RpS---a~eLL~Hpff~~~~~~ 264 (641)
.||.. .+..+.+..+.........+ ...++.+++||.+||.+|.+|++ +.++|.||||+...+.
T Consensus 237 ~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 237 PPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred CCCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 99987 44566666665543322222 23478999999999999999997 9999999999876543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=370.36 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=216.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||.||+|.+..+|..||+|+++.... ........+.+|+.+|+.++||||+++++++... ..+++|
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv 79 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLYLA 79 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEEEE
Confidence 3688999999999999999999999999999986532 2234566788999999999999999999988665 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
|||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~-~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT-YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-cc
Confidence 999999999999998888999999999999999999999999 99999999999997 568999999999976543 34
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc------cCChHHHH
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA------KVNDPQIK 233 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~------~~~~~~l~ 233 (641)
....||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+.+..+.........+ ...++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 45689999999998764 689999999999999999999999986 45666666555432211111 13367899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccccC
Q 006528 234 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
+||.+||. +|.+||++.++++||||....+
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 99999999 6899999999999999986544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=368.21 Aligned_cols=248 Identities=20% Similarity=0.330 Sum_probs=212.7
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 86 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~g 86 (641)
+|+|+||+||+|.+..+|..||+|.++.... ........+.+|+.+|++++||||+++++++... ..+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence 6999999999999999999999999975432 2344567788999999999999999999988655 569999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCcccc
Q 006528 87 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARSVI 164 (641)
Q Consensus 87 GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~~~~~~~ 164 (641)
|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..... ......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 999999998888999999999999999999999999 99999999999997 557999999999875422 2234467
Q ss_pred CCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-C
Q 006528 165 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-P 242 (641)
Q Consensus 165 GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-d 242 (641)
||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+..+++..+..+. ..++...++.+++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEP--LRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcCCC
Confidence 9999999998764 589999999999999999999999986 45666667666543 23455667899999999999 8
Q ss_pred CCCCC---CHHHHHcCcccccccC
Q 006528 243 ASERL---SAKDLLKDPFLQVENQ 263 (641)
Q Consensus 243 P~~Rp---Sa~eLL~Hpff~~~~~ 263 (641)
|.+|| ++.++|.||||....+
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCCH
Confidence 99997 5899999999986543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=377.87 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=211.8
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
+..||.|+||.||+|+|..||+.||+|+|++... .+.......+||.+|++|+||||+++.+...+.....+|||+||
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY 199 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY 199 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence 4579999999999999999999999999998763 34566778999999999999999999999888766789999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006528 84 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 159 (641)
Q Consensus 84 ~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~--- 159 (641)
|+. +|.-++.. .-.|++.+|+.+++||+.||+|||++| |+|||||+.||||| +.|.+||+|||||+.+....
T Consensus 200 Mdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 200 MDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred ccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCCCCcc
Confidence 987 88888776 347999999999999999999999999 99999999999998 66999999999998765432
Q ss_pred CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-CCCCCc-------------
Q 006528 160 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPAS------------- 223 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-g~~~~~------------- 223 (641)
....+-|.+|+|||++-+ .|+.++|+||+||||.||++|++.|.+.+..+|+.+.+.- |.+...
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~ 355 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF 355 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence 334577999999997764 5999999999999999999999999986666665443321 111110
Q ss_pred ------------cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 224 ------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 224 ------------l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
.....++.+.+|+..+|. ||.+|.||.++|+|+||..
T Consensus 356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 012335778999999999 9999999999999999943
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=372.64 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=218.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCC-eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG-~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++..+|.|+||.||+|.+..++ ..||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~lv 109 (340)
T PTZ00426 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYLYLV 109 (340)
T ss_pred EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEEEEE
Confidence 57889999999999999977665 68999998765432 234566789999999999999999999998765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
|||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+.. ..
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~-~~ 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDT-RT 185 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecCC-Cc
Confidence 999999999999999889999999999999999999999999 99999999999997 558999999999976543 23
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
....||+.|||||++.+ .++.++|||||||++|||++|..||.. .++..+++.+..+... ++...++.++++|++|
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~~ 262 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGIIY--FPKFLDNNCKHLMKKL 262 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHH
Confidence 45689999999998764 589999999999999999999999986 4566777777776432 3455678899999999
Q ss_pred cC-CCCCCC-----CHHHHHcCcccccccCCC
Q 006528 240 LV-PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 240 L~-dP~~Rp-----Sa~eLL~Hpff~~~~~~~ 265 (641)
|. +|.+|+ +++++++||||....+..
T Consensus 263 l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 263 LSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred cccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 99 899995 899999999998766543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=370.58 Aligned_cols=257 Identities=21% Similarity=0.372 Sum_probs=217.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||+|.+..+|+.||+|+++..... .......+..|+.+|+.++||||+++++++.+. ..+++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 79 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLYLV 79 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEEEE
Confidence 36889999999999999999999999999999865432 224566789999999999999999999988765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
|||+.+|+|.+++.+...+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCc
Confidence 999999999999998888999999999999999999999999 99999999999997 55899999999997654322
Q ss_pred ------------------------------CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCH
Q 006528 160 ------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP 208 (641)
Q Consensus 160 ------------------------------~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~ 208 (641)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~ 235 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD-TL 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-CH
Confidence 234579999999998764 5899999999999999999999999874 45
Q ss_pred HHHHHHHHcCCCCCcccc--CChHHHHHHHHHhcCCCCCCCC-HHHHHcCcccccccCC
Q 006528 209 AQIFKKVTSGIKPASLAK--VNDPQIKGFIEKCLVPASERLS-AKDLLKDPFLQVENQK 264 (641)
Q Consensus 209 ~~i~~~i~~g~~~~~l~~--~~~~~l~~LI~kcL~dP~~RpS-a~eLL~Hpff~~~~~~ 264 (641)
...+..+........++. ..++.+++||.+||.+|.+||+ ++++|+||||+...+.
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHH
Confidence 555666655222222222 2478999999999999999999 9999999999875543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=373.27 Aligned_cols=259 Identities=22% Similarity=0.373 Sum_probs=216.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||+||+|.+..+|..||+|.++..... .......+..|+.++..++||||+++++++.+. ..+++|
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv 79 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYLI 79 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEE
Confidence 46889999999999999999999999999999864432 234567888999999999999999999988765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+++|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCcccccccc
Confidence 999999999999998889999999999999999999999999 99999999999997 5589999999998643211
Q ss_pred -----------------------------------CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCC
Q 006528 159 -----------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPY 202 (641)
Q Consensus 159 -----------------------------------~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf 202 (641)
.....+||+.|+|||++. ..|+.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 012357999999999876 46999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCccc--cCChHHHHHHHHHhcCCCCCCC---CHHHHHcCcccccccCCCC
Q 006528 203 SECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERL---SAKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 203 ~~~~~~~~i~~~i~~g~~~~~l~--~~~~~~l~~LI~kcL~dP~~Rp---Sa~eLL~Hpff~~~~~~~~ 266 (641)
.. .++...+..+........++ ...++++++||.+|+.+|.+|+ ++.+++.||||+..++...
T Consensus 237 ~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~ 304 (360)
T cd05627 237 CS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHI 304 (360)
T ss_pred CC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence 86 45666666666533222222 2257789999999888898888 5899999999998776553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.55 Aligned_cols=256 Identities=20% Similarity=0.341 Sum_probs=212.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||+|.+..+|+.||+|.+...... .......+.+|+++|++++||||+++++++.+. ..+|+|
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv 79 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYLI 79 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEEE
Confidence 36789999999999999999999999999998764321 234567789999999999999999999988765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+.+|+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeecccccccccccc
Confidence 999999999999998889999999999999999999999999 99999999999997 5589999999998532110
Q ss_pred -----------------------------------------------CCccccCCCCCCCccccc-ccCCcccccccccc
Q 006528 159 -----------------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 190 (641)
Q Consensus 159 -----------------------------------------------~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGi 190 (641)
.....+||+.|+|||++. ..|+.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 001247999999999876 45899999999999
Q ss_pred hhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccc--CChHHHHHHHHHhcCCCCC---CCCHHHHHcCcccccccC
Q 006528 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VNDPQIKGFIEKCLVPASE---RLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 191 il~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~--~~~~~l~~LI~kcL~dP~~---RpSa~eLL~Hpff~~~~~ 263 (641)
++|||++|.+||.. .+....+..+........++. ..++++++||.+||.+|.+ |+++.+++.||||....+
T Consensus 237 il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 237 IMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999976 345566666654332222222 3578899999999986555 569999999999986554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=373.98 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=213.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||+||+|.+..++..||+|.+..... ........+.+|+.+|++++||||++++++|.+. ..+++|
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv 79 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFV 79 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEE
Confidence 4689999999999999999999999999999976542 1234567889999999999999999999998765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC---
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--- 157 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--- 157 (641)
||||++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+..
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCcccccccc
Confidence 999999999999998888999999999999999999999999 99999999999997 568999999999743210
Q ss_pred ----------------------------------------------CCCccccCCCCCCCccccc-ccCCcccccccccc
Q 006528 158 ----------------------------------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 190 (641)
Q Consensus 158 ----------------------------------------------~~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGi 190 (641)
......+||+.|+|||++. ..|+.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 0012357999999999876 46999999999999
Q ss_pred hhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc--ccCChHHHHHHHHHhcCCCCCCCC---HHHHHcCcccccccCC
Q 006528 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQK 264 (641)
Q Consensus 191 il~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l--~~~~~~~l~~LI~kcL~dP~~RpS---a~eLL~Hpff~~~~~~ 264 (641)
++|||++|+.||... ++.+....+......... ....+++++++|.+|+.+|.+|++ +.++++||||+...+.
T Consensus 237 il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 237 ILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 999999999999873 444444454443222212 234578999999998889999987 9999999999875543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=373.83 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=211.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||+||+|.+..+|..||+|++...... .......+.+|+.+|+.++||||+++++++.+. ..+++|
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv 79 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV 79 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEE
Confidence 46889999999999999999999999999999865432 234567899999999999999999999998765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccc
Confidence 999999999999999889999999999999999999999999 99999999999997 5589999999987532100
Q ss_pred -----------------------------------------------CCccccCCCCCCCccccc-ccCCcccccccccc
Q 006528 159 -----------------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 190 (641)
Q Consensus 159 -----------------------------------------------~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGi 190 (641)
...+.+||+.|+|||++. ..|+.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 012457999999999876 45899999999999
Q ss_pred hhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc--ccCChHHHHHHHHHhcC---CCCCCCCHHHHHcCcccccccCC
Q 006528 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIKGFIEKCLV---PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 191 il~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l--~~~~~~~l~~LI~kcL~---dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
++|||+||..||.... .......+......... ....++++++||.+|+. +|..|+++.+++.||||+...+.
T Consensus 237 il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 237 ILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 9999999999998743 44444444432211111 22357899999999664 35569999999999999876554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=365.30 Aligned_cols=254 Identities=24% Similarity=0.425 Sum_probs=212.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||.||+|.+..+|..||+|.+.... .+.....+.+|+++|++++||||+++++++... ..+++|
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEEE
Confidence 468899999999999999999999999999987642 345567899999999999999999999998776 468999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
|||+.+|+|.+++...+.+++..++.++.||+.||.|||+.+ +|+||||||+|||++ ..|.+||+|||++........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEc-CCCcEEEccCccccccccccc
Confidence 999999999999998888999999999999999999999852 299999999999998 557999999999976655555
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHH------------------------
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV------------------------ 215 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i------------------------ 215 (641)
....||+.|+|||++.+ .++.++|||||||++|+|+||+.||.... ..++...+
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD-AKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhcccccccccCCccccCcccccccc
Confidence 56789999999998764 58999999999999999999999996532 22222111
Q ss_pred ----------------------HcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 216 ----------------------TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 216 ----------------------~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
.....+.......++++++||.+||. +|.+|||+++||+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 11111111122356789999999999 899999999999999998544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=372.45 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=212.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||+|.+..+|..||+|.+...... .......+.+|+.+|+.++||||+++++.|.+. ..+++|
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv 79 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV 79 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEEE
Confidence 47899999999999999999999999999998754321 223456788999999999999999999988765 579999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ ..|.+||+|||+|..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCcccccccc
Confidence 999999999999998888999999999999999999999999 99999999999997 5589999999997432100
Q ss_pred -------------------------------------------CCccccCCCCCCCcccccc-cCCcccccccccchhhh
Q 006528 159 -------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILE 194 (641)
Q Consensus 159 -------------------------------------------~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~E 194 (641)
.....+||+.|||||++.+ .++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0123579999999998764 58999999999999999
Q ss_pred hhhccCCCCCCCCHHHHHHHHHcCCCCCc--cccCChHHHHHHHHHhcCCCCCCC---CHHHHHcCcccccccC
Q 006528 195 MVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIKGFIEKCLVPASERL---SAKDLLKDPFLQVENQ 263 (641)
Q Consensus 195 mltG~~Pf~~~~~~~~i~~~i~~g~~~~~--l~~~~~~~l~~LI~kcL~dP~~Rp---Sa~eLL~Hpff~~~~~ 263 (641)
|++|+.||... ++......+........ .....++.+.+||.+|+.+|.+|+ ++.++++||||+...+
T Consensus 237 ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 237 MLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred hhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 99999999874 44444444443222111 122457889999999888999999 9999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=366.85 Aligned_cols=251 Identities=20% Similarity=0.358 Sum_probs=213.5
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|+|+||+||+|.+..+|..||+|.++.... ........+.+|+.+++.++||||+++++++... ..+++||||+.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYAN 78 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCCC
Confidence 58999999999999999999999999986532 2234566788999999999999999999988765 46999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCccc
Q 006528 86 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARSV 163 (641)
Q Consensus 86 gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~~~~~~ 163 (641)
+|+|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ++|.+||+|||++..... ......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCccccc
Confidence 9999999998888999999999999999999999999 99999999999997 558999999999865322 223456
Q ss_pred cCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-
Q 006528 164 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 241 (641)
Q Consensus 164 ~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~- 241 (641)
.||+.|+|||++. ..++.++|||||||++|+|++|+.||.. .+.......+..... .++...++.+++||.+||.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHccC
Confidence 7999999999876 4689999999999999999999999976 345555555554322 2345568899999999999
Q ss_pred CCCCCC-----CHHHHHcCcccccccCCC
Q 006528 242 PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 242 dP~~Rp-----Sa~eLL~Hpff~~~~~~~ 265 (641)
+|.+|+ ++.++++||||....+..
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~~~~~ 261 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSINWQD 261 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 899998 899999999998765543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=366.33 Aligned_cols=250 Identities=21% Similarity=0.364 Sum_probs=213.1
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|.|+||+||+|.+..+|..||+|++..... ........+.+|+.+|+.++||||+++++++... ..+++||||+.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~~ 78 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYVN 78 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCCC
Confidence 58999999999999999999999999986432 2344567888999999999999999999988665 56999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCccc
Q 006528 86 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARSV 163 (641)
Q Consensus 86 gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~~~~~~ 163 (641)
+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..... ......
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCcccccccc
Confidence 9999999998888999999999999999999999999 99999999999998 557999999999865322 223456
Q ss_pred cCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-
Q 006528 164 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 241 (641)
Q Consensus 164 ~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~- 241 (641)
+||+.|+|||++. ..++.++|||||||++|+|++|+.||.. .+...+...+..+.. .++...++.+++||.+||.
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDI--KFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCCc--cCCCCCCHHHHHHHHHHcCC
Confidence 7999999999886 4689999999999999999999999976 345555555554322 3455667899999999999
Q ss_pred CCCCCC-----CHHHHHcCcccccccCC
Q 006528 242 PASERL-----SAKDLLKDPFLQVENQK 264 (641)
Q Consensus 242 dP~~Rp-----Sa~eLL~Hpff~~~~~~ 264 (641)
+|.+|+ ++.++++||||....+.
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 899997 89999999999876554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=357.51 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=212.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|+||+||+|.+..+|..||+|.+....... ......+.+|+.+|++++|+||+++++++.+. ..+++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence 478899999999999999999999999999987654322 23345678999999999999999999988665 469999
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +.+.+||+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCC
Confidence 9999999999888653 46899999999999999999999999 99999999999997 5579999999999765332
Q ss_pred -CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCH---HHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~---~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
......||+.|+|||++. ..|+.++|||||||++|+|++|+.||...... ..+...+... ....+...++.+.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~ 233 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAK 233 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHH
Confidence 234457999999999886 46899999999999999999999999864322 2223333222 2234445678999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHHcCcccccccCCCC
Q 006528 234 GFIEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpS-----a~eLL~Hpff~~~~~~~~ 266 (641)
+||.+||. +|.+||+ ++++++||||...++...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence 99999999 8999997 999999999988776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=365.63 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=212.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc---eEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK---TVN 78 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~---~l~ 78 (641)
+....+|+|+||+||+|...++++.||||++-.+... -.+|+++|+.++|||||++..+|...... +++
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4567899999999999999999999999999765532 25899999999999999999988765433 778
Q ss_pred EEEccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 79 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
+||||++. +|.++++. +..++.-.++-+.+||++||.|||+.| |+||||||.|||+|.+.|.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 99999986 99888874 577999999999999999999999999 999999999999999999999999999987
Q ss_pred ccC-CCCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc--------------
Q 006528 155 MQQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------- 217 (641)
Q Consensus 155 ~~~-~~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-------------- 217 (641)
+.. ....+++.|..|+|||++-+ .|+.++||||.||++.||+-|++-|.+.+...|+...+.-
T Consensus 176 L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred eccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 754 34467788999999997754 6999999999999999999999999986666666543321
Q ss_pred --------CCCCC----ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccC
Q 006528 218 --------GIKPA----SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 218 --------g~~~~----~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
...+. .+....++++.+|+.++|. +|.+|.++.|+|.||||+.-..
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 00111 1334557899999999999 9999999999999999975443
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=364.35 Aligned_cols=250 Identities=21% Similarity=0.351 Sum_probs=212.2
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|+|+||+||+|.+..+|..||+|.++.... ........+..|+++++.++||||+++++++... ..+++||||+.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYAN 78 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCCC
Confidence 58999999999999999999999999986542 2334566788999999999999999999987665 56999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 86 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 86 gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
+|+|..++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++.... ......
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCccccc
Confidence 99999999988889999999999999999999997 68 99999999999997 55899999999986432 222345
Q ss_pred ccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
..||+.|+|||++. ..++.++|||||||++|+|+||..||.. .+...+...+..+.. .++...++++++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHhh
Confidence 67999999999886 4689999999999999999999999986 345566666654422 3445568899999999999
Q ss_pred -CCCCCC-----CHHHHHcCcccccccCC
Q 006528 242 -PASERL-----SAKDLLKDPFLQVENQK 264 (641)
Q Consensus 242 -dP~~Rp-----Sa~eLL~Hpff~~~~~~ 264 (641)
+|.+|+ ++.++++||||....+.
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 899997 99999999999865543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=363.95 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=209.6
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|+|+||+||+|.+..+|..||+|++....... ......+..|.. +++.++||||+++++++... ..+++||||+
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~~ 78 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDYV 78 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcCC
Confidence 5899999999999999999999999998654322 223345555555 56889999999999988665 5689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ++|.+||+|||++.... ......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCcccc
Confidence 99999999998888999999999999999999999999 99999999999997 55899999999986532 223344
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.. .+....++.+.++|.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPL--RLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhh
Confidence 679999999998764 589999999999999999999999986 456677777766532 2333457899999999999
Q ss_pred -CCCCCCCH----HHHHcCcccccccCCC
Q 006528 242 -PASERLSA----KDLLKDPFLQVENQKE 265 (641)
Q Consensus 242 -dP~~RpSa----~eLL~Hpff~~~~~~~ 265 (641)
+|.+||++ .+++.||||....+..
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 89999987 6999999998765543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=363.26 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=213.2
Q ss_pred EEeCccCceEEEEEEEc---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 5 ISSRRIPAVDTYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
..+|.|+||+||+|.+. .+|..||+|.++.............+..|+.+|+.++||||+++++++... ..+++||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 57899999999999874 578999999998654433444566788999999999999999999988765 4689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~ 159 (641)
||+.+|+|.+++.+.+.+.+..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence 99999999999998888999999999999999999999999 99999999999997 55899999999986432 222
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
.....||+.|+|||++.+ .++.++||||||+++|||++|..||.. .+.......+..+.. .++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 344679999999998764 588999999999999999999999987 445555666665533 2345567899999999
Q ss_pred hcC-CCCCCC-----CHHHHHcCcccccccCC
Q 006528 239 CLV-PASERL-----SAKDLLKDPFLQVENQK 264 (641)
Q Consensus 239 cL~-dP~~Rp-----Sa~eLL~Hpff~~~~~~ 264 (641)
||. +|.+|| ++.+++.||||....+.
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~ 265 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999 899999 89999999999866543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=369.56 Aligned_cols=251 Identities=29% Similarity=0.464 Sum_probs=216.0
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
||.++|.|+||.||+|+|+++|..||||+|..+ .+++.+.+||.+|++|+.|+||+||++|.... -+|+|||
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLWIVME 108 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLWIVME 108 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceEeehh
Confidence 567899999999999999999999999999854 46788999999999999999999999988764 4999999
Q ss_pred cCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 83 LFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 83 y~~gGsL~~~l~-~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
||..|+..+.++ +++++.+..+..+++.-|+||+|||... -||||||+.|||++. .|..||+|||.|..+... .
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNT-DGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcc-cchhhhhhccccchhhhhHHh
Confidence 999999999987 4678999999999999999999999988 899999999999984 589999999999877544 4
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCccccCChHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIKGFIE 237 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~-~~~l~~~~~~~l~~LI~ 237 (641)
..+++|||.|||||++.+ +|+.++||||||++..||+.|++||++......++ .|-...+ ...-+..++.++.+||+
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-MIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-MIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-eccCCCCCCCCChHhhhhHHHHHHH
Confidence 567899999999999875 79999999999999999999999999854333332 2222222 22334456788999999
Q ss_pred HhcC-CCCCCCCHHHHHcCcccccccCCC
Q 006528 238 KCLV-PASERLSAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpff~~~~~~~ 265 (641)
+||. +|++|-||.+|++|||.+......
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 9999 799999999999999998776543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=361.92 Aligned_cols=257 Identities=18% Similarity=0.282 Sum_probs=215.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||+|.+..+|..||+|.++.... ........+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~lv 79 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYLV 79 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEEE
Confidence 3678899999999999999999999999999986542 2234566788999999999999999999988665 569999
Q ss_pred EccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCC
Confidence 9999999999999886 67999999999999999999999999 99999999999997 55899999999997654322
Q ss_pred ---CccccCCCCCCCccccc-------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--cC
Q 006528 160 ---ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KV 227 (641)
Q Consensus 160 ---~~~~~GTp~ymAPEvl~-------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~--~~ 227 (641)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||... +....+..+........++ ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCC
Confidence 23347899999999874 34788999999999999999999999873 4455556665443222222 23
Q ss_pred ChHHHHHHHHHhcCCCCCCCCHHHHHcCcccccccCC
Q 006528 228 NDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 228 ~~~~l~~LI~kcL~dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
.++.+++||.+||.+|.+||++.+++.||||....+.
T Consensus 236 ~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 236 VSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred CCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHH
Confidence 4678999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=352.77 Aligned_cols=251 Identities=18% Similarity=0.276 Sum_probs=204.8
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|+|+||+||+|.+..+|..||+|+++.... .....+.+.+|+.+++.++||||+++++++... ..+++|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLYLV 78 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEEEE
Confidence 3688999999999999999999999999999876532 234456788999999999999999999988654 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+.++++..+......+++..++.++.||+.||.|||+++ |+||||||+||+++ ..|.+||+|||++......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCccccccccc
Confidence 999999888777666667999999999999999999999999 99999999999997 5579999999999765432
Q ss_pred -CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-CC----------------
Q 006528 159 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI---------------- 219 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-g~---------------- 219 (641)
......||+.|+|||++. ..++.++|||||||++|+|++|+.||............... +.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 223457899999999775 45899999999999999999999999864433332211110 00
Q ss_pred ---CCC---------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 220 ---KPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 220 ---~~~---------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.+. ......++.+++||.+||. +|.+|||++++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112246789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=368.11 Aligned_cols=256 Identities=19% Similarity=0.333 Sum_probs=214.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|+||+||+|.+..+|..||+|++...... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~~~~lv 121 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--KYLYMV 121 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CEEEEE
Confidence 36788999999999999999999999999999754321 223445678999999999999999999988765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccCCCc
Confidence 9999999999998764 5899999999999999999999999 99999999999997 5689999999999765432
Q ss_pred -CCccccCCCCCCCcccccc-----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccc--CChH
Q 006528 159 -TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VNDP 230 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~-----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~--~~~~ 230 (641)
.....+||+.|+|||++.. .++.++|||||||++|||++|..||.. .+....+..+..+.....++. ..+.
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 2235679999999998753 378999999999999999999999987 455666777766543333332 3578
Q ss_pred HHHHHHHHhcC-CCCC--CCCHHHHHcCcccccccCC
Q 006528 231 QIKGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 231 ~l~~LI~kcL~-dP~~--RpSa~eLL~Hpff~~~~~~ 264 (641)
++++||.+||. +|.+ |++++++++||||+...+.
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 99999999998 6776 9999999999999876553
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=360.86 Aligned_cols=257 Identities=19% Similarity=0.316 Sum_probs=213.2
Q ss_pred CEEEEEeCccCceEEEEEEEc---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~ 76 (641)
.+++..+|+|+||+||+|.+. .+|..||+|.+............+.+..|+.+|+.+ +||||+++++++... ..
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~ 79 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--AK 79 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--CE
Confidence 468899999999999998864 588999999998654433345567788999999999 599999999987655 56
Q ss_pred EEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 77 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
+++||||+.+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCcccc
Confidence 8999999999999999998888999999999999999999999999 99999999999997 45799999999997543
Q ss_pred CC---CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCC---CCHHHHHHHHHcCCCCCccccCC
Q 006528 157 QP---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTSGIKPASLAKVN 228 (641)
Q Consensus 157 ~~---~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~---~~~~~i~~~i~~g~~~~~l~~~~ 228 (641)
.. .....+||+.|||||++.+ .++.++|||||||++|||+||..||... .....+...+.... ..++...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 234 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFI 234 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCC
Confidence 22 2234679999999998864 3788999999999999999999999642 22334444444332 2344556
Q ss_pred hHHHHHHHHHhcC-CCCCCC-----CHHHHHcCcccccccCC
Q 006528 229 DPQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 264 (641)
Q Consensus 229 ~~~l~~LI~kcL~-dP~~Rp-----Sa~eLL~Hpff~~~~~~ 264 (641)
++.+++||.+||. +|.+|| +++++++||||+...+.
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 7899999999999 899999 89999999999875543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=362.83 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=213.0
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|+|+||+||+|.++.+|..||+|.++..... .....+.+..|+.+++.+ +||||+++++++... ..+++||||+
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~ 78 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV 78 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence 589999999999999999999999999864322 234556778899998877 799999999988665 5699999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... ......
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCcccc
Confidence 99999999998889999999999999999999999999 99999999999997 55799999999986532 223345
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
..||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+++..+..+.. ..+...++++++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 679999999998864 589999999999999999999999986 456677777766533 2344567899999999999
Q ss_pred -CCCCCCCH------HHHHcCcccccccCC
Q 006528 242 -PASERLSA------KDLLKDPFLQVENQK 264 (641)
Q Consensus 242 -dP~~RpSa------~eLL~Hpff~~~~~~ 264 (641)
+|.+||++ +++++||||+...+.
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 89999998 999999999876553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=385.60 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=218.9
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
|++.+|.|+||.||+|..++++...|.|.|... +.+.++.+.-||.||..|+||+||++|+.|..+++ +||+.|
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk--LwiliE 109 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK--LWILIE 109 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc--eEEEEe
Confidence 678899999999999999999999999988754 46788999999999999999999999999888765 899999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--CC
Q 006528 83 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PT 159 (641)
Q Consensus 83 y~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~~ 159 (641)
||.||-....+-. ...+++.+|..+|+|+|.||.|||+++ |||||||+.|||++ -+|.|+|+|||.+..... ..
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccccccchhHHhh
Confidence 9999999888765 456999999999999999999999999 99999999999998 558999999998854322 24
Q ss_pred CccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CccccCChHHH
Q 006528 160 ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQI 232 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~-~~l~~~~~~~l 232 (641)
..+++|||.|||||++. .+|+.++|||||||+|.||+.+++|.++ -++....-+|...-+| -..+..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 56799999999999763 4699999999999999999999999988 4555555555554443 34556678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcccccccCCC
Q 006528 233 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 233 ~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~~ 265 (641)
++|+.+||. +|..||++.+||+||||+....+.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 999999999 899999999999999998666544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=357.63 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=202.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..+|..||+|.++.... ......+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 82 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTLVF 82 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEEEEE
Confidence 678999999999999999999999999999875432 22334578899999999999999999988765 4689999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+. ++|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ +.|.+||+|||++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceeccCCCc
Confidence 9996 5787777654 56899999999999999999999999 99999999999997 5589999999998654322
Q ss_pred CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc--CCC--------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK-------------- 220 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~--g~~-------------- 220 (641)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..+.......+.. +..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2334578999999998753 4889999999999999999999999875554443333211 000
Q ss_pred -CCccc-------------cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 221 -PASLA-------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 221 -~~~l~-------------~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+..+. ...++.+++||.+||+ +|.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00000 0123578999999999 899999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.06 Aligned_cols=256 Identities=22% Similarity=0.368 Sum_probs=214.5
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCC----------hhhHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQL----------PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 71 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~----------~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~ 71 (641)
++...+|+|.||.|-+|.+..+|+.||||++.+..+... ....++..+||.+|++|+|||||+++.+.-+
T Consensus 100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD 179 (576)
T ss_pred ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence 467889999999999999999999999999976554311 1225789999999999999999999998767
Q ss_pred CCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecch
Q 006528 72 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151 (641)
Q Consensus 72 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGl 151 (641)
.....+|||+|||..|.+...-.....+++.+++.|++.++.||+|||.+| ||||||||+|+||+. .|+|||+|||.
T Consensus 180 P~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~-~g~VKIsDFGV 256 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSS-DGTVKISDFGV 256 (576)
T ss_pred cccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcC-CCcEEeeccce
Confidence 777889999999999988754333233999999999999999999999999 999999999999985 48999999999
Q ss_pred hhhccCC-------CCccccCCCCCCCccccccc-----CCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC
Q 006528 152 AIAMQQP-------TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 219 (641)
Q Consensus 152 A~~~~~~-------~~~~~~GTp~ymAPEvl~~~-----y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~ 219 (641)
+...... .....+|||.|||||...++ .+.+.||||+|++||.|+.|++||.+ ....+++.+|....
T Consensus 257 s~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 257 SNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVNDP 335 (576)
T ss_pred eeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcCc
Confidence 8654221 12236899999999977542 36789999999999999999999987 56788899998865
Q ss_pred CCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 220 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 220 ~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
............+++||+++|. ||.+|++..++..|||....
T Consensus 336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 4433333456789999999999 89999999999999999754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.44 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=204.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC---ceEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVN 78 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~---~~l~ 78 (641)
++...+|+|+||.||+|.+..+|..||+|++.... .......++.+|+.+|+.++||||+++++++..... ..++
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 67899999999999999999999999999987432 122345678899999999999999999998865432 3589
Q ss_pred EEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+||||+. ++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCccccccccc
Confidence 9999995 699999998888999999999999999999999999 99999999999997 5589999999999754321
Q ss_pred -----CCccccCCCCCCCccccc---ccCCcccccccccchhhhhhhccCCCCCCCCHHHH--------------HHHHH
Q 006528 159 -----TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI--------------FKKVT 216 (641)
Q Consensus 159 -----~~~~~~GTp~ymAPEvl~---~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i--------------~~~i~ 216 (641)
......||+.|+|||++. ..++.++|||||||++|+|+||+.||.+......+ ...+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 123457999999999875 36899999999999999999999999764322111 11110
Q ss_pred c-----------CCCCCc---cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 217 S-----------GIKPAS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 217 ~-----------g~~~~~---l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
. ...+.. .....++.+.+||.+||. +|.+||+++++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 0 000100 111246788999999999 899999999999999997544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=344.51 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=208.0
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
+..+|.|+||+||+|.|.+||+.||||+|+..+.. ........+||+.|+.++||||+.+.++|... ..+.+|+||
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k--dGi~~talREIK~Lqel~h~nIi~LiD~F~~~--~~l~lVfEf 82 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK--DGINRTALREIKLLQELKHPNIIELIDVFPHK--SNLSLVFEF 82 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc--cCccHHHHHHHHHHHHccCcchhhhhhhccCC--CceEEEEEe
Confidence 35689999999999999999999999999988643 34456789999999999999999999998665 459999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc-
Q 006528 84 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR- 161 (641)
Q Consensus 84 ~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~- 161 (641)
++. +|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+..+...
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCCCCccc
Confidence 985 999998754 56999999999999999999999999 99999999999997 5589999999999987654322
Q ss_pred -cccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-C-------------------
Q 006528 162 -SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------------- 218 (641)
Q Consensus 162 -~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-g------------------- 218 (641)
..+-|.+|+|||++-+ .|+..+|+||.||++.||+-+.+-|.+.++-+|+...+.. |
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 2367999999997754 6999999999999999999998778886666666443321 1
Q ss_pred --CCCCc---cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 219 --IKPAS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 219 --~~~~~---l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.+.+. +....+..+.+|+.++|. +|.+|++|.|+|+|+||...
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 00010 112224567999999999 99999999999999999853
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=352.27 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=219.6
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|+|+|+.||++.+..+|+.+|+|.|....+.. ...+.+.+|+.+-+.|+||||+++++++... .+.|||+|+++
T Consensus 18 ~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~--~~~ylvFe~m~ 93 (355)
T KOG0033|consen 18 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLVFDLVT 93 (355)
T ss_pred HHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhccc--ceeEEEEeccc
Confidence 4799999999999999999999999998776543 3678899999999999999999999987544 67899999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC--CCCcEEEeecchhhhccCC-CCcc
Q 006528 86 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP-TARS 162 (641)
Q Consensus 86 gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~--~~G~VKL~DFGlA~~~~~~-~~~~ 162 (641)
||+|..-|.+...+++..+-.+++|||.||.|+|.++ |+|||+||.|+++.. +...|||+|||+|..+... ....
T Consensus 94 G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G 171 (355)
T KOG0033|consen 94 GGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHG 171 (355)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCcccccc
Confidence 9999888877777899999999999999999999999 999999999999943 2346999999999877633 4556
Q ss_pred ccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCChHHHHHHHHHh
Q 006528 163 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 163 ~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--~~~l~~~~~~~l~~LI~kc 239 (641)
+.|||.|||||++. .+|+..+|||+.|+++|-|+.|.+||.+ .+...+|+.|..+.. +...+...++++++||.+|
T Consensus 172 ~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrM 250 (355)
T KOG0033|consen 172 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRM 250 (355)
T ss_pred ccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHH
Confidence 79999999999887 5699999999999999999999999987 568899999998754 3334556678999999999
Q ss_pred cC-CCCCCCCHHHHHcCccccccc
Q 006528 240 LV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
|. ||.+|.|+.|.|+|||+....
T Consensus 251 L~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 251 LTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred hccChhhhccHHHHhCCchhcchH
Confidence 98 999999999999999997543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=354.13 Aligned_cols=253 Identities=25% Similarity=0.322 Sum_probs=214.3
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
.|..++.|+||.||+|.|+.|++.||.|+++.+. .....--...+||.+|.+++|||||.+..+.+..+.+.+|||||
T Consensus 80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek--ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK--EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHhhcccCcceeEEEeccCCcceeEEeeeccccc--ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 4567899999999999999999999999999876 23344556789999999999999999999998887788999999
Q ss_pred cCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006528 83 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 159 (641)
Q Consensus 83 y~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~-- 159 (641)
||.. +|+.++.+.+ +|...+++.++.|+|+||+|||.+. |+|||||++|+|++ +.|.+||+|||+|+.+..+.
T Consensus 158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCccc
Confidence 9986 9999998865 8999999999999999999999999 99999999999997 77999999999999887652
Q ss_pred CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-CCC-----C----------
Q 006528 160 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK-----P---------- 221 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-g~~-----~---------- 221 (641)
....+.|.+|+|||++-+ .|++++|+||+|||+.||+++++-|.+.....|+.+.+.- |.+ |
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 334567999999997754 5999999999999999999999999987766766554421 100 0
Q ss_pred ------------CccccC-ChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 222 ------------ASLAKV-NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 222 ------------~~l~~~-~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
..+... .+....+|+..+|. ||.+|.||++.|+|.||...
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 000111 24567899999999 99999999999999999754
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=365.05 Aligned_cols=255 Identities=20% Similarity=0.348 Sum_probs=211.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||+|.+..+|..||+|.+...... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~lv 121 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KYLYMV 121 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEE
Confidence 36788999999999999999999999999998754321 233456688999999999999999999988765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+++|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecccCCc
Confidence 9999999999999765 5899999999999999999999999 99999999999997 5589999999999765432
Q ss_pred -CCccccCCCCCCCcccccc-----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccc--CChH
Q 006528 159 -TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VNDP 230 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~-----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~--~~~~ 230 (641)
...+.+||+.|||||++.. .++.++|||||||++|+|++|..||.. .+....+..+........++. ..++
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 2245689999999998753 278899999999999999999999986 445566666665433222222 3477
Q ss_pred HHHHHHHHhcCC-C--CCCCCHHHHHcCcccccccC
Q 006528 231 QIKGFIEKCLVP-A--SERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 231 ~l~~LI~kcL~d-P--~~RpSa~eLL~Hpff~~~~~ 263 (641)
.++++|.+||.+ + ..|+++.++++||||+...+
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 899999999984 3 34899999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.84 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=200.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..+|..||+|.++.... ......+.+|+.++++++||||+++++++... ..+++||
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 82 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLTLVF 82 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEEEE
Confidence 578899999999999999999999999999875432 22345678999999999999999999988654 5689999
Q ss_pred ccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+.+ +|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccCCCc
Confidence 99985 9999887654 5799999999999999999999999 99999999999997 5579999999998654322
Q ss_pred CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC--CCC-------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP------------- 221 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g--~~~------------- 221 (641)
......+++.|+|||++.+ .++.++|||||||++|+|+||+.||...... +....+... ..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhccccchhh
Confidence 2334578999999998753 5899999999999999999999999874333 322222110 000
Q ss_pred ------C-------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 222 ------A-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 222 ------~-------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
. ......++++++||.+||. +|.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0 0011246789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=359.30 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=213.7
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|+|+||+||+|.+..+|..||+|.++.... ......+.+..|..+++.+ +||||+++++++... ..+++||||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 58999999999999999999999999986432 2234566778899999876 899999999998765 4699999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
.+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... ......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCccccc
Confidence 99999999998889999999999999999999999999 99999999999997 55799999999986532 223345
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
..||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+..+.. ..+...++++.+||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhc
Confidence 679999999998764 689999999999999999999999987 456677777766533 2344567899999999999
Q ss_pred -CCCCCC-------CHHHHHcCcccccccCCC
Q 006528 242 -PASERL-------SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 242 -dP~~Rp-------Sa~eLL~Hpff~~~~~~~ 265 (641)
+|.+|| ++.++++||||....+..
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~ 264 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence 899999 999999999997765543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.82 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=209.1
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|+|+||+||+|.+..+|..||+|.++.... ........+.+|+.+++.+ +||||+++++++... ..+++||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~ 78 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV 78 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 57999999999999999999999999986542 2334566788999999999 799999999988765 4699999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
++|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++... ......
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCcccc
Confidence 99999999988889999999999999999999999999 99999999999997 55799999999986432 223345
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCC--------CCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~--------~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+.+.+..... .++...++.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~ 233 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKAS 233 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 689999999998764 5899999999999999999999999631 112234444444322 24455678899
Q ss_pred HHHHHhcC-CCCCCCC------HHHHHcCcccccccC
Q 006528 234 GFIEKCLV-PASERLS------AKDLLKDPFLQVENQ 263 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpS------a~eLL~Hpff~~~~~ 263 (641)
++|.+||. +|.+|++ ++++++||||....+
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999999 8999987 799999999976544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.47 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=216.3
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVk~~~~~~~~~~~~l~l 79 (641)
++++..+|.|+||+||+|.+..++..||+|.+...... .....+.+..|+.+++.++| ++|+++++++... ..+++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 46889999999999999999999999999999865432 23456778899999999976 4688898887655 46999
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--C
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--Q 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~ 157 (641)
||||+.+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCC
Confidence 9999999999999998888999999999999999999999999 99999999999997 45799999999986432 2
Q ss_pred CCCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 158 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+..+.+..+..... .++...++.+.+||
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li 232 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSIC 232 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Confidence 23345679999999998764 589999999999999999999999986 456667777766433 34456688999999
Q ss_pred HHhcC-CCCCCCCH-----HHHHcCcccccccCC
Q 006528 237 EKCLV-PASERLSA-----KDLLKDPFLQVENQK 264 (641)
Q Consensus 237 ~kcL~-dP~~RpSa-----~eLL~Hpff~~~~~~ 264 (641)
.+||. +|.+|+++ .++++||||...++.
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99999 89999976 899999999876654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.54 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=211.8
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHH---HhCCCCCcceeeEEEEeCCCceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL---KSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iL---k~L~HpNIVk~~~~~~~~~~~~l 77 (641)
++++..+|.|+||+||+|.+..+|..||+|.++..... .....+.+.+|++++ +.++||||+++++++... ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEE
Confidence 47899999999999999999999999999999865422 234456777777665 566899999999988765 468
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++||||+.+|+|..++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCC
Confidence 999999999999988865 56999999999999999999999999 99999999999998 557999999999864322
Q ss_pred --CCCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 158 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 158 --~~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
......+|++.|||||++.+ .++.++|||||||++|+|++|+.||.. .+..++...+..+.. ..+...++.+.+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 230 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAIS 230 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence 22345689999999998764 589999999999999999999999986 455666666665433 234456788999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHHcCcccccccCC
Q 006528 235 FIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 264 (641)
Q Consensus 235 LI~kcL~-dP~~Rp-----Sa~eLL~Hpff~~~~~~ 264 (641)
||.+||. +|.+|| ++.++++||||....+.
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 9999999 899999 79999999999865543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=357.33 Aligned_cols=257 Identities=21% Similarity=0.326 Sum_probs=217.3
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~l 79 (641)
++++..+|.|+||+||+|.+..++..||+|.++..... .....+.+..|..++..+ +||+|+++++++... ..+++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 46889999999999999999999999999999865422 234455677888888887 689999999988665 56999
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--C
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--Q 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~ 157 (641)
||||+.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCC
Confidence 9999999999999998888999999999999999999999999 99999999999997 55799999999986532 2
Q ss_pred CCCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 158 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
......+||+.|+|||++. ..++.++|||||||++|||+||..||.. .+...++..+..... .++...++++++||
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 232 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAIC 232 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHH
Confidence 2334567999999999876 4589999999999999999999999987 456677777766533 23455678999999
Q ss_pred HHhcC-CCCCCCC-----HHHHHcCcccccccCCCC
Q 006528 237 EKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 237 ~kcL~-dP~~RpS-----a~eLL~Hpff~~~~~~~~ 266 (641)
.+||. +|.+|++ ..++++||||+..++...
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~ 268 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 99999 8999998 489999999987766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.93 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=211.1
Q ss_pred EEeCccCceEEEEEEE---cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 5 ISSRRIPAVDTYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d---~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
..+|+|+||+||++.+ ..+|..||+|+++.... .......+.+|+.+|++++||||+++++++... ..+++||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEE
Confidence 5689999999999886 46889999999986542 223455678899999999999999999988765 5689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
||+.+|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ +.|.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999999 99999999999997 5579999999998765432 2
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+....+..... .++...++.+++||.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998764 588999999999999999999999986 445566666655432 2344567899999999
Q ss_pred hcC-CCCCCCC-----HHHHHcCcccccccCC
Q 006528 239 CLV-PASERLS-----AKDLLKDPFLQVENQK 264 (641)
Q Consensus 239 cL~-dP~~RpS-----a~eLL~Hpff~~~~~~ 264 (641)
||. +|.+||+ +.+++.||||+...+.
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 999 8999999 7889999999876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=372.05 Aligned_cols=251 Identities=28% Similarity=0.497 Sum_probs=224.4
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
++..+|+|+||.+++.+++.++..||+|.|..... +....+...+|+.++++++|||||.|+++|+.++ .+++|||+
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~Ivm~ 84 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCIVME 84 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEEEEe
Confidence 45679999999999999999999999999998874 4455668999999999999999999999998764 45999999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 83 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 83 y~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||.||+|.+.|++.+ .|+++.+..|+.||+.|+.|||+.. |.||||||.|||++.+ +.|||+|||+|+.+...
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-CceeecchhhhhhcCCchh
Confidence 999999999998654 5999999999999999999999888 9999999999999855 68899999999998766
Q ss_pred CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHH
Q 006528 159 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
...+++|||.||.||++.+ +|+.++||||||||+|||++.+.+|.. .+...+..+|..+. -..++...+.+++.+|+
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHHHHHHH
Confidence 5778899999999999975 699999999999999999999999987 67777888887776 33456777889999999
Q ss_pred HhcC-CCCCCCCHHHHHcCcccccc
Q 006528 238 KCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.||. +|..||+|.+||.+|.++..
T Consensus 240 ~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHhhcCCccCCCHHHHhhChhhhhH
Confidence 9999 79999999999999988743
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=360.53 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=221.5
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
|+++.+|+|.-|+||+|....++..+|+|++.+.... ....+.+++.|-+||+.++||.++.+|..|..+ +++|++|
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~--~~~cl~m 156 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASFETD--KYSCLVM 156 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhheeecc--ceeEEEE
Confidence 5677899999999999999999999999999877653 467788999999999999999999999988655 6899999
Q ss_pred ccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc----
Q 006528 82 ELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM---- 155 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~---- 155 (641)
|||+||+|..++++. +.|++..++.|+.+|+.||+|||..| ||+|||||+||||. ++|+|.|.||.|+...
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCCC
Confidence 999999999998864 56999999999999999999999999 99999999999997 6699999999987311
Q ss_pred ---c---------------------------C-C-----------------------CCccccCCCCCCCcccccc-cCC
Q 006528 156 ---Q---------------------------Q-P-----------------------TARSVIGTPEFMAPELYEE-EYN 180 (641)
Q Consensus 156 ---~---------------------------~-~-----------------------~~~~~~GTp~ymAPEvl~~-~y~ 180 (641)
. . . ...+++||-+|+|||++.+ +.+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0 0113579999999999986 589
Q ss_pred cccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCC----HHHHHcC
Q 006528 181 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS----AKDLLKD 255 (641)
Q Consensus 181 ~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpS----a~eLL~H 255 (641)
.++|+|+|||++|||+.|..||.+..+.+.+...+.+...-+..+ ..+..+++||+++|+ ||.+|+. |.||.+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999999999999999777777766666554433333 345689999999999 8999998 9999999
Q ss_pred cccccccCCC
Q 006528 256 PFLQVENQKE 265 (641)
Q Consensus 256 pff~~~~~~~ 265 (641)
|||+..+|.-
T Consensus 393 pFF~gVnWaL 402 (459)
T KOG0610|consen 393 PFFEGVNWAL 402 (459)
T ss_pred ccccCCChhh
Confidence 9999999973
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=357.53 Aligned_cols=251 Identities=24% Similarity=0.435 Sum_probs=209.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..+|..||+|.+.... .......+.+|+++|++++||||+++++++... ..+++||
T Consensus 8 ~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 82 (333)
T cd06650 8 EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICM 82 (333)
T ss_pred heeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEEEE
Confidence 57889999999999999999999999999887642 344567799999999999999999999998875 4699999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~-gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
||+.+|+|.+++...+.+++..++.++.||+.||.|||+. + |+||||||+|||++ ..|.+||+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhhhhcc
Confidence 9999999999999888899999999999999999999975 6 99999999999997 557999999999976655444
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHH---------------------------
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF--------------------------- 212 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~--------------------------- 212 (641)
....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..++.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 55689999999998864 58899999999999999999999997522 22211
Q ss_pred -----------------HHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 213 -----------------KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 213 -----------------~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
..+.....+.......+.++++||.+||. +|.+|||+.+|++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11111111111122346789999999999 89999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=376.13 Aligned_cols=252 Identities=31% Similarity=0.497 Sum_probs=224.3
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
..+|.|+||+||.|+|..|...+|||.|...+ ....+.+..||.+.++|+|.|||+|.|++- .+.++-+.||-.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecC
Confidence 46899999999999999999999999987554 355678999999999999999999999853 346788999999
Q ss_pred CCCCHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006528 85 TSGNLRQYRKK-HKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 159 (641)
Q Consensus 85 ~gGsL~~~l~~-~~~l--~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~ 159 (641)
+||+|..+++. ++++ ++.++..+.+||+.||.|||.+. |+|||||-+|+||+.-.|.+||.|||-++.+. ++.
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 99999999874 6888 89999999999999999999999 99999999999999999999999999997764 456
Q ss_pred CccccCCCCCCCcccccc---cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
..++.||..|||||++.. +|+.++|||||||++.||+||++||.+..++...+-++.--...+.++.-.+.+++.||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 678899999999999973 59999999999999999999999999888887776666555556667777789999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 237 EKCLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
.+|+. +|.+||+|.+||.+||++..+.+
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCCCC
Confidence 99999 89999999999999999877433
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.33 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=208.0
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHH-HHHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEV-HLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei-~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|+|+||+||+|.+..++..||+|.+........ .....+..|. .+++.++||||+++++++... ..+++||||+
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYI 78 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeCC
Confidence 58999999999999999999999999986543222 2233444454 457889999999999988765 4689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
.+|+|.+++...+.+.+..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... ......
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCccc
Confidence 99999999998888999999999999999999999999 99999999999997 55799999999986532 223345
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+..... ......++.++++|.+||+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCc--CCCCCCCHHHHHHHHHHcc
Confidence 679999999998764 589999999999999999999999986 456666666655422 2334557889999999999
Q ss_pred -CCCCCCCHH----HHHcCcccccccCCC
Q 006528 242 -PASERLSAK----DLLKDPFLQVENQKE 265 (641)
Q Consensus 242 -dP~~RpSa~----eLL~Hpff~~~~~~~ 265 (641)
+|.+|+++. ++++|+||....+..
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 899999865 999999998766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.86 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=207.2
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|.|+||+||+|.+..+|..||+|++...... .......+..|.. +++.++||||+++++++... ..+++||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDFV 78 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcCC
Confidence 589999999999999999999999999765322 2233445566655 57789999999999988765 5689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ +.|.+||+|||++.... ......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCccc
Confidence 99999999998889999999999999999999999999 99999999999997 55899999999986432 223345
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..... .+....+..+.++|.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPL--VLRPGASLTAWSILEELLE 232 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCc--cCCCCCCHHHHHHHHHHhc
Confidence 679999999998764 589999999999999999999999986 456666666665432 2233457789999999998
Q ss_pred -CCCCCCCH----HHHHcCcccccccC
Q 006528 242 -PASERLSA----KDLLKDPFLQVENQ 263 (641)
Q Consensus 242 -dP~~RpSa----~eLL~Hpff~~~~~ 263 (641)
+|.+||++ .++++||||....+
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 89999876 69999999986554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=349.69 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=205.7
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 86 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~g 86 (641)
+|+|+||+||++.+..+|..||+|.+...... .....+.+..|+.+|+.++||||+++++++... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence 69999999999999999999999998765421 223456778999999999999999999987654 568999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006528 87 GNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 160 (641)
Q Consensus 87 GsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~ 160 (641)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ +.|.+||+|||++..+... ..
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 999988743 356999999999999999999999999 99999999999997 5689999999998765432 23
Q ss_pred ccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCH---HHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 161 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~---~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
....||+.|+|||++. ..++.++||||||+++|+|++|+.||...... ..+...+... +...+...++.+++|+
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 3457999999999876 46899999999999999999999999753322 2222333222 2233445678999999
Q ss_pred HHhcC-CCCCCC-----CHHHHHcCcccccccCCC
Q 006528 237 EKCLV-PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 237 ~kcL~-dP~~Rp-----Sa~eLL~Hpff~~~~~~~ 265 (641)
.+||. +|.+|| +++++++||||+...+..
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 99998 899999 899999999998755543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.28 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=209.7
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|.|+||+||+|.+..+|..||+|.++..... .....+.+..|..++..+ +||||+++++++... ..+++||||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~ 78 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYL 78 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 589999999999999999999999999865422 233455567777777655 899999999988655 5699999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
.+|+|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... ......
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCcccc
Confidence 99999999998888999999999999999999999999 99999999999997 55799999999996543 223345
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+..... .++...++++++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRP--HFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 679999999998764 589999999999999999999999987 455666666665432 3445567899999999999
Q ss_pred -CCCCCCCH-HHHHcCcccccccCC
Q 006528 242 -PASERLSA-KDLLKDPFLQVENQK 264 (641)
Q Consensus 242 -dP~~RpSa-~eLL~Hpff~~~~~~ 264 (641)
+|.+||++ .+++.||||....+.
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05592 233 RDPTKRLGVDGDIRQHPFFRGIDWE 257 (316)
T ss_pred CCHHHcCCChHHHHcCcccCCCCHH
Confidence 89999986 589999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=360.29 Aligned_cols=255 Identities=18% Similarity=0.325 Sum_probs=213.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||+|.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~lv 121 (371)
T cd05622 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLYMV 121 (371)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEEEE
Confidence 36789999999999999999999999999998754322 233456688999999999999999999988765 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+++|+|.++++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+...
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcCCc
Confidence 9999999999998764 5899999999999999999999999 99999999999997 5589999999999765432
Q ss_pred -CCccccCCCCCCCcccccc-----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--cCChH
Q 006528 159 -TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDP 230 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~-----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~--~~~~~ 230 (641)
.....+||+.|||||++.. .++.++|||||||++|||++|..||.. .+....+..+........++ ...++
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 2235679999999998753 278999999999999999999999986 55666777776654332222 24578
Q ss_pred HHHHHHHHhcCCCC---CCCCHHHHHcCcccccccC
Q 006528 231 QIKGFIEKCLVPAS---ERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 231 ~l~~LI~kcL~dP~---~RpSa~eLL~Hpff~~~~~ 263 (641)
.+++||.+||.+|. .|+++.++++||||+...+
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 99999999998543 3789999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=355.92 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=210.6
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|+|+||+||+|.++.+|..||+|.++..... .......+..|..++..+ +||||+++++++.+. ..+++||||+
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~ 78 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL 78 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence 589999999999999999999999999864321 123455677888888765 899999999988765 5799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
.+|+|..++.....+++..+..++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++.... ......
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCceec
Confidence 99999999998888999999999999999999999999 99999999999997 45799999999986432 223345
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++.+.+..+. ..++...++++++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLFE 232 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHcc
Confidence 679999999998864 689999999999999999999999986 45666666666543 23345567899999999998
Q ss_pred -CCCCCCCH-HHHHcCcccccccCC
Q 006528 242 -PASERLSA-KDLLKDPFLQVENQK 264 (641)
Q Consensus 242 -dP~~RpSa-~eLL~Hpff~~~~~~ 264 (641)
+|.+||++ +++++||||+...+.
T Consensus 233 ~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 233 RDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred CCHHHcCCChHHHHcCCCcCCCCHH
Confidence 89999997 589999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=356.13 Aligned_cols=250 Identities=20% Similarity=0.322 Sum_probs=208.5
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|+|+||+||+|.+..+|..||+|.++.... ........+.+|+.++.++ +||||+++++++... ..+++||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 78 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV 78 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence 58999999999999999999999999986543 2334566788999998877 899999999988765 4689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~~~~~ 162 (641)
.+|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..... .....
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCcccc
Confidence 99999999988889999999999999999999999999 99999999999997 557999999999865322 22345
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCC--------CCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~--------~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
..||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+.... ..++...+..++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~ 233 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAA 233 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 689999999998764 5899999999999999999999999521 11223344444432 234555678899
Q ss_pred HHHHHhcC-CCCCCCC------HHHHHcCcccccccC
Q 006528 234 GFIEKCLV-PASERLS------AKDLLKDPFLQVENQ 263 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpS------a~eLL~Hpff~~~~~ 263 (641)
+||.+||. +|.+||+ +.++++||||+...+
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999999 8999998 589999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=356.51 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=207.8
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
+|+|+||+||+|.+..+|..||+|.+....... .........|..++..+ +||||+++++++... ..+++||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcC
Confidence 699999999999999999999999997644322 23344566677777665 699999999988665 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTAR 161 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~ 161 (641)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999999998889999999999999999999999999 99999999999997 55799999999986532 22334
Q ss_pred cccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 162 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+..... ....++.+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHH
Confidence 5689999999998753 489999999999999999999999986 456677777766543221 234578899999999
Q ss_pred cC-CCCCCC----CHHHHHcCcccccccC
Q 006528 240 LV-PASERL----SAKDLLKDPFLQVENQ 263 (641)
Q Consensus 240 L~-dP~~Rp----Sa~eLL~Hpff~~~~~ 263 (641)
|. +|.+|| ++.++++||||....+
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 99 899998 7999999999986543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=372.73 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=201.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeC------CCc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD------KKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~------~~~ 75 (641)
++...+|+|+||+||+|.+..+|..||||++.... ....+|+.+|+.++|||||+++++|... ...
T Consensus 69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 57788999999999999999999999999886432 1245799999999999999999887542 223
Q ss_pred eEEEEEccCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecch
Q 006528 76 TVNMITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~----~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGl 151 (641)
++++||||+++ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||+
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeecccc
Confidence 67899999985 7777665 3467999999999999999999999999 999999999999986666899999999
Q ss_pred hhhccCC-CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC-CC-------
Q 006528 152 AIAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK------- 220 (641)
Q Consensus 152 A~~~~~~-~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g-~~------- 220 (641)
|+.+... ......||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+.....++.+.+... .+
T Consensus 218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 9765432 3345678999999998753 58999999999999999999999998755544444333210 00
Q ss_pred ----------C--------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 221 ----------P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 221 ----------~--------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+ ..++...++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0 01122346789999999999 899999999999999997543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=354.99 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=208.1
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|.|+||+||+|.+..+|..||+|.+....... ......+..|+. +++.++||||+++++++.+. ..+++||||+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDYV 78 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 5899999999999999999999999987654322 233445556654 67889999999999987655 5689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~~~~~ 162 (641)
.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCcccc
Confidence 99999999988888999999999999999999999999 99999999999997 558999999999865322 22344
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+++..+.... ..++...+..+.++|.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKP--LQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 679999999998764 589999999999999999999999987 45566667766543 23444567789999999999
Q ss_pred -CCCCCCCH----HHHHcCcccccccCC
Q 006528 242 -PASERLSA----KDLLKDPFLQVENQK 264 (641)
Q Consensus 242 -dP~~RpSa----~eLL~Hpff~~~~~~ 264 (641)
+|.+||++ .++++||||....+.
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 89999875 599999999866554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=355.72 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=210.3
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEe---CCCceEEEE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD---DKKKTVNMI 80 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~---~~~~~l~lV 80 (641)
+..+|.|++|.|..|.++.+|+.||||.+. +.....-..++..+|+.+|+.++|+||+.+++.+.. ..-.-+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV 104 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLV 104 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEe
Confidence 467999999999999999999999999876 222346678899999999999999999999998865 223568999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc----
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ---- 156 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~---- 156 (641)
+|+|. .+|.+.++..+.++...++.++.|||+||+|+|+.+ |+||||||.|+|++.+ ..+||+|||+|+...
T Consensus 105 ~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 105 FELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLARYLDKFFE 180 (359)
T ss_pred hhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccceeeccccCc
Confidence 99995 599999999888999999999999999999999999 9999999999999865 589999999998874
Q ss_pred CCCCccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHH--------------HHH----
Q 006528 157 QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--------------KVT---- 216 (641)
Q Consensus 157 ~~~~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~--------------~i~---- 216 (641)
......++-|.+|+|||++. ..|+.++||||+|||+.||++|++-|.+.....|+.. .+.
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 33445678899999999774 4699999999999999999999999987554444321 111
Q ss_pred -----c-CC-CC---CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 217 -----S-GI-KP---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 217 -----~-g~-~~---~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
+ .. ++ ..+....++.+.+|+++||. ||.+|+|++|+|.||||..
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 0 00 11 12223457899999999999 9999999999999999975
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=355.22 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=212.7
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|.|+||+||+|.+..++..||+|.++.... ........+..|+.+++.+ +||||+++++++... ..+++||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~ 78 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV 78 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 58999999999999999999999999986532 1234566778899999888 799999999988765 4699999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
.+|+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... ......
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCcccc
Confidence 99999999998888999999999999999999999999 99999999999997 55799999999986432 222344
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..... ..+...++.+++||.+||.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcc
Confidence 679999999998764 689999999999999999999999976 456666666665433 2345567899999999999
Q ss_pred -CCCCCCCH-----HHHHcCcccccccCC
Q 006528 242 -PASERLSA-----KDLLKDPFLQVENQK 264 (641)
Q Consensus 242 -dP~~RpSa-----~eLL~Hpff~~~~~~ 264 (641)
+|.+||++ .+++.||||....+.
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 89999999 999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=371.63 Aligned_cols=251 Identities=28% Similarity=0.432 Sum_probs=216.6
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
|..||+|+||.||-|.|..+.+.||||.+..... ++.+.-+.+.+|+..|++|+|||+|.|.++|.-+ .+.|+||||
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWLVMEY 107 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWLVMEY 107 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHHHHHH
Confidence 3579999999999999999999999999987654 4556678899999999999999999999999876 568999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006528 84 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 162 (641)
Q Consensus 84 ~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~ 162 (641)
|- |+..+++.-+ +++-+-.|..|+.+.|.||+|||+++ .||||||+.|||++ +.|.|||+|||.|.... .+.+
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~--PAns 181 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADFGSASIMA--PANS 181 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeeccccchhhcC--chhc
Confidence 96 5999988754 67999999999999999999999999 99999999999997 66999999999997654 3568
Q ss_pred ccCCCCCCCcccc----cccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 163 VIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 163 ~~GTp~ymAPEvl----~~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
++|||.|||||++ ++.|+-++|||||||+..||+..++|+... |.....-.|..+-.|......++..++.||..
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 9999999999965 367999999999999999999999998874 44444444555545555556678899999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
||+ -|.+|||+++||+|+|..-..+.
T Consensus 261 CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred HHhhCcccCCcHHHHhhcchhccCCCc
Confidence 999 59999999999999999755443
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=354.55 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=210.4
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|+|+||+||+|.+..+|..||+|.++..... ..........|..+++.+ +||||+++++++... ..+++||||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 589999999999999999999999999864321 123445677788888765 999999999988765 4699999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
++|+|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... ......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCceee
Confidence 99999999998888999999999999999999999999 99999999999997 45799999999986432 223345
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
..||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..... .++...+..+++||.+||.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP--CYPRWLTREAKDILVKLFV 232 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHhc
Confidence 679999999998764 589999999999999999999999987 456666666655432 2344567889999999999
Q ss_pred -CCCCCCCHH-HHHcCcccccccCC
Q 006528 242 -PASERLSAK-DLLKDPFLQVENQK 264 (641)
Q Consensus 242 -dP~~RpSa~-eLL~Hpff~~~~~~ 264 (641)
+|.+||++. ++++||||....+.
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 233 REPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred cCHhhcCCChHHHHcCcccCCCCHH
Confidence 899999996 99999999876654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=361.98 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=219.7
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEEEEc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
...+|+|.||+||++.++.+|..+|+|.+.+..... ....+.+.+|+.+|+++. |||||.++++|.+. ..+++|||
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~~~lvmE 116 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DSVYLVME 116 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--CeEEEEEE
Confidence 357999999999999999999999999998776533 235678999999999998 99999999998776 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC---CCcEEEeecchhhhccC-C
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAIAMQQ-P 158 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~---~G~VKL~DFGlA~~~~~-~ 158 (641)
+|.||.|.+.+... .+++..+..+++||+.|+.|||+.| |+||||||+|+|+... .+.+|++|||++..... .
T Consensus 117 L~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~ 193 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE 193 (382)
T ss_pred ecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence 99999999999877 5999999999999999999999999 9999999999999644 24899999999987765 3
Q ss_pred CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCChHHHHHH
Q 006528 159 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGF 235 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--~~~l~~~~~~~l~~L 235 (641)
.....+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.+ .+.......|..+.. ....+...+..+++|
T Consensus 194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~ 272 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDISESAKDF 272 (382)
T ss_pred eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence 456789999999999998 6899999999999999999999999987 455666667777754 223334447899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
|.+||. ||.+|+||.++|+|||++...
T Consensus 273 i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 273 IRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHhcccCcccCCCHHHHhcCccccCCc
Confidence 999999 899999999999999998653
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.82 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=215.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~l 79 (641)
++++..+|.|+||+||+|.++.+|..||+|.+...... .....+.+..|+.+++.+. |++|+++++++... ..+++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 46788999999999999999999999999998865322 2344567788999998885 57788899887665 46999
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-- 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~-- 157 (641)
||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCC
Confidence 9999999999999998889999999999999999999999999 99999999999998 557999999999875432
Q ss_pred CCCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 158 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
.......||+.|+|||++. ..++.++|||||||++|+|++|+.||.. .+...++..+..... ..+...++.+++++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 232 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSIC 232 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHH
Confidence 2234567999999999876 4589999999999999999999999987 456667777765433 23455678899999
Q ss_pred HHhcC-CCCCCCC-----HHHHHcCcccccccCCC
Q 006528 237 EKCLV-PASERLS-----AKDLLKDPFLQVENQKE 265 (641)
Q Consensus 237 ~kcL~-dP~~RpS-----a~eLL~Hpff~~~~~~~ 265 (641)
.+||. +|.+|++ ..++++||||+...+..
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~ 267 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDK 267 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHH
Confidence 99999 8999997 58999999998766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.50 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=210.4
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|+|+||+||+|.+..++..||+|+++.... ........+.+|+.++.++ +||||+++++++... ..+++||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 58999999999999999999999999986542 2234567788999999888 699999999988765 4699999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~~~~ 162 (641)
++|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... ......
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCceec
Confidence 99999999988888999999999999999999999999 99999999999998 55799999999986432 223345
Q ss_pred ccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCC------CCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 163 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC------KNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 163 ~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~------~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
.+||+.|+|||++. ..++.++|||||||++|+|++|..||... .....+++.+... +..++...++.++++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~l 233 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHV 233 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHH
Confidence 68999999999876 46899999999999999999999999532 2223444444443 233455667899999
Q ss_pred HHHhcC-CCCCCCC------HHHHHcCcccccccCC
Q 006528 236 IEKCLV-PASERLS------AKDLLKDPFLQVENQK 264 (641)
Q Consensus 236 I~kcL~-dP~~RpS------a~eLL~Hpff~~~~~~ 264 (641)
|.+||. +|.+|++ +.+++.||||....+.
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 999999 8999998 5799999999876654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.68 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=210.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||+|.+..+|..||+|.+...... .......+.+|+.+++.++||||+++++++... ..+++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence 46889999999999999999999999999998754432 223345678899999999999999999987655 469999
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+.+|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ +.+.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCC
Confidence 9999999999888653 46999999999999999999999999 99999999999997 5589999999998765432
Q ss_pred -CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHH---HHHHHHHcCCCCCccccCChHHHH
Q 006528 159 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~---~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
......|++.|+|||++. ..++.++||||||+++|+|++|+.||.+..... .+...+... +...+...++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAAR 233 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHH
Confidence 223457899999999876 458899999999999999999999998643221 222222222 2223444677899
Q ss_pred HHHHHhcC-CCCCCC-----CHHHHHcCcccccccCCC
Q 006528 234 GFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 234 ~LI~kcL~-dP~~Rp-----Sa~eLL~Hpff~~~~~~~ 265 (641)
+||.+||. +|.+|| ++++|++||||...+++.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 99999999 899999 999999999998766554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=348.49 Aligned_cols=257 Identities=17% Similarity=0.312 Sum_probs=210.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||+|.+..+|..||+|.+...... .....+.+.+|+.+++.++||||+++++++... ..+++|
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 79 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYLV 79 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEEE
Confidence 36889999999999999999999999999999754321 234456688999999999999999999988765 569999
Q ss_pred EccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCCCC
Confidence 999999999999986 457999999999999999999999999 99999999999997 55899999999986543321
Q ss_pred ---CccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc---cccC
Q 006528 160 ---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAKV 227 (641)
Q Consensus 160 ---~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~---l~~~ 227 (641)
.....||+.|||||++. +.++.++|||||||++|+|++|+.||.. .+..+.+..+........ ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVTD 235 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccCC
Confidence 12346999999999875 3478899999999999999999999986 345555666654322111 1223
Q ss_pred ChHHHHHHHHHhcCC---CCCCCCHHHHHcCcccccccCC
Q 006528 228 NDPQIKGFIEKCLVP---ASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 228 ~~~~l~~LI~kcL~d---P~~RpSa~eLL~Hpff~~~~~~ 264 (641)
.++.+++||.+||.. +..|+++.++++||||....+.
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 577899999999973 3348899999999999765543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.00 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=198.1
Q ss_pred EEEEEeCccCceEEEEEEEcC-CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceeeEEEEeC---CC
Q 006528 2 RILISSRRIPAVDTYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDD---KK 74 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~-tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVk~~~~~~~~---~~ 74 (641)
+++..+|.|+||+||+|.+.. +|..||+|.++..... ......+.+|+.+++.+ +||||+++++++... ..
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 578899999999999999865 4788999998765422 22334566777777766 699999999987532 23
Q ss_pred ceEEEEEccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 75 KTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
..+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccccce
Confidence 56899999997 6999998764 45899999999999999999999999 99999999999997 4579999999999
Q ss_pred hhccCC-CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC---CC-----
Q 006528 153 IAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PA----- 222 (641)
Q Consensus 153 ~~~~~~-~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~---~~----- 222 (641)
...... ......||+.|+|||++. ..++.++|||||||++|||++|..||.+... .+.+..+..... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhchhh
Confidence 765433 234557899999999875 4689999999999999999999999987443 333333322110 00
Q ss_pred -----------------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 223 -----------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 223 -----------------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.+....++.+++||.+||. +|.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112246778999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=332.65 Aligned_cols=251 Identities=30% Similarity=0.491 Sum_probs=210.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+...+|.|++|.||+|.+..+|..||+|.+....... .......+.+|+.++++++||||+++++++... ..+++|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 82 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETLSIF 82 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeEEEE
Confidence 45678999999999999999999999999987654221 123456789999999999999999999998765 479999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
+||+++++|.+++...+.+++..++.++.||+.||.|||+.+ |+||||+|+||+++ .++.++|+|||++.......
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecccccc
Confidence 999999999999998888999999999999999999999999 99999999999997 55799999999986543221
Q ss_pred --C--ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 --A--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 --~--~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
. ....|++.|+|||++.+ .++.++||||||+++|+|++|+.||........ ...+........++...+..+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHHHhccCCCCCCCccCCHHHHH
Confidence 1 33567889999998764 488999999999999999999999987443333 33444433344455667889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 235 FIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
||.+||. +|.+||++.++|+||||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.67 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=201.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..+|+.||+|.+.... .......+.+|+.+|+.++|+||+++++++... ..+++||
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 151 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQVLL 151 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEEEEE
Confidence 35678999999999999999999999999986443 344567789999999999999999999988654 5689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
||+.+|+|... ...++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++..+... .
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceeccccccc
Confidence 99999998653 34678889999999999999999999 99999999999998 5579999999999765432 2
Q ss_pred CccccCCCCCCCcccccc-----c-CCcccccccccchhhhhhhccCCCCCCC--CHHHHHHHHHcCCCCCccccCChHH
Q 006528 160 ARSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLAKVNDPQ 231 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-----~-y~~ksDIwSlGiil~EmltG~~Pf~~~~--~~~~i~~~i~~g~~~~~l~~~~~~~ 231 (641)
.....||+.|+|||++.. . ++.++|||||||++|||++|+.||.... ....+...+.... ........+++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 303 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATASRE 303 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCccCHH
Confidence 245679999999998742 2 3468999999999999999999997422 1222333333222 22334456788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+++||.+||. +|.+||++.|+|+||||....
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999 899999999999999998653
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=336.45 Aligned_cols=250 Identities=30% Similarity=0.525 Sum_probs=207.5
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.+..+|..||+|.+..... .........+|+.++++++||||+++++++.+. ..+++||
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v~ 77 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYIVM 77 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccc--ccccccc
Confidence 678999999999999999999999999999987653 222333446699999999999999999998874 5688999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc--cCCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~--~~~~ 159 (641)
||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+|+||||+||+++ ..|.++|+|||.+... ....
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccccccccc
Confidence 99999999999998888999999999999999999999999 99999999999998 6689999999998643 2333
Q ss_pred CccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCC--CHHHHHHHHHcCCCCCccc--cCChHHHH
Q 006528 160 ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLA--KVNDPQIK 233 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~--~~~~i~~~i~~g~~~~~l~--~~~~~~l~ 233 (641)
.....+++.|+|||++. ..++.++||||||+++|+|++|..||.... +.................. ....+.++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 44567899999999887 468999999999999999999999998741 2223333332221111111 11237899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 234 GFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
++|.+||. +|.+||++.++++||||
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999 89999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=347.34 Aligned_cols=257 Identities=17% Similarity=0.314 Sum_probs=211.1
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|+||+||++.++.++..||+|.+...... .......+..|+.++..++|+||+++++++.+. ..+++|
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 79 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYLV 79 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEEE
Confidence 36889999999999999999999999999998754321 233455688899999999999999999988665 569999
Q ss_pred EccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 81 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
|||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCC
Confidence 999999999999987 467999999999999999999999999 99999999999997 5579999999998654322
Q ss_pred --CCccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc---ccC
Q 006528 159 --TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL---AKV 227 (641)
Q Consensus 159 --~~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l---~~~ 227 (641)
.....+||+.|+|||++. +.++.++|||||||++|||++|+.||.. .+..+.+..+........+ ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCcccc
Confidence 122357999999999874 3488999999999999999999999987 4556666666554322212 223
Q ss_pred ChHHHHHHHHHhcC-C--CCCCCCHHHHHcCcccccccCC
Q 006528 228 NDPQIKGFIEKCLV-P--ASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-d--P~~RpSa~eLL~Hpff~~~~~~ 264 (641)
.++++++||.+||. + +..|++++++++||||+...+.
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 47899999999997 3 3347899999999999876554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=347.11 Aligned_cols=258 Identities=16% Similarity=0.313 Sum_probs=211.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|+|+||+||+|.+..++..||+|.+...... .......+.+|+.+++.++|+||+++++++.+. ..+|+|
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~lv 79 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYLV 79 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEE
Confidence 36889999999999999999999999999998754321 234456688899999999999999999988665 569999
Q ss_pred EccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccCCC
Confidence 999999999999987 467999999999999999999999999 99999999999997 55799999999997654322
Q ss_pred ---CccccCCCCCCCcccccc------cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc---cC
Q 006528 160 ---ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA---KV 227 (641)
Q Consensus 160 ---~~~~~GTp~ymAPEvl~~------~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~---~~ 227 (641)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+..+.+..+........++ ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHITD 235 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcccc
Confidence 123579999999998753 478899999999999999999999986 44556666665533221122 22
Q ss_pred ChHHHHHHHHHhcCCCCC---CCCHHHHHcCcccccccCCC
Q 006528 228 NDPQIKGFIEKCLVPASE---RLSAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 228 ~~~~l~~LI~kcL~dP~~---RpSa~eLL~Hpff~~~~~~~ 265 (641)
.++++++||.+||..+.+ |++++++++||||+...+..
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 467899999999984333 57999999999998765543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=351.72 Aligned_cols=251 Identities=28% Similarity=0.373 Sum_probs=200.5
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC----ceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~----~~l 77 (641)
+++..+|.|+||+||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++..... ..+
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 57889999999999999999999999999987543 233456678899999999999999999998865432 357
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++||||+.+ +|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 102 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 102 YLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACT 175 (359)
T ss_pred EEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCcccccc
Confidence 899999975 6666654 35889999999999999999999999 99999999999997 558999999999975433
Q ss_pred C-CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHH-------------------
Q 006528 158 P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT------------------- 216 (641)
Q Consensus 158 ~-~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~------------------- 216 (641)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..........+.
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 2 2344678999999998764 689999999999999999999999986433222111110
Q ss_pred --cCCC--C----------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 217 --SGIK--P----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 217 --~g~~--~----------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
.... + .......++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000 0 00112235678999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=337.48 Aligned_cols=251 Identities=28% Similarity=0.377 Sum_probs=198.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceeeEEEEeC---CC
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDD---KK 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVk~~~~~~~~---~~ 74 (641)
.+++..+|+|+||+||+|.+..+|..||+|.++..... ......+.+|+.+++.+ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 36889999999999999999999999999998764321 12223456677777665 799999999987643 23
Q ss_pred ceEEEEEccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 75 KTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
..+++|+||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ +.|.+||+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCcc
Confidence 46899999998 4899988764 34899999999999999999999999 99999999999997 5579999999999
Q ss_pred hhccCC-CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC--CC-----C--
Q 006528 153 IAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK-----P-- 221 (641)
Q Consensus 153 ~~~~~~-~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g--~~-----~-- 221 (641)
...... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||........+ .++... .. +
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH-HHHHHHhCCCChhhCccc
Confidence 766433 223457899999999775 46899999999999999999999999764433332 222110 00 0
Q ss_pred ----------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 222 ----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 222 ----------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.......+..+++||.+||. ||.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112235678999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.97 Aligned_cols=252 Identities=26% Similarity=0.433 Sum_probs=210.1
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|+||.||+|.+..+|..||+|.++... ......++.+|++++++++||||+++++++... ..+++|
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 77 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISIC 77 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEE
Confidence 478899999999999999999999999999987542 344566789999999999999999999998765 469999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|||+++|+|.+++++.+.+++..++.++.||+.||.|||+ ++ ++||||||+|||++ ++|.+||+|||++.......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCcccccccc
Confidence 9999999999999988889999999999999999999997 57 99999999999998 45799999999987665555
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc---------------------
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--------------------- 217 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~--------------------- 217 (641)
.....|++.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 556789999999998764 58899999999999999999999986422 2222222211
Q ss_pred ---------------CCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 218 ---------------GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 218 ---------------g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
...+.......++++++||.+||. +|.+||++.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 111111112346789999999998 89999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=339.54 Aligned_cols=242 Identities=21% Similarity=0.276 Sum_probs=206.1
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEe--CCCceEEEEEc
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD--DKKKTVNMITE 82 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~--~~~~~l~lV~E 82 (641)
..+|.|+++.||+|.. +|..||+|.++.... ......+.+.+|+.+|++++||||+++++++.+ ....++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5688999999999987 699999999876542 223345778899999999999999999999877 44457899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~-gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
|+++|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+|||++ ++|.+||+|||++..+.... .
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~~-~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSPP-F 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhcccc-c
Confidence 999999999999888899999999999999999999985 7 88999999999998 55899999999997654322 3
Q ss_pred cccCCCCCCCcccccc---cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 162 SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
...|++.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+..+++..+..+.....++...++.+++||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4578999999998864 689999999999999999999999987 456667777755444444554567899999999
Q ss_pred hcC-CCCCCCCHHHHHc
Q 006528 239 CLV-PASERLSAKDLLK 254 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~ 254 (641)
||. +|.+|||++++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 999 8999999999986
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=356.97 Aligned_cols=244 Identities=27% Similarity=0.336 Sum_probs=196.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||.||+|.+..+++.||+|.... ..+.+|+++|++|+||||++++++|... ...++|+
T Consensus 95 ~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~ 162 (391)
T PHA03212 95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYN--KFTCLIL 162 (391)
T ss_pred EEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeEEEE
Confidence 678999999999999999999999999996431 2467899999999999999999998765 4688999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC---C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---P 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~---~ 158 (641)
|++. ++|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|..... .
T Consensus 163 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 163 PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCccccccccccc
Confidence 9995 699999988888999999999999999999999999 99999999999997 557999999999964322 2
Q ss_pred CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCC-------CHHHHHHHHHc-CCC---------
Q 006528 159 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK-------NPAQIFKKVTS-GIK--------- 220 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~-------~~~~i~~~i~~-g~~--------- 220 (641)
......||+.|+|||++. ..|+.++|||||||++|||++|..||.... ...++...+.. +..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 233468999999999876 468999999999999999999998875321 11111111100 000
Q ss_pred -----------------CCccc-----cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 221 -----------------PASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 221 -----------------~~~l~-----~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
+...+ ...+.++++||.+||. ||.+||||+|+|+||||+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00000 0124578999999999 99999999999999999753
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.76 Aligned_cols=255 Identities=31% Similarity=0.498 Sum_probs=212.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEeccccc-CChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL-QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
+++...+|.|+||+||+|.+..+|..||+|.+...... ......+.+.+|+.++++++||||+++++++.+.....+++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 36788999999999999999999999999998754321 22345678899999999999999999999987765567899
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
+|||+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+|+||||+||+++ ..|.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCcccccccccc
Confidence 9999999999999998888999999999999999999999999 99999999999997 5579999999998754321
Q ss_pred ----CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 ----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ----~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
......|+..|+|||++. ..++.++||||||+++|+|++|+.||........+. .+.........+...+..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPVLPPHVSDHCR 239 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHhcCCCCCCCchhhCHHHH
Confidence 223356889999999875 458899999999999999999999998754444443 33333333334445567899
Q ss_pred HHHHHhcCCCCCCCCHHHHHcCcccc
Q 006528 234 GFIEKCLVPASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 234 ~LI~kcL~dP~~RpSa~eLL~Hpff~ 259 (641)
++|.+||.+|.+||+++++++|||+.
T Consensus 240 ~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 240 DFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHhcChhhCCCHHHHhcCcccC
Confidence 99999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=338.05 Aligned_cols=250 Identities=20% Similarity=0.327 Sum_probs=202.2
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 86 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~g 86 (641)
+|.|+||+||++.+..+|..||+|.+....... ......+..|+++|++++||||+++++++... ..+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCC
Confidence 699999999999999999999999987544321 22334566799999999999999999987654 568999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCccc
Q 006528 87 GNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSV 163 (641)
Q Consensus 87 GsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-~~~~~ 163 (641)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ +.+.+||+|||++...... .....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 99999886543 5889999999999999999999999 99999999999997 5579999999998765433 22345
Q ss_pred cCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCC---HHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 164 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 164 ~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~---~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.|++.|+|||++. ..++.++|||||||++|+|++|..||..... ..++.........+. .....++++++||.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 7899999999875 4589999999999999999999999975332 223333333322221 1234578899999999
Q ss_pred cC-CCCCCCCH----HHHHcCcccccccC
Q 006528 240 LV-PASERLSA----KDLLKDPFLQVENQ 263 (641)
Q Consensus 240 L~-dP~~RpSa----~eLL~Hpff~~~~~ 263 (641)
|. +|.+||++ +++++||||+..++
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 99 89999999 77889999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.37 Aligned_cols=255 Identities=32% Similarity=0.497 Sum_probs=210.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEeccccc-CChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL-QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++...+|.|+||.||+|.+..+|..||+|.+...... ........+.+|+.++++++||||+++++++.......++++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 4567899999999999999999999999998765421 123456678999999999999999999998876655678999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
+||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||+|+||+++ ..+.+||+|||++..+...
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccccc
Confidence 999999999999998888999999999999999999999998 99999999999997 5579999999998754321
Q ss_pred ---CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 159 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 159 ---~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+..... ......++...++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-CCCCCCCchhcCHHHHH
Confidence 1223468889999998764 588999999999999999999999987544444443333 22334445556788999
Q ss_pred HHHHhcCCCCCCCCHHHHHcCccccc
Q 006528 235 FIEKCLVPASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 235 LI~kcL~dP~~RpSa~eLL~Hpff~~ 260 (641)
||..|+.+|.+||+++++++||||+.
T Consensus 241 li~~~~~~p~~Rp~~~eil~hp~~~~ 266 (266)
T cd06651 241 FLGCIFVEARHRPSAEELLRHPFAQL 266 (266)
T ss_pred HHHHhcCChhhCcCHHHHhcCccccC
Confidence 99544449999999999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.81 Aligned_cols=250 Identities=25% Similarity=0.459 Sum_probs=208.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||+||+|.+..+|..||+|.+.... .......+.+|+.+|++++||||+++++++... ...++|
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 77 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISIC 77 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEE
Confidence 467788999999999999999999999999987542 344556789999999999999999999998776 468899
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
|||+++|+|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+|||++ .+|.+||+|||++........
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIA 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceecccccc
Confidence 999999999765 35789999999999999999999999 99999999999997 558999999999976655555
Q ss_pred ccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCC------HHHHHHHHHcCCCCCccccCChHHHH
Q 006528 161 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKN------PAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~------~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
....||+.|+|||++. ..++.++|+||||+++|+|++|..||..... +......+.....+.......+++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 5678999999999876 4589999999999999999999999964221 22333333333333333344578899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 234 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+||.+||. +|.+||+++++++||||+..+
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 99999998 899999999999999997553
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=326.41 Aligned_cols=250 Identities=28% Similarity=0.484 Sum_probs=216.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..+|..||+|.+..... .....+++..|+++++.++||||+++++++.......++++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 678899999999999999999999999999876543 345567889999999999999999999988876667889999
Q ss_pred ccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 82 ELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLH-----SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 82 Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLH-----s~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
||+++++|.+++.. ...+++..++.++.||+.||.||| +.+ ++|+||+|+||+++ +.+.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEeccccc
Confidence 99999999999876 357899999999999999999999 777 99999999999998 5589999999999
Q ss_pred hhccCCC--CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 153 IAMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 153 ~~~~~~~--~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
....... .....+++.|+|||++.. .++.++|+||||+++|+|++|..||... +...+.+.+..+..+ .++...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 235 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRYS 235 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCccccC
Confidence 7765433 345678999999998764 5889999999999999999999999874 466666777666443 3445567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
..+.+++.+||. +|.+||++.+||+|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 889999999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=342.27 Aligned_cols=245 Identities=25% Similarity=0.375 Sum_probs=192.3
Q ss_pred EEeCccCceEEEEEEEc--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 5 ISSRRIPAVDTYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
..+|+|+||+||+|.+. .++..||+|.+..... ...+.+|+.+|++++||||+++++++.......+++|+|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 47899999999999965 4778999998864431 235678999999999999999999988776678999999
Q ss_pred cCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEe---CCCCcEEEeecc
Q 006528 83 LFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKIGDLG 150 (641)
Q Consensus 83 y~~gGsL~~~l~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~---~~~G~VKL~DFG 150 (641)
|+. ++|.+++... ..+++..++.+++||+.||.|||+++ |+||||||+|||++ ...+.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 996 5898887642 24899999999999999999999999 99999999999994 244789999999
Q ss_pred hhhhccCC-----CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCH--------HHHHHHH
Q 006528 151 LAIAMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNP--------AQIFKKV 215 (641)
Q Consensus 151 lA~~~~~~-----~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~--------~~i~~~i 215 (641)
++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|++||...... ......+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 99765432 2234678999999998754 4899999999999999999999999642211 0111111
Q ss_pred Hc--C--------------------------CCC--------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 216 TS--G--------------------------IKP--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 216 ~~--g--------------------------~~~--------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.. + ... .......+..+.+||.+||. ||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0 000 00001124568899999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=346.23 Aligned_cols=246 Identities=22% Similarity=0.323 Sum_probs=200.6
Q ss_pred CEEEEEeCccCceEEEEEEE-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCC
Q 006528 1 MRILISSRRIPAVDTYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~ 74 (641)
+++...+|.|+||+||+|.+ ..++..||+|.++... .......+.+|+.+|+.+ +||||+++++++... .
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTKP-N 84 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-C
Confidence 46788999999999999975 3456789999987432 234566799999999999 899999999987654 3
Q ss_pred ceEEEEEccCCCCCHHHHHHhC----------------------------------------------------------
Q 006528 75 KTVNMITELFTSGNLRQYRKKH---------------------------------------------------------- 96 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~---------------------------------------------------------- 96 (641)
..+++||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4688999999999999998753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC----CccccCCCC
Q 006528 97 ----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPE 168 (641)
Q Consensus 97 ----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ 168 (641)
..+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+++...... .....+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 24778889999999999999999999 99999999999998 45799999999997653221 223356788
Q ss_pred CCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCC
Q 006528 169 FMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASE 245 (641)
Q Consensus 169 ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~ 245 (641)
|+|||++. ..|+.++|||||||++|||++ |..||.+..........+..+... ..+...++.++++|.+||. +|.+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCChhh
Confidence 99999775 568999999999999999997 999998755445555555554332 2345567889999999999 8999
Q ss_pred CCCHHHHHc
Q 006528 246 RLSAKDLLK 254 (641)
Q Consensus 246 RpSa~eLL~ 254 (641)
|||+.+|++
T Consensus 321 RPs~~el~~ 329 (338)
T cd05102 321 RPTFSALVE 329 (338)
T ss_pred CcCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.96 Aligned_cols=252 Identities=28% Similarity=0.400 Sum_probs=208.5
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-cceeeEEEEeCC----CceEEEE
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDK----KKTVNMI 80 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVk~~~~~~~~~----~~~l~lV 80 (641)
.+|.|+||+||+|+++.+|..||+|+++...-. +.......+|+.+|+.|+|+| ||.+++++...+ ...+++|
T Consensus 18 klGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 18 KLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 489999999999999999999999999987532 334556799999999999999 999999887654 2378999
Q ss_pred EccCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 81 TELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~----~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
+||+.. +|..|+.... .++...++.+++||+.||+|||+++ |+||||||+||||+ ..|.+||+|||+|+...
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGLARAFS 171 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccchHHHhc
Confidence 999975 9999998765 5888999999999999999999999 99999999999998 47899999999998765
Q ss_pred CC--CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-CCCC-Ccc------
Q 006528 157 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP-ASL------ 224 (641)
Q Consensus 157 ~~--~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-g~~~-~~l------ 224 (641)
-+ .....++|..|+|||++-+ .|+..+||||+||+++||++++.-|.+.....++...... |.+. ..+
T Consensus 172 ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 172 IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSL 251 (323)
T ss_pred CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccc
Confidence 33 3445688999999997754 4999999999999999999999999887666665543321 1000 000
Q ss_pred -------c------------cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccC
Q 006528 225 -------A------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 225 -------~------------~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
+ ...++...+++.+||. +|.+|.||+.+|.||||+....
T Consensus 252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0 1113578999999999 9999999999999999986543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=352.86 Aligned_cols=255 Identities=26% Similarity=0.340 Sum_probs=206.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC---CceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~---~~~l 77 (641)
+++...+|.|+||+||+|.+..+|..||+|.+.... .......++.+|+.+|+.++||||+++++++.... ...+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 467889999999999999999999999999886432 22344567899999999999999999999886543 1268
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++|+||+. ++|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeeccc
Confidence 99999997 589998888888999999999999999999999999 99999999999998 557999999999975432
Q ss_pred C---CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc---------------
Q 006528 158 P---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--------------- 217 (641)
Q Consensus 158 ~---~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~--------------- 217 (641)
. ......+|+.|+|||++.+ .|+.++|||||||++|||++|+.||... ++.+....+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ-SPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 2 2233468999999998764 4789999999999999999999999764 33333332211
Q ss_pred --------C-CCCC------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 218 --------G-IKPA------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 218 --------g-~~~~------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
. ..+. ......++++.+||.+||. ||.+|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 1111 1122346789999999999 899999999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=333.88 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=222.1
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+=+-+|+|-||.||+|+.+.++..||+|++.+..+.. ....+++.+|+++-+.|+||||+++|++|.+. ..+|+++|
T Consensus 26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~riyLilE 102 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--KRIYLILE 102 (281)
T ss_pred ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheecc--ceeEEEEE
Confidence 3456899999999999999999999999998877543 35567899999999999999999999999887 46999999
Q ss_pred cCCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 83 LFTSGNLRQYRK--KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 83 y~~gGsL~~~l~--~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
|.+.|+|...|. ..+++++...+.+++|++.||.|+|..+ ||||||||+|+|+. ..|.+||+|||-+........
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~~kR 179 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSNKR 179 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecCCCCc
Confidence 999999999999 6778999999999999999999999999 99999999999996 558999999999977666677
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.+.|||..|.|||..++ .++..+|+|++|++.||++.|.+||... +..+.|++|..-. ..++...+.+++++|.+|
T Consensus 180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~-~~~etYkrI~k~~--~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ-SHSETYKRIRKVD--LKFPSTISGGAADLISRL 256 (281)
T ss_pred eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh-hhHHHHHHHHHcc--ccCCcccChhHHHHHHHH
Confidence 88999999999998875 5999999999999999999999999874 4788888887642 234466788999999999
Q ss_pred cC-CCCCCCCHHHHHcCccccc
Q 006528 240 LV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~Hpff~~ 260 (641)
|. +|.+|++..|++.|||...
T Consensus 257 l~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred hccCccccccHHHHhhhHHHHh
Confidence 99 8999999999999999864
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=324.77 Aligned_cols=248 Identities=27% Similarity=0.494 Sum_probs=212.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
.+...+|.|++|.||+|.+..+|..|++|.+..... .......+.+|+.+++.++||||+++++++... ..+++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 567889999999999999999999999999876543 245667899999999999999999999988765 5689999
Q ss_pred ccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 82 ELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
||+++++|.+++... ..++...++.++.||+.||.|||+.+ ++|+||||+||+++ ..+.+||+|||++......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCcc
Confidence 999999999999774 56899999999999999999999998 99999999999998 4579999999998765432
Q ss_pred -CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 159 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
......|++.|+|||++.+ .++.++||||||+++++|++|+.||... +.......+..+..+. .....+..+.++|
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i 233 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQLI 233 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHHHH
Confidence 2234578999999998764 5889999999999999999999999763 4566666666654433 3335678899999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccc
Q 006528 237 EKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.+||. +|.+||++.++++|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 99998 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.04 Aligned_cols=252 Identities=27% Similarity=0.351 Sum_probs=201.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----CceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~----~~~l 77 (641)
+++..+|.|+||+||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++.... ...+
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 67889999999999999999999999999987543 23345677889999999999999999999886532 2357
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++||||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++....
T Consensus 98 ~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 98 YLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT 171 (355)
T ss_pred EEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcccccCCC
Confidence 999999975 67776653 5889999999999999999999999 99999999999997 557999999999976543
Q ss_pred C-CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc------------------
Q 006528 158 P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------------------ 217 (641)
Q Consensus 158 ~-~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~------------------ 217 (641)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 3 2345678999999998764 5899999999999999999999999764322221111110
Q ss_pred ---CCC-------C-----------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 218 ---GIK-------P-----------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 218 ---g~~-------~-----------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
... + .......+..+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 0 00111234578999999999 89999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=362.36 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=210.0
Q ss_pred EEEEEeCccCceEEEEEEEcCC-CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFA-GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~t-G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++...+|+|+||+||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||++++++... ..+++|
T Consensus 70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv 143 (478)
T PTZ00267 70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND----ERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLLI 143 (478)
T ss_pred EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEEE
Confidence 5678899999999999999888 7889998765432 34556788899999999999999999998766 469999
Q ss_pred EccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 81 TELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
|||+.+|+|.+++.. ..++++..+..++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCcCceecC
Confidence 999999999988754 356899999999999999999999999 99999999999998 55799999999997654
Q ss_pred CC----CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHH
Q 006528 157 QP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 231 (641)
Q Consensus 157 ~~----~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~ 231 (641)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+++..+..+..+ ..+...++.
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~s~~ 298 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PFPCPVSSG 298 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CCCccCCHH
Confidence 32 2345679999999998864 589999999999999999999999986 4556666666655433 233445788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
+++||.+||. +|.+||++.++|.|+|++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999999999 8999999999999999964
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.96 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=217.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|+||+|.+..+++.||+|.+..... ........+.+|+++|++++||||+++++++.+. ..+++||
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 80 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYLVM 80 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEEEE
Confidence 578899999999999999999999999999875443 1234567889999999999999999999988765 4689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
||+.+|+|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|.|||++ .+|.+||+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~-~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR-TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC-CC
Confidence 99999999999998889999999999999999999999999 99999999999997 4579999999999766544 34
Q ss_pred cccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhc
Q 006528 162 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL 240 (641)
...|++.|+|||.+. ..++.++||||||+++|+|++|..||... ......+.+..+.. .++...++.++++|.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKV--RFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCc--cCCccCCHHHHHHHHHHc
Confidence 557899999999775 45788999999999999999999999864 35556666655432 234445789999999999
Q ss_pred C-CCCCCC-----CHHHHHcCcccccccCCC
Q 006528 241 V-PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 241 ~-dP~~Rp-----Sa~eLL~Hpff~~~~~~~ 265 (641)
. +|.+|+ ++++|++||||+...+..
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred cCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence 8 899999 999999999997665443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=328.04 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=213.9
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 86 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~g 86 (641)
+|.|++|.||+|.+..++..||+|.+...... .....+.+.+|+.+++.++||||+++++++.+. ..+++|+||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence 68999999999999999999999999765432 234557899999999999999999999987665 458999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCccccC
Q 006528 87 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIG 165 (641)
Q Consensus 87 GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-~~~~~~G 165 (641)
|+|.+++.+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++...... ......|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccC
Confidence 999999998888999999999999999999999999 99999999999997 4579999999999766543 2334578
Q ss_pred CCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCC-CHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-C
Q 006528 166 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-P 242 (641)
Q Consensus 166 Tp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~-~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-d 242 (641)
++.|+|||.+. ..++.++|+||||+++|+|++|..||.... ++...+..+..+......+...++.+++||.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 99999999775 458899999999999999999999997643 35666666665444444455557899999999998 8
Q ss_pred CCCCCC-----HHHHHcCcccccccC
Q 006528 243 ASERLS-----AKDLLKDPFLQVENQ 263 (641)
Q Consensus 243 P~~RpS-----a~eLL~Hpff~~~~~ 263 (641)
|.+||+ ++|+++||||+...+
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCCC
Confidence 999999 999999999986544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.28 Aligned_cols=250 Identities=20% Similarity=0.410 Sum_probs=221.2
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+...+|.|+||+|-+|.+...|++||||.|++... .++.++-.+.+||++|+.|+||||+.+|.+|... +.+++|||
T Consensus 57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk--dKIvivME 133 (668)
T KOG0611|consen 57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK--DKIVIVME 133 (668)
T ss_pred HHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC--ceEEEEEE
Confidence 34578999999999999999999999999987765 5678888999999999999999999999988554 55999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC-CCCc
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTAR 161 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~-~~~~ 161 (641)
|..+|.|++|+...+.+++..++.+++||++|+.|+|.++ ++|||||.+|||+|. ++.+||+|||++..+.. ....
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~-N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQ-NNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecC-CCCeeeeccchhhhhccccHHH
Confidence 9999999999999999999999999999999999999999 999999999999984 57999999999977654 4678
Q ss_pred cccCCCCCCCccccccc-C-CcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 162 SVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~~-y-~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
++||+|-|.+||++++. | ++.+|.||||++||-|+.|..||.+ .+-..++++|..|..... ..+..+..||..|
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIRwm 286 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDASGLIRWM 286 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHHHHHHHH
Confidence 89999999999999874 5 6789999999999999999999998 456777888888754321 1234688999999
Q ss_pred cC-CCCCCCCHHHHHcCccccccc
Q 006528 240 LV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
|. +|.+|.|+.++-.|=|+....
T Consensus 287 LmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred HhcCcccchhHHHHhhhheeeccc
Confidence 97 999999999999999986443
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.88 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=201.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..++..||+|.++.... ......+.+|+.++++++||||+++++++... ..+++||
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 83 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTLVF 83 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEEEE
Confidence 578899999999999999999999999999976542 22334577899999999999999999988765 4689999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCCCcc
Confidence 99985 888887654 45899999999999999999999999 99999999999998 5579999999998654322
Q ss_pred CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC---CC-------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---IK------------- 220 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g---~~------------- 220 (641)
......+|+.|+|||++.+ .++.++|||||||++|+|+||+.||..... .+....+... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV-EDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2234568999999997753 588999999999999999999999986433 2222222110 00
Q ss_pred -----CC-------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 221 -----PA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 221 -----~~-------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+. ......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00 0111246789999999999 899999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=331.98 Aligned_cols=251 Identities=25% Similarity=0.469 Sum_probs=212.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..++..||+|.+.... .......+.+|++++++++||||+++++++... ..+++++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM 78 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence 45667999999999999999999999999987653 235567789999999999999999999988766 5699999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+ ++|+||||+||+++ +.|.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHH
Confidence 999999999999876 789999999999999999999999 88 99999999999998 46899999999987665443
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCC----CCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~----~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
.....+++.|+|||.+.+ .++.++||||||+++|+|++|..||... ....+..+.+..+..+.......++++++
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 334778999999997754 5889999999999999999999999764 23344455555544433333336788999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 235 FIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
||.+||. +|.+||++.+++.||||+.
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999998 8999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.30 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=201.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----CceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~----~~~l 77 (641)
+++..+|.|+||+||+|.+..++..||+|.+..... .......+.+|+.+|++++||||+++++++.... ...+
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 18 QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 467889999999999999999999999999875431 2234566889999999999999999999876432 1357
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
+++++++ +++|.++++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 96 ~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 96 YLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADD 170 (343)
T ss_pred EEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccceecCC
Confidence 8999998 6799988764 56999999999999999999999999 99999999999997 557999999999976543
Q ss_pred CCCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC--CCC------------
Q 006528 158 PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP------------ 221 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g--~~~------------ 221 (641)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ..+....+... ..+
T Consensus 171 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07878 171 E-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND-YIDQLKRIMEVVGTPSPEVLKKISSEHA 248 (343)
T ss_pred C-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence 2 345678999999998764 58999999999999999999999997633 22222222110 000
Q ss_pred ------------C---ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 222 ------------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 222 ------------~---~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
. ......++.+.+||.+||. +|.+|||+.++|.||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 0011235678999999999 89999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=380.37 Aligned_cols=257 Identities=23% Similarity=0.411 Sum_probs=217.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..||.|+||+||+|.+..++..||+|.+..... .......+..|+.+|++|+|||||+++++|.+.....+||||
T Consensus 16 eIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 16 EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred EEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 688999999999999999999999999999886543 344567899999999999999999999999887777899999
Q ss_pred ccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeEeeccCCCcEEEeCC------------
Q 006528 82 ELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHN-----PPIIHRDLKCDNIFVNGN------------ 140 (641)
Q Consensus 82 Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~g-----p~IiHrDLKp~NILl~~~------------ 140 (641)
||+.+|+|.++|.. ...+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 99999999999875 357999999999999999999999854 249999999999999531
Q ss_pred ----CCcEEEeecchhhhccCC-CCccccCCCCCCCccccc---ccCCcccccccccchhhhhhhccCCCCCCCCHHHHH
Q 006528 141 ----HGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 212 (641)
Q Consensus 141 ----~G~VKL~DFGlA~~~~~~-~~~~~~GTp~ymAPEvl~---~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~ 212 (641)
.+.+||+|||++..+... .....+||+.|+|||++. ..++.++|||||||++|+|+||..||.......++.
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli 253 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253 (1021)
T ss_pred ccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHH
Confidence 235899999999765432 234568999999999874 348899999999999999999999998766666776
Q ss_pred HHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 213 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 213 ~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
..+..+.... ....++.+.+||..||. +|.+||++.++|.||||+...
T Consensus 254 ~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 254 SELKRGPDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 6666543221 23346789999999999 899999999999999997543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=346.09 Aligned_cols=250 Identities=28% Similarity=0.371 Sum_probs=201.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----CceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~----~~~l 77 (641)
+++..+|.|+||+||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++.... ...+
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 57889999999999999999999999999987543 23345567889999999999999999999875432 2457
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++||||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++....
T Consensus 105 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 105 YIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCccccCC
Confidence 999999975 77777753 4889999999999999999999999 99999999999997 557999999999976543
Q ss_pred C-CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC---------------
Q 006528 158 P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--------------- 220 (641)
Q Consensus 158 ~-~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--------------- 220 (641)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+..+.....
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 3 2345678999999998764 58999999999999999999999998643 3333332221100
Q ss_pred ------C-------------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 221 ------P-------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 221 ------~-------------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
+ .......+..+++||.+||. ||.+|||+.++|+||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00011124578999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.47 Aligned_cols=249 Identities=18% Similarity=0.253 Sum_probs=195.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC------CCcceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD------DNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H------pNIVk~~~~~~~~~~~ 75 (641)
+++..+|.|+||+||+|.+..++..||||+++... .....+..|+.+++.++| ++|++++++|.... .
T Consensus 132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~-~ 205 (467)
T PTZ00284 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET-G 205 (467)
T ss_pred EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC-c
Confidence 67889999999999999999999999999986432 223445667777777754 45889998876543 5
Q ss_pred eEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCC-------------
Q 006528 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNH------------- 141 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~------------- 141 (641)
.+++||+++ +++|.+++.+++.+++..++.++.||+.||.|||+ .| ||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccccCC
Confidence 688999998 67999999888899999999999999999999998 48 99999999999997432
Q ss_pred --CcEEEeecchhhhccCCCCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-
Q 006528 142 --GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS- 217 (641)
Q Consensus 142 --G~VKL~DFGlA~~~~~~~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~- 217 (641)
+.+||+|||++..... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||....+...+ ..+..
T Consensus 283 ~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~~i~~~ 360 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL-HLMEKT 360 (467)
T ss_pred CCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHH
Confidence 1499999998854322 2345689999999998764 6999999999999999999999999864433222 11111
Q ss_pred -CCCCCc--------------------------------------cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 006528 218 -GIKPAS--------------------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 257 (641)
Q Consensus 218 -g~~~~~--------------------------------------l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpf 257 (641)
+..+.. .....++.+.+||.+||+ ||.+||||+|+|+|||
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 000000 001124668899999999 9999999999999999
Q ss_pred cccc
Q 006528 258 LQVE 261 (641)
Q Consensus 258 f~~~ 261 (641)
|+..
T Consensus 441 ~~~~ 444 (467)
T PTZ00284 441 VLKY 444 (467)
T ss_pred cccc
Confidence 9754
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.47 Aligned_cols=250 Identities=21% Similarity=0.386 Sum_probs=200.4
Q ss_pred EEEEeCcc--CceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 3 ILISSRRI--PAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 3 il~~lG~G--afgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++..+|+| +|++||++.+..+|+.||+|+++.... .....+.+.+|+.+++.++||||++++++|..+ ..+++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEE
Confidence 45678888 678999999999999999999876542 234556788999999999999999999998776 468999
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+++|+|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.++++||+.+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence 9999999999999763 45899999999999999999999999 99999999999998 4579999999875433211
Q ss_pred ---------CCccccCCCCCCCcccccc---cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC----
Q 006528 159 ---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---- 222 (641)
Q Consensus 159 ---------~~~~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~---- 222 (641)
......++..|+|||++.+ .|+.++|||||||++|||++|..||............+ .+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh-cCCccccccc
Confidence 1122356778999998863 48999999999999999999999998644333222222 111110
Q ss_pred ----------------------------------------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 223 ----------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 223 ----------------------------------------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
......++.+++||.+||. ||.+|||+++||+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0111235689999999999 9999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=323.12 Aligned_cols=249 Identities=25% Similarity=0.485 Sum_probs=209.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..+|..||+|.+..... .....+.+.+|+.++++++||||+++++.+... ...+++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 688999999999999999999999999999976542 234566789999999999999999999977533 34689999
Q ss_pred ccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 82 ELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
||+++++|.+++... ..+++..++.++.||+.||.|||+.| ++||||||+||+++ +.+.++|+|||++..+...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEecccC
Confidence 999999999999763 45899999999999999999999999 99999999999997 5579999999998765432
Q ss_pred -CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 159 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
......+++.|+|||++.+ .++.++||||||+++++|++|+.||... +.......+..+..+. .+...++.+.+||
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li 234 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLPP-MPKDYSPELGELI 234 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCCC-CccccCHHHHHHH
Confidence 2334578999999998764 5889999999999999999999999763 3444444555554332 3445678999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccc
Q 006528 237 EKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.+||. +|.+||++.++++||||
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHhccCcccCCCHHHHhcCCCC
Confidence 99999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=363.03 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=214.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC------c
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK------K 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~------~ 75 (641)
++...+|.|+||+||+|.+..+|..||+|.+..... .......+.+|+.+|..++|+||++++..+..... .
T Consensus 35 ~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 577899999999999999999999999999987653 45667788999999999999999999987764321 2
Q ss_pred eEEEEEccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecch
Q 006528 76 TVNMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGl 151 (641)
.+++||||+.+|+|.++++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCCEEEEeccc
Confidence 478999999999999998753 46899999999999999999999999 99999999999998 457999999999
Q ss_pred hhhccCC----CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 006528 152 AIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 226 (641)
Q Consensus 152 A~~~~~~----~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~ 226 (641)
++.+... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..+.... ++.
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~~-~~~ 267 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYDP-LPP 267 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCCC-CCC
Confidence 8765322 2345689999999998874 589999999999999999999999986 45666667666654432 445
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
..+++++++|.+||. +|.+||++.++|+|||++.
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 567899999999999 8999999999999999864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=330.54 Aligned_cols=248 Identities=25% Similarity=0.463 Sum_probs=204.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC----Cce
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK----KKT 76 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~----~~~ 76 (641)
+++..+|.|+||+||+|.+..++..||+|.+.... .....+.+|+.+++++ +||||+++++++.... ...
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 34567899999999999999999999999987543 2345688999999999 7999999999987643 246
Q ss_pred EEEEEccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 77 VNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEEccCCCcee
Confidence 89999999999999999864 35899999999999999999999999 99999999999998 557999999999875
Q ss_pred ccCC--CCccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 006528 155 MQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 226 (641)
Q Consensus 155 ~~~~--~~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~ 226 (641)
.... ......|++.|+|||++. ..|+.++|||||||++|+|++|..||.... +......+.....+.....
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcCCCCCCCCC
Confidence 5322 234467899999999874 248889999999999999999999997643 3333333333322323333
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
..+..+++||.+||. +|.+|||+.++++||||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 456789999999999 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.73 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=208.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++...+|.|+||+||+|.+..+|+.||+|.+...... .......+.+|+.++++++|+||+++++.+.+. ..+++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEE
Confidence 46788899999999999999999999999998755432 223345678899999999999999999988665 469999
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ ..+.++|+|||++......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCC
Confidence 9999999999998654 35899999999999999999999999 99999999999997 4579999999998654322
Q ss_pred -CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCH--HHHHHHHHcCCCCCccccCChHHHHH
Q 006528 159 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~--~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
......|++.|+|||++. ..++.++||||||+++|+|++|+.||...... ......+.... +.......++.+++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDARS 234 (285)
T ss_pred ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHHHH
Confidence 223457899999999876 45899999999999999999999999763321 11222222211 22234456788999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHHcCcccccccCC
Q 006528 235 FIEKCLV-PASERLS-----AKDLLKDPFLQVENQK 264 (641)
Q Consensus 235 LI~kcL~-dP~~RpS-----a~eLL~Hpff~~~~~~ 264 (641)
||.+||+ +|.+||| ++++++||||+...+.
T Consensus 235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred HHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 9999999 8999999 9999999999865443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=335.71 Aligned_cols=250 Identities=22% Similarity=0.378 Sum_probs=213.0
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCC----hhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEE
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~----~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+|+|..++|-++.++.+|.+.|+|.+....-..+ ...++.-.+|+.+|+++ .||+|+++.++|... ..+++|
T Consensus 24 ilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~--sF~FlV 101 (411)
T KOG0599|consen 24 ILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD--AFVFLV 101 (411)
T ss_pred HhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc--chhhhh
Confidence 47899999999999999999999999876443222 23355667899999999 699999999988554 678899
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-C
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-~ 159 (641)
+|+|+.|.|.+|+...-.++++..+++++|++.|+.|||.++ |+||||||+|||++.+ -.|||.|||+|+.+... .
T Consensus 102 Fdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa~~l~~Gek 178 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFACQLEPGEK 178 (411)
T ss_pred hhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEeccceeeccCCchh
Confidence 999999999999999889999999999999999999999999 9999999999999855 59999999999887644 5
Q ss_pred CccccCCCCCCCccccc-------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--cCChH
Q 006528 160 ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDP 230 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~-------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~--~~~~~ 230 (641)
.+..||||.|+|||.+. .+|+..+|+|++|++||-|+.|.+||-. .....+...|..|......+ ...+.
T Consensus 179 LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWadis~ 257 (411)
T KOG0599|consen 179 LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWADISA 257 (411)
T ss_pred HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchhhccc
Confidence 67789999999999774 3599999999999999999999999964 22334567788886654333 33456
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 231 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 231 ~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.+++||.+||+ ||.+|.|++|+|.||||.+.
T Consensus 258 ~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred cHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 89999999999 99999999999999999654
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.87 Aligned_cols=245 Identities=27% Similarity=0.461 Sum_probs=203.0
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
+..+|.|+||.||+|.+..++..||+|.++... ......+.+|+.+++.++||||+++++++... ..+++||||
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~lv~e~ 87 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWICMEF 87 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEEEec
Confidence 456899999999999999999999999987653 23345678999999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 161 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~~ 161 (641)
+++|+|.+++...+.+++..++.++.||+.||.|||++| ++|+||||+||+++ ..+.+||+|||++...... ...
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEccCcccccc
Confidence 999999999998889999999999999999999999999 99999999999997 5579999999998655332 223
Q ss_pred cccCCCCCCCccccc----ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccc--CChHHHHHH
Q 006528 162 SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VNDPQIKGF 235 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~----~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~--~~~~~l~~L 235 (641)
...|++.|+|||++. ..++.++|+|||||++|+|++|..||........+.........+..... ..+..+++|
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF 244 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence 457899999999863 35889999999999999999999999764433333333222222222211 245689999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCcc
Q 006528 236 IEKCLV-PASERLSAKDLLKDPF 257 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpf 257 (641)
|.+||. +|.+||++++|+.|||
T Consensus 245 i~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 245 VKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHccCCchhCcCHHHHhcCCC
Confidence 999999 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=330.29 Aligned_cols=251 Identities=26% Similarity=0.456 Sum_probs=208.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+++++.++||||+++++++... ...++|+
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~ 81 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILI 81 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEE
Confidence 35678999999999999999999999999986432 45567789999999999999999999988765 4689999
Q ss_pred ccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+.+|+|..++.+ ..++++..+..++.||+.||.|||+.+ ++||||||+||+++ .+|.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEcccccccccccccc
Confidence 99999999998765 457999999999999999999999999 99999999999997 5579999999998654322
Q ss_pred CCccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCccccCChHH
Q 006528 159 TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQ 231 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~-~~~l~~~~~~~ 231 (641)
......+++.|+|||++. ..++.++|||||||++|+|++|..||.... +......+..... ....+...+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHH
Confidence 223457899999999873 237789999999999999999999998743 4444444443322 22233445678
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+++||.+||. +|.+||++.++++||||....
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999998 899999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.31 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=200.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|+||+|.+..+|..||+|.++.... .......+.+|+.++++++||||+++++++.+. ..+++|+
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF 78 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence 578899999999999999999999999999976542 223345678899999999999999999988765 4689999
Q ss_pred ccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ ..|.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCCCC
Confidence 9997 578887765 567999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC----------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---------------- 220 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~---------------- 220 (641)
......+++.|+|||++.+ .++.++||||||+++|+|+||..||....+....+..+.....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2233467899999998754 3789999999999999999999986544444443333321100
Q ss_pred --CC---------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 221 --PA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 221 --~~---------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.. ......++++++||.+||. +|.+|||++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 0012246789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=328.60 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=204.3
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHH-HHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL-LKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~i-Lk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
++++..+|.|+||.||+|.+..+|..||+|+++.... ......+..|+.+ ++.++||||+++++++... ..+++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~l 77 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWI 77 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEE
Confidence 4688999999999999999999999999999876432 1223455666665 6777999999999988765 45899
Q ss_pred EEccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 80 ITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~-gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
+|||+. |+|.+++.. ...+++..++.++.||+.||.|||++ + ++||||||+|||++ ..+.+||+|||++..
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~ 153 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGY 153 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecccccc
Confidence 999997 688888764 24689999999999999999999997 7 99999999999998 457999999999976
Q ss_pred ccCCCC-ccccCCCCCCCcccccc-----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 006528 155 MQQPTA-RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 228 (641)
Q Consensus 155 ~~~~~~-~~~~GTp~ymAPEvl~~-----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~ 228 (641)
+..... ....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.......+....+..+..+.......
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 543322 23568899999998753 468899999999999999999999976444444444444443333323345
Q ss_pred hHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 229 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 229 ~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+.++++||.+||. +|.+||++.+++.||||+...
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 7789999999998 899999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=326.69 Aligned_cols=251 Identities=29% Similarity=0.422 Sum_probs=207.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEeccccc--CChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL--QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~--~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
++...+|.|+||+||+|.+ .+|..||+|.++..... ........+.+|+++|++++|+||+++++++.+. ..+++
T Consensus 3 ~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 79 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTISI 79 (265)
T ss_pred cccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEEE
Confidence 4567899999999999987 48899999998765321 1233456789999999999999999999988765 57999
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-- 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~-- 157 (641)
|+||+++|+|.+++.+...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++ ..|.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhcc
Confidence 9999999999999998888999999999999999999999999 99999999999997 557999999999865421
Q ss_pred ------CCCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChH
Q 006528 158 ------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 230 (641)
Q Consensus 158 ------~~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~ 230 (641)
.......|++.|+|||++.+ .++.++|+||||+++|+|++|..||......................+...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11224568999999998764 58899999999999999999999998644443333322221222334555678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 231 QIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 231 ~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
++.+||.+||. +|.+||++.++|.||||
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 89999999998 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.27 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=211.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||.||+|.+..+|..||+|.+... .....+.+.+|+.+++.++||||+++++++... ..+++||
T Consensus 15 ~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 88 (292)
T cd06644 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWIMI 88 (292)
T ss_pred hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEEEE
Confidence 5778999999999999999999999999998754 345677889999999999999999999988765 4689999
Q ss_pred ccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+.+++|..++.+ ...+++..++.++.||+.||.|||+++ ++||||||+||+++ ..|.+||+|||++......
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccceecccccc
Confidence 99999999988764 456899999999999999999999999 99999999999997 4579999999988653322
Q ss_pred CCccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CccccCChHH
Q 006528 159 TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQ 231 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~-~~l~~~~~~~ 231 (641)
......+++.|+|||++. ..++.++|||||||++|+|++|..||... ++...+..+.....+ ...+...+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCCCcccCHH
Confidence 223457889999999873 23688999999999999999999999764 344444455444332 2233445678
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCcccccccCCC
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~~ 265 (641)
+.+||.+||. +|.+||++.++++||||....+..
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 9999999999 899999999999999998665544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=326.30 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=209.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
++...+|.|++|.||+|.+..+|..||+|.+........ ....+.+.+|+.+|++++||||+++++++.+. ..+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~ 80 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHFNL 80 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeEEE
Confidence 455678999999999999999999999999875432111 23467899999999999999999999988655 46899
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|+||+.+++|.+++.+.+.+++..++.|+.||+.||.|||++| ++|+||+|+||+++.++..+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999999998888999999999999999999999999 99999999999997654579999999986654321
Q ss_pred ------CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCC--HHHHHHHHHcCCCCCccccCChH
Q 006528 160 ------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDP 230 (641)
Q Consensus 160 ------~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~--~~~i~~~i~~g~~~~~l~~~~~~ 230 (641)
.....|+..|+|||++. ..++.++|+||||+++|+|++|+.||..... .......+.........+...++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 22346889999999776 4588999999999999999999999964322 22333233333334445555678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 231 QIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 231 ~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
.+++++.+||. +|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999998 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=326.18 Aligned_cols=247 Identities=30% Similarity=0.446 Sum_probs=204.6
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
...+|+|+||+||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++... ..+++|+||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEec
Confidence 467999999999999999999999999887543 34566889999999999999999999987665 568999999
Q ss_pred CCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 84 FTSGNLRQYRKKH-KNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 84 ~~gGsL~~~l~~~-~~l--~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
+.+++|.+++... ..+ ++..+..++.||+.||.|||+.+ |+||||||+||+++.+.+.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999999864 455 88999999999999999999999 9999999999999865679999999998655322
Q ss_pred CCccccCCCCCCCcccccc---cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 159 TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
......|++.|+|||++.. .++.++||||||+++|+|++|..||.....................++...++++++|
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 2233468999999998753 3789999999999999999999999764443333222222122233455567899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccc
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+.+||. +|.+||++.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999998 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.99 Aligned_cols=256 Identities=26% Similarity=0.446 Sum_probs=212.3
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|++|+||+|.+..++..||+|.+.... ......++.+|++++++++||||+++++++.+.....+++|
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 467889999999999999999999999999987553 23456779999999999999999999999887766789999
Q ss_pred EccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 81 TELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ +.+.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeecccccccc
Confidence 999999999988753 345899999999999999999999999 99999999999997 45789999999987655
Q ss_pred CCCCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCC----CCHHHHHHHHHcCCCCCcc---c--c
Q 006528 157 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPASL---A--K 226 (641)
Q Consensus 157 ~~~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~----~~~~~i~~~i~~g~~~~~l---~--~ 226 (641)
........++..|+|||.+. ..++.++||||||+++|+|++|..||... ..+.+....+.....+... . .
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 44444556888999999775 46899999999999999999999999764 2334444444442221111 1 1
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
..++.+++||.+||. +|.+|||+.|+++||||+...
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 235789999999998 899999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.77 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=201.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|++|+||+|.+..+|..||+|.++.... .......+.+|+.++++++||||+++++++.++ ..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLI 77 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEE
Confidence 3678899999999999999999999999999876532 223446688999999999999999999998765 468999
Q ss_pred EccCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 81 TELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~---~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
|||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ ++|.+||+|||++.....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGI 153 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCC
Confidence 99997 6898888653 46899999999999999999999999 99999999999997 568999999999865432
Q ss_pred CC--CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-------------
Q 006528 158 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------------- 220 (641)
Q Consensus 158 ~~--~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~------------- 220 (641)
.. .....+++.|+|||++.+ .++.++||||||+++|+|+||+.||.+................
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 21 223467899999998753 4788999999999999999999999864443333322111000
Q ss_pred -------------CCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 221 -------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 221 -------------~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
........++++++||.+||. +|.+|||+.+|+.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001112346789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.44 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=201.4
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHH---HhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL---KSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iL---k~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
+|.|+||.||+|.+..+|..||+|.+........ .......+|..++ ...+||||+.+++++... ..+++||||
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 7999999999999999999999999876543221 2222334454444 344799999999988765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 163 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~~ 163 (641)
+.+|+|.+++..++.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...........
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccCc
Confidence 999999999998888999999999999999999999999 99999999999997 557999999999876554444456
Q ss_pred cCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCC--HHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 164 IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 164 ~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~--~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.|++.|+|||.+. ..++.++|||||||++|+|++|..||..... ...+... .. ..+..++...++.+++||.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TL-TVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hh-cCCcCCccccCHHHHHHHHHH
Confidence 7999999999875 3488999999999999999999999975322 2222121 11 122334455678999999999
Q ss_pred cC-CCCCCC-----CHHHHHcCcccccccCCC
Q 006528 240 LV-PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 240 L~-dP~~Rp-----Sa~eLL~Hpff~~~~~~~ 265 (641)
|. +|.+|| +++++++||||+..++..
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 99 899999 699999999998766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=328.37 Aligned_cols=247 Identities=27% Similarity=0.447 Sum_probs=202.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||.||+|.+..+|..||+|.+.... ......+.+|+.++++++||||+++++++... ..+++||
T Consensus 12 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~iv~ 85 (267)
T cd06646 12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWICM 85 (267)
T ss_pred chhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEEEE
Confidence 56788999999999999999999999999987543 23345678999999999999999999998765 4689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~-- 159 (641)
||+++|+|.+++.....+++..+..++.||+.||.|||+++ |+||||+|+||+++ ..|.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCccceeecccccc
Confidence 99999999999988888999999999999999999999999 99999999999997 55799999999997654322
Q ss_pred CccccCCCCCCCccccc----ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc--ccCChHHHH
Q 006528 160 ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIK 233 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~----~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l--~~~~~~~l~ 233 (641)
.....|++.|+|||.+. ..++.++||||||+++|+|++|+.||..................+... ....+..++
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 23457899999999773 347889999999999999999999997543222222211222122111 123467899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcc
Q 006528 234 GFIEKCLV-PASERLSAKDLLKDPF 257 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~Hpf 257 (641)
+||.+||. +|.+||+++++|+|+|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.74 Aligned_cols=247 Identities=28% Similarity=0.480 Sum_probs=207.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..++..+|+|.+.... ....+.+.+|+.++++++||||+++++++... ..++++|
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l~~ 79 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLWIVM 79 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEEEEE
Confidence 57889999999999999999999999999998654 23567899999999999999999999988765 4699999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||+|+||+++ +.|.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchhhhhhhh
Confidence 999999999999876 78999999999999999999999999 99999999999998 5679999999998765432
Q ss_pred CCccccCCCCCCCcccccc----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc--cccCChHHH
Q 006528 159 TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQI 232 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~--l~~~~~~~l 232 (641)
......+++.|+|||++.. .++.++||||||+++|+|+||..||..................+.. .....+.++
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 2234578899999998753 5888999999999999999999999875544443333333222211 122345789
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCcc
Q 006528 233 KGFIEKCLV-PASERLSAKDLLKDPF 257 (641)
Q Consensus 233 ~~LI~kcL~-dP~~RpSa~eLL~Hpf 257 (641)
++||.+||. +|.+||++.+++.|||
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.40 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=214.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccc-cCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDV-LQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~-~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
.++...+|.|++|.||+|.+..+|..||+|.+..... .........+.+|+.++++++||||+++++++.+.....+++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 3678899999999999999999999999999865421 123455678999999999999999999999987766667889
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
++||+++++|.+++...+.+++..++.|+.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcccccccccccc
Confidence 9999999999999988788999999999999999999999999 99999999999997 4579999999999755321
Q ss_pred ----CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 ----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ----~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
......+++.|+|||++.+ .++.++|+||||+++|+|++|+.||........+. .+.....+..++...++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-KIATQPTKPMLPDGVSDACR 239 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-HHHcCCCCCCCCcccCHHHH
Confidence 1223568999999998764 58899999999999999999999998754444443 34433334455666778899
Q ss_pred HHHHHhcCCCCCCCCHHHHHcCccc
Q 006528 234 GFIEKCLVPASERLSAKDLLKDPFL 258 (641)
Q Consensus 234 ~LI~kcL~dP~~RpSa~eLL~Hpff 258 (641)
++|.+||.+|..||++.+++.|||.
T Consensus 240 ~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhcCcccCccHHHHhcCCCC
Confidence 9999999988999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=354.17 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=206.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-C-----CCcceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-D-----DNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-H-----pNIVk~~~~~~~~~~~ 75 (641)
.|+.-||+|+||.|.+|.|..||+.||||+|+-. +....+...|+.+|..|+ | -|||++|++|...+
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-- 261 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-- 261 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc--
Confidence 4688999999999999999999999999999843 456677899999999996 4 48999999998874
Q ss_pred eEEEEEccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC-CCCcEEEeecchh
Q 006528 76 TVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLA 152 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~-~~G~VKL~DFGlA 152 (641)
.+|||+|++. -+|++||+.++ +|+...++.+++|||.||.+||+.+ |||+||||+||||.. ....|||+|||.|
T Consensus 262 HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccc
Confidence 5999999996 59999999764 5899999999999999999999999 999999999999952 2237999999999
Q ss_pred hhccCCCCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-CC-----------
Q 006528 153 IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI----------- 219 (641)
Q Consensus 153 ~~~~~~~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-g~----------- 219 (641)
+...+... +++.+..|+|||++- .+|+.++||||||||++||++|.+.|.+....+++...+.- |.
T Consensus 339 c~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 339 CFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred cccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 87766554 888999999999765 57999999999999999999998888885544444322210 00
Q ss_pred -----------------------------------------CC-------CccccCChHHHHHHHHHhcC-CCCCCCCHH
Q 006528 220 -----------------------------------------KP-------ASLAKVNDPQIKGFIEKCLV-PASERLSAK 250 (641)
Q Consensus 220 -----------------------------------------~~-------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~ 250 (641)
.| ..+....+..+.+||++||. ||.+|+|+.
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 00 00001224578999999999 999999999
Q ss_pred HHHcCcccccccC
Q 006528 251 DLLKDPFLQVENQ 263 (641)
Q Consensus 251 eLL~Hpff~~~~~ 263 (641)
+.|+||||.....
T Consensus 498 qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 498 QALNHPFLTGTSL 510 (586)
T ss_pred HHhcCcccccccc
Confidence 9999999985443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=333.47 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=202.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||.||+|.+..++..||+|.++.... ......+.+|+.+++.++||||+++++++... ..+++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv~ 83 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVF 83 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEEEEE
Confidence 578899999999999999999999999999976542 22344677899999999999999999998765 5689999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccCCCCC
Confidence 9997 5898888754 56899999999999999999999999 99999999999997 5579999999998654322
Q ss_pred CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC---C--------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---I-------------- 219 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g---~-------------- 219 (641)
......+++.|+|||++.+ .++.++||||||+++|+|+||++||..... ......+... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhccccc
Confidence 2233467899999998754 478899999999999999999999987433 2222222110 0
Q ss_pred ----CCC-------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 220 ----KPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 220 ----~~~-------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
.+. ......++.+++||.+||. +|.+|||++++|+||||+.-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 0112346789999999999 899999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=328.65 Aligned_cols=248 Identities=25% Similarity=0.441 Sum_probs=205.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeC----CCce
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD----KKKT 76 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~----~~~~ 76 (641)
+++..+|.|+||+||+|.+..++..||+|.+.... .....+..|+.+++++ +||||++++++|... ....
T Consensus 19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 45678999999999999999999999999886542 3345688999999999 799999999998643 2457
Q ss_pred EEEEEccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 77 VNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
++++|||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||+|+||+++ +.+.++|+|||++..
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~dfg~~~~ 170 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCcchhh
Confidence 89999999999999999764 45889999999999999999999999 99999999999997 567999999999875
Q ss_pred ccCC--CCccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 006528 155 MQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 226 (641)
Q Consensus 155 ~~~~--~~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~ 226 (641)
.... ......|++.|+|||++. ..++.++||||||+++|+|++|..||........+ ..+.....+.....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-FLIPRNPPPKLKSK 249 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-hhHhhCCCCCCccc
Confidence 5422 234467899999999764 34888999999999999999999999875433333 33333333333344
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
..+..+.+||.+||. +|.+||++.+||+||||
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 567899999999999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.65 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=209.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.+.||||+++++.+... ..+++||
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~~~~lv~ 96 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVM 96 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--CEEEEee
Confidence 567889999999999999999999999999886542 2346788999999999999999999998765 4689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
||+.+|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++...... .
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccccchhccccccc
Confidence 99999999999875 45899999999999999999999999 99999999999997 5579999999998755332 2
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
.....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||........++.....+..+...+...++.+.+||.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 234578999999998764 4789999999999999999999999864433344443333332323334456789999999
Q ss_pred hcC-CCCCCCCHHHHHcCccccccc
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
||. +|.+||++.+++.||||....
T Consensus 253 ~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 253 CLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HCcCCcccCcCHHHHhhChhhhccC
Confidence 999 899999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.54 Aligned_cols=258 Identities=20% Similarity=0.334 Sum_probs=211.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|++|+||+|.+..+|..||+|.+....... ......+..|+++|+.++||||+++++.+... ..+++|
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 79 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLCLV 79 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEEEE
Confidence 367889999999999999999999999999998765321 23567789999999999999999999987654 568999
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+|||++ .+|.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccccc
Confidence 9999999999999864 56999999999999999999999999 99999999999997 4589999999998643211
Q ss_pred -------------------------------CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCC
Q 006528 159 -------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK 206 (641)
Q Consensus 159 -------------------------------~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~ 206 (641)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1123468899999997764 58889999999999999999999998744
Q ss_pred CHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCC----HHHHHcCcccccccCCC
Q 006528 207 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS----AKDLLKDPFLQVENQKE 265 (641)
Q Consensus 207 ~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpS----a~eLL~Hpff~~~~~~~ 265 (641)
.. ..+..+.............++.+++||.+||. +|.+||+ +.++|.||||+...+..
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 237 RD-ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred hH-HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 43 33444433322222222257889999999998 8999999 99999999998766543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=327.61 Aligned_cols=252 Identities=27% Similarity=0.481 Sum_probs=212.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+++|+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIM 78 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEE
Confidence 45678999999999999999999999999987653 234556788999999999999999999998776 5689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
||+.+++|.+++... ++++..++.++.||+.||.|||+.+ ++||||+|+||+++ +.|.++|+|||++..+... .
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeecccccc
Confidence 999999999999875 7999999999999999999999999 99999999999998 4679999999999766543 2
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
.....+++.|+|||++.+ .++.++||||||+++|+|+||..||... ++......+..+..+.......++.+.++|.+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 233 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL 233 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHHHHH
Confidence 334578899999997764 5899999999999999999999999763 34455555555443332222267789999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccccccC
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
||. +|.+||+++++++||||+....
T Consensus 234 ~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 234 CLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HhhCChhhCcCHHHHhhChhhcCCCc
Confidence 998 8999999999999999986544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.80 Aligned_cols=249 Identities=29% Similarity=0.475 Sum_probs=207.3
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCC-----hhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQL-----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~-----~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
+...+|.|++|.||+|.+..++..||+|.+........ ....+.+.+|+.++++++||||+++++++... .+.
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--DHL 81 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--Ccc
Confidence 45678999999999999999999999999876543221 22346788999999999999999999988765 468
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++|+||+++++|.+++...+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ +.+.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCccccc
Confidence 899999999999999998888999999999999999999999999 99999999999997 557999999999876542
Q ss_pred C--------CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 006528 158 P--------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 228 (641)
Q Consensus 158 ~--------~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~ 228 (641)
. ......|++.|+|||.+.+ .++.++|+||||+++|+|++|+.||........ +..+..... ...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~ 236 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IFKIGENAS-PEIPSNI 236 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-HHHHhccCC-CcCCccc
Confidence 1 1123458899999998764 588899999999999999999999987544333 333333322 2334456
Q ss_pred hHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 229 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 229 ~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+..++++|.+||. +|.+||++.++++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 7889999999999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.97 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=209.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++...+|.|+||+||+|.+..+|+.||+|.+...... .......+.+|+++|+.++|+||+++++++... ..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEE
Confidence 46788999999999999999999999999998765432 223345678899999999999999999987665 469999
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCC
Confidence 9999999999888653 46999999999999999999999999 99999999999997 4579999999998654322
Q ss_pred -CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHH---HHHHHHcCCCCCccccCChHHHH
Q 006528 159 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~---i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
......|++.|+|||++. ..++.++|+||||+++|+|++|..||........ +...+... ........++.+.
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAK 233 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHH
Confidence 223457899999999775 4689999999999999999999999986433221 22222222 1223344567899
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHHcCcccccccCC
Q 006528 234 GFIEKCLV-PASERLS-----AKDLLKDPFLQVENQK 264 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpS-----a~eLL~Hpff~~~~~~ 264 (641)
+|+.+||. +|.+||+ +.+++.||||.....+
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 99999999 8999999 8999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=329.49 Aligned_cols=251 Identities=27% Similarity=0.470 Sum_probs=209.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..+|..||+|.++... .......+.+|+.++++++||||+++++++... ..+++||
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMCM 78 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEEE
Confidence 56788999999999999999999999999987532 344557889999999999999999999988765 5699999
Q ss_pred ccCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 82 ELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~---~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
||+++++|..++... ..+++..++.++.||+.||.|||+ ++ |+||||||+||+++. .+.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECC-CCCEEEeecCCcccccC
Confidence 999999999998763 379999999999999999999997 47 999999999999984 67999999999976655
Q ss_pred CCCccccCCCCCCCcccccc-------cCCcccccccccchhhhhhhccCCCCCCCCHHHH---HHHHHcCCCCCccccC
Q 006528 158 PTARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI---FKKVTSGIKPASLAKV 227 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~-------~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i---~~~i~~g~~~~~l~~~ 227 (641)
.......+++.|+|||++.+ .++.++|||||||++|+|++|..||.... .... ...+..+.. ...+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 233 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGDP-PTLPSG 233 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcCC-CCCCcc
Confidence 55556678999999998743 25789999999999999999999997532 2222 233333332 334444
Q ss_pred ChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 228 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
.++++++||.+||. +|.+||++.+++.||||....
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 67899999999998 899999999999999997554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=320.79 Aligned_cols=248 Identities=29% Similarity=0.475 Sum_probs=206.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|+||+|.+..+|..||+|++..... ......+.+|+.+|+.++|+||+++++.+... ..+++|+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~ 78 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLVM 78 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEEE
Confidence 578889999999999999999999999999875542 23567899999999999999999999988765 5689999
Q ss_pred ccCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 82 ELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~---~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|++.+++|.+++... ..+++..++.++.||+.||.|||+++ ++||||+|+||+++. .+.+||+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGE-DGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcC-CCCEEEcccchHHHhccC
Confidence 999999999999764 45899999999999999999999999 999999999999984 579999999998765432
Q ss_pred C------CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc----c
Q 006528 159 T------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA----K 226 (641)
Q Consensus 159 ~------~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~----~ 226 (641)
. .....|++.|+|||++.. .++.++|+||||+++|+|++|+.||..... ...+..+.....+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCCCcCCccccc
Confidence 2 233468999999997754 588999999999999999999999987433 33444444332221111 2
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
..++.+++||.+||. +|.+||++.+|++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 346789999999999 89999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.55 Aligned_cols=249 Identities=24% Similarity=0.416 Sum_probs=211.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..++..||+|.+..... .......+.+|+.+|+.++||||+++++.+... ..+++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMIVM 78 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEEEE
Confidence 678899999999999999999999999999986543 334567899999999999999999999987654 5689999
Q ss_pred ccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 82 ELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+.+.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999999764 35899999999999999999999999 9999999999999866667899999999766433
Q ss_pred CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHH
Q 006528 159 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||... +.......+..+... .++...++.++++|.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 234 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA-PISDRYSPDLRQLIL 234 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC-CCCCCcCHHHHHHHH
Confidence 2234578999999998864 4788999999999999999999999874 444455555544332 234446778999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccc
Q 006528 238 KCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+||. +|.+|||+.+++.||||
T Consensus 235 ~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 235 SMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHccCChhhCCCHHHHhhCCCC
Confidence 9998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.73 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=203.1
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHH---HHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSE---VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~E---i~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
+|.|+||+||+|.+..+|+.||+|.+........ ........| +.+++...||||+++++++... ..+++||||
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 7999999999999999999999999876543221 111223333 3445556899999999988665 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 163 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~~ 163 (641)
+.||+|..++.+.+.+++..++.|+.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||++...........
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcCc
Confidence 999999999988888999999999999999999999999 99999999999997 457999999999976655445566
Q ss_pred cCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCC--CHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 164 IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 164 ~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~--~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.|++.|+|||++.. .++.++||||||+++|+|++|..||.... ........... ....++...++.+.++|.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHHH
Confidence 89999999998863 48999999999999999999999997642 22222222222 22334445578999999999
Q ss_pred cC-CCCCCC-----CHHHHHcCcccccccCCC
Q 006528 240 LV-PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 240 L~-dP~~Rp-----Sa~eLL~Hpff~~~~~~~ 265 (641)
|. +|.+|| ++.++++||||....+..
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 99 899999 999999999998766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.79 Aligned_cols=245 Identities=26% Similarity=0.368 Sum_probs=191.0
Q ss_pred EEeCccCceEEEEEEEcC--CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 5 ISSRRIPAVDTYKAFDEF--AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~--tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
..+|.|+||+||+|.+.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++.......+++|+|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 469999999999999653 67899999886433 1235788999999999999999999988766678999999
Q ss_pred cCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEe---CCCCcEEEeecc
Q 006528 83 LFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKIGDLG 150 (641)
Q Consensus 83 y~~gGsL~~~l~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~---~~~G~VKL~DFG 150 (641)
|+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...|.+||+|||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 987 4888887532 24889999999999999999999999 99999999999994 245789999999
Q ss_pred hhhhccCC-----CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCH---------HHHHHH
Q 006528 151 LAIAMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------AQIFKK 214 (641)
Q Consensus 151 lA~~~~~~-----~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~---------~~i~~~ 214 (641)
+++..... ......||+.|+|||++.+ .++.++|||||||++|||+||++||...... .++...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 99765432 1234578999999998754 4889999999999999999999999642210 111110
Q ss_pred HHc-C--------------------------CC-C-------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 215 VTS-G--------------------------IK-P-------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 215 i~~-g--------------------------~~-~-------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+.. + .. . .......+..+.+||.+||. ||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0 00 0 00011224568899999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.84 Aligned_cols=249 Identities=23% Similarity=0.432 Sum_probs=213.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||.||.+.+..+|..|++|.+..... .......+.+|+.+|++++|+||+++++++.+. ..++++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~ 77 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIE 77 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEE
Confidence 3688999999999999999999999999999876653 345566789999999999999999999998765 568999
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++ +.+.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEcccc
Confidence 9999999999999875 46899999999999999999999999 99999999999998 4579999999998765433
Q ss_pred C--CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 159 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 159 ~--~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
. .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+....+..+..+. .....+..+.++
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELISL 232 (256)
T ss_pred cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHH
Confidence 2 344578999999997764 578899999999999999999999976 45666666666654433 234557789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccc
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
|.+||. +|.+||++.++|+|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.25 Aligned_cols=252 Identities=36% Similarity=0.543 Sum_probs=217.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|.||+|.+..+|..|++|.+..... .+...+.+.+|+.++++++||||+++++.+.......+++++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 567889999999999999999999999999876653 245678899999999999999999999988766446789999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~-- 159 (641)
||+.+++|.+++.....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. .|.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcC-CCCEEEcccccEEeccccccc
Confidence 99999999999998889999999999999999999999998 999999999999984 5799999999987665443
Q ss_pred --CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 160 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 160 --~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
.....+++.|+|||.+.. .++.++||||||+++|+|++|..||....+.......+..+.....++...+..+++||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 345678999999998764 48999999999999999999999998755555555555543444445556688999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccc
Q 006528 237 EKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.+||. +|.+||++.++++||||
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHhCcCChhhCCCHHHHhhCCCC
Confidence 99999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.36 Aligned_cols=252 Identities=28% Similarity=0.488 Sum_probs=209.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|+||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..+++|+
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 95 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVG--DELFVVM 95 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecC--ceEEEEE
Confidence 57789999999999999999999999999987543 23356788999999999999999999988765 4689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~-- 159 (641)
||+.+|+|..++... .+++..+..++.||+.||.|||+++ ++||||||+||+++ ..|.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccchhccccccc
Confidence 999999999998754 5899999999999999999999999 99999999999997 56899999999987654322
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
.....+++.|+|||.+.. .++.++|||||||++|+|++|..||..................+...+...++.+++||.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 234578999999997764 5889999999999999999999999874433333332223322323344557889999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccccccC
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
||. +|.+||++.+++.||||+....
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhhccc
Confidence 998 8999999999999999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.97 Aligned_cols=248 Identities=25% Similarity=0.442 Sum_probs=204.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC----Cce
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK----KKT 76 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~----~~~ 76 (641)
+++..+|.|++|+||+|.+..++..|++|.+.... ...+.+.+|+.+++++ +||||+++++++.... ...
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 57789999999999999999999999999987543 2346789999999999 7999999999987643 356
Q ss_pred EEEEEccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 77 VNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++. .+.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~-~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTK-NAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEcc-CCeEEECCCccc
Confidence 8999999999999999875 357999999999999999999999999 999999999999984 579999999998
Q ss_pred hhccCC--CCccccCCCCCCCcccccc------cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006528 153 IAMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 224 (641)
Q Consensus 153 ~~~~~~--~~~~~~GTp~ymAPEvl~~------~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l 224 (641)
...... ......|++.|+|||++.. .++.++||||||+++|+|++|..||........ ...+..+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~ 239 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFKIPRNPPPTLK 239 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHHhhccCCCCCC
Confidence 654322 2234568999999998742 377899999999999999999999976433333 3334433322211
Q ss_pred -ccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 225 -AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 225 -~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
....+..+++||.+||. +|.+|||+.++++|||+
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 12245689999999998 89999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=329.05 Aligned_cols=250 Identities=28% Similarity=0.504 Sum_probs=209.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|+||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++... ..+++||
T Consensus 8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (280)
T cd06611 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES----EEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLWILI 81 (280)
T ss_pred HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC----HHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEEEEe
Confidence 35667999999999999999999999999987543 45567788999999999999999999988765 5689999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+++|+|..++... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++ ..+.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccchhhccccc
Confidence 999999999998764 56999999999999999999999999 99999999999997 5579999999988654322
Q ss_pred CCccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CccccCChHH
Q 006528 159 TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQ 231 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~-~~l~~~~~~~ 231 (641)
......+++.|+|||++. ..++.++||||||+++|+|++|+.||... ........+..+..+ ...+...+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 223457899999999764 23678999999999999999999999874 444445555554332 2223445678
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
+.+||.+||. +|.+||++.++|+||||...
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999999998 89999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=323.68 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=211.7
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.++...+|.|+||.||+|.+..+|..||+|.+..... ........+.+|++++++++||||+++++++... ..+++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 78 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENMYLV 78 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeEEEE
Confidence 3688999999999999999999999999999986543 2234567899999999999999999999987654 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-C
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-~ 159 (641)
+||+.+++|..++.....+++..+..|+.||+.||.|||+++ ++|+||+|+||+++ +++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCcc
Confidence 999999999999988878999999999999999999999999 99999999999998 5579999999998765433 2
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCC--HHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~--~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
.....|+..|+|||++.. .++.++|+||||+++|+|++|..||..... .......... .....+...+..+.++|
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAI 233 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHH
Confidence 344578899999998764 579999999999999999999999986543 3444333332 22233445568999999
Q ss_pred HHhcC-CCCCCCCH--HHHHcCccc
Q 006528 237 EKCLV-PASERLSA--KDLLKDPFL 258 (641)
Q Consensus 237 ~kcL~-dP~~RpSa--~eLL~Hpff 258 (641)
.+||. +|.+||++ ++++.||||
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHccCChhHcCCccHHHHhcCCCC
Confidence 99999 89999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.52 Aligned_cols=253 Identities=28% Similarity=0.486 Sum_probs=216.8
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|++|.||+|.+..+|..||+|++..... ......+.+|+.++++++||||+++++++... ..+++|
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIV 77 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEE
Confidence 4678899999999999999999999999999876542 24567899999999999999999999988766 568999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
+||+.+++|.+++.....+++..++.++.||+.||.|||+ .+ ++||||+|+||+++ .++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCC
Confidence 9999999999999988889999999999999999999999 98 99999999999997 45799999999987665433
Q ss_pred Cc--cccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCC--CHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 AR--SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 ~~--~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~--~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
.. ...+++.|+|||.+.. .++.++|+||||+++|+|+||..||.... ...+....+.....+.......+..+.+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 22 4578899999997764 57889999999999999999999998754 5556666666554443322226788999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 235 FIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
+|.+||. +|.+||++.+++.||||+..
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999998 89999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=339.38 Aligned_cols=263 Identities=21% Similarity=0.362 Sum_probs=228.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
..|+.+|.|.||+|-++..+.+|+.+|+|+++++-+. ..++...-..|-++|+.++||.+..+..+|... +.+||||
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii-akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~--drlCFVM 247 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII-AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ--DRLCFVM 247 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhhee-ehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC--ceEEEEE
Confidence 3467899999999999999999999999999877654 356677788999999999999999998888655 6799999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~~~ 159 (641)
||..||.|.-++.+.+.|++...+.+-..|+.||.|||+++ |++||||.+|+|++ .+|+|||+|||+++.-- ...
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhcccccce
Confidence 99999999999999899999999999999999999999999 99999999999998 55899999999997532 345
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
..++||||+|+|||+++. .|+.++|+|.+|++||||++|++||.. .+...++..|.-+ ...++...+++++.|+..
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~e--d~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILME--DLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhh--hccCCccCCHHHHHHHHH
Confidence 678999999999999985 599999999999999999999999987 4556677776654 234567778999999999
Q ss_pred hcC-CCCCCCC-----HHHHHcCcccccccCCCCcCCCCCC
Q 006528 239 CLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKL 273 (641)
Q Consensus 239 cL~-dP~~RpS-----a~eLL~Hpff~~~~~~~~~~~~~~~ 273 (641)
+|. ||.+|+. |.|+.+|+||...+|.......+.+
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~P 442 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEP 442 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCC
Confidence 998 8999985 8999999999998886554443433
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.99 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=203.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC---CceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK---KKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~---~~~l 77 (641)
+++..+|.|+||.||+|.+..+|..||+|.+.... .....+.+|+.+++++ +||||+++++++...+ ...+
T Consensus 25 ~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 57788999999999999999999999999886432 2345678899999999 8999999999987543 2468
Q ss_pred EEEEccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 78 NMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
++||||+.+|+|.++++. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEeecccch
Confidence 999999999999998863 456899999999999999999999998 99999999999997 55799999999987
Q ss_pred hccCC--CCccccCCCCCCCcccccc------cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-Ccc
Q 006528 154 AMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASL 224 (641)
Q Consensus 154 ~~~~~--~~~~~~GTp~ymAPEvl~~------~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~-~~l 224 (641)
..... ......|++.|+|||++.. .++.++|||||||++|+|++|+.||........+ ..+..+..+ ...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 255 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FKIPRNPPPTLLH 255 (291)
T ss_pred hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHhcCCCCCCCc
Confidence 65432 2234578999999998752 2688999999999999999999999874333333 334333222 112
Q ss_pred ccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 225 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 225 ~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
+......+.+||.+||. +|.+||++.+++.||||+
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 22345689999999999 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=329.45 Aligned_cols=252 Identities=22% Similarity=0.420 Sum_probs=209.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..+|..||+|.+.... .+.....+.+|+++++.++||||+++++++... ..+++||
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCM 82 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEE
Confidence 45678999999999999999999999999887543 244567889999999999999999999998776 5689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
||+++|+|..++.+.+.+++..++.++.||+.||.|||+ ++ ++||||+|+||+++ +.+.++|+|||++........
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhcc
Confidence 999999999999988889999999999999999999997 57 99999999999997 567999999999866544444
Q ss_pred ccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCH----------HHHHHHHHcCCCCCccccCCh
Q 006528 161 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP----------AQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~----------~~i~~~i~~g~~~~~l~~~~~ 229 (641)
....|+..|+|||++. ..++.++|||||||++|+|+||..||...... ......+.....+.......+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 4567899999999765 56889999999999999999999999753321 122333333222222222256
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
..+.+||.+||. +|.+||++.++++||||...
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 789999999999 89999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.01 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=204.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..+|..||+|++..... .....+.+.+|+.++++++||||+++++++... ..+++||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~ 79 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHLVF 79 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEEEE
Confidence 577889999999999999999999999999875432 223345678999999999999999999998765 4689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~-- 159 (641)
||+++++|..++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ ..|.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCCccc
Confidence 99999999988877778999999999999999999999999 99999999999997 55799999999997654332
Q ss_pred CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc--CC----------------
Q 006528 160 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GI---------------- 219 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~--g~---------------- 219 (641)
.....++..|+|||++.+ .++.++||||||+++|+|++|+.||.+..+...+...... ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 234567889999998753 4789999999999999999999999875544443322110 00
Q ss_pred --CCC--------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 220 --KPA--------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 220 --~~~--------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.+. ......+..+.+||.+||. +|.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0011235678999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=354.89 Aligned_cols=233 Identities=27% Similarity=0.388 Sum_probs=200.1
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.=+|.|+.|.||+|.- .++.||||.|+.- -..+|+-|++|+||||++|.+++ ....++|||||||
T Consensus 130 eWlGSGaQGAVF~Grl--~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEfC 194 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL--HNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEFC 194 (904)
T ss_pred hhhccCcccceeeeec--cCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeee--cCCceeEEeeecc
Confidence 3479999999999985 4889999988632 25689999999999999999965 5557899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCccc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSV 163 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-~~~~~ 163 (641)
..|-|...|+....++...+..|.++|+.|+.|||.+. |||||||.-||||..+ ..|||+|||-++..... +.-.+
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhh
Confidence 99999999999999999999999999999999999999 9999999999999855 49999999999776543 44568
Q ss_pred cCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-
Q 006528 164 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 241 (641)
Q Consensus 164 ~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~- 241 (641)
+||..|||||++.. +.++|+|||||||+||||+||+.||.+.. ...|+-.+-.+...-..+...+..++-||+.||.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd-ssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD-SSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc-hheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 99999999999874 68999999999999999999999998743 2333333444444455666778899999999999
Q ss_pred CCCCCCCHHHHHcCc
Q 006528 242 PASERLSAKDLLKDP 256 (641)
Q Consensus 242 dP~~RpSa~eLL~Hp 256 (641)
+|..||++.++|.|-
T Consensus 351 KpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHL 365 (904)
T ss_pred CCCCCccHHHHHHHH
Confidence 899999999999983
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.86 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=202.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeC---CCceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD---KKKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~---~~~~l 77 (641)
+++..+|+|+||+||+|.+..+|..||+|.+.... .....+..|+.+++.+ +||||+++++++... ....+
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 57889999999999999999999999999875432 2235678899999999 799999999987542 23578
Q ss_pred EEEEccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 78 NMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ ..|.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEEEccCCcee
Confidence 999999999999998753 356899999999999999999999999 99999999999997 45789999999987
Q ss_pred hccCC--CCccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCcc
Q 006528 154 AMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASL 224 (641)
Q Consensus 154 ~~~~~--~~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~-~~~l 224 (641)
.+... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||........+. .+..... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~ 251 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPPPTLHQ 251 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hccccCCCcccC
Confidence 65432 233457899999999874 347889999999999999999999998744333332 2222222 2223
Q ss_pred ccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 225 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 225 ~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+...+..+++||.+||. +|.+||++.++++|+||
T Consensus 252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 34456789999999998 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.46 Aligned_cols=253 Identities=27% Similarity=0.463 Sum_probs=209.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|+||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..+++||
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~ 95 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVM 95 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEEEee
Confidence 578899999999999999999999999999875442 2346688999999999999999999988765 4689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++ .+|.++|+|||++...... .
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCccceEccCCccC
Confidence 99999999999875 45899999999999999999999999 99999999999997 5689999999998655332 2
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
.....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||........+......+..+...+...++.+++||.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 234578999999997764 5889999999999999999999999764433333332222333333344557789999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
||. +|.+||++.++++||||+.....
T Consensus 252 ~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 252 CLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HccCChhhCcCHHHHhcCchhcccccc
Confidence 999 89999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.58 Aligned_cols=251 Identities=31% Similarity=0.443 Sum_probs=210.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEeccccc-CChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL-QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+....+|+|++|+||+|.+..+|..|++|.+...... ...+..+.+.+|+.+++.++||||+++++++... ..++++
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv 80 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLYIF 80 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEEEE
Confidence 3456789999999999999999999999998765422 2344567899999999999999999999987655 568999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
+||+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++ ..+.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceecccccc
Confidence 999999999999998888999999999999999999999999 99999999999997 45799999999987654332
Q ss_pred CccccCCCCCCCcccccc-c-CCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~-y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
.....|++.|+|||.+.. . ++.++|+||||+++|+|++|+.||......... ..+.........+...++.+++||.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-FKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-HHHHhcccCCCcCCCcCHHHHHHHH
Confidence 345678999999997653 3 789999999999999999999999875433333 3333322333445556789999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccc
Q 006528 238 KCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+||. +|.+||++.+++.|||+
T Consensus 237 ~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 237 KCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHhhcCcccCcCHHHHhcCCCC
Confidence 9998 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.11 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=203.7
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHH-HHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL-LKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~i-Lk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
..+|.|++|.||+|.+..+|..||+|.+....... ......+..|..+ ...++||||+++++++... ..+++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEec
Confidence 46899999999999999999999999987544221 2223344555554 4555899999999988654 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 163 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~~ 163 (641)
+.+|+|.+++...+.+++..+..++.||+.||.|||+.+ ++||||+|+||+++ +.+.+||+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccC
Confidence 999999999998888999999999999999999999999 99999999999997 557999999999865432 3345
Q ss_pred cCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCChHHHHHHHHHhc
Q 006528 164 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 164 ~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--~~~l~~~~~~~l~~LI~kcL 240 (641)
.|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .+..+.+..+..+.. +.......++.+.++|.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 68899999998764 478999999999999999999999976 345555555544322 22333345789999999999
Q ss_pred C-CCCCCCC---HHHHHcCcccccccC
Q 006528 241 V-PASERLS---AKDLLKDPFLQVENQ 263 (641)
Q Consensus 241 ~-dP~~RpS---a~eLL~Hpff~~~~~ 263 (641)
. +|.+||+ ++|+|.||||...+|
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 8 8999995 479999999986654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.69 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=209.3
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 86 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~g 86 (641)
+|.|+||+||+|.+..+|..||+|.+..... ......+.+.+|++++++++||||+++++.+... ..+++|+||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEecCCC
Confidence 5899999999999999999999999875543 2235677899999999999999999999987654 568999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--------
Q 006528 87 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-------- 158 (641)
Q Consensus 87 GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-------- 158 (641)
++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ ..+.+||+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccc
Confidence 999999998888999999999999999999999999 99999999999998 5579999999998654322
Q ss_pred --CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 159 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 159 --~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
......+++.|+|||.+. ..++.++||||||+++|+|++|..||.. ......+..+..+..+.......++.+.+|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 223356888999999765 4588899999999999999999999976 446666666665443322222237889999
Q ss_pred HHHhcC-CCCCCCCH---HHHHcCccccccc
Q 006528 236 IEKCLV-PASERLSA---KDLLKDPFLQVEN 262 (641)
Q Consensus 236 I~kcL~-dP~~RpSa---~eLL~Hpff~~~~ 262 (641)
|.+||. +|.+||++ .++|+||||...+
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 999999 89999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.15 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=216.4
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
+.+|+|-|.+|-+|.+-.||+.||||+|.+.++ .......+++|++.|+.++|||||++|.+. +....+|||+|+-
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLiLELG 99 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLILELG 99 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEEEEec
Confidence 468999999999999999999999999988765 234456799999999999999999999964 3345699999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc-CCCCcc
Q 006528 85 TSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~-~~~~~~ 162 (641)
.+|+|++||-++ ..+++..+++|++||+.|+.|+|+.. ++||||||+|+.+-...|.|||.|||++..+. .....+
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 999999999876 56999999999999999999999998 99999999999887788999999999996554 446678
Q ss_pred ccCCCCCCCcccccc-cCC-cccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhc
Q 006528 163 VIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~-~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL 240 (641)
.||+..|.|||++-+ .|+ +++||||||+|||-|++|++||.+. |..+-.-+|..... ..+...+.++++||..||
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA-NDSETLTmImDCKY--tvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA-NDSETLTMIMDCKY--TVPSHVSKECRDLIQSML 254 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc-cchhhhhhhhcccc--cCchhhhHHHHHHHHHHH
Confidence 999999999997765 575 6799999999999999999999985 44445555655432 346677899999999999
Q ss_pred C-CCCCCCCHHHHHcCcccccccC
Q 006528 241 V-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 241 ~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
+ ||.+|.+.++|..|+|++....
T Consensus 255 vRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred hcCchhhccHHHHhccccccCCCC
Confidence 9 9999999999999999997654
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=322.66 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=203.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++... ..+++|+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~ 78 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVLVM 78 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEEEe
Confidence 678899999999999999999999999999886543 234456789999999999999999999988765 5689999
Q ss_pred ccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++. .|.++|+|||++.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISA-DGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcC-CCcEEEeeeeecccccCCCC
Confidence 999 9999999865 456999999999999999999999999 999999999999984 5799999999997665432
Q ss_pred --CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-C-------------
Q 006528 160 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-P------------- 221 (641)
Q Consensus 160 --~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~-~------------- 221 (641)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|.+||....+.. .+..+..... +
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcch
Confidence 234578999999998753 46899999999999999999988887643332 2222221100 0
Q ss_pred --------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 222 --------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 222 --------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
.......+..+.+||.+||. +|.+||+++++|+||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00111235789999999999 899999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.38 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=202.8
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|++|+||+|.++.+|..||||.+..... .......+.+|++++++++||||+++++++.+. ..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 77 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEE
Confidence 4688899999999999999999999999999876542 233446788999999999999999999988654 468999
Q ss_pred EccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+. ++|..++.. ...+++..++.++.||+.||+|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccC
Confidence 99996 689998865 356899999999999999999999999 99999999999998 5579999999998765432
Q ss_pred --CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC------------
Q 006528 159 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA------------ 222 (641)
Q Consensus 159 --~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~------------ 222 (641)
......+++.|+|||++.+ .++.++||||||+++|+|+||+.||..........+.+.....+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 2233457889999998764 368899999999999999999999987544444433322111100
Q ss_pred --------------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 223 --------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 223 --------------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
......++.++++|.+||. +|.+||++.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112346788999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=328.83 Aligned_cols=259 Identities=21% Similarity=0.341 Sum_probs=214.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|+||.||+|.+..++..||+|.+..... ........+.+|+++++.++||||+++++++... ..+++|
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 79 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCMV 79 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEEE
Confidence 3678999999999999999999999999999876532 2234556788999999999999999999987654 568999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|||+.+|+|.+++...+.+++..+..++.||+.||.|||+++ ++||||||+||+++ ..|.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCcc
Confidence 999999999999998888999999999999999999999999 99999999999997 5689999999988531100
Q ss_pred ---------------CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-
Q 006528 159 ---------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP- 221 (641)
Q Consensus 159 ---------------~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~- 221 (641)
......+++.|+|||.+. ..++.++||||||+++|+|++|..||.+ ....++...+..+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~~ 235 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEW 235 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCC
Confidence 011245788999999765 4689999999999999999999999986 3456666666554322
Q ss_pred CccccCChHHHHHHHHHhcC-CCCCCCC---HHHHHcCcccccccCCCC
Q 006528 222 ASLAKVNDPQIKGFIEKCLV-PASERLS---AKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 222 ~~l~~~~~~~l~~LI~kcL~-dP~~RpS---a~eLL~Hpff~~~~~~~~ 266 (641)
.......++.++++|.+||. +|.+||+ +.++|.||||....+...
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence 22223457789999999999 8999998 899999999987665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.63 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=198.4
Q ss_pred EEEEEeCccCceEEEEEEEc--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 2 RILISSRRIPAVDTYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
+++..+|.|+||+||+|... .++..||+|.+.... ...+|+.+|++|+||||+++++++... ..+++
T Consensus 95 ~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 163 (392)
T PHA03207 95 NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWK--STVCM 163 (392)
T ss_pred EEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeC--CEEEE
Confidence 67889999999999999754 467889999876432 246899999999999999999988765 46899
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
|||++. ++|.+++.....+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccccCccc
Confidence 999996 689999987888999999999999999999999999 99999999999997 5579999999999765432
Q ss_pred ---CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCH--HHHHHHHHcC--------------
Q 006528 159 ---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSG-------------- 218 (641)
Q Consensus 159 ---~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~--~~i~~~i~~g-------------- 218 (641)
......||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.... ...+..+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 223467999999999886 45899999999999999999999999753321 1111111110
Q ss_pred ------------CC-CCccc-----cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 219 ------------IK-PASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 219 ------------~~-~~~l~-----~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
.. +...+ ...+.++++||.+||. +|.+||++.++|.||||+...+.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 00 00011 1235678999999999 89999999999999999865543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=329.22 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=204.8
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|+||.||+|.+..+|..||+|.++..... ......+.+|+.++++++|+||+++++++.+.....+++|
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 36788999999999999999999999999999765421 1223346689999999999999999999887665678999
Q ss_pred EccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 81 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
|||+.+ +|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ +.|.+||+|||++......
T Consensus 87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeeecCCcc
Confidence 999974 88888876 367999999999999999999999999 99999999999997 5579999999999765432
Q ss_pred -CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CC-----------
Q 006528 159 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PA----------- 222 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--~~----------- 222 (641)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||... +..+.+..+..... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK-SEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 2223356888999998753 4789999999999999999999999864 34444433322100 00
Q ss_pred ----cc-----------ccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 223 ----SL-----------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 223 ----~l-----------~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.. ....++.+.+||.+||. ||.+|||+.++|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 00 01236788999999999 89999999999999999744
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=374.61 Aligned_cols=258 Identities=21% Similarity=0.339 Sum_probs=225.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++|++.||+|+||.|.++.++.|++.||.|++.+-.... ..+..-|..|-.+|...+.+-|+.++..|.|+ .++|||
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--~~LYlV 153 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQDE--RYLYLV 153 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--cceEEE
Confidence 357888999999999999999999999999998744322 34456788999999999999999999999877 569999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC-CC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~-~~ 159 (641)
|||++||+|-.++.+..++++..++.|+..|+.||.-||+.| +|||||||+|||++ ..|+|||+|||.+..+.. ..
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCc
Confidence 999999999999999999999999999999999999999999 99999999999998 569999999999977663 32
Q ss_pred --CccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--cCCh
Q 006528 160 --ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVND 229 (641)
Q Consensus 160 --~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~--~~~~ 229 (641)
....+|||.|.+||++. +.|+..+|+||+|||+|||+.|..||+. .+...-|.+|........+| ...+
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccC
Confidence 34568999999999884 3599999999999999999999999986 56777888888764444444 3368
Q ss_pred HHHHHHHHHhcCCCCCCCC---HHHHHcCcccccccCCC
Q 006528 230 PQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQKE 265 (641)
Q Consensus 230 ~~l~~LI~kcL~dP~~RpS---a~eLL~Hpff~~~~~~~ 265 (641)
+++++||.+.|.+|..|+. ++++..||||....|..
T Consensus 310 eeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 310 EEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred HHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhh
Confidence 8999999999999999988 99999999999999854
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.19 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=191.8
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||+|.+..++..||+|..... ....|+.+|++++||||+++++++... ...++|
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 135 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMV 135 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeEEE
Confidence 36889999999999999999999999999974322 235699999999999999999998776 458899
Q ss_pred EccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC-C
Q 006528 81 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-P 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~-~ 158 (641)
+||+. |+|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..... .
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCccccccccCc
Confidence 99996 588888765 467999999999999999999999999 99999999999997 557999999999965432 2
Q ss_pred CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCC--C--------HHHHHHHHHc-CCCCCccc-
Q 006528 159 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK--N--------PAQIFKKVTS-GIKPASLA- 225 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~--~--------~~~i~~~i~~-g~~~~~l~- 225 (641)
......||+.|+|||++. ..|+.++|||||||++|||+++..|+.... . ...+...+.. +..+..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 334567999999999876 468999999999999999998655543211 1 1111111111 11111111
Q ss_pred -----------------------------cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 226 -----------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 226 -----------------------------~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
...+..+.+||.+||. ||.+||||.|+|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1224567789999999 8999999999999999974
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=324.14 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=206.4
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 86 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~g 86 (641)
+|.|+||+||+|.+..+|..||+|.+...... .......+..|+.+|++++||||+++++++... ..+++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence 58999999999999999999999998754321 223455678899999999999999999988655 468999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCccc
Q 006528 87 GNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSV 163 (641)
Q Consensus 87 GsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-~~~~~ 163 (641)
++|.+++.+.+ .+++..++.++.||+.||.|||+++ ++||||+|+||+++ +++.+||+|||++...... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 99999998765 7999999999999999999999999 99999999999997 5579999999998765432 23345
Q ss_pred cCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCC---HHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 164 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 164 ~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~---~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.+++.|+|||++. +.++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.+++||.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 6788999999875 4588999999999999999999999975332 2233222222 22334445688999999999
Q ss_pred cC-CCCCCC-----CHHHHHcCcccccccCCC
Q 006528 240 LV-PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 240 L~-dP~~Rp-----Sa~eLL~Hpff~~~~~~~ 265 (641)
|. +|.+|| ++.+|+.||||...++..
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~ 264 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence 98 899999 999999999998766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=316.12 Aligned_cols=249 Identities=33% Similarity=0.550 Sum_probs=210.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
.+...+|.|++|.||+|.+..++..||+|.++.... .+.....+..|+.+++.++|+||+++++++... ..+++|+
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYIFM 78 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEEEE
Confidence 467889999999999999999999999999987653 245778899999999999999999999976544 5689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~- 160 (641)
||+.+++|.+++.....+++..++.++.||+.||.|||+++ |+|+||+|+||+++ +.+.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCCCc
Confidence 99999999999998878999999999999999999999999 99999999999997 468999999999876543211
Q ss_pred -----ccccCCCCCCCcccccc-c---CCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccC--Ch
Q 006528 161 -----RSVIGTPEFMAPELYEE-E---YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV--ND 229 (641)
Q Consensus 161 -----~~~~GTp~ymAPEvl~~-~---y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~--~~ 229 (641)
....+++.|+|||++.+ . ++.++||||||+++|+|++|..||....+.......+..+.. ..++.. .+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK-PPIPDSLQLS 234 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCC-CCCCcccccC
Confidence 13467899999998763 2 788999999999999999999999875555544444444322 223333 37
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+.+.+||.+||. +|.+||++.+++.|||+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 889999999998 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.70 Aligned_cols=245 Identities=33% Similarity=0.522 Sum_probs=203.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|.||+|.+..++..||+|.+.... ..+.+.+|+++++.++||||+++++++... ..+++++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~ 77 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIVM 77 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEEE
Confidence 45677999999999999999999999999987542 267899999999999999999999988766 5689999
Q ss_pred ccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++ +.+.+||+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchhcccCcc
Confidence 99999999999975 456899999999999999999999999 99999999999998 45799999999997665432
Q ss_pred -CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCccccCChHHHHHHH
Q 006528 160 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIKGFI 236 (641)
Q Consensus 160 -~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~-~~~l~~~~~~~l~~LI 236 (641)
.....+++.|+|||++.+ .++.++||||||+++|+|++|..||..... ......+..... ........+..+.+||
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-MRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch-hhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 234568899999998764 588999999999999999999999986433 222222222211 1122234467899999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccc
Q 006528 237 EKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.+||. +|.+||++.++|.||||
T Consensus 234 ~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHhcChhhCcCHHHHhcCCCC
Confidence 99998 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=315.87 Aligned_cols=249 Identities=23% Similarity=0.434 Sum_probs=210.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|+||+||++.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++... ...++|
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYIV 77 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEEE
Confidence 3678999999999999999999999999999986543 234456789999999999999999999987654 578999
Q ss_pred EccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+||+.+++|.+++.... .+++..+..|+.||+.||.|||+++ ++|+||+|+|||++ ..+.++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNST 154 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCcc
Confidence 99999999999987643 5789999999999999999999999 99999999999997 4579999999998655432
Q ss_pred C--CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 159 T--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 159 ~--~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
. .....|++.|+|||++. ..++.++|+||||+++++|++|..||.. .+...++..+..+..+. .+...+..+.++
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLRNL 232 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHHHH
Confidence 2 23456889999999875 4578899999999999999999999976 45556666666554433 234457789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccc
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
|.+||. +|.+||++.++|+||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.67 Aligned_cols=252 Identities=21% Similarity=0.404 Sum_probs=214.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++..+|+|+.|+|++++.+.+|...|||++.... ..++..+++..+.++...+ .|+||+.|++|+.+.. +++.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~Ic 169 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFIC 169 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHHH
Confidence 45678999999999999999999999999998765 3567788999998877764 8999999999998754 7788
Q ss_pred EccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
||+|. .-+..++++ .++++|..+-.+..-+++||.||.... +|||||+||+|||+| +.|.|||||||++..+-...
T Consensus 170 MelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeeccc
Confidence 89995 355555554 467999999999999999999997653 299999999999998 66999999999998776655
Q ss_pred Ccc-ccCCCCCCCcccccc----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccC-ChHHHH
Q 006528 160 ARS-VIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV-NDPQIK 233 (641)
Q Consensus 160 ~~~-~~GTp~ymAPEvl~~----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~-~~~~l~ 233 (641)
+++ ..|-+.|||||.+.. .|+.++||||||+.++||+||.+||.+|....+...+|....+|...... .++.++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 544 478999999998863 59999999999999999999999999999999998888886554332222 689999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 234 GFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
+|+..||. |+.+||...+||+|||+...
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 99999999 89999999999999999643
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=380.89 Aligned_cols=249 Identities=30% Similarity=0.467 Sum_probs=221.2
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|.|.||.||.|.+..||+..|+|.+++.+.. ......+.+|..+|..|+|||+|+||++-++.++ ++|.||||.
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--v~IFMEyC~ 1317 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--VYIFMEYCE 1317 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHH--HHHHHHHhc
Confidence 589999999999999999999999999987643 3445668899999999999999999997776654 788899999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC------
Q 006528 86 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT------ 159 (641)
Q Consensus 86 gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~------ 159 (641)
+|+|.+.+...+..++...+.+..|++.||.|||++| |+||||||.|||++ .+|.+|++|||.|..+....
T Consensus 1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCchhcCCHH
Confidence 9999999998888899999999999999999999999 99999999999998 55899999999997654432
Q ss_pred CccccCCCCCCCcccccc----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
.....|||.|||||++.+ +...+.|||||||+++||+||+.||...++..+|+-++..|..|..... .+++.++|
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~g~dF 1473 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSEGRDF 1473 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHhHHHH
Confidence 335689999999999864 4678999999999999999999999999999999999999988765444 78899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
|+.||. ||.+|+++.|||.|.|=+...
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 999998 999999999999999976544
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=322.38 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=205.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCC-----eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG-----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
++++..+|.|+||.||+|.+...+ ..||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~ 81 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--Q 81 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--C
Confidence 467889999999999999986655 789999876433 345567789999999999999999999988655 4
Q ss_pred eEEEEEccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC
Q 006528 76 TVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~ 139 (641)
..+++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~- 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG- 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-
Confidence 588999999999999999864 45788999999999999999999999 99999999999997
Q ss_pred CCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHH
Q 006528 140 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 213 (641)
Q Consensus 140 ~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~ 213 (641)
+++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+ ....++..
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIE 237 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 55799999999986543221 22345688999999765 568999999999999999998 9999987 45667777
Q ss_pred HHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 214 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 214 ~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.+..+..+. .+...++++.+|+.+||. +|.+||++.+++++
T Consensus 238 ~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777665443 344567899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=352.81 Aligned_cols=241 Identities=29% Similarity=0.409 Sum_probs=208.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
.+.-.||+|+||+||+|.+..+ ||||.++.... .+++++.|..|+.+|++-+|.||+-|.|++.... +.||+
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIiT 466 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAIIT 466 (678)
T ss_pred hccceeccccccceeecccccc---eEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeeee
Confidence 3566899999999999999866 99999998775 5679999999999999999999999999887653 58999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc----
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ---- 156 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~---- 156 (641)
.+|.|-+|+.++.-. .+|+....+.|++||++|+.|||.++ |||||||..|||+. +++.|||+|||++..-.
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeeecc
Confidence 999999999998743 46999999999999999999999999 99999999999997 55899999999996433
Q ss_pred CCCCccccCCCCCCCcccccc----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC---CCccccCCh
Q 006528 157 QPTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PASLAKVND 229 (641)
Q Consensus 157 ~~~~~~~~GTp~ymAPEvl~~----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~---~~~l~~~~~ 229 (641)
........|...|||||+++. +|++.+|||||||++|||+||..||. ..+.++|.-++.+|.. .........
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCH
Confidence 222334467889999998763 59999999999999999999999999 6889999999999833 333334446
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.++++|+..||. ++.+||...+||.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 699999999999 8999999999987
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=320.12 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=199.1
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~l 79 (641)
.+++..+|.|+||.||+|.+..++..||+|.++.... .. ......+|+.+++++. ||||+++++++.+.....+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 3688899999999999999999999999998865421 11 2234467999999995 999999999988765567999
Q ss_pred EEccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 80 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|+||+. |+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||+|+||+++. |.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 999997 578777765 457899999999999999999999999 999999999999985 89999999999766433
Q ss_pred C-CccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC----------------
Q 006528 159 T-ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---------------- 219 (641)
Q Consensus 159 ~-~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~---------------- 219 (641)
. .....+++.|+|||++. +.++.++|||||||++|||++|..||... +....+..+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT-NELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC-CHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 23456899999999664 34788999999999999999999999763 3333333222100
Q ss_pred CCC-----------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 220 KPA-----------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 220 ~~~-----------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
... .+....+..+++||.+||. +|.+||++.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000 0012346789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=323.32 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=198.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..+|..||+|.+..... ......+.+|+.+|+.++|+||+++++++... ...++|+
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~ 82 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTFVF 82 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--CeEEEEE
Confidence 678899999999999999999999999999876542 22234567899999999999999999988654 4689999
Q ss_pred ccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccCCCCC
Confidence 9996 677776654 456888999999999999999999999 99999999999997 5579999999998654322
Q ss_pred CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc--CCC--------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK-------------- 220 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~--g~~-------------- 220 (641)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......+....+.. +.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2233467899999998754 4788999999999999999999999865444333332211 000
Q ss_pred ---------CCcc-----ccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 221 ---------PASL-----AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 221 ---------~~~l-----~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+..+ ....++.+.+|+.+||. +|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 00124688999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=322.46 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=200.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCC---ceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK---KTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~---~~l 77 (641)
++...+|.|+||+||+|.+..+|..||+|.++.... .......+.+|+.+++.+ +||||+++++++..... ..+
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 578899999999999999999999999999876432 223345688899999999 56999999998865432 247
Q ss_pred EEEEccCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 78 NMITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+.+.+||+|||++
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccc
Confidence 899999985 898887642 35899999999999999999999999 9999999999999864789999999998
Q ss_pred hhccCC--CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-------
Q 006528 153 IAMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------- 221 (641)
Q Consensus 153 ~~~~~~--~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~------- 221 (641)
...... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......+..+....-..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 754322 1223357889999997753 47899999999999999999999998754444433222110000
Q ss_pred ------------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 222 ------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 222 ------------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
.......++.+.+||.+||. +|.+||++.++|.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00012246789999999999 899999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=323.88 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=203.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|+||+|.+..+|..||+|.++..... ......+.+|+.++++++||||+++++++.......+++||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4567899999999999999999999999999865432 23344677899999999999999999998877557899999
Q ss_pred ccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+|||++ +.|.+||+|||++......
T Consensus 86 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccCCcc
Confidence 9997 49999887654 5999999999999999999999999 99999999999998 5589999999998765443
Q ss_pred CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC-----------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----------------- 219 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~----------------- 219 (641)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||....... ...++....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhccchh
Confidence 2234567899999998754 36889999999999999999999998644332 222221100
Q ss_pred ------------CCCccccC-ChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 220 ------------KPASLAKV-NDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 220 ------------~~~~l~~~-~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
....++.. .++.+++||.+||. +|++|||+.|+|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00111222 36779999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=348.62 Aligned_cols=243 Identities=22% Similarity=0.294 Sum_probs=195.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|+||.||+|.+..++..||+|.... ..+.+|+++|++|+|||||++++++... ...++||
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~lv~ 239 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCLVL 239 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEEE
Confidence 678899999999999999999999999996432 2356899999999999999999988765 4588999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
|++. |+|..++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||+++......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceecccccc
Confidence 9995 6888888764 46999999999999999999999999 99999999999997 45799999999997654321
Q ss_pred ---CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCC-------CHHHHHHHHHcCCCC-Cc----
Q 006528 160 ---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-------NPAQIFKKVTSGIKP-AS---- 223 (641)
Q Consensus 160 ---~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~-------~~~~i~~~i~~g~~~-~~---- 223 (641)
.....||+.|||||++.+ .++.++|||||||++|||++|..|+.... ...++.+.+...... ..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 224579999999998764 58999999999999999999876653211 123444443332110 00
Q ss_pred -------------------------cc--cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 224 -------------------------LA--KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 224 -------------------------l~--~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
+. ...++.+++||.+||. ||.+|||+.|||+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 1234578999999999 9999999999999999974
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=314.68 Aligned_cols=250 Identities=25% Similarity=0.436 Sum_probs=208.1
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+... ..+++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~lv 77 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFIV 77 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEEE
Confidence 3678899999999999999999999999999877543 223456788999999999999999999987654 568999
Q ss_pred EccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+||+++++|.+++.... .+++..+..|+.||+.||.|||+++ ++|+||||+||+++.+...+||+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999999997643 4799999999999999999999999 9999999999999865446799999998766433
Q ss_pred C--CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 159 T--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 159 ~--~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
. .....|++.|+|||++. ..++.++|+||||+++++|++|..||... +.......+..+..+. .....+..++++
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP-ISPNFSRDLRSL 233 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCCC-CCCCCCHHHHHH
Confidence 2 23346899999999775 45889999999999999999999999764 3444444444443332 233446789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccc
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
|.+||. +|.+|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.16 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=204.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++...+|.|++|.||+|.+..+|..||||.++...... .......+..|+.+++.++|+||+++++++.+. ..+++|
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv 80 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--SNINLV 80 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--CEEEEE
Confidence 56778999999999999999999999999998665321 122345678899999999999999999998774 579999
Q ss_pred EccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 81 TELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||+++ |+|+||+|+|||++ ..|.+||+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccCCC
Confidence 9999 899999998766 7999999999999999999999999 99999999999998 4589999999999765433
Q ss_pred -CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-C-------------
Q 006528 159 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-P------------- 221 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~-~------------- 221 (641)
......+++.|+|||.+.+ .++.++|||||||++|+|++|.+||..... ...+.++..... +
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2223456889999997753 478999999999999999999877766433 233333221100 0
Q ss_pred ------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 222 ------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 222 ------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
.......+..+++||.+||. +|.+|||+.++|.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 00112235678999999999 899999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=311.68 Aligned_cols=246 Identities=25% Similarity=0.411 Sum_probs=208.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.++...+|.|+||.||++.+..+|..||+|.++... .....+.+.+|+.+++.++||||+++++++.+. ..++++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 76 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIV 76 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEE
Confidence 367899999999999999999999999999987543 234567888999999999999999999998765 569999
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+++|+|.+++... ..+++..++.|+.||+.||.|||+++ |+|+||||+||+++ ..+.++|+|||++......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeeccc
Confidence 9999999999998753 45899999999999999999999999 99999999999997 5579999999998765432
Q ss_pred --CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 159 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 159 --~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+. .+...+..+++|
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 231 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYKP-LPSHYSYELRSL 231 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCCC-CCcccCHHHHHH
Confidence 2234578999999998864 588999999999999999999999986 45555555665554332 344456789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCc
Q 006528 236 IEKCLV-PASERLSAKDLLKDP 256 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hp 256 (641)
|.+||. +|.+||++.+++.--
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhcc
Confidence 999999 899999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.42 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=205.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++++.+. ...++|+
T Consensus 18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 94 (307)
T cd06607 18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTAWLVM 94 (307)
T ss_pred hhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeEEEEH
Confidence 456789999999999999999999999999875432 2344556789999999999999999999998775 4588999
Q ss_pred ccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||+|+||+++ +.|.+||+|||++..... .
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~--~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVSP--A 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeecCcceecCC--C
Confidence 9997 577777654 456999999999999999999999999 99999999999997 557999999999865432 2
Q ss_pred ccccCCCCCCCccccc----ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 161 RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~----~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
....+++.|+|||++. +.++.++||||||+++|+|+||..||.... .......+.....+.......+..++++|
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence 3457889999999763 458899999999999999999999997643 33333334333333333334567899999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 237 EKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
.+||. +|.+||++.+++.||||....
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99998 899999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=309.23 Aligned_cols=249 Identities=27% Similarity=0.495 Sum_probs=213.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|+|++|.||+|.+..++..||+|++..... .......+.+|+++++.++|||++++++.+... ..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv 77 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIV 77 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEE
Confidence 3678899999999999999999999999999876543 235567789999999999999999999988766 578999
Q ss_pred EccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 81 TELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
+||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++ +.+.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeecc
Confidence 9999999999999864 67999999999999999999999999 99999999999998 55799999999997654
Q ss_pred CC--CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 157 QP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 157 ~~--~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.. ......|++.|+|||.+. ..++.++|+||||+++++|++|..||... +...+...+..... ..++...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (258)
T cd08215 155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQY-PPIPSQYSSELR 232 (258)
T ss_pred cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCCC-CCCCCCCCHHHH
Confidence 43 233457899999999765 45889999999999999999999999763 45666666655433 334446678899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 234 GFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
++|.+||. +|.+||++.++|.||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.02 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=201.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|++|+||+|.+..+|..||||++++... ......+.+|+.++++++||||+++++++.+.. .+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 76 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLV 76 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEE
Confidence 4688999999999999999999999999999986542 233456778999999999999999999988764 58899
Q ss_pred EccCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 81 TELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~---~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
|||+.+ +|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++ +.|.+||+|||++.....
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGI 152 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcC
Confidence 999985 898888754 35899999999999999999999999 99999999999997 557999999999975543
Q ss_pred C--CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC------------
Q 006528 158 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------ 221 (641)
Q Consensus 158 ~--~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~------------ 221 (641)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+................+
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 2 1233467899999997754 47889999999999999999999998754433322211110000
Q ss_pred --------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 222 --------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 222 --------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
..+....++.++++|.+||. +|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00111235788999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.90 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=197.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|+||+|.++.+|..||+|.+..... ......+.+|+.++++++||||+++++++... ...++||
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTLTLVF 82 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeEEEEE
Confidence 578899999999999999999999999999876432 12223467899999999999999999988654 5789999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++......
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccCCCCc
Confidence 99985 999988764 46899999999999999999999999 99999999999997 5579999999998654322
Q ss_pred CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC---C-------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---K------------- 220 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~---~------------- 220 (641)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.......+....+.... .
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1223356889999998753 488999999999999999999999976543333322221100 0
Q ss_pred ---------CCcc---ccCCh--HHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 221 ---------PASL---AKVND--PQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 221 ---------~~~l---~~~~~--~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+..+ ....+ ..+.++|.+||. +|.+|||+.++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 00112 678899999999 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=325.54 Aligned_cols=248 Identities=27% Similarity=0.534 Sum_probs=206.0
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
...+|.|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++.+... ...++||||
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~e~ 100 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVMEF 100 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEEeC
Confidence 356899999999999999999999999986533 34566789999999999999999999988765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 161 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~~ 161 (641)
+++++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++...... ...
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccCc
Confidence 999999998864 46899999999999999999999999 99999999999997 4579999999998655332 223
Q ss_pred cccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCChHHHHHHHHHh
Q 006528 162 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~-~l~~~~~~~l~~LI~kc 239 (641)
...|++.|+|||++.+ .++.++||||||+++|||++|..||.. ......+..+.....+. ......+..+++||.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 4578999999998764 588999999999999999999999976 34444444444432221 11223467899999999
Q ss_pred cC-CCCCCCCHHHHHcCccccccc
Q 006528 240 LV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
|. +|.+|||++++++||||....
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhccC
Confidence 98 899999999999999998554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.47 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=205.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..+|..||+|.++.... .......+.+|++++++++|+||+++++++... ..+++|+
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~ 79 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLYLVF 79 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEEEEE
Confidence 678899999999999999999999999999875432 234457889999999999999999999998774 5689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--- 158 (641)
||+.++.+..++.+...+++..++.++.||+.||.|||+++ ++||||+|+||+++ +.+.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCCccc
Confidence 99999888877777677999999999999999999999999 99999999999998 5689999999998765433
Q ss_pred CCccccCCCCCCCccccc-c-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-------------------
Q 006528 159 TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------------------- 217 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~-~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~------------------- 217 (641)
......+++.|+|||++. . .++.++||||||+++|+|++|..||........+......
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 223457889999999775 3 5789999999999999999999999865444333221110
Q ss_pred C--CCC--------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 218 G--IKP--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 218 g--~~~--------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+ ..+ ...+...++++++||.+||. +|.+||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 000 01122336789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.04 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=206.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|+||.||+|.+..+|..||+|.++.... ........+.+|+.+++.++||||+++++++.+. ..+++|+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 81 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNIVL 81 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEEEE
Confidence 577889999999999999999999999999876443 2345567789999999999999999999998765 4688999
Q ss_pred ccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 82 ELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 82 Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++ ..+.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccceeccc
Confidence 99999999998863 345899999999999999999999999 99999999999997 557999999999876543
Q ss_pred CC--CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCC-CHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 158 PT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 158 ~~--~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~-~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.. .....|++.|+|||.+. ..++.++|+||||+++|+|++|+.||.... +...+...+.....+.......+..++
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 22 23456889999999775 458899999999999999999999986432 345555666555444444445567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcC
Q 006528 234 GFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
++|.+||. +|.+||++.++++.
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999 89999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.87 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=204.5
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccC------ChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQ------LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~------~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
+...+|.|++|.||+|.+..+|..||+|.++...... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 82 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE--EY 82 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC--Cc
Confidence 4567999999999999999999999999987542211 112345788999999999999999999987654 56
Q ss_pred EEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 77 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ ..+.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeecccccccc
Confidence 8999999999999999998888999999999999999999999999 99999999999997 56899999999986543
Q ss_pred CC----CCccccCCCCCCCcccccc---cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC---CCCcccc
Q 006528 157 QP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAK 226 (641)
Q Consensus 157 ~~----~~~~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~---~~~~l~~ 226 (641)
.. ......|++.|+|||++.. .++.++|+||||+++|+|++|..||........+........ .+.....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 22 1223468899999998753 378999999999999999999999976444333333222211 1222223
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
..+..+++||.+||. +|.+||+++++|+||||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 446789999999999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.25 Aligned_cols=251 Identities=31% Similarity=0.482 Sum_probs=206.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC---CCCcceeeEEEEeCCCceEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVk~~~~~~~~~~~~l~ 78 (641)
+++..+|.|+||.||+|.+..+|..||+|.++... .......+.+|+.+++.++ ||||+++++++... ..++
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~~ 78 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRLW 78 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEEE
Confidence 45677999999999999999999999999987543 2345667889999999996 99999999988765 5689
Q ss_pred EEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++ ..|.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCCC
Confidence 99999999999999876 47999999999999999999999999 99999999999998 4689999999998765433
Q ss_pred C--CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 159 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 159 ~--~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
. .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||.... .......+.....+.......++++.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccCCCCCCCcccCCHHHHH
Confidence 2 234578999999997753 36889999999999999999999997643 333333332222222222235678999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 235 FIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
|+.+||. +|.+||++.++++||||+...
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 9999998 899999999999999996543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.38 Aligned_cols=251 Identities=27% Similarity=0.365 Sum_probs=200.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC----ceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~----~~l 77 (641)
+++..+|.|+||+||+|.+..+|..||+|.+.... ........+.+|+.++++++||||++++++|..... ..+
T Consensus 19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 67889999999999999999999999999886432 133445678899999999999999999998864432 357
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++||||+. ++|.+++... +++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++.....
T Consensus 97 ~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 97 YLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT 170 (353)
T ss_pred EEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccceeCCC
Confidence 89999996 5888887654 899999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC-CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC----------------
Q 006528 158 PT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---------------- 219 (641)
Q Consensus 158 ~~-~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~---------------- 219 (641)
.. .....+++.|+|||++. ..++.++|||||||++|+|++|+.||...... ..+..+....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 32 23456899999999775 46899999999999999999999999764322 2222221100
Q ss_pred ------C-----------CCc--------cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 220 ------K-----------PAS--------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 220 ------~-----------~~~--------l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
. +.. .....++.+++||.+||. ||.+|||+.|+|.||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 0 000 011235578999999999 89999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=337.32 Aligned_cols=245 Identities=21% Similarity=0.295 Sum_probs=200.1
Q ss_pred EEEEEeCccCceEEEEEEE-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~ 75 (641)
++...+|.|+||+||+|.+ ..++..||+|.++... .....+.+.+|+.+|+.+ +||||+++++++... .
T Consensus 38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--~ 112 (375)
T cd05104 38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTVG--G 112 (375)
T ss_pred ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--C
Confidence 5667899999999999974 4567799999987443 234456789999999999 899999999988665 4
Q ss_pred eEEEEEccCCCCCHHHHHHhCC----------------------------------------------------------
Q 006528 76 TVNMITELFTSGNLRQYRKKHK---------------------------------------------------------- 97 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~---------------------------------------------------------- 97 (641)
..++|||||++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 5889999999999999986421
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 98 -----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 98 -----------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
.+++..+..++.||+.||.|||+++ |+||||||+|||++ +.+.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccceeccCccc
Confidence 4778899999999999999999999 99999999999998 457999999999976543221
Q ss_pred ----ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 161 ----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 161 ----~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
....+++.|+|||++. ..++.++|||||||++|||++ |..||..........+.+..+..+. .+...+.++++
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 348 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECAPSEMYD 348 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCCCHHHHH
Confidence 1233456799999876 468999999999999999998 8899987555566666666654332 33455778999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcC
Q 006528 235 FIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~H 255 (641)
||.+||. +|.+||++.++++.
T Consensus 349 li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 349 IMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=316.20 Aligned_cols=244 Identities=17% Similarity=0.250 Sum_probs=200.4
Q ss_pred CEEEEEeCccCceEEEEEEEc---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 1 MRILISSRRIPAVDTYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
+++...+|.|+||.||+|.+. ..+..||+|.++... .......+.+|+.+|++++||||+++++++... ..+
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 81 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTM 81 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCc
Confidence 467888999999999999875 456789999987542 334556789999999999999999999988654 468
Q ss_pred EEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 78 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+|||++ .++.+||+|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCccccccc
Confidence 9999999999999999874 56899999999999999999999999 99999999999997 45799999999875432
Q ss_pred CCC---CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHH
Q 006528 157 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 231 (641)
Q Consensus 157 ~~~---~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~ 231 (641)
... .....+++.|+|||++. ..++.++|||||||++|||++ |+.||... ....+.+.+..+...+ .+...+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 236 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRLP-APRNCPNL 236 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCCC-CCCCCCHH
Confidence 211 11234567899999775 568999999999999999774 99999873 4555666666654332 34556778
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+.+++.+||. +|.+||++++|++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.24 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=200.9
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEEEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
.+..+|.|+||+||++.+..+|..||+|.+..... ......+.+|+.++.++. ||||+++++++... ...+++|
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~~ 82 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWICM 82 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEEE
Confidence 34568999999999999999999999999876542 245667899999999996 99999999988765 4578899
Q ss_pred ccCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 82 ELFTSGNLRQYRK-----KHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 82 Ey~~gGsL~~~l~-----~~~~l~e~~i~~i~~QIl~gL~yLHs~-gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
||+.. +|.++.. ....+++..+..++.|++.||+|||+. + ++||||||+||+++ ..+.+||+|||++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHHh
Confidence 99874 6555432 246799999999999999999999975 7 99999999999997 4579999999999765
Q ss_pred cCCC-CccccCCCCCCCcccccc----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc---cC
Q 006528 156 QQPT-ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA---KV 227 (641)
Q Consensus 156 ~~~~-~~~~~GTp~ymAPEvl~~----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~---~~ 227 (641)
.... .....|++.|+|||++.. .++.++||||||+++|+|++|+.||.......+....+..+..+.... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 4332 233468999999998764 488999999999999999999999987543333333333333222111 23
Q ss_pred ChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 228 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
.++++.+||.+||. +|.+|||++++++||||+...
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 56789999999999 899999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=341.95 Aligned_cols=238 Identities=22% Similarity=0.361 Sum_probs=199.6
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
+..||+|-||.||.|.... ...||+|.++.... ..+.+.+|+++|++|+|+|||++|+++..+. .++|||||
T Consensus 211 ~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~ 282 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEY 282 (468)
T ss_pred HHHhcCCccceEEEEEEcC-CCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEe
Confidence 4679999999999999853 23799999986532 2356789999999999999999999876553 69999999
Q ss_pred CCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 84 FTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 84 ~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
|+.|+|.+||+. +..++......++.||++|++||++++ +|||||-+.||||+ +++.+||+|||+|+......-.
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccCCCcee
Confidence 999999999997 567999999999999999999999999 99999999999997 5579999999999954433221
Q ss_pred c---ccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 162 S---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 162 ~---~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
. ..-...|.|||.+. +.++.++|||||||+|+||+| |+.||.+ ....+..+.+.+|..-+. +..+++++.+++
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp~-P~~CP~~vY~lM 437 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLPR-PEGCPDEVYELM 437 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCCC-CCCCCHHHHHHH
Confidence 1 12245799999776 679999999999999999998 7899988 456777788888865443 445678999999
Q ss_pred HHhcC-CCCCCCCHHHHHc
Q 006528 237 EKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~ 254 (641)
..||. +|.+|||.+.|..
T Consensus 438 ~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHhhCCcccCCCHHHHHH
Confidence 99999 8999999986653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.07 Aligned_cols=245 Identities=22% Similarity=0.288 Sum_probs=193.2
Q ss_pred CEEEEEeCccCceEEEEEEEc----------------CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcce
Q 006528 1 MRILISSRRIPAVDTYKAFDE----------------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 64 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~----------------~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk 64 (641)
.++...+|+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+|++++||||++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 367889999999999999863 245579999887542 3445667899999999999999999
Q ss_pred eeEEEEeCCCceEEEEEccCCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006528 65 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-------------------NVDIKVIKNWARQILHGLVYLHSHNPPI 125 (641)
Q Consensus 65 ~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~-------------------~l~e~~i~~i~~QIl~gL~yLHs~gp~I 125 (641)
+++++.+. ..+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i 159 (304)
T cd05096 84 LLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--F 159 (304)
T ss_pred EEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 99998766 45899999999999999986532 3677889999999999999999999 9
Q ss_pred EeeccCCCcEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh--c
Q 006528 126 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--F 198 (641)
Q Consensus 126 iHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt--G 198 (641)
+||||||+|||++ ..+.+||+|||++..+.... .....+++.|||||++. +.++.++||||||+++|+|++ +
T Consensus 160 vH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999998 55799999999997553322 12234578899999765 568999999999999999986 5
Q ss_pred cCCCCCCCCHHHHHHHHHc----CC--CCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 199 EYPYSECKNPAQIFKKVTS----GI--KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 199 ~~Pf~~~~~~~~i~~~i~~----g~--~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..||.... ..+....+.. .. .....+...+..+.+||.+||. +|.+|||+.+|.+
T Consensus 239 ~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 239 EQPYGELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 67887643 3333332221 10 1111223446789999999999 8999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=305.70 Aligned_cols=246 Identities=33% Similarity=0.545 Sum_probs=206.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|.||+|.+..+|..|++|++..... .....+.+|+.+++.++||||+++++++... ...++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~ 76 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVM 76 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence 567889999999999999999999999999876542 4567899999999999999999999988766 5688999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
||+++++|.+++... ..+++..+..++.||+.||.|||.++ ++||||+|+||+++ +.+.++|+|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeecccccccccccc
Confidence 999999999999876 67999999999999999999999998 99999999999998 45799999999987665433
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc-ccCChHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-AKVNDPQIKGFIE 237 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l-~~~~~~~l~~LI~ 237 (641)
.....++..|+|||.+.+ .++.++|+||||+++|+|++|..||........+..... ...+... ....+..+.+||.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHH
Confidence 345678999999998764 478899999999999999999999987543333333322 2222221 1222678999999
Q ss_pred HhcC-CCCCCCCHHHHHcCcc
Q 006528 238 KCLV-PASERLSAKDLLKDPF 257 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpf 257 (641)
+||. +|.+|||+.++|+|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 9999 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.29 Aligned_cols=254 Identities=31% Similarity=0.435 Sum_probs=200.3
Q ss_pred CEEEEEeCccCceEEEEEEEcC--CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEF--AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~--tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~ 78 (641)
++++..+|+|++|.||+|.+.. +|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.....++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4688999999999999999988 899999999886431 2233446678999999999999999999999877557899
Q ss_pred EEEccCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC---CCCcEEEeecc
Q 006528 79 MITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLG 150 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~---~~G~VKL~DFG 150 (641)
+||||+.+ +|.+++..+ ..+++..++.++.||+.||.|||+.+ |+||||||+||+++. ..|.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999975 777776532 36899999999999999999999999 999999999999974 15799999999
Q ss_pred hhhhccCCC-----CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHH--------HHHHHH
Q 006528 151 LAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPA--------QIFKKV 215 (641)
Q Consensus 151 lA~~~~~~~-----~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~--------~i~~~i 215 (641)
++....... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||....... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 987654322 234567899999997754 47899999999999999999999997532211 000000
Q ss_pred Hc------------------------CCCCCccc-----------cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 216 TS------------------------GIKPASLA-----------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 216 ~~------------------------g~~~~~l~-----------~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.. ........ ...+..+.++|.+||. +|.+|||+.+++.||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 00000000 1345678999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=318.04 Aligned_cols=248 Identities=27% Similarity=0.520 Sum_probs=208.5
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
...+|.|++|.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++|+||
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~e~ 97 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVMEF 97 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEEec
Confidence 468999999999999999999999999886543 23456688999999999999999999988765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 161 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~~ 161 (641)
+.+++|.+++.. .++++..+..++.||+.||.|||+++ |+||||+|+||+++ .+|.++|+|||++...... ...
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchhhccCCcccc
Confidence 999999999987 67999999999999999999999999 99999999999997 5579999999988654322 223
Q ss_pred cccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc-cccCChHHHHHHHHHh
Q 006528 162 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVNDPQIKGFIEKC 239 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~-l~~~~~~~l~~LI~kc 239 (641)
...|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. .++......+.....+.. .....+..+.+||.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 4578999999998764 589999999999999999999999976 445555666665532221 1222567899999999
Q ss_pred cC-CCCCCCCHHHHHcCccccccc
Q 006528 240 LV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
|. +|.+||++.++++||||....
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccChhhCcCHHHHccCcccccCC
Confidence 98 899999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.13 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=202.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|+||+|.+..+|..||+|.+..... .......+.+|++++++++||||+++++++.+. ..+++||
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 80 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLVF 80 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEEE
Confidence 578899999999999999999999999999876532 223345688999999999999999999998765 4689999
Q ss_pred ccCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 82 ELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~--l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
||+. ++|.+++..... +++..++.++.||+.||.|||+++ ++||||+|+||+++..++.+||+|||++......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9996 588888765443 588999999999999999999999 9999999999999866668999999999654322
Q ss_pred -CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-CCCC-------------
Q 006528 159 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP------------- 221 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-g~~~------------- 221 (641)
......+++.|+|||++.+ .++.++||||||+++|+|+||..||........+.+.+.. +...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 2233467899999997754 4789999999999999999999999764444443332211 0000
Q ss_pred ---------C---ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 222 ---------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 222 ---------~---~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
. ......++.+++||.+||. +|.+||++.+++.||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0 0112246789999999998 899999999999999997543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.67 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=198.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCC-----eEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG-----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~ 75 (641)
++...+|.|+||.||+|.+..+| ..||+|.++... .....+.+.+|+.+|+.+ +||||+++++++... .
T Consensus 41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--~ 115 (374)
T cd05106 41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTHG--G 115 (374)
T ss_pred eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--C
Confidence 57788999999999999965444 579999987543 234567789999999999 899999999988765 4
Q ss_pred eEEEEEccCCCCCHHHHHHhC-----------------------------------------------------------
Q 006528 76 TVNMITELFTSGNLRQYRKKH----------------------------------------------------------- 96 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~----------------------------------------------------------- 96 (641)
.+++||||+.+|+|.+++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 589999999999999998642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc----
Q 006528 97 -----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---- 161 (641)
Q Consensus 97 -----------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~---- 161 (641)
.++++..++.++.||+.||.|||+++ |+||||||+|||++ +.+.+||+|||+++........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcceeecc
Confidence 24788899999999999999999999 99999999999998 5579999999999765433221
Q ss_pred cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 162 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
...+++.|||||++. ..|+.++|||||||++|+|++ |..||............+..+.. ...+...+++++++|.+|
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ-MSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-ccCCCCCCHHHHHHHHHH
Confidence 223456899999775 569999999999999999997 99999875444444455544432 233445578999999999
Q ss_pred cC-CCCCCCCHHHHHc
Q 006528 240 LV-PASERLSAKDLLK 254 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~ 254 (641)
|. +|.+||++.++++
T Consensus 352 l~~dp~~RPs~~~l~~ 367 (374)
T cd05106 352 WNLEPTERPTFSQISQ 367 (374)
T ss_pred cCCChhhCcCHHHHHH
Confidence 99 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.31 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=197.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------Cc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK------KK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~------~~ 75 (641)
+++..+|.|+||+||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.... ..
T Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 578899999999999999999999999999875432 2223345678999999999999999999876543 24
Q ss_pred eEEEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 76 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
.+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++ ..+.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcEEECcCCCccc
Confidence 57999999974 888877654 36899999999999999999999999 99999999999997 557999999999975
Q ss_pred ccCCC------CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc---CCCCC-
Q 006528 155 MQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPA- 222 (641)
Q Consensus 155 ~~~~~------~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~---g~~~~- 222 (641)
..... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+.. ...+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-EQHQLTLISQLCGSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhh
Confidence 53321 123457889999997754 37889999999999999999999997633 2222111111 10000
Q ss_pred --------------------------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 223 --------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 223 --------------------------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
......++.+++||.+||. +|.+|||++++|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0111235678899999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=319.45 Aligned_cols=243 Identities=26% Similarity=0.456 Sum_probs=198.3
Q ss_pred EEEEEeCccCceEEEEEEEc----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 2 RILISSRRIPAVDTYKAFDE----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
.+...+|.|+||.||+|... ..+..|+||.++.. ......+.+.+|++.|++++||||+++++++.... .+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccc--cc
Confidence 57789999999999999988 56778999998542 24556789999999999999999999999998543 48
Q ss_pred EEEEccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 78 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
++|+||+++|+|.+++... ..++...+..|+.||+.||.|||+++ ++|++|+|+|||++. ++.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~-~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDS-NGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEET-TTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccc-ccccccccccccccc
Confidence 8999999999999999987 67999999999999999999999999 999999999999985 579999999999765
Q ss_pred cCCC----CccccCCCCCCCcccccc-cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 156 QQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 156 ~~~~----~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
.... .....+...|+|||.+.. .++.++||||||+++|||++ |+.||.+. +..++...+..+..+. .+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchh
Confidence 2211 123346778999998864 58999999999999999999 68999875 6677777776654433 445567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+.++|.+||. +|.+||++.+|++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 789999999998 8999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.97 Aligned_cols=250 Identities=27% Similarity=0.471 Sum_probs=209.2
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
++..+|.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 82 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWIIME 82 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEEe
Confidence 4567999999999999999999999999987543 245567899999999999999999999998765 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--C
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--A 160 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~--~ 160 (641)
|+.+|+|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceeccCCcccc
Confidence 9999999999875 46899999999999999999999999 99999999999998 55799999999986554322 2
Q ss_pred ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
....++..|+|||++.+ .++.++|+||||+++|+|+||..||... .+......+..+. +.......+..+.+||.+|
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhcCC-CCCCchhhhHHHHHHHHHH
Confidence 33467889999998754 5889999999999999999999999874 3444444443332 3334445577899999999
Q ss_pred cC-CCCCCCCHHHHHcCcccccccC
Q 006528 240 LV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
|. +|.+||++.++++||||.....
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 237 LNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred cccCcccCcCHHHHHhChHhhhcch
Confidence 98 8999999999999999975544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.58 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=206.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++|+
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~ 95 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVG--DELWVVM 95 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEEEEE
Confidence 57789999999999999999999999999986543 23356789999999999999999999998776 4589999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
||+.+|+|.+++.+. .+++..+..++.||+.||.|||+++ ++||||+|+||+++ ..+.+||+|||++...... .
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcceecccccccc
Confidence 999999999998764 5889999999999999999999999 99999999999997 5579999999988654322 2
Q ss_pred CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
.....|++.|+|||.+. ..++.++|+||||+++|+|++|+.||.......++......+..........+..+++||.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 23346889999999775 45889999999999999999999999764333332222222222222233346789999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccccccC
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
||. +|.+||++.+++.||||+..+.
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcCcc
Confidence 998 8999999999999999986653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=308.96 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=213.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|++|.||++.+..+|..+|+|.+..... .......+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIV 77 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEE
Confidence 3688899999999999999999999999999876543 234567788999999999999999999988765 568999
Q ss_pred EccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 81 TELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
+||+++++|.+++.+ ...+++..++.++.||+.||.|||+.| ++|+||+|+||+++. .+.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVA-NDLVKIGDLGISKVLK 154 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEec-CCcEEEeeccchhhhc
Confidence 999999999999876 356899999999999999999999999 999999999999984 5799999999997776
Q ss_pred CCCCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 157 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 157 ~~~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
........+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +...+...+..+..+. .....+.+++++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (256)
T cd08530 155 KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQNF 232 (256)
T ss_pred cCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHHHH
Confidence 554455678999999997754 5888999999999999999999999874 4555555665554433 333567889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccc
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
|.+||. +|.+||++.++++||++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 233 IRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHhcCCCC
Confidence 999998 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.37 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=202.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|++|.||+|.+..+|..||+|++..... .....+.+.+|+++++.++||||+++++++... ..+++|+
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 79 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRLYLVF 79 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeEEEEE
Confidence 678899999999999999999999999998765432 223456688999999999999999999988654 5689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
||+.+++|..+......+++..++.++.||+.||.|||+.+ ++||||+|+||+++ .++.++|+|||++...... .
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCccc
Confidence 99999999988877777999999999999999999999999 99999999999997 5579999999998765432 2
Q ss_pred CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-------------------C
Q 006528 160 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------------G 218 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-------------------g 218 (641)
.....+++.|+|||++.+ .++.++||||||+++|+|++|+.||............... +
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 234568899999998753 4788999999999999999999999764332222211110 0
Q ss_pred CCCC---------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 219 IKPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 219 ~~~~---------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.... ......+..+++|+.+||. +|.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 0011235679999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.31 Aligned_cols=235 Identities=22% Similarity=0.322 Sum_probs=192.1
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
+|.|+||+||++.++.+|..+|+|.+....... .|+.....+ +||||+++++++...+ .+++||||++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~--~~~iv~e~~~ 92 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLK--GHVLIMDYIK 92 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCC--eeEEEEEcCC
Confidence 599999999999999999999999987543211 122222222 7999999999987764 6999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccccC
Q 006528 86 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 165 (641)
Q Consensus 86 gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~~~G 165 (641)
+|+|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+||+++.+.+.++|+|||++...... ....+
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 168 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDG 168 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCC
Confidence 9999999998888999999999999999999999999 9999999999999865448999999998765432 23568
Q ss_pred CCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCH----HHHHHHHHcCCCCCccccCChHHHHHHHHHhc
Q 006528 166 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP----AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 166 Tp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~----~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL 240 (641)
++.|+|||++.+ .++.++||||||+++|+|++|..||...... ..+.... ..+.......++.+++||.+||
T Consensus 169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l 245 (267)
T PHA03390 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSML 245 (267)
T ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHHHHHHHHHHh
Confidence 999999998864 6899999999999999999999999753322 1121222 1222344467889999999999
Q ss_pred C-CCCCCCC-HHHHHcCcccc
Q 006528 241 V-PASERLS-AKDLLKDPFLQ 259 (641)
Q Consensus 241 ~-dP~~RpS-a~eLL~Hpff~ 259 (641)
+ +|.+||+ ++++|+||||+
T Consensus 246 ~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 246 KYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ccChhhCCchHHHHhcCCccc
Confidence 9 8999996 59999999996
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.07 Aligned_cols=248 Identities=27% Similarity=0.463 Sum_probs=205.9
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
+..+|.|+||.||+|.+..+|..||+|.+.... .....+.+.+|+.++++++||||+++++++... ..+++||||
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 83 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWIIMEY 83 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEEEEc
Confidence 345899999999999999999999999887543 234567899999999999999999999988765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Cc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 161 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~--~~ 161 (641)
+++++|.+++.. ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++ +.+.++|+|||++..+.... ..
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccCcchhhh
Confidence 999999999865 56899999999999999999999999 99999999999997 56899999999987654322 22
Q ss_pred cccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhc
Q 006528 162 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL 240 (641)
...|+..|+|||.+.+ .++.++|+||||+++|+|++|..||... .+......+..+.. ..+....+..+.+||.+||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSP-PTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCCC-CCCCcccCHHHHHHHHHHc
Confidence 3468899999998764 5889999999999999999999999763 33344334433332 2334445678999999999
Q ss_pred C-CCCCCCCHHHHHcCccccccc
Q 006528 241 V-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 241 ~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
. +|.+||++.++++||||..-.
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHHh
Confidence 9 899999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.36 Aligned_cols=247 Identities=30% Similarity=0.518 Sum_probs=205.6
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
..+|.|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..+++|+||+
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv~e~~ 100 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVLMEFL 100 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEEEecC
Confidence 468999999999999999999999999875432 2345688999999999999999999988765 4689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCcc
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARS 162 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~~~ 162 (641)
++++|..++.. ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++...... ....
T Consensus 101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhcccccccccc
Confidence 99999998765 56899999999999999999999999 99999999999997 5589999999998755432 2334
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CccccCChHHHHHHHHHhc
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~-~~l~~~~~~~l~~LI~kcL 240 (641)
..|++.|+|||++.+ .++.++|||||||++|+|++|+.||... .+......+.....+ .......+..+.+||.+||
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 678999999998764 5889999999999999999999999763 444444554443222 1222334678999999999
Q ss_pred C-CCCCCCCHHHHHcCccccccc
Q 006528 241 V-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 241 ~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
. +|.+||++.++++||||....
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCC
Confidence 9 899999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.28 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=201.5
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|+||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+. ...++|+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~ 77 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVF 77 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEE
Confidence 577899999999999999999999999999886542 223345678899999999999999999988655 5689999
Q ss_pred ccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006528 82 ELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~- 158 (641)
||+. ++|.+++.... .+++..+..++.||+.||.|||+++ ++||||+|+||+++. ++.++|+|||++......
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPV 153 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcC-CCcEEEeecccccccCCCc
Confidence 9995 69999998766 7999999999999999999999998 999999999999984 689999999998654322
Q ss_pred -CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC---------------
Q 006528 159 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--------------- 220 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--------------- 220 (641)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......+..+.......
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1223356889999997754 4788999999999999999999999764433333322211000
Q ss_pred -----------CCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 221 -----------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 221 -----------~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
........+..+.++|.+||. +|.+||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001112335689999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=323.35 Aligned_cols=244 Identities=23% Similarity=0.366 Sum_probs=200.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeE----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIE----VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~----VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
++++..+|+|+||+||+|.+..+|.. ||+|.++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~ 82 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 82 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---C
Confidence 46889999999999999998766664 8999876432 345567889999999999999999999988654 3
Q ss_pred EEEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 77 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
.++|++|+.+|+|.+++... ..++...+..++.||+.||+|||+++ |+||||||+|||++ +.+.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEccccccccc
Confidence 67899999999999999875 45889999999999999999999999 99999999999997 5579999999999765
Q ss_pred cCCCC----ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 156 QQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 156 ~~~~~----~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
..... ....+++.|+|||++. ..++.++||||||+++|||++ |..||.+ ....++...+..+.... .+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~ 237 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPICT 237 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-CCCCCC
Confidence 43221 1223467899999775 568999999999999999997 9999976 34455555555443332 234456
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
..+.++|.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 789999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=315.61 Aligned_cols=249 Identities=29% Similarity=0.486 Sum_probs=209.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++||||+++++++... ..+++||
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 81 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM 81 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEE
Confidence 56788999999999999999999999999876543 234556789999999999999999999998765 4689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
||+.+|+|..++.. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ +.|.++|+|||++..+... .
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhh
Confidence 99999999999875 46899999999999999999999999 99999999999997 5579999999998655432 2
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
.....++..|+|||.+.. .++.++|+||||+++|+|++|..||.. .........+..+. +..+....+..+.++|.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCC-CCCCCcccCHHHHHHHHH
Confidence 233568899999998754 578899999999999999999999976 34445555554433 233444567889999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccccc
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
||. +|.+||++.++++||||...
T Consensus 236 ~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 236 CLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HccCChhhCcCHHHHHhCHHHhhh
Confidence 998 89999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.36 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=211.9
Q ss_pred CEEEEEeCccCceEEEEEEEc---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~ 76 (641)
.++...+|.|+||.||+|.+. .+|..||+|.++...........+.+.+|+++|+++ +|+||+++++++... ..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~ 79 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--TK 79 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--Ce
Confidence 367889999999999999984 489999999998654333344567788999999999 699999999887654 56
Q ss_pred EEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 77 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
+++||||+++|+|.+++.....+++..+..++.||+.||.|||+.+ ++||||+|+|||++ .++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceecc
Confidence 8999999999999999998888999999999999999999999999 99999999999997 45899999999986553
Q ss_pred CC---CCccccCCCCCCCcccccc---cCCcccccccccchhhhhhhccCCCCCCC---CHHHHHHHHHcCCCCCccccC
Q 006528 157 QP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKV 227 (641)
Q Consensus 157 ~~---~~~~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~---~~~~i~~~i~~g~~~~~l~~~ 227 (641)
.. ......|++.|+|||.+.. .++.++||||||+++|+|++|..||.... ....+...+..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCcc
Confidence 32 2234568999999998753 47889999999999999999999996422 22333344433322 23445
Q ss_pred ChHHHHHHHHHhcC-CCCCCC-----CHHHHHcCcccccccCCC
Q 006528 228 NDPQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~Rp-----Sa~eLL~Hpff~~~~~~~ 265 (641)
.++.+.+|+.+||. +|.+|| ++.+++.||||+..++..
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 67889999999999 899997 899999999999877543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=308.76 Aligned_cols=240 Identities=23% Similarity=0.353 Sum_probs=205.0
Q ss_pred EeCccCceEEEEEEEcCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 6 SSRRIPAVDTYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
.+|.|+||.||+|.+... +..||+|.+..... ....+.+.+|+.+++.++|+||+++++++.. ...+++|||
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e 76 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLE 76 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEE
Confidence 589999999999999866 89999999876542 2256789999999999999999999998876 356999999
Q ss_pred cCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 83 LFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 83 y~~gGsL~~~l~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
|+++|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||+|+||+++. ++.+||+|||.+.
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~-~~~~~l~dfg~~~ 153 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGE-DLVVKISDFGLSR 153 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECC-CCcEEEccccccc
Confidence 99999999999875 77999999999999999999999999 999999999999984 4899999999997
Q ss_pred hccCC----CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 006528 154 AMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 227 (641)
Q Consensus 154 ~~~~~----~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~ 227 (641)
..... ......+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+... ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 231 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPEY 231 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCcc
Confidence 66542 2334567899999998764 68999999999999999999 59999874 566777777765433 33445
Q ss_pred ChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 228 NDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.++++.+++.+||. +|.+||++.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 57899999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=313.04 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=204.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++..+|.|++|.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.+.....+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 368899999999999999999999999999998654 223445668899999999999999999999876634679999
Q ss_pred EccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
+||+++ +|..++... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||+++ ++|.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCC
Confidence 999974 899988765 57999999999999999999999999 99999999999998 56899999999997665432
Q ss_pred ---CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC---CC----------
Q 006528 160 ---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KP---------- 221 (641)
Q Consensus 160 ---~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~---~~---------- 221 (641)
.....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||..... ......+.... .+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccch
Confidence 233456889999997653 478999999999999999999999987443 33333322110 00
Q ss_pred ----------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 222 ----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 222 ----------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
..+....++.+.++|.+||. +|.+||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00111226788999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.31 Aligned_cols=248 Identities=31% Similarity=0.493 Sum_probs=211.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|.||+|.+..+|..||+|.+..... .......+.+|++++++++||||+++++++... ..+++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 577899999999999999999999999999986653 235667899999999999999999999987665 5689999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~- 160 (641)
||+.+++|.+++.....+++..++.++.|++.||.|||+.| |+||||+|+||+++. .|.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTK-DGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECC-CCCEEEeccccceecCCCccc
Confidence 99999999999998888999999999999999999999999 999999999999984 68999999999976554332
Q ss_pred -ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 161 -RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 161 -~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
....+++.|+|||.+.+ .++.++|||+||+++|+|++|..||..........+. .... ...++...+..++++|.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-VQDD-HPPLPEGISPELKDFLMQ 233 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-hccC-CCCCCCCCCHHHHHHHHH
Confidence 34578999999997753 4788999999999999999999999864433333333 3222 223445567899999999
Q ss_pred hcC-CCCCCCCHHHHHcCccc
Q 006528 239 CLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff 258 (641)
||. +|.+||++.+++.||||
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 998 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=309.66 Aligned_cols=239 Identities=19% Similarity=0.313 Sum_probs=195.8
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|.|+||+||+|.+..+|..||+|.+.... ..+....+.+|+++|+.++||||+++++++... ..+++||||+.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~ 76 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQ 76 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeecc
Confidence 4899999999999999999999999876332 345567899999999999999999999987655 46899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc---
Q 006528 86 SGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--- 161 (641)
Q Consensus 86 gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~--- 161 (641)
+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.........
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCcccccccccccC
Confidence 99999999764 46899999999999999999999999 99999999999997 5579999999998654322111
Q ss_pred -cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 162 -SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 162 -~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
...++..|+|||.+. +.++.++||||||+++|+|++ |..||... ........+..+... ..+...+..+.+|+.+
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 231 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVRL-PCPELCPDAVYRLMER 231 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCcccCCHHHHHHHHH
Confidence 112345799999775 458999999999999999997 88898763 344444445443332 3344567889999999
Q ss_pred hcC-CCCCCCCHHHHHc
Q 006528 239 CLV-PASERLSAKDLLK 254 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~ 254 (641)
||. +|.+||++.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=342.29 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=220.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|+|.|++|.+|.+..+|.+||||.+.+... ....++++.+|+++|+.|+|||||++|.+.... ..+|+||
T Consensus 59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~~lylV~ 134 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--ATLYLVM 134 (596)
T ss_pred eeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--ceeEEEE
Confidence 578899999999999999999999999999987764 445667799999999999999999999977655 5699999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC-CCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTA 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~-~~~ 160 (641)
||+.+|.+++|+.+++++.+..++.++.|+++|++|||+++ |+|||||++|||++.+. .+||+|||++..+.. ...
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENM-NIKIADFGFSTFFDYGLML 211 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccccccc-ceeeeccccceeecccccc
Confidence 99999999999999999999999999999999999999999 99999999999998664 799999999987763 457
Q ss_pred ccccCCCCCCCccccccc-C-CcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 161 RSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~~-y-~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
.+++|+|.|.|||++.+. | ++.+|+||+|+++|-|+.|.+||.+ .+...+...+..+... ++...+.+.+++|.+
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk 288 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYMSCDCEDLLRK 288 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--ccceeechhHHHHHH
Confidence 789999999999999864 4 6889999999999999999999987 4455555555555443 233446689999999
Q ss_pred hcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
+|. +|.+|++.+++++|+|.......
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhhh
Confidence 999 89999999999999999755443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.85 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=196.9
Q ss_pred CccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCCC
Q 006528 8 RRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSG 87 (641)
Q Consensus 8 G~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gG 87 (641)
|.|+|++||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||++++++|... ..+++|+||+.+|
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e~~~~~ 84 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPFMAYG 84 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEecccCC
Confidence 444999999999999999999999876542 334567899999999999999999999998775 4589999999999
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--C---
Q 006528 88 NLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--A--- 160 (641)
Q Consensus 88 sL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~--~--- 160 (641)
+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+|++||+.+....... .
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCcccccc
Confidence 999999874 35899999999999999999999999 99999999999998 45799999998654322110 0
Q ss_pred ----ccccCCCCCCCcccccc---cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC-------------
Q 006528 161 ----RSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------------- 220 (641)
Q Consensus 161 ----~~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~------------- 220 (641)
....++..|+|||++.+ .++.++||||||+++|+|++|..||............+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 11234567999998764 3789999999999999999999999875544443333221100
Q ss_pred -------------------------------CCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 221 -------------------------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 221 -------------------------------~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
........++.+++||.+||. +|.+|||++++|+||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 000112235678999999998 999999999999999997544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=314.40 Aligned_cols=243 Identities=21% Similarity=0.324 Sum_probs=201.5
Q ss_pred EEEEEeCccCceEEEEEEEc-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 2 RILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
.++..+|.|+||.||+|.+. .++..||+|.++... ..+..+.+.+|+++|+.++||||+++++++... ..
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 82 (280)
T cd05049 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--DP 82 (280)
T ss_pred hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--CC
Confidence 35677999999999999874 446889999886543 233567899999999999999999999988766 46
Q ss_pred EEEEEccCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCC
Q 006528 77 VNMITELFTSGNLRQYRKKHK--------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 142 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~--------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G 142 (641)
+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG-YDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc-CCC
Confidence 899999999999999997642 4788999999999999999999999 99999999999997 458
Q ss_pred cEEEeecchhhhccCC----CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHH
Q 006528 143 EVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 216 (641)
Q Consensus 143 ~VKL~DFGlA~~~~~~----~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~ 216 (641)
.+||+|||++...... ......+++.|+|||++. ..++.++||||||+++|+|++ |..||... +.......+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~~ 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECIT 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHH
Confidence 9999999998654321 122345678999999876 468999999999999999998 99999874 4556666676
Q ss_pred cCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 217 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 217 ~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+..+. .+...+..+++||.+||. +|.+||++.|+++
T Consensus 239 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 665433 334567889999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.47 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=201.8
Q ss_pred CEEEEEeCccCceEEEEEEE----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFD----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
++++..+|+|+||+||+|.+ ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 81 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP 81 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence 47889999999999999985 3466789999987432 344556788999999999999999999987665 45
Q ss_pred EEEEEccCCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC
Q 006528 77 VNMITELFTSGNLRQYRKKH-----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~-----------------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~ 139 (641)
.++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~- 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG- 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-
Confidence 89999999999999998632 23788899999999999999999999 99999999999998
Q ss_pred CCCcEEEeecchhhhccCC----CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHH
Q 006528 140 NHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 213 (641)
Q Consensus 140 ~~G~VKL~DFGlA~~~~~~----~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~ 213 (641)
+.+.+||+|||+++..... ......++..|+|||.+. ..++.++||||||+++|||++ |..||.+ .....+..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIE 237 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 5579999999999765322 122344577899999775 458999999999999999998 8899976 34566666
Q ss_pred HHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 214 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 214 ~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.+.....+ ..+...++.++++|.+||. +|.+||++.+|+++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66655433 2445567899999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=314.36 Aligned_cols=250 Identities=33% Similarity=0.561 Sum_probs=208.4
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+...+|.|++|.||+|.+..++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++... ..+++|+|
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 95 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWVVME 95 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEEEEe
Confidence 34568999999999999999999999999876542 456788999999999999999999998876 56999999
Q ss_pred cCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 83 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 83 y~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
|+.+++|.+++..++ .++...+..++.||+.||.|||+.| ++|+||+|+||+++ ..|.++|+|||++...... .
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchhhhhccchhh
Confidence 999999999999876 8999999999999999999999999 99999999999998 5579999999998654432 2
Q ss_pred CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC-CCCCccccCChHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g-~~~~~l~~~~~~~l~~LI~ 237 (641)
.....+++.|+|||++.+ .++.++|+||||+++|+|++|..||... ++......+... ..+.......+..+++||.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 233467899999997764 5899999999999999999999999864 344443443332 2222222235678999999
Q ss_pred HhcC-CCCCCCCHHHHHcCcccccccC
Q 006528 238 KCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
+||. +|.+||++.++|.||||....+
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhccCc
Confidence 9999 8999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=320.38 Aligned_cols=246 Identities=23% Similarity=0.396 Sum_probs=198.4
Q ss_pred cCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCCCCH
Q 006528 10 IPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL 89 (641)
Q Consensus 10 GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL 89 (641)
|+++.||.+.+..+|..||+|+++.... .......+.+|+.+++.++||||++++++|... ...+++|||+++|+|
T Consensus 11 ~~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l 86 (314)
T cd08216 11 EDLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSC 86 (314)
T ss_pred cCCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCH
Confidence 4667788888888999999999986532 345677899999999999999999999998765 458999999999999
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC---------
Q 006528 90 RQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--------- 158 (641)
Q Consensus 90 ~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--------- 158 (641)
.+++... ..+++..++.+++||+.||.|||+++ |+||||||+||+++ ..|.+||+|||.+......
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeecccccccccccc
Confidence 9999864 45899999999999999999999999 99999999999998 5589999999988544211
Q ss_pred CCccccCCCCCCCcccccc---cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC---------------
Q 006528 159 TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--------------- 220 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--------------- 220 (641)
......+++.|+|||++.. .|+.++|||||||++|+|++|..||...........++.....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1123457788999998764 4889999999999999999999999875544444444322110
Q ss_pred ----------------CCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 221 ----------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 221 ----------------~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
........+.++.+||.+||. +|.+|||++++|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000111124578899999999 999999999999999997544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.09 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=202.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++...+|+|++|+||+|.+..++..||+|.+.... .....+.+|+.+|+.++||||+++++++... ..+++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 80 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEE
Confidence 357789999999999999999999999999876432 2356788999999999999999999987655 458899
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+|||++ +++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccccc
Confidence 9999999999999764 35899999999999999999999999 99999999999997 5679999999999765433
Q ss_pred CCc---cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 TAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ~~~---~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
... ...+++.|+|||.+. ..++.++||||||+++|||++ |..||.. .+.......+..+..+ ..+...++++.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVY 235 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence 211 123456899999776 458899999999999999998 8999976 4566666777665433 33455678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
++|.+||. +|.+||++.++++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 99999999 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.89 Aligned_cols=239 Identities=21% Similarity=0.300 Sum_probs=199.8
Q ss_pred EeCccCceEEEEEEE--cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 6 SSRRIPAVDTYKAFD--EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 6 ~lG~GafgtVYkA~d--~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
.+|+|+||+||+|.+ ..++..||+|.++... ......+.+..|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 589999999999965 5678899999886543 234556789999999999999999999997643 347899999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC---
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--- 160 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~--- 160 (641)
+.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||.||+++ +.+.+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999999 99999999999998 457999999999976543221
Q ss_pred --ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 161 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 161 --~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
....+++.|+|||.+. ..++.++||||||+++|||++ |..||.. .+...+...+..+..+. .+...++.++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERME-CPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHHH
Confidence 1223467899999876 458889999999999999998 9999976 45667777777664433 4455678999999
Q ss_pred HHhcC-CCCCCCCHHHHHc
Q 006528 237 EKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~ 254 (641)
.+||+ +|.+||++.+|.+
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99999 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=325.70 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=203.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC---ceEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVN 78 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~---~~l~ 78 (641)
+++..+|.|+||+||+|.+..+|..||||.+..... .......+.+|+.+|+.++||||+++++++..... ..++
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred eEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 678899999999999999999999999999875321 22334567889999999999999999998765432 3579
Q ss_pred EEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccccCCC
Confidence 9999996 699999988888999999999999999999999999 99999999999997 4579999999999765432
Q ss_pred --CCccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc---C-------------
Q 006528 159 --TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---G------------- 218 (641)
Q Consensus 159 --~~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~---g------------- 218 (641)
......++..|+|||++. ..++.++||||||+++|+|++|+.||.+... ......+.. .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhcCchh
Confidence 223456889999999775 3588999999999999999999999975321 111111100 0
Q ss_pred -----------CCC--CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 219 -----------IKP--ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 219 -----------~~~--~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
..+ .......++.+++||.+||. +|.+|||++++|+||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 01112346789999999999 89999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.61 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=201.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC------
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK------ 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~------ 74 (641)
+++...+|.|+||+||+|.+..+|..||+|.+..... .....+.+|+.+|+.++||||+++++++.....
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 3678899999999999999999999999999876542 345678899999999999999999987654321
Q ss_pred ------ceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEee
Q 006528 75 ------KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 148 (641)
Q Consensus 75 ------~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~D 148 (641)
..+++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++..++.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 599988864 46899999999999999999999999 999999999999986667899999
Q ss_pred cchhhhccCCC-----CccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC--
Q 006528 149 LGLAIAMQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-- 219 (641)
Q Consensus 149 FGlA~~~~~~~-----~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~-- 219 (641)
||++..+.... .....+++.|+|||++. ..++.++|||||||++|+|++|+.||..... ......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE-LEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCC
Confidence 99987553221 12236788999999764 3588899999999999999999999976433 22222221110
Q ss_pred ----------------------CC----CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 220 ----------------------KP----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 220 ----------------------~~----~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
.+ .......+.++++||.+||. +|.+|||+.++|.||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 00112346789999999999 8999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.14 Aligned_cols=248 Identities=18% Similarity=0.272 Sum_probs=202.2
Q ss_pred CEEEEEeCccCceEEEEEEEcC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC---
Q 006528 1 MRILISSRRIPAVDTYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~--- 74 (641)
+++...+|+|+||+||+|.+.. ++..||+|.++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 3577889999999999999765 447899999876432 34456789999999999999999999998765432
Q ss_pred -ceEEEEEccCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEe
Q 006528 75 -KTVNMITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 147 (641)
Q Consensus 75 -~~l~lV~Ey~~gGsL~~~l~~~------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~ 147 (641)
...++|+||+.+|+|..++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ +.+.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEEC
Confidence 3478999999999999998542 35899999999999999999999999 99999999999997 45799999
Q ss_pred ecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 006528 148 DLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 221 (641)
Q Consensus 148 DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~ 221 (641)
|||+++...... .....+++.|+|||.+. ..++.++||||||+++|||++ |..||.+ ....++++.+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRL 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 999997654321 11223467899999876 458999999999999999999 8899976 3455666666665433
Q ss_pred CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 222 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 222 ~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
..+...++.+.++|.+||. +|.+||++.+++++
T Consensus 235 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3345567899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.51 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=206.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|.||+|.+..+|..||+|.++.... ......+.+.+|+.++++++|+||+++++++... ...++||
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 81 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNIVL 81 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEEEE
Confidence 567889999999999999999999999999876543 2334567899999999999999999999998765 4689999
Q ss_pred ccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 82 ELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
||+++|+|..++... ..+++..++.|+.||+.||.|||++| |+||||+|+||+++ ..|.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeeeccC
Confidence 999999999998642 45899999999999999999999999 99999999999997 557999999999865543
Q ss_pred C--CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCC-CCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 158 P--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC-KNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 158 ~--~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~-~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
. ......+++.|+|||.+. ..++.++||||||+++|+|++|..||... .+.......+..+..+.......+..++
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 2 223457899999999775 45899999999999999999999999643 2344555555555444433335567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
++|.+||. +|.+||++.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 99999999 8999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.72 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=204.6
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
+..+|.|+||+||+|.+..+|..||+|.+..... ........+.+|+.+++.++||||+++++++.+. ...|+||||
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 102 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVMEY 102 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEEec
Confidence 4579999999999999999999999999876543 2334556788999999999999999999998776 468999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006528 84 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 162 (641)
Q Consensus 84 ~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~ 162 (641)
+. |+|.+++.. ...+++..+..++.||+.||.|||++| ++||||+|+||+++ ..+.+||+|||++.... ....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg~~~~~~--~~~~ 176 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--PANS 176 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecCCCcccC--CCCC
Confidence 96 577777765 456899999999999999999999999 99999999999997 55799999999885432 2234
Q ss_pred ccCCCCCCCccccc----ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 163 VIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 163 ~~GTp~ymAPEvl~----~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
..|++.|+|||++. +.++.++||||||+++|+|++|..||.......... .+.....+.......+..+++||.+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCccccCHHHHHHHHH
Confidence 57899999999873 458889999999999999999999998754333333 3333333333334456679999999
Q ss_pred hcC-CCCCCCCHHHHHcCccccccc
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
||. +|.+||++.++++||||....
T Consensus 256 ~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 256 CLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HccCChhhCcCHHHHhcCcccCCCc
Confidence 998 899999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=326.49 Aligned_cols=247 Identities=21% Similarity=0.325 Sum_probs=199.7
Q ss_pred CEEEEEeCccCceEEEEEEEc-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCC
Q 006528 1 MRILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~ 74 (641)
++++..+|.|+||.||+|.+. .+++.||+|+++... .......+.+|+.+++++ +||||+++++++....
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~- 84 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG- 84 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-
Confidence 367889999999999999743 456789999887432 234456788999999999 8999999999876543
Q ss_pred ceEEEEEccCCCCCHHHHHHhC----------------------------------------------------------
Q 006528 75 KTVNMITELFTSGNLRQYRKKH---------------------------------------------------------- 96 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~---------------------------------------------------------- 96 (641)
..+++++||+++|+|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5688999999999999998642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCC
Q 006528 97 ---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEF 169 (641)
Q Consensus 97 ---~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~y 169 (641)
..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++..+.... .....+++.|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 25789999999999999999999999 999999999999984 5799999999997653221 1234557789
Q ss_pred CCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCC
Q 006528 170 MAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASER 246 (641)
Q Consensus 170 mAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~R 246 (641)
+|||++. ..++.++|||||||++|||++ |..||.+..........+..+..+ ..+...++++.+++.+||+ +|.+|
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~R 320 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDR 320 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCChhhC
Confidence 9999765 569999999999999999998 999997644334444444444332 3344567889999999999 89999
Q ss_pred CCHHHHHcC
Q 006528 247 LSAKDLLKD 255 (641)
Q Consensus 247 pSa~eLL~H 255 (641)
|++.+|++|
T Consensus 321 Ps~~ell~~ 329 (337)
T cd05054 321 PTFSELVEI 329 (337)
T ss_pred cCHHHHHHH
Confidence 999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=312.56 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=208.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+...+|+|++|.||+|.+..+|..||+|.+...... .......+.+|+.++++++ ||||+++++++... ..+++|
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~lv 80 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLYFV 80 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEEEE
Confidence 5678899999999999999999999999998764432 2344577889999999998 99999999987654 568999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
|||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCccc
Confidence 999999999999999888999999999999999999999999 99999999999997 56899999999986553321
Q ss_pred ---------------------CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc
Q 006528 160 ---------------------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 217 (641)
Q Consensus 160 ---------------------~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~ 217 (641)
.....+++.|+|||++. ..++.++||||||+++++|++|+.||.... ....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~ 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKILK 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHh
Confidence 12346789999999775 458889999999999999999999998743 3444444443
Q ss_pred CCCCCccccCChHHHHHHHHHhcC-CCCCCCCH----HHHHcCccc
Q 006528 218 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSA----KDLLKDPFL 258 (641)
Q Consensus 218 g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa----~eLL~Hpff 258 (641)
... .++...++.+.+||.+||. +|.+||++ ++||+||||
T Consensus 237 ~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 LEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 222 2334447889999999998 89999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.33 Aligned_cols=247 Identities=19% Similarity=0.272 Sum_probs=201.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCe--EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----Cc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGI--EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~--~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~----~~ 75 (641)
.+...+|+|+||.||+|.+..++. .||+|.++... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 456789999999999999987775 69999887543 23456778899999999999999999999775432 23
Q ss_pred eEEEEEccCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeec
Q 006528 76 TVNMITELFTSGNLRQYRKK------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 149 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~------~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DF 149 (641)
..++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCC
Confidence 46899999999999998753 234889999999999999999999998 99999999999997 5579999999
Q ss_pred chhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006528 150 GLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 223 (641)
Q Consensus 150 GlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~ 223 (641)
|++..+.... .....+++.|+|||.+. ..++.++||||||+++|+|++ |+.||.. ....+++..+..+..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCCC
Confidence 9997654321 12234677899999876 458999999999999999999 7899976 455677777776544322
Q ss_pred cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 224 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 224 l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
....+..++++|.+||. +|.+|||+.+|+++
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 236 -PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 23456789999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.08 Aligned_cols=246 Identities=18% Similarity=0.319 Sum_probs=200.4
Q ss_pred CEEEEEeCccCceEEEEEEEcC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
++++..+|+|++|.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 82 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--L 82 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence 4678899999999999999987 78899999876432 234456789999999999999999999987665 4
Q ss_pred eEEEEEccCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC--CCcEEE
Q 006528 76 TVNMITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKI 146 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~-------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~--~G~VKL 146 (641)
..++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++.+ ...+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEe
Confidence 5789999999999999997653 4899999999999999999999999 9999999999999743 236999
Q ss_pred eecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC
Q 006528 147 GDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 220 (641)
Q Consensus 147 ~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~ 220 (641)
+|||+++...... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||... ....+...+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~ 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGGR 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCc
Confidence 9999997653221 11223356899999875 569999999999999999997 99999873 44555566655433
Q ss_pred CCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 221 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 221 ~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
. ..+...++.+.+|+.+||. +|.+||++.++++|
T Consensus 240 ~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2 2344456789999999999 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.38 Aligned_cols=252 Identities=20% Similarity=0.315 Sum_probs=202.0
Q ss_pred CEEEEEeCccCceEEEEEEEc-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
++++..+|+|+||.||+|.++ ..+..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 82 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--Q 82 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--C
Confidence 367899999999999999765 245689999876432 233455688999999999999999999987655 4
Q ss_pred eEEEEEccCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEE
Q 006528 76 TVNMITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~----------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VK 145 (641)
..++||||+.+|+|.+++... ..++...+..++.||+.||.|||+++ |+||||||+||+++ .++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCCcEE
Confidence 589999999999999999753 23466788999999999999999999 99999999999998 457999
Q ss_pred EeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCC
Q 006528 146 IGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 219 (641)
Q Consensus 146 L~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~ 219 (641)
|+|||+++...... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.. ....+..+.+..+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~ 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGG 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCC
Confidence 99999987543221 12234567899999775 468999999999999999998 7889976 44555666665543
Q ss_pred CCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc------Cccccccc
Q 006528 220 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK------DPFLQVEN 262 (641)
Q Consensus 220 ~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~------Hpff~~~~ 262 (641)
.+. .+...++.++++|.+||. +|.+||++.++++ ||||....
T Consensus 239 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 239 YLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 322 233446789999999999 8999999999987 89887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.67 Aligned_cols=241 Identities=19% Similarity=0.349 Sum_probs=198.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||.||+|..+ .+..||+|.+..... ....+.+|+.+|+.++||||+++++++... ..+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv 77 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIV 77 (256)
T ss_pred cEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEE
Confidence 467889999999999999875 456799998764332 235688899999999999999999987654 468999
Q ss_pred EccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCCc
Confidence 9999999999999753 46899999999999999999999999 99999999999998 45799999999987553222
Q ss_pred C---ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 A---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 ~---~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
. ....++..|+|||++. ..++.++||||||+++|+|++ |+.||.. .+..+....+..+..+ ..+...+..+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTVYE 232 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHH
Confidence 1 1223456899999876 468999999999999999999 8999976 4456666777665433 234455778999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 006528 235 FIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~ 254 (641)
++.+||. +|.+||++.++++
T Consensus 233 li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 9999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=316.35 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=196.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC------Cc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK------KK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~------~~ 75 (641)
+++..+|.|++|.||+|.+..+|..||+|++...... ......+.+|+++++.++||||+++++++.+.. ..
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 6788999999999999999999999999998765421 122345678999999999999999999876543 23
Q ss_pred eEEEEEccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 76 TVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
.+++|+||+.+ +|..++.. ...+++..++.++.||++||.|||++| |+||||||+|||++ +.|.+||+|||++..
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~ 164 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARP 164 (311)
T ss_pred eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcCccchh
Confidence 67999999975 67666654 457999999999999999999999999 99999999999997 558999999999975
Q ss_pred ccCCC-------------CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC-
Q 006528 155 MQQPT-------------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG- 218 (641)
Q Consensus 155 ~~~~~-------------~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g- 218 (641)
..... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.+... ......+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHh
Confidence 43221 112356889999997753 488999999999999999999999976433 2222222110
Q ss_pred --CCC----------------------Ccc---ccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 219 --IKP----------------------ASL---AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 219 --~~~----------------------~~l---~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
..+ ..+ .....+.+.+||.+||. +|.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 000 01123578899999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.83 Aligned_cols=247 Identities=29% Similarity=0.466 Sum_probs=204.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|+|++|.||+|.+..+|..||+|.+...+. ........+.+|+.+++.++||||+++++++... ..++++|
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~ 81 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNIVL 81 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEEEE
Confidence 355679999999999999999999999998876542 2334557889999999999999999999998765 4688999
Q ss_pred ccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 82 ELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 82 Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ ..+.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhcccc
Confidence 99999999999874 356899999999999999999999999 99999999999998 457999999999876543
Q ss_pred CC--CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCC-CHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 158 PT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 158 ~~--~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~-~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.. .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||.... ......+.+.....+.......++.++
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 22 23457899999999875 458889999999999999999999997532 233445555554444444455678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+||.+||. +|.+|||+.++++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 99999998 8999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=323.80 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=204.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeC--CCceEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKKTVNM 79 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~--~~~~l~l 79 (641)
++...+|.|++|.||+|.+..+|..||+|++..... .......+.+|+.+|++++||||+++++++... ....+++
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 567789999999999999999999999999875432 223456788999999999999999999987543 2356899
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|+||+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.......
T Consensus 86 v~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 86 VMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceeecccC
Confidence 999996 699999988788999999999999999999999999 99999999999998 56899999999986543221
Q ss_pred ------CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc--CC----------
Q 006528 160 ------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GI---------- 219 (641)
Q Consensus 160 ------~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~--g~---------- 219 (641)
.....|++.|+|||.+.. .++.++||||||+++|+|++|+.||.......++ ..+.. +.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-KLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-HHHHHHhCCChhHhhhhhc
Confidence 123478999999998753 4889999999999999999999999764322221 11110 00
Q ss_pred --------------CCC---ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccC
Q 006528 220 --------------KPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 220 --------------~~~---~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
.+. ......++.+++||.+||. +|.+||++.+++.||||.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 000 0112346789999999999 8999999999999999985443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.87 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=198.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC---CceEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVN 78 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~---~~~l~ 78 (641)
++...+|.|++|+||+|.+..+|..||+|++.... ......++.+|+.+|+.++||||+++++++.... ...++
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 57889999999999999999999999999986432 2334567889999999999999999999875442 23579
Q ss_pred EEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+|+||+. ++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccceeecccc
Confidence 9999997 488887754 56999999999999999999999999 99999999999997 5579999999998654322
Q ss_pred C-----CccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHH---------------
Q 006528 159 T-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--------------- 216 (641)
Q Consensus 159 ~-----~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~--------------- 216 (641)
. .....|++.|+|||.+. ..++.++||||||+++|+|++|+.||.+...... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhh
Confidence 1 12357899999999764 3588999999999999999999999976332211 11110
Q ss_pred cC--------C-C--CC---ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 217 SG--------I-K--PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 217 ~g--------~-~--~~---~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.. . . .. ......++++.+||.+||. +|.+||++.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 0 0 00 0011235679999999999 89999999999999999744
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.37 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=201.3
Q ss_pred CEEEEEeCccCceEEEEEEE-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
+++...+|.|+||+||++.+ ..++..||+|.+... .......+.+|+.++++++||||+++++++... .
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--D 80 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 35778899999999999986 345678999987643 234566799999999999999999999988765 4
Q ss_pred eEEEEEccCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCC
Q 006528 76 TVNMITELFTSGNLRQYRKKHK-------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 142 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~-------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G 142 (641)
.+++|+||+.+|+|.+++...+ .+++..++.++.||+.||+|||+++ ++||||||+|||++ +.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCC
Confidence 6899999999999999997653 3899999999999999999999999 99999999999997 557
Q ss_pred cEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHH
Q 006528 143 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 216 (641)
Q Consensus 143 ~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~ 216 (641)
.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||... ........+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH
Confidence 99999999997553221 22334577899999876 458999999999999999998 89999763 4556667777
Q ss_pred cCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 217 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 217 ~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+..+. .....++++.+|+.+||. +|.+|||+.+++.
T Consensus 237 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 665432 344567899999999999 8999999999955
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.18 Aligned_cols=243 Identities=21% Similarity=0.329 Sum_probs=199.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
++++..+|.|+||+||+|.+..+|. .||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~ 82 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---T 82 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---C
Confidence 4678899999999999999887777 47989886543 345567789999999999999999999987643 3
Q ss_pred EEEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 77 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
.+++++|+++|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ +.+.+||+|||+++..
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCceeec
Confidence 67899999999999999764 56999999999999999999999999 99999999999997 5579999999999765
Q ss_pred cCCCC----ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 156 QQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 156 ~~~~~----~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
..... ....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+. .+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~ 237 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPPICT 237 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCccCC
Confidence 43221 1123467899999765 568999999999999999998 8999876 34555556565554332 234467
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+.+.++|.+||. +|.+||++.+++.
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 789999999999 8999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.04 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=199.3
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCCh----------hhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLP----------GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~----------~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~ 74 (641)
..+|.|+||+||+|.+..+|..||+|.++........ .....+.+|+.++++++||||+++++++...
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 92 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG-- 92 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC--
Confidence 4599999999999999999999999998765432111 0112477999999999999999999988765
Q ss_pred ceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
..+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++ |+||||+|+||+++ ..|.+||+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARR 168 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCCEEECCccceee
Confidence 46899999997 699999988888999999999999999999999999 99999999999997 557999999999865
Q ss_pred ccCC----------------CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHH
Q 006528 155 MQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 216 (641)
Q Consensus 155 ~~~~----------------~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~ 216 (641)
.... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... ..+..+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~~~~i~ 247 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-DQLGRIF 247 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 4411 1122356889999998754 3789999999999999999999999864433 3222221
Q ss_pred cC---CCCC-----------------------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 217 SG---IKPA-----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 217 ~g---~~~~-----------------------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.. .... ......+..+.+||.+||. +|.+||+++++|.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 10 0000 0012235678999999999 89999999999999999854
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.65 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=207.6
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 86 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~g 86 (641)
+|.|++|.||++.+..+|..||+|.+..... ........+..|+.++++++||||+++++.+... ..+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEecCCC
Confidence 6899999999999999999999999876543 2334567899999999999999999999987654 569999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCcccc
Q 006528 87 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 164 (641)
Q Consensus 87 GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~~~~~ 164 (641)
++|.+++.....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 999999998888999999999999999999999999 99999999999997 5579999999998765432 234557
Q ss_pred CCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-C
Q 006528 165 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-P 242 (641)
Q Consensus 165 GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-d 242 (641)
++..|+|||...+ .++.++|+||||+++|+|++|..||... ........+.... ..++...+..+.+||.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCC
Confidence 8899999997764 4788999999999999999999999763 4455566665532 23445557889999999998 8
Q ss_pred CCCCCCH---HHHHcCccc
Q 006528 243 ASERLSA---KDLLKDPFL 258 (641)
Q Consensus 243 P~~RpSa---~eLL~Hpff 258 (641)
|.+||++ ++++.||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=307.71 Aligned_cols=244 Identities=20% Similarity=0.340 Sum_probs=200.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCC-----CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFDEFA-----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~t-----G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
++++..+|.|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++... .
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 82 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--Q 82 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--C
Confidence 46788999999999999998654 4889999876432 234456788999999999999999999988665 5
Q ss_pred eEEEEEccCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEE
Q 006528 76 TVNMITELFTSGNLRQYRKKHK----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~----------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VK 145 (641)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ..|.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCCCEE
Confidence 6889999999999999997532 3678899999999999999999999 99999999999998 558999
Q ss_pred EeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCC
Q 006528 146 IGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 219 (641)
Q Consensus 146 L~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~ 219 (641)
|+|||+++.+.... .....+++.|+|||.+. +.++.++||||||+++|||++ |..||.. .+..+..+.+..+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCC
Confidence 99999987654321 22345678999999775 568999999999999999998 8999976 45666666666543
Q ss_pred CCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 220 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 220 ~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+ ..+...+..+.++|.+||. +|.+|||+.+|+.
T Consensus 239 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 HL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 32 3344457899999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.71 Aligned_cols=245 Identities=21% Similarity=0.322 Sum_probs=197.5
Q ss_pred CEEEEEeCccCceEEEEEEEc-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
+++...+|+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~ 82 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--Q 82 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--C
Confidence 367889999999999999875 346789999875432 233456788999999999999999999987544 4
Q ss_pred eEEEEEccCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEE
Q 006528 76 TVNMITELFTSGNLRQYRKKHK----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~----------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VK 145 (641)
..++||||+++|+|.+++.... .++...+..++.||+.||.|||+.+ ++||||||+||+++ ..+.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CCCCEE
Confidence 6889999999999999997532 3577889999999999999999998 99999999999998 457999
Q ss_pred EeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCC
Q 006528 146 IGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 219 (641)
Q Consensus 146 L~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~ 219 (641)
|+|||++....... .....+++.|||||++. +.++.++||||||+++|||++ |..||.+ .+.....+.+..+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFVMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCC
Confidence 99999986543221 11234577899999876 458999999999999999999 6889876 44555555555543
Q ss_pred CCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 220 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 220 ~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 239 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32 2344456789999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=305.69 Aligned_cols=241 Identities=22% Similarity=0.393 Sum_probs=198.7
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|++|+||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+. ...+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYII 79 (261)
T ss_pred eEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEEE
Confidence 478999999999999999974 56779999876432 2356789999999999999999999987654 458999
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++ ..+.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecCCC
Confidence 9999999999999763 56889999999999999999999998 99999999999998 5579999999999765432
Q ss_pred C---CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ~---~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
. .....++..|+|||.+. +.++.++||||||+++|+|+| |..||.. .........+..+...+. ....+.++.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMPR-MENCPDELY 234 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCCC-CCCCCHHHH
Confidence 2 12234567899999776 458889999999999999998 9999976 345556666665543332 334567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
++|.+||. +|.+||+++++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 99999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.59 Aligned_cols=267 Identities=22% Similarity=0.358 Sum_probs=237.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|-|+||.|=++.-......+|.|.+++..... ..+.+.+..|-++|..++.|.||++|..|.+. .++||.|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--kyvYmLm 499 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--KYVYMLM 499 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--hhhhhhH
Confidence 46778999999999888766555568999888776543 46678899999999999999999999988765 6799999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC-CCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTA 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~-~~~ 160 (641)
|-|-||.|+..++..+.|++.+.+.++..++.|++|||++| ||+|||||+|++++ +.|.+||.|||+|+.+.. ...
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCce
Confidence 99999999999999999999999999999999999999999 99999999999997 668999999999988764 456
Q ss_pred ccccCCCCCCCcc-cccccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 161 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPE-vl~~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.++||||+|.||| +++.+.+.++|.||||+++|||+||.+||++ .++...|..|.+|+....+++.....+.+||+++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence 7899999999999 5567899999999999999999999999998 6899999999999998889999999999999998
Q ss_pred cC-CCCCCCC-----HHHHHcCcccccccCCCCcCCCCCCcc
Q 006528 240 LV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPI 275 (641)
Q Consensus 240 L~-dP~~RpS-----a~eLL~Hpff~~~~~~~~~~~~~~~~~ 275 (641)
.. +|.+|+. +.++-+|.||..-+|.......++.|.
T Consensus 656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi 697 (732)
T KOG0614|consen 656 CRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPI 697 (732)
T ss_pred HhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCc
Confidence 87 7999986 899999999998888765554454443
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.95 Aligned_cols=238 Identities=21% Similarity=0.347 Sum_probs=197.6
Q ss_pred EeCccCceEEEEEEEcCCC---eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 6 SSRRIPAVDTYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG---~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
.+|+|+||.||+|.+..++ ..||+|.+..... ......+.+|+.+++.++||||+++++++.. ..+++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e 75 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVME 75 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEE
Confidence 5899999999999876655 7999999876543 2455678999999999999999999997643 34789999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc-
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR- 161 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~- 161 (641)
|+.+|+|.+++...+.+++..+..|+.||+.||.|||.++ ++||||||+|||++ ..+.+||+|||++..+......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCccc
Confidence 9999999999998888999999999999999999999999 99999999999997 5579999999999765432211
Q ss_pred ----cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 162 ----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 162 ----~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
...++..|+|||.+. ..++.++||||||+++|+|++ |..||... +..++...+..+.. ...+...++.++++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 230 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEIYSI 230 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHHHHH
Confidence 112346799999776 458999999999999999998 99999874 45566666665533 23344567889999
Q ss_pred HHHhcC-CCCCCCCHHHHHc
Q 006528 236 IEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~ 254 (641)
|.+||. +|.+||++.+|++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 999999 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.38 Aligned_cols=241 Identities=20% Similarity=0.271 Sum_probs=189.8
Q ss_pred EeCccCceEEEEEEEc--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 6 SSRRIPAVDTYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
.+|+|+||.||+|.+. .++..+|+|.++... .......+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEEC
Confidence 5899999999999854 456789999876543 233445788999999999999999999987654 458899999
Q ss_pred CCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 84 FTSGNLRQYRKKHK-----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 84 ~~gGsL~~~l~~~~-----~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+++|+|.+++.... ..+...+..++.||+.||.|||+.+ ++||||||+||+++ ..+.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccCc
Confidence 99999999997532 3567788899999999999999999 99999999999998 4579999999998654322
Q ss_pred C----CccccCCCCCCCcccccc--------cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC---CC
Q 006528 159 T----ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK---PA 222 (641)
Q Consensus 159 ~----~~~~~GTp~ymAPEvl~~--------~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~---~~ 222 (641)
. .....+++.|+|||++.. .++.++||||||+++|||++ |..||............+..... .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 1 223457888999998753 25789999999999999996 99999875444433333332211 12
Q ss_pred ccccCChHHHHHHHHHhcCCCCCCCCHHHHHc
Q 006528 223 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254 (641)
Q Consensus 223 ~l~~~~~~~l~~LI~kcL~dP~~RpSa~eLL~ 254 (641)
.+....++.+++++.+|+.+|.+|||+++|++
T Consensus 234 ~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 22334567899999999989999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=315.61 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=206.1
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
++..+|.|+||+||+|.+..+|..||+|.+..... ...+....+.+|+.+++.++||||+++++++... ...++|||
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 105 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWLVME 105 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEEEEe
Confidence 45679999999999999999999999999876543 2345566789999999999999999999988765 45889999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 83 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 83 y~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
|+.+ +|.+++.. ..++++..+..++.||+.||.|||+++ |+||||+|+||+++ +.+.+||+|||++..... ..
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~~--~~ 179 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIASP--AN 179 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCCCccccCC--cc
Confidence 9975 77777754 456899999999999999999999999 99999999999997 457999999998865432 23
Q ss_pred cccCCCCCCCccccc----ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHH
Q 006528 162 SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~----~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
...|++.|+|||++. +.++.++||||||+++|+|++|..||.... .......+..+..+.......++.+++||.
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 457899999999763 458899999999999999999999998743 333334444433333334455678999999
Q ss_pred HhcC-CCCCCCCHHHHHcCcccccccC
Q 006528 238 KCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
+||. +|.+||++.++++|+|+.....
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccCc
Confidence 9998 8999999999999999965443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.01 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=199.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC--------
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK-------- 73 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~-------- 73 (641)
++...+|.|+||+||+|.+..+|..||+|.++.... .......+.+|+.++++++||||+++++++.+..
T Consensus 10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred heeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 567889999999999999999999999999986542 1233456788999999999999999999886543
Q ss_pred CceEEEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 74 KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 74 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
...+++|+||+++ +|..++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++ +.+.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~ 163 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLA 163 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCccccc
Confidence 2378999999986 777777654 46999999999999999999999999 99999999999997 5579999999999
Q ss_pred hhccCCCC---ccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc---CCCCCc-
Q 006528 153 IAMQQPTA---RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPAS- 223 (641)
Q Consensus 153 ~~~~~~~~---~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~---g~~~~~- 223 (641)
........ ....+++.|+|||++.+ .++.++|||||||++|+|++|++||..... ......+.. +..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhc
Confidence 76543321 22346788999997753 478899999999999999999999976333 222222221 111100
Q ss_pred ------------------------cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 224 ------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 224 ------------------------l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 111246789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.34 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=195.0
Q ss_pred EEEEEeCccCceEEEEEE----EcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 2 RILISSRRIPAVDTYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
+++..+|+|+||+||++. ...++..||+|.++... .......+.+|+++|+.++||||+++++++.......+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 578899999999997764 44678899999987543 23445678899999999999999999998877666678
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++||||+.+|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccccccCC
Confidence 9999999999999999764 5999999999999999999999999 99999999999997 457999999999876543
Q ss_pred CCC-----ccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHH--------------HHHHHHc
Q 006528 158 PTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ--------------IFKKVTS 217 (641)
Q Consensus 158 ~~~-----~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~--------------i~~~i~~ 217 (641)
... ....++..|+|||.+. ..++.++||||||+++|+|+||..||........ +...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 211 1234566799999775 4589999999999999999999999864221110 0111111
Q ss_pred CCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 218 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 218 g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+.. ...+...+.++++++.+||. +|++||++++++.
T Consensus 240 ~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 240 GMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111 11233456799999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=348.39 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=203.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEE-EeC---C-C
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSW-VDD---K-K 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~-~~~---~-~ 74 (641)
++|.+-|-.|+|+.||+|.+...|.+||+|++-.. .+..++.+.+||.+|++|+ |+|||.|+++. ... . .
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 47888899999999999999988899999997654 3677889999999999996 99999999943 221 1 2
Q ss_pred ceEEEEEccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 75 KTVNMITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
..+.|.||||.||.|-+++.+ ..+|++..|.+|+.|+++|+++||...|||||||||-+||||+ +.|..||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCccccc
Confidence 457899999999999999985 3459999999999999999999999999999999999999998 5589999999999
Q ss_pred hhccCCC-Cc----------cccCCCCCCCccccc---c-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc
Q 006528 153 IAMQQPT-AR----------SVIGTPEFMAPELYE---E-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 217 (641)
Q Consensus 153 ~~~~~~~-~~----------~~~GTp~ymAPEvl~---~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~ 217 (641)
+...... .. ...-||.|+|||+++ + ..++|+|||+|||+||-|+....||.+... . .|..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-l----aIln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-L----AILN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-e----eEEe
Confidence 6432221 11 124699999999764 3 589999999999999999999999987321 1 2444
Q ss_pred CCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 218 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 218 g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+.........++..+++||..||+ +|.+||++-+++.+-|.
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 433322234456789999999999 89999999999987554
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.64 Aligned_cols=255 Identities=27% Similarity=0.364 Sum_probs=208.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC---CceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~---~~~l 77 (641)
.++...+|.|++|.||+|.+..+|..||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ...+
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 367889999999999999999999999999987542 12345677999999999999999999999887653 2368
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++||||+. ++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++. .|.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~-~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNS-NCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC-CCCEEEcccCceEeecc
Confidence 99999998 589999988788999999999999999999999999 999999999999985 48999999999976654
Q ss_pred CC-----CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CC------
Q 006528 158 PT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PA------ 222 (641)
Q Consensus 158 ~~-----~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--~~------ 222 (641)
.. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... ....+..+..... +.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhhc
Confidence 32 334568999999998763 58899999999999999999999998743 3333333332110 00
Q ss_pred ---------------------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 223 ---------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 223 ---------------------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
......++.+.+||.+||. +|.+||++.++|.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0011235788999999999 899999999999999998544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.95 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=200.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCC-----eEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG-----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~ 75 (641)
++...+|+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++++ +||||+++++++... .
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~ 89 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE--G 89 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--C
Confidence 57788999999999999986443 789999887542 234556789999999999 899999999987654 4
Q ss_pred eEEEEEccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC
Q 006528 76 TVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~ 139 (641)
.+++||||+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~- 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT- 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc-
Confidence 689999999999999999642 45889999999999999999999999 99999999999997
Q ss_pred CCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHH
Q 006528 140 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 213 (641)
Q Consensus 140 ~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~ 213 (641)
+++.+||+|||++..+.... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. ....+.++
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHHHH
Confidence 56899999999997654322 11223456899999765 468999999999999999997 9999986 45566666
Q ss_pred HHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 214 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 214 ~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++++
T Consensus 246 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 666654332 334456789999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.88 Aligned_cols=241 Identities=20% Similarity=0.304 Sum_probs=188.8
Q ss_pred EeCccCceEEEEEEEc--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 6 SSRRIPAVDTYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
.+|+|+||+||+|... .....||+|.+.... .......+.+|+.+++.++||||+++++++... ..+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEe
Confidence 5899999999999643 244568888765432 334456788999999999999999999988655 458999999
Q ss_pred CCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 84 FTSGNLRQYRKKHK-----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 84 ~~gGsL~~~l~~~~-----~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+++|+|.+++.... ..++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEeccccccccccc
Confidence 99999999997643 2467888999999999999999999 99999999999998 4579999999998643221
Q ss_pred ----CCccccCCCCCCCccccc--------ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC---CC
Q 006528 159 ----TARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK---PA 222 (641)
Q Consensus 159 ----~~~~~~GTp~ymAPEvl~--------~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~---~~ 222 (641)
......+++.|+|||++. ..++.++|||||||++|||++ |..||....+...+...+..+.. .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 112234567899999864 246789999999999999999 78899875444434343433321 22
Q ss_pred ccccCChHHHHHHHHHhcCCCCCCCCHHHHHc
Q 006528 223 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254 (641)
Q Consensus 223 ~l~~~~~~~l~~LI~kcL~dP~~RpSa~eLL~ 254 (641)
......++.+.+++..|+.+|.+||++++|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 33445677889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.52 Aligned_cols=252 Identities=25% Similarity=0.315 Sum_probs=202.5
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+...+|.|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++++ +||||+++++++...+...+++||
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 4567899999999999999999999999885432 1233456678999999999 999999999988766556789999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--- 158 (641)
||+. ++|..++... .+++..++.++.||+.||.|||+.| |+||||||+|||++ .+|.+||+|||++......
T Consensus 89 e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 89 EYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred cccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhcccccccc
Confidence 9997 5999998875 7889999999999999999999999 99999999999997 5589999999999755322
Q ss_pred ----CCccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC-------------
Q 006528 159 ----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI------------- 219 (641)
Q Consensus 159 ----~~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~------------- 219 (641)
......|++.|+|||++. ..++.++||||||+++|+|++|+.||..........+.+....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 222356899999999764 3478899999999999999999999976443332221111100
Q ss_pred ---------------CCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 220 ---------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 220 ---------------~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.........+.++.+||.+||. +|.+|||+.++++||||+.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0011112246789999999999 89999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=304.37 Aligned_cols=245 Identities=20% Similarity=0.328 Sum_probs=200.8
Q ss_pred CEEEEEeCccCceEEEEEEEcCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
+++...+|.|+||+||+|.+..+ ...||+|.++... .......+.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPV 80 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--Cce
Confidence 36778999999999999998654 4589999876443 344566788999999999999999999987654 458
Q ss_pred EEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 78 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
++||||+.+|+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++ ..+.+||+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhccc
Confidence 9999999999999999764 46899999999999999999999999 99999999999998 45799999999997764
Q ss_pred CCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChH
Q 006528 157 QPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 230 (641)
Q Consensus 157 ~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~ 230 (641)
... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.... .......+..+.... .+...++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 235 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRLP-PPMDCPS 235 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCCC-CCCCCCH
Confidence 211 11223467899999876 468999999999999999998 999997743 455556665543322 2344578
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 231 QIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 231 ~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.+.+|+.+||. +|.+||++.+++++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 89999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=303.85 Aligned_cols=239 Identities=26% Similarity=0.367 Sum_probs=197.9
Q ss_pred EeCccCceEEEEEEEcC-CC--eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 6 SSRRIPAVDTYKAFDEF-AG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~-tG--~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
.+|+|++|+||+|.+.. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++++.. ..+++|+|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e 75 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTE 75 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEE
Confidence 47999999999999865 33 36999998765532 567789999999999999999999998876 56899999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 83 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 83 y~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
|+.+|+|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++..+....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEecccccccccccccc
Confidence 999999999998754 6899999999999999999999999 9999999999999844 799999999997654321
Q ss_pred ----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 160 ----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 160 ----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.....++..|+|||.+. ..++.++|||||||++|+|++ |..||... +..++.+.+.........+...+..+.
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDIY 231 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHHH
Confidence 11245678899999876 468999999999999999998 99999763 455566655543233333444567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+++.+||. +|.+||++.+++.
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 99999999 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=314.01 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=197.1
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeE--EEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIE--VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~--VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l 77 (641)
+++...+|+|+||+||+|.+..+|.. +|+|.++.. ........+.+|+.++.++ +||||+++++++... ..+
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~ 83 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYL 83 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCc
Confidence 35778899999999999999888865 466655422 2345567788999999999 899999999987655 468
Q ss_pred EEEEccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCC
Q 006528 78 NMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~ 141 (641)
++||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++| ++||||||+|||++ ..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-EN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CC
Confidence 99999999999999997542 4789999999999999999999999 99999999999997 45
Q ss_pred CcEEEeecchhhhccCCC-CccccCCCCCCCcccccc-cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcC
Q 006528 142 GEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 218 (641)
Q Consensus 142 G~VKL~DFGlA~~~~~~~-~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g 218 (641)
+.+||+|||++....... .....+++.|+|||++.. .++.++||||||+++|+|+| |..||.. .+..+.+..+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~ 239 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG 239 (303)
T ss_pred CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcC
Confidence 799999999985332111 111234567999997764 47899999999999999998 9999976 3455566666554
Q ss_pred CCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 006528 219 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 256 (641)
Q Consensus 219 ~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hp 256 (641)
.... .+...++.+.+||.+||. +|.+||++.++|.+.
T Consensus 240 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 240 YRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred CcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 3222 233456789999999999 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=333.16 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=206.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++.||+|+.+.||++.... ...||+|.+.... .....+.-+..||.+|.+| .|.+||++|+|-+.+ .++|||
T Consensus 364 eilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~lYmv 438 (677)
T KOG0596|consen 364 EILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYLYMV 438 (677)
T ss_pred hHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceEEEE
Confidence 467899999999999999754 4456666665443 3567788899999999999 599999999987765 679999
Q ss_pred EccCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l-~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|||-. -+|.++|++.... +...++.|..|||.++.++|.+| |||.||||.|+|+- .|.+||+|||+|..+...+
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhcccCccc
Confidence 99975 5999999987654 34689999999999999999999 99999999999985 3799999999998776543
Q ss_pred ----CccccCCCCCCCcccccc------------cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006528 160 ----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 223 (641)
Q Consensus 160 ----~~~~~GTp~ymAPEvl~~------------~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~ 223 (641)
..+.+||+.||+||.+.. +.++++||||||||||+|+.|+.||....+....+..|+.......
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 345689999999996631 1567899999999999999999999887666666777776544445
Q ss_pred cccCChHH-HHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 224 LAKVNDPQ-IKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 224 l~~~~~~~-l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
++...... +.++++.||. ||.+||++.+||+|||++.
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 55555444 9999999998 9999999999999999985
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.94 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=209.0
Q ss_pred CEEEEEeCccCceEEEEEEEc---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~ 76 (641)
+++...+|.|++|+||+|.+. .++..||+|.++.............+.+|+.+++++ +||||+++++++... ..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~~ 79 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--TK 79 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--CE
Confidence 367889999999999999864 577899999988654333344566788999999999 699999999987654 56
Q ss_pred EEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 77 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
+++||||+.+|+|.+++.....+++..++.++.|++.||.|||+.+ ++||||+|+||+++ .++.++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECccccccc
Confidence 8899999999999999988788999999999999999999999998 99999999999997 45799999999986543
Q ss_pred CCC---CccccCCCCCCCccccccc---CCcccccccccchhhhhhhccCCCCCCC---CHHHHHHHHHcCCCCCccccC
Q 006528 157 QPT---ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKV 227 (641)
Q Consensus 157 ~~~---~~~~~GTp~ymAPEvl~~~---y~~ksDIwSlGiil~EmltG~~Pf~~~~---~~~~i~~~i~~g~~~~~l~~~ 227 (641)
... .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.... ....+.+.+..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKT 234 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcc
Confidence 321 2234689999999987542 6889999999999999999999996321 22333344433322 23344
Q ss_pred ChHHHHHHHHHhcC-CCCCCCC---HHHHHcCcccccccCCC
Q 006528 228 NDPQIKGFIEKCLV-PASERLS---AKDLLKDPFLQVENQKE 265 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~RpS---a~eLL~Hpff~~~~~~~ 265 (641)
.++.+++||.+||. +|++||| +.++|+||||+...+..
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 57889999999999 8999998 67889999998776643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=308.60 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=196.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeE----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIE----VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~----VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
++++..+|.|+||+||+|.+..+|.. |++|.+... ........+..|+.++++++||||+++++++.. ..
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~ 82 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---AS 82 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Cc
Confidence 46788999999999999999877774 666665422 223445678889999999999999999998643 34
Q ss_pred EEEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 77 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
.++|+||+++|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+|||++ +++.+||+|||+++..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccceec
Confidence 77899999999999999764 56899999999999999999999999 99999999999997 5579999999999755
Q ss_pred cCC----CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 156 QQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 156 ~~~----~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
... ......+++.|+|||.+. +.++.++||||||+++|||++ |..||.+. .+..+...+..+..+ ..+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 237 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERL-AQPQICT 237 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcC-CCCCCCC
Confidence 322 122345677899999875 569999999999999999998 99999763 445555555554433 2334456
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+.+++.+||. +|.+||++.++++
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 788999999998 8999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=318.65 Aligned_cols=254 Identities=27% Similarity=0.353 Sum_probs=203.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC----ceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~----~~l 77 (641)
+++..+|.|+||+||+|.+..+|..||+|++.... ........+.+|+.+|+.++||||+++++++..... ..+
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 57889999999999999999999999999986432 233445678899999999999999999998865432 246
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++||||+ +++|..++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++ +.|.+||+|||++.....
T Consensus 96 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDS 170 (343)
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeccccccccc
Confidence 8999999 6799988864 56999999999999999999999999 99999999999997 557999999999876543
Q ss_pred CCCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC---------------
Q 006528 158 PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--------------- 220 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--------------- 220 (641)
. .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||..........+.......
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 171 E-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred C-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 2 234567899999998764 4789999999999999999999999874433222221110000
Q ss_pred ----------C---CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccC
Q 006528 221 ----------P---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 221 ----------~---~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
+ ..+....++.+.++|.+||. +|.+|||+.+++.||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0 01112346679999999999 8999999999999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.26 Aligned_cols=245 Identities=21% Similarity=0.281 Sum_probs=198.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCC----------------eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcce
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAG----------------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 64 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG----------------~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk 64 (641)
++++..+|+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|+++|++++||||++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 467899999999999999887644 568999877543 2355678899999999999999999
Q ss_pred eeEEEEeCCCceEEEEEccCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCC
Q 006528 65 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133 (641)
Q Consensus 65 ~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~-----------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~ 133 (641)
+++++... ..+++++||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATR 159 (296)
T ss_pred EEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence 99988765 46889999999999999998765 6899999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCCCCcccccc-cCCcccccccccchhhhhhh--ccCCCCCCC
Q 006528 134 NIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT--FEYPYSECK 206 (641)
Q Consensus 134 NILl~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~Emlt--G~~Pf~~~~ 206 (641)
||+++ +.+.++|+|||++....... .....+++.|+|||++.. .++.++|||||||++|+|++ +..||....
T Consensus 160 Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 160 NCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred ceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99997 44799999999986543221 223456788999997764 68999999999999999998 678887643
Q ss_pred CHHHHHHHHHcC------CCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 207 NPAQIFKKVTSG------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 207 ~~~~i~~~i~~g------~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+....+... ......+...+.++.++|.+||. +|.+||++.+|++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred -hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 34444444322 11111223346789999999999 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.48 Aligned_cols=242 Identities=20% Similarity=0.345 Sum_probs=198.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++...+|.|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++... ..+++|
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIV 77 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEE
Confidence 356788999999999999886 567899998764332 234678899999999999999999987554 568999
Q ss_pred EccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++ +.|.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccccc
Confidence 9999999999999764 46899999999999999999999999 99999999999997 56899999999987554332
Q ss_pred Cccc---cCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 ARSV---IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 ~~~~---~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
.... .++..|+|||.+. ..++.++||||||+++|+|++ |..||... ...+....+..+... ..+...++.+.+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRL-YRPKLAPTEVYT 232 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 2222 2345799999776 568999999999999999999 79999763 455666666655332 334556889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcC
Q 006528 235 FIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~H 255 (641)
++.+||. +|.+||++.++++.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=310.98 Aligned_cols=252 Identities=23% Similarity=0.413 Sum_probs=202.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++..+|.|++|+||+|.+..+|..||+|.++.... ......+..|+.++..+ .||||+++++++.+. ..+++|
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v 92 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFIC 92 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEEE
Confidence 678899999999999999999999999999875532 23455677788777667 599999999998765 468999
Q ss_pred EccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+. ++|..++.. ...+++..+..++.||+.||.|||+ ++ |+||||+|+||+++ +++.+||+|||++..+...
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchhccCC
Confidence 99985 578777765 4578999999999999999999997 57 99999999999997 5679999999998765432
Q ss_pred C-CccccCCCCCCCcccccc-----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc-cccCChHH
Q 006528 159 T-ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVNDPQ 231 (641)
Q Consensus 159 ~-~~~~~GTp~ymAPEvl~~-----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~-l~~~~~~~ 231 (641)
. .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+....+.....+.. .....+.+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 2 223357889999998753 3788999999999999999999999764444455555544432221 12235678
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+++||.+||. +|.+||++.++++||||+...
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 9999999999 899999999999999998543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=303.97 Aligned_cols=242 Identities=21% Similarity=0.359 Sum_probs=198.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|+||+||+|.+.. +..||+|.+..... ....+.+|+.++++++||||+++++++... ..+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIV 77 (256)
T ss_pred eEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEE
Confidence 3678899999999999998753 55699998874432 235688999999999999999999987554 458999
Q ss_pred EccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+|||++ +++.+||+|||++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCc
Confidence 9999999999999764 46899999999999999999999999 99999999999997 45799999999987553322
Q ss_pred Ccc---ccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 ARS---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 ~~~---~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
... ..++..|+|||++. ..++.++|||||||++|+|++ |..||... +.......+..+..+. .....+..+++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRLY-RPHLASEKVYA 232 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCCC-CCCCCCHHHHH
Confidence 111 23456799999886 468999999999999999998 99999864 4555666666654332 33445788999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcC
Q 006528 235 FIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~H 255 (641)
++.+||. +|.+||++.+|+.+
T Consensus 233 li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 233 IMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHcCCCcccCCCHHHHHHh
Confidence 9999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=304.63 Aligned_cols=238 Identities=17% Similarity=0.314 Sum_probs=195.3
Q ss_pred EeCccCceEEEEEEEc--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 6 SSRRIPAVDTYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
.+|.|+||.||+|.+. ..+..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEe
Confidence 5899999999999875 456689999886442 34456779999999999999999999997642 358899999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC--
Q 006528 84 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-- 160 (641)
Q Consensus 84 ~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~-- 160 (641)
+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCccce
Confidence 999999999975 456899999999999999999999999 99999999999997 557999999999875432211
Q ss_pred ---ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 161 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 161 ---~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ....+...+..+..+ ..+...++++.++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 230 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYAL 230 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1122357899999776 468999999999999999996 99999874 455566666665443 3445567899999
Q ss_pred HHHhcC-CCCCCCCHHHHHc
Q 006528 236 IEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~ 254 (641)
|.+||. +|.+||++.++++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.75 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=204.3
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
++..+|.|++|+||+|.+..+|..||+|.+..... .......++.+|+++++.++||||+++++++... ...++|+|
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 95 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVME 95 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEEEEE
Confidence 34568999999999999999999999999875432 2334456788999999999999999999988765 46889999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 83 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 83 y~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
|+. |+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||+|+||+++ ..|.+||+|||++..... ..
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~--~~ 169 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--AN 169 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcccceeecC--cc
Confidence 997 588777654 456899999999999999999999998 99999999999997 457999999999865443 23
Q ss_pred cccCCCCCCCccccc----ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHH
Q 006528 162 SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~----~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
...+++.|+|||.+. +.++.++|||||||++|+|++|..||..... ......+..+..+.......+..+++||.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFRNFVD 248 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-HHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence 456899999999763 3578899999999999999999999976433 33333344443443334456788999999
Q ss_pred HhcC-CCCCCCCHHHHHcCcccccc
Q 006528 238 KCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
+||. +|.+||++.++++|||+...
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHhhCCcccCCCHHHHhhCcccccc
Confidence 9998 89999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=302.60 Aligned_cols=241 Identities=22% Similarity=0.383 Sum_probs=198.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++...+|+|++|.||+|.+. .+..||+|.++.... ..+.+.+|+.++++++||||+++++++... ..+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIV 79 (261)
T ss_pred eeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeee
Confidence 467899999999999999975 567899999875432 245688999999999999999999987655 458899
Q ss_pred EccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++ ..|.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEccCC
Confidence 99999999999997654 6899999999999999999999999 99999999999998 5579999999999766533
Q ss_pred CCccccC---CCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 TARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ~~~~~~G---Tp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
......| +..|+|||++. ..++.++||||||+++|+|+| |+.||.. .........+..+... ..+...+..+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPPGCPKELY 234 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCHHHH
Confidence 2222222 35799999776 458999999999999999999 9999986 3455566666554332 23344567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+++.+||. +|.+||++.+|++
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHH
Confidence 99999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=307.15 Aligned_cols=249 Identities=26% Similarity=0.367 Sum_probs=200.7
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~l 79 (641)
.++...+|.|++|+||+|.+..++..||+|++..... ........+|+..+++++ ||||+++++++.+. ...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---SWEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---chhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEE
Confidence 3678899999999999999999999999999865432 122334567999999998 99999999988764 56899
Q ss_pred EEccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 80 ITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
||||+ +|+|.+++.... .+++..+..++.||+.||.|||+++ ++|+||+|+||+++ ..+.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccC
Confidence 99999 789999988764 7899999999999999999999999 99999999999998 558999999999976543
Q ss_pred C-CCccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-------------
Q 006528 158 P-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------- 221 (641)
Q Consensus 158 ~-~~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~------------- 221 (641)
. ......++..|+|||++. ..++.++|+||||+++++|++|+.||..........+.......+
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 3 223456889999999874 347899999999999999999999997654443333222110000
Q ss_pred --------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 222 --------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 222 --------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.......++.+++||.+||. +|.+||+++|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00011225789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.48 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=202.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|.||+|.+..+|..+|+|+++.... .+.....+.+|+.+|++++||||+++++++.+. ..+++|+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 77 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVF 77 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEE
Confidence 567899999999999999999999999999876542 234567888999999999999999999988765 5689999
Q ss_pred ccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++ ..+.+||+|||.+.......
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcc
Confidence 99975 88887766 467999999999999999999999999 99999999999998 45799999999987654432
Q ss_pred -CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCC---------------
Q 006528 160 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--------------- 221 (641)
Q Consensus 160 -~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~--------------- 221 (641)
.....++..|+|||.+.+ .++.++|+||||+++|+|+||+.||.......++.........+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 223467889999997753 58899999999999999999999997744433332222110000
Q ss_pred ------------CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 222 ------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 222 ------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
.......+..+++||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00112246789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=312.08 Aligned_cols=244 Identities=21% Similarity=0.316 Sum_probs=199.8
Q ss_pred EEEEEeCccCceEEEEEEE-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~ 75 (641)
++...+|.|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++... .
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~ 112 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTIG--G 112 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--C
Confidence 5677899999999999986 3456789999877543 234567789999999999 899999999988665 4
Q ss_pred eEEEEEccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 76 TVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
.+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+|+||||+|||++ ..+.+||+|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCcccc
Confidence 5899999999999999997643 3899999999999999999999999 99999999999997 55799999999997
Q ss_pred hccCCCC----ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 006528 154 AMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 227 (641)
Q Consensus 154 ~~~~~~~----~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~ 227 (641)
....... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..........+.+..+..+ ..+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCC
Confidence 5543221 1234577899999765 458999999999999999998 999998755445555555554332 23445
Q ss_pred ChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 228 NDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.++.+.+|+.+||. +|.+||++.++++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 57899999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=308.17 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=199.5
Q ss_pred CEEEEEeCccCceEEEEEEE-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
+++...+|.|+||+||+|.. ..++..||+|.+... .......+.+|+++++.++||||+++++++... .
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 80 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--R 80 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--C
Confidence 46788999999999999974 346778999987643 345567899999999999999999999988765 4
Q ss_pred eEEEEEccCCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC
Q 006528 76 TVNMITELFTSGNLRQYRKKHK---------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 140 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~---------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~ 140 (641)
..+++|||+.+|+|.+++..++ .+++..+..++.||+.||+|||+++ ++||||||+|||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-Q 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-C
Confidence 5899999999999999998653 4889999999999999999999999 99999999999997 5
Q ss_pred CCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHH
Q 006528 141 HGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKK 214 (641)
Q Consensus 141 ~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~ 214 (641)
.+.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||... ........
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHHHH
Confidence 6799999999986543221 12234578899999776 458999999999999999998 89999764 34555555
Q ss_pred HHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 215 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 215 i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+..+.... .+...++.+.+||.+||. +|.+||++.+|+.
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 65554332 334557889999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=311.99 Aligned_cols=246 Identities=28% Similarity=0.502 Sum_probs=204.3
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|.|+||.||+|.+..+|..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++||||++
T Consensus 27 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~ 100 (292)
T cd06657 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFLE 100 (292)
T ss_pred HcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecCC
Confidence 5899999999999999999999999876432 34456789999999999999999999998765 46899999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCccc
Q 006528 86 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSV 163 (641)
Q Consensus 86 gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~~~~~ 163 (641)
+++|.+++.. ..+++..++.++.||+.||+|||+.| ++||||+|+||+++ .+|.++|+|||++...... .....
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceeccccccccccc
Confidence 9999998764 46899999999999999999999999 99999999999998 4579999999988654332 22345
Q ss_pred cCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCChHHHHHHHHHhcC
Q 006528 164 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 164 ~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~-~l~~~~~~~l~~LI~kcL~ 241 (641)
.|++.|+|||.+. ..++.++|+||||+++|+|++|..||.. .........+..+..+. ......++.+.++|.+||.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 6899999999775 4578899999999999999999999976 33444444444433221 1223457789999999999
Q ss_pred -CCCCCCCHHHHHcCccccccc
Q 006528 242 -PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 242 -dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+|.+||++.++|.||||....
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CCcccCcCHHHHhcChHHhccC
Confidence 899999999999999998655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.82 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=213.1
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
.+|.|+++.|-.+....+|.+||||+|.+.. ...+.++.+|++++.++ .|+||++++++|.++. .+|||||-|
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfEKm 158 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFEKM 158 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEecc
Confidence 3799999999999999999999999987653 35578999999999999 5999999999997774 599999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCC--CcEEEeecchhhhcc------
Q 006528 85 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQ------ 156 (641)
Q Consensus 85 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~--G~VKL~DFGlA~~~~------ 156 (641)
.||+|...|.+++.|++..+.++.+.|+.||.|||.+| |.||||||+|||....+ ..||||||.+...+.
T Consensus 159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99999999999999999999999999999999999999 99999999999985332 358999999874332
Q ss_pred ---CCCCccccCCCCCCCccccc---c---cCCcccccccccchhhhhhhccCCCCCCC--------------CHHHHHH
Q 006528 157 ---QPTARSVIGTPEFMAPELYE---E---EYNELVDIYSFGMCILEMVTFEYPYSECK--------------NPAQIFK 213 (641)
Q Consensus 157 ---~~~~~~~~GTp~ymAPEvl~---~---~y~~ksDIwSlGiil~EmltG~~Pf~~~~--------------~~~~i~~ 213 (641)
.+...+.+|+-+|||||+.. + .|+.+.|.|||||++|-|+.|.+||.+.- -...++.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 12234568888999999764 2 48999999999999999999999996521 1346788
Q ss_pred HHHcCCC--CCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 214 KVTSGIK--PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 214 ~i~~g~~--~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
.|+.|.. |..-+...+.+++++|..+|. ++.+|.+|.++++|||++.....
T Consensus 317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 8888854 444445567899999999998 89999999999999999865544
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=308.80 Aligned_cols=242 Identities=23% Similarity=0.352 Sum_probs=198.7
Q ss_pred EEEEEeCccCceEEEEEEEc-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 2 RILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
.+...+|+|+||.||+|.+. .++..|++|.+.... ......+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DP 81 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--Cc
Confidence 46778999999999999853 456679988876432 34456789999999999999999999988654 46
Q ss_pred EEEEEccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC
Q 006528 77 VNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 140 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~ 140 (641)
+++||||+++|+|.+++..+. .+++..++.++.||+.||.|||+++ |+||||||+|||++ +
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~-~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG-A 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-c
Confidence 899999999999999997643 3789999999999999999999999 99999999999998 4
Q ss_pred CCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHH
Q 006528 141 HGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKK 214 (641)
Q Consensus 141 ~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~ 214 (641)
++.+||+|||++....... .....+++.|+|||.+. ..++.++||||||+++|+|+| |..||... +.......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~ 237 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIEC 237 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHH
Confidence 5799999999996543321 22345678999999775 458899999999999999999 99998763 45555566
Q ss_pred HHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 215 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 215 i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+..+..+. .....+..+.+++.+||. +|.+||++.++++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 66554432 344557789999999999 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.02 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=197.6
Q ss_pred EEEEEeCccCceEEEEEEE----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 2 RILISSRRIPAVDTYKAFD----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
+++..+|+|+||.||+|.. ..++..||+|.++... .......+.+|+.+|+.++||||+++++++.......+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 5788999999999999974 5678899999986443 34456789999999999999999999998877655678
Q ss_pred EEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 78 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
++||||+++++|.+++.+. ..+++..+..++.||+.||.|||++| ++||||||+||+++ ++|.+||+|||++..+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCccccccc
Confidence 9999999999999999765 35899999999999999999999999 99999999999997 45799999999997654
Q ss_pred CCC-----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCC--------------CHHHHHHHHH
Q 006528 157 QPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK--------------NPAQIFKKVT 216 (641)
Q Consensus 157 ~~~-----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~--------------~~~~i~~~i~ 216 (641)
... .....++..|+|||++. ..++.++||||||+++|+|+|+..|+.... ........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 321 12345677899999765 458899999999999999999876643211 1111222222
Q ss_pred cCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 217 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 217 ~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.+... ..+...+..+.+||.+||. +|.+||++.+++++
T Consensus 241 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 241 EGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 33222 2233456789999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=310.71 Aligned_cols=245 Identities=20% Similarity=0.303 Sum_probs=198.8
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCe--EEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI--EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~--~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l 77 (641)
+++...+|.|+||.||+|.+..+|. .+++|.++... .....+.+.+|+.+++++ +||||+++++++... ..+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~ 78 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYL 78 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccc
Confidence 4678899999999999999987775 46888766322 334566789999999999 799999999987655 458
Q ss_pred EEEEccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCC
Q 006528 78 NMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~ 141 (641)
++|+||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++ .+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-EN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CC
Confidence 99999999999999997542 4888999999999999999999999 99999999999997 45
Q ss_pred CcEEEeecchhhhccCCCCcc-ccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcC
Q 006528 142 GEVKIGDLGLAIAMQQPTARS-VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 218 (641)
Q Consensus 142 G~VKL~DFGlA~~~~~~~~~~-~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g 218 (641)
+.+||+|||++.......... ...+..|+|||++. ..++.++|||||||++|||++ |..||.. .........+..+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~ 234 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG 234 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcC
Confidence 799999999986433221111 22345799999775 458999999999999999997 9999976 4556666666655
Q ss_pred CCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 219 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 219 ~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
..+ ..+...++.+++||.+||. +|.+||+++++++.
T Consensus 235 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 432 2344567889999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=327.97 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=211.3
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|.|-||+||-|.++.+|+.||||.|.+..+ .......+..|+.+|.++.||.||.+--.|. ....+++|||-+.
T Consensus 571 vLGSGQFG~VYgg~hRktGrdVAvKvIdKlrF--p~kqesqlR~EVaILq~l~HPGiV~le~M~E--T~ervFVVMEKl~ 646 (888)
T KOG4236|consen 571 VLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRF--PTKQESQLRNEVAILQNLHHPGIVNLECMFE--TPERVFVVMEKLH 646 (888)
T ss_pred hccCCcceeeecceecccCceeeeeeeecccC--CCchHHHHHHHHHHHHhcCCCCeeEEEEeec--CCceEEEEehhhc
Confidence 48999999999999999999999999987765 3345578999999999999999999986554 4467999999997
Q ss_pred CCCHHHHH-H-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC--CCcEEEeecchhhhccC-CCC
Q 006528 86 SGNLRQYR-K-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQ-PTA 160 (641)
Q Consensus 86 gGsL~~~l-~-~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~--~G~VKL~DFGlA~~~~~-~~~ 160 (641)
| ++.+.| . ..+++++..-+.++.|||.||.|||-.+ |+|+||||+|||+... ...+||||||+|+.+.. ...
T Consensus 647 G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 647 G-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred c-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 5 555554 3 3578999999999999999999999999 9999999999999643 34799999999998875 467
Q ss_pred ccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC--CCCCccccCChHHHHHHHH
Q 006528 161 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g--~~~~~l~~~~~~~l~~LI~ 237 (641)
++++|||.|+|||++. .+|+..-|+||.|+|+|.-+.|..||.+ .++|..+|+.. ..|+..++..++++.+||.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE---dEdIndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE---DEDINDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC---ccchhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 8899999999999887 5699999999999999999999999987 35566666653 3455566677889999999
Q ss_pred HhcC-CCCCCCCHHHHHcCcccccc
Q 006528 238 KCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.+|+ +-.+|.|.+..|.|||+|..
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhcc
Confidence 9999 89999999999999999854
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=301.32 Aligned_cols=238 Identities=21% Similarity=0.345 Sum_probs=200.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|.||+|.+. |..||+|.++... ....++.+|+.+++.++|+||+++++++.+. ...++||
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 79 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPLYIVT 79 (256)
T ss_pred cceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCeEEEE
Confidence 57788999999999999875 8899999987543 2467899999999999999999999987664 5689999
Q ss_pred ccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 82 ELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
||+++++|.++++... .+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEccccccccccccc
Confidence 9999999999998765 6999999999999999999999999 99999999999998 55799999999997664322
Q ss_pred CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
. ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .....+...+..+... ..+...++.+.++|.
T Consensus 157 ~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 233 (256)
T cd05039 157 D-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYKVMK 233 (256)
T ss_pred c-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHHHHH
Confidence 2 334466799999775 568899999999999999997 9999976 3556666666655332 334455789999999
Q ss_pred HhcC-CCCCCCCHHHHHc
Q 006528 238 KCLV-PASERLSAKDLLK 254 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~ 254 (641)
+||. +|.+||++.++++
T Consensus 234 ~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 234 DCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.47 Aligned_cols=239 Identities=22% Similarity=0.363 Sum_probs=198.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++...+|+|+||.||+|... |..||+|.++.. ...+.+.+|+.++++++|+||+++++++.... ..+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~lv 78 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV 78 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceEEE
Confidence 367889999999999999764 788999987533 23457889999999999999999999765443 468899
Q ss_pred EccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ ++|.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceecccc
Confidence 99999999999998654 4889999999999999999999999 99999999999997 5579999999998654332
Q ss_pred CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 159 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
. ....++..|+|||++.. .++.++|||||||++|+|++ |+.||.. .+..++...+..+..+ ......++.++++|
T Consensus 156 ~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (256)
T cd05082 156 Q-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVM 232 (256)
T ss_pred C-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence 2 23345678999998764 58899999999999999997 9999976 4566677777665433 33455678999999
Q ss_pred HHhcC-CCCCCCCHHHHHc
Q 006528 237 EKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~ 254 (641)
.+||. +|.+|||+.++++
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 233 KQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 99998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.02 Aligned_cols=258 Identities=23% Similarity=0.368 Sum_probs=218.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+|+-..+|+|+||.||-+.-..||+-+|.|.+.+..+. ..........|-++|.+++.+.||.+-..|... +.++||
T Consensus 187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK-kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk--d~LClV 263 (591)
T KOG0986|consen 187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK-KRKGETMALNEKQILEKVSSPFIVSLAYAFETK--DALCLV 263 (591)
T ss_pred eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC--CceEEE
Confidence 46778899999999999999999999999988765542 234455678999999999999999998877554 569999
Q ss_pred EccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
+.+|.||+|+-+|.+++ .|+++.+..|+.+|+.||++||..+ |++|||||+|||+| +.|+|+|+|+|||..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEecCCC
Confidence 99999999999998876 7999999999999999999999999 99999999999998 6799999999999877655
Q ss_pred CC-ccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCH---HHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 TA-RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ~~-~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~---~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.. +..+||..|||||++. +.|+..+|+|||||++|||+.|+.||...... +++-+.+.. .+..++...+++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAK 418 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHH
Confidence 43 3449999999999886 46999999999999999999999999653221 233333333 34556677789999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHHcCcccccccCCCC
Q 006528 234 GFIEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpS-----a~eLL~Hpff~~~~~~~~ 266 (641)
+|.+.+|. ||++|+. +.++.+||||+..+|...
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 99999998 8999875 789999999999888754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.97 Aligned_cols=251 Identities=29% Similarity=0.375 Sum_probs=198.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceeeEEEEeCCC---
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDDKK--- 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVk~~~~~~~~~~--- 74 (641)
.+++..+|.|+||.||+|.++.+|..||+|.++.... .......+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 3688999999999999999999999999999976542 222344566788877666 59999999999876532
Q ss_pred ceEEEEEccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 75 KTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
..++++|||+.+ +|.+++.... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.+ +.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcc
Confidence 248899999974 8999887643 4899999999999999999999999 9999999999999855 89999999998
Q ss_pred hhccCC-CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC----------
Q 006528 153 IAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---------- 220 (641)
Q Consensus 153 ~~~~~~-~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~---------- 220 (641)
...... ......+++.|+|||++. ..++.++||||||+++|+|++|.+||.... ..+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhcCCC
Confidence 765433 223446788999999776 458899999999999999999999998644 3333333322100
Q ss_pred ------------CC---ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 221 ------------PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 221 ------------~~---~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+. ......++.+.+||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 0001224678899999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=314.99 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=212.6
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHH-hCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK-SLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk-~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+..+|+|+||+|+|..++.+|+..|||+|+.... +.+..++..|..... .-+.||||+|||....+.. .|+.||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eeeeHH
Confidence 5679999999999999999999999999987653 566778899988654 4489999999998877644 789999
Q ss_pred cCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 83 LFTSGNLRQYRK-----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 83 y~~gGsL~~~l~-----~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
+|. .+|..+.+ +...++|..+..+.--.+.||.||-..- .|||||+||+|||++ ..|.|||||||++..+..
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHhHHH
Confidence 996 48877654 3467999999999999999999997652 399999999999998 558999999999987766
Q ss_pred CCCccc-cCCCCCCCccccc---ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccC----Ch
Q 006528 158 PTARSV-IGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV----ND 229 (641)
Q Consensus 158 ~~~~~~-~GTp~ymAPEvl~---~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~----~~ 229 (641)
..+.+. .|-..|||||.+. .+|+.++|+||||++|||++||.+||.+..+..+...++..|-+|...... .+
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 655543 7888999999886 359999999999999999999999999988888888888888666544332 46
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
..++.||..||. |.+.||...+|+++||+..-.
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 789999999998 899999999999999997543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=319.71 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=199.9
Q ss_pred CEEEEEeCccCceEEEEEEE-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCC
Q 006528 1 MRILISSRRIPAVDTYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~ 74 (641)
+++...+|.|+||+||+|.+ ..+++.||+|.++... .......+.+|+.+|.++ +||||+++++++....
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 84 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence 36788999999999999984 4578899999987543 234456788999999999 7899999999876543
Q ss_pred ceEEEEEccCCCCCHHHHHHhC----------------------------------------------------------
Q 006528 75 KTVNMITELFTSGNLRQYRKKH---------------------------------------------------------- 96 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~---------------------------------------------------------- 96 (641)
..+++||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4688999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC----Cccc
Q 006528 97 ---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSV 163 (641)
Q Consensus 97 ---------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~----~~~~ 163 (641)
..++...+..++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||++....... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhcCCC
Confidence 23677888999999999999999999 99999999999997 55799999999987643221 1223
Q ss_pred cCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 164 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 164 ~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+++.|+|||++. ..++.++||||||+++|+|++ |..||........+...+..+... ..+...++.+.+++.+||.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHcc
Confidence 4567899999765 468999999999999999997 899998755455555555554332 2344567889999999999
Q ss_pred -CCCCCCCHHHHHcC
Q 006528 242 -PASERLSAKDLLKD 255 (641)
Q Consensus 242 -dP~~RpSa~eLL~H 255 (641)
+|.+||++.+|++|
T Consensus 321 ~~p~~Rps~~eil~~ 335 (343)
T cd05103 321 GEPSQRPTFSELVEH 335 (343)
T ss_pred CChhhCcCHHHHHHH
Confidence 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=299.50 Aligned_cols=244 Identities=23% Similarity=0.386 Sum_probs=204.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCC----eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
+.+...+|.|+||.||+|.+...+ ..||+|.++... .......+..|+.+|+.++||||+++++++.+. ..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Ce
Confidence 456788999999999999998877 899999986543 223567899999999999999999999988765 56
Q ss_pred EEEEEccCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 77 VNMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~~--l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
.++||||+++++|.+++..... +++..+..++.||+.||.|||+.+ ++||||||+||+++ +.+.++|+|||++..
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCcee
Confidence 8999999999999999986554 999999999999999999999999 99999999999997 557999999999966
Q ss_pred ccCCCCc---cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 155 MQQPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 155 ~~~~~~~---~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
....... ...+++.|+|||.+. ..++.++||||||+++++|++ |..||.. .+...+...+..+..+. .+...+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~ 230 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCP 230 (258)
T ss_pred cccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCC
Confidence 5432111 123678999999775 458999999999999999998 7888876 55666677776665443 334467
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+.+++.+||. +|.+|||+.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 231 PEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 889999999999 8999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.06 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=194.8
Q ss_pred CEEEEEeCccCceEEEEEE----EcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
++++..+|.|+||+||+|. +..+|..||+|.+.... ......+.+|+++|+.++||||+++++++.......
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4788999999999999997 56689999999987442 455678899999999999999999999876665567
Q ss_pred EEEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 77 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
+++||||+++|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCcccccc
Confidence 89999999999999999764 46899999999999999999999999 99999999999997 4579999999999765
Q ss_pred cCCCC-----ccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCH---------------HHHHHH
Q 006528 156 QQPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------------AQIFKK 214 (641)
Q Consensus 156 ~~~~~-----~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~---------------~~i~~~ 214 (641)
..... ....++..|+|||++.+ .++.++||||||+++|||++|..|+...... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43221 11223456999998764 5889999999999999999987765431110 011111
Q ss_pred HHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 215 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 215 i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+..+... ......+..+.+||.+||. +|.+|||+.+|++
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2222111 1223446789999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=327.41 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=198.5
Q ss_pred EEEEEeCccCceEEEEEEEcC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~ 75 (641)
++...||.|+||+||+|.+.. .+..||+|.++... .....+.+.+|+++|+++. ||||++++++|... .
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~--~ 114 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS--G 114 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--C
Confidence 567889999999999998743 34579999986543 2345678999999999996 99999999998655 4
Q ss_pred eEEEEEccCCCCCHHHHHHhC-----------------------------------------------------------
Q 006528 76 TVNMITELFTSGNLRQYRKKH----------------------------------------------------------- 96 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~----------------------------------------------------------- 96 (641)
.+++|||||.+|+|.+++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 689999999999999998642
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC
Q 006528 97 -------------------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139 (641)
Q Consensus 97 -------------------------------------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~ 139 (641)
..+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~- 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA- 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe-
Confidence 23778888999999999999999999 99999999999998
Q ss_pred CCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHH
Q 006528 140 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 213 (641)
Q Consensus 140 ~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~ 213 (641)
+.+.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.........+.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 45799999999997553221 22345678899999775 458999999999999999997 8999987555555666
Q ss_pred HHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 214 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 214 ~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+..+..+ ..+...+..++++|.+||. +|.+||++.+|.+
T Consensus 352 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 66665433 2334557789999999999 8999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.83 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=199.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----CceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~----~~~l 77 (641)
.++..+|+|+||.||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++.... ...+
T Consensus 20 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 56788999999999999999999999999887532 12334567889999999999999999999876432 2347
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
+++++++ +++|.++++. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.....
T Consensus 98 ~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 98 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD 172 (345)
T ss_pred EEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEecccccccccc
Confidence 7888887 6799988765 46999999999999999999999999 99999999999997 557999999999875433
Q ss_pred CCCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcC-----------------
Q 006528 158 PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG----------------- 218 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g----------------- 218 (641)
......+++.|+|||++.+ .++.++||||||+++|+|++|+.||..... ......+...
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 173 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred -cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 2334578999999997754 478899999999999999999999975332 2222222110
Q ss_pred ---------CCCC---ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 219 ---------IKPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 219 ---------~~~~---~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
.... ......++.+++||.+||. +|.+||++.++|.||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0000 0011246789999999999 89999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=304.04 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=200.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||+||+|.+.. +..||+|.+.... ......+..|+.+++.++||||+++++++... ..+++||
T Consensus 9 ~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 81 (261)
T cd05148 9 TLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYIIT 81 (261)
T ss_pred HHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEEEE
Confidence 356779999999999999987 8999999987543 23456788999999999999999999987655 4589999
Q ss_pred ccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 82 ELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
||+++|+|.+++... ..++...++.++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhcCCcc
Confidence 999999999999863 45899999999999999999999999 99999999999997 55799999999997654322
Q ss_pred --CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHH
Q 006528 160 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 160 --~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
.....+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .+..+.+..+..+..+ ..+...++.+.++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEIYKI 236 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHHHHH
Confidence 12334567899999775 468899999999999999998 8999976 4455666666655333 2344567889999
Q ss_pred HHHhcC-CCCCCCCHHHHHc
Q 006528 236 IEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~ 254 (641)
|.+||. +|.+|||+.+|++
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 237 MLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=319.77 Aligned_cols=252 Identities=28% Similarity=0.391 Sum_probs=204.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC----ceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~----~~l 77 (641)
+++..+|.|++|+||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++..... ..+
T Consensus 18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 57889999999999999999999999999886532 223445678899999999999999999987754432 358
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++|+||+ +++|.+++.. .++++..++.++.||+.||.|||+.| |+||||||+||+++ +.|.+||+|||++.....
T Consensus 96 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLARHTDD 170 (343)
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEccccccccccc
Confidence 8999999 5799999876 56999999999999999999999999 99999999999997 558999999999976543
Q ss_pred CCCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCC--C------------
Q 006528 158 PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--P------------ 221 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~--~------------ 221 (641)
. .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||.... ....+..+..... +
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 171 E-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD-HIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred c-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 3 345578999999998753 57899999999999999999999997643 3333333322110 0
Q ss_pred ------------C---ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 222 ------------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 222 ------------~---~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
. ......++.+.+||.+||. +|.+|||+.+|+.||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0 0111236789999999999 899999999999999998544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=317.38 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=200.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC----ceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~----~~l 77 (641)
+++..+|.|+||+||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++..... ..+
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 467889999999999999999999999999875421 22344568899999999999999999998865432 346
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++|+||+.. +|..++ ...+++..++.++.||+.||.|||+++ |+||||||+||+++ ..|.+||+|||++.....
T Consensus 96 ~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 96 YLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADA 169 (342)
T ss_pred EEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCcCCCC
Confidence 899999964 787765 346899999999999999999999999 99999999999998 458999999999865433
Q ss_pred CCCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC--C-------------
Q 006528 158 PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--K------------- 220 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~--~------------- 220 (641)
......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ....+..+.... .
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 2234567899999998754 48899999999999999999999998633 222222222100 0
Q ss_pred -------C----Cc---cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 221 -------P----AS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 221 -------~----~~---l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
+ .. .....++.+.+||.+||. +|.+||++.++|.||||+.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0 00 011245678999999999 89999999999999999876543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.51 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=198.9
Q ss_pred CEEEEEeCccCceEEEEEEEcC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
+++...+|.|+||+||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++.+... .
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 76 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--G 76 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--C
Confidence 4677889999999999999753 33578888876432 234567899999999999999999999987655 4
Q ss_pred eEEEEEccCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccC
Q 006528 76 TVNMITELFTSGNLRQYRKKH------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~------------------------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLK 131 (641)
..++++||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 588999999999999998642 24788999999999999999999999 9999999
Q ss_pred CCcEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCC
Q 006528 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSEC 205 (641)
Q Consensus 132 p~NILl~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~ 205 (641)
|+|||++ +.+.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+
T Consensus 155 p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~- 232 (290)
T cd05045 155 ARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG- 232 (290)
T ss_pred hheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-
Confidence 9999997 55799999999987543221 12234567899999765 458999999999999999998 9999976
Q ss_pred CCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 206 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 206 ~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+..+...+..+.... .+...+..+++||.+||. +|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 45667777666654332 344556789999999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.63 Aligned_cols=241 Identities=18% Similarity=0.267 Sum_probs=192.9
Q ss_pred EeCccCceEEEEEEEcC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 6 SSRRIPAVDTYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
.+|+|+||+||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++...+ ...++|+|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e 77 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLP 77 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEe
Confidence 47999999999998653 44679999875322 3455678889999999999999999999765433 45789999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006528 83 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 159 (641)
Q Consensus 83 y~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~-- 159 (641)
|+.+|+|.+++.+. ..++...+..++.||+.||.|||+.+ ++||||||+|||++ +.+.+||+|||++..+....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcce
Confidence 99999999999764 44678888999999999999999998 99999999999997 55799999999987543211
Q ss_pred ----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhc-cCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 160 ----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 160 ----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG-~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.....+++.|+|||.+. ..++.++||||||+++|||++| .+||.. .+...+...+..+..+. .+...++.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPLY 232 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHHH
Confidence 12334577899999775 5689999999999999999995 555654 45666666666554332 2344567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcC
Q 006528 234 GFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
+++.+||. +|.+||++.++++.
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999 89999999999873
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=307.87 Aligned_cols=244 Identities=19% Similarity=0.231 Sum_probs=199.4
Q ss_pred EEEEEeCccCceEEEEEEEcC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 2 RILISSRRIPAVDTYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
+++..+|.|+||+||+|.+.. .+..||+|.++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~ 82 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--QP 82 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--Cc
Confidence 455678999999999999754 36789999987443 234557789999999999999999999987655 45
Q ss_pred EEEEEccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC
Q 006528 77 VNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 140 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~ 140 (641)
+++++||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-D 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-C
Confidence 88999999999999998632 34788899999999999999999999 99999999999997 5
Q ss_pred CCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHH
Q 006528 141 HGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKK 214 (641)
Q Consensus 141 ~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~ 214 (641)
++.+||+|||+++...... .....+++.|+|||.+. +.++.++||||||+++|||++ |..||.+ ....++...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~ 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEM 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 5789999999987553221 12334678999999765 568999999999999999998 8888876 455677777
Q ss_pred HHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 215 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 215 i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
+..+.... .+...+..+.+|+.+||. +|.+||++++|+..
T Consensus 239 i~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 77654332 334567789999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.37 Aligned_cols=246 Identities=20% Similarity=0.306 Sum_probs=201.2
Q ss_pred CEEEEEeCccCceEEEEEEEcC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
++++..+|.|+||+||+|.++. +...||+|.+.... .....+.+.+|+++|++++||||+++++++.+. .
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 81 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--E 81 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--C
Confidence 4688899999999999999754 34678888765432 233567899999999999999999999977554 5
Q ss_pred eEEEEEccCCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEE
Q 006528 76 TVNMITELFTSGNLRQYRKKHK---------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 146 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~---------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL 146 (641)
..++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ ..+.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCcEEE
Confidence 6899999999999999998765 6899999999999999999999999 99999999999997 4579999
Q ss_pred eecchhhhccCC---CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 006528 147 GDLGLAIAMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 221 (641)
Q Consensus 147 ~DFGlA~~~~~~---~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~ 221 (641)
+|||++...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... .....+..+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~~~~ 237 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAGKLE 237 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcCCcC
Confidence 999998644321 122335677899999765 457889999999999999998 78899763 345556666655444
Q ss_pred CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 222 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 222 ~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.......+..+.++|.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 33444567899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=305.39 Aligned_cols=249 Identities=20% Similarity=0.229 Sum_probs=202.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeC---CCceEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD---KKKTVN 78 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~---~~~~l~ 78 (641)
||...+|.|+|+-||++.+..++..+|+|+|.+.. .++.+...+|++..++++||||++++++.+.+ .+...|
T Consensus 24 ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 24 RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred EEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 78999999999999999999999999999999865 46788899999999999999999999887643 346799
Q ss_pred EEEccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 79 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
++++|+..|+|.+.+... ..+++..+..|+.+|++||++||+..||++||||||.|||+. +.+.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceEEEeccCccc
Confidence 999999999999998753 369999999999999999999999999999999999999997 468999999999865
Q ss_pred ccCCC--C---------ccccCCCCCCCcccccc----cCCcccccccccchhhhhhhccCCCCCCCCH-HHHHHHHHcC
Q 006528 155 MQQPT--A---------RSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIFKKVTSG 218 (641)
Q Consensus 155 ~~~~~--~---------~~~~GTp~ymAPEvl~~----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~-~~i~~~i~~g 218 (641)
..-.. . ..-..|..|+|||++.- ..++++|||||||++|.|+.|..||...... ..+.-.+..+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~ 258 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA 258 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence 43111 0 11235889999999873 3689999999999999999999999641100 0000111222
Q ss_pred CCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 219 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 219 ~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
..........+..+.+||++||+ ||.+||++.+|+.+
T Consensus 259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11111223367889999999999 99999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=322.80 Aligned_cols=267 Identities=22% Similarity=0.350 Sum_probs=231.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
-.+..+|.|+||+|.+|..+.+.+.+|||++++.-+.+. ++.+--..|-++|... +-|.+++++.+|..- +++|+|
T Consensus 352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTm--DRLyFV 428 (683)
T KOG0696|consen 352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRLYFV 428 (683)
T ss_pred ceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhh--hheeeE
Confidence 467889999999999999999999999999987766554 4455566788888877 678999999988665 469999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh--ccCC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~--~~~~ 158 (641)
|||+.||+|--.+++.+++.+..+..++.+|+-||-|||++| ||+||||.+|||++++ |+|||+|||+++. ....
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccccccccCCc
Confidence 999999999999999999999999999999999999999999 9999999999999855 8999999999964 3455
Q ss_pred CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHH
Q 006528 159 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
+.++++|||.|+|||++. ++|+..+|+||||++||||+.|++||.+ .+..++++.|.... ...++..+.++.++++
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehn--vsyPKslSkEAv~ick 582 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHN--VSYPKSLSKEAVAICK 582 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcc--CcCcccccHHHHHHHH
Confidence 678899999999999765 7899999999999999999999999998 67888999998753 3467777899999999
Q ss_pred HhcC-CCCCCCC-----HHHHHcCcccccccCCCCcCCCCCCcchh
Q 006528 238 KCLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQS 277 (641)
Q Consensus 238 kcL~-dP~~RpS-----a~eLL~Hpff~~~~~~~~~~~~~~~~~~~ 277 (641)
..|. .|.+|+. -.++-.||||+...|.......++.|..+
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkP 628 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKP 628 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCC
Confidence 9998 7999986 47899999999998877655555555443
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.67 Aligned_cols=244 Identities=18% Similarity=0.255 Sum_probs=199.0
Q ss_pred CEEEEEeCccCceEEEEEEEc-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
++++..+|+|+||.||+|.+. .++..||+|.+.... .......+.+|+.++++++||||+++++++.+. .
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--~ 81 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG--K 81 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--C
Confidence 467889999999999999974 367899999886443 334556788999999999999999999987665 4
Q ss_pred eEEEEEccCCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCC
Q 006528 76 TVNMITELFTSGNLRQYRKKHK----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~----------------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~ 133 (641)
.+++|+||+++|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence 5889999999999999997532 3678889999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCC
Q 006528 134 NIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKN 207 (641)
Q Consensus 134 NILl~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~ 207 (641)
|||++ ..+.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+
T Consensus 160 nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~-~~ 237 (288)
T cd05050 160 NCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG-MA 237 (288)
T ss_pred heEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CC
Confidence 99997 55799999999986543221 12234467799999765 568999999999999999997 7889876 34
Q ss_pred HHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 208 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 208 ~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+....+..+.... .+...+.++.+||.+||. +|.+||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 566666666554332 233456789999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.21 Aligned_cols=244 Identities=26% Similarity=0.353 Sum_probs=198.8
Q ss_pred EEEEEeCccCceEEEEEEEcC-------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 006528 2 RILISSRRIPAVDTYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK 73 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~-------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~ 73 (641)
.+...+|+|+||+||+|.+.. ++..||+|.++... .......+..|+.+++.+ +||||+++++++...
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~- 96 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD- 96 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence 467899999999999998743 33579999887542 234566788999999999 799999999988665
Q ss_pred CceEEEEEccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEE
Q 006528 74 KKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137 (641)
Q Consensus 74 ~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl 137 (641)
..+++||||+.+|+|.+++...+ .++...+..++.||+.||+|||++| ++||||||+|||+
T Consensus 97 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 173 (307)
T cd05098 97 -GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV 173 (307)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEE
Confidence 46899999999999999997642 3788999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHH
Q 006528 138 NGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 211 (641)
Q Consensus 138 ~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i 211 (641)
+ .++.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .+..++
T Consensus 174 ~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~ 251 (307)
T cd05098 174 T-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEEL 251 (307)
T ss_pred c-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHH
Confidence 8 45799999999986553211 11123457899999775 458999999999999999998 8888876 456666
Q ss_pred HHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 212 ~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
...+..+... ..+...+.++++||.+||. +|.+||++.+++++
T Consensus 252 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 6666665432 3344567899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.54 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=201.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCC--CeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeC--CCc
Q 006528 1 MRILISSRRIPAVDTYKAFDEFA--GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD--KKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~t--G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~--~~~ 75 (641)
+++...+|.|+||.||+|.+..+ |..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 36788999999999999999988 9999999986432 1223456788999999999 599999999876432 224
Q ss_pred eEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
.++++++|+. ++|..++.....+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceec
Confidence 5788999986 699999988888999999999999999999999999 99999999999997 4579999999999754
Q ss_pred cCC------CCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc----------
Q 006528 156 QQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---------- 217 (641)
Q Consensus 156 ~~~------~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~---------- 217 (641)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD-YVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC-HHHHHHHHHHHhCCCCHHHH
Confidence 321 1223578999999997653 58999999999999999999999997633 2212111110
Q ss_pred ----------------CCCCC---ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 218 ----------------GIKPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 218 ----------------g~~~~---~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
..... ......++.+++||.+||. +|.+|||+.+++.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00000 1112236789999999999 89999999999999999644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.97 Aligned_cols=243 Identities=24% Similarity=0.343 Sum_probs=197.9
Q ss_pred EEEEEeCccCceEEEEEEEc-------CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 006528 2 RILISSRRIPAVDTYKAFDE-------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK 73 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~-------~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~ 73 (641)
.+...+|.|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++++ +||||+++++++...
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE- 90 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-
Confidence 57789999999999999863 245579999876432 344567789999999999 699999999987654
Q ss_pred CceEEEEEccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEE
Q 006528 74 KKTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137 (641)
Q Consensus 74 ~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl 137 (641)
..+++||||+.+|+|.+++... ..++...+..++.||+.||.|||++| ++||||||+|||+
T Consensus 91 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 167 (314)
T cd05099 91 -GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLV 167 (314)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEE
Confidence 4689999999999999999763 24788999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHH
Q 006528 138 NGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 211 (641)
Q Consensus 138 ~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i 211 (641)
+ +++.+||+|||+++...... .....+++.|||||++. +.++.++||||||+++|+|++ |..||.. .....+
T Consensus 168 ~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~ 245 (314)
T cd05099 168 T-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEEL 245 (314)
T ss_pred c-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHH
Confidence 7 55799999999997654321 11223456899999775 458999999999999999999 8899976 456667
Q ss_pred HHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 212 ~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+..+..+.... .+...+..++++|.+||. +|.+||++.++++
T Consensus 246 ~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHRMD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 77766654332 234456789999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=342.38 Aligned_cols=147 Identities=25% Similarity=0.334 Sum_probs=132.7
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|.|+||+||+|.+..+|..||+|+++.... ........+..|+.+++.++||||+++++++... ..+|||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~lV 82 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNVYLV 82 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEEEEE
Confidence 3688999999999999999999999999999986543 2345567899999999999999999999887665 469999
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
|||+.+|+|.+++...+.+++..++.|+.||+.||.|||.++ |+||||||+|||++ ..|.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 999999999999998888999999999999999999999999 99999999999997 55899999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=347.23 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=196.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.+..+|..||+|++.... ...+...+++.+|+.++++++||||+++++++.+. ...++||
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~lyLVM 81 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVYYTM 81 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEEEEE
Confidence 68899999999999999999999999999987532 23345567899999999999999999999987665 5689999
Q ss_pred ccCCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecc
Q 006528 82 ELFTSGNLRQYRKKH-----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 150 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-----------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFG 150 (641)
||++||+|.+++... ..++...+..++.||+.||+|||++| |+||||||+||+++ ..|.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEEEecC
Confidence 999999999998642 23566788899999999999999999 99999999999997 55799999999
Q ss_pred hhhhccCC--------------------CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHH
Q 006528 151 LAIAMQQP--------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPA 209 (641)
Q Consensus 151 lA~~~~~~--------------------~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~ 209 (641)
++...... .....+||+.|||||++.+ .++.++|||||||++|||+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99754110 1123469999999998764 58999999999999999999999997633222
Q ss_pred HHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 210 QIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 210 ~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
...................++.+.+++.+||. +|.+||+..+.+.+
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22221111111111122446789999999999 89999886666654
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.11 Aligned_cols=244 Identities=20% Similarity=0.334 Sum_probs=199.3
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCe---EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~---~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
+++...+|.|+||.||+|.+..++. .||+|.++... .......+.+|+.+|++++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KPV 80 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Ccc
Confidence 3678899999999999999865543 79998876432 234567889999999999999999999988654 468
Q ss_pred EEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 78 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
++||||+++|+|.+++... +.+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCcccccc
Confidence 9999999999999999765 46899999999999999999999999 99999999999997 45799999999997654
Q ss_pred CCCC-----ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 157 QPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 157 ~~~~-----~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
.... ....+++.|+|||.+. +.++.++|+||||+++|++++ |..||.+. ...+....+..+..++ .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 235 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRLP-APMDCP 235 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcCC-CCCCCC
Confidence 3211 1122356899999876 468999999999999999886 99999764 3455666666653322 233456
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+.+.+++.+||. +|.+||++.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHH
Confidence 789999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=298.56 Aligned_cols=240 Identities=22% Similarity=0.369 Sum_probs=197.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.. ..++++
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYII 78 (260)
T ss_pred ceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEE
Confidence 468899999999999999964 678899998874432 24578899999999999999999997632 358899
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+.+|+|.+++... ..++...+..++.||+.||.|||+++ ++||||||+||+++ +.+.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceeecCCC
Confidence 9999999999998753 45899999999999999999999999 99999999999997 5579999999998665422
Q ss_pred C---CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ~---~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
. .....++..|+|||++. ..++.++||||||+++|+|++ |+.||.+. +.......+..+... ..+...+.+++
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPEELY 233 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence 1 12234567899999876 458899999999999999999 99999874 455556666555333 23344567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
++|.+||. +|.+||++++++.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 99999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.12 Aligned_cols=240 Identities=18% Similarity=0.277 Sum_probs=187.1
Q ss_pred EeCccCceEEEEEEEcCC--CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 6 SSRRIPAVDTYKAFDEFA--GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~t--G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
.+|+|+||+||+|..... ...+++|.+.... .......+.+|+.+++.++||||+++++.+... ..+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEec
Confidence 589999999999975433 2345666655432 344567899999999999999999999988765 458999999
Q ss_pred CCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--
Q 006528 84 FTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-- 157 (641)
Q Consensus 84 ~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~-- 157 (641)
+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcch
Confidence 9999999999764 34677888999999999999999999 99999999999997 457999999999854221
Q ss_pred --CCCccccCCCCCCCcccccc--------cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCC----CCC
Q 006528 158 --PTARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI----KPA 222 (641)
Q Consensus 158 --~~~~~~~GTp~ymAPEvl~~--------~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~----~~~ 222 (641)
.......+++.|+|||++.. .++.++||||||+++|||++ |..||.... ....+..+..+. ..+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhhcccccCCC
Confidence 11234567899999998742 35788999999999999997 567887644 344444433321 122
Q ss_pred ccccCChHHHHHHHHHhcCCCCCCCCHHHHHc
Q 006528 223 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254 (641)
Q Consensus 223 ~l~~~~~~~l~~LI~kcL~dP~~RpSa~eLL~ 254 (641)
.+....++.+.+++..||.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 33344577899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=301.37 Aligned_cols=244 Identities=21% Similarity=0.272 Sum_probs=201.6
Q ss_pred EEEEEeCccCceEEEEEEEcC----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 2 RILISSRRIPAVDTYKAFDEF----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
++...+|.|+||+||+|.+.. ++..||+|.+... ........+.+|+.+|+.++||||+++++++... ....
T Consensus 9 ~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~ 84 (280)
T cd05043 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEPP 84 (280)
T ss_pred EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCCC
Confidence 567889999999999999876 3688999987632 2345677889999999999999999999987664 3567
Q ss_pred EEEEccCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeec
Q 006528 78 NMITELFTSGNLRQYRKKH--------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 149 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~--------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DF 149 (641)
+++++|+++|+|..++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEECCC
Confidence 8999999999999999764 35889999999999999999999999 99999999999997 4579999999
Q ss_pred chhhhccCCCC----ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006528 150 GLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 223 (641)
Q Consensus 150 GlA~~~~~~~~----~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~ 223 (641)
|+++.+..... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||.. .++..+...+..+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 239 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYRLA- 239 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCCCC-
Confidence 99976533211 1234567899999776 458999999999999999999 9999987 46677777776654332
Q ss_pred cccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 224 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 224 l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.....++.+.+++.+||. +|++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 233456789999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=300.64 Aligned_cols=243 Identities=24% Similarity=0.363 Sum_probs=201.5
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
++++..+|.|+||+||+|.+..+|. .||+|.+.... .......+.+|+.++++++||||+++++++.. ..
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 82 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQ 82 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cc
Confidence 4678899999999999999877765 58888776443 34566788999999999999999999998875 45
Q ss_pred EEEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 77 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
.++|+||+.+|+|.+++... ..+++..+..|+.||+.||+|||+++ ++||||||+||+++ ..+.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCcccccc
Confidence 88999999999999999874 46999999999999999999999998 99999999999997 5579999999999765
Q ss_pred cCCCC----ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 156 QQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 156 ~~~~~----~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
..... ....+++.|+|||.+. ..++.++||||||+++|||++ |..||... ...++...+..+... ..+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 237 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERL-PQPPICT 237 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCCC-CCCCCCC
Confidence 43211 1122356899999775 568999999999999999998 99999874 566677777665332 3344567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+.+++.+||. +|.+||++.++++
T Consensus 238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 238 IDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 789999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=352.45 Aligned_cols=249 Identities=30% Similarity=0.481 Sum_probs=208.0
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC---------
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--------- 73 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~--------- 73 (641)
.+..+|+|+||.||+++++-+|.+||||+|.+.. +.....++.+|+.+|.+|+|||||+||.+|+...
T Consensus 483 EL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~ 559 (1351)
T KOG1035|consen 483 ELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV 559 (1351)
T ss_pred HHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence 3556899999999999999999999999998764 4466788999999999999999999997774210
Q ss_pred --------------------------------------------------------------------------------
Q 006528 74 -------------------------------------------------------------------------------- 73 (641)
Q Consensus 74 -------------------------------------------------------------------------------- 73 (641)
T Consensus 560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~ 639 (1351)
T KOG1035|consen 560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS 639 (1351)
T ss_pred ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence
Q ss_pred --------------------C--------ceEEEEEccCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCC
Q 006528 74 --------------------K--------KTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPP 124 (641)
Q Consensus 74 --------------------~--------~~l~lV~Ey~~gGsL~~~l~~~~~l-~e~~i~~i~~QIl~gL~yLHs~gp~ 124 (641)
+ .++||-||||+..+|++++..+... ....+|++++||+.||.|+|+.|
T Consensus 640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g-- 717 (1351)
T KOG1035|consen 640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG-- 717 (1351)
T ss_pred cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--
Confidence 0 3578999999998889888876654 57889999999999999999999
Q ss_pred eEeeccCCCcEEEeCCCCcEEEeecchhhhcc--------------------CCCCccccCCCCCCCcccccc----cCC
Q 006528 125 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--------------------QPTARSVIGTPEFMAPELYEE----EYN 180 (641)
Q Consensus 125 IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--------------------~~~~~~~~GTp~ymAPEvl~~----~y~ 180 (641)
||||||||.|||++ ..+.|||+|||+|+... .......+||.-|+|||++.+ .|+
T Consensus 718 iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999998 55799999999997510 012235689999999999863 599
Q ss_pred cccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc--cccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 006528 181 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 257 (641)
Q Consensus 181 ~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~--l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpf 257 (641)
.|+|+|||||+++||+. ||...+....+...++.+..|.. +....-+.-..+|.+||. ||++||||.|||++-|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l 873 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSEL 873 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence 99999999999999984 78877777788888888777655 122222456789999999 8999999999999999
Q ss_pred ccc
Q 006528 258 LQV 260 (641)
Q Consensus 258 f~~ 260 (641)
|..
T Consensus 874 lpp 876 (1351)
T KOG1035|consen 874 LPP 876 (1351)
T ss_pred CCc
Confidence 974
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=301.25 Aligned_cols=227 Identities=19% Similarity=0.253 Sum_probs=186.7
Q ss_pred cCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCCCCH
Q 006528 10 IPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL 89 (641)
Q Consensus 10 GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL 89 (641)
|++++||+|.|..+|..||+|.+.... ...+|...+....||||+++++++... ..+++||||+.+|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence 889999999999999999999987543 123455556666899999999988765 568999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccccCCCCC
Q 006528 90 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 169 (641)
Q Consensus 90 ~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~~~GTp~y 169 (641)
.+++.+...+++..+..|+.||+.||.|||+.+ |+||||||+||+++ ..|.++|+|||.+....... ....+++.|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~~-~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSC-DGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhcccccc-ccCCcCccc
Confidence 999988888999999999999999999999999 99999999999998 45799999999886554332 234567889
Q ss_pred CCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCC
Q 006528 170 MAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERL 247 (641)
Q Consensus 170 mAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~Rp 247 (641)
+|||.+. ..++.++||||||+++|+|++|..|+.... ..+ .......++...++.+++||.+||. ||.+||
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP--SGI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCc--hhc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999876 458899999999999999999998875421 111 1111122344567889999999998 899999
Q ss_pred CH-----HHHHcCccc
Q 006528 248 SA-----KDLLKDPFL 258 (641)
Q Consensus 248 Sa-----~eLL~Hpff 258 (641)
++ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.83 Aligned_cols=232 Identities=22% Similarity=0.339 Sum_probs=187.6
Q ss_pred EeCccCceEEEEEEEcCCC----------eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 6 SSRRIPAVDTYKAFDEFAG----------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG----------~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
.+|+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+|+.++||||+++++++.. .
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 73 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR---D 73 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---C
Confidence 5799999999999998877 457777665433 115778999999999999999999998876 3
Q ss_pred eEEEEEccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCC-------cEEEe
Q 006528 76 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-------EVKIG 147 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G-------~VKL~ 147 (641)
..++||||+.+|+|.+++...+ .++...+..++.||+.||.|||+++ |+||||||+|||++.+ + .+||+
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~-~~~~~~~~~~kl~ 150 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARY-GLNEGYVPFIKLS 150 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecC-ccccCCceeEEeC
Confidence 4689999999999999998766 7999999999999999999999999 9999999999999744 4 69999
Q ss_pred ecchhhhccCCCCccccCCCCCCCcccccc---cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006528 148 DLGLAIAMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 223 (641)
Q Consensus 148 DFGlA~~~~~~~~~~~~GTp~ymAPEvl~~---~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~ 223 (641)
|||++..... .....+++.|+|||++.. .++.++||||||+++|+|++ |..||.... ............ .
T Consensus 151 Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~~---~ 224 (259)
T cd05037 151 DPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQH---R 224 (259)
T ss_pred CCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcCC---C
Confidence 9999976543 233457788999998864 48899999999999999999 588887643 222222222211 1
Q ss_pred cccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 224 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 224 l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+......+.++|.+||. +|.+||++.++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 225 LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 122223789999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=298.27 Aligned_cols=244 Identities=21% Similarity=0.333 Sum_probs=198.7
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCe---EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~---~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
++....+|+|+||.||+|.+..++. .||+|.++... .....+.+..|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPA 81 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCc
Confidence 3567889999999999999976665 78888876432 244567789999999999999999999988655 458
Q ss_pred EEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 78 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
++||||+.+|+|.+++... +.+++..+..++.|++.||.|||+.+ ++||||||+||+++ +.+.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceecc
Confidence 8999999999999999764 57899999999999999999999999 99999999999997 55799999999986554
Q ss_pred CCCCc-----cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 157 QPTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 157 ~~~~~-----~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
..... ....++.|+|||++. ..++.++||||||+++|||++ |..||... +...+...+..+...+ .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~~-~~~~~~ 236 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRLP-APMDCP 236 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCCC-CCCCCC
Confidence 32111 112345799999776 468999999999999999997 99999763 4556666666543322 233456
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+.+++.+||. +|.+||++.++++
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 789999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.65 Aligned_cols=249 Identities=31% Similarity=0.432 Sum_probs=201.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|++|.||+|.+..+|..||+|.+.... ......+.+..|+.+++.++||||+++++++.+. ..+++|+
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~ 77 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVF 77 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEe
Confidence 57788999999999999999999999999988654 1233456778899999999999999999988765 5689999
Q ss_pred ccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~- 159 (641)
||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||+|+||+++ +.|.+||+|||++.......
T Consensus 78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCcc
Confidence 9998 5999999886 57999999999999999999999999 99999999999997 45899999999987654322
Q ss_pred -CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-------------------
Q 006528 160 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------------------- 217 (641)
Q Consensus 160 -~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~------------------- 217 (641)
.....+++.|+|||.+.+ .++.++||||||+++|+|++|.+||........+.+....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 223456788999997753 5889999999999999999999999764333222211110
Q ss_pred CCCCC-------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 218 GIKPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 218 g~~~~-------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
...+. ......+..+.+||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00000 0001125689999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=295.80 Aligned_cols=238 Identities=23% Similarity=0.343 Sum_probs=195.9
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|.|++|.||+|.+.. |..||+|.+..... ......+.+|++++++++||||+++++++... ...++|+||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~ 75 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELVP 75 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcCC
Confidence 58999999999999987 99999998876542 24567899999999999999999999988765 45889999999
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC----
Q 006528 86 SGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA---- 160 (641)
Q Consensus 86 gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~---- 160 (641)
+++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++ ..+.+||+|||++........
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceecc
Confidence 9999999976 456899999999999999999999999 99999999999997 557999999999875432111
Q ss_pred ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHH
Q 006528 161 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
....++..|+|||.+. +.++.++||||||+++|+|+| |..||... ........+..+. ....+...+.++.++|.+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 230 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGY-RMPAPQLCPEEIYRLMLQ 230 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCC-CCCCCccCCHHHHHHHHH
Confidence 1223356799999775 468999999999999999999 88898763 3445555555442 222344557899999999
Q ss_pred hcC-CCCCCCCHHHHHc
Q 006528 239 CLV-PASERLSAKDLLK 254 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~ 254 (641)
||. +|.+||++.++++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=298.61 Aligned_cols=244 Identities=18% Similarity=0.306 Sum_probs=198.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCe---EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~---~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
+++...+|+|+||.||+|.+..+|. .||+|.++... .......+..|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~ 80 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPV 80 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--Cce
Confidence 3678899999999999999987775 59999876432 355677899999999999999999999987654 458
Q ss_pred EEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 78 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
++||||+.+|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccccc
Confidence 8999999999999999764 56899999999999999999999999 99999999999998 45799999999986553
Q ss_pred CCCCc-c----c--cCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 006528 157 QPTAR-S----V--IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 227 (641)
Q Consensus 157 ~~~~~-~----~--~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~ 227 (641)
..... . . ..+..|+|||.+. ..++.++||||||+++|||++ |..||... +.......+....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~~~-~~~~ 235 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYRLP-PPMD 235 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCcCC-Cccc
Confidence 22110 1 1 1245799999876 468999999999999999886 99999763 4455566665443222 2234
Q ss_pred ChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 228 NDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+..+.+++.+||. +|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 46789999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.87 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=203.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+...+|+|+||+||+|.+..++..+++|.++...... .......+..|+.+++.++||||+++++++.+. ...++|
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFCII 80 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceEEE
Confidence 46788999999999999998888777777765433211 223445677899999999999999999988665 358899
Q ss_pred EccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 81 TELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++ + +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~-~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK-N-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee-c-CCEeecccCceeecC
Confidence 999999999998864 356999999999999999999999999 99999999999996 3 579999999986553
Q ss_pred CC--CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 157 QP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 157 ~~--~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.. ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||.. .........+..+..+ ..+...+.++.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP-SLPETYSRQLN 234 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCC-CCcchhcHHHH
Confidence 32 223456889999999775 4588899999999999999999999975 3444455555554333 34455678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 234 GFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
++|.+||. +|.+||++.++++||||
T Consensus 235 ~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 235 SIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=305.81 Aligned_cols=244 Identities=25% Similarity=0.354 Sum_probs=199.4
Q ss_pred EEEEEeCccCceEEEEEEEc-------CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 006528 2 RILISSRRIPAVDTYKAFDE-------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK 73 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~-------~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~ 73 (641)
++...+|.|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 93 (304)
T cd05101 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD- 93 (304)
T ss_pred eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEEEecC-
Confidence 46788999999999999752 345689999876432 234567899999999999 899999999988665
Q ss_pred CceEEEEEccCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEE
Q 006528 74 KKTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137 (641)
Q Consensus 74 ~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl 137 (641)
..+++||||+.+|+|.+++... ..++...+..++.||+.||.|||++| |+||||||+||++
T Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili 170 (304)
T cd05101 94 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLV 170 (304)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEE
Confidence 4689999999999999999764 24778889999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHH
Q 006528 138 NGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 211 (641)
Q Consensus 138 ~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i 211 (641)
+ ..+.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.. ....++
T Consensus 171 ~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~ 248 (304)
T cd05101 171 T-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEEL 248 (304)
T ss_pred c-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHH
Confidence 7 55799999999997654221 12234567899999775 458999999999999999998 7888876 456677
Q ss_pred HHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 212 ~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
...+..+... ..+...+..+++||.+||. +|.+||++.++++.
T Consensus 249 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 7777665433 2334557889999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.34 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=200.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|+||.||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||++++++|.... ..+++|+
T Consensus 13 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~lv~ 89 (328)
T cd07856 13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-EDIYFVT 89 (328)
T ss_pred EEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-CcEEEEe
Confidence 578899999999999999999999999998865432 2334567889999999999999999999886543 4678999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
||+ +++|..+++. ..+++..+..++.||+.||.|||+.+ |+||||+|+||+++ ..|.+||+|||++...... ..
T Consensus 90 e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~~-~~ 163 (328)
T cd07856 90 ELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQDPQ-MT 163 (328)
T ss_pred ehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccCCC-cC
Confidence 998 5689988864 45889999999999999999999999 99999999999997 5689999999998754332 23
Q ss_pred cccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHH---------------cC------
Q 006528 162 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT---------------SG------ 218 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~---------------~g------ 218 (641)
...+++.|+|||++.+ .++.++||||||+++|+|++|+.||.... ....+..+. .+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 4567889999998754 58999999999999999999999997632 211111110 00
Q ss_pred ---C--CC---CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 219 ---I--KP---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 219 ---~--~~---~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
. .+ .......++.++++|.+||. +|.+||++.+++.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0 00 01112346789999999998 89999999999999999744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=298.70 Aligned_cols=239 Identities=22% Similarity=0.363 Sum_probs=195.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++..+|.|++|+||+|.+. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++.. ..++++|
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~ 79 (260)
T cd05070 9 QLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIVT 79 (260)
T ss_pred hhhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEEE
Confidence 57889999999999999875 567799999875432 23568899999999999999999997632 3478999
Q ss_pred ccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 82 ELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
||+.+++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ +++.+||+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeeeccCcc
Confidence 999999999999763 45899999999999999999999999 99999999999997 55799999999997654322
Q ss_pred C---ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 A---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 ~---~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
. ....++..|+|||++. ..++.++||||||+++|+|++ |..||.+. +.......+..+..+ ..+...+..+++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCPISLHE 234 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHH
Confidence 1 1223456799999765 458899999999999999999 89999763 455555666554332 234455778999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 006528 235 FIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~ 254 (641)
|+.+||. +|.+|||+.+++.
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 9999998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.41 Aligned_cols=236 Identities=19% Similarity=0.294 Sum_probs=187.8
Q ss_pred EeCccCceEEEEEEEcCCCe-------EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEE
Q 006528 6 SSRRIPAVDTYKAFDEFAGI-------EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~-------~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~ 78 (641)
.+|.|+||+||+|.+..++. .||+|.+.... ....+.+..|+.+++.++||||+++++++.... ..+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~ 75 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ESI 75 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--CcE
Confidence 48999999999999866554 38888765332 345567889999999999999999999988764 478
Q ss_pred EEEccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCC-------cEEEeecc
Q 006528 79 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-------EVKIGDLG 150 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G-------~VKL~DFG 150 (641)
+||||+.+|+|..++...+ .+++..+..++.||+.||.|||+++ |+||||||+||+++.+.. .++++|||
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999999997654 5899999999999999999999999 999999999999974432 37999999
Q ss_pred hhhhccCCCCccccCCCCCCCcccccc--cCCcccccccccchhhhhhhc-cCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 006528 151 LAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKV 227 (641)
Q Consensus 151 lA~~~~~~~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG-~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~ 227 (641)
++..... .....+++.|+|||++.+ .++.++||||||+++|+|++| ..||... .+.......... ..++..
T Consensus 154 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~~~~~~~~~~---~~~~~~ 227 (258)
T cd05078 154 ISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQKKLQFYEDR---HQLPAP 227 (258)
T ss_pred cccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHHHHHHHHHcc---ccCCCC
Confidence 8865432 234568899999998864 478999999999999999998 4666543 333222222211 123334
Q ss_pred ChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 228 NDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.+..+.+||.+||. +|.+|||++++++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 45789999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.26 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=193.4
Q ss_pred CEEEEEeCccCceEEEEEEEcCCC--------------eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceee
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAG--------------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 66 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG--------------~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~ 66 (641)
+++...+|+|+||.||+|.+..++ ..||+|.++... .......+.+|+++|++++||||++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 467889999999999999886532 358999886432 345567799999999999999999999
Q ss_pred EEEEeCCCceEEEEEccCCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCc
Q 006528 67 KSWVDDKKKTVNMITELFTSGNLRQYRKKHK------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134 (641)
Q Consensus 67 ~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~N 134 (641)
+++... ..+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+|
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159 (295)
T ss_pred EEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhh
Confidence 988655 46899999999999999986532 3688899999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh--ccCCCCCCCC
Q 006528 135 IFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSECKN 207 (641)
Q Consensus 135 ILl~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt--G~~Pf~~~~~ 207 (641)
|+++ +++.+||+|||++....... .....+++.|+|||++. +.++.++||||||+++|+|++ +..||....
T Consensus 160 ill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~- 237 (295)
T cd05097 160 CLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS- 237 (295)
T ss_pred EEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-
Confidence 9997 55799999999986543221 12234567899999765 568999999999999999988 677887633
Q ss_pred HHHHHHHHHc------CCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 208 PAQIFKKVTS------GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 208 ~~~i~~~i~~------g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..++...+.. ...........++.+++||.+||. +|.+||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3333333221 111122233456789999999999 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.35 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=205.0
Q ss_pred EEEEeCccCceEEEEEEEcCCCe---E-EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGI---E-VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~---~-VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~ 78 (641)
+-+.+|.|+||.||+|.-+..+. . ||+|..+... ....+....+.+|.++|++++|||||++||+..... .++
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--Pl~ 237 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--PLM 237 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ccE
Confidence 34789999999999999876433 3 8999988533 235678899999999999999999999999877764 599
Q ss_pred EEEccCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 79 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~-l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
+|||+|.||+|.+||++.+. ++......++.+.+.||+|||+++ +|||||-..|+|++ ..+.+||+|||+++....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcc
Confidence 99999999999999999874 999999999999999999999999 99999999999997 445789999999865431
Q ss_pred CC-Cc-cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 158 PT-AR-SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 158 ~~-~~-~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.. .. ...-...|+|||.+. +-|++++|||||||++||+++ |..||.+ ....++..+|.....+...+...++.+.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 11 11 122456899999887 469999999999999999998 7889998 4566777888554455555667788899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.++.+|+. +|.+||++.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 99999999 9999999999876
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=297.99 Aligned_cols=243 Identities=23% Similarity=0.382 Sum_probs=197.2
Q ss_pred EEEEEeCccCceEEEEEEEcCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~ 78 (641)
.+...+|.|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~ 82 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PVW 82 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---CcE
Confidence 5677899999999999997654 4468988876443 245667899999999999999999999987643 367
Q ss_pred EEEccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 79 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
+||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeeccc
Confidence 9999999999999998744 5899999999999999999999999 99999999999998 457999999999875543
Q ss_pred CCC---ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHH
Q 006528 158 PTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 232 (641)
Q Consensus 158 ~~~---~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l 232 (641)
... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..... .+....+..+... ..+...++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCCCCCHHH
Confidence 221 1223456899999775 458899999999999999986 9999987543 4444555554333 2344557899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 233 KGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 233 ~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
+++|.+||. +|.+|||+.+++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999998 89999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=300.05 Aligned_cols=239 Identities=22% Similarity=0.314 Sum_probs=192.5
Q ss_pred EeCccCceEEEEEEEcCCCe--EEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEc
Q 006528 6 SSRRIPAVDTYKAFDEFAGI--EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~--~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
.+|.|+||.||+|.+..+|. .+|+|.++... .....+.+.+|+++++++ +||||+++++++... ..++++||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEE
Confidence 47999999999999988876 46777766321 334566789999999999 899999999988665 45899999
Q ss_pred cCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEE
Q 006528 83 LFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 146 (641)
Q Consensus 83 y~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL 146 (641)
|+++|+|.+++.... .+++..++.++.||+.||+|||+++ ++||||||+|||++ ..+.+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEEE
Confidence 999999999997543 4789999999999999999999999 99999999999997 4579999
Q ss_pred eecchhhhccCCC-CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006528 147 GDLGLAIAMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 223 (641)
Q Consensus 147 ~DFGlA~~~~~~~-~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~ 223 (641)
+|||++....... ......++.|+|||++. ..++.++||||||+++|||++ |..||.. .+....+..+..+... .
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~-~ 231 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-E 231 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-C
Confidence 9999985332111 11123356799999875 458899999999999999997 9999976 4455566666554332 2
Q ss_pred cccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 224 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 224 l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+...+..+.+++.+||. +|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 334456789999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.68 Aligned_cols=255 Identities=31% Similarity=0.438 Sum_probs=202.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
.+++.+|+|+||.||+|..+.++. ++|+|.++-++.. ...-...-+|+.+++.|+||||+.+..+|+.. ...+
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v 103 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--TGISMSACREIALLRELKHPNVISLVKVFLSH-DKKV 103 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceE
Confidence 457789999999999997665544 7899998866432 23345678999999999999999999998875 4689
Q ss_pred EEEEccCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC---CCcEEEeec
Q 006528 78 NMITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDL 149 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~---~G~VKL~DF 149 (641)
||++||.+. +|.+.|+-+ +.++...++.++.||+.|+.|||++- |+||||||.||||.++ .|.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999986 999999754 35899999999999999999999999 9999999999999865 379999999
Q ss_pred chhhhccCCC-----CccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCC------CCHHHH--HHH
Q 006528 150 GLAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSEC------KNPAQI--FKK 214 (641)
Q Consensus 150 GlA~~~~~~~-----~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~------~~~~~i--~~~ 214 (641)
|+++.+..+- ...++.|..|+|||++-+ .|+.++|||+.|||+.||+|.++-|.+. .+|.+. ..+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999887652 334677999999997754 5999999999999999999999887541 112111 111
Q ss_pred HHc--CCC-----------C----------------C------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 215 VTS--GIK-----------P----------------A------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 215 i~~--g~~-----------~----------------~------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
|.. |.+ | . ...+..++...+|+.++|. ||-+|.||++.|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 111 000 0 0 0012345668899999999 99999999999999999
Q ss_pred cccc
Q 006528 259 QVEN 262 (641)
Q Consensus 259 ~~~~ 262 (641)
....
T Consensus 341 ~~d~ 344 (438)
T KOG0666|consen 341 TEDP 344 (438)
T ss_pred ccCC
Confidence 8664
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=295.24 Aligned_cols=242 Identities=17% Similarity=0.353 Sum_probs=198.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++...+|.|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++||||+++++++... ..+++|
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLV 77 (256)
T ss_pred eEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEE
Confidence 468899999999999999885 477899998764332 234688999999999999999999987655 458999
Q ss_pred EccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
+||+.+|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCc
Confidence 9999999999999764 46899999999999999999999999 99999999999997 55799999999986543322
Q ss_pred Cc---cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 AR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 ~~---~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
.. ...++..|+|||++. +.++.++||||||+++|+|++ |..||.. .....+...+..+... ..+...+..+.+
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVYE 232 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHHH
Confidence 11 223457899999876 568899999999999999998 8999976 4455666666655332 223445788999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcC
Q 006528 235 FIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~H 255 (641)
|+.+||. +|.+||++.+++++
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHh
Confidence 9999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=296.17 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=197.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++...+|.|++|+||+|.+. .+..||+|.+..... ....+.+|+.++++++||||+++++++... ..+++|
T Consensus 8 ~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 79 (261)
T cd05034 8 LKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIYIV 79 (261)
T ss_pred eeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceEEE
Confidence 367889999999999999985 557899998875432 245688999999999999999999987654 458999
Q ss_pred EccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+.+++|.+++.... .++...+..++.||+.||.|||+++ ++|+||||+||+++ +++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccceeccch
Confidence 99999999999997653 6899999999999999999999999 99999999999997 5589999999998765432
Q ss_pred C---CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ~---~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
. .....++..|+|||.+. ..++.++||||||+++|+|++ |+.||.+. ........+..+.... .+...+..++
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRMP-RPPNCPEELY 234 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHH
Confidence 1 11223456899999776 458899999999999999998 99999764 4555566665543322 2233467899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+++.+||. +|.+||++++++.
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHH
Confidence 99999999 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.75 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=188.7
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
..+|.|+||+||+|.-. +|..||||++....... ...|.+|+.+|.+++|||+|+++|||.+... ..+||+||+
T Consensus 81 ~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym 154 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYM 154 (361)
T ss_pred cceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEcc
Confidence 46899999999999974 55899999776543211 3449999999999999999999999987653 588999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC-CCC
Q 006528 85 TSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTA 160 (641)
Q Consensus 85 ~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~-gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~-~~~ 160 (641)
++|+|.++|.... .+++....+|+.++++||+|||.. .|||||||||+.|||+|. +...||+|||+|+.... ...
T Consensus 155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~aKlsDFGLa~~~~~~~~~ 233 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNAKLSDFGLAKLGPEGDTS 233 (361)
T ss_pred CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCEEccCccCcccCCccccc
Confidence 9999999998655 899999999999999999999995 458999999999999984 46999999999966543 222
Q ss_pred -ccc-cCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCC--CHHHHHH----HHHcCC----CCCccc-c
Q 006528 161 -RSV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFK----KVTSGI----KPASLA-K 226 (641)
Q Consensus 161 -~~~-~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~--~~~~i~~----~i~~g~----~~~~l~-~ 226 (641)
.+. .||..|+|||.+. +..+.++||||||++++||+||+.|..... ....+.. .+..+. ..+.+. .
T Consensus 234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 222 8999999999876 679999999999999999999998876422 1111222 222221 111221 2
Q ss_pred CCh--HH---HHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 227 VND--PQ---IKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 227 ~~~--~~---l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+ .+ +..+..+|+. +|.+||++.++++
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 222 23 4456678998 7999999999755
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=334.57 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=187.3
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCe-EEEEEEEe-------------cccccCChhhHHHHHHHHHHHHhCCCCCcceee
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI-EVAWSRVK-------------IDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 66 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~-~VAIK~v~-------------~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~ 66 (641)
.+++..||.|+||+||+|..+.... .++.|.+. .............+.+|+.+|++++||||++++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 3688999999999999987654332 22222110 011112233456788999999999999999999
Q ss_pred EEEEeCCCceEEEEEccCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCC
Q 006528 67 KSWVDDKKKTVNMITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141 (641)
Q Consensus 67 ~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~ 141 (641)
+++... ...++|++++. ++|..++... .......++.++.||+.||.|||+++ |+||||||+|||++ ..
T Consensus 230 ~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~-~~ 303 (501)
T PHA03210 230 EILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN-CD 303 (501)
T ss_pred EEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CC
Confidence 998766 45889999996 5777776532 23446778899999999999999999 99999999999997 55
Q ss_pred CcEEEeecchhhhccCC---CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCC-CCCC-CCH-HHHHHH
Q 006528 142 GEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYP-YSEC-KNP-AQIFKK 214 (641)
Q Consensus 142 G~VKL~DFGlA~~~~~~---~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~P-f~~~-~~~-~~i~~~ 214 (641)
|.+||+|||++..+... ......||+.|+|||++.+ .|+.++|||||||++|||++|.+| |... ..+ .++.+.
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 79999999999765432 2234679999999998764 599999999999999999999864 4322 122 222222
Q ss_pred HHcCC-----CC-------------------Cc----c-ccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 215 VTSGI-----KP-------------------AS----L-AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 215 i~~g~-----~~-------------------~~----l-~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+..-. .+ .. + ....+..+.++|.+||. ||.+||||.|+|.||||....
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 21100 00 00 0 01124567888999999 999999999999999997654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=298.19 Aligned_cols=240 Identities=21% Similarity=0.341 Sum_probs=195.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.++...+|.|+||+||+|.+..++ .||+|.++.... ..+.+.+|+++++.++||||+++++++.. ...++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEE
Confidence 368899999999999999987664 599999875332 23468899999999999999999987632 347899
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++ +++.+||+|||.+..+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCceeecccc
Confidence 9999999999999864 35889999999999999999999999 99999999999997 5579999999999765433
Q ss_pred CC---ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 TA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ~~---~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.. ....++..|+|||++. ..++.++||||||+++|+|+| |..||... ...++...+..+.... .....+..+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~ 233 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMP-CPPECPESLH 233 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCCC-CccccCHHHH
Confidence 21 1234567899999775 568999999999999999999 88898763 4455556655543322 2334567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
++|.+||. +|.+||++.+++.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 99999999 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=292.82 Aligned_cols=239 Identities=22% Similarity=0.319 Sum_probs=194.6
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.+|.|+||.||+|... ++..||+|.+.... .......+.+|+++++.++||||+++++++... ...++||||++
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELVP 75 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECCC
Confidence 4799999999999864 68899999876432 234456788999999999999999999987655 45899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---Cc
Q 006528 86 SGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT---AR 161 (641)
Q Consensus 86 gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~---~~ 161 (641)
+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....... ..
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccCC
Confidence 99999998754 45899999999999999999999999 99999999999997 56799999999986543221 11
Q ss_pred cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHh
Q 006528 162 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
...+++.|+|||++. +.++.++||||||+++|+|++ |..||... ........+..+... ..+...+..+.+|+.+|
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHH
Confidence 224466799999876 458899999999999999998 99999874 445555555554332 23344568899999999
Q ss_pred cC-CCCCCCCHHHHHcC
Q 006528 240 LV-PASERLSAKDLLKD 255 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~H 255 (641)
|. +|.+||++.++++.
T Consensus 231 l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 231 WDYKPENRPKFSELQKE 247 (250)
T ss_pred cccCcccCCCHHHHHHH
Confidence 99 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=296.10 Aligned_cols=239 Identities=22% Similarity=0.341 Sum_probs=194.4
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++|+||+|.+..+ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 9 RLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred eeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEE
Confidence 5778999999999999998655 459999876433 223568899999999999999999987632 3478999
Q ss_pred ccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 82 ELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++ +.+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceEccCCc
Confidence 999999999999764 34889999999999999999999999 99999999999997 55799999999997654322
Q ss_pred C---ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 A---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 ~---~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
. ....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+. ........+..+..+ ..+...+..+++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGCPESLHE 234 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcccCHHHHH
Confidence 1 1234567899999775 458899999999999999999 89999873 445555566554332 233445678999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 006528 235 FIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+|.+||. +|.+||+++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 9999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=320.95 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=198.9
Q ss_pred EEEEEeCccCceEEEEEEEc-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~ 75 (641)
.+...+|.|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+|.++. ||||+++++++... .
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~--~ 114 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG--G 114 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--C
Confidence 35578999999999999953 456789999997543 2334567899999999997 99999999998765 4
Q ss_pred eEEEEEccCCCCCHHHHHHhCC----------------------------------------------------------
Q 006528 76 TVNMITELFTSGNLRQYRKKHK---------------------------------------------------------- 97 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~---------------------------------------------------------- 97 (641)
.+++||||+.+|+|.+++.+.+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 5899999999999999996532
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEE
Q 006528 98 ----------------------------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137 (641)
Q Consensus 98 ----------------------------------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl 137 (641)
.++...+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl 272 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI 272 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence 2566778899999999999999998 9999999999999
Q ss_pred eCCCCcEEEeecchhhhccCC----CCccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHH
Q 006528 138 NGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 211 (641)
Q Consensus 138 ~~~~G~VKL~DFGlA~~~~~~----~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i 211 (641)
+ +.+.+||+|||+++..... ......+++.|||||.+. ..++.++||||||+++|||++ |+.||.........
T Consensus 273 ~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 C-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred e-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 8 4579999999999754321 122345778999999776 458899999999999999998 89999875555555
Q ss_pred HHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 212 ~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
...+..+..+ ..+...+.++.+|+.+||. +|.+||++++|++.
T Consensus 352 ~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5666655332 2344557899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=305.21 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=197.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
++++..+|+|+||.||+|.+..+|. .||+|.+.... .+.....+.+|+.+++.++||||+++++++... .
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~ 82 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---T 82 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---C
Confidence 4678899999999999999988886 46777765432 234445688999999999999999999987643 3
Q ss_pred EEEEEccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 77 VNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
.++++||+++|+|.+++..+. .+++..+..|+.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEccccccccc
Confidence 568999999999999998754 5899999999999999999999999 99999999999997 5579999999999765
Q ss_pred cCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 156 QQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 156 ~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
.... .....+++.|+|||.+. ..++.++||||||+++|||++ |..||.+. ........+..+..+. .+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 237 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLP-QPPICT 237 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCCC-CCCCCC
Confidence 4321 12234567899999776 458999999999999999997 89999763 3444444554443332 234456
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
..+.+++.+||. +|.+||+++++++.
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999998 89999999999884
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=331.39 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=211.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeC---CCceE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD---KKKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~---~~~~l 77 (641)
.|.-.+|.|.+|.||++.+..+|..+|+|+..... +..+.+..|.++|+.+ +|||++.||++|.-. ..+.+
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 57788999999999999999999999999766543 3345678899999888 799999999999753 24679
Q ss_pred EEEEccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 78 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
|||||||.|||.-+++++. .++.+..|..+++.++.||.+||.+. +||||||-.|||++ ..|.|||+|||++..+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEEeeeeeeeee
Confidence 9999999999999999864 56999999999999999999999998 99999999999998 4589999999999776
Q ss_pred cCC--CCccccCCCCCCCccccc------ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc-cc
Q 006528 156 QQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-AK 226 (641)
Q Consensus 156 ~~~--~~~~~~GTp~ymAPEvl~------~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l-~~ 226 (641)
... ...+++|||+|||||++. ..|+..+|+||||++..||.-|.+|+.+.. +...+-.|..+.+|... +.
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-PmraLF~IpRNPPPkLkrp~ 252 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPPPKLKRPK 252 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-hhhhhccCCCCCCccccchh
Confidence 543 456789999999999885 238889999999999999999999998844 44444444444444433 56
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
..+.++.+||..||. |..+||+..++|+|||+.
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 678899999999999 899999999999999998
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.18 Aligned_cols=247 Identities=20% Similarity=0.276 Sum_probs=207.2
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEe--CCCceEEEEEc
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVD--DKKKTVNMITE 82 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~--~~~~~l~lV~E 82 (641)
.+|-|-.|.|..++++.||+.+|+|.+.- ..+..+|+++.-.. .|||||.++++|.. ....++.+|||
T Consensus 69 vLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 69 VLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 47888899999999999999999997652 23567899876555 69999999998854 33568899999
Q ss_pred cCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC--CCcEEEeecchhhhcc-C
Q 006528 83 LFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ-Q 157 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~--l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~--~G~VKL~DFGlA~~~~-~ 157 (641)
.+.||.|+..+..++. |++..+..+++||..|+.|||+.+ |.||||||+|+|..+. +..+||+|||+|+... .
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 9999999999987654 999999999999999999999999 9999999999999643 3469999999998765 3
Q ss_pred CCCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCC---CHHHHHHHHHcCCC--CCccccCChHH
Q 006528 158 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIK--PASLAKVNDPQ 231 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~---~~~~i~~~i~~g~~--~~~l~~~~~~~ 231 (641)
....+.+-||.|.|||++. ++|+...|+||+|++||-|++|.+||.... -......+|..|.. |..-+...+..
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~ 297 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEA 297 (400)
T ss_pred ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHH
Confidence 4566778899999999997 569999999999999999999999996422 23445566776643 33344555788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCcccccccC
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
++++|+++|. +|++|+|+.+++.|||+.....
T Consensus 298 aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 298 AKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred HHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 9999999998 9999999999999999976544
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=297.87 Aligned_cols=246 Identities=22% Similarity=0.370 Sum_probs=197.1
Q ss_pred EEEEEeCccCceEEEEEEEc----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 2 RILISSRRIPAVDTYKAFDE----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
+++..+|+|+||+||+|... .++..||+|.++.... ....+.+.+|+.+++.++||||+++++++........
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56788999999999999864 3588999999875542 1356789999999999999999999998877556678
Q ss_pred EEEEccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 78 NMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++. ++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVES-EDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcC-CCCEEEcccccccccc
Confidence 99999999999999998755 6999999999999999999999999 999999999999984 4799999999997654
Q ss_pred CCCC-----ccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCH--------------HHHHHHHH
Q 006528 157 QPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP--------------AQIFKKVT 216 (641)
Q Consensus 157 ~~~~-----~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~--------------~~i~~~i~ 216 (641)
.... ....++..|+|||.+. ..++.++||||||+++|+|+||..|+...... ..+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 2211 1223456799999765 46889999999999999999999998653211 11222222
Q ss_pred cCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 217 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 217 ~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+.. ...+...+.++.+++.+||. +|.+||++.+++.
T Consensus 241 ~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222 12233445789999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.02 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=191.9
Q ss_pred CEEEEEeCccCceEEEEEEEcC----------------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcce
Q 006528 1 MRILISSRRIPAVDTYKAFDEF----------------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 64 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~----------------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk 64 (641)
+++...+|.|+||+||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3678899999999999986532 45579999886442 3445678899999999999999999
Q ss_pred eeEEEEeCCCceEEEEEccCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCC
Q 006528 65 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133 (641)
Q Consensus 65 ~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~-----------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~ 133 (641)
+++++... ..+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ ++||||||+
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~ 159 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATR 159 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChh
Confidence 99988765 45899999999999999997643 3667889999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh--ccCCCCCCC
Q 006528 134 NIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSECK 206 (641)
Q Consensus 134 NILl~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt--G~~Pf~~~~ 206 (641)
|||++ ..+.++|+|||++..+.... .....+++.|+|||+.. +.++.++|||||||++|||++ |..||....
T Consensus 160 Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 160 NCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred eEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99997 55799999999987553322 11233467899999654 568999999999999999998 778987633
Q ss_pred CHHHHHHHHHc----C--CCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 207 NPAQIFKKVTS----G--IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 207 ~~~~i~~~i~~----g--~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..++...... . ......+...++.+++||.+||. +|.+||++.+|++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 239 -DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred -hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3333322211 1 01111223345789999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=301.09 Aligned_cols=236 Identities=18% Similarity=0.262 Sum_probs=185.7
Q ss_pred EeCccCceEEEEEEEcCC------------------------CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC
Q 006528 6 SSRRIPAVDTYKAFDEFA------------------------GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 61 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~t------------------------G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN 61 (641)
.||.|+||.||+|....+ ...||+|.+.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 589999999999985332 2458888875432 234567889999999999999
Q ss_pred cceeeEEEEeCCCceEEEEEccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC
Q 006528 62 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 140 (641)
Q Consensus 62 IVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~ 140 (641)
|+++++++... ...++||||+++|+|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 99999998765 458899999999999999875 467899999999999999999999998 9999999999999732
Q ss_pred ------CCcEEEeecchhhhccCCCCccccCCCCCCCcccccc--cCCcccccccccchhhhhh-hccCCCCCCCCHHHH
Q 006528 141 ------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV-TFEYPYSECKNPAQI 211 (641)
Q Consensus 141 ------~G~VKL~DFGlA~~~~~~~~~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~Eml-tG~~Pf~~~~~~~~i 211 (641)
.+.+||+|||++...... ....+++.|+|||.+.+ .++.++||||||+++|||+ +|..||.... +.+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHH
Confidence 224899999988543221 23457888999997753 4899999999999999995 7899997643 3333
Q ss_pred HHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 212 ~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
...+.... ..+....+.+.++|.+||. +|.+||++.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222211 1222335689999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.45 Aligned_cols=245 Identities=25% Similarity=0.348 Sum_probs=198.5
Q ss_pred EEEEEeCccCceEEEEEEEcC-------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 006528 2 RILISSRRIPAVDTYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK 73 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~-------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~ 73 (641)
++...+|.|+||.||+|.+.. .+..||+|.++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD- 90 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence 577889999999999998643 23478999876432 334567899999999999 899999999988655
Q ss_pred CceEEEEEccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEE
Q 006528 74 KKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137 (641)
Q Consensus 74 ~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl 137 (641)
..+++++||+++|+|.+++.... .++...+..++.||+.||.|||++| |+||||||+|||+
T Consensus 91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill 167 (334)
T cd05100 91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLV 167 (334)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEE
Confidence 46899999999999999997532 3778889999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHH
Q 006528 138 NGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 211 (641)
Q Consensus 138 ~~~~G~VKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i 211 (641)
+ ..+.+||+|||+++...... .....+++.|+|||++. ..++.++||||||+++|||++ |..||.. .+....
T Consensus 168 ~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~ 245 (334)
T cd05100 168 T-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEEL 245 (334)
T ss_pred c-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHH
Confidence 7 45799999999997554321 11223456799999775 458999999999999999998 8889976 456667
Q ss_pred HHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 006528 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 256 (641)
Q Consensus 212 ~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hp 256 (641)
...+..+..+. .+...+..+.+||.+||. +|.+||++.+++.+-
T Consensus 246 ~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 246 FKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 77776654332 233456789999999999 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=297.47 Aligned_cols=235 Identities=18% Similarity=0.313 Sum_probs=185.1
Q ss_pred EeCccCceEEEEEEEcC------------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 006528 6 SSRRIPAVDTYKAFDEF------------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~------------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~ 73 (641)
.+|.|+||+||+|.... ....||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~- 76 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCVRD- 76 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 57999999999998532 23468888765432 34456788999999999999999999988765
Q ss_pred CceEEEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCc-------EE
Q 006528 74 KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-------VK 145 (641)
Q Consensus 74 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~-------VK 145 (641)
...++||||+++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |. +|
T Consensus 77 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~~~~~~~~~ 152 (262)
T cd05077 77 -VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLARE-GIDGECGPFIK 152 (262)
T ss_pred -CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecC-CccCCCCceeE
Confidence 4578999999999999998764 56999999999999999999999999 9999999999999633 33 89
Q ss_pred EeecchhhhccCCCCccccCCCCCCCccccc--ccCCcccccccccchhhhhh-hccCCCCCCCCHHHHHHHHHcCCCCC
Q 006528 146 IGDLGLAIAMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV-TFEYPYSECKNPAQIFKKVTSGIKPA 222 (641)
Q Consensus 146 L~DFGlA~~~~~~~~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~Eml-tG~~Pf~~~~~~~~i~~~i~~g~~~~ 222 (641)
++|||++..... .....+++.|+|||++. ..++.++|||||||++|+|+ +|..||... ...+.. ....+...
T Consensus 153 l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~- 227 (262)
T cd05077 153 LSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM- 227 (262)
T ss_pred eCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc-
Confidence 999999865432 23456788999999875 45899999999999999997 588888753 222222 22222111
Q ss_pred ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 223 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 223 ~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.....++++++||.+||. +|.+||++.+|+++
T Consensus 228 -~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 -LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 122235689999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=336.23 Aligned_cols=243 Identities=22% Similarity=0.305 Sum_probs=204.4
Q ss_pred CEEEEEeCccCceEEEEEEEc-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCc
Q 006528 1 MRILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~ 75 (641)
++++.++|.|+||+||+|.-. .....||||.++... +.+..+.|.+|+.+|..|+|||||+++|++... +
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~ 562 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREG--D 562 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--C
Confidence 467788999999999999863 344579999988654 455788999999999999999999999987665 5
Q ss_pred eEEEEEccCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCC
Q 006528 76 TVNMITELFTSGNLRQYRKKHK--------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~--------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~ 141 (641)
.++||+|||..|+|.+||..+. +++..+...++.||+.|+.||-++. ++||||-..|+||. ++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-EN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-cc
Confidence 6999999999999999997431 2888999999999999999999998 99999999999996 55
Q ss_pred CcEEEeecchhhhccCCCCccc----cCCCCCCCcc-cccccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHH
Q 006528 142 GEVKIGDLGLAIAMQQPTARSV----IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 215 (641)
Q Consensus 142 G~VKL~DFGlA~~~~~~~~~~~----~GTp~ymAPE-vl~~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i 215 (641)
-.|||+|||+++..-...-+.. .-..+||||| ++.++|++++|||||||+|||+++ |..||.+..| ++.++.|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-HHHHHHH
Confidence 6999999999976533222211 2256899999 667899999999999999999996 8999998655 5566778
Q ss_pred HcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHH
Q 006528 216 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 253 (641)
Q Consensus 216 ~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL 253 (641)
+.|.. -.-+...+.++..|+..||+ .|.+||+++||-
T Consensus 719 ~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 88766 44566778899999999999 899999999984
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=296.37 Aligned_cols=239 Identities=24% Similarity=0.374 Sum_probs=193.7
Q ss_pred EeCccCceEEEEEEEcCCC------eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 6 SSRRIPAVDTYKAFDEFAG------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG------~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
.+|.|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEE
Confidence 4899999999999986544 789999876432 234466788999999999999999999988665 45899
Q ss_pred EEccCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCC-----cEEEe
Q 006528 80 ITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-----EVKIG 147 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~-------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G-----~VKL~ 147 (641)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ + .+||+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEK-GYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecC-CCCCCcceEEC
Confidence 99999999999999742 34788999999999999999999999 9999999999999743 4 79999
Q ss_pred ecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 006528 148 DLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 221 (641)
Q Consensus 148 DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~ 221 (641)
|||++....... .....+++.|+|||++. +.++.++||||||+++|+|++ |..||... +..+....+..+...
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCcc
Confidence 999986553221 12234578899999776 468999999999999999998 99999763 445555555544322
Q ss_pred CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 222 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 222 ~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+...+..+.+||.+||. +|.+||+++++++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 -QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2334457789999999999 8999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.29 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=201.5
Q ss_pred EEEEEeCccCceEEEEEEEcC-CCeEEEEEEEeccccc------CChhhHHHHHHHHHHHHh-CCCCCcceeeEEEEeCC
Q 006528 2 RILISSRRIPAVDTYKAFDEF-AGIEVAWSRVKIDDVL------QLPGDLQKLYSEVHLLKS-LKDDNVVKFYKSWVDDK 73 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~-tG~~VAIK~v~~~~~~------~~~~~~~~l~~Ei~iLk~-L~HpNIVk~~~~~~~~~ 73 (641)
.+...+|.|+||.||+|.+.. .+..+|+|.+...... .......++.+|+.++++ ++||||+++++++...
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~- 81 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN- 81 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC-
Confidence 467789999999999999988 7889999998754321 223455678889998875 7999999999988665
Q ss_pred CceEEEEEccCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCCCCcEEEee
Q 006528 74 KKTVNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGD 148 (641)
Q Consensus 74 ~~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~~G~VKL~D 148 (641)
..+++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++ ..+.+||+|
T Consensus 82 -~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~d 157 (269)
T cd08528 82 -DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTITD 157 (269)
T ss_pred -CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEec
Confidence 568999999999999998743 3468999999999999999999996 56 99999999999997 557999999
Q ss_pred cchhhhccCC-CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 006528 149 LGLAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 226 (641)
Q Consensus 149 FGlA~~~~~~-~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~ 226 (641)
||++...... ......|+..|+|||.+.+ .++.++|+||||+++|+|++|+.||.. .+.......+..+...+....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCcc
Confidence 9999765433 2334578999999997764 588999999999999999999999976 344455555555444333334
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
..++.+.+||.+||. +|.+||++.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 567899999999998 89999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.43 Aligned_cols=248 Identities=19% Similarity=0.251 Sum_probs=198.3
Q ss_pred CEEEEEeCccCceEEEEEEEc---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC---
Q 006528 1 MRILISSRRIPAVDTYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~--- 74 (641)
+++...+|+|+||+||+|.+. .+|..||+|++.... ......+.+.+|+++|+.++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 356778999999999999864 467899999987543 234456778999999999999999999998865432
Q ss_pred -ceEEEEEccCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEe
Q 006528 75 -KTVNMITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 147 (641)
Q Consensus 75 -~~l~lV~Ey~~gGsL~~~l~~~------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~ 147 (641)
...+++++|+.+|+|.+++... ..++...++.++.||+.||+|||+++ |+||||||+||+++ +.+.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEEC
Confidence 1346889999999999887532 24789999999999999999999999 99999999999997 55799999
Q ss_pred ecchhhhccCCC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 006528 148 DLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 221 (641)
Q Consensus 148 DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~ 221 (641)
|||++....... .....+++.|++||.+. ..++.++||||||+++|+|++ |..||.. .+...++..+..+...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence 999987653221 12234567899999776 458889999999999999999 8899876 4456666666554332
Q ss_pred CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 222 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 222 ~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
. .....+..+.+++.+||. +|.+||++.+++.+
T Consensus 235 ~-~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 K-QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred C-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 223456789999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=291.07 Aligned_cols=240 Identities=21% Similarity=0.352 Sum_probs=195.3
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+++...+|+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 8 ~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYII 78 (260)
T ss_pred eeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEE
Confidence 368899999999999999865 45679999876432 235678899999999999999999998765 457899
Q ss_pred EccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
|||+++|+|.+++... ..++...+..++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcceeeccCC
Confidence 9999999999999763 45788899999999999999999998 99999999999997 4579999999998655432
Q ss_pred CC---ccccCCCCCCCcccccc-cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHH
Q 006528 159 TA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ~~---~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
.. ....++..|+|||++.. .++.++|+||||+++|+|+| |..||... +...+...+..+.... .....+.++.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPENCPEELY 233 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCCC-CcccCCHHHH
Confidence 11 12235667999998764 58889999999999999998 89999863 4455555555553332 2344567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 006528 234 GFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+++.+||. +|.+||++.+++.
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 99999999 8999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.43 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=208.7
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccC---ChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQ---LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~---~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
-.+|+|+|+.||+|+|....+.||+|+-...+.-. .+......-+|..+.+.|+||.||++|++|.-+. +.+|-|+
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt-dsFCTVL 547 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT-DSFCTVL 547 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc-ccceeee
Confidence 35899999999999999999999999765433111 1122455779999999999999999999986543 5789999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC--CCCcEEEeecchhhhccCCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~--~~G~VKL~DFGlA~~~~~~~ 159 (641)
|||+|.+|.-||+.++-++++.++.|+.||+.||.||....|||||-||||.|||+-. ..|.|||.|||+++++....
T Consensus 548 EYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddS 627 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDS 627 (775)
T ss_pred eecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCc
Confidence 9999999999999999999999999999999999999999999999999999999842 23689999999999886432
Q ss_pred C---------ccccCCCCCCCccccc-c----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHH--cC-CCCC
Q 006528 160 A---------RSVIGTPEFMAPELYE-E----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SG-IKPA 222 (641)
Q Consensus 160 ~---------~~~~GTp~ymAPEvl~-~----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~--~g-~~~~ 222 (641)
- ....||.+|++||.|- + ..+.++||||+|+|+|..+.|+.||........|.+.-+ .. ....
T Consensus 628 y~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqF 707 (775)
T KOG1151|consen 628 YNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQF 707 (775)
T ss_pred cCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccC
Confidence 1 2357999999999663 2 378899999999999999999999987555555554322 11 1111
Q ss_pred ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 223 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 223 ~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
....+.++++++||.+||. .-.+|....+|-.||+|.+
T Consensus 708 P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 708 PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 2234557899999999999 6889999999999999975
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.82 Aligned_cols=236 Identities=20% Similarity=0.338 Sum_probs=194.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|+|+||.||++. .+|..||+|.++... ..+.+.+|+.+++.++||||+++++++... ..++||
T Consensus 9 ~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v~ 77 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIVM 77 (254)
T ss_pred eeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEEE
Confidence 577889999999999986 478899999886432 245788999999999999999999987543 368999
Q ss_pred ccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 82 ELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
||+.+|+|.+++.... .+++..+..++.||+.||.|||++| ++||||||+||+++ .+|.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecccc-
Confidence 9999999999998653 4899999999999999999999999 99999999999997 4579999999998654322
Q ss_pred CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHH
Q 006528 160 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
......+..|+|||.+. +.++.++|+||||+++|+|++ |..||... ........+..+..+. .....++.+++++.
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 231 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRME-PPEGCPADVYVLMT 231 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHHHHHHHH
Confidence 12234467899999775 468899999999999999997 99999874 4555566666554333 23445678999999
Q ss_pred HhcC-CCCCCCCHHHHHc
Q 006528 238 KCLV-PASERLSAKDLLK 254 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~ 254 (641)
+||. +|.+||++++|+.
T Consensus 232 ~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 232 SCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9999 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=279.35 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=198.8
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCC
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
++|.|++|+||+|.+..+++.||.|+++..+- .+.......+||-+|+.|+|.|||++|++...+ ..+-+|+|||.
T Consensus 9 kigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsd--kkltlvfe~cd 84 (292)
T KOG0662|consen 9 KIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLVFEFCD 84 (292)
T ss_pred hhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--ceeEEeHHHhh
Confidence 68999999999999999999999999998763 445567789999999999999999999976554 44888999997
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Ccc
Q 006528 86 SGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARS 162 (641)
Q Consensus 86 gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~--~~~ 162 (641)
. +|..|... ++.++.+.++.++.|+++||.|+|+++ +.||||||+|+||+ .+|.+||+|||+++.+.-+. ...
T Consensus 85 q-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 85 Q-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred H-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCceEeeec
Confidence 5 88888875 577999999999999999999999999 99999999999998 45899999999998776543 223
Q ss_pred ccCCCCCCCcccccc--cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHc--CCC-CCcccc----------
Q 006528 163 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS--GIK-PASLAK---------- 226 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~--g~~-~~~l~~---------- 226 (641)
.+.|..|.+|.++-+ -|+...|+||.||++.|+.. |++.|.+.+-..++ ++|-. |.+ ...++.
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql-krif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH-HHHHHHhCCCccccCCccccCCCCccc
Confidence 467999999998765 39999999999999999996 55556664433443 33321 111 000110
Q ss_pred --------------CChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 227 --------------VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 227 --------------~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
..+..-++++.++|. +|.+|.+|++.|+||||..
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 012346899999998 8999999999999999964
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=318.36 Aligned_cols=258 Identities=20% Similarity=0.327 Sum_probs=215.6
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
-.++.||-|+||.|-++....|...||.|.+++.+++. ..+...+..|-.||..-+++-||++|.+|.+. +.+||||
T Consensus 632 vkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDk--dnLYFVM 708 (1034)
T KOG0608|consen 632 VKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFVM 708 (1034)
T ss_pred EEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccC--CceEEEE
Confidence 35789999999999999998999999999998887653 46677899999999999999999999999876 4599999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc---CC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ---QP 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~---~~ 158 (641)
+|++||++-.+|-+.+-|.|..++.|+.++.+|+++.|..| +|||||||+||||| .+|+|||.||||++-++ ..
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceecccc
Confidence 99999999999999999999999999999999999999999 99999999999998 56899999999995321 00
Q ss_pred C-----------------------------------------CccccCCCCCCCccccc-ccCCcccccccccchhhhhh
Q 006528 159 T-----------------------------------------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 196 (641)
Q Consensus 159 ~-----------------------------------------~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Eml 196 (641)
. .+..+||+.|+|||++. .+|+..+|+||.|+|||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0 01346999999999876 57999999999999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHc-CCCCCccccCChHHHHHHHHHhcCCCCCCCC---HHHHHcCcccccccCCC
Q 006528 197 TFEYPYSECKNPAQIFKKVTS-GIKPASLAKVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQKE 265 (641)
Q Consensus 197 tG~~Pf~~~~~~~~i~~~i~~-g~~~~~l~~~~~~~l~~LI~kcL~dP~~RpS---a~eLL~Hpff~~~~~~~ 265 (641)
.|+.||...+.....++.+.- ...........++++.+||.++...+..|+. ++++..||||+...+..
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 999999874433332222211 1122233445688999999999998888875 88899999999887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=322.51 Aligned_cols=237 Identities=20% Similarity=0.305 Sum_probs=203.0
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
..++|.|+|+.|-.+.+..++...++|++..... ...+|+.++... +||||+++++.+.+. ..+|+|||
T Consensus 327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~~v~e 396 (612)
T KOG0603|consen 327 REELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYEDG--KEIYLVME 396 (612)
T ss_pred ccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceecCC--ceeeeeeh
Confidence 4568999999999999999999999999876521 235677666665 899999999987655 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 162 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~ 162 (641)
++.||.|.+-+...+.+. ..+..|++||+.|+.|||.+| |+||||||+|||++++.|+++|+|||.++..+.. ..+
T Consensus 397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~t 472 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDT 472 (612)
T ss_pred hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-hcc
Confidence 999999988887766555 778889999999999999999 9999999999999656789999999999877654 334
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+-|..|.|||++.. +|++++||||||++||+|++|..||....+..+++.++..+... ...+..+++||..||+
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDEAKDLLQQLLQ 548 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHHHHHHHHHhcc
Confidence 466889999998874 69999999999999999999999998755556777777665333 5668899999999999
Q ss_pred -CCCCCCCHHHHHcCccc
Q 006528 242 -PASERLSAKDLLKDPFL 258 (641)
Q Consensus 242 -dP~~RpSa~eLL~Hpff 258 (641)
+|.+||++.+++.||||
T Consensus 549 ~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 549 VDPALRLGADEIGAHPWF 566 (612)
T ss_pred CChhhCcChhhhccCcch
Confidence 99999999999999999
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=280.92 Aligned_cols=240 Identities=33% Similarity=0.550 Sum_probs=204.6
Q ss_pred CceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCCCCHH
Q 006528 11 PAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR 90 (641)
Q Consensus 11 afgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~ 90 (641)
+||.||+|.+..+|..||+|.+...... .....+.+|++.+++++|+||+++++++... ...++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence 5789999999999999999998765421 1167899999999999999999999988765 4689999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCccccCCCCC
Q 006528 91 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEF 169 (641)
Q Consensus 91 ~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-~~~~~~GTp~y 169 (641)
.++.....++...+..++.+++.+|.|||+.+ ++|+||+|+||+++. .+.++|+|||.+...... ......+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCCcCC
Confidence 99988777999999999999999999999999 999999999999985 479999999999766543 34456789999
Q ss_pred CCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccC-ChHHHHHHHHHhcC-CCCCC
Q 006528 170 MAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV-NDPQIKGFIEKCLV-PASER 246 (641)
Q Consensus 170 mAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~-~~~~l~~LI~kcL~-dP~~R 246 (641)
+|||.+. ..++.++|||+||+++++|++|..||........+...+..+......... .+..+.+++.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999775 568889999999999999999999998756666777766665444322221 56789999999998 89999
Q ss_pred CCHHHHHcCccc
Q 006528 247 LSAKDLLKDPFL 258 (641)
Q Consensus 247 pSa~eLL~Hpff 258 (641)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=333.45 Aligned_cols=243 Identities=20% Similarity=0.323 Sum_probs=200.1
Q ss_pred EEEEEeCccCceEEEEEEEcCCC-----eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce
Q 006528 2 RILISSRRIPAVDTYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG-----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~ 76 (641)
....-+|+|+||.||.|+-.... ..||+|.++.. .+.++...|.+|..+|+.++|||||++.|++.+. ..
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~~ 769 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--GP 769 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--CC
Confidence 45678999999999999965432 34888887654 3577889999999999999999999999998885 45
Q ss_pred EEEEEccCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeec
Q 006528 77 VNMITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 149 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~-------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DF 149 (641)
.++++|||.+|+|+.||++. ..++...+..++.||++|+.||++++ +|||||-+.|+|++.. ..|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEEccc
Confidence 78999999999999999875 34899999999999999999999999 9999999999999855 79999999
Q ss_pred chhhhccCCCCccc----cCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006528 150 GLAIAMQQPTARSV----IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 223 (641)
Q Consensus 150 GlA~~~~~~~~~~~----~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~ 223 (641)
|+|+.+........ .-...|||||.+. +.++.++|||||||++||++| |..||....+ .++...+..+- .-.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~~~~~~gg-RL~ 924 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVLLDVLEGG-RLD 924 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHHHHHHhCC-ccC
Confidence 99985543321111 1235899999776 679999999999999999998 7899988554 45555444433 333
Q ss_pred cccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 224 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 224 l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+..++..+.++|..||. +|.+||++..|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 456667778899999999 8999999999998
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.80 Aligned_cols=246 Identities=19% Similarity=0.171 Sum_probs=183.9
Q ss_pred EEEEEeCccCceEEEEEEEcCC---CeEEEEEEEecccccCChh-h------HHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 006528 2 RILISSRRIPAVDTYKAFDEFA---GIEVAWSRVKIDDVLQLPG-D------LQKLYSEVHLLKSLKDDNVVKFYKSWVD 71 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~t---G~~VAIK~v~~~~~~~~~~-~------~~~l~~Ei~iLk~L~HpNIVk~~~~~~~ 71 (641)
++...+|.|+||+||+|.+..+ +..+|+|...........+ . ......+...+..+.|+||+++++++..
T Consensus 15 ~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 94 (294)
T PHA02882 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSF 94 (294)
T ss_pred EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeE
Confidence 5778899999999999999887 6777877654332110000 0 0112233445667799999999987655
Q ss_pred CCC--ceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeec
Q 006528 72 DKK--KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 149 (641)
Q Consensus 72 ~~~--~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DF 149 (641)
... .+.+++++++. .++.++++.....++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+||
T Consensus 95 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~~~~~l~DF 170 (294)
T PHA02882 95 KRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GNNRGYIIDY 170 (294)
T ss_pred ecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCcEEEEEc
Confidence 432 24467888875 478888877666789999999999999999999999 99999999999997 4579999999
Q ss_pred chhhhccCC---------CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHH--------
Q 006528 150 GLAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI-------- 211 (641)
Q Consensus 150 GlA~~~~~~---------~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i-------- 211 (641)
|+|+..... ......||+.|+|||++.+ .|+.++|||||||++|||++|..||.........
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~ 250 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF 250 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHH
Confidence 999754311 1123469999999998764 5899999999999999999999999875332222
Q ss_pred HHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 212 ~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
...+..+.. .....++.+.+++..|+. +|.+||++.+|++
T Consensus 251 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 251 IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222332221 122346789999999998 9999999999975
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=322.11 Aligned_cols=198 Identities=26% Similarity=0.417 Sum_probs=171.2
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC----CceEEEEE
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVNMIT 81 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~----~~~l~lV~ 81 (641)
.+|.||||.||+++++++|+.||||.++... .....++.-+|+++|++|+|||||+++++-.... .+.-.+||
T Consensus 20 ~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 20 RLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 5899999999999999999999999998755 3456778899999999999999999999643333 34467999
Q ss_pred ccCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEe-CCCCc--EEEeecchhhhc
Q 006528 82 ELFTSGNLRQYRKK---HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGE--VKIGDLGLAIAM 155 (641)
Q Consensus 82 Ey~~gGsL~~~l~~---~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~-~~~G~--VKL~DFGlA~~~ 155 (641)
|||+||+|+..+.. ...+++.++..++..+..||.|||++| |+||||||+||++- |.+|+ -||+|||.|+.+
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999974 467999999999999999999999999 99999999999984 33243 599999999988
Q ss_pred cCC-CCccccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCH
Q 006528 156 QQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNP 208 (641)
Q Consensus 156 ~~~-~~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~ 208 (641)
... ...+.+||+.|.+||+++ +.|+..+|.|||||++|+.+||..||-....+
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 644 567789999999999998 46899999999999999999999999654333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=321.09 Aligned_cols=251 Identities=21% Similarity=0.255 Sum_probs=176.3
Q ss_pred EEEEEeCccCceEEEEEEEcCC----CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEe----CC
Q 006528 2 RILISSRRIPAVDTYKAFDEFA----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD----DK 73 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~t----G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~----~~ 73 (641)
++...+|+|+||+||+|.+..+ |..||+|++.... . .+....+ .++...+.++..+...+.. ..
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----A--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----h--hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 5678999999999999999998 9999999875322 1 1111111 1223333333333332211 33
Q ss_pred CceEEEEEccCCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCC
Q 006528 74 KKTVNMITELFTSGNLRQYRKKHKN--------------------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133 (641)
Q Consensus 74 ~~~l~lV~Ey~~gGsL~~~l~~~~~--------------------l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~ 133 (641)
...+++|+||+.+|+|.+++..... .....++.++.||+.||.|||+++ |+||||||+
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~ 284 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQ 284 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCHH
Confidence 4578999999999999999875321 123457789999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeecchhhhccCC---CCccccCCCCCCCcccccc-----------------------cCCccccccc
Q 006528 134 NIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEE-----------------------EYNELVDIYS 187 (641)
Q Consensus 134 NILl~~~~G~VKL~DFGlA~~~~~~---~~~~~~GTp~ymAPEvl~~-----------------------~y~~ksDIwS 187 (641)
|||++.+.+.+||+|||+|+.+... ....+++++.|||||.+.. .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 9999866689999999999765432 2345789999999996521 2345679999
Q ss_pred ccchhhhhhhccCCCCCCCCHHHHHHHHHcCC----------CCC---------ccccCChHHHHHHHHHhcC-CCCCCC
Q 006528 188 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----------KPA---------SLAKVNDPQIKGFIEKCLV-PASERL 247 (641)
Q Consensus 188 lGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~----------~~~---------~l~~~~~~~l~~LI~kcL~-dP~~Rp 247 (641)
|||++|||+++..|+.. ...+....+.... .+. ......+...++||.+||. ||.+||
T Consensus 365 lGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 99999999998776543 2222222222110 000 0011123345689999999 999999
Q ss_pred CHHHHHcCcccccccCC
Q 006528 248 SAKDLLKDPFLQVENQK 264 (641)
Q Consensus 248 Sa~eLL~Hpff~~~~~~ 264 (641)
|++++|+||||+.....
T Consensus 443 ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 443 SAKAALAHPYFDREGLL 459 (566)
T ss_pred CHHHHhCCcCcCCCCcc
Confidence 99999999999865543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=293.08 Aligned_cols=263 Identities=20% Similarity=0.306 Sum_probs=219.3
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~l 79 (641)
++.+..+|+|+|.+|.++..+.|.+.+|+|+++++-+. ..+++.-.+.|..+..+. +||.+|-++.+|..+ ..++|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~n-ddedidwvqtek~vfe~asn~pflvglhscfqte--srlff 328 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE--SRLFF 328 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcC-CcccchhHHhhHHHHHhccCCCeEEehhhhhccc--ceEEE
Confidence 57889999999999999999999999999999876553 445677788999999887 899999999988766 46999
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc--C
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--Q 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~--~ 157 (641)
|.||.+||+|--++++..+++++.++.+...|+.||.|||++| ||+||||.+|+|++.+ |++||.|+|.++.-- .
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-CceeecccchhhcCCCCC
Confidence 9999999999999999899999999999999999999999999 9999999999999854 899999999997543 2
Q ss_pred CCCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCC--CCCCH-----HHHHHHHHcCCCCCccccCCh
Q 006528 158 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYS--ECKNP-----AQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~--~~~~~-----~~i~~~i~~g~~~~~l~~~~~ 229 (641)
....++||||.|.|||++.+ .|+..+|+|+||++|+||+.|+.||. +..|+ .-+++.|... ...++...+
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--qiriprsls 483 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--QIRIPRSLS 483 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--cccccceee
Confidence 35668999999999999986 59999999999999999999999994 22222 3345555443 223344445
Q ss_pred HHHHHHHHHhcC-CCCCCCC------HHHHHcCcccccccCCCCcCCCC
Q 006528 230 PQIKGFIEKCLV-PASERLS------AKDLLKDPFLQVENQKEPICDPL 271 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpS------a~eLL~Hpff~~~~~~~~~~~~~ 271 (641)
-.+..+++..|. ||.+|+. ..++..|+||....|.-..+..+
T Consensus 484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v 532 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQV 532 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhccc
Confidence 556778888888 8999874 78999999999888865443333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.86 Aligned_cols=251 Identities=28% Similarity=0.478 Sum_probs=219.8
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
..+..+|.|++|.||||+|+.+|+..|+|.|+.+. .++..-+++||-+++.++|||||.||+++.-.++ +|+.|
T Consensus 18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk--lwicM 91 (829)
T KOG0576|consen 18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK--LWICM 91 (829)
T ss_pred hheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhhcC--cEEEE
Confidence 45788999999999999999999999999999875 3456678999999999999999999999987654 89999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~--~ 159 (641)
|||.+|+|.+.-.-.+++++.++...++..++||+|||+.| -+|||||-.||+++ +.|.||++|||.+..+... .
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCchhhhhhhhhh
Confidence 99999999998877889999999999999999999999999 99999999999997 6689999999999776543 4
Q ss_pred CccccCCCCCCCccccc----ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccc--CChHHHH
Q 006528 160 ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VNDPQIK 233 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~----~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~--~~~~~l~ 233 (641)
.+.++|||.|||||+-. ++|+.++|||++|+...|+.-.++|..+......++-.-+++..|+.+.. ..++.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 66889999999999753 67999999999999999999999997765544555666667777665543 3477899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 234 GFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
+|++.||. +|.+||+++.+|.|||....
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc
Confidence 99999998 79999999999999998654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=291.30 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=200.8
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEe------CCCceEE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD------DKKKTVN 78 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~------~~~~~l~ 78 (641)
..+|+|.||.||+|..+.+|+.||+|.+-.+.- .+..-....+|+.+|..|+|+|++.++..+.. ....++|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 468999999999999999999999998766432 23445567899999999999999988875532 2235699
Q ss_pred EEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 79 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
+|+.+|.. +|.-++.+. .+++...|+.++++++.||.|+|... |+|||+||.|+||+++ |.+||+|||+++.+..
T Consensus 101 lVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-gilklADFGlar~fs~ 176 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-GILKLADFGLARAFST 176 (376)
T ss_pred eeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-ceEEeeccccccceec
Confidence 99999986 888888765 67999999999999999999999999 9999999999999854 8999999999976643
Q ss_pred CCCc------cccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHH--HHHcCCCCC-----
Q 006528 158 PTAR------SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--KVTSGIKPA----- 222 (641)
Q Consensus 158 ~~~~------~~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~--~i~~g~~~~----- 222 (641)
.... ..+.|..|++||++- ..|+++.|||..||++.||.|+.+-+.+.++..++.- .+-....+.
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 3221 234599999999664 4699999999999999999999988887555544321 111110010
Q ss_pred -------------------------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 223 -------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 223 -------------------------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
.-+.+.++++.+|++++|. ||.+|+.++++|.|.||..+.
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 1112336788999999999 999999999999999997543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=299.41 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=204.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC------CCCcceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK------DDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~------HpNIVk~~~~~~~~~~~ 75 (641)
.|....|.|-|++|..|.|...|.+||||+|.-..++ ...-+.|+++|++|+ --++++|+..|... .
T Consensus 435 ~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk--n 507 (752)
T KOG0670|consen 435 EVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-----HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK--N 507 (752)
T ss_pred EEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc--c
Confidence 4677889999999999999999999999999865433 345688999999995 35889999988665 4
Q ss_pred eEEEEEccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 76 TVNMITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
.+|||+|-+. -+|++.|++.+ .|...+++.|+.|++.||..|-.+| |+|.||||+||||+.....+||||||.|
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccc
Confidence 6999999995 69999999865 4899999999999999999999999 9999999999999977778999999999
Q ss_pred hhccCCCCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHHHHH-----------HHHcC--
Q 006528 153 IAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK-----------KVTSG-- 218 (641)
Q Consensus 153 ~~~~~~~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~-----------~i~~g-- 218 (641)
..........+..+..|.|||++-+ .|+...|+||+||+||||.||+..|++.+|...+-- .+..|
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 8777666667777889999997665 699999999999999999999999998776554421 11111
Q ss_pred ------------------------------CCC-Cccc----c---CC------hHHHHHHHHHhcC-CCCCCCCHHHHH
Q 006528 219 ------------------------------IKP-ASLA----K---VN------DPQIKGFIEKCLV-PASERLSAKDLL 253 (641)
Q Consensus 219 ------------------------------~~~-~~l~----~---~~------~~~l~~LI~kcL~-dP~~RpSa~eLL 253 (641)
..| ..+. . .. -..+++|+.+||. ||.+|.|..++|
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 011 0000 0 00 1368999999999 999999999999
Q ss_pred cCccccc
Q 006528 254 KDPFLQV 260 (641)
Q Consensus 254 ~Hpff~~ 260 (641)
+||||+.
T Consensus 745 ~HpFi~~ 751 (752)
T KOG0670|consen 745 KHPFITE 751 (752)
T ss_pred cCCcccC
Confidence 9999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=311.42 Aligned_cols=235 Identities=26% Similarity=0.340 Sum_probs=186.1
Q ss_pred eCccCceE-EEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccC
Q 006528 7 SRRIPAVD-TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 7 lG~Gafgt-VYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
+|.|+.|+ ||+|.- .|++||||++-.+ ......+||.+|+.. +|||||+||+ .+.+...+|+..|+|
T Consensus 517 lG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 517 LGYGSNGTVVFRGVY--EGREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIALELC 585 (903)
T ss_pred cccCCCCcEEEEEee--CCceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEehHh
Confidence 58888888 899985 5889999998643 345689999999999 6999999998 555567899999999
Q ss_pred CCCCHHHHHHhCC-CC---CHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCC----CCcEEEeecchhhhcc
Q 006528 85 TSGNLRQYRKKHK-NV---DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN----HGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 85 ~gGsL~~~l~~~~-~l---~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~----~G~VKL~DFGlA~~~~ 156 (641)
.. +|.++++... .+ ..-..+..+.|+++||++||+.+ |+||||||+||||+.. ..+++|+|||+++.+.
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 75 9999998741 11 11345788999999999999999 9999999999999762 2468999999998765
Q ss_pred CC-----CCccccCCCCCCCccccccc-CCcccccccccchhhhhhhc-cCCCCCCCCHHHHHHHHHcCCC-CCccccCC
Q 006528 157 QP-----TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-PASLAKVN 228 (641)
Q Consensus 157 ~~-----~~~~~~GTp~ymAPEvl~~~-y~~ksDIwSlGiil~EmltG-~~Pf~~~~~~~~i~~~i~~g~~-~~~l~~~~ 228 (641)
.. ...+..||-.|+|||++... -+.++||+||||++|+.++| ..||.+. ... -..|..+.. ...+....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R-~~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LER-QANILTGNYTLVHLEPLP 739 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHh-hhhhhcCccceeeeccCc
Confidence 33 23356799999999998754 56789999999999999987 8999762 222 223344432 22233333
Q ss_pred hHHHHHHHHHhcC-CCCCCCCHHHHHcCccc
Q 006528 229 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 229 ~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff 258 (641)
+.++++||.+||. +|..||+|.++|.||||
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 3489999999999 89999999999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=275.78 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=207.0
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEEEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++..+|+|-++.||.|+...+++.++||.++. -...++.+|+.+|..|. ||||+++++...+....+..+|+
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 34578999999999999999999999998873 34567999999999996 99999999999888888899999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
||+.+.+.+++. +.++...|+.++.|+++||.|+|+.| |+|||+||.|++|+.....++|+|+|+|...+.....
T Consensus 115 E~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 115 EYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 999998887764 45888999999999999999999999 9999999999999977778999999999888765444
Q ss_pred c-ccCCCCCCCccccc--ccCCcccccccccchhhhhhhccCCCC-CCCCHHHHHHHHHc--------------------
Q 006528 162 S-VIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYS-ECKNPAQIFKKVTS-------------------- 217 (641)
Q Consensus 162 ~-~~GTp~ymAPEvl~--~~y~~ksDIwSlGiil~EmltG~~Pf~-~~~~~~~i~~~i~~-------------------- 217 (641)
. .+.+..|--||++- ..|+..-|+|||||++..|+..+-||. +.+|..|+++...-
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 3 35577788999775 469999999999999999999988864 56777777543210
Q ss_pred -----C---------CCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 218 -----G---------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 218 -----g---------~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+ ..+.......+|++.+|+.++|. |..+||||+|++.||||....
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 0 00111122336899999999999 999999999999999997544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.20 Aligned_cols=239 Identities=24% Similarity=0.404 Sum_probs=198.4
Q ss_pred EEeCccCceEEEEEEEcC----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 5 ISSRRIPAVDTYKAFDEF----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
..+|.|-||.||+|.... ...-||||..+... .++..+.|.+|..+|+.++|||||+++|++.+. .+|+|
T Consensus 395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~Wiv 468 (974)
T KOG4257|consen 395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMWIV 468 (974)
T ss_pred HhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---ceeEE
Confidence 468999999999998532 33468888877543 567799999999999999999999999988764 48999
Q ss_pred EccCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 81 TELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
||+++-|.|+.|++.++ .++...+..++.||+.||+|||+.. ++||||-..|||+... ..|||+|||+++.+....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ceeeecccchhhhccccc
Confidence 99999999999999765 5999999999999999999999999 9999999999999865 489999999999886543
Q ss_pred C---ccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHH
Q 006528 160 A---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 160 ~---~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
. ....-..-|||||-++ ..++.++|||-||+||||++. |..||.+..|.+.+ -.+.+|... ..+..++|.+..
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRl-P~P~nCPp~LYs 623 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERL-PCPPNCPPALYS 623 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCC-CCCCCCChHHHH
Confidence 2 2223355799999776 679999999999999999985 88999986665544 334444333 345667889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 006528 235 FIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~ 254 (641)
++.+||. +|++||...+|..
T Consensus 624 lmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHhccCcccCCcHHHHHH
Confidence 9999999 9999999887754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-33 Score=288.74 Aligned_cols=249 Identities=18% Similarity=0.283 Sum_probs=196.5
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC--CC----cceeeEEEEeCCCc
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DN----VVKFYKSWVDDKKK 75 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pN----IVk~~~~~~~~~~~ 75 (641)
.|+..+|.|+||.|-.+.|.+++..||+|+++-- ....+...-|+++|.++.+ |+ +|.+.++|-- ++
T Consensus 92 ~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--rg 164 (415)
T KOG0671|consen 92 EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--RG 164 (415)
T ss_pred ehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--cC
Confidence 4677899999999999999999999999988743 3456778889999999942 32 5666665533 35
Q ss_pred eEEEEEccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC----------C---
Q 006528 76 TVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----------N--- 140 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~----------~--- 140 (641)
.+|+|+|.+ |-+++++++.+ .+++...|+.+++|++.+++|||+.+ ++|.||||+|||+.. .
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccc
Confidence 699999999 34999999875 46999999999999999999999999 999999999999832 1
Q ss_pred ------CCcEEEeecchhhhccCCCCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHH--
Q 006528 141 ------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI-- 211 (641)
Q Consensus 141 ------~G~VKL~DFGlA~~~~~~~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i-- 211 (641)
.-.|+|+|||.|+...+.. .+.+.|..|+|||++- -+++.++||||+||||+|++||...|..-.+.+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 1248999999997665443 5678899999999765 48999999999999999999999999876655543
Q ss_pred HHHHHcCCCCCccc--------------------------------------cCC---hHHHHHHHHHhcC-CCCCCCCH
Q 006528 212 FKKVTSGIKPASLA--------------------------------------KVN---DPQIKGFIEKCLV-PASERLSA 249 (641)
Q Consensus 212 ~~~i~~g~~~~~l~--------------------------------------~~~---~~~l~~LI~kcL~-dP~~RpSa 249 (641)
++.|....+...+. ... -.++.+||++||. ||.+|+|+
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 33333211100000 001 1357899999999 99999999
Q ss_pred HHHHcCcccccc
Q 006528 250 KDLLKDPFLQVE 261 (641)
Q Consensus 250 ~eLL~Hpff~~~ 261 (641)
.|+|.||||...
T Consensus 401 ~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 401 REALSHPFFARL 412 (415)
T ss_pred HHHhcCHHhhcC
Confidence 999999999743
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=298.87 Aligned_cols=257 Identities=22% Similarity=0.260 Sum_probs=183.7
Q ss_pred CEEEEEeCccCceEEEEEEEc----------------CCCeEEEEEEEecccccCCh----------hhHHHHHHHHHHH
Q 006528 1 MRILISSRRIPAVDTYKAFDE----------------FAGIEVAWSRVKIDDVLQLP----------GDLQKLYSEVHLL 54 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~----------------~tG~~VAIK~v~~~~~~~~~----------~~~~~l~~Ei~iL 54 (641)
+++...||+|+||+||+|.+. ..+..||||++......... ...+....|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 467889999999999999752 34568999998754311000 0112334577778
Q ss_pred HhCCCCCc-----ceeeEEEEeC------CCceEEEEEccCCCCCHHHHHHhC------------------------CCC
Q 006528 55 KSLKDDNV-----VKFYKSWVDD------KKKTVNMITELFTSGNLRQYRKKH------------------------KNV 99 (641)
Q Consensus 55 k~L~HpNI-----Vk~~~~~~~~------~~~~l~lV~Ey~~gGsL~~~l~~~------------------------~~l 99 (641)
.+++|.++ ++++++|... .+...++|+||+.+|+|.+++... ..+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 88876554 6777776532 124589999999999999988642 124
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-Cc--cccCCCCCCCccccc
Q 006528 100 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-AR--SVIGTPEFMAPELYE 176 (641)
Q Consensus 100 ~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~-~~--~~~GTp~ymAPEvl~ 176 (641)
++..++.++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||++..+.... .. ...+||.|+|||++.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 56788999999999999999999 999999999999984 4799999999996553321 11 234589999999764
Q ss_pred cc---------------------CC--cccccccccchhhhhhhccC-CCCCCCCHH----------HHHHHHHcCCCCC
Q 006528 177 EE---------------------YN--ELVDIYSFGMCILEMVTFEY-PYSECKNPA----------QIFKKVTSGIKPA 222 (641)
Q Consensus 177 ~~---------------------y~--~ksDIwSlGiil~EmltG~~-Pf~~~~~~~----------~i~~~i~~g~~~~ 222 (641)
.. |+ .++||||+||++|+|+++.. ||....... ..+..+.......
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 21 22 34799999999999999986 775321111 1112222222223
Q ss_pred ccccCChHHHHHHHHHhcC-CC---CCCCCHHHHHcCccccc
Q 006528 223 SLAKVNDPQIKGFIEKCLV-PA---SERLSAKDLLKDPFLQV 260 (641)
Q Consensus 223 ~l~~~~~~~l~~LI~kcL~-dP---~~RpSa~eLL~Hpff~~ 260 (641)
......++..++|+.+||. +| .+|+|++|+|+||||..
T Consensus 464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 3344457889999999998 44 68999999999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=265.98 Aligned_cols=211 Identities=26% Similarity=0.407 Sum_probs=183.0
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+..+|+|++|.|-+.++..+|...|+|++...-. .....++.+|+.+..+. ..|++|.||+.+..+.+ +|+.||
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn---~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd--vwIcME 125 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN---SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD--VWICME 125 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcC---hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc--EEEeHH
Confidence 4578999999999999999999999999986542 45667889999987666 79999999998877654 899999
Q ss_pred cCCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006528 83 LFTSGNLRQYR----KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 83 y~~gGsL~~~l----~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~ 158 (641)
.|. .+|..|- ++.+.++|..+-+++..|+.||.|||++= .+||||+||+|||+| ..|+|||||||.+..+...
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehhh
Confidence 996 4887664 45678999999999999999999999983 399999999999998 5589999999999888777
Q ss_pred CCcc-ccCCCCCCCcccccc-----cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC
Q 006528 159 TARS-VIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 222 (641)
Q Consensus 159 ~~~~-~~GTp~ymAPEvl~~-----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~ 222 (641)
.+.+ -.|-..|||||.+.. +|+.++||||||+.++||+++++||.....+.+..+++.....|.
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 6666 578889999998753 599999999999999999999999999999999999998875554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=295.15 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=197.3
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+++.+||.|-||.|.++.-. .+..||+|.++-... ......|.+||++|.+|+|||||+++++++.++ .+++|+
T Consensus 541 ~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~---~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI~ 614 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT---KNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMIT 614 (807)
T ss_pred ehhhhhcCcccceeEEEEec-CceEEEEeecCcccc---hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHHH
Confidence 56788999999999999864 369999999887653 345678999999999999999999999988764 499999
Q ss_pred ccCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 82 ELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
||+..|+|.+|+..+. .+..+....+|.||+.|++||.+.+ ++||||.+.|+|++++ +++||+|||.++-+-...
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCcccccccccCC
Confidence 9999999999999883 3344555669999999999999999 9999999999999866 699999999997554333
Q ss_pred Ccc----ccCCCCCCCcc-cccccCCcccccccccchhhhhhh--ccCCCCCCCCHHHHHHHHHc---CC---CCCcccc
Q 006528 160 ARS----VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTS---GI---KPASLAK 226 (641)
Q Consensus 160 ~~~----~~GTp~ymAPE-vl~~~y~~ksDIwSlGiil~Emlt--G~~Pf~~~~~~~~i~~~i~~---g~---~~~~l~~ 226 (641)
.+. .+-...||||| ++.++++.++|+|+||+++||+++ .+.||+..++ +++...... .. .....+.
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcceeccCCC
Confidence 222 33467999999 667999999999999999999986 5799988544 344333221 11 1233455
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
..+..+.++|.+||. +-.+||+.++|-.
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 667788999999999 8999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=294.47 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=205.9
Q ss_pred EEEEeCccCceEEEEEEEcCCC---eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG---~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
....+|.|+||+|++|.++.-+ ..||||.++...... ....|.+|+.+|.+|+|||++++||+..+. .+.|
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~---~mddflrEas~M~~L~H~hliRLyGvVl~q---p~mM 187 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA---IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAMM 187 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch---hHHHHHHHHHHHHhccCcceeEEeeeeccc---hhhH
Confidence 3457899999999999986533 379999998766432 677899999999999999999999987763 3789
Q ss_pred EEccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 80 ITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
|||+++.|+|.+.|.+ ...|....+..|+.||+.|+.||.+++ +|||||-..|+|+-. ...|||+||||.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllas-prtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLAS-PRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecc-cceeeeecccceeccCC
Confidence 9999999999999987 345889999999999999999999999 999999999999975 45999999999987764
Q ss_pred CCCcc-c----cCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChH
Q 006528 158 PTARS-V----IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 230 (641)
Q Consensus 158 ~~~~~-~----~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~ 230 (641)
..-.. + .-...|.|||.++ ..++.++|+|+||+++|||+| |+-||.++ +..+|.+.|..+. .-..++.++.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~e-rLpRPk~cse 342 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGE-RLPRPKYCSE 342 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccc-cCCCCCCChH
Confidence 43221 1 2244799999886 679999999999999999997 68999985 6788888888543 3344677788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 231 QIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 231 ~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
.+.++++.||. +|.+||++..|...-+++
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999999 899999999997666654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=316.10 Aligned_cols=235 Identities=21% Similarity=0.280 Sum_probs=177.8
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
...+|+|+||.||+|.+..+|..||+|.++.... ....|++++++++|||||++++++.+. ...++||||
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~Ey 764 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIHEY 764 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEEeC
Confidence 3468999999999999999999999998864321 123468899999999999999998765 458899999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006528 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 162 (641)
Q Consensus 84 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~-gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~ 162 (641)
+++|+|.++++. +++..+..++.||+.||+|||.+ .++|+||||||+||+++.+ +..++. ||.+..... ...
T Consensus 765 ~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~--~~~ 837 (968)
T PLN00113 765 IEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT--DTK 837 (968)
T ss_pred CCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc--CCC
Confidence 999999999964 88999999999999999999954 3449999999999999844 566665 665533221 123
Q ss_pred ccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCC-HHHHHHHHH---cCC-----CCCccc------c
Q 006528 163 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN-PAQIFKKVT---SGI-----KPASLA------K 226 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~-~~~i~~~i~---~g~-----~~~~l~------~ 226 (641)
..||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ...+..... ... ..+.+. .
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 468999999998764 599999999999999999999999853211 111111111 000 000110 0
Q ss_pred CChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
....++.+++.+||. +|.+||++.|+++.
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 112356788999999 89999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=273.86 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=196.1
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC----ceEEEE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNMI 80 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~----~~l~lV 80 (641)
.-+|.|+- .|--|.|..++..||+|.+.... .......+.++|..++..++|+||++++.+|.-... ..+|+|
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf--~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v 99 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF--QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV 99 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCcc--ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence 34566666 68889999999999999987663 223456789999999999999999999998854321 347899
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-C
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-~ 159 (641)
||||. ++|.+.+. -.++-+.++.++.|++.|++|||+.| |+||||||+||+++ ..+.+||.|||+|+.-... .
T Consensus 100 ~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ar~e~~~~~ 173 (369)
T KOG0665|consen 100 MELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLARTEDTDFM 173 (369)
T ss_pred HHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhhcccCcccc
Confidence 99997 59999887 45788999999999999999999999 99999999999998 4579999999999765544 3
Q ss_pred CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-C-------------------
Q 006528 160 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------------- 218 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~-g------------------- 218 (641)
...++.|..|.|||++- -+|.+.+||||+||++.||++|..-|.+...-.+..+.+.. |
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 45678899999999664 46999999999999999999999998874444433332211 0
Q ss_pred ------------CCCCc-c------ccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 219 ------------IKPAS-L------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 219 ------------~~~~~-l------~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
..|.. + .......+++++.+||. +|++|.+++++|+||||+
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00100 0 01223468999999999 999999999999999998
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=284.75 Aligned_cols=239 Identities=24% Similarity=0.358 Sum_probs=203.8
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEcc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
..++|.|-||.||.|.++.....||||.++-+. -..+.|+.|..+|+.++|||+|++.++|..+ ..+|||+||
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYIiTEf 344 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYIITEF 344 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcc-----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEEEEec
Confidence 457899999999999999999999999987432 4578899999999999999999999977555 459999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006528 84 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 84 ~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~ 161 (641)
|..|+|.+||+.. ..++.-.+..++.||.+|++||..++ +|||||-..|+||. ++..||++||||++.+......
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeeccchhhhhcCCcee
Confidence 9999999999864 34777788899999999999999999 99999999999996 5458999999999988765433
Q ss_pred cccC---CCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 162 SVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 162 ~~~G---Tp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
...| .+-|.|||-+. ..++.++|||+||++|||++| |-.||.+ -+..+.|..+..+..- .-+..+++.+.+|+
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM-~~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRM-DGPEGCPPKVYELM 499 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhccccc-cCCCCCCHHHHHHH
Confidence 3333 45799999665 669999999999999999997 7789988 4678888888877543 34556788999999
Q ss_pred HHhcC-CCCCCCCHHHHHc
Q 006528 237 EKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~ 254 (641)
..||+ .|++||++.|+-+
T Consensus 500 raCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 500 RACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHhcCCcccCccHHHHHH
Confidence 99999 9999999988744
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=272.67 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=199.6
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCC---ceEEEEE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVNMIT 81 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~---~~l~lV~ 81 (641)
.-||.|+||+||...|..+|+.||.|.+. .+.+.-....++.+|+.+|..++|.|++...+...-.+- ..+|+|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 45899999999999999999999998764 333344556789999999999999999998886543322 2478899
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~- 160 (641)
|++.+ +|...|..-..++...++-++.||++||+|||+.+ |.||||||.|+|++.+ -.+||||||+|+.-.....
T Consensus 137 ELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 137 ELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchhhhh
Confidence 99986 89988888888999999999999999999999999 9999999999999865 5899999999986543322
Q ss_pred --ccccCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc-------------------
Q 006528 161 --RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------------------- 217 (641)
Q Consensus 161 --~~~~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~------------------- 217 (641)
...+.|..|+|||++.+ .|+.++||||.||++.||+..+..|.. .++-+..+.|+.
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA-q~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA-AGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc-cChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 22356889999998875 599999999999999999999988876 455544444422
Q ss_pred -----CCCCCcccc---CC-----hHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 218 -----GIKPASLAK---VN-----DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 218 -----g~~~~~l~~---~~-----~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
+.+++.++. .. ..+...++.++|. +|.+|.+..+.+.|+++...+
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 222332221 11 2356677778888 899999999999999986544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=292.50 Aligned_cols=242 Identities=23% Similarity=0.332 Sum_probs=201.9
Q ss_pred EEEeCccCceEEEEEEEc----C---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCc
Q 006528 4 LISSRRIPAVDTYKAFDE----F---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~----~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~ 75 (641)
-..+|.|+||.|++|.-. . ....||||..+... ...+.+.+..|+++|+.+ +||||+.+.+++.. ..
T Consensus 301 ~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~~ 375 (609)
T KOG0200|consen 301 GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--DG 375 (609)
T ss_pred cceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--CC
Confidence 347999999999999742 1 25589999887554 236788899999999999 79999999998766 45
Q ss_pred eEEEEEccCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC
Q 006528 76 TVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~ 139 (641)
.+++|+||+..|+|..|++..+ .++...+..++.||+.|++||++.. ++||||-+.|||+..
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITK 453 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecC
Confidence 6999999999999999998765 3889999999999999999999998 999999999999974
Q ss_pred CCCcEEEeecchhhhccCCCCcc---ccC--CCCCCCcccccc-cCCcccccccccchhhhhhh-ccCCCCCCCCHHHHH
Q 006528 140 NHGEVKIGDLGLAIAMQQPTARS---VIG--TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 212 (641)
Q Consensus 140 ~~G~VKL~DFGlA~~~~~~~~~~---~~G--Tp~ymAPEvl~~-~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~ 212 (641)
+ ..+||+|||+|+......... ..| ...|||||.+.. .|+.++||||||++|||++| |..||.+......++
T Consensus 454 ~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 N-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred C-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 4 699999999998654432222 122 235999997764 69999999999999999997 689998866577778
Q ss_pred HHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 213 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 213 ~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+.+..|.... .+...++++.+++..||. +|.+||+..++..
T Consensus 533 ~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 8888886644 355558899999999999 8999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=288.53 Aligned_cols=245 Identities=21% Similarity=0.336 Sum_probs=206.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCe---EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~---~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l 77 (641)
+.|-.-||.|-||.||+|.-+..|+ .||||.++..- .+.+...|+.|..||-+++||||+++-++. ...+.+
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks~Pv 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKSKPV 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecCcee
Confidence 3567789999999999999988774 69999988653 577888999999999999999999999965 444679
Q ss_pred EEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 78 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
.||+|||++|+|..||+++ +.|+.-++..+++-|+.|++||-+.+ ++||||-+.|||||.+ -.+|++|||+++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsn-LvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccc-eEEEeccccceeecc
Confidence 9999999999999999875 56888999999999999999999999 9999999999999855 588999999999775
Q ss_pred CCC--Ccccc---CCCCCCCccccc-ccCCcccccccccchhhhhh-hccCCCCCCCCHHHHHHHHHcCCCCCccccCCh
Q 006528 157 QPT--ARSVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMV-TFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 157 ~~~--~~~~~---GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Eml-tG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
... ..+.. -..+|.|||.+. ++++.++|||||||+|||.+ .|+.||=+.+| ++.++.|..+...+. +...+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLPp-PmDCP 860 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLPP-PMDCP 860 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCCC-CCCCc
Confidence 432 22222 246899999765 78999999999999999987 59999988554 556677777754332 33456
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
..+.+|+..||+ |..+||...+|+.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 789999999999 89999999999873
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=276.81 Aligned_cols=239 Identities=25% Similarity=0.357 Sum_probs=181.7
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC--CCCCcceeeEEEEeCC--CceEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL--KDDNVVKFYKSWVDDK--KKTVN 78 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVk~~~~~~~~~--~~~l~ 78 (641)
.+..+|+|.||.||||.- +++.||||++.. .+.+.++.|.++.+.. +|+||++|+++-.... ...++
T Consensus 214 l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred hHHHhhcCccceeehhhc--cCceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 455689999999999985 469999999874 4456788888877655 8999999998532221 34789
Q ss_pred EEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeEeeccCCCcEEEeCCCCcEEEeecch
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~-------gp~IiHrDLKp~NILl~~~~G~VKL~DFGl 151 (641)
||++|.+.|+|.+||+.+- ++.....+++.-|++||+|||+- .|+|+|||||..||||. ++++.-|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccce
Confidence 9999999999999999754 89999999999999999999984 36899999999999996 668999999999
Q ss_pred hhhccCC----CCccccCCCCCCCcccccccCC-------cccccccccchhhhhhhcc------------CCCCC----
Q 006528 152 AIAMQQP----TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTFE------------YPYSE---- 204 (641)
Q Consensus 152 A~~~~~~----~~~~~~GTp~ymAPEvl~~~y~-------~ksDIwSlGiil~EmltG~------------~Pf~~---- 204 (641)
|..+... .....+||.+|||||++++..+ .+.||||+|.++|||++.. .||..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9766432 2344689999999999987533 2489999999999998753 22320
Q ss_pred CCCHHHHHHHHHcCCCCCcc----ccCC-hHHHHHHHHHhcC-CCCCCCCHHHH
Q 006528 205 CKNPAQIFKKVTSGIKPASL----AKVN-DPQIKGFIEKCLV-PASERLSAKDL 252 (641)
Q Consensus 205 ~~~~~~i~~~i~~g~~~~~l----~~~~-~~~l~~LI~kcL~-dP~~RpSa~eL 252 (641)
.-..+++...+......+.+ .+.. -..+++.++.||. ||.-|+||.=+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 01122333333333332222 2222 2458899999999 89999997544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-29 Score=238.03 Aligned_cols=209 Identities=34% Similarity=0.558 Sum_probs=184.1
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 86 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~g 86 (641)
+|.|++|.||++.+..+|..+++|.+...... ...+.+.+|++.++.+.|++|+++++++... ...++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence 58999999999999888999999998865421 1457899999999999999999999988665 568899999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Cccc
Q 006528 87 GNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSV 163 (641)
Q Consensus 87 GsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~--~~~~ 163 (641)
++|.+++... ..++...++.++.+++.+|.|||+.+ ++|+||+|.||+++...+.++|+|||.+....... ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9999999876 57899999999999999999999999 99999999999998525799999999997665443 4446
Q ss_pred cCCCCCCCcccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC
Q 006528 164 IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 164 ~GTp~ymAPEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~ 241 (641)
.+...|++||.+.. .++.+.|+|+||+++++| ..+.+++.+|+.
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence 68889999998865 688999999999999999 579999999998
Q ss_pred -CCCCCCCHHHHHcCc
Q 006528 242 -PASERLSAKDLLKDP 256 (641)
Q Consensus 242 -dP~~RpSa~eLL~Hp 256 (641)
+|.+||++.++++|+
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 899999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=267.86 Aligned_cols=128 Identities=27% Similarity=0.348 Sum_probs=110.4
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-----C---CCcceeeEEEEeC--
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----D---DNVVKFYKSWVDD-- 72 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-----H---pNIVk~~~~~~~~-- 72 (641)
|..++|.|-|+|||+|.|..+.+.||+|+++-. ....+....||.+|++++ | ..||++++.|...
T Consensus 82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred EEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 678999999999999999999999999998843 345678899999999983 3 3699999999764
Q ss_pred CCceEEEEEccCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEE
Q 006528 73 KKKTVNMITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137 (641)
Q Consensus 73 ~~~~l~lV~Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl 137 (641)
+...+|||+|++. -+|..+|++ ++.++...++.|++|||.||.|||..- +|||.||||+|||+
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 3457999999995 577777775 467999999999999999999999872 49999999999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=268.02 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=184.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC--CCCCcceeeEEEEeCC--Cce
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL--KDDNVVKFYKSWVDDK--KKT 76 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVk~~~~~~~~~--~~~ 76 (641)
++++..+|+|.||.||+|.+. |+.||||++.-.+ .....+|.++.+.. +|+||+.|+++=.... ...
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred eEEEEEecCccccceeecccc--CCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 467889999999999999976 8999999987433 34577887777654 9999999998533222 246
Q ss_pred EEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEeeccCCCcEEEeCCCCcEEEeecc
Q 006528 77 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------NPPIIHRDLKCDNIFVNGNHGEVKIGDLG 150 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~------gp~IiHrDLKp~NILl~~~~G~VKL~DFG 150 (641)
+|||++|.+.|||++||.+ ..++.....+++.-++.||++||.. .|.|.|||||..||||. .+|..-|+|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IADLG 361 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 361 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEEeece
Confidence 8999999999999999998 6699999999999999999999973 37899999999999996 56899999999
Q ss_pred hhhhccCC------CCccccCCCCCCCcccccccCC-------cccccccccchhhhhhhc----------cCCCCCCC-
Q 006528 151 LAIAMQQP------TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTF----------EYPYSECK- 206 (641)
Q Consensus 151 lA~~~~~~------~~~~~~GTp~ymAPEvl~~~y~-------~ksDIwSlGiil~EmltG----------~~Pf~~~~- 206 (641)
||-..... .....+||-+|||||++.+..+ ..+||||||.++||++-. .+||.+..
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99544322 2345689999999999986432 358999999999999752 57886532
Q ss_pred ---CHHHHHHHHHcCCCCCccccC--ChHH---HHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 207 ---NPAQIFKKVTSGIKPASLAKV--NDPQ---IKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 207 ---~~~~i~~~i~~g~~~~~l~~~--~~~~---l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+.+++.+-+--....+.++.. .++. +-.+++.||. +|.-|.||--+.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 223333222222222222222 2344 4567899998 8999999866544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=269.12 Aligned_cols=247 Identities=24% Similarity=0.415 Sum_probs=197.8
Q ss_pred EEEEEeCccCceEEEEEEEcC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceE
Q 006528 2 RILISSRRIPAVDTYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l 77 (641)
+++..+|.|+|++||+|++.. .+..||+|.+.... ...++..|+++|..+ -+.||+++.+++-.. +..
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn--d~v 110 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFRNN--DQV 110 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhccC--Cee
Confidence 567889999999999999988 78899999987654 245799999999999 699999999987555 558
Q ss_pred EEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc-
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ- 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~- 156 (641)
.+|+||++....+++... ++...++.+++.++.||.++|.+| ||||||||+|+|.+...+.-.|.|||+|....
T Consensus 111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHh
Confidence 899999999999998765 678999999999999999999999 99999999999999888999999999996210
Q ss_pred --------C------CC-------------------------------CccccCCCCCCCccccc--ccCCccccccccc
Q 006528 157 --------Q------PT-------------------------------ARSVIGTPEFMAPELYE--EEYNELVDIYSFG 189 (641)
Q Consensus 157 --------~------~~-------------------------------~~~~~GTp~ymAPEvl~--~~y~~ksDIwSlG 189 (641)
. .. .....|||+|+|||++. +.-++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 00 00135999999999876 4578899999999
Q ss_pred chhhhhhhccCCCCCCCCHHHHHHHHH--------------cCC-----------------------------------C
Q 006528 190 MCILEMVTFEYPYSECKNPAQIFKKVT--------------SGI-----------------------------------K 220 (641)
Q Consensus 190 iil~EmltG~~Pf~~~~~~~~i~~~i~--------------~g~-----------------------------------~ 220 (641)
++++-++++.+||....+.......+. .|. .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999965443322111110 011 0
Q ss_pred CCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccc
Q 006528 221 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 221 ~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~ 261 (641)
........+..+.+|+.+||. +|.+|.||+++|+||||...
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 011112234578999999999 99999999999999999843
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=280.80 Aligned_cols=241 Identities=25% Similarity=0.340 Sum_probs=200.0
Q ss_pred EEEEeCccCceEEEEEEEcCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~ 78 (641)
-.+.+|.|+||+||+|.+-..|+ +||||++.... .++.-..+..|.-+|.+|+|||++++.+++.... +.
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~q 773 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLST---LQ 773 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---HH
Confidence 45789999999999999976666 68888765432 4555678999999999999999999999876543 78
Q ss_pred EEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 79 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
||++|++.|+|.+|++.+ .++..+....|+.||++||.|||.+. ++||||-..|+||. ....|||.|||+|+.+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhccCc
Confidence 999999999999999876 46999999999999999999999999 99999999999997 446999999999987653
Q ss_pred CC----CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCChHH
Q 006528 158 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 231 (641)
Q Consensus 158 ~~----~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~ 231 (641)
.. .....-.+.|||-|.+. ..|+.++|||||||++||++| |..||.+ ....+|-+.+..|.. -..+.+.+-.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiD 928 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTID 928 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHH
Confidence 22 11223356788988665 679999999999999999997 7899987 456777777776654 4455667778
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+..++.+||. |+..||++++|..
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHH
Confidence 9999999998 9999999988864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=272.89 Aligned_cols=197 Identities=26% Similarity=0.362 Sum_probs=175.4
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCCh----hhHHHHHHHHHHHHhCC---CCCcceeeEEEEeCCCc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLP----GDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~----~~~~~l~~Ei~iLk~L~---HpNIVk~~~~~~~~~~~ 75 (641)
.+..+|.||||.|++|+++++..+|+||.|.+++.+..- ..+-.+-.||++|..|+ |+||+|+.++|.++ +
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd--d 642 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD--D 642 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC--C
Confidence 577899999999999999999999999999887654321 12335678999999997 99999999998765 6
Q ss_pred eEEEEEccCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 76 TVNMITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 76 ~l~lV~Ey~~g-GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
++|++||-... -+|++||..++.++|..++.+++||+.|+++||++| |+|||||-+|+.++++ |.+||+|||.|..
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccchhh
Confidence 79999998764 599999999999999999999999999999999999 9999999999999865 8999999999988
Q ss_pred ccCCCCccccCCCCCCCccccccc-C-CcccccccccchhhhhhhccCCCCC
Q 006528 155 MQQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSE 204 (641)
Q Consensus 155 ~~~~~~~~~~GTp~ymAPEvl~~~-y-~~ksDIwSlGiil~EmltG~~Pf~~ 204 (641)
........++||..|.|||++.+. | +..-|||++|+++|-++..+.||..
T Consensus 720 ~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 777777889999999999999864 5 6678999999999999999999964
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=235.38 Aligned_cols=211 Identities=30% Similarity=0.447 Sum_probs=181.9
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
++...+|.|++++||+|.+..++..+|+|.+...... .....+.+|+..++.++|+||+++++++... ...++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~ 76 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVM 76 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEE
Confidence 5778899999999999999988999999998865421 2567899999999999999999999987665 4588999
Q ss_pred ccCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006528 82 ELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~-l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-- 158 (641)
|++.+++|.+++..... +++..+..++.|++.+|.|||+++ ++|+||+|.||+++.+ +.++|+|||++......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLA 153 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCccc
Confidence 99999999999988776 899999999999999999999998 9999999999999854 79999999998766543
Q ss_pred -CCccccCCCCCCCcccc-c-ccCCcccccccccchhhhhhhccCCCCC-CCCHHHHHHHHHcCCC
Q 006528 159 -TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTFEYPYSE-CKNPAQIFKKVTSGIK 220 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl-~-~~y~~ksDIwSlGiil~EmltG~~Pf~~-~~~~~~i~~~i~~g~~ 220 (641)
......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. ..+...+.+.+..+..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 23445788899999987 3 3477899999999999999999999976 5566678888877753
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-28 Score=284.30 Aligned_cols=199 Identities=20% Similarity=0.230 Sum_probs=147.4
Q ss_pred HhCCC-CCcceeeEEEEeC-----CCceEEEEEccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEe
Q 006528 55 KSLKD-DNVVKFYKSWVDD-----KKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 127 (641)
Q Consensus 55 k~L~H-pNIVk~~~~~~~~-----~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiH 127 (641)
+.++| +||++++++|... ....+++++|++ +++|++++.. ...+++..++.+++||+.||.|||++| |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 45556 6888888876211 124577889987 5699999975 356999999999999999999999999 999
Q ss_pred eccCCCcEEEeC------------------CCCcEEEeecchhhhccCC------------------CCccccCCCCCCC
Q 006528 128 RDLKCDNIFVNG------------------NHGEVKIGDLGLAIAMQQP------------------TARSVIGTPEFMA 171 (641)
Q Consensus 128 rDLKp~NILl~~------------------~~G~VKL~DFGlA~~~~~~------------------~~~~~~GTp~ymA 171 (641)
|||||+||||+. ..+.+||+|||+++..... .....+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999952 2345677777776532110 0012468999999
Q ss_pred ccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCH
Q 006528 172 PELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSA 249 (641)
Q Consensus 172 PEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa 249 (641)
||++. ..|+.++|||||||++|||++|..|+.. .......+.....+.... ...+....++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE---KSRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh---HHHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence 99765 5699999999999999999999888754 222222332222222211 123567789999999 89999999
Q ss_pred HHHHcCccccc
Q 006528 250 KDLLKDPFLQV 260 (641)
Q Consensus 250 ~eLL~Hpff~~ 260 (641)
.|+|+||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=224.37 Aligned_cols=160 Identities=24% Similarity=0.344 Sum_probs=127.9
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccccC
Q 006528 87 GNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 165 (641)
Q Consensus 87 GsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~~~G 165 (641)
|+|.+++..+ ..+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeeccc---cCCC
Confidence 7999999874 56999999999999999999999987 99999997 5578999 9998765432 2368
Q ss_pred CCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc-----cccCChH--HHHHHHH
Q 006528 166 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-----LAKVNDP--QIKGFIE 237 (641)
Q Consensus 166 Tp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~-----l~~~~~~--~l~~LI~ 237 (641)
|+.|||||++. ..|+.++|||||||++|||+||+.||............+..+..+.. .....+. .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 99999999876 46899999999999999999999999765444444444443322221 1111122 6999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccccc
Q 006528 238 KCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 238 kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
+||. +|.+||++.++++|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9999 8999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-24 Score=211.60 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=204.9
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-CcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp-NIVk~~~~~~~~~~~~l~l 79 (641)
++++..+|.|+|+.||++.+. ..+++|.+....... ......+.+|+.+++.+.|+ +|+++++.+... ...++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEE
Confidence 367889999999999999998 779999887665322 23577899999999999988 799999988444 34789
Q ss_pred EEccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 80 ITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
+++++.++++.+++.... .+....+..++.|++.+|.|+|+.+ ++|||+||+||+++.....++++|||.+....
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999998888765 7999999999999999999999999 99999999999998553379999999997554
Q ss_pred CC--------CCccccCCCCCCCcccccc----cCCcccccccccchhhhhhhccCCCCCCCC---HHHHHHHHHcCCCC
Q 006528 157 QP--------TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKP 221 (641)
Q Consensus 157 ~~--------~~~~~~GTp~ymAPEvl~~----~y~~ksDIwSlGiil~EmltG~~Pf~~~~~---~~~i~~~i~~g~~~ 221 (641)
.. ......||+.|+|||.+.+ .+....|+|++|++++++++|..||..... ..+....+.....+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 32 2356789999999998764 578899999999999999999999876543 45555555554433
Q ss_pred -CccccCC------hHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 222 -ASLAKVN------DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 222 -~~l~~~~------~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
....... ...+.+++.+|+. +|..|.+..+...++|.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 1111111 2478999999998 899999999999997665433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=229.84 Aligned_cols=242 Identities=20% Similarity=0.248 Sum_probs=196.4
Q ss_pred EEEeCccCceEEEEEEEcCCCe-----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGI-----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~-----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~ 78 (641)
...+-.|.||.||.|++.+... .|.+|.++.. .++-+...+.+|--+|..+.|||++.+.++.+.+. ...+
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-~~P~ 364 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-ATPF 364 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-Ccce
Confidence 3445579999999997765332 4666666543 35667888999999999999999999999887654 4567
Q ss_pred EEEccCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecc
Q 006528 79 MITELFTSGNLRQYRKKH--------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 150 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~--------~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFG 150 (641)
.++.++.-|+|+.|+..- ..++..++..++.|+..|++|||+++ |||.||-..|++|+ +.-+|||+|=.
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVkltDsa 441 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLTDSA 441 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEeccch
Confidence 889999999999999831 23667778888999999999999999 99999999999998 55799999999
Q ss_pred hhhhccCCCCc----cccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006528 151 LAIAMQQPTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 224 (641)
Q Consensus 151 lA~~~~~~~~~----~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l 224 (641)
+++.+-...-+ .-.....||+||.+. ..|+.++|+||||++||||+| |+.||.+ -+|.+....+..|..-. .
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRla-Q 519 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRLA-Q 519 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccceec-C
Confidence 99765432211 112355799999664 679999999999999999997 7899988 57999999999986543 3
Q ss_pred ccCChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 225 AKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 225 ~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+..++.++..++..||. .|++||+.+||..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 55567799999999999 8999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=224.18 Aligned_cols=247 Identities=19% Similarity=0.267 Sum_probs=188.1
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
|.+.+|.|.||.+-++.|+.++.++++|.+.... .....|.+|.+---.| .|.||+.-|++-... .++++|++
T Consensus 28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF~q 101 (378)
T KOG1345|consen 28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVFVQ 101 (378)
T ss_pred HHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEEee
Confidence 3457899999999999999999999999987654 3456799999876666 699999999864433 35889999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEE-eCCCCcEEEeecchhhhccCCCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV-NGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl-~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
||++-|+|+.-+.. ..+.+..-+.++.|+++|+.|+|+.+ ++|||||.+|||| +.+.-+|||||||+.+..... .
T Consensus 102 E~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-V 177 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-V 177 (378)
T ss_pred ccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce-e
Confidence 99999999987765 45889999999999999999999999 9999999999998 445568999999988543322 1
Q ss_pred ccccCCCCCCCccccc----cc--CCcccccccccchhhhhhhccCCCCCCCCHH---HHHHHHHcCCCC--CccccCCh
Q 006528 161 RSVIGTPEFMAPELYE----EE--YNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIKP--ASLAKVND 229 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~----~~--y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~---~i~~~i~~g~~~--~~l~~~~~ 229 (641)
.....+..|.|||+.. +. .++.+|||.||+++|.++||.+||....... ..+.+...+..+ +...+..+
T Consensus 178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs 257 (378)
T KOG1345|consen 178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFS 257 (378)
T ss_pred hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccC
Confidence 2223466789999664 22 4778999999999999999999997532222 222333333222 22334456
Q ss_pred HHHHHHHHHhcC-CCCCC---CCHHHHHcCcccc
Q 006528 230 PQIKGFIEKCLV-PASER---LSAKDLLKDPFLQ 259 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~R---pSa~eLL~Hpff~ 259 (641)
+.+..+.++-|. ++.+| .+++...+..|..
T Consensus 258 ~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 258 EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred HHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 778888888888 67777 5677777776753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=244.35 Aligned_cols=255 Identities=20% Similarity=0.251 Sum_probs=194.2
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecc--cccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKID--DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~--~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
...+|.|++|.|+.+.........++|.+... ...........+..|+-+-..|.||||+.....+.+.. .+.-+|
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~~m 400 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GILQSM 400 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cchhhh
Confidence 35678899998888888777777887766532 11122222333777888888999999977766544332 344459
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~-- 159 (641)
|||++ +|..++.....+....+..+++|++.|+.|+|+.| |.|||||++|+++. ..|.+||+|||.+.....+.
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceeeccCcch
Confidence 99999 99999998878999999999999999999999999 99999999999998 55799999999997665332
Q ss_pred ----CccccCCCCCCCcccccc-cCCc-ccccccccchhhhhhhccCCCCCCCCHHHHHHHHHc------CCCCCccccC
Q 006528 160 ----ARSVIGTPEFMAPELYEE-EYNE-LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------GIKPASLAKV 227 (641)
Q Consensus 160 ----~~~~~GTp~ymAPEvl~~-~y~~-ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~------g~~~~~l~~~ 227 (641)
....+|+..|+|||++.+ .|++ .+||||.|++++.|++|+.||.......+.+..... ...+..+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 345689999999998875 5764 589999999999999999999653333222111110 1112233344
Q ss_pred ChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 228 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
.+...+.+|.+||+ +|.+|.|+++|++++||+.....
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 46678999999999 99999999999999999876543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-25 Score=224.93 Aligned_cols=239 Identities=34% Similarity=0.567 Sum_probs=184.8
Q ss_pred EEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC---CceEEEEEccCCCCCHHH
Q 006528 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVNMITELFTSGNLRQ 91 (641)
Q Consensus 15 VYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~---~~~l~lV~Ey~~gGsL~~ 91 (641)
||+|.|++.|.+|+|+.|+...........++...-+..|-++-|.|||+++.||-+.+ +....|++||+..|+|.+
T Consensus 82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~ 161 (458)
T KOG1266|consen 82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQ 161 (458)
T ss_pred HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHH
Confidence 89999999999999999987766666666677777788889999999999999997643 357889999999999999
Q ss_pred HHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh------ccCCCCc
Q 006528 92 YRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA------MQQPTAR 161 (641)
Q Consensus 92 ~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~------~~~~~~~ 161 (641)
+|++ ++.+....+++|+.||+.||.|||+..|||+|+++.|+.||+. .+|.|||+--..... .......
T Consensus 162 fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 162 FLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhhh
Confidence 9986 3568999999999999999999999999999999999999998 778999865432211 0111111
Q ss_pred cccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhc
Q 006528 162 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL 240 (641)
...+-+.|.|||.-. .+.+.++|||+||+|+++|..++..-.........-..+.. .+....++.-+++|.+||
T Consensus 241 ~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-----~i~~len~lqr~~i~kcl 315 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-----VIIGLENGLQRGSITKCL 315 (458)
T ss_pred ccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh-----heeeccCccccCcCcccc
Confidence 234678899998654 35678899999999999999998664332221111111111 112223445678999999
Q ss_pred C-CCCCCCCHHHHHcCcccc
Q 006528 241 V-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 241 ~-dP~~RpSa~eLL~Hpff~ 259 (641)
. .|..||+|+++|.||.+-
T Consensus 316 ~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 316 EGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred cCCCCCCcchhhhhcCceee
Confidence 9 799999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=214.71 Aligned_cols=169 Identities=18% Similarity=0.153 Sum_probs=128.7
Q ss_pred EEEEEeCccCceEEEEEEEcC-CCeEEEEEEEecccc-cCChhhHHHHHHHHHHHHhCCCCCcce-eeEEEEeCCCceEE
Q 006528 2 RILISSRRIPAVDTYKAFDEF-AGIEVAWSRVKIDDV-LQLPGDLQKLYSEVHLLKSLKDDNVVK-FYKSWVDDKKKTVN 78 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~-tG~~VAIK~v~~~~~-~~~~~~~~~l~~Ei~iLk~L~HpNIVk-~~~~~~~~~~~~l~ 78 (641)
++...+|+|+||+||+|.+.. +|..||||++..... .......+.+.+|+++|++|+|+||++ ++. + ...+
T Consensus 21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~-----~~~~ 94 (365)
T PRK09188 21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T-----GKDG 94 (365)
T ss_pred eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c-----CCcE
Confidence 466789999999999999876 678889998652210 012344677999999999999999985 543 1 2378
Q ss_pred EEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeecc-CCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL-KCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDL-Kp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
+||||+.|++|... .. .. ...|+.|++.||.|||++| |+|||| ||+|||++ ..|.+||+|||+|+.+..
T Consensus 95 LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 95 LVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECccceeccc
Confidence 99999999999732 11 11 1578999999999999999 999999 99999997 457999999999976543
Q ss_pred CC----------CccccCCCCCCCccccccc-------CCcccccc
Q 006528 158 PT----------ARSVIGTPEFMAPELYEEE-------YNELVDIY 186 (641)
Q Consensus 158 ~~----------~~~~~GTp~ymAPEvl~~~-------y~~ksDIw 186 (641)
.. .....+++.|+|||.+... .+...|-|
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 22 1345788899999988632 33446766
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-23 Score=230.85 Aligned_cols=242 Identities=19% Similarity=0.245 Sum_probs=200.6
Q ss_pred eCccCceEEEEE---EEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEEEEc
Q 006528 7 SRRIPAVDTYKA---FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 7 lG~GafgtVYkA---~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+|.|+||.|+++ .....|.-+|.|..++......... .-..|..++..++ ||.+|+++..|..+.+ ++++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~k--l~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGK--LYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccc--hhHhhh
Confidence 688999998744 3456677899888776554333222 5667888899996 9999999998877654 888999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 162 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~ 162 (641)
+..||.|...+.+...+++...+.+...++-+++++|+.+ |+|||+|++||+++. .|.+|+.|||+++..-.....
T Consensus 78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~-~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecc-cCccccCCchhhhHhHhhhhc-
Confidence 9999999999999899999999999999999999999999 999999999999984 589999999999766443333
Q ss_pred ccCCCCCCCcccccccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-
Q 006528 163 VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 241 (641)
Q Consensus 163 ~~GTp~ymAPEvl~~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~- 241 (641)
|||..|||||+.. +....+|+||||++++||+||..||.. ++...|..... .++...++.+++++..++.
T Consensus 154 -cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~--~~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAEL--EMPRELSAEARSLFRQLFKR 224 (612)
T ss_pred -ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhcc--CCchhhhHHHHHHHHHHHhh
Confidence 9999999999998 778899999999999999999999976 55555555322 2345557889999999998
Q ss_pred CCCCCCC-----HHHHHcCcccccccCCC
Q 006528 242 PASERLS-----AKDLLKDPFLQVENQKE 265 (641)
Q Consensus 242 dP~~RpS-----a~eLL~Hpff~~~~~~~ 265 (641)
+|..|.. +.++++|+||+...|..
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred CHHHHhccCcchhHHHhccchheeeeHhh
Confidence 8998875 58999999999888763
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-20 Score=198.18 Aligned_cols=246 Identities=19% Similarity=0.168 Sum_probs=183.0
Q ss_pred EEEEEeCccCceEEEEEEEcCCC-eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC----CCcceeeEEEEeCCCce
Q 006528 2 RILISSRRIPAVDTYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD----DNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG-~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H----pNIVk~~~~~~~~~~~~ 76 (641)
++...+|.|+||.||++.+..++ ..+|+|......... ...+..|+.+|..+.. +++.++++... ....+
T Consensus 21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 57889999999999999998875 688888876543211 1157889999998863 68888888664 33457
Q ss_pred EEEEEccCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCC----CcEEEeecc
Q 006528 77 VNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH----GEVKIGDLG 150 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~----G~VKL~DFG 150 (641)
-++||+++ |-+|.++.+.. +.++..++..++.|++.+|.+||+.| ++||||||+|+++.... -.+.|.|||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 78999998 56999988665 47999999999999999999999999 99999999999996332 369999999
Q ss_pred hhhhcc---CC--------C-CccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCCCCCCCCHHH--HHHHH
Q 006528 151 LAIAMQ---QP--------T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ--IFKKV 215 (641)
Q Consensus 151 lA~~~~---~~--------~-~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~--i~~~i 215 (641)
+++... .. . ...+.||..|.++....+ ..+++-|+||++.++.+|+.|..||........ .+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998221 11 1 223569999999997764 588999999999999999999999976443322 22222
Q ss_pred HcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 216 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 216 ~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
...............++..+...+-. +...+|....+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22211111223344566666666655 67788887777654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-21 Score=219.70 Aligned_cols=216 Identities=25% Similarity=0.387 Sum_probs=169.2
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
|..++.+-.|++|.||...|+++...+|.| +++..+ +.+- +|.....|.+|
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~k-iNkq~l---------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL---------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhc-ccccch---------hhhc--cccccCCccee-----------------
Confidence 356889999999999999999999999983 443321 1111 23333333333
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC---
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--- 157 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--- 157 (641)
|+-...++.-+.++... +.+++|||+.| |+|||+||+|.+|+ .-|++|+.|||+.+....
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhcc
Confidence 77788888777776555 77999999999 99999999999997 668999999999854210
Q ss_pred --------------CCCccccCCCCCCCcccc-cccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC--C
Q 006528 158 --------------PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--K 220 (641)
Q Consensus 158 --------------~~~~~~~GTp~ymAPEvl-~~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~--~ 220 (641)
-..+.++|||.|.|||++ ..+|+..+|+|++|+++||.+.|..||.+ +.+++++..+.... .
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEW 277 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhccc
Confidence 012356899999999965 56799999999999999999999999998 67888888876542 2
Q ss_pred CCccccCChHHHHHHHHHhcC-CCCCCC---CHHHHHcCcccccccCC
Q 006528 221 PASLAKVNDPQIKGFIEKCLV-PASERL---SAKDLLKDPFLQVENQK 264 (641)
Q Consensus 221 ~~~l~~~~~~~l~~LI~kcL~-dP~~Rp---Sa~eLL~Hpff~~~~~~ 264 (641)
++. .....++++++|.++|+ +|..|. .+-++.+|+||+.-.|+
T Consensus 278 pE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 278 PEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 333 44457899999999998 798886 58899999999988877
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=183.44 Aligned_cols=145 Identities=15% Similarity=0.100 Sum_probs=113.1
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChh----------------------hHHHHHHHHHHHHhCCCCC
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPG----------------------DLQKLYSEVHLLKSLKDDN 61 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~----------------------~~~~l~~Ei~iLk~L~HpN 61 (641)
...+|.|++|+||+|.+. +|+.||+|.++......... .......|+++|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357899999999999997 99999999997643210000 0123346999999998888
Q ss_pred cceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEeeccCCCcEEEeCC
Q 006528 62 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGN 140 (641)
Q Consensus 62 IVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~gp~IiHrDLKp~NILl~~~ 140 (641)
|...+.... . . .+|||||++|+++...+.....+++..+..++.||+.+|.|| |+.| |+||||||+|||++ +
T Consensus 81 v~~p~~~~~-~-~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL-K-S--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe-c-C--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence 754443222 1 1 379999999988876655567899999999999999999999 7989 99999999999997 3
Q ss_pred CCcEEEeecchhhhccC
Q 006528 141 HGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 141 ~G~VKL~DFGlA~~~~~ 157 (641)
+.++|+|||+|.....
T Consensus 154 -~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 -GKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CcEEEEEccccccCCC
Confidence 6899999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-20 Score=179.84 Aligned_cols=145 Identities=18% Similarity=0.125 Sum_probs=114.3
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccC--------------------Ch--hhHHHHHHHHHHHHhCCCCC
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQ--------------------LP--GDLQKLYSEVHLLKSLKDDN 61 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~--------------------~~--~~~~~l~~Ei~iLk~L~HpN 61 (641)
...+|.|++|.||+|.+. +|..||+|.++...... .. .....+..|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 567999999999999987 99999999988652110 00 01233468999999999999
Q ss_pred cceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEeCC
Q 006528 62 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGN 140 (641)
Q Consensus 62 IVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~~~ 140 (641)
|.....++... .+|||||++|+++.........++...+..++.|++.+|.+||. .| |+||||||+|||++
T Consensus 81 i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 85555443322 37999999988654443334568889999999999999999999 88 99999999999997
Q ss_pred CCcEEEeecchhhhccC
Q 006528 141 HGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 141 ~G~VKL~DFGlA~~~~~ 157 (641)
+|.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 47999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=180.95 Aligned_cols=229 Identities=19% Similarity=0.235 Sum_probs=176.5
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCcceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVk~~~~~~~~~~~~l~lV 80 (641)
++++.||+|+||.+|.|....+|++||||.-..... .-.+..|..+.+.|++ ..|..++.+..+ ..+-.+|
T Consensus 18 ~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~------hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlV 89 (341)
T KOG1163|consen 18 KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK------HPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLV 89 (341)
T ss_pred EEEEeecCCchhheeeeeeccCCceEEEEeecccCC------CcchhHHHHHHHHhccCCCCchhhhhccc--cccceee
Confidence 789999999999999999999999999997543221 2247789999999965 566655554433 3567799
Q ss_pred EccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEe--CCCCcEEEeecchhhhccC
Q 006528 81 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~--~~~G~VKL~DFGlA~~~~~ 157 (641)
|+++ |-+|.++..- .+.++.+++.-++-|++.-++|+|.++ +|||||||+|+|.- .....+-|+|||+|+....
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 9999 5699998874 467999999999999999999999999 99999999999972 2334689999999976543
Q ss_pred CC---------CccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCC--CCHHHHHHHHHcCC---CCC
Q 006528 158 PT---------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGI---KPA 222 (641)
Q Consensus 158 ~~---------~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~--~~~~~i~~~i~~g~---~~~ 222 (641)
.. .+...||..|.+--..- -.-+.+-|+-|+|.++..+.-|..||.+. .+..|.+++|.... .+.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 22 23346888888765333 24567789999999999999999999874 35567777776543 334
Q ss_pred ccccCChHHHHHHHHHhcC
Q 006528 223 SLAKVNDPQIKGFIEKCLV 241 (641)
Q Consensus 223 ~l~~~~~~~l~~LI~kcL~ 241 (641)
.+.+-.+.++.-.+.-|-.
T Consensus 247 ~LC~G~P~EF~myl~Y~R~ 265 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRG 265 (341)
T ss_pred HHhCCCcHHHHHHHHHHhh
Confidence 4555567788888888764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=183.65 Aligned_cols=172 Identities=15% Similarity=0.137 Sum_probs=132.0
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHH------HHHHHHHHHhCCCCCcceeeEEEEeCCC
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK------LYSEVHLLKSLKDDNVVKFYKSWVDDKK 74 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~------l~~Ei~iLk~L~HpNIVk~~~~~~~~~~ 74 (641)
.|++..+|.|+||.||++.+ ++..||+|.+..... ..+...++ +.+|++.+.+|.||+|..+++++.+...
T Consensus 33 y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~-~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 33 IKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK-RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred eEEEEEecCCCceEEEEEec--CCCcEEEEEechhcC-chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 47899999999999999755 477899999864432 23344444 5799999999999999999998775432
Q ss_pred ------ceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEee
Q 006528 75 ------KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 148 (641)
Q Consensus 75 ------~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~D 148 (641)
...++||||++|.+|.++.. +++ ....+|+.+|..||..| ++|||+||+||+++ .+| ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC-EEEEE
Confidence 34789999999999988742 333 24669999999999999 99999999999998 456 99999
Q ss_pred cchhhhccCCCCccccCCCCCCCcccccccCCcccccccccchhhhhh
Q 006528 149 LGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 196 (641)
Q Consensus 149 FGlA~~~~~~~~~~~~GTp~ymAPEvl~~~y~~ksDIwSlGiil~Eml 196 (641)
||............. =++...|+.++|||+||+++..+.
T Consensus 178 fg~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 998754432211110 023456888999999999987664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-20 Score=214.81 Aligned_cols=240 Identities=20% Similarity=0.247 Sum_probs=181.5
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
.+..+|++.|=+|.+|.|. .|. |+||++-+.+...+-....+...|++ .+.++|||+++|..+-+. .+..|||-+
T Consensus 27 ~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAylvRq 101 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYLVRQ 101 (1431)
T ss_pred eecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHHHHH
Confidence 4678999999999999985 466 88998866553333344444555666 677799999999875333 356788999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc--c--CC
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--Q--QP 158 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~--~--~~ 158 (641)
|... +|++.+..++.+..-..+.++.||+.||..+|..| |+|||||++||||+ ..+.+.|+||...+.. . ++
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCCCCc
Confidence 9976 99999998888899999999999999999999999 99999999999997 5568999999876422 1 11
Q ss_pred CCc-----cccCCCCCCCcccccc-----------c-CCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC
Q 006528 159 TAR-----SVIGTPEFMAPELYEE-----------E-YNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 220 (641)
Q Consensus 159 ~~~-----~~~GTp~ymAPEvl~~-----------~-y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~ 220 (641)
.-. +...-.+|.|||.+.. . .+++-||||+||+++||++ |++||. ..|++..-..+..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCcc
Confidence 111 1223458999997632 1 4567899999999999997 566663 3455444333211
Q ss_pred --CCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 006528 221 --PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 221 --~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
...+.++.+..++.||..|++ ||++|.+|++.|+-
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 123455667789999999999 99999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9e-19 Score=174.90 Aligned_cols=184 Identities=14% Similarity=0.031 Sum_probs=137.5
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEEEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~lV~ 81 (641)
+...+++|+||+||.+.. .+..++.+.+.....-...-....+.+|+++|++|. |++|++++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 567899999999998765 567777666654432111122336889999999995 5889999884 2368999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeecc-CCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL-KCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDL-Kp~NILl~~~~G~VKL~DFGlA~~~~~~~~ 160 (641)
||+.|.+|.+.+.. . ...++.|++.+|.++|.+| |+|||| ||+|||++ .+|.++|+|||+|........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence 99999999764321 1 1357889999999999999 999999 79999997 557999999999975433221
Q ss_pred ------c---------cccCCCCCCCcccc---cccCCcccccccccchhhhhhhccCCCCC
Q 006528 161 ------R---------SVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEMVTFEYPYSE 204 (641)
Q Consensus 161 ------~---------~~~GTp~ymAPEvl---~~~y~~ksDIwSlGiil~EmltG~~Pf~~ 204 (641)
. -..++|.|+.|+.- ...--...++++.|.-+|.++|++.|+-.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 11368889999833 23333667889999999999999988643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-18 Score=172.19 Aligned_cols=136 Identities=16% Similarity=0.120 Sum_probs=108.2
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-----CCCCcceeeEEEEeCCC-ce-E
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-----KDDNVVKFYKSWVDDKK-KT-V 77 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-----~HpNIVk~~~~~~~~~~-~~-l 77 (641)
..+|+|+++.||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++|+++..... .. +
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 4689999999995 7777776 5898876432 2346789999999999 57999999999876532 34 3
Q ss_pred EEEEcc--CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeEeeccCCCcEEEeCC---CCcEEEeecch
Q 006528 78 NMITEL--FTSGNLRQYRKKHKNVDIKVIKNWARQILHGL-VYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGL 151 (641)
Q Consensus 78 ~lV~Ey--~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL-~yLHs~gp~IiHrDLKp~NILl~~~---~G~VKL~DFGl 151 (641)
.+|+|| +.+|+|.+++++. .+++. ..+++|++.++ +|||+++ |+||||||+|||++.. .+.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 378999 5589999999774 46666 46789999888 8999999 9999999999999732 24799999543
Q ss_pred h
Q 006528 152 A 152 (641)
Q Consensus 152 A 152 (641)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=178.13 Aligned_cols=208 Identities=17% Similarity=0.258 Sum_probs=167.6
Q ss_pred CEEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEE
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~l 79 (641)
.||=++||.|+||..+.|.+..+++.||||.-.... ..-++..|....+.| ..++|..+|.+-.+. .+=.|
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG--~~NiL 101 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG--KYNIL 101 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccC------CcchHHHHHHHHHHHcCCCCCCceeeecccc--chhhh
Confidence 367789999999999999999999999998644322 234577888888888 468999988654433 34568
Q ss_pred EEccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEe----CCCCcEEEeecchhhh
Q 006528 80 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN----GNHGEVKIGDLGLAIA 154 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~----~~~G~VKL~DFGlA~~ 154 (641)
|+|++ |-+|.++..- ..+|+.+++..++.|++.-++|+|++. +|+|||||+|+||. .+...|-|+|||+|+.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99999 5699998874 567999999999999999999999999 99999999999993 1223689999999988
Q ss_pred ccCCCC---------ccccCCCCCCCcc-cccccCCcccccccccchhhhhhhccCCCCCC--CCHHHHHHHHHcCC
Q 006528 155 MQQPTA---------RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGI 219 (641)
Q Consensus 155 ~~~~~~---------~~~~GTp~ymAPE-vl~~~y~~ksDIwSlGiil~EmltG~~Pf~~~--~~~~~i~~~i~~g~ 219 (641)
...+.. ++..||-.||+-- .+...-+.+-|.-|||-+++..+-|.+||.+. .+..+.|++|-...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 765532 3456999999977 34455788899999999999999999999863 45567788876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=182.66 Aligned_cols=197 Identities=22% Similarity=0.358 Sum_probs=144.5
Q ss_pred CCCCcceeeEEEEeC-------------------------CCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 006528 58 KDDNVVKFYKSWVDD-------------------------KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQIL 112 (641)
Q Consensus 58 ~HpNIVk~~~~~~~~-------------------------~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl 112 (641)
+|||||++++.|.+. ...++|+||.-+.. +|++|+-.. ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 699999999988653 24679999999875 999999753 356777788999999
Q ss_pred HHHHHHHhCCCCeEeeccCCCcEEEeC-CC--CcEEEeecchhhhccC-----CCC---ccccCCCCCCCccccccc---
Q 006528 113 HGLVYLHSHNPPIIHRDLKCDNIFVNG-NH--GEVKIGDLGLAIAMQQ-----PTA---RSVIGTPEFMAPELYEEE--- 178 (641)
Q Consensus 113 ~gL~yLHs~gp~IiHrDLKp~NILl~~-~~--G~VKL~DFGlA~~~~~-----~~~---~~~~GTp~ymAPEvl~~~--- 178 (641)
+|+.|||.+| |.|||||.+|||+.- ++ ..+.|+|||++---.. +.. -..-|.-..||||+....
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 999999999999932 22 2578999998732111 111 122467789999988632
Q ss_pred ----CCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCH---H
Q 006528 179 ----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSA---K 250 (641)
Q Consensus 179 ----y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa---~ 250 (641)
.-.++|.|+.|.+.||+++...||.+. ....+-..--+...-+.++...++.+++++..+|+ +|++|+++ .
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCccccc-chheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 235899999999999999999999762 11111111111223345667778999999999999 89999984 4
Q ss_pred HHHcCcccc
Q 006528 251 DLLKDPFLQ 259 (641)
Q Consensus 251 eLL~Hpff~ 259 (641)
.+|+-..+.
T Consensus 509 Nvl~LsLw~ 517 (598)
T KOG4158|consen 509 NVLNLSLWR 517 (598)
T ss_pred hHHHHHHhc
Confidence 555544343
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=179.93 Aligned_cols=231 Identities=14% Similarity=0.111 Sum_probs=146.8
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC----------CCcceeeEEEEeC
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD----------DNVVKFYKSWVDD 72 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H----------pNIVk~~~~~~~~ 72 (641)
.-.-||.|+++.||.++|.+||+++|+|++.... .......+.+.+|......+.+ -.++.-++.....
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3456899999999999999999999999998776 4455567788888766655433 1222222222211
Q ss_pred C----------Cc-----eEEEEEccCCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCeEeecc
Q 006528 73 K----------KK-----TVNMITELFTSGNLRQYRKK---HKN----VDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130 (641)
Q Consensus 73 ~----------~~-----~l~lV~Ey~~gGsL~~~l~~---~~~----l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDL 130 (641)
. .. ..+++|+-+. ++|.+++.- ... +.......+..|+++.+++||.+| ++|+||
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi 171 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDI 171 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEeccc
Confidence 1 11 1357788875 699888652 222 222233444589999999999999 999999
Q ss_pred CCCcEEEeCCCCcEEEeecchhhhccCCCCccccCCCCCCCcccccc---------cCCcccccccccchhhhhhhccCC
Q 006528 131 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMCILEMVTFEYP 201 (641)
Q Consensus 131 Kp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~~~GTp~ymAPEvl~~---------~y~~ksDIwSlGiil~EmltG~~P 201 (641)
+|+|+|++ .+|.++|+||+........... ...+..|.|||+... .++.+.|.|+||+++|.|.+++.|
T Consensus 172 ~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 99999998 4589999999877543332221 345678999996642 378899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCC
Q 006528 202 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASER 246 (641)
Q Consensus 202 f~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~R 246 (641)
|....... .... ........+..++.||..+|+ +|.+|
T Consensus 250 f~~~~~~~-~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEA-DPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGS-TSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccc-cccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 97532111 0000 111112335679999999999 78877
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-18 Score=174.03 Aligned_cols=232 Identities=16% Similarity=0.270 Sum_probs=174.4
Q ss_pred ccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCCCC
Q 006528 9 RIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGN 88 (641)
Q Consensus 9 ~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGs 88 (641)
....|..|+|.+. |..+++|+++..++ ....-..|..|.-.|+-+.||||+.+.+.+... ..+.+|..||+.|+
T Consensus 200 e~hsgelwrgrwq--gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~isq~mp~gs 273 (448)
T KOG0195|consen 200 ESHSGELWRGRWQ--GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIISQYMPFGS 273 (448)
T ss_pred cCCCccccccccc--Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEeeeeccchH
Confidence 3445778888876 44566777766554 334456688999999999999999999977555 45889999999999
Q ss_pred HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEE--eecchhhhccCCCCcccc
Q 006528 89 LRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI--GDLGLAIAMQQPTARSVI 164 (641)
Q Consensus 89 L~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL--~DFGlA~~~~~~~~~~~~ 164 (641)
|+..+.... .++..++.+++..|++|++|||+..|-|.--.|....++|+.+ -+.+| +|--++. + .....
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kfsf---q--e~gr~ 347 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKFSF---Q--EVGRA 347 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecccceeee---e--ccccc
Confidence 999998654 3677888999999999999999998655555788899999743 34443 3322221 1 11234
Q ss_pred CCCCCCCccccccc----CCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhc
Q 006528 165 GTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 165 GTp~ymAPEvl~~~----y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL 240 (641)
..|.||+||.+... .-.++|+|||.+++|||.|.+.||.+....+.-++....|..+ .++...++.+..|+.-|+
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm~klm~icm 426 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHMNKLMNICM 426 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHHHHHHHHHh
Confidence 58999999987643 3467999999999999999999999866555555555555443 344555678999999999
Q ss_pred C-CCCCCCCHHHHH
Q 006528 241 V-PASERLSAKDLL 253 (641)
Q Consensus 241 ~-dP~~RpSa~eLL 253 (641)
. ||.+||..+.++
T Consensus 427 nedpgkrpkfdmiv 440 (448)
T KOG0195|consen 427 NEDPGKRPKFDMIV 440 (448)
T ss_pred cCCCCcCCCcceeh
Confidence 9 899999876553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-18 Score=189.99 Aligned_cols=174 Identities=26% Similarity=0.507 Sum_probs=138.3
Q ss_pred ceEEEEEccCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecch
Q 006528 75 KTVNMITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGl 151 (641)
.++||.|++|..++|.+||...+ ..+....+.|+.||..|+.| ++ .+|||+||.||+.. ++..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhh
Confidence 46899999999999999997543 36777899999999999999 77 99999999999996 556899999999
Q ss_pred hhhccCCC--------CccccCCCCCCCccccc-ccCCcccccccccchhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 006528 152 AIAMQQPT--------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 221 (641)
Q Consensus 152 A~~~~~~~--------~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~Emlt-G~~Pf~~~~~~~~i~~~i~~g~~~ 221 (641)
........ .....||+.||+||.+. ..|+.++||||||++|+|++. ...+|. ....+..+..+..|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCC
Confidence 87654322 22457999999999877 569999999999999999997 333333 22334456667666
Q ss_pred CccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 222 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 222 ~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
+.+.. ..|.-..|+..+|. .|.+||++.+.-.|+|++
T Consensus 479 ~~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 479 PEFLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hHHhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 43332 24567799999998 799999988888888764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=165.55 Aligned_cols=146 Identities=20% Similarity=0.128 Sum_probs=113.7
Q ss_pred EEEEeCccCceEEEEEE-EcCCCeEEEEEEEecccccC------------------Ch--hhHHHHHHHHHHHHhCCCCC
Q 006528 3 ILISSRRIPAVDTYKAF-DEFAGIEVAWSRVKIDDVLQ------------------LP--GDLQKLYSEVHLLKSLKDDN 61 (641)
Q Consensus 3 il~~lG~GafgtVYkA~-d~~tG~~VAIK~v~~~~~~~------------------~~--~~~~~l~~Ei~iLk~L~HpN 61 (641)
+...+|.|++|.||+|. +..+|..||+|.++...... .+ .....+..|+++++++.+.+
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 55679999999999999 77899999999998643110 00 01234678999999997533
Q ss_pred --cceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC
Q 006528 62 --VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139 (641)
Q Consensus 62 --IVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~ 139 (641)
+.++++. . ..++||||+.|++|..+......+....+..++.||+.+|.+||.+| +|+||||||+||+++
T Consensus 112 i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~- 183 (237)
T smart00090 112 VPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH- 183 (237)
T ss_pred CCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE-
Confidence 4455542 2 24799999999998776544556777788999999999999999987 499999999999998
Q ss_pred CCCcEEEeecchhhhccC
Q 006528 140 NHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 140 ~~G~VKL~DFGlA~~~~~ 157 (641)
.+.++|+|||.+.....
T Consensus 184 -~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 -DGKVVIIDVSQSVELDH 200 (237)
T ss_pred -CCCEEEEEChhhhccCC
Confidence 46899999999875544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.1e-17 Score=181.23 Aligned_cols=196 Identities=26% Similarity=0.406 Sum_probs=153.8
Q ss_pred HHhCCCCCcceeeEEEEeCCCceEEEEEccCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCe-EeeccC
Q 006528 54 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPI-IHRDLK 131 (641)
Q Consensus 54 Lk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~gp~I-iHrDLK 131 (641)
|+.+.|.|+.+|++..++. ..++.|.+||+.|+|.+.+.. .-.++......++++|+.||.|||... | .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999887 568899999999999999987 456888899999999999999999975 4 999999
Q ss_pred CCcEEEeCCCCcEEEeecchhhhccC----CCCccccCCCCCCCccccccc--------CCcccccccccchhhhhhhcc
Q 006528 132 CDNIFVNGNHGEVKIGDLGLAIAMQQ----PTARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTFE 199 (641)
Q Consensus 132 p~NILl~~~~G~VKL~DFGlA~~~~~----~~~~~~~GTp~ymAPEvl~~~--------y~~ksDIwSlGiil~EmltG~ 199 (641)
+.|++++... .+||.|||+...... .......-...|.|||++... .+.+.|||||||+++|+++..
T Consensus 77 s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 77 SSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999664 899999999865532 111112234579999988752 466799999999999999999
Q ss_pred CCCCCC---CCHHHHHHHHHcCCCCCcccc-----CChHHHHHHHHHhcC-CCCCCCCHHHHHc
Q 006528 200 YPYSEC---KNPAQIFKKVTSGIKPASLAK-----VNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 200 ~Pf~~~---~~~~~i~~~i~~g~~~~~l~~-----~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
-||... ..+.++..++..+......+. ...+++..++..||. +|.+||+++++-.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 999752 233567777766222211221 223478899999999 8999999888754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=156.15 Aligned_cols=138 Identities=19% Similarity=0.165 Sum_probs=111.7
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCC----hhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
..+|.|++|.||+|.+ .|..|++|.......... .....++.+|+.++..+.|++|.....++.+.. ..+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence 4689999999999987 678899997553321111 112356889999999999999877666665553 46799
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
|||++|++|.+++..... ....++.+|+.+|.+||+.+ ++|||++|.|||++ .+.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999999876442 78899999999999999999 99999999999998 46899999998854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.6e-16 Score=152.21 Aligned_cols=133 Identities=19% Similarity=0.183 Sum_probs=105.1
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCC----hhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+|+|++|+||+|. .+|..|++|.......... .....++.+|+++++.+.|+++.....++.... ..++|||
T Consensus 2 ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e 77 (199)
T TIGR03724 2 IAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVME 77 (199)
T ss_pred CCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEE
Confidence 7999999999998 4678899998654322111 112467889999999999887654444444443 3679999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
|++|++|.+++..... .++.||+.+|.+||+.+ ++|||++|.||+++ .+.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 9999999998765331 78999999999999999 99999999999998 47999999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.9e-18 Score=194.22 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=198.3
Q ss_pred EEEEEeCccCceEEEEEEEcC-CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~-tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~l 79 (641)
++...+|.|+|+.|-.+.... ....+|.|.+.... .......++..|..+-+.+. |+|++.+++.+... ...++
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~~~~ 98 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RSYLL 98 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCC--ccccc
Confidence 345678999999998887643 33356666665543 34556677788999999997 99999999976554 56889
Q ss_pred EEccCCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeEeeccCCCcEEEeCCCC-cEEEeecchhhhc
Q 006528 80 ITELFTSGNLRQYR-KKHK-NVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHG-EVKIGDLGLAIAM 155 (641)
Q Consensus 80 V~Ey~~gGsL~~~l-~~~~-~l~e~~i~~i~~QIl~gL~yLH-s~gp~IiHrDLKp~NILl~~~~G-~VKL~DFGlA~~~ 155 (641)
+++|..||++...+ .... ..+......++.|+..+|.|+| ..+ +.|||+||+|.+++ ..| .+|++|||+|...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCchhhccc
Confidence 99999999999988 5554 6788888999999999999999 888 99999999999998 446 8999999999877
Q ss_pred cC-CC----CccccC-CCCCCCcccccc-c-CCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC--CCCccc
Q 006528 156 QQ-PT----ARSVIG-TPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLA 225 (641)
Q Consensus 156 ~~-~~----~~~~~G-Tp~ymAPEvl~~-~-y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~--~~~~l~ 225 (641)
.. .. ....+| ++.|+|||++.+ . .....|+||.|+++.-|++|..|+.........+....... ......
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 65 22 234578 999999998876 3 57889999999999999999999876433333332222221 123344
Q ss_pred cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 226 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 226 ~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
...+....+++.++|. +|+.|.+.+++-.+||+..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 4556788999999997 8999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-16 Score=185.91 Aligned_cols=188 Identities=21% Similarity=0.226 Sum_probs=149.2
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC---CCCcceeeEEEEeCCCceEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVk~~~~~~~~~~~~l~ 78 (641)
.|-..+|.|+||+||+|.+.. |+.||+|+=+.... + .++-=.+++.+|+ -+.|+.++..++..+ .-+
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--~S~ 770 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--W-----EFYICLQVMERLKPQMLPSIMHISSAHVFQN--ASV 770 (974)
T ss_pred EEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--e-----eeeehHHHHHhhchhhhcchHHHHHHHccCC--cce
Confidence 467899999999999999876 99999997543331 1 1233334455555 345666666555553 367
Q ss_pred EEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC------CCCcEEEeecchh
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG------NHGEVKIGDLGLA 152 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~------~~G~VKL~DFGlA 152 (641)
+|+||.+.|+|.+++...+.+++..+..+..|+|.-++.||..+ |||+||||+|.||.. +.--++|+|||.+
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 89999999999999998899999999999999999999999999 999999999999941 2235899999999
Q ss_pred hhccC---C-CCccccCCCCCCCcccccc-cCCcccccccccchhhhhhhccCC
Q 006528 153 IAMQQ---P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYP 201 (641)
Q Consensus 153 ~~~~~---~-~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGiil~EmltG~~P 201 (641)
..+.- . .....++|-.|--+|+..+ .++..+|.|.|.-+++.|+.|++-
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 65531 1 2345577888999998876 589999999999999999999743
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-15 Score=149.37 Aligned_cols=139 Identities=22% Similarity=0.162 Sum_probs=106.4
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccC--Ch----------------hhHHHHHHHHHHHHhCCCCC--c
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQ--LP----------------GDLQKLYSEVHLLKSLKDDN--V 62 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~--~~----------------~~~~~l~~Ei~iLk~L~HpN--I 62 (641)
+...+|.|+||.||+|.+. +|..||||.+....... .. ........|+.++..+.|++ +
T Consensus 19 ~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v 97 (198)
T cd05144 19 LGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV 97 (198)
T ss_pred cCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence 3456899999999999875 89999999877543100 00 11224678999999998874 4
Q ss_pred ceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCC
Q 006528 63 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 142 (641)
Q Consensus 63 Vk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G 142 (641)
.+.++ . ...++||||+.|++|..+... .....++.+|+.++.++|..+ |+||||||+||+++. ++
T Consensus 98 ~~~~~----~--~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~-~~ 162 (198)
T cd05144 98 PKPID----W--NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD-DE 162 (198)
T ss_pred Cceee----c--CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC-CC
Confidence 44443 1 235799999999999875431 345788999999999999999 999999999999984 57
Q ss_pred cEEEeecchhhhccC
Q 006528 143 EVKIGDLGLAIAMQQ 157 (641)
Q Consensus 143 ~VKL~DFGlA~~~~~ 157 (641)
.++|+|||.+.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.1e-15 Score=168.83 Aligned_cols=136 Identities=16% Similarity=0.086 Sum_probs=106.6
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccC----ChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQ----LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~----~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
...+|+|+||+||+|.+... .+++|......... .....+++.+|+++++.++|++|+..+.++.+.. ..++
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~l 413 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EKTI 413 (535)
T ss_pred cceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCEE
Confidence 45789999999999987543 44444432221111 1123467889999999999999988777666543 3679
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~ 155 (641)
||||+++++|.+++. ....++.||+.+|.|||+.+ ++||||||+|||++ .+.++|+|||+++..
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCcccccC
Confidence 999999999999886 34678999999999999999 99999999999994 468999999999653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=9e-15 Score=142.08 Aligned_cols=140 Identities=21% Similarity=0.170 Sum_probs=100.2
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHH---------------------HHHHHHHHHHhCCCCC-
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQ---------------------KLYSEVHLLKSLKDDN- 61 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~---------------------~l~~Ei~iLk~L~HpN- 61 (641)
...+|+|+||+||+|.+. +|..||+|+++...... ..... ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSF-KKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccch-hhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 356899999999999986 89999999987543211 11111 1145677777775443
Q ss_pred -cceeeEEEEeCCCceEEEEEccCCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEEe
Q 006528 62 -VVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVN 138 (641)
Q Consensus 62 -IVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~-l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl~ 138 (641)
+.+.++. ...++||||++++.+... +.... . ...++.++.+++.++.++|. ++ |+||||||+||+++
T Consensus 80 ~~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEec------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence 4555542 125799999999543211 11111 1 16678999999999999999 88 99999999999998
Q ss_pred CCCCcEEEeecchhhhccC
Q 006528 139 GNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 139 ~~~G~VKL~DFGlA~~~~~ 157 (641)
++.++|+|||.+.....
T Consensus 150 --~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 --DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred --CCcEEEEECcccccccC
Confidence 57999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-13 Score=141.51 Aligned_cols=138 Identities=13% Similarity=0.137 Sum_probs=103.2
Q ss_pred eC-ccCceEEEEEEEcCCCeEEEEEEEecccc----c-----CChhhHHHHHHHHHHHHhCCCCCc--ceeeEEEEeCCC
Q 006528 7 SR-RIPAVDTYKAFDEFAGIEVAWSRVKIDDV----L-----QLPGDLQKLYSEVHLLKSLKDDNV--VKFYKSWVDDKK 74 (641)
Q Consensus 7 lG-~GafgtVYkA~d~~tG~~VAIK~v~~~~~----~-----~~~~~~~~l~~Ei~iLk~L~HpNI--Vk~~~~~~~~~~ 74 (641)
+| .|+.|+||++... |..+++|.+....+ . .......++.+|+.++..|.|++| ++.+++......
T Consensus 39 lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 39 VGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred eecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 44 5666688888764 77899998864321 0 112334678999999999998875 667765443322
Q ss_pred c--eEEEEEccCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecch
Q 006528 75 K--TVNMITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 151 (641)
Q Consensus 75 ~--~l~lV~Ey~~g-GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGl 151 (641)
. ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||.+| |+||||||.|||++. ++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~-~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDP-DGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcC-CCCEEEEECCC
Confidence 1 23599999997 699998865 3466543 578999999999999 999999999999974 46899999998
Q ss_pred hhh
Q 006528 152 AIA 154 (641)
Q Consensus 152 A~~ 154 (641)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=125.53 Aligned_cols=134 Identities=19% Similarity=0.045 Sum_probs=109.0
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC--CCcceeeEEEEeCCCceEEEE
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVk~~~~~~~~~~~~l~lV 80 (641)
++..+|.|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.+.| .++.+++.+.... ...+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLL 71 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEE
Confidence 46789999999999999854 6799998764321 4568899999999976 5888988765443 568899
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN-PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~g-p~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
+||+.++.+..+ +......++.+++.+|.+||... ++++|+||+|.||+++. .+.+++.|||.+..
T Consensus 72 ~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 72 MEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 999999888765 55677788999999999999852 24999999999999985 57999999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.7e-14 Score=155.78 Aligned_cols=251 Identities=23% Similarity=0.242 Sum_probs=195.1
Q ss_pred EEEEeCc--cCceEEEEEEE--cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceE
Q 006528 3 ILISSRR--IPAVDTYKAFD--EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 3 il~~lG~--GafgtVYkA~d--~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l 77 (641)
+...+|. |.+|.||.+.. ..++..+|+|.=++.- ..+....+=.+|+...+.+ .|+|.++.+..|... ..+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~--~~l 193 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS--GIL 193 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCcccccC--Ccc
Confidence 4556788 99999999999 9999999998844322 2334444557788877778 599999999988766 458
Q ss_pred EEEEccCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 78 NMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILH----GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~-l~e~~i~~i~~QIl~----gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
++-+|+|. .+|..+...... ++...++..+.+... ||.++|+.+ ++|-|+||.||+...+....+++|||+.
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCccee
Confidence 88899996 688888876555 889999999999999 999999999 9999999999999866578999999998
Q ss_pred hhccCCC-Cc------cccCCCCCCCcccccccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 006528 153 IAMQQPT-AR------SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 225 (641)
Q Consensus 153 ~~~~~~~-~~------~~~GTp~ymAPEvl~~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~ 225 (641)
..+.... .. ...|...|++||+.++-++...|||++|.+.++..++-.+.....+. ....+..+..+..+.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQLRQGYIPLEFC 348 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--CccccccccCchhhh
Confidence 7665432 11 12467789999999999999999999999999999886555432111 112233333454555
Q ss_pred cCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccccc
Q 006528 226 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 226 ~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~ 262 (641)
...+.++...+..++. +|..|+++..++.|+++....
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence 4555667778888888 799999999999999997433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.6e-14 Score=165.57 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=201.7
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEc
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~E 82 (641)
+...+-+++++.++.+.-..+|...++|.......... ...+.+.++-.++....||.++.++..+... ...+++++
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r--sP~~L~~~ 884 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPCR--SPLPLVGH 884 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCCC--CCcchhhH
Confidence 33456678889999888888887677766554443222 2345566666677667789998888765544 34889999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc------
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ------ 156 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~------ 156 (641)
|..+|+|...+.+.+..+....+.++..+..+++|||+.. +.|||++|.|+++. ..|..++.|||......
T Consensus 885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcC
Confidence 9999999999999888999999999999999999999997 89999999999996 66899999998431100
Q ss_pred -C--------------------------CCCccccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCH
Q 006528 157 -Q--------------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP 208 (641)
Q Consensus 157 -~--------------------------~~~~~~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~ 208 (641)
. .......||+.|.|||.+. ......+|+|++|++++|.++|..||.. ..+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cch
Confidence 0 0012346899999999665 4578899999999999999999999987 567
Q ss_pred HHHHHHHHcCCCCC-ccccCChHHHHHHHHHhcC-CCCCCCCHH---HHHcCcccccccCCCC
Q 006528 209 AQIFKKVTSGIKPA-SLAKVNDPQIKGFIEKCLV-PASERLSAK---DLLKDPFLQVENQKEP 266 (641)
Q Consensus 209 ~~i~~~i~~g~~~~-~l~~~~~~~l~~LI~kcL~-dP~~RpSa~---eLL~Hpff~~~~~~~~ 266 (641)
.+++..+..+..+. .-+...++++++++.+.|. +|.+|..+. ++-.||||+...|...
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 88888777665442 2334457889999999998 899999987 9999999998887653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.8e-12 Score=138.17 Aligned_cols=245 Identities=19% Similarity=0.143 Sum_probs=179.3
Q ss_pred EEEEEeCccCceEEEEEEEc-CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEEeCCCceEEE
Q 006528 2 RILISSRRIPAVDTYKAFDE-FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~-~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~l 79 (641)
..+..+|.|.|+.||+..-. .++..|++|.+...-. .......-..|+.+...| .|.+++.++..|....+ .++
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--~~i 343 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--GYI 343 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--ccC
Confidence 46789999999998876654 6788899998764432 233344567788888777 69999999999976654 557
Q ss_pred EEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~ 159 (641)
=.|||.++++...+.-...+++...+....|++.++.++|+.. ++|+|+||+||++..+++.-+++|||.++.+....
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccceec
Confidence 8899999999988866677899999999999999999999998 99999999999997544788999999986533221
Q ss_pred CccccCCCCCC-Ccccccc--cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHH
Q 006528 160 ARSVIGTPEFM-APELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 160 ~~~~~GTp~ym-APEvl~~--~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
....+.-.++ .+|++.+ .+..++|++|||.-+.+.+++. |+... .+....+..+..+ ..+... .++..+.
T Consensus 422 -~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~-~ls~~---~~~~~~i~~~~~p-~~~~~~-~~~q~~~ 494 (524)
T KOG0601|consen 422 -GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS-PLSES---GVQSLTIRSGDTP-NLPGLK-LQLQVLL 494 (524)
T ss_pred -ccccccccccccchhhccccccccccccccccccccccccCc-ccCcc---cccceeeeccccc-CCCchH-Hhhhhhh
Confidence 1122233444 3555443 4788999999999999999986 33321 1112233333222 122222 5677788
Q ss_pred HHhcC-CCCCCCCHHHHHcCcccc
Q 006528 237 EKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
+.++. ++..||.+.++..|+-|.
T Consensus 495 kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 495 KVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhcCCccccchhhhhhcccchhh
Confidence 88877 788999999999887664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.7e-11 Score=131.94 Aligned_cols=142 Identities=20% Similarity=0.167 Sum_probs=93.4
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhh------------------------------H------HHHHH
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGD------------------------------L------QKLYS 49 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~------------------------------~------~~l~~ 49 (641)
-+|.|++|.||+|.. .+|+.||||+.+..-......+ . -.+.+
T Consensus 124 plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 124 PLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred ceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 478999999999987 4899999998753211000000 0 12344
Q ss_pred HHHHHHhC----C-CCCcceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 006528 50 EVHLLKSL----K-DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILH-GLVYLHSHN 122 (641)
Q Consensus 50 Ei~iLk~L----~-HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~-gL~yLHs~g 122 (641)
|...+.++ + +++| .+-.++.+.. ...++||||+.|++|.++.... ...+ ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 55555554 2 3333 3222222211 2357999999999999886532 1222 2345566665 467889999
Q ss_pred CCeEeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006528 123 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 123 p~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~ 156 (641)
++|+|+||.||+++ .+|.++|+|||++..+.
T Consensus 278 --~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 99999999999997 55899999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=7e-11 Score=132.85 Aligned_cols=170 Identities=22% Similarity=0.255 Sum_probs=130.4
Q ss_pred EE-EEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCCCCHHHHH
Q 006528 15 TY-KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYR 93 (641)
Q Consensus 15 VY-kA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l 93 (641)
+| .|..+.+|.+|.|...+... ....+.+.+-++-|+.|+||||++|++.+... .++|+|||-+. .|..++
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTErV~--Pl~~~l 98 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTERVR--PLETVL 98 (690)
T ss_pred cccccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeeccc--cHHHHH
Confidence 55 57888999999999887654 24566788899999999999999999988765 47999999995 788888
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--CccccCCCCCCC
Q 006528 94 KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMA 171 (641)
Q Consensus 94 ~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~--~~~~~GTp~ymA 171 (641)
++.+ ...+..-+.||+.||.|||..+ .++|++|.-+.|||+ ..|..||++|.++....... .+...---.|..
T Consensus 99 k~l~---~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~ 173 (690)
T KOG1243|consen 99 KELG---KEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDD 173 (690)
T ss_pred HHhH---HHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccC
Confidence 7744 6777888999999999998543 399999999999998 66899999999875443222 111111223455
Q ss_pred cccccccCCcccccccccchhhhhhhc
Q 006528 172 PELYEEEYNELVDIYSFGMCILEMVTF 198 (641)
Q Consensus 172 PEvl~~~y~~ksDIwSlGiil~EmltG 198 (641)
|+.+... .-..|.|-|||++++++.|
T Consensus 174 P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 174 PEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 5543211 1457999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.8e-11 Score=134.97 Aligned_cols=141 Identities=15% Similarity=0.100 Sum_probs=92.0
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEeccccc--------------------------CCh----hhHHHHHH------
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL--------------------------QLP----GDLQKLYS------ 49 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~--------------------------~~~----~~~~~l~~------ 49 (641)
-+|.|++|.||+|..+.+|++||||+.+..-.. ... +....+.+
T Consensus 126 PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~ 205 (537)
T PRK04750 126 PLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMR 205 (537)
T ss_pred hhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHH
Confidence 579999999999999888999999998643100 000 11223333
Q ss_pred HHHHHHhCC----CCCcceeeEEEEeCCCceEEEEEccCCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHH
Q 006528 50 EVHLLKSLK----DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHK----NVDIKVIKNWARQILHGLVYLH 119 (641)
Q Consensus 50 Ei~iLk~L~----HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~--l~~~~----~l~e~~i~~i~~QIl~gL~yLH 119 (641)
|...+.++. +.+.+.+-.++.+-. ...++||||+.|+.+.++ +...+ .+.+..+..++.||+
T Consensus 206 Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 206 EAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 333343332 333333333332211 235699999999999875 33333 255556666666665
Q ss_pred hCCCCeEeeccCCCcEEEeCCC---CcEEEeecchhhhcc
Q 006528 120 SHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAMQ 156 (641)
Q Consensus 120 s~gp~IiHrDLKp~NILl~~~~---G~VKL~DFGlA~~~~ 156 (641)
..| ++|+|+||.||+++.++ +.+++.|||++..+.
T Consensus 278 ~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 467 99999999999997442 289999999986554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-10 Score=110.92 Aligned_cols=129 Identities=18% Similarity=0.063 Sum_probs=94.7
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcc-eeeEEEEeCCCceEEEEEc
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV-KFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV-k~~~~~~~~~~~~l~lV~E 82 (641)
+..++.|.++.||++... |..|++|....... ....+..|..+++.+.+.+++ +++.+ +... -++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~--~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYF--DPET--GVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEE--eCCC--CeEEEE
Confidence 456788989999999864 78899998653321 122457899999998655544 45543 2322 468999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP---PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp---~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
|++|.++... . .....++.+++.+|..||..+. .++|+|++|.||+++ + +.++++|||.+.
T Consensus 72 ~i~G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~ 135 (170)
T cd05151 72 FIEGSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG 135 (170)
T ss_pred ecCCCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence 9999888653 1 1124567899999999999871 259999999999998 3 589999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.7e-10 Score=109.74 Aligned_cols=143 Identities=15% Similarity=0.082 Sum_probs=101.3
Q ss_pred EEeCccCceEEEEEEEcC------CCeEEEEEEEecccc--cC-------C---------hhhHHHHH----HHHHHHHh
Q 006528 5 ISSRRIPAVDTYKAFDEF------AGIEVAWSRVKIDDV--LQ-------L---------PGDLQKLY----SEVHLLKS 56 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~------tG~~VAIK~v~~~~~--~~-------~---------~~~~~~l~----~Ei~iLk~ 56 (641)
..+|-|-=+.||.|.... .+..+|+|..+..-. .. . ..-...+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 456777778899998754 357999999864221 00 0 11122334 89999999
Q ss_pred CCC--CCcceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEeeccCCC
Q 006528 57 LKD--DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCD 133 (641)
Q Consensus 57 L~H--pNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~gp~IiHrDLKp~ 133 (641)
|.. -++.+.+++ . .-+|||||+.++.+..-.-+...+++..+..+..|++.+|..| |..| |+|+||++.
T Consensus 83 l~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 953 566777763 1 2468999998754432222223466677788899999999998 8999 999999999
Q ss_pred cEEEeCCCCcEEEeecchhhhccC
Q 006528 134 NIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 134 NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
||++. + |.+.|+|||.+.....
T Consensus 155 NIL~~-~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH-D-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE-C-CcEEEEECCCceeCCC
Confidence 99996 3 6899999998865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.6e-09 Score=116.19 Aligned_cols=216 Identities=20% Similarity=0.268 Sum_probs=154.4
Q ss_pred eEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeCC--CceEEEEEccCCC-CCH
Q 006528 13 VDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--KKTVNMITELFTS-GNL 89 (641)
Q Consensus 13 gtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~--~~~l~lV~Ey~~g-GsL 89 (641)
.+.|+|+...+|..|+.|++...+.. +. -+...-+++++++.|+|||+|..+|.... ...++||++|.++ ++|
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQ-ST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ceeEeeeeccCCceeeeeeecccccc-Cc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 46899999999999999999544322 22 12355688999999999999999987322 3468999999986 677
Q ss_pred HHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 90 RQYRK---------------KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 90 ~~~l~---------------~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
.++.- .....++..+|.++.|+..||.++|+.| +..+-|.|.+|+++|+. +|+|...|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccceee
Confidence 77542 1235788999999999999999999999 99999999999999764 788877776544
Q ss_pred ccCCCCccccCCCCCCCcccccccCCcccccccccchhhhhhhccCCCCCCCCHHHH-HHHHHcCCCCCccccCChHHHH
Q 006528 155 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 155 ~~~~~~~~~~GTp~ymAPEvl~~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i-~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
+.... + +.+++ -.+-|.=.||.+++.|+||..--...+...+. ...| ....+.+++
T Consensus 443 l~~d~-----~-------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I---------~~~yS~D~r 499 (655)
T KOG3741|consen 443 LQEDP-----T-------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI---------TTTYSTDLR 499 (655)
T ss_pred ecCCC-----C-------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---------hhhhhHHHH
Confidence 43322 0 11111 13457778999999999995332111222222 2222 234567899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcC---cccc
Q 006528 234 GFIEKCLV-PASERLSAKDLLKD---PFLQ 259 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~H---pff~ 259 (641)
++|.-+.. .+.+ .++.+|+.| .||.
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~~~~~ff~ 528 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPMIGSRFFT 528 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHHHHHHHHH
Confidence 99998887 4665 788888876 4554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.2e-09 Score=102.88 Aligned_cols=144 Identities=20% Similarity=0.181 Sum_probs=105.0
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC--CCcceeeEEEEeCC-CceEEEEE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDK-KKTVNMIT 81 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVk~~~~~~~~~-~~~l~lV~ 81 (641)
..++.|..+.||++... +|..+++|........ .....+.+|..+++.+.+ .++.+++.+..... ....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 45788999999999874 3688999987544321 124468899999999965 34566766433221 12568999
Q ss_pred ccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN--------------------------------------- 122 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~g--------------------------------------- 122 (641)
||++|+++.+.+.. ..+++.....++.+++++|.+||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988775432 45677777788888888888888521
Q ss_pred ---------------CCeEeeccCCCcEEEeCC-CCcEEEeecchhh
Q 006528 123 ---------------PPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAI 153 (641)
Q Consensus 123 ---------------p~IiHrDLKp~NILl~~~-~G~VKL~DFGlA~ 153 (641)
..++|+|++|+||+++.+ .+.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 247999999999999853 4568999999774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.4e-08 Score=93.82 Aligned_cols=143 Identities=15% Similarity=0.194 Sum_probs=103.0
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChh-----hHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPG-----DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~-----~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~l 79 (641)
..+-+|+-++|+++.. .|+.++||.= ..+...-|. ...+..+|.++|.+|.--.|.--.-+|++...+. +
T Consensus 13 ~likQGAEArv~~~~~--~Ge~~iIK~R-f~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~--i 87 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF--SGEAAIIKER-FSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ--I 87 (229)
T ss_pred eeeeccceeeEeeecc--CCceeEEeec-ccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe--E
Confidence 3445677779999985 4888887752 222222222 3567889999999997656644444556766544 5
Q ss_pred EEccCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcE--EEeecchhhh
Q 006528 80 ITELFTS-GNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV--KIGDLGLAIA 154 (641)
Q Consensus 80 V~Ey~~g-GsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~V--KL~DFGlA~~ 154 (641)
+|||+.| -++++|+.... .........++++|-..+.-||..+ |||+||..+||++..+++.+ .|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 6799976 48899887642 2333344789999999999999999 99999999999997665555 8999999854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.9e-08 Score=94.17 Aligned_cols=133 Identities=19% Similarity=0.194 Sum_probs=96.9
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhh-----HHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEE
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGD-----LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~-----~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV 80 (641)
.+++|+=+.+|.+.. -|..+++|. ++.+....+.. .++-.+|..+|.++.--.|.--+=+.++..+ ..++
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I~ 77 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN--GLIV 77 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEEE
Confidence 356788889999854 455666664 44443334443 3556688889998865454332223356644 5589
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
|||++|-.|++++... ...+++.|-.-+.-||..| |+|+||+++||.+.+ +.+.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeC--CcEEEEECCcccc
Confidence 9999999999998875 1466777778888899999 999999999999974 3599999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.7e-07 Score=92.87 Aligned_cols=130 Identities=27% Similarity=0.282 Sum_probs=85.0
Q ss_pred EEEEEEEcCCCeEEEEEEEeccccc------------C----------ChhhHHHHHHHHHHHHhCCCC--CcceeeEEE
Q 006528 14 DTYKAFDEFAGIEVAWSRVKIDDVL------------Q----------LPGDLQKLYSEVHLLKSLKDD--NVVKFYKSW 69 (641)
Q Consensus 14 tVYkA~d~~tG~~VAIK~v~~~~~~------------~----------~~~~~~~l~~Ei~iLk~L~Hp--NIVk~~~~~ 69 (641)
.||.|.. ..|..||+|..+..... . .........+|.+.|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899987 57889999998753211 0 011245678999999999765 56677653
Q ss_pred EeCCCceEEEEEccCC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeEeeccCCCcEEEeCCCCcEEE
Q 006528 70 VDDKKKTVNMITELFT--SGNLRQYRKKHKNVDIKVIKNWARQILHGLVY-LHSHNPPIIHRDLKCDNIFVNGNHGEVKI 146 (641)
Q Consensus 70 ~~~~~~~l~lV~Ey~~--gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~y-LHs~gp~IiHrDLKp~NILl~~~~G~VKL 146 (641)
.. -++||||+. |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.||+++. +.+.|
T Consensus 79 -~~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~--~~~~i 147 (188)
T PF01163_consen 79 -NR----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDD--GKVYI 147 (188)
T ss_dssp -ET----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEET--TCEEE
T ss_pred -eC----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeec--ceEEE
Confidence 33 258999999 65565543321 2245567788888886665 57888 999999999999973 38999
Q ss_pred eecchhhhcc
Q 006528 147 GDLGLAIAMQ 156 (641)
Q Consensus 147 ~DFGlA~~~~ 156 (641)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.8e-09 Score=116.87 Aligned_cols=234 Identities=19% Similarity=0.209 Sum_probs=163.2
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-cceeeEEEEeCCCceEEEEEccCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
.++++.+++||++...+...+ .+.|... ....-++++|.+++||| .+.+++.+ +...+.++.++++.
T Consensus 250 fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhhhhhc
Confidence 467888999999988777666 6666533 24566888999999999 55555543 33467899999999
Q ss_pred CC-CHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006528 86 SG-NLRQYR-KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 162 (641)
Q Consensus 86 gG-sL~~~l-~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~-~~~~ 162 (641)
+| +-...+ ...-.+..-++...++.-+++|+|||+.. -+||| ||+.. .+.+|.+||+.+..+... ..++
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~~~~t 389 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAVPPQLTRTMKPRT 389 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccCCcccCccccccc
Confidence 87 222211 11123445566677778889999999985 58888 77764 368999999998766543 5677
Q ss_pred ccCCCCCCCccccc-ccCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHHHcCC-CCCccc-cCChHHH-HHHHHH
Q 006528 163 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-KPASLA-KVNDPQI-KGFIEK 238 (641)
Q Consensus 163 ~~GTp~ymAPEvl~-~~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i~~g~-~~~~l~-~~~~~~l-~~LI~k 238 (641)
..+++.++|||+.. +.+....|.|++|.-..+|.-|..|-.. |......+..+. .+.... ....+.. +++...
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~ 466 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAP 466 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhhhcCcccccCCccc
Confidence 89999999999654 5699999999999999999988877543 111111111111 011111 1111222 248888
Q ss_pred hcC-CCCCCCCHHHHHcCcccccccC
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpff~~~~~ 263 (641)
|+. -|..|+.+-..+.|.||..-..
T Consensus 467 ~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 467 CLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ccCCCCCCCcchhhHHHHHHhccCcc
Confidence 998 6999999999999999975443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.8e-08 Score=110.06 Aligned_cols=152 Identities=18% Similarity=0.285 Sum_probs=107.7
Q ss_pred HHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc-----------cccCCCCCCCcccccc
Q 006528 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-----------SVIGTPEFMAPELYEE 177 (641)
Q Consensus 109 ~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~-----------~~~GTp~ymAPEvl~~ 177 (641)
.++..||.|+|.+- .++|++|.|++|.+++ .|.+||+.|+++.....+... .......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc-ceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34459999999983 5999999999999985 489999999988544332111 1134568999997765
Q ss_pred -cCCcccccccccchhhhhhhccCCCCCCCCHHHHHHHH--HcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHH
Q 006528 178 -EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV--TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 253 (641)
Q Consensus 178 -~y~~ksDIwSlGiil~EmltG~~Pf~~~~~~~~i~~~i--~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL 253 (641)
..+.++|+||||+++|-+..|..+-....+....+... ..+..........+.++++=+.++|. ++..||++..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 46789999999999999995554532212212122111 11222223334557889999999998 899999999999
Q ss_pred cCccccccc
Q 006528 254 KDPFLQVEN 262 (641)
Q Consensus 254 ~Hpff~~~~ 262 (641)
.-|||+...
T Consensus 264 ~~~ff~D~~ 272 (700)
T KOG2137|consen 264 SIPFFSDPG 272 (700)
T ss_pred cccccCCch
Confidence 999997544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.3e-07 Score=93.56 Aligned_cols=136 Identities=16% Similarity=0.087 Sum_probs=95.0
Q ss_pred EEEEEEEcCCCeEEEEEEEecccccC-------ChhhHHHHHHHHHHHHhCCCCCc--ceeeEEEEeCC---CceEEEEE
Q 006528 14 DTYKAFDEFAGIEVAWSRVKIDDVLQ-------LPGDLQKLYSEVHLLKSLKDDNV--VKFYKSWVDDK---KKTVNMIT 81 (641)
Q Consensus 14 tVYkA~d~~tG~~VAIK~v~~~~~~~-------~~~~~~~l~~Ei~iLk~L~HpNI--Vk~~~~~~~~~---~~~l~lV~ 81 (641)
.|++.. ..|+.|.||+........ ...-...+.+|...+..|..-+| .+...+..... ...-++||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 466653 467889999764322100 00001147789998888843333 33333333221 23467999
Q ss_pred ccCCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeC------CCCcEEEeecchh
Q 006528 82 ELFTSG-NLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG------NHGEVKIGDLGLA 152 (641)
Q Consensus 82 Ey~~gG-sL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~------~~G~VKL~DFGlA 152 (641)
|++++- +|.+++.. ....+......++.+|+..+.-||..| |+|+||++.|||++. +.+.+.|+||+.+
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 999986 89999864 244667788899999999999999999 999999999999974 2468999999987
Q ss_pred h
Q 006528 153 I 153 (641)
Q Consensus 153 ~ 153 (641)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.1e-06 Score=87.87 Aligned_cols=109 Identities=20% Similarity=0.203 Sum_probs=85.3
Q ss_pred HHHHHHHHHHHHhCCCCCc--ceeeEEEEeCC--CceEEEEEccCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 006528 44 LQKLYSEVHLLKSLKDDNV--VKFYKSWVDDK--KKTVNMITELFTSG-NLRQYRKKHKNVDIKVIKNWARQILHGLVYL 118 (641)
Q Consensus 44 ~~~l~~Ei~iLk~L~HpNI--Vk~~~~~~~~~--~~~l~lV~Ey~~gG-sL~~~l~~~~~l~e~~i~~i~~QIl~gL~yL 118 (641)
..+..+|...+..|..-+| .+.+++..... ....++|||++++. +|.+++......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4578899998888854333 45554443322 13457999999974 8999998866678888899999999999999
Q ss_pred HhCCCCeEeeccCCCcEEEeCCC--CcEEEeecchhhh
Q 006528 119 HSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIA 154 (641)
Q Consensus 119 Hs~gp~IiHrDLKp~NILl~~~~--G~VKL~DFGlA~~ 154 (641)
|..| |+|+|+++.|||++.+. ..+.|+||+.+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999998543 2689999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.3e-07 Score=106.01 Aligned_cols=208 Identities=22% Similarity=0.342 Sum_probs=147.8
Q ss_pred hhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCce--EEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 006528 42 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT--VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 119 (641)
Q Consensus 42 ~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~--l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLH 119 (641)
.+++....|+..+..+.|+|++.++.+-....... +.+..++|+..++...+.....++...++.|..++++||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 34555666777788889999999998876543222 3356789999999999999999999999999999999999999
Q ss_pred hCCCCeEeeccCCC---cEEEeCCCCcEEEe--ecchhhhccCC-CCccccCCCCCCCccccccc---CCcccccccccc
Q 006528 120 SHNPPIIHRDLKCD---NIFVNGNHGEVKIG--DLGLAIAMQQP-TARSVIGTPEFMAPELYEEE---YNELVDIYSFGM 190 (641)
Q Consensus 120 s~gp~IiHrDLKp~---NILl~~~~G~VKL~--DFGlA~~~~~~-~~~~~~GTp~ymAPEvl~~~---y~~ksDIwSlGi 190 (641)
+.. ..|.-|... +--+++. +.+.++ ||+....+... ......-+..+.|||..... .....|+|.+|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 986 677666665 3333333 456666 88777655433 22333456677888877643 334479999999
Q ss_pred hhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccccccCC
Q 006528 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 191 il~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~~~~~ 264 (641)
....+..|..+-.... .... .+.........+++.+|+. ++++|+++.+++.|||.......
T Consensus 381 l~~~~~~~~~i~~~~~----~~~~--------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA----VPVS--------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred HHhhhhhcCccccccc----chhh--------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccc
Confidence 9999998865422111 1011 1111122267889999998 79999999999999999765443
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.1e-07 Score=65.63 Aligned_cols=32 Identities=41% Similarity=0.534 Sum_probs=27.5
Q ss_pred eEEEEEecCCCC------CcceeeeccccCCCCHHHHH
Q 006528 341 VSLTLRIADSSG------RVRNIHFLFYLDSDTALSVA 372 (641)
Q Consensus 341 i~L~Lri~d~~~------~~~~i~F~f~~~~DTa~~vA 372 (641)
|.|+||++|+++ ++++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 689999999998 89999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.2e-06 Score=89.89 Aligned_cols=234 Identities=17% Similarity=0.213 Sum_probs=148.7
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceeeEEEE------eCCCceE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWV------DDKKKTV 77 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk~~~~~~------~~~~~~l 77 (641)
+.+|+|+-+.+|..- +-+..|| |++..... ... .+-+..|... .||-+-. .-.|- ......+
T Consensus 17 r~LgqGgea~ly~l~--e~~d~VA-KIYh~Ppp----a~~---aqk~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 17 RPLGQGGEADLYTLG--EVRDQVA-KIYHAPPP----AAQ---AQKVAELAATPDAPLLNY-RVAWPQATLHGGRRGKVI 85 (637)
T ss_pred ccccCCccceeeecc--hhhchhh-eeecCCCc----hHH---HHHHHHhccCCCCcchhh-hhcccHHHhhCCCcccee
Confidence 467889888888543 2333444 76665432 211 1223334333 6765433 11231 1122347
Q ss_pred EEEEccCCCCC-HHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecc
Q 006528 78 NMITELFTSGN-LRQYRK------KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 150 (641)
Q Consensus 78 ~lV~Ey~~gGs-L~~~l~------~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFG 150 (641)
-|.|..+++-. ...++. ..+..+...+.+.++.|+.+.+.||.+| ..-+|+.++|+|+. +.+.|.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEEccc
Confidence 78899888742 222221 2245788899999999999999999999 99999999999997 66899998855
Q ss_pred hhhhccCC-CCccccCCCCCCCccccc-c-----cCCcccccccccchhhhhhhc-cCCCCCCC----CHHHHHHHHHc-
Q 006528 151 LAIAMQQP-TARSVIGTPEFMAPELYE-E-----EYNELVDIYSFGMCILEMVTF-EYPYSECK----NPAQIFKKVTS- 217 (641)
Q Consensus 151 lA~~~~~~-~~~~~~GTp~ymAPEvl~-~-----~y~~ksDIwSlGiil~EmltG-~~Pf~~~~----~~~~i~~~i~~- 217 (641)
......+. .-...+|.++|.+||+-. + .-+...|-|.||+++++++.| +.||++.. .+.-....|..
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 43222222 223457999999999654 1 346779999999999999987 89997632 11111112222
Q ss_pred ----------CCCCC--c-cccCChHHHHHHHHHhcCC---CCCCCCHHHH
Q 006528 218 ----------GIKPA--S-LAKVNDPQIKGFIEKCLVP---ASERLSAKDL 252 (641)
Q Consensus 218 ----------g~~~~--~-l~~~~~~~l~~LI~kcL~d---P~~RpSa~eL 252 (641)
+.++. . ......+.+..|..+|+.+ +.-|||++.-
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 22221 1 1234568899999999974 5589997643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.6e-05 Score=76.80 Aligned_cols=142 Identities=17% Similarity=0.153 Sum_probs=100.6
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEe--cccccCChhhHHHHHHHHHHHHhCCCCC--cceee--EEEEeCCCceEEEE
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVK--IDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFY--KSWVDDKKKTVNMI 80 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~--~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVk~~--~~~~~~~~~~l~lV 80 (641)
.|+|+-+.|+.... .|..+-+|+-. ......-|--...+.+|+..|.+|..-+ +.+.. +.........-+||
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 47788888998654 34467778753 1111111345678999999999995322 33333 22122223346789
Q ss_pred EccCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCc--EEEeecchhh
Q 006528 81 TELFTS-GNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLAI 153 (641)
Q Consensus 81 ~Ey~~g-GsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~--VKL~DFGlA~ 153 (641)
+|-+.+ -+|.+++... .+.+......++.+|...+.-||..| +.|+|+-+.|||++.+ |. |+++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 996654 5899988764 34577778899999999999999999 9999999999999744 45 9999998664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.9e-05 Score=81.79 Aligned_cols=134 Identities=21% Similarity=0.185 Sum_probs=97.7
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccc-----cCC-------------hhhHHHHHHHHHHHHhCCCC--Cccee
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDV-----LQL-------------PGDLQKLYSEVHLLKSLKDD--NVVKF 65 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~-----~~~-------------~~~~~~l~~Ei~iLk~L~Hp--NIVk~ 65 (641)
.+|-|-=+.||.|.+. .|.++|+|.=+.... ... .......++|+++|..|... .|.+.
T Consensus 98 ~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P 176 (304)
T COG0478 98 KIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKP 176 (304)
T ss_pred ccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCc
Confidence 5777878899999985 799999997543211 000 11245678999999999655 77777
Q ss_pred eEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEE
Q 006528 66 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145 (641)
Q Consensus 66 ~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VK 145 (641)
++. ++-.+||||+.|-.|.... ++.+.+..++..|+.-+.-+-..| |+|+|+.+=||+++ ++|.+.
T Consensus 177 ~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~-~dg~~~ 242 (304)
T COG0478 177 IAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT-EDGDIV 242 (304)
T ss_pred ccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-cCCCEE
Confidence 762 3467899999997776542 234555666677777666666777 99999999999998 558999
Q ss_pred Eeecchhhh
Q 006528 146 IGDLGLAIA 154 (641)
Q Consensus 146 L~DFGlA~~ 154 (641)
++||--+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999976643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00014 Score=71.79 Aligned_cols=142 Identities=17% Similarity=0.167 Sum_probs=81.4
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC--CcceeeEEEEeCC-CceEEEE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKSWVDDK-KKTVNMI 80 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVk~~~~~~~~~-~~~l~lV 80 (641)
+..++.|..+.||+..... | .+++|..... .....+.+|..+++.|... .+.+++....... ....+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 4567788888999999765 4 7888875422 3456788999999888533 3556665433322 3357899
Q ss_pred EccCCCCCHHH----------------HHH---hC----CCCCH------HHHHHH---------------HHHHHH-HH
Q 006528 81 TELFTSGNLRQ----------------YRK---KH----KNVDI------KVIKNW---------------ARQILH-GL 115 (641)
Q Consensus 81 ~Ey~~gGsL~~----------------~l~---~~----~~l~e------~~i~~i---------------~~QIl~-gL 115 (641)
|++++|..+.. .+. .. ..+.. ...... ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999988877 111 11 00000 000000 011122 23
Q ss_pred HHHHh-----CCCCeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 116 VYLHS-----HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 116 ~yLHs-----~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
..++. ..+.++|+|+.|.||+++..++.|-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 223599999999999998445677899998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=9.8e-05 Score=83.73 Aligned_cols=142 Identities=15% Similarity=0.139 Sum_probs=84.6
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCCh------------------------------hhHHH------HHHH
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLP------------------------------GDLQK------LYSE 50 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~------------------------------~~~~~------l~~E 50 (641)
++.++-|.||+|.-. +|++||||+.+..-..... +..+. +.+|
T Consensus 133 iAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~E 211 (517)
T COG0661 133 IASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRRE 211 (517)
T ss_pred hhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHH
Confidence 456778899999985 5999999976532111000 01111 2233
Q ss_pred HHHHHhC-----CCCCcceeeEEEEeCCCceEEEEEccCCCCCHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006528 51 VHLLKSL-----KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYR--KKHKNVDIKVIKNWARQILHGLVYLHSHNP 123 (641)
Q Consensus 51 i~iLk~L-----~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l--~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp 123 (641)
...+.++ +.|+|.-- .++.+-. ..-+|+|||+.|-.+.+.. +. ..++.+.+.....++.- ..+-..|
T Consensus 212 A~n~~~~~~nf~~~~~v~VP-~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~dg- 285 (517)
T COG0661 212 AANAERFRENFKDDPDVYVP-KVYWEYT-TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHcCCCCCeEec-eeehhcc-CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhcC-
Confidence 3333333 12333111 1222211 2356999999999998874 44 45665544443333332 2222356
Q ss_pred CeEeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006528 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 124 ~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
++|.|.+|.||+++.+ |.+.+.|||....+..
T Consensus 286 -ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 -FFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP 317 (517)
T ss_pred -ccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence 9999999999999855 8999999998865543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00033 Score=71.34 Aligned_cols=134 Identities=13% Similarity=0.123 Sum_probs=78.0
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc--ceeeEEEEeCCCceEEEEEcc
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV--VKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI--Vk~~~~~~~~~~~~l~lV~Ey 83 (641)
.+|.|..+.||+. .|..+++|...... ....+.+|.++++.+..-.+ .+.+++..+. ....+|||+
T Consensus 8 ~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e~ 75 (226)
T TIGR02172 8 QTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYEL 75 (226)
T ss_pred eecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--Ceeeeeeee
Confidence 5788988999984 24567778765321 23457899999999864433 5666644333 446789999
Q ss_pred CCCCC-HHH--------------HHHh-----C----CCCCHHH-HHHHHHHH----------HHH-HHHH--HhCCCCe
Q 006528 84 FTSGN-LRQ--------------YRKK-----H----KNVDIKV-IKNWARQI----------LHG-LVYL--HSHNPPI 125 (641)
Q Consensus 84 ~~gGs-L~~--------------~l~~-----~----~~l~e~~-i~~i~~QI----------l~g-L~yL--Hs~gp~I 125 (641)
+.|.+ +.. .+.. | ....... ...+..++ ... ..+| +...+.+
T Consensus 76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 99863 111 1110 1 1111111 11111111 111 1222 2233458
Q ss_pred EeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 126 IHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 126 iHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
+|+|+.|.||++++ .| +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~-~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSG-KG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcC-CC-cEEEechhcC
Confidence 99999999999974 45 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=2.8e-06 Score=102.90 Aligned_cols=215 Identities=13% Similarity=0.018 Sum_probs=150.2
Q ss_pred hhHHHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHH
Q 006528 42 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVY 117 (641)
Q Consensus 42 ~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~y 117 (641)
...+.+..|...++.+.|+++...+.-.........|..++|+.+|.+.+.|-+. ..+++..+....++.+.+..-
T Consensus 1271 Plkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred HHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence 4456677777788888999999988765555556778899999999999998653 456666666666665777777
Q ss_pred HHhC---CCCeEeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCccccCCCCCCCcccccc-cCCcccccccccch
Q 006528 118 LHSH---NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC 191 (641)
Q Consensus 118 LHs~---gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~--~~~~~~~GTp~ymAPEvl~~-~y~~ksDIwSlGii 191 (641)
+|+. |--.+|++||+-|.+|.++. .||++++|+.+.... ...+...++|.|++|++.+. .++.++|||..|+.
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred hhhcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 6654 23468999999999998775 899999999984332 23456678999999998875 58888999999999
Q ss_pred hhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCcccc
Q 006528 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 192 l~EmltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~ 259 (641)
+|+..-|..||-.. ..-..+.+........++...+.+.-.....+|. +-..||.-...+.-+.|.
T Consensus 1430 ly~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999888776431 1122223333333344444433333333333333 566778877777766664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00016 Score=73.43 Aligned_cols=126 Identities=16% Similarity=0.208 Sum_probs=78.1
Q ss_pred EEEEEEcCCCeEEEEEEEecccccCChhhHHH------HHHHHHHHHhCCC---CCcceeeEEEEeCC---CceEEEEEc
Q 006528 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK------LYSEVHLLKSLKD---DNVVKFYKSWVDDK---KKTVNMITE 82 (641)
Q Consensus 15 VYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~------l~~Ei~iLk~L~H---pNIVk~~~~~~~~~---~~~l~lV~E 82 (641)
-|.+.-..+|..+++|..+-.... .+..... ..+++..+..+.. -.+..+|.+..-.. ....+|+||
T Consensus 45 ~~ValIei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~E 123 (229)
T PF06176_consen 45 NYVALIEIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLME 123 (229)
T ss_pred cEEEEEEECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEE
Confidence 455555667888888876644321 1111111 2344444444432 23334333222111 134568999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
|++|..|.++.. +++ .+...|..++.-||..| +.|+|.+|.|++++ + +.+++.||+..+
T Consensus 124 YIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~-~-~~i~iID~~~k~ 182 (229)
T PF06176_consen 124 YIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS-N-NGIRIIDTQGKR 182 (229)
T ss_pred EecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE-C-CcEEEEECcccc
Confidence 999988877543 232 24456778899999999 99999999999997 3 369999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00026 Score=80.39 Aligned_cols=142 Identities=18% Similarity=0.121 Sum_probs=86.0
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCC----------------------------hhhHHHHHHHH------H
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQL----------------------------PGDLQKLYSEV------H 52 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~----------------------------~~~~~~l~~Ei------~ 52 (641)
+|.-+.+.||+|.-+. |+.||||+= ...+... .+..+.+..|+ +
T Consensus 169 iaaASlaQVhrA~L~~-G~~VaVKVQ-~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 169 IAAASLAQVHRARLKN-GEDVAVKVQ-HPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred hhhcchhheEEEEecC-CCEEEEEec-CcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5666788999999865 999999963 3332210 01122233333 2
Q ss_pred H----HHhCCCCC------cceeeEEEEeCCCceEEEEEccCCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 006528 53 L----LKSLKDDN------VVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHS 120 (641)
Q Consensus 53 i----Lk~L~HpN------IVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~--l~~~~~l~e~~i~~i~~QIl~gL~yLHs 120 (641)
. .+.+.|-+ |.++|-.+. ..-+|+||||.|..+.+. +++.+ ++...+...+.+...-+ +-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~q--If~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQ--IFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHH--HHh
Confidence 2 22233444 444543221 236799999999877554 44443 55554444333333222 334
Q ss_pred CCCCeEeeccCCCcEEEeC---CCCcEEEeecchhhhccCCC
Q 006528 121 HNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 121 ~gp~IiHrDLKp~NILl~~---~~G~VKL~DFGlA~~~~~~~ 159 (641)
.| ++|.|-+|.||++.. .++.+.+.|||+...+....
T Consensus 320 ~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 320 TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 56 999999999999983 35789999999987665443
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00087 Score=68.17 Aligned_cols=69 Identities=13% Similarity=0.015 Sum_probs=46.1
Q ss_pred eEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceeeEEEEeCCCceEEEEEccCCCCCHHH
Q 006528 13 VDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 91 (641)
Q Consensus 13 gtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~ 91 (641)
..||+.... +..+++|...-.. ...+.+|+++++.+. +--+.+++.+.... ...++|||+++|.+|..
T Consensus 13 ~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 13 ATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAAA 81 (244)
T ss_pred CeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHhH
Confidence 679999753 4567777654221 234678999998883 44456777655433 45678999999987764
Q ss_pred H
Q 006528 92 Y 92 (641)
Q Consensus 92 ~ 92 (641)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00076 Score=69.42 Aligned_cols=143 Identities=17% Similarity=0.132 Sum_probs=96.4
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChh-------------------h--HHHHHHHHHHHHhCC--C
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPG-------------------D--LQKLYSEVHLLKSLK--D 59 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~-------------------~--~~~l~~Ei~iLk~L~--H 59 (641)
+.+.+..|--++||+|.. .++..||+|+++..-.. +.. . ..=..+|+..|+++. +
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~-fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG 129 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSE-FKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG 129 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhh-hhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence 456677777788999986 57889999998753211 111 1 111346788888884 4
Q ss_pred CCcceeeEEEEeCCCceEEEEEccCCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEeeccCCCcEEE
Q 006528 60 DNVVKFYKSWVDDKKKTVNMITELFTSGN-LRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFV 137 (641)
Q Consensus 60 pNIVk~~~~~~~~~~~~l~lV~Ey~~gGs-L~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~gp~IiHrDLKp~NILl 137 (641)
=.+.+-+.+. . -.|||||+.... -.-.|+. -.+....+..+..++++.+.-|-. .+ ++|+||..=|||+
T Consensus 130 VrvP~Pi~~~--~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~ 200 (268)
T COG1718 130 VRVPEPIAFR--N----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILV 200 (268)
T ss_pred CCCCCceeec--C----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEE
Confidence 4556666532 1 358999997641 1111111 123333678888899999988876 67 9999999999999
Q ss_pred eCCCCcEEEeecchhhhccCC
Q 006528 138 NGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 138 ~~~~G~VKL~DFGlA~~~~~~ 158 (641)
. .|.+.|+|||-|.....+
T Consensus 201 ~--~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 201 H--DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred E--CCeEEEEECccccccCCC
Confidence 6 468999999988665544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.003 Score=76.08 Aligned_cols=148 Identities=19% Similarity=0.226 Sum_probs=90.6
Q ss_pred EEEeCccCceEEEEEEEcCCC--eEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCc--ceeeEEEEeCC-CceE
Q 006528 4 LISSRRIPAVDTYKAFDEFAG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNV--VKFYKSWVDDK-KKTV 77 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG--~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNI--Vk~~~~~~~~~-~~~l 77 (641)
+..++.|.+..+|+......+ ..+++|+....... .....+.+|+++|+.|. |++| .+++.++.+.. ....
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 566788888889988764432 46776765432211 12346889999999995 7765 67666544321 1346
Q ss_pred EEEEccCCCCCHHH--------------------HHHh-CC-------------C--CCHHHHHHHHHHH----------
Q 006528 78 NMITELFTSGNLRQ--------------------YRKK-HK-------------N--VDIKVIKNWARQI---------- 111 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~--------------------~l~~-~~-------------~--l~e~~i~~i~~QI---------- 111 (641)
++||||+.|..+.+ .+.. |. + .....+..|..|.
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 79999999864321 1110 10 0 1123444443332
Q ss_pred -----HHHHHHHHhCCC---------CeEeeccCCCcEEEeCCCCc-EEEeecchhhh
Q 006528 112 -----LHGLVYLHSHNP---------PIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIA 154 (641)
Q Consensus 112 -----l~gL~yLHs~gp---------~IiHrDLKp~NILl~~~~G~-VKL~DFGlA~~ 154 (641)
...+.+|..+-| .++|+|++++||+++.+.+. +-|.||+++..
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 233567755433 39999999999999754334 57999998753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.002 Score=63.34 Aligned_cols=131 Identities=22% Similarity=0.187 Sum_probs=89.7
Q ss_pred EEEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCCceEEEE
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 Ril~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vk~~~~~~~~~~~~l~lV 80 (641)
++...+|.|.++.||++... |.++|+|.=+.+ .-...+..|.++|..++-.++ .++|.+ +. .++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d------s~r~~l~kEakiLeil~g~~~~p~vy~y--g~----~~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD------SPRRNLEKEAKILEILAGEGVTPEVYFY--GE----DFIR 90 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCC------cchhhHHHHHHHHHHhhhcCCCceEEEe--ch----hhhh
Confidence 56678999999999999864 779998864433 335678999999999988777 455543 22 3456
Q ss_pred EccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCC--CcEEEeCCCCcEEEeecchhhhccC
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC--DNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp--~NILl~~~~G~VKL~DFGlA~~~~~ 157 (641)
|||+.|-.|...-... +.+. +..++..---|-..| |-|..|.- .||+++ + +.+.|+||..|+....
T Consensus 91 me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~-~-~~~~iIDFd~At~k~~ 158 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN-D-RDVYIIDFDSATFKKK 158 (201)
T ss_pred hhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEec-C-CcEEEEEccchhhccC
Confidence 9999997887654321 2233 334444433355556 88888864 366664 3 5899999999975443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0019 Score=65.50 Aligned_cols=29 Identities=24% Similarity=0.240 Sum_probs=23.7
Q ss_pred CeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 124 ~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
.++|+|+.+.||+++ +.+..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~-~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQ-DGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEE-CCCEEEEEeCcccC
Confidence 389999999999997 43445799999774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0014 Score=65.00 Aligned_cols=100 Identities=23% Similarity=0.156 Sum_probs=77.9
Q ss_pred HHHHHHHHhCCC-CCcceeeEEEEeCCCceEEEEEccCCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006528 48 YSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ---YRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 123 (641)
Q Consensus 48 ~~Ei~iLk~L~H-pNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~---~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp 123 (641)
..|.-+|+.+++ +++.+++|++ + -.+|+||...+++.. .+...-..++....+++.+++..+.+|+....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--G----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--G----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--C----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 458889999976 6999999976 2 246889998776642 12222346788999999999999999987421
Q ss_pred -CeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 124 -PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 124 -~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
.+.-.|++++|+-++ ++|.+|+.|...+..
T Consensus 81 ~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEe-CCCcEEEEechhcch
Confidence 388899999999998 558999999987744
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.011 Score=59.55 Aligned_cols=129 Identities=17% Similarity=0.110 Sum_probs=89.8
Q ss_pred CEEEEEeCccCc-eEEEEEEEcCCCeEEEEEEEecccccCC----------h-------hhHHHHHHHHHHHHhC---CC
Q 006528 1 MRILISSRRIPA-VDTYKAFDEFAGIEVAWSRVKIDDVLQL----------P-------GDLQKLYSEVHLLKSL---KD 59 (641)
Q Consensus 1 ~Ril~~lG~Gaf-gtVYkA~d~~tG~~VAIK~v~~~~~~~~----------~-------~~~~~l~~Ei~iLk~L---~H 59 (641)
|+.+.-+|.|.- |.||++.- .|..+|+|.++.-..... + .....|..|.+..-+| .+
T Consensus 39 I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 39 IEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred EeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 467888999999 99999985 588999999433111100 0 2344677888876666 45
Q ss_pred CCc--ceeeEEEEeCC----------------CceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 006528 60 DNV--VKFYKSWVDDK----------------KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 121 (641)
Q Consensus 60 pNI--Vk~~~~~~~~~----------------~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~ 121 (641)
.++ |+.||+..-.. .....||.||.+... .+.. .-+.+|++-|..+|..
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~k~ 183 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILHKL 183 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHHHC
Confidence 677 99999874331 112357788777643 2232 3367888889999999
Q ss_pred CCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 122 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 122 gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
| |+-+|+++.|.. + -||+|||.+
T Consensus 184 g--I~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 184 G--IVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred C--eeeccCcccccc-C-----CEEEecccC
Confidence 9 999999999965 2 478999854
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.017 Score=63.84 Aligned_cols=81 Identities=17% Similarity=0.054 Sum_probs=55.5
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccc---cCChhhHHHHHHHHHHHHhCC---CCCcceeeEEEEeCCCceE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDV---LQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~---~~~~~~~~~l~~Ei~iLk~L~---HpNIVk~~~~~~~~~~~~l 77 (641)
+..+|.|.+..||++.+...++.|+||+-..... ...+-..++...|.+.|+.+. -.++.++|.+ +. ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~--~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE--ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC--CCC
Confidence 4578999999999999864446899998542111 011334667888888888873 3467788774 44 236
Q ss_pred EEEEccCCCCC
Q 006528 78 NMITELFTSGN 88 (641)
Q Consensus 78 ~lV~Ey~~gGs 88 (641)
++|||++++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 69999998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0088 Score=60.29 Aligned_cols=74 Identities=14% Similarity=0.045 Sum_probs=44.6
Q ss_pred EEeCccCceEEEEEEEcC-CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-cceeeEEEEeCCCceEEEEEc
Q 006528 5 ISSRRIPAVDTYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~-tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVk~~~~~~~~~~~~l~lV~E 82 (641)
..+..|-...+|+..... .+..|++|...... .......+|+.+++.+...+ ..+++..+ .. .+|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-----~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-----ELIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-----cceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEE
Confidence 445556666899887543 35678888654321 11112357999999885333 45555432 21 27999
Q ss_pred cCCCCCH
Q 006528 83 LFTSGNL 89 (641)
Q Consensus 83 y~~gGsL 89 (641)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.011 Score=62.59 Aligned_cols=78 Identities=10% Similarity=0.052 Sum_probs=53.2
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC---CCcceeeEEEEeCC-CceEEE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD---DNVVKFYKSWVDDK-KKTVNM 79 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H---pNIVk~~~~~~~~~-~~~l~l 79 (641)
+..+|.|..+.||...+. +| .+++|..+... ....+..|...|+.|.- -.+.++++++.+.. ...-++
T Consensus 19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDS-QG-NPMPLMARSFS------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcC-CC-CEEEEEecccc------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 567899999999998643 33 46667643210 12468899999998843 36788887654321 244789
Q ss_pred EEccCCCCCH
Q 006528 80 ITELFTSGNL 89 (641)
Q Consensus 80 V~Ey~~gGsL 89 (641)
|||++.|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.033 Score=55.86 Aligned_cols=131 Identities=20% Similarity=0.236 Sum_probs=81.7
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEeccccc------------CChhhHHHHHHHHHHHHhCC------CCCcceeeE
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL------------QLPGDLQKLYSEVHLLKSLK------DDNVVKFYK 67 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~------------~~~~~~~~l~~Ei~iLk~L~------HpNIVk~~~ 67 (641)
.+|.|+.=.||.--+ +. ...||+....... ..........+|+.-...+. +.+|.++||
T Consensus 8 ~i~~G~~R~cy~HP~--dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 8 LIAQGGERDCYQHPD--DP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred ccccCCCceEEECCC--CC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 467887777885433 22 3557877654400 00112345566766665555 889999999
Q ss_pred EEEeCCCceEEEEEccCCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCC
Q 006528 68 SWVDDKKKTVNMITELFTS------GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141 (641)
Q Consensus 68 ~~~~~~~~~l~lV~Ey~~g------GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~ 141 (641)
..... ..+-+|+|.+.. -+|.++++. +.++. .++..+. .-..||-.++ |+.+||+|.||++....
T Consensus 85 ~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 85 FVETN--LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEecC--CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHHHcC--CeecCCCcccEEEEecC
Confidence 65443 456777777653 468888855 44665 3333333 3455677777 99999999999995322
Q ss_pred -C--cEEEee
Q 006528 142 -G--EVKIGD 148 (641)
Q Consensus 142 -G--~VKL~D 148 (641)
| .+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.011 Score=60.81 Aligned_cols=133 Identities=17% Similarity=0.149 Sum_probs=74.3
Q ss_pred eCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCCceEEEEEccCC
Q 006528 7 SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITELFT 85 (641)
Q Consensus 7 lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vk~~~~~~~~~~~~l~lV~Ey~~ 85 (641)
+..|-...+|+.. .+|..+++|....... ...-...+|..+|+.+..-.+ .+++. .+. -++|+||++
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~--~~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPIL--VNE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEE--EeC----CEEEEEecc
Confidence 3456667799886 4567788876432211 110124779999999864433 34443 222 258999999
Q ss_pred CCCHHH--------------HHHh-C------CCCCH-HHHHHHHHHH---------HHHHHHHHhC------CCCeEee
Q 006528 86 SGNLRQ--------------YRKK-H------KNVDI-KVIKNWARQI---------LHGLVYLHSH------NPPIIHR 128 (641)
Q Consensus 86 gGsL~~--------------~l~~-~------~~l~e-~~i~~i~~QI---------l~gL~yLHs~------gp~IiHr 128 (641)
|..+.. .+.+ | .+++. ..+..+..++ ...+..+-.. .+.++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 866532 1111 1 11221 1222332222 1112222221 1248999
Q ss_pred ccCCCcEEEeCCCCcEEEeecchhh
Q 006528 129 DLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 129 DLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
|+.|.||+++++ | +.|+||..|.
T Consensus 152 Dl~~~Nil~~~~-~-~~lIDwE~a~ 174 (256)
T TIGR02721 152 DVHAYNLVVTPQ-G-LKLIDWEYAS 174 (256)
T ss_pred CCCcCcEEEeCC-C-CEEEeccccC
Confidence 999999999854 4 7899999774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.046 Score=59.62 Aligned_cols=84 Identities=11% Similarity=-0.026 Sum_probs=56.4
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEecccc---cCChhhHHHHHHHHHHHHhCC--CC-CcceeeEEEEeCCCceEEE
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDV---LQLPGDLQKLYSEVHLLKSLK--DD-NVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~---~~~~~~~~~l~~Ei~iLk~L~--Hp-NIVk~~~~~~~~~~~~l~l 79 (641)
.+|.|-...||++.+...+..|+||+-...-. ...+-...+..-|...|+... -| .+.++|. .+.. ...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e--~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE--MAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc--ccee
Confidence 46888888899999864447899998642211 133566778888999998873 24 5666765 3443 3568
Q ss_pred EEccCCCC-CHHHHH
Q 006528 80 ITELFTSG-NLRQYR 93 (641)
Q Consensus 80 V~Ey~~gG-sL~~~l 93 (641)
|||+++.. .|++.+
T Consensus 78 vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 78 VMEDLSHHKIARKGL 92 (370)
T ss_pred hHhhCccchHHHHHH
Confidence 99999653 455555
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.0081 Score=67.39 Aligned_cols=163 Identities=20% Similarity=0.223 Sum_probs=101.8
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006528 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 124 (641)
Q Consensus 45 ~~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~ 124 (641)
.++....++++.+.|+|.-.+.++-. ....+..+|+|+++ .+|.++++.+. +-.... + .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r-~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~----------~----~~~-- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSR-GKHERVIVVMEHYT-MSLEDILKTGN-LKDESL----------L----AHG-- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeec-CccceEEEEehhhc-cchHHHHHhcc-cchhhh----------c----ccc--
Confidence 35778889999999999999987543 33456889999995 59999988755 221111 1 222
Q ss_pred eEeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccccCCCCCCCcccccccCCcccccccccchhhhhhhccCCCCC
Q 006528 125 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSE 204 (641)
Q Consensus 125 IiHrDLKp~NILl~~~~G~VKL~DFGlA~~~~~~~~~~~~GTp~ymAPEvl~~~y~~ksDIwSlGiil~EmltG~~Pf~~ 204 (641)
+.|- +.++++| .++ ... .+.. .+++|||++|.++.++..|...+..
T Consensus 88 ~~~~-------------~~~~~td-~~~---t~~--~~~~---------------~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 88 VLHL-------------NIIYITD-HFL---TKY--PSPI---------------GPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ccee-------------hhhhccc-ccc---ccC--CCCC---------------CcchhhhhHHHHHHHHHHhhHHHHH
Confidence 3321 2334444 111 000 1111 1499999999999999998777655
Q ss_pred CCCHHHHHHHHHcCCCCC---------ccccCChHHHHHHHHHhcC-CCCCCCCHHHHHcCccccc
Q 006528 205 CKNPAQIFKKVTSGIKPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 205 ~~~~~~i~~~i~~g~~~~---------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpff~~ 260 (641)
-.+..+.....+-...+. .+....|..+..+..+|+. .|..||...++.+++-|..
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 333333222111111111 1112235667888999998 7999999999999998853
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.035 Score=61.22 Aligned_cols=86 Identities=15% Similarity=0.040 Sum_probs=58.8
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecc--cccCChhhHHHHHHHHHHHHhCC--CC-CcceeeEEEEeCCCceEE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKID--DVLQLPGDLQKLYSEVHLLKSLK--DD-NVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~--~~~~~~~~~~~l~~Ei~iLk~L~--Hp-NIVk~~~~~~~~~~~~l~ 78 (641)
+..+|.|--..||++.+...+..|+||+-... .....+-..++..-|.+.|+.+. -| .+.++|. .++ ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~--e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDS--VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECc--HHhh
Confidence 56789998888999998544567999985321 11234666888899999998873 34 5666776 344 2356
Q ss_pred EEEccCCC-CCHHHHH
Q 006528 79 MITELFTS-GNLRQYR 93 (641)
Q Consensus 79 lV~Ey~~g-GsL~~~l 93 (641)
+|||+++. ..|++.|
T Consensus 110 ~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 110 CVMEDLSDHTILRTAL 125 (409)
T ss_pred HHHHhCcccHHHHHHH
Confidence 89999965 3355554
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.034 Score=58.42 Aligned_cols=74 Identities=18% Similarity=0.074 Sum_probs=44.5
Q ss_pred EeCccCceEEEEEEEcC------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCCceEE
Q 006528 6 SSRRIPAVDTYKAFDEF------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVN 78 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vk~~~~~~~~~~~~l~ 78 (641)
.+..|-.-.+|+..... ++..|++|...... .......+|..+++.+...++ .++++++ .. .
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----~ 73 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN----G 73 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----C
Confidence 34444445689887543 25788888754321 122346789888888853333 4555543 22 2
Q ss_pred EEEccCCCCCHH
Q 006528 79 MITELFTSGNLR 90 (641)
Q Consensus 79 lV~Ey~~gGsL~ 90 (641)
+|++|++|..+.
T Consensus 74 ~v~e~i~G~~l~ 85 (302)
T cd05156 74 RIEEFIPSRTLT 85 (302)
T ss_pred chhheeCCCcCC
Confidence 578999887663
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.0043 Score=70.40 Aligned_cols=68 Identities=26% Similarity=0.389 Sum_probs=57.6
Q ss_pred CCceEEEEEecCCCC----CcceeeeccccCCCCHHHHHHHHHHccccCCccHHHHHHHHHHHHHHhCCCCC
Q 006528 338 DTSVSLTLRIADSSG----RVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 405 (641)
Q Consensus 338 ~~~i~L~Lri~d~~~----~~~~i~F~f~~~~DTa~~vA~EmV~~~~i~~~D~~~iA~~i~~~i~~l~~~~~ 405 (641)
+..++|.+|..|.++ ..+.|+|.|++..|+++.||+|||+++++++.|...+|..+...+.++--.-.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~ 387 (632)
T KOG0584|consen 316 DPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRN 387 (632)
T ss_pred cccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhh
Confidence 345667788888763 35689999999999999999999999999999999999999998887765543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.082 Score=57.28 Aligned_cols=133 Identities=13% Similarity=0.161 Sum_probs=75.2
Q ss_pred cCceEEEEEEEcC----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCCceEEEEEccC
Q 006528 10 IPAVDTYKAFDEF----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITELF 84 (641)
Q Consensus 10 GafgtVYkA~d~~----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vk~~~~~~~~~~~~l~lV~Ey~ 84 (641)
|-.-.+|++.... .+..|+++...... ..... -.+|+.+++.+..-++ .++++.+ .+ . .|++|+
T Consensus 47 GlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~--~~-g---~v~efi 115 (344)
T PLN02236 47 AMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFD-RDDEIRTFECMSRHGQGPRLLGRF--PN-G---RVEEFI 115 (344)
T ss_pred cccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeec-hHHHHHHHHHHHHcCCCCceEEEE--CC-c---eEEEee
Confidence 4445588876422 34678887654321 12222 3779999999965444 4566654 22 1 478888
Q ss_pred CCCCHHHH--------------HHh-C--C------CCCHHHHHHHHHHHH-----------------HHHHH----HHh
Q 006528 85 TSGNLRQY--------------RKK-H--K------NVDIKVIKNWARQIL-----------------HGLVY----LHS 120 (641)
Q Consensus 85 ~gGsL~~~--------------l~~-~--~------~l~e~~i~~i~~QIl-----------------~gL~y----LHs 120 (641)
.+.+|... +++ | . ......+..|..++. ..+.. +..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87665321 111 1 0 111234445543331 11111 221
Q ss_pred --CCCCeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 121 --HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 121 --~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
....++|+|+++.||+++..++.+.|+||..|.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 112489999999999998555789999998774
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.092 Score=54.86 Aligned_cols=139 Identities=14% Similarity=0.115 Sum_probs=76.3
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC--cceeeEE----EEeCCCceEE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFYKS----WVDDKKKTVN 78 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVk~~~~----~~~~~~~~l~ 78 (641)
..+..|....+|+... .+..+++|.... .....+..|+.++..|.+.+ +.+++.. +........+
T Consensus 20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 20 EGISAGIENTNYFVTT--DSGRYVLTLFEK-------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred ecccCccccceEEEEe--CCCcEEEEEcCC-------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 3455565567998753 334688887653 11345777888888884332 4454432 0111123467
Q ss_pred EEEccCCCCCHHH-----H------HHh-C---CCCCH--------HHHH------------HHHHHHHHHHHHHHhC--
Q 006528 79 MITELFTSGNLRQ-----Y------RKK-H---KNVDI--------KVIK------------NWARQILHGLVYLHSH-- 121 (641)
Q Consensus 79 lV~Ey~~gGsL~~-----~------l~~-~---~~l~e--------~~i~------------~i~~QIl~gL~yLHs~-- 121 (641)
+|+++++|..+.. + +.+ | ..+.. .-.. .....+..++.++...
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 8999999866421 1 100 0 00000 0000 0111123344555431
Q ss_pred ---CCCeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 122 ---NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 122 ---gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
...++|+|+.|.||++++ ++.+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 124999999999999984 4456899999773
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.086 Score=56.65 Aligned_cols=142 Identities=14% Similarity=0.149 Sum_probs=81.7
Q ss_pred eCccCceE-EEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC--cceeeEEEEeCCCceEEEEEcc
Q 006528 7 SRRIPAVD-TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 7 lG~Gafgt-VYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVk~~~~~~~~~~~~l~lV~Ey 83 (641)
...|+++. +|...+. +..+++. ............+..+|..+++.+.--- +.+.++++.++.....++||+|
T Consensus 32 ~~~~G~sn~t~~~~~~--~~~~vlR---~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 32 EISGGWSNDTFRLGDT--GQKYVLR---KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eccCCcccceEEEecC--CceEEEe---cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 33444444 5656554 6677755 2211223345677888999888885422 2444444443333467899999
Q ss_pred CCCCCH---------H-HHHH--------h-C-------------CCCCHHHHHHHHHHH--------------HHHHHH
Q 006528 84 FTSGNL---------R-QYRK--------K-H-------------KNVDIKVIKNWARQI--------------LHGLVY 117 (641)
Q Consensus 84 ~~gGsL---------~-~~l~--------~-~-------------~~l~e~~i~~i~~QI--------------l~gL~y 117 (641)
+.|..+ . ++.. . | .......+..|..+. ..-..|
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 988322 1 2211 1 0 011223334444333 223456
Q ss_pred HHhCCC------CeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 118 LHSHNP------PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 118 LHs~gp------~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
|+.+-| .++|+|+++.||+++.. +.+=+.||+++..
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~l 228 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATL 228 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEecccccc
Confidence 665543 59999999999999854 5699999998854
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.22 Score=55.33 Aligned_cols=84 Identities=12% Similarity=-0.034 Sum_probs=54.6
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEeccccc---CChhhHHHHHHHHHHHHhCC---CCCcceeeEEEEeCCCceE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL---QLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~---~~~~~~~~l~~Ei~iLk~L~---HpNIVk~~~~~~~~~~~~l 77 (641)
+..+|.|-.-.||+..+. +..|+||+-...... ..+....+...|...|+.+. ..++.++|.+. ++ .-
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed--~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--RT--MA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CC--CC
Confidence 456788888889998873 456889986522211 11234666777788887774 24788888743 32 25
Q ss_pred EEEEccCCC--CCHHHHH
Q 006528 78 NMITELFTS--GNLRQYR 93 (641)
Q Consensus 78 ~lV~Ey~~g--GsL~~~l 93 (641)
+++||++++ ..+++.+
T Consensus 111 vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 111 LIGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEEeecCCcceehhhhh
Confidence 688999977 3455543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.16 Score=53.24 Aligned_cols=32 Identities=19% Similarity=0.245 Sum_probs=24.9
Q ss_pred CCeEeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006528 123 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 123 p~IiHrDLKp~NILl~~~~G~VKL~DFGlA~~ 154 (641)
+.++|+|++|.|||++.+....-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999985332356999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.13 Score=56.11 Aligned_cols=138 Identities=17% Similarity=0.181 Sum_probs=88.2
Q ss_pred cCceEEEEEEEcCCCeEEEEEEEeccccc--------------------CChhhHHH--HHHHHHHHHhCCCCCcceeeE
Q 006528 10 IPAVDTYKAFDEFAGIEVAWSRVKIDDVL--------------------QLPGDLQK--LYSEVHLLKSLKDDNVVKFYK 67 (641)
Q Consensus 10 GafgtVYkA~d~~tG~~VAIK~v~~~~~~--------------------~~~~~~~~--l~~Ei~iLk~L~HpNIVk~~~ 67 (641)
|--+.||.|.. .+|.++|||+++-.-+. ..|-.+-+ ...|++.|++|+...|.----
T Consensus 155 GKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PeP 233 (520)
T KOG2270|consen 155 GKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEP 233 (520)
T ss_pred CccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCc
Confidence 43456999985 68999999987632110 11111222 346777888887655422211
Q ss_pred EEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEeeccCCCcEEEeCCCCcEEE
Q 006528 68 SWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHGEVKI 146 (641)
Q Consensus 68 ~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLH-s~gp~IiHrDLKp~NILl~~~~G~VKL 146 (641)
..+- .-+|||+|+.......=.-+.-.++...+..+-.|++.-+.-|- .++ ++|.||.-=|+|+. .|.+.|
T Consensus 234 IlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh--dG~lyi 305 (520)
T KOG2270|consen 234 ILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH--DGKLYI 305 (520)
T ss_pred eeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE--CCEEEE
Confidence 1121 24689999974222111112345777788888888888887774 455 99999999999995 479999
Q ss_pred eecchhhhcc
Q 006528 147 GDLGLAIAMQ 156 (641)
Q Consensus 147 ~DFGlA~~~~ 156 (641)
+|.+-+....
T Consensus 306 IDVSQSVE~D 315 (520)
T KOG2270|consen 306 IDVSQSVEHD 315 (520)
T ss_pred EEccccccCC
Confidence 9998775433
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.59 Score=49.47 Aligned_cols=29 Identities=31% Similarity=0.393 Sum_probs=23.8
Q ss_pred CeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 124 ~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
++||+|++|+||+++++ ...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 49999999999999843 345799999773
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.27 Score=51.93 Aligned_cols=139 Identities=17% Similarity=0.106 Sum_probs=74.3
Q ss_pred EEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC--cceeeEEE----EeCCCceEE
Q 006528 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFYKSW----VDDKKKTVN 78 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVk~~~~~----~~~~~~~l~ 78 (641)
..++.|-...+|+... .+| .+++|...... . ...+..|+.++..|.... +.+++... ........+
T Consensus 28 ~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~---~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT-DVG-RYILTLYEKRV---K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred cccCCccccceEEEEe-CCC-cEEEEEecCCC---C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 3345555567998764 344 56678664321 1 234566777777774222 44444321 111124578
Q ss_pred EEEccCCCCCHH-----HH------HHh-C---CCC--------CHHHHHH---------------HHHHHHHHHHHHHh
Q 006528 79 MITELFTSGNLR-----QY------RKK-H---KNV--------DIKVIKN---------------WARQILHGLVYLHS 120 (641)
Q Consensus 79 lV~Ey~~gGsL~-----~~------l~~-~---~~l--------~e~~i~~---------------i~~QIl~gL~yLHs 120 (641)
++++|++|..+. ++ +.+ | ..+ ....... ....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 11 110 0 101 0111000 01122334555543
Q ss_pred -----CCCCeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 121 -----HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 121 -----~gp~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
..+.++|+|+++.||+++++ +.+.|+||+.+
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~ 215 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFA 215 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECC-ceEEEeecccc
Confidence 12359999999999999854 56689999977
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.23 Score=53.48 Aligned_cols=30 Identities=23% Similarity=0.398 Sum_probs=25.9
Q ss_pred CeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 124 ~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
-++|.||.+.||+++.+++.++++||..|.
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 379999999999997555789999999873
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.13 Score=56.14 Aligned_cols=90 Identities=17% Similarity=0.139 Sum_probs=63.0
Q ss_pred HhCCCCCcceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCc
Q 006528 55 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134 (641)
Q Consensus 55 k~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~N 134 (641)
+.+-.++..+.+-+-. ....+.|++|++- |+.+.- + +....+++..++++-+.-|.-|...- +.-||+|.-+|
T Consensus 280 ~~~g~~~~e~~~vv~~-de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~n 352 (488)
T COG5072 280 RECGSVFLETLKVVSL-DETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDN 352 (488)
T ss_pred hhccchhhhcceEEec-CCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccc
Confidence 3334455555443322 3346788888886 344432 2 22456777888888888777777765 59999999999
Q ss_pred EEEeCCCCcEEEeecchhh
Q 006528 135 IFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 135 ILl~~~~G~VKL~DFGlA~ 153 (641)
|||+ .|.|.|+||-+++
T Consensus 353 iLId--~GnvtLIDfklsR 369 (488)
T COG5072 353 ILID--EGNVTLIDFKLSR 369 (488)
T ss_pred eeee--cCceEEEEeeeee
Confidence 9997 4899999999997
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.43 E-value=0.1 Score=56.05 Aligned_cols=134 Identities=20% Similarity=0.177 Sum_probs=88.3
Q ss_pred EeCccCceEEEEEEEcCCCeEEEEEEEeccc-----ccCCh-------------hhHHHHHHHHHHHHhCC-CC-Cccee
Q 006528 6 SSRRIPAVDTYKAFDEFAGIEVAWSRVKIDD-----VLQLP-------------GDLQKLYSEVHLLKSLK-DD-NVVKF 65 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~-----~~~~~-------------~~~~~l~~Ei~iLk~L~-Hp-NIVk~ 65 (641)
.+|-|--+.||.+-+ ..|.+.+.|.-++.. +.... -.+-...+|+..|+.|. |- -|.+.
T Consensus 99 qIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkp 177 (465)
T KOG2268|consen 99 QIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKP 177 (465)
T ss_pred ccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCc
Confidence 466676677999987 568888877543221 11111 01234578999999984 32 34444
Q ss_pred eEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEeeccCCCcEEEeCCCCcEE
Q 006528 66 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145 (641)
Q Consensus 66 ~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~IiHrDLKp~NILl~~~~G~VK 145 (641)
++ . .+.++|||++.|-.|.+..+ ..+.. .+...+..-+.-|..+| +||+|..-=||++. +.+.++
T Consensus 178 iD----~--~RH~Vvmelv~g~Pl~~v~~---v~d~~---~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~-dd~~i~ 242 (465)
T KOG2268|consen 178 ID----H--NRHCVVMELVDGYPLRQVRH---VEDPP---TLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK-DDDKIV 242 (465)
T ss_pred cc----c--cceeeHHHhhcccceeeeee---cCChH---HHHHHHHHHHHHHHHcC--ceecccchheeEEe-cCCCEE
Confidence 44 2 34678999999988876532 12333 34444555556677899 99999999999997 557899
Q ss_pred Eeecchhhhc
Q 006528 146 IGDLGLAIAM 155 (641)
Q Consensus 146 L~DFGlA~~~ 155 (641)
++||--....
T Consensus 243 vIDFPQmvS~ 252 (465)
T KOG2268|consen 243 VIDFPQMVST 252 (465)
T ss_pred EeechHhhcc
Confidence 9999765433
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.00 E-value=0.65 Score=49.22 Aligned_cols=29 Identities=10% Similarity=0.104 Sum_probs=24.9
Q ss_pred CeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 124 ~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
.++|+|+.++|++++++ |.+-|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhcc
Confidence 49999999999999744 689999998774
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.39 E-value=0.78 Score=50.63 Aligned_cols=28 Identities=29% Similarity=0.222 Sum_probs=23.4
Q ss_pred CeEeeccCCCcEEEeCCCCcEEEeecchhh
Q 006528 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 124 ~IiHrDLKp~NILl~~~~G~VKL~DFGlA~ 153 (641)
..+|.||-+.||+.+ + +.+.++||..|.
T Consensus 228 VfCHNDL~~gNIL~~-~-~~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDF-N-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEec-C-CCEEEEEecccc
Confidence 379999999999985 3 469999998773
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.72 E-value=1.4 Score=46.85 Aligned_cols=73 Identities=15% Similarity=0.011 Sum_probs=42.7
Q ss_pred EEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC---CCCcceeeEEEEeCCCceEEEE
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVk~~~~~~~~~~~~l~lV 80 (641)
+..++.|....+|+.. .++..+.+|.-... ....+..|..-|+.|. --.+.+++++....+. -+||
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSES-------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEE
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChh-------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEE
Confidence 4567777778888876 67778998876521 2235788888888883 3446777776544433 4799
Q ss_pred EccCCCC
Q 006528 81 TELFTSG 87 (641)
Q Consensus 81 ~Ey~~gG 87 (641)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.70 E-value=0.75 Score=47.26 Aligned_cols=87 Identities=18% Similarity=0.268 Sum_probs=60.2
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEeCCCceEEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006528 46 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 125 (641)
Q Consensus 46 ~l~~Ei~iLk~L~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~gp~I 125 (641)
-+..+..++.+++ .|+++.. ++...+-+|.|+|..-.. .. ..++.-=+++|.-+|+..+..
T Consensus 104 ~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i---------~~----~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI---------NF----SNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc---------ch----hHHHHHhHHHHHHhhccCCCe
Confidence 4567788888876 6788774 344456789999964111 11 111122256788889776789
Q ss_pred EeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 126 IHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 126 iHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
+|+|-.|+||+-+ ..|.+||.|-+.-
T Consensus 165 lHGD~np~NiM~D-~~G~lKlVDP~~L 190 (308)
T PF07387_consen 165 LHGDCNPDNIMCD-KFGYLKLVDPVCL 190 (308)
T ss_pred ecCCCChhheeec-CCCCEEecChhhh
Confidence 9999999999998 5589999997643
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=88.80 E-value=2.1 Score=44.24 Aligned_cols=74 Identities=18% Similarity=0.190 Sum_probs=49.7
Q ss_pred CccCceEEEEEEEcCCCe-EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC---CcceeeEEEEeCCCceEEEEEcc
Q 006528 8 RRIPAVDTYKAFDEFAGI-EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD---NVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 8 G~GafgtVYkA~d~~tG~-~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp---NIVk~~~~~~~~~~~~l~lV~Ey 83 (641)
...+.|.|..|....+|. ++.+|+=. ......+..|+.-|+.|.-- .|.+++. ....+.+.|+|+||
T Consensus 22 ~~v~gG~inea~~v~dg~~~~FvK~n~-------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylVle~ 92 (286)
T COG3001 22 EEVSGGDINEAWRLRDGTDPFFVKCNQ-------REQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLVLEY 92 (286)
T ss_pred cccCCccccceeEeecCCcceEEEecc-------hhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEEEee
Confidence 344556777777666665 67666422 34456788899888888544 4566665 44555778999999
Q ss_pred CCCCCHH
Q 006528 84 FTSGNLR 90 (641)
Q Consensus 84 ~~gGsL~ 90 (641)
++-|.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9986664
|
|
| >KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism] | Back alignment and domain information |
|---|
Probab=87.51 E-value=1.3 Score=47.14 Aligned_cols=99 Identities=23% Similarity=0.324 Sum_probs=61.3
Q ss_pred HHHHHHHHhC-CCCCcceeeEEEEeCCCceEEEEEccCCCCCHHHH----------HHh-----C---------CCCCHH
Q 006528 48 YSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY----------RKK-----H---------KNVDIK 102 (641)
Q Consensus 48 ~~Ei~iLk~L-~HpNIVk~~~~~~~~~~~~l~lV~Ey~~gGsL~~~----------l~~-----~---------~~l~e~ 102 (641)
.+|+...+.| .|-.-.++|+.|-.+ ||+||+.|.+|.-- +.+ | ++.-..
T Consensus 126 e~Ev~afk~L~a~G~ap~Ly~tF~NG------Lvyefi~g~tL~p~~mr~pki~~lIAr~mak~H~~~~~g~~pkp~lw~ 199 (391)
T KOG4720|consen 126 ENEVIAFKLLAAYGFAPKLYGTFNNG------LVYEFIQGKTLEPEHMREPKIFRLIARRMAKIHSIVATGGNPKPPLWE 199 (391)
T ss_pred HHHHHHHHHHHHcCcChhhhheecCc------eEEeeecCcccChhhccChHHHHHHHHHHHHhheeccCCCCCCCcHHH
Confidence 5678888888 477888999977433 78899999888321 100 0 000001
Q ss_pred HHHHH--------------------------HHHHHHHHHHHHhCCCC--eEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 103 VIKNW--------------------------ARQILHGLVYLHSHNPP--IIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 103 ~i~~i--------------------------~~QIl~gL~yLHs~gp~--IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
.+..+ -..|..--++|-..+.| ++|.||=+.||+.+...|.|.++||..+
T Consensus 200 km~~f~~lv~~~f~de~~kq~~~~~~~~~~L~~Ei~~l~E~l~~L~sPVVFcHNDLL~~Niiy~~~~~~v~fIDYEYa 277 (391)
T KOG4720|consen 200 KMRKFLQLVPTSFEDEINKQNLFDEPSPEDLGEEISKLKEMLSMLKSPVVFCHNDLLCGNIIYDSEKGSVEFIDYEYA 277 (391)
T ss_pred HHHHHHHhcCchhhcccchhhcccCCCHHHHHHHHHHHHHHHHhhCCCeEEeecchhhcceeeccccCcEEEEeeccc
Confidence 11111 11222222233333334 5799999999999999999999999866
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=87.45 E-value=1.1 Score=46.81 Aligned_cols=27 Identities=26% Similarity=0.417 Sum_probs=23.6
Q ss_pred CeEeeccCCCcEEEeCCCCcEEEeecchh
Q 006528 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152 (641)
Q Consensus 124 ~IiHrDLKp~NILl~~~~G~VKL~DFGlA 152 (641)
.++|+|+.+.||++++ +.+.|+||+.+
T Consensus 188 ~liHgD~~~~Nil~~~--~~i~lIDfd~~ 214 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD--NEVYVIDFDYC 214 (313)
T ss_pred ceEcCCCCcccEEEeC--CcEEEEECccc
Confidence 5999999999999974 57899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=85.96 E-value=1.7 Score=48.40 Aligned_cols=62 Identities=18% Similarity=0.240 Sum_probs=44.8
Q ss_pred EEEEEccCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEeeccCCCcEEEeCCC
Q 006528 77 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNH 141 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~gp~IiHrDLKp~NILl~~~~ 141 (641)
..++-+|..|-++..+++. +..+++..+.++.-...||--+ --.+ ++|.|++|.||++..+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecC
Confidence 5577788889899888875 4456666677766666665432 3335 99999999999996443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=85.52 E-value=0.19 Score=56.49 Aligned_cols=67 Identities=12% Similarity=0.184 Sum_probs=57.5
Q ss_pred EEEEeCccCceEEEEEEEcCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceeeEEEEeC
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72 (641)
Q Consensus 3 il~~lG~GafgtVYkA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk~~~~~~~~ 72 (641)
.-..+|+|+||+|+.+..+..+-.+|||+|..... .....+..+|..-+..+.|++|++++..|...
T Consensus 53 ~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~---e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 53 PGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNR---EESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred ccccccccCccccCCccccccchhhHHHHhcccch---hhhhhhhhccccchhhhcccchhhheeceecC
Confidence 34578999999999999988888999999987764 44567788999999999999999999988654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 641 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-69 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 387 bits (996), Expect = e-131
Identities = 130/247 (52%), Positives = 168/247 (68%), Gaps = 5/247 (2%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD--DK 73
YK D +EVAW ++ + Q+ E +LK L+ N+V+FY SW
Sbjct: 43 YKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
KK + ++TEL TSG L+ Y K+ K + IKV+++W RQIL GL +LH+ PPIIHRDLKCD
Sbjct: 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 193
NIF+ G G VKIGDLGLA + A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+L
Sbjct: 161 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 220
Query: 194 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 252
EM T EYPYSEC+N AQI+++VTSG+KPAS KV P++K IE C+ ER S KDL
Sbjct: 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280
Query: 253 LKDPFLQ 259
L F Q
Sbjct: 281 LNHAFFQ 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-56
Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 18/262 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
K + G + W + + Q L SEV+LL+ LK N+V++Y +D
Sbjct: 23 QKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80
Query: 76 TVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP---IIHR 128
T+ ++ E G+L + K+ + +D + + Q+ L H + ++HR
Sbjct: 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDI 185
DLK N+F++G VK+GD GLA + T A++ +GTP +M+PE YNE DI
Sbjct: 141 DLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDI 199
Query: 186 YSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-A 243
+S G C+L E+ P+ + ++ K+ G K + ++ I + L
Sbjct: 200 WSLG-CLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKD 256
Query: 244 SERLSAKDLLKDPFLQVENQKE 265
R S +++L++P + +
Sbjct: 257 YHRPSVEEILENPLILEHHHHH 278
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-56
Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 16/248 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
+K + G A R + P D + +EV + + V+ ++W +
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 75 KTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ + TE +L+Q+ + ++ + + R L L +LHS ++H D+K
Sbjct: 132 --LYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPA 186
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCI 192
NIF+ G K+GD GL + + G P +MAPEL + Y D++S G+ I
Sbjct: 187 NIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTI 245
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 251
LE+ + Q+ + A L +++ + L P R +A+
Sbjct: 246 LEVACNMELPHGGEGWQQLRQGYLPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEA 301
Query: 252 LLKDPFLQ 259
LL P L+
Sbjct: 302 LLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-55
Identities = 57/250 (22%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
G + + I + ++ EV +L ++K N+V++ +S+ ++
Sbjct: 41 ILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQYRESFEENGS- 97
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDI--KVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ ++ + G+L + K V I +W QI L ++H I+HRD+K
Sbjct: 98 -LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQ 154
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGM 190
NIF+ + G V++GD G+A + AR+ IGTP +++PE+ E + YN DI++ G
Sbjct: 155 NIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGC 213
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 249
+ E+ T ++ + E + + K+ SG ++ ++ + + +R S
Sbjct: 214 VLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSV 271
Query: 250 KDLLKDPFLQ 259
+L+ F+
Sbjct: 272 NSILEKGFIA 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-54
Identities = 79/259 (30%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y D + +A + D Q L+ E+ L K LK N+V++ S+ ++
Sbjct: 39 YAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF- 93
Query: 76 TVNMITELFTSGNLRQ-YRKKHKNVDIK--VIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ + E G+L R K + I + +QIL GL YLH + I+HRD+K
Sbjct: 94 -IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKG 150
Query: 133 DNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE---LYEEEYNELVDIYS 187
DN+ +N G +KI D G + +A P + GT ++MAPE Y + DI+S
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWS 210
Query: 188 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 246
G I+EM T + P+ E P KV + + + K FI KC P +R
Sbjct: 211 LGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270
Query: 247 LSAKDLLKDPFLQVENQKE 265
A DLL D FL+V ++K+
Sbjct: 271 ACANDLLVDEFLKVSSKKK 289
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-54
Identities = 65/269 (24%), Positives = 108/269 (40%), Gaps = 38/269 (14%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--- 72
+KA G RVK ++ +K EV L L N+V + W
Sbjct: 28 FKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79
Query: 73 -----------KKKTVNMITELFTSGNLRQYRKKHKNVDI--KVIKNWARQILHGLVYLH 119
K K + + E G L Q+ +K + + + QI G+ Y+H
Sbjct: 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH 139
Query: 120 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPELYEEE 178
S +I+RDLK NIF+ +VKIGD GL +++ R GT +M+PE +
Sbjct: 140 SKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ 196
Query: 179 -YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237
Y + VD+Y+ G+ + E++ E F + GI D + K ++
Sbjct: 197 DYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIISDIF----DKKEKTLLQ 249
Query: 238 KCLVP-ASERLSAKDLLKDPFLQVENQKE 265
K L +R + ++L+ + + E
Sbjct: 250 KLLSKKPEDRPNTSEILRTLTVW-KKSPE 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 15/253 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y+A G+ VA +V+I D L E+ LLK L NV+K+Y S+++D
Sbjct: 49 YRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-- 105
Query: 76 TVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
+N++ EL +G+L + ++K+ + + + + + Q+ L ++HS ++HRD+K
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIK 163
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSF 188
N+F+ G VK+GDLGL T A S++GTP +M+PE E YN DI+S
Sbjct: 164 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222
Query: 189 GMCILEMVTFEYPY-SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 246
G + EM + P+ + N + KK+ P + +++ + C+ P +R
Sbjct: 223 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282
Query: 247 LSAKDLLKDPFLQ 259
+
Sbjct: 283 PDVTYVYDVAKRM 295
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 61/273 (22%), Positives = 114/273 (41%), Gaps = 39/273 (14%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--- 72
++A ++ A R+++ + +K+ EV L L+ +V+++ +W++
Sbjct: 22 FEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 73 -------KKKTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHN 122
K + + +L NL+ + R + + V + QI + +LHS
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138
Query: 123 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--------------SVIGTPE 168
++HRDLK NIF + VK+GD GL AM Q +GT
Sbjct: 139 --LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195
Query: 169 FMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 227
+M+PE Y+ VDI+S G+ + E++ YP+S + V + P +
Sbjct: 196 YMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQK 252
Query: 228 NDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
P ++ L P ER A +++++ +
Sbjct: 253 Y-PCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 84/290 (28%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--- 72
KA + A +++ + L + SEV LL SL VV++Y +W++
Sbjct: 23 VKARNALDSRYYAIKKIRHTE-----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77
Query: 73 --------KKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNP 123
KK T+ + E +G L ++ N RQIL L Y+HS
Sbjct: 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG- 136
Query: 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR----------------SVIGTP 167
IIHRDLK NIF++ + VKIGD GLA + + S IGT
Sbjct: 137 -IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 168 EFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PAS 223
++A E+ + YNE +D+YS G+ EM+ YP+S I KK+ S P
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPD 251
Query: 224 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 272
K I + ++R A+ LL +L V++Q E I + LK
Sbjct: 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 56/273 (20%), Positives = 105/273 (38%), Gaps = 23/273 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ D+ G + A +V+++ E+ L +V Y + +
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRV---------EELVACAGLSSPRIVPLYGAVREGPW- 124
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
VN+ EL G+L Q K+ + + Q L GL YLH+ I+H D+K DN+
Sbjct: 125 -VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNV 181
Query: 136 FVNGNHGEVKIGDLGLA-------IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYS 187
++ + + D G A + T + GT MAPE+ + + VDI+S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 188 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 246
+L M+ +P+++ K + + P I++ L R
Sbjct: 242 SCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301
Query: 247 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 279
SA +L + ++ + + P K + +
Sbjct: 302 ASAMELRRKVGKALQ-EVGGLKSPWKGEYKEPR 333
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 20/230 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
KA ++ +VA +K ++ + + E+ L + N+VK Y +
Sbjct: 25 CKA--KWRAKDVA---IK---QIESESERKAFIVELRQLSRVNHPNIVKLYGAC----LN 72
Query: 76 TVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLK 131
V ++ E G+L + +W Q G+ YLHS P +IHRDLK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 190
N+ + +KI D G A +Q + G+ +MAPE++E Y+E D++S+G+
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQT-HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 191 CILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKC 239
+ E++T P+ E PA I V +G +P L K I+ + +C
Sbjct: 192 ILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLMTRC 240
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 55/275 (20%), Positives = 103/275 (37%), Gaps = 39/275 (14%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
+K G A R K D Q EV+ L +VV+++ +W +D
Sbjct: 28 FKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDI----KVIKNWARQILHGLVYLHSHNPPIIHRDL 130
+ + E G+L ++ + +K+ Q+ GL Y+HS + ++H D+
Sbjct: 86 --MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDI 141
Query: 131 KCDNIFVNGN------------------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAP 172
K NIF++ KIGDLG + + + G F+A
Sbjct: 142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH--VTRISSPQVEEGDSRFLAN 199
Query: 173 ELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 230
E+ +E + DI++ + ++ E + ++ G P + +V
Sbjct: 200 EVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGRLP-RIPQVLSQ 254
Query: 231 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 264
+ ++ + P R SA L+K L ++K
Sbjct: 255 EFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 8e-49
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 25/240 (10%)
Query: 16 YKAFDEFAGIEVAWSRVKI------DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSW 69
+K VA +K + ++ Q+ EV ++ +L N+VK Y
Sbjct: 36 HKGRLVKDKSVVA---IKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 70 VDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 128
M+ E G+L K + V I G+ Y+ + NPPI+HR
Sbjct: 93 ----HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHR 148
Query: 129 DLKCDNIFVNGNHGE----VKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE---YNE 181
DL+ NIF+ K+ D GL+ + ++G ++MAPE E Y E
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHSVSGLLGNFQWMAPETIGAEEESYTE 207
Query: 182 LVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239
D YSF M + ++T E P+ E I G++P ++ + P+++ IE C
Sbjct: 208 KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TIPEDCPPRLRNVIELC 266
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-48
Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 14/223 (6%)
Query: 24 GIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82
G +VA VKI + + + EV ++K L+ N+V F + + ++++TE
Sbjct: 60 GSDVA---VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT--QPPNLSIVTE 114
Query: 83 LFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 139
+ G+L + + +D + + A + G+ YLH+ NPPI+HR+LK N+ V+
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD- 173
Query: 140 NHGEVKIGDLGLAIAMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 196
VK+ D GL+ +++S GTPE+MAPE+ E NE D+YSFG+ + E+
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 197 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239
T + P+ + + + + +PQ+ IE C
Sbjct: 234 TLQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLNPQVAAIIEGC 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-47
Identities = 58/320 (18%), Positives = 130/320 (40%), Gaps = 38/320 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKD--DNVVKFYKSWVDD 72
++ +E A +K ++ + L +E+ L L+ D +++ Y + D
Sbjct: 26 FQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ + M+ E + +L + KK K++D K++ + +L + +H H I+H DLK
Sbjct: 82 QY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKP 136
Query: 133 DNI-FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPEL------------Y 175
N V+G +K+ D G+A MQ T S +GT +M PE
Sbjct: 137 ANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193
Query: 176 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235
+ + + D++S G + M + P+ + N + + + ++
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 253
Query: 236 IEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDID 294
++ CL +R+S +LL P++Q++ ++ + + ++ + ++
Sbjct: 254 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVN-----QMAKGTTEEMKYVLGQLVGLNSP 308
Query: 295 SDYKQLSLSTCTESNNGSPH 314
+ + + + + G H
Sbjct: 309 NSILKAAKTLYEHYSGGESH 328
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 59/273 (21%), Positives = 116/273 (42%), Gaps = 35/273 (12%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDD 72
++ +E A +K ++ + L +E+ L L+ D +++ Y + D
Sbjct: 45 FQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ + M+ E + +L + KK K++D K++ + +L + +H H I+H DLK
Sbjct: 101 QY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKP 155
Query: 133 DNI-FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEEE--------- 178
N V+G +K+ D G+A MQ T S +GT +M PE ++
Sbjct: 156 ANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212
Query: 179 ---YNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234
+ D++S G CIL M + P+ + N + + + ++
Sbjct: 213 KSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 271
Query: 235 FIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 266
++ CL +R+S +LL P++Q++
Sbjct: 272 VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 62/288 (21%), Positives = 121/288 (42%), Gaps = 37/288 (12%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDD 72
++ +E A +K ++ + L +E+ L L+ D +++ Y + D
Sbjct: 73 FQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ + M+ E + +L + KK K++D K++ + +L + +H H I+H DLK
Sbjct: 129 QY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKP 183
Query: 133 DNI-FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEEE--------- 178
N V+G +K+ D G+A MQ T S +G +M PE ++
Sbjct: 184 ANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240
Query: 179 ---YNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234
+ D++S G CIL M + P+ + N + + + ++
Sbjct: 241 KSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 299
Query: 235 FIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKML 281
++ CL +R+S +LL P++Q Q P+ K + +K +
Sbjct: 300 VLKCCLKRDPKQRISIPELLAHPYVQ--IQTHPVNQMAKGTTEEMKYV 345
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 13/225 (5%)
Query: 24 GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83
G EVA + D + ++ + E L LK N++ + K+ + ++ E
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL--KEPNLCLVMEF 87
Query: 84 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLKCDNIFVN---- 138
G L + + + ++ NWA QI G+ YLH PIIHRDLK NI +
Sbjct: 88 ARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 139 ---GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 194
++ +KI D GLA + T S G +MAPE+ +++ D++S+G+ + E
Sbjct: 147 NGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE 206
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239
++T E P+ A + + + + +E C
Sbjct: 207 LLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKLMEDC 250
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-45
Identities = 42/223 (18%), Positives = 86/223 (38%), Gaps = 15/223 (6%)
Query: 24 GIEVAWSRVKIDDVLQLPGDLQKLY-SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82
G ++ VK+ V + + E L+ NV+ + +IT
Sbjct: 33 GNDIV---VKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89
Query: 83 LFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 140
G+L + VD +A + G+ +LH+ P I L ++ ++
Sbjct: 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-E 148
Query: 141 HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMV 196
+I + + Q P + P ++APE +++ D++SF + + E+V
Sbjct: 149 DMTARISMADVKFSFQSPG---RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 197 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239
T E P+++ N K G++P ++ P + ++ C
Sbjct: 206 TREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSKLMKIC 247
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 28/234 (11%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNVDI 101
++ + N V + K + + +L NL+ + R ++ +
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPS--SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
V + QI + +LHS ++HRDLK NIF + VK+GD GL AM Q
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEE 220
Query: 162 --------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECK 206
+GT +M+PE Y+ VDI+S G+ + E++ Y +S
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQM 277
Query: 207 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
+I V + P + PQ ++ L P +ER A D++++ +
Sbjct: 278 ERVRIITDVRNLKFPLLFTQKY-PQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 53/233 (22%), Positives = 101/233 (43%), Gaps = 29/233 (12%)
Query: 26 EVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84
EVA +++ D+ + D L+ EV + + +NVV F + + + +IT L
Sbjct: 57 EVA---IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM--SPPHLAIITSLC 111
Query: 85 TSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 143
L R +D+ + A++I+ G+ YLH+ I+H+DLK N+F ++G+
Sbjct: 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFY--DNGK 167
Query: 144 VKIGDLGLA-------IAMQQPTARSVIGTPEFMAPEL----------YEEEYNELVDIY 186
V I D GL ++ R G +APE+ + +++ D++
Sbjct: 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 187 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239
+ G E+ E+P+ + I ++ +G+KP +I + C
Sbjct: 228 ALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 22/227 (9%)
Query: 26 EVAWSRVKIDDVLQLPGDLQKLY-SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84
+VA VK+ +V + + +EV +L+ + N++ F + ++T+
Sbjct: 48 DVA---VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS---TAPQLAIVTQWC 101
Query: 85 TSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 143
+L + ++K + + ARQ G+ YLH+ + IIHRDLK +NIF+
Sbjct: 102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL-HEDNT 158
Query: 144 VKIGDLGLAIAMQQ----PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEM 195
VKIGD GLA + + G+ +MAPE+ + Y+ D+Y+FG+ + E+
Sbjct: 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218
Query: 196 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKC 239
+T + PYS N QI + V G L+KV ++K + +C
Sbjct: 219 MTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 78/258 (30%), Positives = 132/258 (51%), Gaps = 34/258 (13%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
A ++ +G +VA VK+ D+ + + L++EV +++ + NVV+ YKS++ ++
Sbjct: 62 CLAREKHSGRQVA---VKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 76 TVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 128
V M +T++ + L + I + +L L YLH+ +IHR
Sbjct: 118 WVLMEFLQGGALTDIVSQVRLNEE-------QIATV---CEAVLQALAYLHAQG--VIHR 165
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPEL-YEEEYNELVDI 185
D+K D+I + + G VK+ D G I+ P +S++GTP +MAPE+ Y VDI
Sbjct: 166 DIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 186 YSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP 242
+S G+ ++EMV E PY +P Q + + S P L + P ++ F+E+ LV
Sbjct: 225 WSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSP--PPKLKNSHKVSPVLRDFLERMLVR 281
Query: 243 -ASERLSAKDLLKDPFLQ 259
ER +A++LL PFL
Sbjct: 282 DPQERATAQELLDHPFLL 299
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 80/268 (29%), Positives = 128/268 (47%), Gaps = 31/268 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+K D VA +KI D+ + +++ + E+ +L V K+Y S++ D K
Sbjct: 39 FKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95
Query: 76 TVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 128
+ M +L G L + I I R+IL GL YLHS IHR
Sbjct: 96 WIIMEYLGGGSALDLLEPGPLDE-------TQIATI---LREILKGLDYLHSEK--KIHR 143
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEE-EYNELVDI 185
D+K N+ ++ HGEVK+ D G+A + + + +GTP +MAPE+ ++ Y+ DI
Sbjct: 144 DIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 186 YSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-A 243
+S G+ +E+ E P+SE +P + +F + P +L +K F+E CL
Sbjct: 203 WSLGITAIELARGEPPHSE-LHPMKVLFLIPKN--NPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 244 SERLSAKDLLKDPFLQVENQKEPICDPL 271
S R +AK+LLK F+ +K L
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTSYLTEL 287
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 74/258 (28%), Positives = 129/258 (50%), Gaps = 34/258 (13%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y A D G EVA ++ ++ Q P + + +E+ +++ K+ N+V + S++ +
Sbjct: 37 YTAMDVATGQEVA---IRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 76 TVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 128
V M +T++ T + + I + R+ L L +LHS+ +IHR
Sbjct: 93 WVVMEYLAGGSLTDVVTETCMDE-------GQIAAV---CRECLQALEFLHSNQ--VIHR 140
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPEL-YEEEYNELVDI 185
D+K DNI + + G VK+ D G I +Q +++GTP +MAPE+ + Y VDI
Sbjct: 141 DIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 186 YSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVND--PQIKGFIEKCL-V 241
+S G+ +EM+ E PY +NP + ++ T+G L + F+ +CL +
Sbjct: 200 WSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNG--TPELQNPEKLSAIFRDFLNRCLEM 256
Query: 242 PASERLSAKDLLKDPFLQ 259
+R SAK+LL+ FL+
Sbjct: 257 DVEKRGSAKELLQHQFLK 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 35/270 (12%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
A+ +VA +K ++ + + +L E+ + N+V +Y S+V +
Sbjct: 32 QAAYCAPKKEKVA---IKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 76 TVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 128
+ M + ++ + + K +D I R++L GL YLH + IHR
Sbjct: 89 WLVMKLLSGGSVLDIIKHI-VAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHR 145
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLA-------IAMQQPTARSVIGTPEFMAPELYEE--EY 179
D+K NI + + G V+I D G++ + ++ +GTP +MAPE+ E+ Y
Sbjct: 146 DVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY 204
Query: 180 NELVDIYSFGMCILEMVTFEYPYSECKNPAQ----IFKKVTSGIKPASLAKVND----PQ 231
+ DI+SFG+ +E+ T PY + P + + ++ K
Sbjct: 205 DFKADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263
Query: 232 IKGFIEKCLV--PASERLSAKDLLKDPFLQ 259
+ I CL P +R +A +LL+ F Q
Sbjct: 264 FRKMISLCLQKDP-EKRPTAAELLRHKFFQ 292
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-39
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA ++ G A K+ + +L+ E+ +L + +VK ++ D K
Sbjct: 36 YKAKNKETGALAA---AKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91
Query: 76 TVNMITELFTSGNLRQYRKKHKNV----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
+ + E G + + I+V+ RQ+L L +LHS IIHRDLK
Sbjct: 92 WIMI--EFCPGGAVDAIMLELDRGLTEPQIQVV---CRQMLEALNFLHSKR--IIHRDLK 144
Query: 132 CDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE------LYEEEYNELV 183
N+ + G++++ D G++ S IGTP +MAPE + + Y+
Sbjct: 145 AGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 184 DIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVND--PQIKGFIEKCL 240
DI+S G+ ++EM E P+ E NP + + K S P +L + + + F++ L
Sbjct: 204 DIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSD--PPTLLTPSKWSVEFRDFLKIAL 260
Query: 241 VP-ASERLSAKDLLKDPFLQVENQKEPICD 269
R SA LL+ PF+ + + +
Sbjct: 261 DKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-39
Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 22/252 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA + G VA +K V ++ K E+ +++ +VVK+Y S+ +
Sbjct: 46 YKAIHKETGQIVA---IKQVPVESDLQEIIK---EISIMQQCDSPHVVKYYGSYFKNTDL 99
Query: 76 TVNMITELFTSGNLRQ-YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ M E +G++ R ++K + I + L GL YLH IHRD+K N
Sbjct: 100 WIVM--EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGN 155
Query: 135 IFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 191
I +N G K+ D G+A + +VIGTP +MAPE + E YN + DI+S G+
Sbjct: 156 ILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGIT 214
Query: 192 ILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERL 247
+EM + PY++ +P + IF T+ P + K F+++CLV +R
Sbjct: 215 AIEMAEGKPPYAD-IHPMRAIFMIPTNP--PPTFRKPELWSDNFTDFVKQCLVKSPEQRA 271
Query: 248 SAKDLLKDPFLQ 259
+A LL+ PF++
Sbjct: 272 TATQLLQHPFVR 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 55/246 (22%), Positives = 98/246 (39%), Gaps = 43/246 (17%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNW 107
E++ ++ +N++ F + + + IT+ +G+L Y K +D K +
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKL 139
Query: 108 ARQILHGLVYLHS------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
A + GL +LH+ P I HRDLK NI V N G I DLGLA+ T
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNE 198
Query: 162 ------SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVT----------F 198
+ +GT +M PE+ +E + + D+YSFG+ + E+ +
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 199 EYPYSECKNPAQIFKKVTSG---------IKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
+ PY + ++ + + Q+ + +C + RL+
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 249 AKDLLK 254
A + K
Sbjct: 319 ALRVKK 324
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 22/253 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPG--DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
Y A D VA +K Q + EV L+ L+ N +++ ++ +
Sbjct: 71 YFARDVRNSEVVA---IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ M E K + I L GL YLHSHN +IHRD+K
Sbjct: 128 TAWLVM--EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAG 183
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE----LYEEEYNELVDIYSFG 189
NI ++ G VK+GD G A M A S +GTP +MAPE + E +Y+ VD++S G
Sbjct: 184 NILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240
Query: 190 MCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVN-DPQIKGFIEKCL-VPASER 246
+ +E+ + P N ++ + +L + + F++ CL +R
Sbjct: 241 ITCIELAERKPPLFNM-NAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDR 297
Query: 247 LSAKDLLKDPFLQ 259
+++ LLK F+
Sbjct: 298 PTSEVLLKHRFVL 310
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 54/275 (19%), Positives = 106/275 (38%), Gaps = 33/275 (12%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ + G A +K+ + + + E +LK L N+VK + + +
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+I E G+L ++ N R ++ G+ +L + I+HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 133 DNIFVNGN---HGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE---------EEY 179
NI K+ D G A ++ S+ GT E++ P++YE ++Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 180 NELVDIYSFGMCIL-EMVT----FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234
VD++S G T F P+ + ++ K+ +G +++ V +
Sbjct: 201 GATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 235 FIEKCLVPASERLS--AKDLLKDPF---LQVENQK 264
+P S LS + LL L+ + +K
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 49/277 (17%), Positives = 89/277 (32%), Gaps = 34/277 (12%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK-- 73
G A R+ + D ++ E + + N+++ + ++
Sbjct: 46 DLVEGLHDGHFYALKRILCHE----QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101
Query: 74 KKTVNMITELFTSGNLRQY----RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
K ++ F G L + K + I I GL +H+ HRD
Sbjct: 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRD 159
Query: 130 LKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVI----------GTPEFMAPELYEEE 178
LK NI + G+ + DLG A T + APEL+ +
Sbjct: 160 LKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ 218
Query: 179 ----YNELVDIYSFGMCIL-EMVTFEYPY-SECKNPAQIFKKVTSGIKPASLAKVNDPQI 232
+E D++S G C+L M+ E PY + + V + + + + +
Sbjct: 219 SHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS-SAL 276
Query: 233 KGFIEKCLVP-ASERLSAKDLLKDP-FLQVENQKEPI 267
+ + +R LL LQ +
Sbjct: 277 WQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 50/280 (17%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ + G VA VKI ++ E++ L+ +N++ F S + +
Sbjct: 25 WRG--SWQGENVA---VKIFSSRDEKSWFRET--ELYNTVMLRHENILGFIASDMTSRHS 77
Query: 76 TVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIH 127
+ + IT G+L Y + +D I GL +LH P I H
Sbjct: 78 STQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 128 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR------SVIGTPEFMAPELYEE---- 177
RDLK NI V N G+ I DLGLA+ Q T + +GT +MAPE+ +E
Sbjct: 137 RDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 178 ---EYNELVDIYSFGMCILEMVT----------FEYPYSECKNPAQIFKKVTSG------ 218
+ + VDI++FG+ + E+ ++ P+ + F+ +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 219 ---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 254
I + + +++C S RL+A + K
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 33/287 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
YK G A +K+ DV + +++ E+++LK N+ +Y +++
Sbjct: 41 YKGRHVKTGQLAA---IKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95
Query: 75 KTVN----MITELFTSGNLRQYRKKHKNVDIK--VIKNWARQILHGLVYLHSHNPPIIHR 128
++ ++ E +G++ K K +K I R+IL GL +LH H +IHR
Sbjct: 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHR 153
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE------LYEEEYN 180
D+K N+ + + EVK+ D G++ + + R + IGTP +MAPE + Y+
Sbjct: 154 DIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 212
Query: 181 ELVDIYSFGMCILEMVTFEYPYSECKNPA----QIFKKVTSGIKPASLAKVNDPQIKGFI 236
D++S G+ +EM P + +P I + +K +K + + FI
Sbjct: 213 FKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWSK----KFQSFI 267
Query: 237 EKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
E CLV S+R + + L+K PF++ + + + LK I K R
Sbjct: 268 ESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKR 314
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 29/274 (10%)
Query: 16 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
++ D A KI +L P +K+ E+ + +SL +VV F+ + D+
Sbjct: 32 FEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
V ++ EL +L + K+ K + + + RQI+ G YLH + +IHRDLK
Sbjct: 89 F--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 144
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGM 190
N+F+N + EVKIGD GLA ++ R + GTP ++APE L ++ ++ VD++S G
Sbjct: 145 NLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG- 202
Query: 191 CIL-EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 246
CI+ ++ P E + + ++ P + P I+K L + R
Sbjct: 203 CIMYTLLV-GKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTAR 257
Query: 247 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKM 280
+ +LL D F P +LPI L +
Sbjct: 258 PTINELLNDEFFTSG------YIPARLPITCLTI 285
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 53/261 (20%), Positives = 114/261 (43%), Gaps = 19/261 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
+K G +A VK + +++ ++ ++ D +V+ + +++ +
Sbjct: 42 WKMRFRKTGHVIA---VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
V + EL + + ++ + +++ I+ L YL + +IHRD+K N
Sbjct: 99 --VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSN 155
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE------LYEEEYNELVDIYS 187
I ++ G++K+ D G++ + A+ G +MAPE + +Y+ D++S
Sbjct: 156 ILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 188 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLV-PAS 244
G+ ++E+ T ++PY CK ++ KV +P L + F++ CL
Sbjct: 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHR 273
Query: 245 ERLSAKDLLKDPFLQVENQKE 265
+R LL+ F++ E
Sbjct: 274 KRPKYNKLLEHSFIKRYETLE 294
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 54/274 (19%), Positives = 105/274 (38%), Gaps = 31/274 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ + G A +K+ + + + E +LK L N+VK + + +
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+I E G+L ++ N R ++ G+ +L + I+HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 133 DNIFVNGN---HGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE---------EEY 179
NI K+ D G A ++ S+ GT E++ P++YE ++Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 180 NELVDIYSFGMCIL-EMVT----FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234
VD++S G T F P+ + ++ K+ +G +++ V +
Sbjct: 201 GATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 235 FIEKCLVPASERLS--AKDLLKDPFLQVENQKEP 266
+P S LS + LL P L + +
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLT-PVLANILEADQ 291
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 60/280 (21%), Positives = 109/280 (38%), Gaps = 50/280 (17%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ ++ G EVA VKI + ++ +E++ L+ +N++ F + D
Sbjct: 59 WRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGT 111
Query: 76 TVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIH 127
+ +++ G+L Y ++ V ++ + A GL +LH P I H
Sbjct: 112 WTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 128 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEE---- 177
RDLK NI V N G I DLGLA+ T +GT +MAPE+ ++
Sbjct: 171 RDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 178 ---EYNELVDIYSFGMCILEMVT----------FEYPYSECKNPAQIFKKVTSG------ 218
E + DIY+ G+ E+ ++ PY + +++
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 289
Query: 219 ---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 254
I + + + +C + RL+A + K
Sbjct: 290 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 82/295 (27%), Positives = 136/295 (46%), Gaps = 30/295 (10%)
Query: 16 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
++ D A KI +L P +K+ E+ + +SL +VV F+ + D+
Sbjct: 58 FEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
V ++ EL +L + K+ K + + + RQI+ G YLH + +IHRDLK
Sbjct: 115 F--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 170
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGM 190
N+F+N + EVKIGD GLA ++ R + GTP ++APE L ++ ++ VD++S G
Sbjct: 171 NLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG- 228
Query: 191 CIL-EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 246
CI+ ++ P E + + ++ P + P I+K L + R
Sbjct: 229 CIMYTLLV-GKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTAR 283
Query: 247 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLS 301
+ +LL D F P +LPI L + PSS+D + K L+
Sbjct: 284 PTINELLNDEFFTSG------YIPARLPITCLTIPPRFSIAPSSLDPSNR-KPLT 331
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 62/262 (23%), Positives = 114/262 (43%), Gaps = 20/262 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKK 74
K +G +A VK + ++L ++ ++++ V FY + +
Sbjct: 24 EKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80
Query: 75 KTVNMITELFTSGN---LRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDL 130
V + EL + +Q K + + ++ A I+ L +LHS + +IHRD+
Sbjct: 81 --VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDV 136
Query: 131 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE-----LYEEEYNELVD 184
K N+ +N G+VK+ D G++ + A+ G +MAPE L ++ Y+ D
Sbjct: 137 KPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSD 195
Query: 185 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PA 243
I+S G+ ++E+ +PY P Q K+V P A + F +CL +
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNS 255
Query: 244 SERLSAKDLLKDPFLQVENQKE 265
ER + +L++ PF + K
Sbjct: 256 KERPTYPELMQHPFFTLHESKG 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 57/267 (21%), Positives = 113/267 (42%), Gaps = 26/267 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
K + +G +A VK + ++L ++ ++ D +V+FY + +
Sbjct: 39 NKMVHKPSGQIMA---VKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95
Query: 75 KTVNMITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRD 129
+ EL ++ + Y+ + +++ + L +L IIHRD
Sbjct: 96 --CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRD 151
Query: 130 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-IGTPEFMAPE-----LYEEEYNELV 183
+K NI ++ G +K+ D G++ + A++ G +MAPE + Y+
Sbjct: 152 IKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS 210
Query: 184 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND----PQIKGFIEKC 239
D++S G+ + E+ T +PY + + +V G P L+ + P F+ C
Sbjct: 211 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLC 269
Query: 240 LV-PASERLSAKDLLKDPFLQVENQKE 265
L S+R K+LLK PF+ + ++
Sbjct: 270 LTKDESKRPKYKELLKHPFILMYEERA 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 24/227 (10%)
Query: 32 VKIDDVLQLPGDLQKLY-SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR 90
+ + ++++ + Q+ + EV +++ L+ NV+KF K K +N ITE G LR
Sbjct: 38 MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY--KDKRLNFITEYIKGGTLR 95
Query: 91 QY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 149
+ ++A+ I G+ YLHS N IIHRDL N V N V + D
Sbjct: 96 GIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENK-NVVVADF 152
Query: 150 GLA----------------IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 192
GLA + +V+G P +MAPE + Y+E VD++SFG+ +
Sbjct: 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVL 212
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239
E++ + F G P +C
Sbjct: 213 CEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRC 259
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 52/334 (15%), Positives = 108/334 (32%), Gaps = 69/334 (20%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
A + G V V+ ++ + + L E+H+ K N+V + +++ D +
Sbjct: 44 NLARYKPTGEYVT---VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIK--VIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ ++T G+ + H + I + +L L Y+H +HR +K
Sbjct: 101 --LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKA 156
Query: 133 DNIFVNGNHGEVKIGDLGLAIAMQQPTAR---------SVIGTPEFMAPELYEEE---YN 180
+I ++ + G+V + L ++M R + +++PE+ ++ Y+
Sbjct: 157 SHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 215
Query: 181 ELVDIYSFGMCILEMVTFEYPYSEC----------KNPAQIFKKVTSGIKPASLAKVND- 229
DIYS G+ E+ P+ + ++ +
Sbjct: 216 AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRS 275
Query: 230 --------------------------------PQIKGFIEKCLVP-ASERLSAKDLLKDP 256
P F+E+CL R SA LL
Sbjct: 276 VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335
Query: 257 FLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSS 290
F + K + L ++ + + S
Sbjct: 336 FFK--QIKRRASEALPELLRPVTPITNFEGSQSQ 367
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 66/294 (22%), Positives = 120/294 (40%), Gaps = 52/294 (17%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+K + +G+ +A K+ + P ++ E+ +L +V FY ++ D +
Sbjct: 50 FKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 105
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDN 134
+++ E G+L Q KK + +++ + ++ GL YL H I+HRD+K N
Sbjct: 106 -ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSN 162
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 193
I VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++
Sbjct: 163 ILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221
Query: 194 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--------------------------- 226
EM YP A+
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
Query: 227 ---VND-----------PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 265
VN+ + + F+ KCL+ +ER K L+ F++ + +E
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 54/293 (18%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
Y+A D +G E A R+ ++ + + EV +K L N+V+F + K+
Sbjct: 45 YEAQDVGSGREYALKRLLSNE----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100
Query: 75 KTVN-----MITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPII 126
++ ++ G L ++ KK ++ + Q + ++H PPII
Sbjct: 101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160
Query: 127 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV--------------IGTPEFMAP 172
HRDLK +N+ ++ G +K+ D G A + S TP + P
Sbjct: 161 HRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
Query: 173 ELYE----EEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 227
E+ + E DI++ G CIL + ++P+ E +I K
Sbjct: 220 EIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPF-EDGAKLRIVN-----------GKY 266
Query: 228 NDPQ-------IKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 272
+ P I L ERLS +++ + P+
Sbjct: 267 SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-34
Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 20/280 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ + G +VA +K P + ++ E+ ++K L NVV + +K
Sbjct: 31 LRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87
Query: 76 TVN----MITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHR 128
N + E G+LR+Y + +N I+ I L YLH + IIHR
Sbjct: 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHR 145
Query: 129 DLKCDNI--FVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE-EEYNELVD 184
DLK +NI KI DLG A + Q +GT +++APEL E ++Y VD
Sbjct: 146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD 205
Query: 185 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPAS 244
+SFG E +T P+ P Q KV + + F P
Sbjct: 206 YWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265
Query: 245 ERLSAKDLLKDPFLQ---VENQKEPICDPLKLPIQSLKML 281
L+ +LQ + +Q++ DP + + L
Sbjct: 266 LSGILAGKLE-RWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 53/234 (22%), Positives = 109/234 (46%), Gaps = 14/234 (5%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 104
+L EV + L+ N+++ Y + D + V +I E G + + +K D +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 105 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 164
+ ++ + L Y HS +IHRD+K +N+ + G+ GE+KI D G ++ +
Sbjct: 112 ATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLC 168
Query: 165 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-P 221
GT +++ PE+ E ++E VD++S G+ E + + P+ E + +K+++ P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFP 227
Query: 222 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLP 274
+ + I + L S+R +++L+ P++ + K C +
Sbjct: 228 DFV----TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 66/276 (23%), Positives = 121/276 (43%), Gaps = 17/276 (6%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
D+ +E A +KI + KL EV +LK L N++K Y + D +
Sbjct: 53 VLLCRDKVTHVERA---IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
++ E + G L + +Q+L G+ YLH HN I+HRDLK +
Sbjct: 110 N--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPE 165
Query: 134 NI-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 190
N+ + +KI D GL+ + + +GT ++APE+ ++Y+E D++S G+
Sbjct: 166 NLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGV 225
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASER 246
+ ++ P+ + +I +KV G V K I++ L + R
Sbjct: 226 ILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDLIKQMLQFDSQRR 283
Query: 247 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
+SA+ L+ P+++ K+ L +++ +R
Sbjct: 284 ISAQQALEHPWIKEMCSKKESGIELPSLANAIENMR 319
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 24/254 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
Y+A G+EVA +K+ D + G +Q++ +EV + LK ++++ Y + D
Sbjct: 28 YRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84
Query: 74 KKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
V ++ E+ +G + +Y + + K +++ QI+ G++YLHSH I+HRDL
Sbjct: 85 Y--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTL 140
Query: 133 DNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFG 189
N+ + N +KI D GLA ++ P + ++ GTP +++PE + D++S G
Sbjct: 141 SNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLG 199
Query: 190 MCIL-EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASE 245
C+ ++ P+ + KV P+ L+ + K I + L ++
Sbjct: 200 -CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS----IEAKDLIHQLLRRNPAD 253
Query: 246 RLSAKDLLKDPFLQ 259
RLS +L PF+
Sbjct: 254 RLSLSSVLDHPFMS 267
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-32
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 17/276 (6%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
K D E A VK+ + D + EV LLK L N++K ++ D
Sbjct: 38 VLKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
++ EL+T G L K K +Q+ G+ Y+H HN I+HRDLK +
Sbjct: 95 S--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPE 150
Query: 134 NI-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 190
NI + ++KI D GL+ QQ + IGT ++APE+ Y+E D++S G+
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGV 210
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASER 246
+ +++ P+ KN I K+V +G ++D K I K L S R
Sbjct: 211 ILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLR 268
Query: 247 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
++A L+ P++Q + + P L ++ +R
Sbjct: 269 ITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIR 304
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 34/274 (12%), Positives = 77/274 (28%), Gaps = 34/274 (12%)
Query: 5 ISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 64
P + K E +K ++ + L+K + +++
Sbjct: 106 PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV---HLRFIFPFDLVKDPQKKKMIR 162
Query: 65 FYKSWVDDKKKTVNMITELFTS------GNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 118
D + + S L + HK++ Q++ L L
Sbjct: 163 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222
Query: 119 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE 178
H + ++H L+ +I ++ G V + + + F PEL
Sbjct: 223 HHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGARV--VSSVSRGFEPPELEARR 277
Query: 179 ------------YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 226
D ++ G+ I + + P ++ + + K
Sbjct: 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWIFRSCKNIP--- 333
Query: 227 VNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
++ +E L +RL ++ P +
Sbjct: 334 ---QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 67/268 (25%), Positives = 105/268 (39%), Gaps = 30/268 (11%)
Query: 20 DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVN 78
F +VA VK LP EV LL+ + NV++++ + D +
Sbjct: 44 GMFDNRDVA---VKR----ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQF--QY 94
Query: 79 MITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137
+ EL + L++Y +K +Q GL +LHS N I+HRDLK NI +
Sbjct: 95 IAIEL-CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILI 151
Query: 138 NGNHGE----VKIGDLGLAIAMQQP-----TARSVIGTPEFMAPELYEEE----YNELVD 184
+ + I D GL + V GT ++APE+ E+ VD
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211
Query: 185 IYSFGMCILEMVTFEY-PYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP- 242
I+S G +++ P+ + + K D + IEK +
Sbjct: 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMD 271
Query: 243 ASERLSAKDLLKDPFLQ-VENQKEPICD 269
+R SAK +LK PF +E Q + D
Sbjct: 272 PQKRPSAKHVLKHPFFWSLEKQLQFFQD 299
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 19/277 (6%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG--DLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
D+ G E A VK+ Q+ D + L EV LLK L N++K Y+ + D
Sbjct: 42 VILCKDKITGQECA---VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK 98
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
++ E++T G L K RQ+L G+ Y+H + I+HRDLK
Sbjct: 99 GY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKP 154
Query: 133 DNI-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFG 189
+N+ + ++I D GL+ + + IGT ++APE+ Y+E D++S G
Sbjct: 155 ENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTG 214
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASE 245
+ + +++ P++ N I KKV G + KV++ K I K L S
Sbjct: 215 VILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSE-SAKDLIRKMLTYVPSM 272
Query: 246 RLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
R+SA+D L ++Q +++ D ++ +R
Sbjct: 273 RISARDALDHEWIQTYTKEQISVDV-PSLDNAILNIR 308
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 56/237 (23%), Positives = 114/237 (48%), Gaps = 16/237 (6%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 104
+L E+ + L+ N+++ Y + D K+ + ++ E G L + +KH D +
Sbjct: 59 HQLRREIEIQSHLRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRS 116
Query: 105 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 164
+ ++ L Y H +IHRD+K +N+ + G GE+KI D G ++ R++
Sbjct: 117 ATFMEELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMC 173
Query: 165 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-P 221
GT +++ PE+ E + ++E VD++ G+ E + P+ + + + +++ + +K P
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFP 232
Query: 222 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 277
L K I K L +RL K +++ P+++ N + + P+ QS
Sbjct: 233 PFL----SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK-ANSR-RVLPPVYQSTQS 283
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 72/294 (24%), Positives = 130/294 (44%), Gaps = 41/294 (13%)
Query: 15 TYKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYK 67
AF+ +VA +KI + + +E+ +LK L ++K
Sbjct: 26 VKLAFERKTCKKVA---IKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK- 81
Query: 68 SWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 127
++ D + ++ EL G L +K + K + Q+L + YLH + IIH
Sbjct: 82 NFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIH 137
Query: 128 RDLKCDNIFVNGNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE----LYEEEYN 180
RDLK +N+ ++ + +KI D G + + + + R++ GTP ++APE + YN
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 197
Query: 181 ELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDP 230
VD +S G IL + P+SE + + ++TSG P A+V++
Sbjct: 198 RAVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 250
Query: 231 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 283
++K LV R + ++ L+ P+LQ E+ K D L +S + ++
Sbjct: 251 -ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 303
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 54/262 (20%), Positives = 114/262 (43%), Gaps = 33/262 (12%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
+ + +G+E +K + + ++++ +E+ +LKSL N++K ++ + D
Sbjct: 38 VHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94
Query: 75 KTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130
+ ++ E G L + + K + + +Q+++ L Y HS + ++H+DL
Sbjct: 95 --MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDL 150
Query: 131 KCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYS 187
K +NI F + H +KI D GLA + + GT +MAPE+++ + DI+S
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWS 210
Query: 188 FGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI-------KPASLAKVNDPQIKGFIEK 238
G ++ + + ++ +K T +P + PQ +++
Sbjct: 211 AG-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVECRPLT------PQAVDLLKQ 261
Query: 239 CLVP-ASERLSAKDLLKDPFLQ 259
L R SA +L + +
Sbjct: 262 MLTKDPERRPSAAQVLHHEWFK 283
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-31
Identities = 73/285 (25%), Positives = 125/285 (43%), Gaps = 25/285 (8%)
Query: 15 TYKAFDEFAGIEVA---------WSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF 65
++ E A DD + +++Y+E+ LLKSL N++K
Sbjct: 52 VLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111
Query: 66 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 125
+ + D K ++TE + G L + D N +QIL G+ YLH HN I
Sbjct: 112 FDVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--I 167
Query: 126 IHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNEL 182
+HRD+K +NI N + +KI D GL+ + R +GT ++APE+ +++YNE
Sbjct: 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEK 227
Query: 183 VDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEK 238
D++S G I+ ++ P+ +N I KKV G + + K I+
Sbjct: 228 CDVWSCG-VIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNI-SDEAKELIKL 284
Query: 239 CLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
L ++R +A++ L +++ D K +L +R
Sbjct: 285 MLTYDYNKRCTAEEALNSRWIKKYANNINKSD-QKTLCGALSNMR 328
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 77/261 (29%), Positives = 118/261 (45%), Gaps = 21/261 (8%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
K D E A VK+ + D + EV LLK L N++K ++ D
Sbjct: 38 VLKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
++ EL+T G L K K +Q+ G+ Y+H HN I+HRDLK +
Sbjct: 95 S--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPE 150
Query: 134 NIFVNGNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSFGM 190
NI + + +KI D GL+ QQ T + IGT ++APE+ Y+E D++S G
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG- 209
Query: 191 CILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-AS 244
IL ++ P Y + N I K+V +G ++D K I K L S
Sbjct: 210 VILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPS 266
Query: 245 ERLSAKDLLKDPFLQVENQKE 265
R++A L+ P++Q + +E
Sbjct: 267 LRITATQCLEHPWIQKYSSEE 287
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 41/278 (14%)
Query: 15 TYKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYK 67
AF+ +VA ++I + + +E+ +LK L ++K
Sbjct: 151 VKLAFERKTCKKVA---IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK- 206
Query: 68 SWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 127
++ D + ++ EL G L +K + K + Q+L + YLH + IIH
Sbjct: 207 NFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIH 262
Query: 128 RDLKCDNIFV--NGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE----LYEEEYN 180
RDLK +N+ + +KI D G + + + + R++ GTP ++APE + YN
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 322
Query: 181 ELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDP 230
VD +S G IL + P+SE + + ++TSG P A+V++
Sbjct: 323 RAVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375
Query: 231 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPI 267
++K LV R + ++ L+ P+LQ E+ K
Sbjct: 376 -ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 412
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 56/267 (20%), Positives = 111/267 (41%), Gaps = 34/267 (12%)
Query: 35 DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRK 94
+D + + +E+ ++ +K++ + + + V +I E + ++ ++ +
Sbjct: 78 NDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDE 135
Query: 95 KHKNVD--------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 146
+D I+VIK + +L+ Y+H+ I HRD+K NI + +G VK+
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKL 193
Query: 147 GDLGLAIAMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYS 203
D G + M + GT EFM PE + E VDI+S G+C+ M P+S
Sbjct: 194 SDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
Query: 204 ECKNPAQIFKKVTSG-----------------IKPASLAKVNDPQIKGFIEKCLVP-ASE 245
+ ++F + + K + F++ L +E
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 246 RLSAKDLLKDPFLQVENQKEPICDPLK 272
R++++D LK +L + E + + K
Sbjct: 314 RITSEDALKHEWLA-DTNIEDLREFSK 339
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 53/265 (20%), Positives = 111/265 (41%), Gaps = 27/265 (10%)
Query: 15 TYKAFDEFAGIEVAW---SRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 71
A + I A + ++DV + E+ ++KSL N+++ Y+++ D
Sbjct: 25 VKIAVQKGTRIRRAAKKIPKYFVEDV-------DRFKQEIEIMKSLDHPNIIRLYETFED 77
Query: 72 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
+ + ++ EL T G L + + + +L + Y H N + HRDLK
Sbjct: 78 NTD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLK 133
Query: 132 CDNIFVNGNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSF 188
+N + + +K+ D GLA + R+ +GTP +++P++ E Y D +S
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSA 193
Query: 189 GMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP- 242
G ++ ++ YP + +++ K+ G V+ Q + I + L
Sbjct: 194 G-VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVSP-QAESLIRRLLTKS 249
Query: 243 ASERLSAKDLLKDPFLQVENQKEPI 267
+R+++ L+ + + + P
Sbjct: 250 PKQRITSLQALEHEWFEKQLSSSPR 274
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 56/246 (22%), Positives = 97/246 (39%), Gaps = 43/246 (17%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNW 107
EV+ L +K +N+++F + V++ IT G+L + K + V + +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHI 126
Query: 108 ARQILHGLVYLHS--------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI----AM 155
A + GL YLH H P I HRD+K N+ + N I D GLA+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGK 185
Query: 156 QQPTARSVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVT----FEYPYSEC 205
+GT +MAPE+ ++ + +D+Y+ G+ + E+ + + P E
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 206 KNPAQ----------------IFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
P + + KK ++ + IE+C A RLS
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 249 AKDLLK 254
A + +
Sbjct: 306 AGCVGE 311
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 61/311 (19%), Positives = 110/311 (35%), Gaps = 69/311 (22%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWV 70
A + A +KI + ++ P D++++ +EV L+K L N+ + Y+ +
Sbjct: 42 VRVAIENQTRAIRA---IKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98
Query: 71 DDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA---------------------- 108
D++ + ++ EL G+L +
Sbjct: 99 DEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156
Query: 109 ------------------RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDL 149
RQI L YLH+ I HRD+K +N F E+K+ D
Sbjct: 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 150 GLAIAMQQPTA------RSVIGTPEFMAPEL---YEEEYNELVDIYSFGMCIL-EMVTFE 199
GL+ + + GTP F+APE+ E Y D +S G +L ++
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGA 273
Query: 200 YPYSECKNPAQIFKKVTSG---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 255
P+ N A +V + + + ++ + + L ER A L+
Sbjct: 274 VPF-PGVNDADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVDERFDAMRALQH 331
Query: 256 PFLQVENQKEP 266
P++ + K
Sbjct: 332 PWISQFSDKIY 342
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-30
Identities = 40/287 (13%), Positives = 85/287 (29%), Gaps = 56/287 (19%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPG--DLQKLYSEVHLLKSL---------------- 57
+A D+ G V + + P ++++ EV L+ L
Sbjct: 95 LEATDQETGESFE---VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151
Query: 58 ------KDDNVVKFYKSWVDDKKKTVNMITELFTS---------GNLRQYRKKHKNVDIK 102
KD K + +D++ V L+ L + HK++
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 211
Query: 103 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 159
Q++ L LH + ++H L+ +I ++ G V + +
Sbjct: 212 ARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGASAVSP 268
Query: 160 ARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 213
PE A + D ++ G+ I + + P ++ +
Sbjct: 269 IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSE 327
Query: 214 KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
+ K ++ +E L +RL ++ P +
Sbjct: 328 WIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 74/287 (25%), Positives = 143/287 (49%), Gaps = 22/287 (7%)
Query: 24 GIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82
G EVA +KI D QL P LQKL+ EV ++K L N+VK ++ V + +KT+ +I E
Sbjct: 40 GREVA---IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE--VIETEKTLYLIME 94
Query: 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 142
+ G + Y H + K ++ RQI+ + Y H I+HRDLK +N+ ++ +
Sbjct: 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-M 151
Query: 143 EVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTFE 199
+KI D G + + G P + APEL++ ++Y+ VD++S G+ + +V+
Sbjct: 152 NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
Query: 200 YPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDP 256
P+ +N ++ ++V G P ++ + +++ LV +R + + ++KD
Sbjct: 212 LPFDG-QNLKELRERVLRGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQIMKDR 266
Query: 257 FLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLS 303
++ ++++ + ++ + R+ + M + Q SLS
Sbjct: 267 WINAGHEEDELKPFVEPELDISDQKRIDIM--VGMGYSQEEIQESLS 311
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-29
Identities = 44/238 (18%), Positives = 83/238 (34%), Gaps = 32/238 (13%)
Query: 41 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 100
P + + LK +KFY + + ++ EL++ G L +KN
Sbjct: 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTP 165
Query: 101 IKVIKN-----WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----------NHGEVK 145
KV+ +A ++L+ + +H IIH D+K DN + +
Sbjct: 166 EKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223
Query: 146 IGDLGLAIAMQQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY 200
+ DLG +I M+ + T F E L + +N +D + + M+ Y
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
Query: 201 PYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPF 257
+ + + + + + F L +P L + DLL+
Sbjct: 284 MKVKNEGGECKPEGLFRRLP-------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 47/215 (21%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSE--VHLLKSLKDDNVVKFYKSWVDDK 73
YK VA VK+ + Q +E ++ + ++ DN+ +F D+
Sbjct: 30 YKG--SLDERPVA---VKVFS----FANRQNFINEKNIYRVPLMEHDNIARFIVG---DE 77
Query: 74 KKTVN------MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------- 120
+ T + ++ E + +G+L +Y H D A + GL YLH+
Sbjct: 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDH 136
Query: 121 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----------QQPTARSVIGTPEFM 170
+ P I HRDL N+ V + G I D GL++ + + A S +GT +M
Sbjct: 137 YKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM 195
Query: 171 APELYE--------EEYNELVDIYSFGMCILEMVT 197
APE+ E E + VD+Y+ G+ E+
Sbjct: 196 APEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 31/271 (11%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG----DLQKLYSEVHLLKSLKDDNVVKFYKSWV 70
+ + G + A VKI DV + + L E + LK ++V+ +++
Sbjct: 40 VRRCINRETGQQFA---VKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS 96
Query: 71 DDKKKTVNMITELFTSGNL--RQYRKKHKNVDI--KVIKNWARQILHGLVYLHSHNPPII 126
D + M+ E +L ++ V ++ RQIL L Y H +N II
Sbjct: 97 SDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--II 152
Query: 127 HRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNE 181
HRD+K + + N VK+G G+AI + + A +GTP FMAPE + E Y +
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGK 212
Query: 182 LVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI 236
VD++ G IL ++ Y ++F+ + G P + +++ K +
Sbjct: 213 PVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQWSHISE-SAKDLV 267
Query: 237 EKCLVP-ASERLSAKDLLKDPFLQVENQKEP 266
+ L+ +ER++ + L P+L+ ++
Sbjct: 268 RRMLMLDPAERITVYEALNHPWLKERDRYAY 298
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 63/261 (24%), Positives = 118/261 (45%), Gaps = 32/261 (12%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ + G+E A KI + +L D QKL E + + L+ N+V+ + S ++
Sbjct: 22 VRRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 78
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
++ +L T G L + + + +QIL + Y HS+ I+HR+LK +
Sbjct: 79 F--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPE 134
Query: 134 NI-FVN-GNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFG 189
N+ + VK+ D GLAI + GTP +++PE L ++ Y++ VDI++ G
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 194
Query: 190 MCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKC 239
IL Y P+ + ++ +++ ++ +G V + K I+
Sbjct: 195 -VIL------YILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLIDSM 245
Query: 240 LVP-ASERLSAKDLLKDPFLQ 259
L +R++A LK P++
Sbjct: 246 LTVNPKKRITADQALKVPWIC 266
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 58/271 (21%), Positives = 107/271 (39%), Gaps = 52/271 (19%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 108
E+ +LK LK N+V + V +K+ ++++ E + + +++ V ++K+
Sbjct: 52 EIRMLKQLKHPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSIT 108
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
Q L + + H HN IHRD+K +NI + H +K+ D G A + P+ E
Sbjct: 109 WQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY---DDE 162
Query: 169 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTFEYPY----SE------------ 204
+PEL + +Y VD+++ G C+ E+++ P S+
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLSGV-PLWPGKSDVDQLYLIRKTLG 220
Query: 205 ----------CKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSA 249
N K+ L G ++ CL P ERL+
Sbjct: 221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPT-ERLTC 279
Query: 250 KDLLKDPFLQVENQKEPICDPLKLPIQSLKM 280
+ LL P+ + + E + P ++L
Sbjct: 280 EQLLHHPYFENIREIEDLAKEHDKPAENLYF 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 70/267 (26%), Positives = 112/267 (41%), Gaps = 52/267 (19%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 108
E+ LLK L+ +N+V + V KKK ++ E F + + N +D +V++ +
Sbjct: 74 EIKLLKQLRHENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYL 130
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
QI++G+ + HSHN IIHRD+K +NI V+ G VK+ D G A + P E
Sbjct: 131 FQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY---DDE 184
Query: 169 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTFEYPY----SE------------ 204
APEL + +Y + VD+++ G C++ EM E P S+
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMCLG 242
Query: 205 ----------CKNP---AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSA 249
KNP ++ + +KCL P +R
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD-KRPFC 301
Query: 250 KDLLKDPFLQVENQKEPICDPLKLPIQ 276
+LL F Q++ E L+L +Q
Sbjct: 302 AELLHHDFFQMDGFAERFSQELQLKVQ 328
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 62/288 (21%), Positives = 104/288 (36%), Gaps = 50/288 (17%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDK 73
T F G VA VK L E+ LL D NV+++Y S D+
Sbjct: 30 TVVFQGSFQGRPVA---VKR----MLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA-------RQILHGLVYLHSHNPPII 126
+ + EL + NL+ + D + RQI G+ +LHS II
Sbjct: 83 F--LYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--II 137
Query: 127 HRDLKCDNIFVN------------GNHGEVKIGDLGLAIAMQ------QPTARSVIGTPE 168
HRDLK NI V+ + + I D GL + + + GT
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197
Query: 169 FMAPEL--------YEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSG 218
+ APEL + +DI+S G +++ + + I + + S
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL 257
Query: 219 IKPASLAKVN-DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 264
+ L + + I + + +R +A +L+ P +++K
Sbjct: 258 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 35/288 (12%), Positives = 76/288 (26%), Gaps = 51/288 (17%)
Query: 15 TYKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDN----------- 61
+ D + A +K+ +L++L+ L ++
Sbjct: 78 VFLVRDVERLEDFA---LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134
Query: 62 -------------VVKFYKSWVDDKKKTVNMITELFTS------GNLRQYRKKHKNVDIK 102
+ D ++ + L + I
Sbjct: 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGIL 194
Query: 103 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 162
+ Q++ L S ++H DN+F+ G + +GD+ + T
Sbjct: 195 ALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPDGRLMLGDVSALWKV--GTRGP 249
Query: 163 VIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVT 216
P AP + + ++ + G+ I + P+ +
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL 309
Query: 217 SGIKPASLAKVNDPQI----KGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
SLA + + K I + L RL + ++ P
Sbjct: 310 RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 66/281 (23%), Positives = 125/281 (44%), Gaps = 33/281 (11%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ + G+E A KI + +L D QKL E + + L+ N+V+ + S ++
Sbjct: 45 VRRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
++ +L T G L + + + +QIL + Y HS+ I+HR+LK +
Sbjct: 102 F--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPE 157
Query: 134 NI-FVN-GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFG 189
N+ + VK+ D GLAI + A GTP +++PE L ++ Y++ VDI++ G
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217
Query: 190 MCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKC 239
IL Y P+ + ++ +++ ++ +G V + K I+
Sbjct: 218 -VIL------YILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLIDSM 268
Query: 240 LVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 279
L +R++A LK P++ ++ + + LK
Sbjct: 269 LTVNPKKRITADQALKVPWIC-NRERVASAIHRQDTVDCLK 308
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 64/284 (22%), Positives = 125/284 (44%), Gaps = 29/284 (10%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-----DLQKLYSEVHLLKSLKDDNVVKFYKSW 69
K ++ G+E A K Q +++ EV +L+ + NV+ + +
Sbjct: 28 VKKCREKSTGLEYA---AKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84
Query: 70 VDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
+ V +I EL + G L + + +++ + ++ +QIL G+ YLH+ I H D
Sbjct: 85 ENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFD 140
Query: 130 LKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVD 184
LK +NI + N +K+ D GLA ++ +++ GTPEF+APE + E D
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD 200
Query: 185 IYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKC 239
++S G I ++ + + +TS + ++ K FI K
Sbjct: 201 MWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHTSE-LAKDFIRKL 256
Query: 240 LVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
LV +RL+ ++ L+ P++ + ++ + + +L+ R
Sbjct: 257 LVKETRKRLTIQEALRHPWITPVDNQQA--MVRRESVVNLENFR 298
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 15 TYKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
Y + G VA VK D Q+ E+ +LK+L D +VK+
Sbjct: 43 RYDPLGDNTGALVA---VKQLQHSGPDQQRDFQR---EIQILKALHSDFIVKYRGVSYGP 96
Query: 73 KKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++++ ++ E SG LR + ++H+ +D + ++ QI G+ YL S +HRDL
Sbjct: 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLA 154
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDI 185
NI V + VKI D GLA + R +P F APE L + ++ D+
Sbjct: 155 ARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDV 213
Query: 186 YSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGI 219
+SFG+ + E+ T+ + S ++
Sbjct: 214 WSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 9e-27
Identities = 61/266 (22%), Positives = 109/266 (40%), Gaps = 45/266 (16%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
+ G A +K L +E+ +LK +K +N+V +
Sbjct: 25 VFLVKQRLTGKLFA---LKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLED-IYESTT 79
Query: 75 KTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ +L + G L R + D ++ +Q+L + YLH + I+HRDLK
Sbjct: 80 H-YYLVMQLVSGGELFDRILERGVYTEKDASLV---IQQVLSAVKYLHENG--IVHRDLK 133
Query: 132 CDNIFV--NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 188
+N+ + ++ I D GL+ Q + GTP ++APE L ++ Y++ VD +S
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193
Query: 189 GMCILEMVTFEYP--YSECKNPAQIFKKVTSGI------------KPASLAKVNDPQIKG 234
G I ++ YP Y E +++F+K+ G + A K
Sbjct: 194 G-VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISESA----------KD 240
Query: 235 FIEKCLVP-ASERLSAKDLLKDPFLQ 259
FI L +ER + + L P++
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWID 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 57/261 (21%), Positives = 111/261 (42%), Gaps = 24/261 (9%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
++ ++ G K + P D + +E+ ++ L ++ + ++ D +
Sbjct: 67 VHRCVEKATGRVFV---AKFINT-PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122
Query: 75 KTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ +I E + G L R + +K + +VI N+ RQ GL ++H H+ I+H D+K
Sbjct: 123 --MVLILEFLSGGELFDRIAAEDYKMSEAEVI-NYMRQACEGLKHMHEHS--IVHLDIKP 177
Query: 133 DNI-FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFG 189
+NI VKI D GLA + + T EF APE + E D+++ G
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 190 MCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-A 243
+ ++ E + + + V + + V+ + K FI+ L
Sbjct: 238 -VLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEP 293
Query: 244 SERLSAKDLLKDPFLQVENQK 264
+RL+ D L+ P+L+ ++
Sbjct: 294 RKRLTVHDALEHPWLKGDHSN 314
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 34/282 (12%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ AG E A I + +L D QKL E + + LK N+V+ + S ++
Sbjct: 27 VRRCVKVLAGQEYA---AMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+I +L T G L + + + +QIL +++ H ++HR+LK +
Sbjct: 84 H--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPE 139
Query: 134 NI-FVN-GNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE-LYEEEYNELVDIYSF 188
N+ + VK+ D GLAI ++ GTP +++PE L ++ Y + VD+++
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 199
Query: 189 GMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEK 238
G IL Y P+ + ++ ++++++ +G V + K I K
Sbjct: 200 G-VIL------YILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTP-EAKDLINK 250
Query: 239 CLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 279
L S+R++A + LK P++ C + + LK
Sbjct: 251 MLTINPSKRITAAEALKHPWIS-HRSTVASCMHRQETVDCLK 291
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 49/248 (19%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 108
E+ LLK LK N+V+ + DKK + ++ E F +L++Y D +++K++
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKK--LTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
Q+L GL + HS N ++HRDLK N+ +N +GE+K+ + GLA A P R + E
Sbjct: 108 FQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY--SAE 161
Query: 169 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTFEYPY----SE------------ 204
+ P++ + Y+ +D++S G CI E+ P
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 205 ----------CKNP-AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKD 251
K P + + + ++ + + ++ L P +R+SA++
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV-QRISAEE 279
Query: 252 LLKDPFLQ 259
L+ P+
Sbjct: 280 ALQHPYFS 287
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 58/241 (24%), Positives = 111/241 (46%), Gaps = 20/241 (8%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKNVD 100
D +++ +E+ ++ L N+++ Y ++ + ++ E G L R + + +
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPT 159
+ I + +QI G+ ++H I+H DLK +NI VN + ++KI D GLA +
Sbjct: 187 LDTI-LFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 160 A-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKV 215
+ GTPEF+APE + + + D++S G+ I M+ + N A+ +
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNI 300
Query: 216 TSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPL 271
+ + +++ + K FI K L+ S R+SA + LK P+L +
Sbjct: 301 LACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQK 359
Query: 272 K 272
K
Sbjct: 360 K 360
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 62/193 (32%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQ--LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
Y + G VA VK LQ L+ E+ +LKSL+ DN+VK+
Sbjct: 61 RYDPLQDNTGEVVA---VK---KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114
Query: 73 KKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ + +I E G+LR Y +KHK +D + + QI G+ YL + IHRDL
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLA 172
Query: 132 CDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--PEF-MAPE-LYEEEYNELVDI 185
NI V N VKIGD GL + + + P F APE L E +++ D+
Sbjct: 173 TRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDV 231
Query: 186 YSFGMCILEMVTF 198
+SFG+ + E+ T+
Sbjct: 232 WSFGVVLYELFTY 244
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 62/193 (32%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQ--LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
Y + G VA VK LQ L+ E+ +LKSL+ DN+VK+
Sbjct: 30 RYDPLQDNTGEVVA---VK---KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83
Query: 73 KKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ + +I E G+LR Y +KHK +D + + QI G+ YL + IHRDL
Sbjct: 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLA 141
Query: 132 CDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--PEF-MAPE-LYEEEYNELVDI 185
NI V N VKIGD GL + + + P F APE L E +++ D+
Sbjct: 142 TRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDV 200
Query: 186 YSFGMCILEMVTF 198
+SFG+ + E+ T+
Sbjct: 201 WSFGVVLYELFTY 213
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y ++ G VA VK P E+ +L++L ++++K+ D
Sbjct: 51 CYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
++ ++ E G+LR Y +H + + + +A+QI G+ YLH+ + IHRDL N
Sbjct: 108 ASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARN 164
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSF 188
+ + N VKIGD GLA A+ + R +P F APE L E ++ D++SF
Sbjct: 165 VLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223
Query: 189 GMCILEMVTF---------------EYPYSECKNPAQIFKKVTSG 218
G+ + E++T + ++ + + G
Sbjct: 224 GVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV-LRLTELLERG 267
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 48/160 (30%), Positives = 83/160 (51%), Gaps = 21/160 (13%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 109
EV LLK L+ N+++ + + +++I E + +L++Y K+ +V ++VIK++
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHR--LHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLY 139
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVN----GNHGEVKIGDLGLAIAMQQPTARSVIG 165
Q+++G+ + HS +HRDLK N+ ++ +KIGD GLA A P +
Sbjct: 140 QLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--- 194
Query: 166 TPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 197
T E + PE+ Y+ VDI+S CI EM+
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 16 YKA--FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
YKA D + A +++ + E+ LL+ LK NV+ K ++
Sbjct: 38 YKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRELKHPNVISLQKVFLSHA 91
Query: 74 KKTVNMITELFTSGNLRQYRKKHKN---------VDIKVIKNWARQILHGLVYLHSHNPP 124
+ V ++ + + +L K H+ + ++K+ QIL G+ YLH++
Sbjct: 92 DRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 148
Query: 125 IIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQPTARSVIGTPEFM-----APELY- 175
++HRDLK NI V G G VKI D+G A P P + APEL
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208
Query: 176 -EEEYNELVDIYSFGMCIL-EMVT 197
Y + +DI++ G CI E++T
Sbjct: 209 GARHYTKAIDIWAIG-CIFAELLT 231
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 63/294 (21%), Positives = 120/294 (40%), Gaps = 25/294 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKI---DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
+ D A VKI + ++P + E+ LL+ L+ NV++ ++
Sbjct: 22 KEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78
Query: 73 KKKTVNMITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
+K+ + M+ E G K + + Q++ GL YLHS I+H+D+K
Sbjct: 79 EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIK 136
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEFMAPELY--EEEYN-ELVD 184
N+ + G +KI LG+A A+ A G+P F PE+ + ++ VD
Sbjct: 137 PGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVD 195
Query: 185 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP 242
I+S G+ + + T YP+ E N ++F+ + G P P + ++ L
Sbjct: 196 IWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGDC----GPPLSDLLKGMLEY 250
Query: 243 -ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDS 295
++R S + + + + + ++ P+ + R P D+
Sbjct: 251 EPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDLHG 304
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 63/285 (22%), Positives = 126/285 (44%), Gaps = 31/285 (10%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-----DLQKLYSEVHLLKSLKDDNVVKFYKSW 69
K ++ G++ A K + + + EV +LK ++ NV+ ++ +
Sbjct: 27 VKKCREKSTGLQYA---AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 83
Query: 70 VDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
+ V +I EL G L + + +++ + + +QIL+G+ YLHS I H D
Sbjct: 84 ENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFD 139
Query: 130 LKCDNI-FVNGNH--GEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVD 184
LK +NI ++ N +KI D GLA + +++ GTPEF+APE + E D
Sbjct: 140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEAD 199
Query: 185 IYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKC 239
++S G I ++ + + V++ + + + K FI +
Sbjct: 200 MWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNTSA-LAKDFIRRL 255
Query: 240 LVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 283
LV +R++ +D L+ P+++ ++ ++ L ++ M +
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIKPKDTQQ----ALSRKASAVNMEKF 296
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 59/278 (21%), Positives = 112/278 (40%), Gaps = 25/278 (8%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
++ + G A K D + + E+ + L+ +V + ++ DD +
Sbjct: 173 VHRVTERATGNNFA---AKFVMT-PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228
Query: 75 KTVNMITELFTSGNL-RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ MI E + G L + +H + + RQ+ GL ++H +N +H DLK +
Sbjct: 229 --MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPE 284
Query: 134 NI-FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 190
NI F E+K+ D GL + + + GT EF APE + D++S G
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG- 343
Query: 191 CILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-AS 244
+ ++ E N + + V S ++ + +++ K FI K L+ +
Sbjct: 344 VLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPN 400
Query: 245 ERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
R++ L+ P+L N ++P +R
Sbjct: 401 TRMTIHQALEHPWLTPGNAPGRD---SQIPSSRYTKIR 435
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 61/275 (22%), Positives = 118/275 (42%), Gaps = 33/275 (12%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-----DLQKLYSEVHLLKSLKDDNVVKFYKSW 69
K ++ G+E A K Q +++ EV +L+ + N++ + +
Sbjct: 28 VKKCREKSTGLEYA---AKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84
Query: 70 VDDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPII 126
+ V +I EL + G L +K+ + + +QIL G+ YLH+ I
Sbjct: 85 ENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSF---IKQILDGVNYLHTKK--IA 137
Query: 127 HRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNE 181
H DLK +NI + N +K+ D GLA ++ +++ GTPEF+APE + E
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL 197
Query: 182 LVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI 236
D++S G I ++ + + +T+ ++ ++ K FI
Sbjct: 198 EADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFSQTSE-LAKDFI 253
Query: 237 EKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDP 270
K LV +RL+ ++ L+ P++ + ++ +
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRR 288
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 58/269 (21%), Positives = 112/269 (41%), Gaps = 33/269 (12%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPG-----DLQKLYSEVHLLKSLKDDNVVKFYKSW 69
K + G E A K +L +++ EV++L+ ++ N++ + +
Sbjct: 21 VRKCRQKGTGKEYA---AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF 77
Query: 70 VDDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPII 126
+ V +I EL + G L K+ + +QIL G+ YLHS I
Sbjct: 78 ENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQF---LKQILDGVHYLHSKR--IA 130
Query: 127 HRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNE 181
H DLK +NI + N + +K+ D G+A ++ +++ GTPEF+APE + E
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL 190
Query: 182 LVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI 236
D++S G I ++ E + +++ + ++ K FI
Sbjct: 191 EADMWSIG-VITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFSNTSE-LAKDFI 246
Query: 237 EKCLVP-ASERLSAKDLLKDPFLQVENQK 264
+ LV R++ L+ +++ ++
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 57/237 (24%), Positives = 109/237 (45%), Gaps = 17/237 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 102
D + + +E+ +L L N++K + + + ++++ EL T G L + +
Sbjct: 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSER 148
Query: 103 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA 160
+ +QIL + YLH + I+HRDLK +N+ + +KI D GL+ ++
Sbjct: 149 DAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206
Query: 161 -RSVIGTPEFMAPE-LYEEEYNELVDIYSFG--MCILEMVTFEYPYSECKNPAQIFKKVT 216
++V GTP + APE L Y VD++S G IL + FE P+ + + +F+++
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL-LCGFE-PFYDERGDQFMFRRIL 264
Query: 217 SGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICD 269
+ +V+ K + K +V +RL+ L+ P++ + D
Sbjct: 265 NCEYYFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMD 320
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY----KSWV 70
+ E I VA +K P +++ E +++ S+ + +V + S
Sbjct: 35 LWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89
Query: 71 DDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
TV +IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRD
Sbjct: 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRD 142
Query: 130 LKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE-LYEEEYNELVD 184
L N+ V VKI D GLA + ++ + G P ++MA E + Y D
Sbjct: 143 LAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201
Query: 185 IYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
++S+G+ + E++TF PY ++I + G
Sbjct: 202 VWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 54/250 (21%), Positives = 108/250 (43%), Gaps = 12/250 (4%)
Query: 17 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76
+ +R +Q G ++++Y E+ +LK L NVVK + D +
Sbjct: 53 RQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH 112
Query: 77 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 136
+ M+ EL G + + + + + + ++ G+ YLH IIHRD+K N+
Sbjct: 113 LYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLL 169
Query: 137 VNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPEL---YEEEYN-ELVDIYSFGM 190
V + G +KI D G++ + A + +GTP FMAPE + ++ + +D+++ G+
Sbjct: 170 VGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 249
+ V + P+ + + + K+ S +K I + L R+
Sbjct: 229 TLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV 287
Query: 250 KDLLKDPFLQ 259
++ P++
Sbjct: 288 PEIKLHPWVT 297
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 58/191 (30%), Positives = 97/191 (50%), Gaps = 13/191 (6%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
Y + G +VA VK + L E+ +L++L +N+VK+ +D
Sbjct: 41 RYDPEGDNTGEQVA---VKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97
Query: 75 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ +I E SG+L++Y K+K +++K +A QI G+ YL S +HRDL
Sbjct: 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAAR 155
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYS 187
N+ V H +VKIGD GL A++ T + +P F APE L + ++ D++S
Sbjct: 156 NVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWS 214
Query: 188 FGMCILEMVTF 198
FG+ + E++T+
Sbjct: 215 FGVTLHELLTY 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 19/157 (12%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 108
E+ LLK L N+V ++ + ++ E F +L++ ++K IK +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERC--LTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
Q+L G+ + H H I+HRDLK N+ +N + G +K+ D GLA A P T E
Sbjct: 126 YQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY---THE 179
Query: 169 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 197
+ AP++ ++Y+ VDI+S G CI EM+T
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 68/266 (25%), Positives = 110/266 (41%), Gaps = 50/266 (18%)
Query: 50 EVHLLKSLKDDNVVK----FYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDI 101
E+ +++ +K NVV FY + + +N++ E + R Y K + + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTA 160
+IK + Q+L L Y+HS I HRD+K N+ ++ G +K+ D G A I +
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 161 RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT-----------------FEY 200
S I + + APEL Y +DI+S G C++ E++ +
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFPGESGIDQLVEIIKV 257
Query: 201 ---PYSE---CKNPAQIFKKVTSGIKPASLAKV----NDPQIKGFIEKCLV--PASERLS 248
P E NP + K I+P +KV P I + L P S RL+
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTP-SARLT 315
Query: 249 AKDLLKDPF---LQVENQKEPICDPL 271
A + L PF L+ + P L
Sbjct: 316 AIEALCHPFFDELRTGEARMPNGREL 341
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 108
E+ +LK LK N+VK Y K+ + ++ E +L++ + + K++
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKR--LVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
Q+L+G+ Y H ++HRDLK N+ +N GE+KI D GLA A P R T E
Sbjct: 107 LQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY--THE 160
Query: 169 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 197
+ AP++ ++Y+ +DI+S G CI EMV
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 57/261 (21%), Positives = 106/261 (40%), Gaps = 29/261 (11%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDD- 72
+ F G + A +K+ D K EV ++V + +
Sbjct: 45 VLECFHRRTGQKCA---LKLLY------DSPKARQEVDHHWQASGGPHIVCILDVYENMH 95
Query: 73 -KKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
K+ + +I E G L R + + + R I + +LHSHN I HRD
Sbjct: 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRD 153
Query: 130 LKCDNI-FVNGNHG-EVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIY 186
+K +N+ + + +K+ D G A Q ++ TP ++APE L E+Y++ D++
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMW 213
Query: 187 SFGMCILEMVTFEYP--YSECKN--PAQIFKKVTSG---IKPASLAKVNDPQIKGFIEKC 239
S G I+ ++ +P YS + +++ G ++V++ K I
Sbjct: 214 SLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE-DAKQLIRLL 271
Query: 240 LVP-ASERLSAKDLLKDPFLQ 259
L +ERL+ + P++
Sbjct: 272 LKTDPTERLTITQFMNHPWIN 292
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 49/280 (17%), Positives = 116/280 (41%), Gaps = 26/280 (9%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
++ + + K V D + E+ +L + N++ ++S+ ++
Sbjct: 21 VHRCVETSSKKTYM---AKF--VKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEE 75
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDI--KVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ MI E + ++ + R ++ + I ++ Q+ L +LHSHN I H D++
Sbjct: 76 --LVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRP 130
Query: 133 DNI-FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFG 189
+NI + +KI + G A ++ R + PE+ APE + + D++S G
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 190 MCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-A 243
++ ++ +E QI + + + + +++ + F+++ LV
Sbjct: 191 -TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISI-EAMDFVDRLLVKER 246
Query: 244 SERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 283
R++A + L+ P+L+ + + ++ L
Sbjct: 247 KSRMTASEALQHPWLK-QKIERVSTKVIRTLKHRRYYHTL 285
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 26/277 (9%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDD-NVVKFYKSWVDD 72
+ + G E A K + ++ E+ +L+ K V+ ++ + +
Sbjct: 45 VRQCISKSTGQEYA---AKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101
Query: 73 KKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130
+ + +I E G + + + V + +QIL G+ YLH +N I+H DL
Sbjct: 102 SE--IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDL 157
Query: 131 KCDNI-FVNGN-HGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIY 186
K NI + G++KI D G++ + R ++GTPE++APE L + D++
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMW 217
Query: 187 SFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLV 241
+ G+ I M+ E + + + ++ + + V+ FI+ LV
Sbjct: 218 NIGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETFSSVSQ-LATDFIQSLLV 273
Query: 242 P-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 277
+R +A+ L +LQ + E + P + S
Sbjct: 274 KNPEKRPTAEICLSHSWLQ-QWDFENLFHPEETSSSS 309
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/273 (18%), Positives = 112/273 (41%), Gaps = 27/273 (9%)
Query: 16 YKAFDEFAGIEVA---WSRVKIDDVLQLPGDLQKLYSEVHLLKSLK--DDNVVKFYKSWV 70
Y + VA + +I D +LP + ++ EV LLK + V++ W
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELP-NGTRVPMEVVLLKKVSSGFSGVIRLLD-WF 117
Query: 71 DDKKKTVNMITELFT-SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
+ V +I E +L + + + ++ +++ Q+L + + H+ ++HRD
Sbjct: 118 ERPDSFV-LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRD 174
Query: 130 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYN-ELVDIYS 187
+K +NI ++ N GE+K+ D G ++ GT + PE Y+ ++S
Sbjct: 175 IKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 188 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVPA-S 244
G+ + +MV + P+ +++ G ++ + + I CL S
Sbjct: 235 LGILLYDMVCGDIPFEH-------DEEIIRGQVFFRQRVS----SECQHLIRWCLALRPS 283
Query: 245 ERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 277
+R + +++ P++Q + + +
Sbjct: 284 DRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 56/276 (20%), Positives = 107/276 (38%), Gaps = 39/276 (14%)
Query: 15 TYKAFDEFAGIEVA-----WSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKS 68
+ + E A + ++ + EV +L+ + N+++ +
Sbjct: 33 VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92
Query: 69 WVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 128
+ + ++ +L G L Y + + K + R +L + LH N I+HR
Sbjct: 93 YETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHR 148
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-------LYEEEYN 180
DLK +NI ++ + +K+ D G + + R V GTP ++APE Y
Sbjct: 149 DLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYG 207
Query: 181 ELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDP 230
+ VD++S G I+ Y P+ + + + + SG +D
Sbjct: 208 KEVDMWSTG-VIM------YTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDT 259
Query: 231 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 265
K + + LV +R +A++ L PF Q +E
Sbjct: 260 V-KDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 68/306 (22%), Positives = 122/306 (39%), Gaps = 20/306 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
A + VA VKI D+ + + + E+ + K L +NVVKFY +
Sbjct: 24 QLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG--HRREGN 78
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ E + G L + + + + Q++ G+VYLH I HRD+K +N+
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 136
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEFMAPELYE-EEYN-ELVDIYSFG 189
++ +KI D GLA + ++ GT ++APEL + E++ E VD++S G
Sbjct: 137 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 190 MCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL 247
+ + M+ E P+ + + Q K+ D + K LV S R+
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAPLALLHKILVENPSARI 254
Query: 248 SAKDLLKDPFLQV---ENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLST 304
+ D+ KD + + K P + + S ++S +
Sbjct: 255 TIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGW 314
Query: 305 CTESNN 310
E ++
Sbjct: 315 SKEHHH 320
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 59/284 (20%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 16 YKAFDEFAGIEVA---WSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD----NVVKFYKS 68
+ ++VA R ++ L D EV LL + V++
Sbjct: 48 FAGHRLTDRLQVAIKVIPRNRVLGWSPLS-DSVTCPLEVALLWKVGAGGGHPGVIRLLD- 105
Query: 69 WVDDKKKTVNMITELFTSGN-LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 127
W + ++ + ++ E L Y + + + + Q++ + + HS ++H
Sbjct: 106 WFETQEGFM-LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVH 162
Query: 128 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI-GTPEFMAPELYE-EEYN-ELVD 184
RD+K +NI ++ G K+ D G A+ + GT + PE +Y+
Sbjct: 163 RDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPAT 221
Query: 185 IYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLV 241
++S G+ +L +MV + P+ +++ PA ++ P I +CL
Sbjct: 222 VWSLGI-LLYDMVCGDIPFER-------DQEILEAELHFPAHVS----PDCCALIRRCLA 269
Query: 242 PA-SERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLP 284
P S R S +++L DP++Q + P+ +P K L LP
Sbjct: 270 PKPSSRPSLEEILLDPWMQTPAEDVPL-NPSKGGPAPLAWSLLP 312
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 61/254 (24%), Positives = 108/254 (42%), Gaps = 22/254 (8%)
Query: 14 DTYKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 71
Y A D I+VA +K + L++ EVH L N+V +
Sbjct: 26 TVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82
Query: 72 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
D ++ E L +Y + H + + N+ QIL G+ + H I+HRD+K
Sbjct: 83 DD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIK 138
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYS 187
NI + ++ +KI D G+A A+ + + V+GT ++ +PE + E +E DIYS
Sbjct: 139 PQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYS 197
Query: 188 FGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVND---PQIKGFIEKCLV-- 241
G+ + EM+ E P++ + I K + + P V + I +
Sbjct: 198 IGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSNVILRATEKD 255
Query: 242 PASERLSAKDLLKD 255
A+ + +++ D
Sbjct: 256 KANRYKTIQEMKDD 269
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 63/251 (25%), Positives = 109/251 (43%), Gaps = 15/251 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
A + VA VKI D+ + + + E+ + K L +NVVKFY +
Sbjct: 24 QLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG--HRREGN 78
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ E + G L + + + + Q++ G+VYLH I HRD+K +N+
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 136
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEFMAPE-LYEEEYN-ELVDIYSFG 189
++ +KI D GLA + ++ GT ++APE L E++ E VD++S G
Sbjct: 137 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
+ + M+ E P+ + + Q + + K D + K LV S R++
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 249 AKDLLKDPFLQ 259
D+ KD +
Sbjct: 256 IPDIKKDRWYN 266
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 108
EV LLK LK N+V + +K + ++ E + +L+QY N+ ++ +K +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKS--LTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFL 106
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
Q+L GL Y H ++HRDLK N+ +N GE+K+ D GLA A PT E
Sbjct: 107 FQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY---DNE 160
Query: 169 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 197
+ P++ +Y+ +D++ G CI EM T
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 63/298 (21%), Positives = 120/298 (40%), Gaps = 51/298 (17%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDK 73
+ E A VKI + +++ EV +L + NV++ + + ++
Sbjct: 29 VQTCINLITSQEYA---VKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84
Query: 74 KKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130
+ ++ E G++ ++++H N ++ V+ + + L +LH+ I HRDL
Sbjct: 85 R--FYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLHNKG--IAHRDL 137
Query: 131 KCDNI-FVNGNHG-EVKIGDLGLAIAMQ---------QPTARSVIGTPEFMAPE------ 173
K +NI + N VKI D L ++ P + G+ E+MAPE
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 174 LYEEEYNELVDIYSFG--MCIL------------EMVTFEYPYSECKNPAQIFKKVTSGI 219
Y++ D++S G + IL ++ + +F+ + G
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 220 ---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKL 273
A ++ K I K LV A +RLSA +L+ P++Q + + P+ L
Sbjct: 258 YEFPDKDWAHISC-AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVL 314
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 24/162 (14%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY------RKKHKNVDIKV 103
E+ L+K LK +N+V+ Y + K + ++ E F +L++Y + +++ +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENK--LTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNL 109
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 163
+K + Q+L GL + H + I+HRDLK N+ +N G++K+GD GLA A P
Sbjct: 110 VKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF- 165
Query: 164 IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 197
+ E + AP++ Y+ +DI+S G CIL EM+T
Sbjct: 166 --SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 57/286 (19%), Positives = 121/286 (42%), Gaps = 36/286 (12%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVD-- 71
+ F++ + A +K+ D K EV L ++V+ + +
Sbjct: 78 VLQIFNKRTQEKFA---LKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLY 128
Query: 72 DKKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
+K + ++ E G L R + + + + I + YLHS N I HRD
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRD 186
Query: 130 LKCDNI-FVNGNHG-EVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPE-LYEEEYNELVDI 185
+K +N+ + + +K+ D G A + + TP ++APE L E+Y++ D+
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 246
Query: 186 YSFGMCILEMVTFEYP--YSECKNPAQ--IFKKVTSGI---KPASLAKVNDPQIKGFIEK 238
+S G I+ ++ YP YS + ++ G ++V++ ++K I
Sbjct: 247 WSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-EVKMLIRN 304
Query: 239 CLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 283
L ++R++ + + P++ ++ K P + P+ + ++L+
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIM-QSTKVP-----QTPLHTSRVLKE 344
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 59/308 (19%), Positives = 112/308 (36%), Gaps = 74/308 (24%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 71
Y+A +G VA +V D + E+ +++ L N+V+ FY S
Sbjct: 71 YQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122
Query: 72 DKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 127
+ +N++ + + R Y + + + + +K + Q+ L Y+HS I H
Sbjct: 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICH 179
Query: 128 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APELY-- 175
RD+K N+ ++ + +K+ D G A+ ++ E APEL
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRG-EPNVSYICSRYYRAPELIFG 230
Query: 176 EEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKN------------PAQIFKKVTSG-- 218
+Y +D++S G C+L E++ + +P + + +++
Sbjct: 231 ATDYTSSIDVWSAG-CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289
Query: 219 ------IKPASLAKV----NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV---ENQ 263
IK KV P+ + L P + RL+ + F N
Sbjct: 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLTPLEACAHSFFDELRDPNV 348
Query: 264 KEPICDPL 271
K P
Sbjct: 349 KLPNGRDT 356
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 57/272 (20%), Positives = 109/272 (40%), Gaps = 44/272 (16%)
Query: 15 TYKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFY 66
+ G E A VKI QL + E H+L+ + +++
Sbjct: 110 VRRCVHRATGHEFA---VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166
Query: 67 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 126
S+ + ++ +L G L Y + + K ++ R +L + +LH++N I+
Sbjct: 167 DSYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IV 222
Query: 127 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-------LYEEE 178
HRDLK +NI ++ N ++++ D G + ++ R + GTP ++APE
Sbjct: 223 HRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281
Query: 179 YNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVN 228
Y + VD+++ G IL + P+ + + + + G +
Sbjct: 282 YGKEVDLWACG-VIL------FTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRS 333
Query: 229 DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
K I + L RL+A+ L+ PF +
Sbjct: 334 STV-KDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 62/276 (22%), Positives = 100/276 (36%), Gaps = 64/276 (23%)
Query: 50 EVHLLKSLKDDNVVKFY------KSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIK 102
E+ +L+ LK +NVV S + K ++ ++ + F +L +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLS 124
Query: 103 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 162
IK + +L+GL Y+H + I+HRD+K N+ + G +K+ D GLA A
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQ 181
Query: 163 VIG-TPE-----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT---------------- 197
T + PEL E +Y +D++ G CI+ EM T
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWTRSPIMQGNTEQHQLAL 240
Query: 198 ----------------FEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240
Y Y + + +KV +K DP I+K L
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR----DPYALDLIDKLL 296
Query: 241 V--PASERLSAKDLLKDPFLQVENQKEPICDPLKLP 274
V PA +R+ + D L F D +
Sbjct: 297 VLDPA-QRIDSDDALNHDFF---WSDPMPSDLKGML 328
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 51/163 (31%), Positives = 76/163 (46%), Gaps = 24/163 (14%)
Query: 50 EVHLLKSLKD---DNVVKFYK---SWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DI 101
EV +L+ L+ NVV+ + D++ + ++ E +L Y K
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPT 119
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
+ IK+ Q+L GL +LHSH ++HRDLK NI V + G++K+ D GLA A
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 162 SVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 197
T + APE L + Y VD++S G CI EM
Sbjct: 177 ----TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
+ E I VA +K P +++ E +++ S+ + +V + +
Sbjct: 35 LWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL---T 88
Query: 75 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
TV +IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRDL
Sbjct: 89 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAAR 146
Query: 134 NIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE-LYEEEYNELVDIYSF 188
N+ V VKI D GLA + ++ + G P ++MA E + Y D++S+
Sbjct: 147 NVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 189 GMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
G+ + E++TF PY ++I + G
Sbjct: 206 GVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 13/177 (7%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 107
E +LK N+V+ V +K+ + ++ EL G+ + R + + +K +
Sbjct: 161 QEARILKQYSHPNIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM 218
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 167
G+ YL S IHRDL N V + +KI D G++ + G
Sbjct: 219 VGDAAAGMEYLESKC--CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLR 275
Query: 168 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
+ APE L Y+ D++SFG+ + E + PY N Q + V G
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 62/305 (20%), Positives = 121/305 (39%), Gaps = 38/305 (12%)
Query: 16 YKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKS 68
+ A D+ EV VK +D L K+ E+ +L ++ N++K
Sbjct: 41 WTAVDKEKNKEVV---VKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD- 96
Query: 69 WVDDKKKTVNMITELFTSGN-LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 127
+ + + ++ E SG L + +H +D + RQ++ + YL + IIH
Sbjct: 97 -IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIH 153
Query: 128 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYE-EEYN-ELVD 184
RD+K +NI + + +K+ D G A +++ + GT E+ APE+ Y ++
Sbjct: 154 RDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELE 212
Query: 185 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP 242
++S G+ + +V E P+ E ++ P ++ ++ + L P
Sbjct: 213 MWSLGVTLYTLVFEENPFCE-------LEETVEAAIHPPYLVS----KELMSLVSGLLQP 261
Query: 243 -ASERLSAKDLLKDPFLQ-----VENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSD 296
R + + L+ DP++ + E + K L L M S D+
Sbjct: 262 VPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQA 321
Query: 297 YKQLS 301
+
Sbjct: 322 QELCG 326
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 39/205 (19%)
Query: 16 YKAFDEFAGIEVAWSRVKIDD----VLQLPGDLQKLYS----EVHLLKSLKD---DNVVK 64
YKA D +G VA V++ + LP EV LL+ L+ NVV+
Sbjct: 26 YKARDPHSGHFVALKSVRVPNGGGGGGGLP-------ISTVREVALLRRLEAFEHPNVVR 78
Query: 65 FYK---SWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLH 119
+ D++ V ++ E +LR Y + + + IK+ RQ L GL +LH
Sbjct: 79 LMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 137
Query: 120 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM-----APE- 173
++ I+HRDLK +NI V + G VK+ D GLA A TP + APE
Sbjct: 138 ANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL----TPVVVTLWYRAPEV 190
Query: 174 LYEEEYNELVDIYSFGMCIL-EMVT 197
L + Y VD++S G CI EM
Sbjct: 191 LLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 19/157 (12%)
Query: 50 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 108
E+ LL+ L N++ ++ ++++ + F +L K + V IK +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
L GL YLH H I+HRDLK +N+ ++ +G +K+ D GLA + P R+ T +
Sbjct: 119 LMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY--THQ 172
Query: 169 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 197
+ APEL Y VD+++ G CIL E++
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 34/287 (11%)
Query: 15 TYKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDD 72
K + + A VK I E+ LK + N+VK ++ + D
Sbjct: 27 CRKCVHKKSNQAFA---VKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
++ EL G L + KK K+ R+++ + ++H ++HRDLK
Sbjct: 79 LH--TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKP 134
Query: 133 DNI-FVNGNHG-EVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYEEEYNELVDIYS 187
+N+ F + N E+KI D G A ++ T + APE L + Y+E D++S
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWS 194
Query: 188 FGMCILEMVTFEYP--YSE-----CKNPAQIFKKVTSG---IKPASLAKVNDPQIKGFIE 237
G IL + S C + +I KK+ G + + V+ + K I+
Sbjct: 195 LG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ-EAKDLIQ 252
Query: 238 KCLVP-ASERLSAKDLLKDPFLQVENQ--KEPICDPLKLPIQSLKML 281
L ++RL L + +LQ +Q P+ P L +
Sbjct: 253 GLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVH 299
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 23/255 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ G +VA VKI + ++ + K+ E+ LK + +++K Y+ V
Sbjct: 28 KIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ--VIST 82
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
M+ E + G L Y KH V+ + +QIL + Y H H ++HRDLK +
Sbjct: 83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPE 140
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPELYE-EEYN-ELVDIYSFG 189
N+ ++ + KI D GL+ M R+ G+P + APE+ Y VDI+S G
Sbjct: 141 NVLLDAH-MNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 246
+ + ++ P+ + ++ +FKK+ G+ P L + + L +R
Sbjct: 199 VILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLN----RSVATLLMHMLQVDPLKR 253
Query: 247 LSAKDLLKDPFLQVE 261
+ KD+ + + + +
Sbjct: 254 ATIKDIREHEWFKQD 268
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 40/183 (21%), Positives = 79/183 (43%), Gaps = 14/183 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDI 101
+ E ++ L +V+ Y V ++ + ++TE G L Y + +
Sbjct: 46 SEEDFIEEAEVMMKLSHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA 103
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
+ + + G+ YL +IHRDL N V G + +K+ D G+ +
Sbjct: 104 ETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYT 160
Query: 162 SVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
S GT +F +PE Y+ D++SFG+ + E+ + + PY N +++ + +
Sbjct: 161 SSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDI 218
Query: 216 TSG 218
++G
Sbjct: 219 STG 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 14/183 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 101
+ + E + L +VKFY V K+ + ++TE ++G L Y R K ++
Sbjct: 46 SEDEFFQEAQTMMKLSHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP 103
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
+ + G+ +L SH IHRDL N V VK+ D G+ +
Sbjct: 104 SQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLV-DRDLCVKVSDFGMTRYVLDDQYV 160
Query: 162 SVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
S +GT +F APE + +Y+ D+++FG+ + E+ + + PY N +++ KV
Sbjct: 161 SSVGT-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKV 218
Query: 216 TSG 218
+ G
Sbjct: 219 SQG 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 13/183 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 102
++++ E ++K +K N+V+ V ++ +ITE T GNL Y ++ ++
Sbjct: 259 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 316
Query: 103 VIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158
+ A QI + YL N IHR+L N V G + VK+ D GL+ M
Sbjct: 317 AVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTY 373
Query: 159 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
TA + P ++ APE L +++ D+++FG+ + E+ T+ PY +Q+++ +
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELL 432
Query: 216 TSG 218
Sbjct: 433 EKD 435
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 86/323 (26%), Positives = 127/323 (39%), Gaps = 78/323 (24%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 71
AFD G+ VA K+ Q ++ Y E+ LLK +K +NV+ F +
Sbjct: 46 CAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103
Query: 72 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ V ++T L + +L K K D ++ QIL GL Y+HS + IIHRDLK
Sbjct: 104 EEFNDVYLVTHLMGA-DLNNIVKCQKLTDDH-VQFLIYQILRGLKYIHSAD--IIHRDLK 159
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APE--LYEEEY 179
N+ VN + E+KI D GL AR T + M APE L Y
Sbjct: 160 PSNLAVNED-CELKILDFGL--------ARH---TADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 180 NELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGF 235
N+ VDI+S G CI+ E++T + K + + L K++ + +
Sbjct: 208 NQTVDIWSVG-CIMAELLTGR-TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 236 I--------------------------EKCLV--PASERLSAKDLLKDPFLQV--ENQKE 265
I EK LV +R++A L + + E
Sbjct: 266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS-DKRITAAQALAHAYFAQYHDPDDE 324
Query: 266 PICDPL-------KLPIQSLKML 281
P+ DP L I K L
Sbjct: 325 PVADPYDQSLESRDLLIDEWKSL 347
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 46/194 (23%), Positives = 92/194 (47%), Gaps = 22/194 (11%)
Query: 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
M+ +L G+LR + +++ + + +K + +++ L YL + IIHRD+K DNI ++
Sbjct: 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD 149
Query: 139 GNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCIL 193
HG V I D +A + + T ++ GT +MAPE++ Y+ VD +S G+
Sbjct: 150 -EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY 208
Query: 194 EMVT----FEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLVP-ASER 246
E++ + S + +I + + P++ ++ ++K L P +R
Sbjct: 209 ELLRGRRPYHIRSST--SSKEIVHTFETTVVTYPSAW----SQEMVSLLKKLLEPNPDQR 262
Query: 247 L-SAKDLLKDPFLQ 259
D+ P++
Sbjct: 263 FSQLSDVQNFPYMN 276
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 41/185 (22%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 41 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 100
P +L +E ++++ L + +V+ + + + + ++ E+ G L +Y +++++V
Sbjct: 59 PALKDELLAEANVMQQLDNPYIVRMIG--ICEAE-SWMLVMEMAELGPLNKYLQQNRHVK 115
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQP 158
K I Q+ G+ YL N +HRDL N+ + H KI D GL+ + +
Sbjct: 116 DKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADEN 172
Query: 159 TARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 213
++ P ++ APE + +++ D++SFG+ + E ++ + PY K ++
Sbjct: 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTA 231
Query: 214 KVTSG 218
+ G
Sbjct: 232 MLEKG 236
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 45/211 (21%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
+ E I V +K+ + Q + + + SL ++V+
Sbjct: 33 VWIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-- 87
Query: 75 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
++ ++T+ G+L + ++H+ + +++ NW QI G+ YL H ++HR+L
Sbjct: 88 -SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAAR 144
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTP-EFMAPE-LYEEEYNELVDIYSF 188
N+ + +V++ D G+A + S TP ++MA E ++ +Y D++S+
Sbjct: 145 NVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203
Query: 189 GMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
G+ + E++TF PY+ + A++ + G
Sbjct: 204 GVTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 25 IEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82
+ VA VK DVL P + EV+ + SL N+++ Y V + M+TE
Sbjct: 47 VSVA---VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG--VV-LTPPMKMVTE 100
Query: 83 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141
L G+L +KH+ + + + +A Q+ G+ YL S IHRDL N+ +
Sbjct: 101 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD 158
Query: 142 GEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEM 195
VKIGD GL + P + APE L ++ D + FG+ + EM
Sbjct: 159 -LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217
Query: 196 VTF-EYPYSECKNPAQIFKKV 215
T+ + P+ +QI K+
Sbjct: 218 FTYGQEPWIGLNG-SQILHKI 237
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 36/191 (18%), Positives = 73/191 (38%), Gaps = 30/191 (15%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKV 103
+ + ++ L ++V Y V ++ E G+L Y KK+KN ++I
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 104 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-------GNHGEVKIGDLGLAIAMQ 156
A+Q+ + +L + +IH ++ NI + GN +K+ D G+
Sbjct: 115 KLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI----- 167
Query: 157 QPTARSVIGTPEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 207
+ +V+ + PE + N D +SFG + E+ + + P S +
Sbjct: 168 ---SITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224
Query: 208 PAQIFKKVTSG 218
+ +
Sbjct: 225 -QRKLQFYEDR 234
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 76/314 (24%), Positives = 124/314 (39%), Gaps = 60/314 (19%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 71
A D+ +G +VA K+ Q ++ Y E+ LLK ++ +NV+ F +
Sbjct: 41 CSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98
Query: 72 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ + +L++ + I+ Q+L GL Y+HS ++HRDLK
Sbjct: 99 RNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLK 153
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 189
N+ VN + E+KI D GLA V+ T + APE L YN+ VDI+S G
Sbjct: 154 PGNLAVNED-CELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 190 MCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI--------- 236
CI+ EM+T + + K+ ++ + K+ND K +I
Sbjct: 212 -CIMAEMLTGK-TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK 269
Query: 237 -----------------EKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDP----- 270
EK L +RL+A L PF + + ++E
Sbjct: 270 DFTQLFPRASPQAADLLEKMLELDV-DKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDS 328
Query: 271 ---LKLPIQSLKML 281
KL + K
Sbjct: 329 LEHEKLTVDEWKQH 342
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 43/183 (23%), Positives = 83/183 (45%), Gaps = 14/183 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 101
+ E ++ +L + +V+ Y V K++ + +ITE +G L Y R+
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
+ + + + + YL S +HRDL N V + G VK+ D GL+ +
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV-NDQGVVKVSDFGLSRYVLDDEYT 176
Query: 162 SVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
S +G+ +F PE L +++ DI++FG+ + E+ + + PY N ++ + +
Sbjct: 177 SSVGS-KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHI 234
Query: 216 TSG 218
G
Sbjct: 235 AQG 237
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 73/313 (23%), Positives = 123/313 (39%), Gaps = 58/313 (18%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 71
A D G +VA K+ Q ++ Y E+ LLK ++ +NV+ F
Sbjct: 42 CSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99
Query: 72 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
D ++ + +L + K K + + I+ Q+L GL Y+H+ IIHRDLK
Sbjct: 100 DDFTDFYLVMPFMGT-DLGKLMKHEKLGEDR-IQFLVYQMLKGLRYIHAAG--IIHRDLK 155
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 189
N+ VN + E+KI D GLA V+ T + APE L Y + VDI+S G
Sbjct: 156 PGNLAVNED-CELKILDFGLARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 190 MCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI--------- 236
CI+ EM+T + + + K++ + ++ + K ++
Sbjct: 214 -CIMAEMITGK-TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271
Query: 237 -----------------EKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPL---- 271
EK LV +R++A + L P+ + + + EP
Sbjct: 272 DFASILTNASPLAVNLLEKMLVLDA-EQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 330
Query: 272 ---KLPIQSLKML 281
+ K +
Sbjct: 331 DDVDRTLDEWKRV 343
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 77/330 (23%), Positives = 125/330 (37%), Gaps = 79/330 (23%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 71
A+D VA K+ Q ++ Y E+ L+K + N++ F
Sbjct: 42 CAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99
Query: 72 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ + V ++ EL + NL Q + +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 100 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK 154
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDI 185
NI V + +KI D GLA + S + TP + APE + Y E VDI
Sbjct: 155 PSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 186 YSFGMCIL-EMVT----F------------------------------------EYPYSE 204
+S G CI+ EM+ F P
Sbjct: 210 WSVG-CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYA 268
Query: 205 CKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV-- 260
+ ++F V + K+ Q + + K LV S+R+S + L+ P++ V
Sbjct: 269 GYSFEKLFPDVLF-PADSEHNKLKASQARDLLSKMLVIDA-SKRISVDEALQHPYINVWY 326
Query: 261 ENQKEPICDPL---------KLPIQSLKML 281
+ + P + I+ K L
Sbjct: 327 DPSEAEAPPPKIPDKQLDEREHTIEEWKEL 356
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 108
E ++ L VK Y ++ DD+K + +G L +Y +K + D + +
Sbjct: 79 RERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----IAMQQPTARSVI 164
+I+ L YLH IIHRDLK +NI +N ++I D G A +Q A S +
Sbjct: 137 AEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 165 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-P 221
GT ++++PE L E+ + D+++ G I ++V P+ N IF+K+ P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEYDFP 252
Query: 222 ASLAKVNDPQIKGFIEKCLVP-ASERL------SAKDLLKDPF 257
P+ + +EK LV A++RL L PF
Sbjct: 253 EKF----FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 24/255 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
A +VA +K +L+ ++ E+ LK L+ +++K Y V
Sbjct: 26 KLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD--VITT 80
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ M+ E + G L Y + K + + + +QI+ + Y H H I+HRDLK +
Sbjct: 81 PTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPE 137
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPELYE-EEYN-ELVDIYSFG 189
N+ ++ N VKI D GL+ + ++ G+P + APE+ + Y VD++S G
Sbjct: 138 NLLLDDN-LNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 246
+ + M+ P+ + + +FKKV S + P L P + I + +V +R
Sbjct: 196 IVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFL----SPGAQSLIRRMIVADPMQR 250
Query: 247 LSAKDLLKDPFLQVE 261
++ +++ +DP+ V
Sbjct: 251 ITIQEIRRDPWFNVN 265
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 79/328 (24%), Positives = 133/328 (40%), Gaps = 73/328 (22%)
Query: 17 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDDK 73
A + G VA +K + P + E+ +LK K +N++ + + +
Sbjct: 29 SATHKPTGEIVA---IKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
V +I EL + +L + D I+ + Q L + LH N +IHRDLK
Sbjct: 86 FNEVYIIQELMQT-DLHRVISTQMLSDDH-IQYFIYQTLRAVKVLHGSN--VIHRDLKPS 141
Query: 134 NIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFM----------APE--LYEEEY 179
N+ +N N ++K+ D GLA I G M APE L +Y
Sbjct: 142 NLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200
Query: 180 NELVDIYSFGMCIL-EMVT-----------------FEY---PYSE-----CKNP-AQIF 212
+ +D++S G CIL E+ F P+S+ ++P A+ +
Sbjct: 201 SRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREY 259
Query: 213 KKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKE 265
K A L K+ +P+ +++ LV P ++R++AK+ L+ P+LQ + E
Sbjct: 260 IKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP-AKRITAKEALEHPYLQTYHDPNDE 318
Query: 266 PICDPL------------KLPIQSLKML 281
P +P+ L + LK L
Sbjct: 319 PEGEPIPPSFFEFDHYKEALTTKDLKKL 346
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 52/263 (19%), Positives = 105/263 (39%), Gaps = 53/263 (20%)
Query: 41 PGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV 99
P +K+ E+ +L++L+ N++ D +T ++ E + + +Q + +
Sbjct: 71 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY 130
Query: 100 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQ 156
DI+ +IL L Y HS I+HRD+K N+ ++ H ++++ D GLA Q
Sbjct: 131 DIRFY---MYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 157 QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT---------------- 197
+ R + + F PE + + Y+ +D++S G C+L M+
Sbjct: 186 EYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLV 242
Query: 198 -----------FEYPYSECKNPAQIF--------KKVTSGIKPASLAKVNDPQIKGFIEK 238
++Y F +K + + P+ F++K
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302
Query: 239 CLV--PASERLSAKDLLKDPFLQ 259
L RL+A++ ++ P+
Sbjct: 303 LLRYDHQ-SRLTAREAMEHPYFY 324
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 26/231 (11%)
Query: 50 EVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIK 105
E+ +L N++ + D K V ++TEL G L + R+K + + +
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKY--VYVVTELMKGGELLDKILRQKFFSEREASAV- 121
Query: 106 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQ--QPTA 160
I + YLH+ ++HRDLK NI +GN ++I D G A ++
Sbjct: 122 --LFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 161 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECK-NPAQIFKKVT 216
+ T F+APE L + Y+ DI+S G +L + Y + P +I ++
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIG 236
Query: 217 SG---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ 263
SG + V+D K + K L +RL+A +L+ P++ +Q
Sbjct: 237 SGKFSLSGGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 14/183 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVD 100
+ E ++K L+ + +V+ Y ++ + ++TE + G+L + K K +
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLR 278
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158
+ + + A QI G+ Y+ N +HRDL+ NI V G + K+ D GLA ++
Sbjct: 279 LPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEY 335
Query: 159 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
TAR P ++ APE + D++SFG+ + E+ T PY N ++ +V
Sbjct: 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV 394
Query: 216 TSG 218
G
Sbjct: 395 ERG 397
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 55/255 (21%), Positives = 96/255 (37%), Gaps = 23/255 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGD---LQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
+ A D +VA VK+ L D + E +L +V Y + +
Sbjct: 29 HLARDLRDHRDVA---VKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84
Query: 73 --KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130
++ E LR + K L + H + IIHRD+
Sbjct: 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDV 142
Query: 131 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-----SVIGTPEFMAPELYE-EEYNELVD 184
K NI + VK+ D G+A A+ +VIGT ++++PE + + D
Sbjct: 143 KPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 185 IYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQ-IKGFIEKCLV- 241
+YS G + E++T E P++ +P + ++ V P S + + K L
Sbjct: 202 VYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK 260
Query: 242 -PASERLSAKDLLKD 255
P + +A ++ D
Sbjct: 261 NPENRYQTAAEMRAD 275
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 43/176 (24%), Positives = 85/176 (48%), Gaps = 13/176 (7%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 107
SE ++K+L ++VK + +++ +I EL+ G L Y + ++ + + +
Sbjct: 62 SEAVIMKNLDHPHIVKLIG--IIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT- 166
+ QI + YL S N +HRD+ NI V VK+GD GL+ ++ T
Sbjct: 119 SLQICKAMAYLESIN--CVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTR 175
Query: 167 -P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
P ++M+PE + + D++ F +C+ E+++F + P+ +N + + G
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-21
Identities = 47/189 (24%), Positives = 90/189 (47%), Gaps = 15/189 (7%)
Query: 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
I +L G+L + +H ++ +A +I+ GL ++H+ +++RDLK NI ++
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 326
Query: 139 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMV 196
HG V+I DLGLA + + +GT +MAPE Y+ D +S G + +++
Sbjct: 327 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 197 TFEYPY--SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL-----S 248
P+ + K+ +I + + L P+++ +E L + RL
Sbjct: 386 RGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 249 AKDLLKDPF 257
A+++ + PF
Sbjct: 444 AQEVKESPF 452
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 4e-21
Identities = 47/183 (25%), Positives = 86/183 (46%), Gaps = 14/183 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 102
+ E ++K L+ + +V+ Y ++ + ++TE + G+L + K ++
Sbjct: 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLR 361
Query: 103 VIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158
+ + + A QI G+ Y+ N +HRDL+ NI V G + K+ D GLA ++
Sbjct: 362 LPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEY 418
Query: 159 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
TAR P ++ APE + D++SFG+ + E+ T PY N ++ +V
Sbjct: 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV 477
Query: 216 TSG 218
G
Sbjct: 478 ERG 480
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 64/300 (21%), Positives = 125/300 (41%), Gaps = 24/300 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
D+ VA VK + + + E+ +SL+ N+V+F + V
Sbjct: 37 RLMRDKLTKELVA---VKYIERGAA--IDENVQREIINHRSLRHPNIVRFKE--VILTPT 89
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ +I E + G L + + + +Q+L G+ Y HS I HRDLK +N
Sbjct: 90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENT 147
Query: 136 FVNGNH-GEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMC 191
++G+ +KI D G + + + +S +GTP ++APE+ +EY+ ++ D++S G+
Sbjct: 148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVT 207
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIK------PASLAKVNDPQIKGFIEKCLVP-AS 244
+ M+ YP+ E + ++K I P + P+ I + V +
Sbjct: 208 LYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSIPDDIRI--SPECCHLISRIFVADPA 264
Query: 245 ERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLST 304
R+S ++ + N + + Q + + S + M I S+ ++
Sbjct: 265 TRISIPEIKTHSWFLK-NLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRN 323
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 15/184 (8%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVD 100
++++ E ++K +K N+V+ V ++ +ITE T GNL Y ++ + V
Sbjct: 52 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 109
Query: 101 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160
V+ A QI + YL N IHRDL N V NH VK+ D GL+ M T
Sbjct: 110 AVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTY 166
Query: 161 RSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 214
+ G +F APE L +++ D+++FG+ + E+ T+ PY +Q+++
Sbjct: 167 TAHAGA-KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYEL 224
Query: 215 VTSG 218
+
Sbjct: 225 LEKD 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 5e-21
Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 42/224 (18%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDD 72
+A+D+ VA KI V + D +++ E+ +L L D+VVK +
Sbjct: 70 CEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
K + ++ E+ S + ++ + + IK +L G+ Y+HS I+HRDLK
Sbjct: 128 KFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKP 184
Query: 133 DNIFVNGNHGEVKIGDLGLA-------------------IAMQQPTARSVIGTPEFM--- 170
N VN + VK+ D GLA M T +
Sbjct: 185 ANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243
Query: 171 -------APE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSE 204
APE L +E Y E +D++S G CI E++
Sbjct: 244 VVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKENVA 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 7e-21
Identities = 44/196 (22%), Positives = 80/196 (40%), Gaps = 23/196 (11%)
Query: 16 YKAFDEF-AGIEVAWSRVKIDDVLQLPGD---LQKLYSEVHLLKSLKDDNVVKFYKSWVD 71
Y A D G V +K L GD +E L + ++V+ + ++V+
Sbjct: 97 YLALDRNVNGRPVV---LK---GLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF-NFVE 149
Query: 72 DKKKTVNMIT----ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 127
+ + + E +L++ + + V + I + +IL L YLHS +++
Sbjct: 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-EAI-AYLLEILPALSYLHSIG--LVY 205
Query: 128 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYS 187
DLK +NI + ++K+ DLG + + GTP F APE+ DIY+
Sbjct: 206 NDLKPENIML--TEEQLKLIDLGAVSRINSFGY--LYGTPGFQAPEIVRTGPTVATDIYT 261
Query: 188 FGMCILEMVTFEYPYS 203
G + + +
Sbjct: 262 VGRTLAALTLDLPTRN 277
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 17/178 (9%)
Query: 49 SEVHLLKSLKDDNVVKFYK--SWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIK 105
E ++ ++VK + + V +I EL T G LR + + K ++D+ +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVIT-----ENPVWIIMELCTLGELRSFLQVRKYSLDLASLI 119
Query: 106 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 165
+A Q+ L YL S +HRD+ N+ V+ N VK+GD GL+ M+ T
Sbjct: 120 LYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASK 176
Query: 166 T--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
P ++MAPE + + D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 41/202 (20%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 25 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84
I+VA +K+ D +++ E ++ L + +V+ V + + + ++ E+
Sbjct: 38 IDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG--VC-QAEALMLVMEMA 91
Query: 85 TSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 143
G L ++ K + + + + Q+ G+ YL N +HRDL N+ + H
Sbjct: 92 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRH-Y 148
Query: 144 VKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 197
KI D GL+ + + P ++ APE + +++ D++S+G+ + E ++
Sbjct: 149 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
Query: 198 F-EYPYSECKNPAQIFKKVTSG 218
+ + PY + K ++ + G
Sbjct: 209 YGQKPYKKMKG-PEVMAFIEQG 229
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-21
Identities = 66/255 (25%), Positives = 119/255 (46%), Gaps = 23/255 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
E G +VA VKI + ++ + K+ E+ LK + +++K Y+ V
Sbjct: 33 KVGKHELTGHKVA---VKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ--VIST 87
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ M+ E + G L Y K+ +D K + +QIL G+ Y H H ++HRDLK +
Sbjct: 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPE 145
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPELYE-EEYN-ELVDIYSFG 189
N+ ++ + KI D GL+ M R+ G+P + APE+ Y VDI+S G
Sbjct: 146 NVLLDAH-MNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSG 203
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 246
+ + ++ P+ + + +FKK+ GI P L +P + ++ L +R
Sbjct: 204 VILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYL----NPSVISLLKHMLQVDPMKR 258
Query: 247 LSAKDLLKDPFLQVE 261
+ KD+ + + + +
Sbjct: 259 ATIKDIREHEWFKQD 273
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 42/184 (22%), Positives = 78/184 (42%), Gaps = 14/184 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDI 101
+ SE ++ N+++ V + + ++TE +G+L + + H I
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPT 159
+ R + G+ YL +HRDL N+ V+ N K+ D GL+ +
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDA 207
Query: 160 ARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 214
A + G P + APE + ++ D++SFG+ + E++ + E PY N +
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISS 266
Query: 215 VTSG 218
V G
Sbjct: 267 VEEG 270
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 69/317 (21%), Positives = 125/317 (39%), Gaps = 61/317 (19%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDD 72
A+D + VA +K + Q+ E+ +L + +N++ ++ +
Sbjct: 44 CSAYDNLNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ K V ++ +L + +L + K + I + QIL GL Y+HS N ++HRDLK
Sbjct: 101 QMKDVYIVQDLMET-DLYKLLKTQHLSNDH-ICYFLYQILRGLKYIHSAN--VLHRDLKP 156
Query: 133 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE--LYEEEYNELVDI 185
N+ +N ++KI D GLA + T + APE L + Y + +DI
Sbjct: 157 SNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 186 YSFGMCIL-EMVTFE--YPYSECKN------------PAQIFKKVTS-----------GI 219
+S G CIL EM++ +P + + + +
Sbjct: 216 WSVG-CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 274
Query: 220 KPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPL- 271
++ D + ++K L P +R+ + L P+L+ + EPI +
Sbjct: 275 NKVPWNRLFPNADSKALDLLDKMLTFNP-HKRIEVEQALAHPYLEQYYDPSDEPIAEAPF 333
Query: 272 -------KLPIQSLKML 281
LP + LK L
Sbjct: 334 KFDMELDDLPKEKLKEL 350
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-20
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 13/184 (7%)
Query: 41 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-V 99
+K E ++ ++VK + V +I EL T G LR + + K +
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSL 488
Query: 100 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159
D+ + +A Q+ L YL S +HRD+ N+ V+ N VK+GD GL+ M+ T
Sbjct: 489 DLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDST 545
Query: 160 ARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 214
P ++MAPE + + D++ FG+C+ E++ P+ KN + +
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGR 604
Query: 215 VTSG 218
+ +G
Sbjct: 605 IENG 608
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 64/302 (21%), Positives = 120/302 (39%), Gaps = 61/302 (20%)
Query: 17 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---------- 66
A D VA ++ + D ++ E+ +++ L DN+VK +
Sbjct: 29 SAVDNDCDKRVAIKKIVLTDPQ----SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 67 --KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 124
+ +V ++ E + +L ++ ++ + + Q+L GL Y+HS N
Sbjct: 85 TDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEH-ARLFMYQLLRGLKYIHSAN-- 140
Query: 125 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE--LYEE 177
++HRDLK N+F+N +KIGD GLA M + + + +P L
Sbjct: 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN 200
Query: 178 EYNELVDIYSFGMCIL-EMVT----F--------------------EYPYSECKNPAQIF 212
Y + +D+++ G CI EM+T F E E + ++
Sbjct: 201 NYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVY 259
Query: 213 KKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKE 265
+ L ++ + F+E+ L P +RL+A++ L P++ + E
Sbjct: 260 IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP-MDRLTAEEALSHPYMSIYSFPMDE 318
Query: 266 PI 267
PI
Sbjct: 319 PI 320
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 60/321 (18%), Positives = 106/321 (33%), Gaps = 91/321 (28%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK---FYKSWVDD 72
++ G+ VA I V+Q P + + L L N+V+ ++ + +
Sbjct: 40 QLGKEKSTGMSVA-----IKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94
Query: 73 KKKTV--NMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 126
++ + N++ E L R Y ++ +IK + Q++ + LH + +
Sbjct: 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVC 153
Query: 127 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APELY- 175
HRD+K N+ VN G +K+ D G A+ + + E APEL
Sbjct: 154 HRDIKPHNVLVNEADGTLKLCDFGS--------AKKLSPS-EPNVAYICSRYYRAPELIF 204
Query: 176 -EEEYNELVDIYSFGMCIL-EMVT------------------------------------ 197
+ Y VDI+S G CI EM+
Sbjct: 205 GNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSH 263
Query: 198 --FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLL 253
+ S+ + +F + + D + L P ER+ + L
Sbjct: 264 TDVDLYNSKGIPWSNVFSDHSLKDAKEAY----D-----LLSALLQYLP-EERMKPYEAL 313
Query: 254 KDPFLQV---ENQKEPICDPL 271
P+ K P L
Sbjct: 314 CHPYFDELHDPATKLPNNKDL 334
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 14/185 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 101
++ E L++ L NV+ + + +++ G+L Q+ R +N +
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPT 159
K + ++ Q+ G+ YL +HRDL N ++ + VK+ D GLA I ++
Sbjct: 124 KDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDREYY 180
Query: 160 ARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 213
+ A E L + D++SFG+ + E++T PY +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTH 239
Query: 214 KVTSG 218
+ G
Sbjct: 240 FLAQG 244
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 14/185 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 101
++ + +E ++K NV+ + + ++ G+LR + R + N +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 127
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
K + + Q+ G+ YL S +HRDL N ++ VK+ D GLA M
Sbjct: 128 KDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYY 184
Query: 162 SVIGTPEF------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 213
SV MA E L +++ D++SFG+ + E++T PY + I
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV 243
Query: 214 KVTSG 218
+ G
Sbjct: 244 YLLQG 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 3e-20
Identities = 80/335 (23%), Positives = 123/335 (36%), Gaps = 89/335 (26%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 71
A+D VA K+ Q ++ Y E+ L+K + N++ F
Sbjct: 79 CAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 72 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ + V ++ EL + NL Q + +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 137 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK 191
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APE-LYEEEYN 180
NI V + +KI D GL AR+ GT M APE + Y
Sbjct: 192 PSNIVVKSD-CTLKILDFGL--------ART-AGTSFMMTPYVVTRYYRAPEVILGMGYK 241
Query: 181 ELVDIYSFGMCIL-EMVT----F------------------------------------E 199
E VDI+S G CI+ EMV F
Sbjct: 242 ENVDIWSVG-CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 200 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPF 257
P ++F + K+ Q + + K LV PA +R+S D L+ P+
Sbjct: 301 RPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPA-KRISVDDALQHPY 358
Query: 258 LQV---ENQKEPICDPL--------KLPIQSLKML 281
+ V + E + + I+ K L
Sbjct: 359 INVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 393
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 3e-20
Identities = 39/202 (19%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 25 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 84
I+VA +K+ D +++ E ++ L + +V+ + + + ++ E+
Sbjct: 364 IDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMA 417
Query: 85 TSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 143
G L ++ + + + + Q+ G+ YL N +HR+L N+ + H
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRH-Y 474
Query: 144 VKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 197
KI D GL+ + + P ++ APE + +++ D++S+G+ + E ++
Sbjct: 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 198 F-EYPYSECKNPAQIFKKVTSG 218
+ + PY + K P ++ + G
Sbjct: 535 YGQKPYKKMKGP-EVMAFIEQG 555
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 14/178 (7%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNW 107
E ++ N+++ V K K V ++TE +G+L + +KH + +
Sbjct: 95 GEASIMGQFDHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 165
R I G+ YL +HRDL NI +N N K+ D GL + A + G
Sbjct: 153 LRGIASGMKYLSDMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 166 T--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
P + +PE + ++ D++S+G+ + E++++ E PY E N + K V G
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEG 266
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 53/203 (26%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 108
+E +L+++ +VK S+ D+ + M+ E G + + ++ + +A
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 109 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 168
QI+ YLHS + +I+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE
Sbjct: 148 AQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPE 203
Query: 169 FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PASLA 225
+APE + + YN+ VD ++ G+ I EM P+ P QI++K+ SG ++ P+
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHF- 261
Query: 226 KVNDPQIKGFIEKCLVP-ASERL 247
+K + L ++R
Sbjct: 262 ---SSDLKDLLRNLLQVDLTKRF 281
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 51/315 (16%), Positives = 103/315 (32%), Gaps = 74/315 (23%)
Query: 25 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDDKKKTVNMIT 81
+ S + ++L +++ E+ LL N++ + + + ++T
Sbjct: 54 VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 82 ELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 140
EL + +L Q + + + I+ + IL GL LH ++HRDL NI + N
Sbjct: 114 ELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN 170
Query: 141 HGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSF 188
++ I D L AR APE + + + +LVD++S
Sbjct: 171 -NDITICDFNL--------ARE-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220
Query: 189 GMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI-------- 236
G C++ EM + K+ + K + + P + ++
Sbjct: 221 G-CVMAEMFNRK-ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278
Query: 237 -------------------EKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPL-- 271
K L P R+S + L+ P+ + +
Sbjct: 279 ARAWTAVVPTADPVALDLIAKMLEFNP-QRRISTEQALRHPYFESLFDPLDLTEGLSERF 337
Query: 272 -----KLPIQSLKML 281
+ + +
Sbjct: 338 HFDESVTDVYDMHKI 352
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 56/348 (16%), Positives = 116/348 (33%), Gaps = 103/348 (29%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 71
+ FD +G A +V D + E+ ++K L N++K FY + +
Sbjct: 24 CEVFDIESGKRFALKKVLQDP--------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75
Query: 72 DKKKT--------------------------------VNMITELFTS---GNLRQYRKKH 96
+ K +N+I E L+ + +
Sbjct: 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSG 135
Query: 97 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156
+++ + +I + Q+ + ++HS I HRD+K N+ VN +K+ D G
Sbjct: 136 RSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGS----- 188
Query: 157 QPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EMVTFE--YP 201
A+ +I + E APEL EY +D++S G C+ E++ + +
Sbjct: 189 ---AKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVFGELILGKPLFS 243
Query: 202 YSECKN------------PAQIFKKVTSG--------IKPASLAKV----NDPQIKGFIE 237
+ + ++ +K K+ +E
Sbjct: 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303
Query: 238 KCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPLKLPIQSLKML 281
+ L P R++ + + PF + + + + P + +
Sbjct: 304 QILRYEP-DLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-20
Identities = 51/183 (27%), Positives = 94/183 (51%), Gaps = 14/183 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 102
++ +E +++K+L+ D +VK + K+ + +ITE G+L + K +
Sbjct: 226 SVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQP 282
Query: 103 VIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158
+ K +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA ++
Sbjct: 283 LPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEY 339
Query: 159 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
TAR P ++ APE + + D++SFG+ ++E+VT+ PY NP ++ + +
Sbjct: 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRAL 398
Query: 216 TSG 218
G
Sbjct: 399 ERG 401
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 49 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNW 107
E ++ N+++ V K K + +ITE +G L ++ ++ + +
Sbjct: 95 GEAGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 152
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 165
R I G+ YL + N +HRDL NI V ++ K+ D GL+ + + G
Sbjct: 153 LRGIAAGMKYLANMN--YVHRDLAARNILV-NSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 166 T--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
P + APE + ++ D++SFG+ + E++T+ E PY E N ++ K + G
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 36/164 (21%), Positives = 73/164 (44%), Gaps = 24/164 (14%)
Query: 106 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQP 158
AR +++ + +H + +HRD+K DNI ++ +G +++ D G +
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTV 231
Query: 159 TARSVIGTPEFMAPELYEEE------YNELVDIYSFGMCILEMVTFEYP-YSECKNPAQI 211
+ +GTP++++PE+ + Y D +S G+C+ EM+ E P Y+E + +
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVET 289
Query: 212 FKKVTSGIK----PASLAKVNDPQIKGFIEKCLVPASERLSAKD 251
+ K+ + + P + V K I + + RL
Sbjct: 290 YGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICSREHRLGQNG 332
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 41/184 (22%), Positives = 82/184 (44%), Gaps = 22/184 (11%)
Query: 45 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIK 102
Q +E ++ L+ N+V+ + ++K + ++TE G+L Y + +
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 103 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTA 160
+ ++ + + YL +N +HRDL N+ V+ ++ K+ D GL + Q T
Sbjct: 118 CLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTG 174
Query: 161 RSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 214
+ APE L E++++ D++SFG+ + E+ +F PY + +
Sbjct: 175 K-------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPR 226
Query: 215 VTSG 218
V G
Sbjct: 227 VEKG 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 11/143 (7%)
Query: 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141
++ ++ + + + QI+ GL +LH N II+RDLK +N+ ++ +
Sbjct: 271 DIRY--HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DD 325
Query: 142 GEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 198
G V+I DLGLA + Q + GTP FMAPE L EEY+ VD ++ G+ + EM+
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 199 EYPY---SECKNPAQIFKKVTSG 218
P+ E ++ ++V
Sbjct: 386 RGPFRARGEKVENKELKQRVLEQ 408
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 68/364 (18%), Positives = 123/364 (33%), Gaps = 107/364 (29%)
Query: 17 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDDK 73
A+D+ VA K++ + + D +++ E+ +L LK D +++ Y K
Sbjct: 44 LAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ ++ E+ S +L++ K + + IK +L G ++H IIHRDLK
Sbjct: 102 FDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPA 158
Query: 134 NIFVNGNHGEVKIGDLGLA--------------IAMQQPTARSVIGTPEFM--------- 170
N +N + VK+ D GLA + + + +
Sbjct: 159 NCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217
Query: 171 -APE--LYEEEYNELVDIYSFGMCIL-EMVTFEY-------------PYSECKNPAQIFK 213
APE L +E Y + +DI+S G CI E++ P S C +
Sbjct: 218 RAPELILLQENYTKSIDIWSTG-CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRN 276
Query: 214 KVTSGIK-----------------PASLAKVNDPQIKGFI-------------------- 236
K L +N P++ +I
Sbjct: 277 SKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336
Query: 237 ------EKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDP---------LKLPIQS 277
E L P ++R++ L P+L+ + + E + L
Sbjct: 337 DGINLLESMLKFNP-NKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQ 395
Query: 278 LKML 281
L+ +
Sbjct: 396 LRYI 399
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 102
+E +L+K L+ +V+ Y + + +ITE +G+L + K + +
Sbjct: 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 103 VIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQP 158
+ K + A QI G+ ++ N IHRDL+ NI V+ KI D GLA I +
Sbjct: 108 INKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEY 164
Query: 159 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 215
TAR P ++ APE + + D++SFG+ + E+VT PY NP ++ + +
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNL 223
Query: 216 TSG 218
G
Sbjct: 224 ERG 226
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 42/200 (21%), Positives = 80/200 (40%), Gaps = 36/200 (18%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFY----KSWVDDKKKTVNMITELFTSGNLRQYRKKHK- 97
D+++ E +K +V K +S + +I G+L + +
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 98 -----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152
N+ ++ + + I G+ YL S N IHRDL N + + V + D GL+
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLS 184
Query: 153 IAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF- 198
R + + +A E L + Y D+++FG+ + E++T
Sbjct: 185 --------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRG 236
Query: 199 EYPYSECKNPAQIFKKVTSG 218
+ PY+ +N A+I+ + G
Sbjct: 237 QTPYAGIEN-AEIYNYLIGG 255
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 23/170 (13%)
Query: 106 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 158
WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G + M +
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMV 224
Query: 159 TARSVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTFEYP-YSECKNPAQIF 212
+ +GTP++++PE+ + Y D +S G+ + EM+ + P Y++ + +
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTY 282
Query: 213 KKVTSGIKPASLAKVND--PQIKGFIEKCLVPASERL---SAKDLLKDPF 257
K+ + + ND + K I L RL +++ + F
Sbjct: 283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 42/185 (22%), Positives = 78/185 (42%), Gaps = 14/185 (7%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 101
++ + +E ++K NV+ + + ++ G+LR + R + N +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161
K + + Q+ G+ +L S +HRDL N ++ VK+ D GLA M
Sbjct: 192 KDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFD 248
Query: 162 SVIGTPE------FMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 213
SV +MA E L +++ D++SFG+ + E++T PY + I
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV 307
Query: 214 KVTSG 218
+ G
Sbjct: 308 YLLQG 312
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 44/206 (21%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------ 96
+ E LL +L+ +++VKFY V + M+ E G+L ++ + H
Sbjct: 60 ARKDFQREAELLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 117
Query: 97 ----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 146
+ + + + A QI G+VYL S + +HRDL N V N VKI
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKI 174
Query: 147 GDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCIL 193
GD G+ +R V T + M PE + ++ D++SFG+ +
Sbjct: 175 GDFGM--------SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 226
Query: 194 EMVTF-EYPYSECKNPAQIFKKVTSG 218
E+ T+ + P+ + N ++ + +T G
Sbjct: 227 EIFTYGKQPWFQLSN-TEVIECITQG 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 72/352 (20%), Positives = 124/352 (35%), Gaps = 99/352 (28%)
Query: 17 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKK 75
K+ D G VA KI D Q D Q+ + E+ +L L +N+V D +
Sbjct: 27 KSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
V ++ + + +L + + + + Q++ + YLHS ++HRD+K NI
Sbjct: 85 DVYLVFDYMET-DLHAVIRANILEPVH-KQYVVYQLIKVIKYLHSGG--LLHRDMKPSNI 140
Query: 136 FVNGNHGEVKIGDLGLA-------------IAMQQPTARSVIGTPEFM----------AP 172
+N VK+ D GL+ + + AP
Sbjct: 141 LLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199
Query: 173 E--LYEEEYNELVDIYSFGMCIL-EMVT----F--------------------------- 198
E L +Y + +D++S G CIL E++ F
Sbjct: 200 EILLGSTKYTKGIDMWSLG-CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESI 258
Query: 199 ----------------EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 241
E S ++ +K + I P + + + ++K L
Sbjct: 259 QSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC---NEEALDLLDKLLQF 315
Query: 242 -PASERLSAKDLLKDPFLQV--ENQKEPICDP---------LKLPIQSLKML 281
P ++R+SA D LK PF+ + +EP CD +K I + L
Sbjct: 316 NP-NKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNL 366
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 54/185 (29%), Positives = 97/185 (52%), Gaps = 24/185 (12%)
Query: 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141
ELF+ LR+ ++ V K +A ++ L YLHS + II+RDLK +NI ++ N
Sbjct: 92 ELFS--LLRKSQR----FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN- 142
Query: 142 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY 200
G +KI D G A + T ++ GTP+++APE + + YN+ +D +SFG+ I EM+
Sbjct: 143 GHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
Query: 201 PYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP-ASERL-----SAKDL 252
P+ N + ++K+ + ++ P + +K + + + S+RL +D+
Sbjct: 202 PF-YDSNTMKTYEKILNAELRFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDV 256
Query: 253 LKDPF 257
P+
Sbjct: 257 KNHPW 261
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 38/200 (19%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---------- 92
+ + +E ++K +VV+ V + + +I EL T G+L+ Y
Sbjct: 71 ERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 93 RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 152
+ + A +I G+ YL+++ +HRDL N V + VKIGD G+
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGM- 184
Query: 153 IAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF- 198
R + T + M+PE L + + D++SFG+ + E+ T
Sbjct: 185 -------TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 199 EYPYSECKNPAQIFKKVTSG 218
E PY N Q+ + V G
Sbjct: 238 EQPYQGLSN-EQVLRFVMEG 256
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 41/174 (23%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 106 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 158
AR +I+ + +H +HRD+K DNI ++ G +++ D G + ++
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTV 218
Query: 159 TARSVIGTPEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTFEYP-YSECKNPA 209
+ +GTP++++PE+ Y D ++ G+ EM + P Y++ + A
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STA 276
Query: 210 QIFKKVTSGIKPASLAKVND---PQIKGFIEKCLVPASERL---SAKDLLKDPF 257
+ + K+ + SL V++ + + FI++ L P RL A D PF
Sbjct: 277 ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPF 330
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 56/251 (22%), Positives = 94/251 (37%), Gaps = 34/251 (13%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVL--QLPGD---LQKLYSEVHLLKSLKDDNVVKFYKSWV 70
Y+A D VA +K ++ L D ++ E L++ +VV +
Sbjct: 51 YEAEDTVRERIVA---LK---LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE 104
Query: 71 DDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130
D + V+M L +L ++ + RQI L H+ HRD+
Sbjct: 105 IDGQLYVDM--RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDV 160
Query: 131 KCDNIFVNGNHGEVKIGDLGLAIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIY 186
K +NI V+ + + D G+A A + +GT +MAPE + DIY
Sbjct: 161 KPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIY 219
Query: 187 SFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE 245
+ C+L E +T PY + + + I S P I A +
Sbjct: 220 ALT-CVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTV---RPGIP--------VAFD 266
Query: 246 RLSAKDLLKDP 256
+ A+ + K+P
Sbjct: 267 AVIARGMAKNP 277
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 165
A +I L YLHS N I++RDLK +NI ++ G + + D GL T + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 224
TPE++APE L+++ Y+ VD + G + EM+ P+ +N A+++ + + KP L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILN--KPLQL 258
Query: 225 AKVNDPQIKGFIEKCLV--PASERLSAKD 251
+ +E L +RL AKD
Sbjct: 259 KPNITNSARHLLEGLLQKDRT-KRLGAKD 286
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 46/216 (21%), Positives = 93/216 (43%), Gaps = 32/216 (14%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
D ++ G +VA VK ++ Q +E ++ L+ N+V+ + ++
Sbjct: 208 DVMLG--DYRGNKVA---VK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV-IVEE 258
Query: 74 KKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
K + ++TE G+L Y + + + ++ + + YL +N +HRDL
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLA 316
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-------FMAPE-LYEEEYNELV 183
N+ V+ ++ K+ D GL + T + + APE L E++++
Sbjct: 317 ARNVLVSEDN-VAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 184 DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
D++SFG+ + E+ +F PY + +V G
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 402
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 20/191 (10%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------ 96
D E ++ N+V+ V + ++ EL G+L+ + ++
Sbjct: 76 DELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQ 133
Query: 97 -KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAI 153
++ + + + AR I G YL ++ IHRD+ N + G KIGD G+A
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 154 AMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 207
+ + + G M PE E + D +SFG+ + E+ + PY N
Sbjct: 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251
Query: 208 PAQIFKKVTSG 218
++ + VTSG
Sbjct: 252 -QEVLEFVTSG 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 45/206 (21%), Positives = 80/206 (38%), Gaps = 44/206 (21%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------ 96
++ E L L+ NVV V K + ++MI + G+L ++
Sbjct: 55 LREEFRHEAMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 112
Query: 97 ----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 146
++ + QI G+ YL SH+ ++H+DL N+ V VKI
Sbjct: 113 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKI 169
Query: 147 GDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCIL 193
DLGL R V + MAPE + +++ DI+S+G+ +
Sbjct: 170 SDLGLF--------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 221
Query: 194 EMVTF-EYPYSECKNPAQIFKKVTSG 218
E+ ++ PY N + + + +
Sbjct: 222 EVFSYGLQPYCGYSN-QDVVEMIRNR 246
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 16/162 (9%)
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIG 165
+A +I GL LH I++RDLK +NI ++ +HG ++I DLGLA+ + + T + +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPA 222
T +MAPE + E Y D ++ G + EM+ + P+ + + ++V + P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPE 406
Query: 223 SLAKVNDPQIKGFIEKCLV--PASERL-----SAKDLLKDPF 257
++ PQ + + L PA ERL SA+++ + P
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPA-ERLGCRGGSAREVKEHPL 447
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 7/112 (6%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 167
+I L +LH II+RDLK +NI +N G VK+ D GL ++ + GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 168 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 218
E+MAPE L +N VD +S G + +M+T P+ +N + K+
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKC 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 167
+I+ GL +LHS I++RDLK DNI ++ + G +KI D G+ M + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 168 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 226
+++APE L ++YN VD +SFG+ + EM+ + P+ ++ ++F + +
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRM--DNPFYPR 239
Query: 227 VNDPQIKGFIEKCLV--PASERL-SAKDLLKDPF 257
+ + K + K V P +RL D+ + P
Sbjct: 240 WLEKEAKDLLVKLFVREPE-KRLGVRGDIRQHPL 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 167
++ L +LHS II+RDLK +NI ++ G +K+ D GL+ ++ A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 168 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 215
E+MAPE + + + D +SFG+ + EM+T P+ + K+ + +
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMI 238
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 34/119 (28%), Positives = 64/119 (53%), Gaps = 14/119 (11%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGT 166
+I+ L +LH II+RD+K +NI ++ ++G V + D GL+ +A + A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 167 PEFMAPELYEEE---YNELVDIYSFGMCILEMVT----FEYPYSECKNPAQIFKKVTSG 218
E+MAP++ +++ VD +S G+ + E++T F E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKS 281
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 36/199 (18%), Positives = 79/199 (39%), Gaps = 35/199 (17%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN---MITELFTSGNLRQYRKKHK-- 97
++++ SE +K NV++ ++ + + +I G+L Y +
Sbjct: 79 EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 98 ----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153
++ ++ + + I G+ YL + N +HRDL N + + V + D GL
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGL-- 193
Query: 154 AMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-E 199
++ + + +A E L + Y D+++FG+ + E+ T
Sbjct: 194 ------SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM 247
Query: 200 YPYSECKNPAQIFKKVTSG 218
PY +N +++ + G
Sbjct: 248 TPYPGVQN-HEMYDYLLHG 265
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 7e-18
Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 17/160 (10%)
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 165
A +I GL +L S II+RDLK DN+ ++ G +KI D G+ T ++ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPA 222
TP+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 223 SLAKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 257
S++K KG + K +RL +D+ + F
Sbjct: 564 SMSKEAVAICKGLMTKH---PGKRLGCGPEGERDIKEHAF 600
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 46/197 (23%), Positives = 83/197 (42%), Gaps = 27/197 (13%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------ 96
Q E LL L+ ++V+F+ V + + + M+ E G+L ++ + H
Sbjct: 86 ARQDFQREAELLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 97 ---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 147
+ + + A Q+ G+VYL + +HRDL N V VKIG
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIG 200
Query: 148 DLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYP 201
D G++ + V G M PE + ++ D++SFG+ + E+ T+ + P
Sbjct: 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 202 YSECKNPAQIFKKVTSG 218
+ + N + +T G
Sbjct: 261 WYQLSN-TEAIDCITQG 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 20/191 (10%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK----- 97
D E ++ N+V+ V + ++ EL G+L+ + ++ +
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 174
Query: 98 --NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAI 153
++ + + + AR I G YL ++ IHRD+ N + G KIGD G+A
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 154 AMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 207
+ + G M PE E + D +SFG+ + E+ + PY N
Sbjct: 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292
Query: 208 PAQIFKKVTSG 218
++ + VTSG
Sbjct: 293 -QEVLEFVTSG 302
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 51/285 (17%), Positives = 108/285 (37%), Gaps = 57/285 (20%)
Query: 15 TYKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVD- 71
+ F++ + A +K + D K EV L ++V+ + +
Sbjct: 34 VLQIFNKRTQEKFA---LKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL 83
Query: 72 -DKKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 128
+K + ++ E G L R + + + + I + YLHS N I HR
Sbjct: 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHR 141
Query: 129 DLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIY 186
D+K +N+ + + + +K+ D G A E E+Y++ D++
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGF-------------------AKETTGEKYDKSCDMW 182
Query: 187 SFGMCILEMVTFEYP--YSECKNPAQ--IFKKVTSGIKPASLAKVNDPQI----KGFIEK 238
S G I+ ++ YP YS + ++ G ++ K I
Sbjct: 183 SLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRN 239
Query: 239 CLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
L ++R++ + + P++ ++ K P + P+ + ++L+
Sbjct: 240 LLKTEPTQRMTITEFMNHPWIM-QSTKVP-----QTPLHTSRVLK 278
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 43 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 101
+ + L SE+ +L + NVV + + +I E GNL Y + +N +
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 102 KVIKN----------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
++ Q+ G+ +L S IHRDL NI ++ + VK
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVK 188
Query: 146 IGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCI 192
I D GL AR + P++ MAPE +++ Y D++SFG+ +
Sbjct: 189 ICDFGL--------ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 193 LEMVTF-EYPYSECKNPAQIFKKVTSG 218
E+ + PY K + +++ G
Sbjct: 241 WEIFSLGASPYPGVKIDEEFCRRLKEG 267
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 46/209 (22%), Positives = 81/209 (38%), Gaps = 46/209 (22%)
Query: 43 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 101
+ + L SE+ +L L + N+V + V ITE G+L + ++ ++ I
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV--ITEYCCYGDLLNFLRRKRDSFI 126
Query: 102 KVIKN------------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 143
+ ++ Q+ G+ +L S N IHRDL NI +
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGR-I 183
Query: 144 VKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGM 190
KI D GL AR + + MAPE ++ Y D++S+G+
Sbjct: 184 TKICDFGL--------ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 191 CILEMVTF-EYPYSECKNPAQIFKKVTSG 218
+ E+ + PY ++ +K + G
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 43/160 (26%), Positives = 85/160 (53%), Gaps = 17/160 (10%)
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIG 165
+I+ L YLHS + +++RD+K +N+ ++ + G +KI D GL + T ++ G
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCG 167
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PA 222
TPE++APE L + +Y VD + G+ + EM+ P+ ++ ++F+ + I+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPR 226
Query: 223 SLAKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 257
+L+ + G ++K +RL AK++++ F
Sbjct: 227 TLSPEAKSLLAGLLKKD---PKQRLGGGPSDAKEVMEHRF 263
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 42/205 (20%)
Query: 43 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVD 100
+ + L SE+ ++ L +N+V V +ITE G+L + R+K + ++
Sbjct: 92 EKEALMSELKIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 101 IKVIKN-------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 147
++ Q+ G+ +L S N IHRD+ N+ + N KIG
Sbjct: 150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIG 206
Query: 148 DLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILE 194
D GL AR ++ + MAPE +++ Y D++S+G+ + E
Sbjct: 207 DFGL--------ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 195 MVTF-EYPYSECKNPAQIFKKVTSG 218
+ + PY ++ +K V G
Sbjct: 259 IFSLGLNPYPGILVNSKFYKLVKDG 283
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 167
+I GL +L S II+RDLK DN+ ++ G +KI D G+ + T ++ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 168 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASL 224
+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 225 AKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 257
+K KG + K +RL +D+ + F
Sbjct: 245 SKEAVAICKGLMTKH---PGKRLGCGPEGERDIKEHAF 279
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 69/312 (22%), Positives = 112/312 (35%), Gaps = 77/312 (24%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-----------DNVVK 64
+ A D VA +KI V + E+ LL+ + D ++++K
Sbjct: 36 WLAKDMVNNTHVA---MKI--VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90
Query: 65 FYKS--WVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHS 120
V M+ E+ NL KK+++ + +K ++Q+L GL Y+H
Sbjct: 91 LLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 149
Query: 121 HNPPIIHRDLKCDNIFV-----NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-L 174
IIH D+K +N+ + N ++KI DLG A + + I T E+ +PE L
Sbjct: 150 RC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVL 207
Query: 175 YEEEYNELVDIYSFGMCILEMVT----FE--------------------------YPYSE 204
+ DI+S I E++T FE Y
Sbjct: 208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRN 267
Query: 205 CKNPAQIFK-----KVTSGIKPASLAKV----------NDPQIKGFIEKCLV--PASERL 247
K F + S +K L V +I F+ L P +R
Sbjct: 268 GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP-RKRA 326
Query: 248 SAKDLLKDPFLQ 259
A L+ P+L+
Sbjct: 327 DAGGLVNHPWLK 338
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 35/108 (32%), Positives = 59/108 (54%), Gaps = 7/108 (6%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 167
+I+ L++LH II+RDLK DN+ ++ G K+ D G+ + T + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 168 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 214
+++APE L E Y VD ++ G+ + EM+ P+ E +N +F+
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEA 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 52/214 (24%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 102
+L+ L SE ++LK + +V+K Y + + +I E G+LR + ++ + V
Sbjct: 69 ELRDLLSEFNVLKQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 103 VIKN------------------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
+ + +A QI G+ YL ++HRDL NI V
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVA 184
Query: 139 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDI 185
++KI D GL +R V + MA E L++ Y D+
Sbjct: 185 EGR-KMKISDFGL--------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 186 YSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
+SFG+ + E+VT PY ++F + +G
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTG 268
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 165
+ +I L YLH II+RDLK DN+ ++ G +K+ D G+ +P T + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 210
TP ++APE L E+Y VD ++ G+ + EM+ P+ +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 41/214 (19%), Positives = 75/214 (35%), Gaps = 52/214 (24%)
Query: 43 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 102
E L+ + N+VK V K + ++ E G+L ++ + +
Sbjct: 93 MQADFQREAALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 150
Query: 103 VIKNW------------------------ARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
+ + ARQ+ G+ YL +HRDL N V
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG 208
Query: 139 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDI 185
N VKI D GL+ R++ + M PE ++ Y D+
Sbjct: 209 ENM-VVKIADFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 259
Query: 186 YSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
+++G+ + E+ ++ PY + ++ V G
Sbjct: 260 WAYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 45/214 (21%), Positives = 78/214 (36%), Gaps = 51/214 (23%)
Query: 43 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 101
+ + L SE+ ++ L +N+V +I E G+L Y + +
Sbjct: 91 EREALMSELKMMTQLGSHENIVNLL-GACTLSGPIY-LIFEYCCYGDLLNYLRSKREKFS 148
Query: 102 KVIKN-----------------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138
+ +A Q+ G+ +L + +HRDL N+ V
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT 206
Query: 139 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDI 185
VKI D GL AR ++ + MAPE L+E Y D+
Sbjct: 207 HGK-VVKICDFGL--------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 257
Query: 186 YSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 218
+S+G+ + E+ + PY A +K + +G
Sbjct: 258 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 45/207 (21%)
Query: 43 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 101
DL L SE+ ++K + N++ + + +I E + GNLR+Y + + +
Sbjct: 83 DLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 102 KVIKN----------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
+ + Q+ G+ YL S IHRDL N+ V N+ +K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMK 197
Query: 146 IGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCI 192
I D GL AR + + MAPE L++ Y D++SFG+ +
Sbjct: 198 IADFGL--------ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 193 LEMVTF-EYPYSECKNPAQIFKKVTSG 218
E+ T PY ++FK + G
Sbjct: 250 WEIFTLGGSPYPGIPV-EELFKLLKEG 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 45/207 (21%)
Query: 43 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 101
DL L SE+ ++K + N++ + + +I E + GNLR+Y + + +
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 102 KVIKN----------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
+ + Q+ G+ YL S IHRDL N+ V N+ +K
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMK 243
Query: 146 IGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCI 192
I D GLA R + + MAPE L++ Y D++SFG+ +
Sbjct: 244 IADFGLA--------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295
Query: 193 LEMVTF-EYPYSECKNPAQIFKKVTSG 218
E+ T PY ++FK + G
Sbjct: 296 WEIFTLGGSPYPGIPV-EELFKLLKEG 321
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 68/320 (21%), Positives = 113/320 (35%), Gaps = 80/320 (25%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD------NVVKFYKSW 69
KA+D VA +K+ V ++ E+ +L+ L+ NV+
Sbjct: 114 VKAYDHKVHQHVA---LKM--VRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML-EN 167
Query: 70 VDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIH 127
+ M EL S NL + KK+K + +++ +A IL L LH + IIH
Sbjct: 168 FTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIH 223
Query: 128 RDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 185
DLK +NI +K+ D G + Q + I + + APE + Y +D+
Sbjct: 224 CDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQSRFYRAPEVILGARYGMPIDM 282
Query: 186 YSFGMCIL-EMVT--------------------------------------FE---YPYS 203
+S G CIL E++T YP
Sbjct: 283 WSLG-CILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRY 341
Query: 204 ECKNPAQIFKKVTSGIKP---------------ASLAKVNDPQIKGFIEKCLVP-ASERL 247
V +G + +L +DP F+++CL + R+
Sbjct: 342 CTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401
Query: 248 SAKDLLKDPFLQVENQKEPI 267
+ L+ P+L+ K P
Sbjct: 402 TPGQALRHPWLRRRLPKPPT 421
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 165
+ +I L YLH II+RDLK DN+ ++ G +K+ D G+ +P T + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 166 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 210
TP ++APE L E+Y VD ++ G+ + EM+ P+ +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 45/207 (21%)
Query: 43 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 101
DL L SE+ ++K + N++ + + +I E + GNLR+Y + + +
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 102 KVIKN----------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
+ N A Q+ G+ YL S IHRDL N+ V ++ +K
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMK 231
Query: 146 IGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCI 192
I D GLA R + + MAPE L++ Y D++SFG+ +
Sbjct: 232 IADFGLA--------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
Query: 193 LEMVTF-EYPYSECKNPAQIFKKVTSG 218
E+ T PY ++FK + G
Sbjct: 284 WEIFTLGGSPYPGVPV-EELFKLLKEG 309
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 16/158 (10%)
Query: 110 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 167
+I+ L YLHS +++RDLK +N+ ++ + G +KI D GL ++ T ++ GTP
Sbjct: 256 EIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 168 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASL 224
E++APE L + +Y VD + G+ + EM+ P+ ++ ++F+ + P +L
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTL 372
Query: 225 AKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 257
+ G ++K +RL AK++++ F
Sbjct: 373 GPEAKSLLSGLLKKD---PKQRLGGGSEDAKEIMQHRF 407
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 44/196 (22%), Positives = 79/196 (40%), Gaps = 26/196 (13%)
Query: 43 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 101
D + E+ +L L N++ + + + + E GNL + +K + ++
Sbjct: 68 DHRDFAGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 102 KVIKNW----------------ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145
A + G+ YL IHRDL NI V N+ K
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAK 182
Query: 146 IGDLGLAIAMQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPY 202
I D GL+ + +++ P +MA E L Y D++S+G+ + E+V+ PY
Sbjct: 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 203 SECKNPAQIFKKVTSG 218
A++++K+ G
Sbjct: 243 CGMTC-AELYEKLPQG 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 50 EVHLLKSLKDD------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDI 101
EV LL+ + +V + + + + ++ E+ S NL + V +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHF--MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTA 160
+ + +A+Q+ L++L + IIH DLK +NI N +KI D G + + Q
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 161 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 197
I + + +PE L Y+ +D++S G CIL EM T
Sbjct: 217 -QYIQSRFYRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-15
Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 20/96 (20%)
Query: 114 GLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-----VIGTP 167
GL YLH H +P IIHRD+K NI ++ E +GD GLA M + V GT
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGTI 199
Query: 168 EFMAPELYEEEY------NELVDIYSFGMCILEMVT 197
+AP EY +E D++ +G+ +LE++T
Sbjct: 200 GHIAP-----EYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 34/127 (26%), Positives = 58/127 (45%), Gaps = 25/127 (19%)
Query: 106 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 165
++ Q+ G+ +L S IHRDL NI ++ + VKI D GL AR +
Sbjct: 197 CYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL--------ARDIYK 245
Query: 166 TPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 211
P++ MAPE +++ Y D++SFG+ + E+ + PY K +
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 212 FKKVTSG 218
+++ G
Sbjct: 306 CRRLKEG 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 33/88 (37%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 114 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARS--VIGTPEF 169
G+ +LH IHRD+K NI ++ KI D GLA T + ++GT +
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 170 MAPELYEEEYNELVDIYSFGMCILEMVT 197
MAPE E DIYSFG+ +LE++T
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 12/91 (13%)
Query: 114 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP------TARSVIGTP 167
GL YLH IIHRD+K NI ++ N KI D G++ + T V GT
Sbjct: 151 GLHYLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGTL 205
Query: 168 EFMAPELYEEEY-NELVDIYSFGMCILEMVT 197
++ PE + + E D+YSFG+ + E++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 55/289 (19%), Positives = 98/289 (33%), Gaps = 88/289 (30%)
Query: 50 EVHLLKSLKDD-----NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIK 102
E +LK +++D N+VK++ + + +I E +L + ++ I+
Sbjct: 81 EADILKKIQNDDINNNNIVKYHGKF--MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 103 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-------------------- 142
IK + +IL L YL + + H DLK +NI ++ +
Sbjct: 138 DIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 143 ----EVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMV 196
+K+ D G A S+I T ++ APE + ++ D++SFG C+L E+
Sbjct: 196 TKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELY 253
Query: 197 T---------------------------------------------FEYPYSECKNPAQI 211
T + + E +
Sbjct: 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313
Query: 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
K V P + F+ L + R S +LLK FL+
Sbjct: 314 IKHVKKC-LPLYK-IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 51/288 (17%), Positives = 101/288 (35%), Gaps = 79/288 (27%)
Query: 50 EVHLLKSLKDD------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DI 101
E+ +L+ L V+ W + ++ EL + + K++ + +
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQML-EWFEHHGHIC-IVFELL-GLSTYDFIKENGFLPFRL 117
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG------------------E 143
I+ A QI + +LHS+ + H DLK +NI + +
Sbjct: 118 DHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 144 VKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT---- 197
+K+ D G A + +++ T + APE + +++ D++S G CIL E
Sbjct: 176 IKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYLGFTV 233
Query: 198 ---------------------------------FEYPYSECKNPAQIFKKVTSGIKP--- 221
F + + + + V+ KP
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293
Query: 222 -ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPI 267
V ++ I+K L ++R++ ++ LK PF + K+ I
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL--LKKSI 339
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 48/297 (16%), Positives = 101/297 (34%), Gaps = 77/297 (25%)
Query: 50 EVHLLKSLKDD------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DI 101
E+++LK +K+ V + + + + EL N ++ K++ +
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSDWF--NFHGHMCIAFELL-GKNTFEFLKENNFQPYPL 122
Query: 102 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN------------------HGE 143
+++ A Q+ H L +LH + + H DLK +NI + +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 144 VKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT---- 197
+++ D G A +++ T + PE + E + + D++S G CIL E
Sbjct: 181 IRVADFGSAT-FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYRGFTL 238
Query: 198 F------------------------------------EYPYSECKNPAQIFKKVTSGIKP 221
F + E + + K+ +K
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298
Query: 222 ASLAK-VNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQ 276
L + Q+ + + L ++R++ + L PF +E + P +
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 52/269 (19%), Positives = 84/269 (31%), Gaps = 101/269 (37%)
Query: 88 NLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV-------- 137
+L ++ K + + +K +Q+L GL YLH+ IIH D+K +NI +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIR 188
Query: 138 ----------------------------------------NGNHGEVKIGDLGLAIAMQQ 157
N +VKI DLG A + +
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248
Query: 158 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY-------------- 202
I T ++ + E L YN DI+S E+ T +Y +
Sbjct: 249 HF-TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
Query: 203 ----------------SECKNPAQIFK-----KVTSGIKPASLAKV----------NDPQ 231
K + F K + +KP L +V
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 232 IKGFIEKCLV--PASERLSAKDLLKDPFL 258
F+ L P +R +A + L+ P+L
Sbjct: 368 FTDFLLPMLELIP-EKRATAAECLRHPWL 395
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 34/184 (18%), Positives = 67/184 (36%), Gaps = 39/184 (21%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y AF + A VK++ + L+SE+ + + + +K W++ K+
Sbjct: 54 YLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQRVAKKDCIK---KWIERKQL 105
Query: 76 TVNMITELFTSG-------------------NLRQYRKKHKNVDIKVIKNWARQILHGLV 116
I + SG +L++ ++ + ++L L
Sbjct: 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLE 165
Query: 117 YLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---------IAMQQPTARSVIGT 166
Y+H + +H D+K N+ + N +V + D GL+ Q+ + GT
Sbjct: 166 YIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223
Query: 167 PEFM 170
EF
Sbjct: 224 IEFT 227
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 2e-09
Identities = 80/552 (14%), Positives = 148/552 (26%), Gaps = 193/552 (34%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF-------- 65
D D I S+ +ID ++ + L S +++ V KF
Sbjct: 34 DCKDVQDMPKSI---LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN 90
Query: 66 YKSWVDDKKKTVN----MITELFTSGNLRQYR-----KKHKNV----DIKVIKNWARQ-- 110
YK ++ KT M+T ++ R Y K+ NV ++ +
Sbjct: 91 YK-FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY-NVSRLQPYLKLRQALLELR 148
Query: 111 -----ILHG--------LVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLGLAI 153
++ G + + K N + L +
Sbjct: 149 PAKNVLIDGVLGSGKTWVALD-------VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM 201
Query: 154 -------AMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC--ILEMV-------T 197
T+RS + + + E L+ + C +L V
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA 261
Query: 198 FEYPYSECKNPAQI-----FKKVTSGIKPASLAKVN-DPQIKGFIEKCLVPASERLSAK- 250
F CK I FK+VT + A+ ++ D + L K
Sbjct: 262 FNL---SCK----ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP----DEVKSLLLKY 310
Query: 251 ------DL------------------LKDPFLQVENQKEPICDPL--------------- 271
DL ++D +N K CD L
Sbjct: 311 LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370
Query: 272 ---------------KLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSP--- 313
+P L ++ + M + + + SL + S
Sbjct: 371 YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--VEKQPKESTISI 428
Query: 314 -------HCPVLEFQRMHKN--NEFRL-RGTKNDDTSVSLT-----------LRIADSSG 352
+ +H++ + + + + +DD L+ +
Sbjct: 429 PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE 488
Query: 353 RVRNIHFLF---YLD----------SDTALSVAGEMVEQL-DL-------ADHDVAFIAE 391
R+ LF +LD TA + +G ++ L L D+D + E
Sbjct: 489 RMT----LFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY--E 542
Query: 392 FIDYLIMKLLPG 403
+ I+ LP
Sbjct: 543 RLVNAILDFLPK 554
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 1e-07
Identities = 42/374 (11%), Positives = 103/374 (27%), Gaps = 107/374 (28%)
Query: 2 RILISSR--------------RIPAVDTYKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQ 45
+IL+++R I DE + + + + D LP ++
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD---LPREVL 323
Query: 46 KLYSEVHLL------KSLKDD-NVVKFYKSWVDDK-KKTVNMITELFTSGNLRQYRKK-- 95
+ +S++D +K DK + + R+ +
Sbjct: 324 T----TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS 379
Query: 96 --HKNVDI--KVIKN-WA-------RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 143
+ I ++ W +++ L H ++ + K I +
Sbjct: 380 VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL-----HKYSLVEKQPKESTISI---P-- 429
Query: 144 VKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYS 203
+ L + ++ ++ + +VD Y+ +
Sbjct: 430 ----SIYLELKVKLENEYAL---------------HRSIVDHYNIPKT--------FDSD 462
Query: 204 ECKNPAQ---IFKKVTSGIKPASLAKVND--PQIK---GFIEKCLVPASERLSAKDLLKD 255
+ P + + +K + + F+E+ + S +A + +
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
Query: 256 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 315
Q++ K ICD + P + + L E+ S +
Sbjct: 523 TLQQLKFYKPYICD----------------NDPKYERLVNAILDF-LPKIEENLICSKYT 565
Query: 316 PVLEFQRMHKNNEF 329
+L M ++
Sbjct: 566 DLLRIALMAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 5e-06
Identities = 80/618 (12%), Positives = 174/618 (28%), Gaps = 184/618 (29%)
Query: 91 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI--FVNG--NHGEVKI 146
+ H + + + + IL + C ++ + E+
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILS-------VFEDAFVDNFDCKDVQDMPKSILSKEEID- 52
Query: 147 GDLGLAIAMQQPT----ARSVIGTPEFMAPELYEEEYNELVDI-YSFGMCILEMVTFEYP 201
+ + + T E+ ++ E++ I Y F ++ +
Sbjct: 53 -HI-----IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF---LMSPIK---- 99
Query: 202 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVE 261
+E + P+ + + ND Q+ K V RL L+ L++
Sbjct: 100 -TEQRQPSMMTRMYIEQRDRLY----NDNQV---FAKYNVS---RLQPYLKLRQALLELR 148
Query: 262 NQKEPICDPLKLPIQSLKMLRLPM--SGPSSMDID--SDYKQ----------LSLSTCTE 307
K + I + SG + + +D YK L+L C
Sbjct: 149 PAK-------NVLIDG-------VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 308 SNNGSPHCPVLE-FQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSD 366
VLE Q++ + T D S ++ LRI +R L +
Sbjct: 195 PET------VLEMLQKLL--YQIDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKSKPYE 244
Query: 367 TALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKP----SYDYSSSGAL---SFY 419
L V L +V +++ S L F
Sbjct: 245 NCLLV-------LL----NV-----------------QNAKAWNAFNLSCK-ILLTTRFK 275
Query: 420 SVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQ---------- 469
V+ L T+ S P E + ++ QDL P +
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDE---VKSLLLKYLDCRPQDL-PREVLTTNPRRLS 331
Query: 470 --GENLHDNAGGGGISSPSLAKLEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSY 527
E++ D + + + + I ++S + +E+ +
Sbjct: 332 IIAESIRDG--------LATWDNWKHVNCDKLTTII---ESSLNVLEPAEYRKM-----F 375
Query: 528 KDL-----NGYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVKNSKLTFPNLSTVLSL 582
L + ++ + L + + + +++ + K S + + +S+
Sbjct: 376 DRLSVFPPSAHIPTILL-------SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 583 TSSYSSLSLTGKDVDEL-KMEIDA--IEAQYEH-----------WFQELS------KMKE 622
S Y L + ++ L + +D I ++ ++ + + E
Sbjct: 429 PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE 488
Query: 623 EALEASRK----RWMAKK 636
R++ +K
Sbjct: 489 RMTLFRMVFLDFRFLEQK 506
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 23/198 (11%), Positives = 51/198 (25%), Gaps = 36/198 (18%)
Query: 16 YKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
++A D +VA + + LQ+ S L + V +
Sbjct: 48 WQALDTALDRQVA---LTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
V E G+L++ + + + + H +
Sbjct: 105 GGLVVA--EWIRGGSLQEVADTSPSPVGAI--RAMQSLAAAADAAHRAG--VALSIDHPS 158
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 193
+ V+ + G+V + M + DI G +
Sbjct: 159 RVRVSID-GDVVLAYPA---TMPDANPQD---------------------DIRGIGASLY 193
Query: 194 EMVTFEYPYSECKNPAQI 211
++ +P E + +
Sbjct: 194 ALLVNRWPLPEAGVRSGL 211
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 37/170 (21%), Positives = 61/170 (35%), Gaps = 24/170 (14%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDD 72
D Y D AG EVA + +L+ E + K ++ + +
Sbjct: 24 DIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77
Query: 73 KKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
M+ EL +L + +K + A Q++ + Y+HS N IHRD+K
Sbjct: 78 DYNV--MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVK 132
Query: 132 CDNIFV--NGNHGEVKIGDLGLAIAMQQP---------TARSVIGTPEFM 170
DN + V I D GLA + +++ GT +
Sbjct: 133 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 17/73 (23%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---------IAMQQ 157
A ++L L +LH + +H ++ +NIFV+ + +V + G A +A +
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 158 PTARSVIGTPEFM 170
+ G EF+
Sbjct: 223 GSRSPHEGDLEFI 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 27/143 (18%), Positives = 55/143 (38%), Gaps = 15/143 (10%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDD 72
+ Y + EVA + +L E + + L+ + V+
Sbjct: 22 EIYLGTNIQTNEEVAIKLENVKT------KHPQLLYESKIYRILQGGTGIPNVRWFGVEG 75
Query: 73 KKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ +L +L + + +K + A Q+++ + ++HS + +HRD+K
Sbjct: 76 DYNV--LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIK 130
Query: 132 CDNIFV--NGNHGEVKIGDLGLA 152
DN + +V I D GLA
Sbjct: 131 PDNFLMGLGRRANQVYIIDFGLA 153
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 3e-06
Identities = 47/244 (19%), Positives = 74/244 (30%), Gaps = 43/244 (17%)
Query: 41 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGN-LRQYRKKHKNV 99
P L K + + K +D F K + ++ E G L Q R K ++
Sbjct: 108 PPLLLKAWDHYNSTKGSANDRPDFF-------KDDQLFIVLEFEFGGIDLEQMRTKLSSL 160
Query: 100 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN------------------GNH 141
K+ Q+ L + HRDL N+ + +
Sbjct: 161 AT--AKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC 217
Query: 142 G-EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEY 200
G +V I D L+ + V+ M +L+ + + DIY EY
Sbjct: 218 GLQVSIIDYTLSRLERDGI---VVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEY 274
Query: 201 -PYSECK-----NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 254
PYS + + K +I+ F L + SA DLL
Sbjct: 275 HPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SATDLLC 330
Query: 255 DPFL 258
L
Sbjct: 331 QHSL 334
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 23/73 (31%), Positives = 32/73 (43%), Gaps = 12/73 (16%)
Query: 108 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---------IAMQQ 157
+ +IL L Y+H H +H D+K N+ +N N +V + D GLA A
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 158 PTARSVIGTPEFM 170
R GT EF
Sbjct: 216 DPKRCHDGTIEFT 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 22/145 (15%), Positives = 51/145 (35%), Gaps = 17/145 (11%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDD 72
++ + +VA D +L E K L + Y +
Sbjct: 25 VIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78
Query: 73 KKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
++ +L +L + +K + A+Q+L + +H + +++RD+K
Sbjct: 79 LHNV--LVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIK 133
Query: 132 CDNIFVNGNHGE----VKIGDLGLA 152
DN + + + + + D G+
Sbjct: 134 PDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 31/145 (21%), Positives = 57/145 (39%), Gaps = 17/145 (11%)
Query: 14 DTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDD 72
+ + + VA +K++ + +L+ E K L D + + Y
Sbjct: 24 ELRLGKNLYTNEYVA---IKLEPM---KSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG 77
Query: 73 KKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
K M+ EL +L + +K + A Q++ + Y+HS N +I+RD+K
Sbjct: 78 KYNA--MVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVK 132
Query: 132 CDNIFV----NGNHGEVKIGDLGLA 152
+N + N + I D LA
Sbjct: 133 PENFLIGRPGNKTQQVIHIIDFALA 157
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 5e-05
Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 9/83 (10%)
Query: 329 FRLRGTKNDD---TSVSLTLRIADS---SGRVRN---IHFLFYLDSDTALSVAGEMVEQL 379
R+ + DD ++ L LRI D G+ ++ I F F L+ D VA EMVE
Sbjct: 11 VRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESG 70
Query: 380 DLADHDVAFIAEFIDYLIMKLLP 402
+ + D +A+ I + +
Sbjct: 71 YVCEGDHKTMAKAIKDRVSLIKR 93
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 641 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-71 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-44 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 8e-71
Identities = 131/247 (53%), Positives = 169/247 (68%), Gaps = 5/247 (2%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD--DK 73
YK D +EVAW ++ D + Q+ E +LK L+ N+V+FY SW
Sbjct: 26 YKGLDTETTVEVAW--CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
KK + ++TEL TSG L+ Y K+ K + IKV+++W RQIL GL +LH+ PPIIHRDLKCD
Sbjct: 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 143
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 193
NIF+ G G VKIGDLGLA + A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+L
Sbjct: 144 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 203
Query: 194 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 252
EM T EYPYSEC+N AQI+++VTSG+KPAS KV P++K IE C+ ER S KDL
Sbjct: 204 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
Query: 253 LKDPFLQ 259
L F Q
Sbjct: 264 LNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-52
Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 16/254 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
K + G + W + + + + Q L SEV+LL+ LK N+V++Y +D
Sbjct: 21 QKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78
Query: 76 TVNMITELFTSGNLRQY----RKKHKNVDIKVIKNWARQILHGLVYLHSHN---PPIIHR 128
T+ ++ E G+L K+ + +D + + Q+ L H + ++HR
Sbjct: 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDI 185
DLK N+F++G VK+GD GLA + T A++ +GTP +M+PE YNE DI
Sbjct: 139 DLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDI 197
Query: 186 YSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-AS 244
+S G + E+ P+ + ++ K+ G K + ++ I + L
Sbjct: 198 WSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDY 255
Query: 245 ERLSAKDLLKDPFL 258
R S +++L++P +
Sbjct: 256 HRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 4e-51
Identities = 52/246 (21%), Positives = 113/246 (45%), Gaps = 11/246 (4%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y A ++ + +A + + + G +L EV + L+ N+++ Y + D +
Sbjct: 23 YLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR- 80
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
V +I E G + + +K D + + ++ + L Y HS +IHRD+K +N+
Sbjct: 81 -VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 137
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 194
+ GE+KI D G ++ ++ GT +++ PE + ++E VD++S G+ E
Sbjct: 138 LLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 196
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLL 253
+ + P+ E + +K+++ + + I + L S+R +++L
Sbjct: 197 FLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
Query: 254 KDPFLQ 259
+ P++
Sbjct: 254 EHPWIT 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (444), Expect = 2e-50
Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 14/272 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y A D VA ++ Q Q + EV L+ L+ N +++ ++ +
Sbjct: 32 YFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT- 89
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
++ E K + I L GL YLHSHN +IHRD+K NI
Sbjct: 90 -AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNI 146
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMC 191
++ G VK+GD G A M A S +GTP +MAPE+ E +Y+ VD++S G+
Sbjct: 147 LLSEP-GLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK 250
+E+ + P N + PA + + F++ CL +R +++
Sbjct: 204 CIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 251 DLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
LLK F+ E I D ++ +++ L
Sbjct: 263 VLLKHRFVLRERPPTVIMDLIQRTKDAVRELD 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-49
Identities = 69/251 (27%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y A D G EVA ++ + + + +E+ +++ K+ N+V + S++ +
Sbjct: 37 YTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE- 91
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ ++ E G+L + D I R+ L L +LHS+ +IHRD+K DNI
Sbjct: 92 -LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 136 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 192
+ + G VK+ D G I +Q +++GTP +MAPE + + Y VDI+S G+
Sbjct: 148 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 251
+EM+ E PY ++ T+G + + F+ +CL +R SAK+
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266
Query: 252 LLKDPFLQVEN 262
LL+ FL++
Sbjct: 267 LLQHQFLKIAK 277
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 64/293 (21%), Positives = 121/293 (41%), Gaps = 50/293 (17%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+K + +G+ +A K+ + P ++ E+ +L +V FY ++ D +
Sbjct: 23 FKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 78
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+++ E G+L Q KK + +++ + ++ GL YL + I+HRD+K NI
Sbjct: 79 -ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNI 136
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 194
VN GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++E
Sbjct: 137 LVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 195 MVTFEYPYS-----------------------------------------ECKNPAQIFK 213
M YP ++
Sbjct: 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLD 255
Query: 214 KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 265
+ + P + V + + F+ KCL+ +ER K L+ F++ + +E
Sbjct: 256 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 308
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 24/274 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA ++ + A + +L+ E+ +L S N+VK ++ +
Sbjct: 29 YKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN- 83
Query: 76 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ ++ E G + + + + I+ +Q L L YLH + IIHRDLK N
Sbjct: 84 -LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGN 140
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIY 186
I + G++K+ D G++ + R S IGTP +MAPE+ + Y+ D++
Sbjct: 141 ILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199
Query: 187 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASE 245
S G+ ++EM E P+ E + K S + K F++KCL
Sbjct: 200 SLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259
Query: 246 RLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 279
R + LL+ PF+ V++ K P++ I K
Sbjct: 260 RWTTSQLLQHPFVTVDSNK-----PIRELIAEAK 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 7e-48
Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 15/251 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
A + VA VKI D+ + + + E+ + K L +NVVKFY +
Sbjct: 22 QLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI- 77
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ E + G L + + + + Q++ G+VYLH I HRD+K +N+
Sbjct: 78 -QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 134
Query: 136 FVNGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFG 189
++ +KI D GLA ++ + GT ++APEL + + E VD++S G
Sbjct: 135 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
+ + M+ E P+ + + Q + + K D + K LV S R++
Sbjct: 194 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 253
Query: 249 AKDLLKDPFLQ 259
D+ KD +
Sbjct: 254 IPDIKKDRWYN 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 159 bits (402), Expect = 5e-44
Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 19/274 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ + G A V D + + E+ + L+ +V + ++ DD +
Sbjct: 43 HRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE- 97
Query: 76 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ MI E + G L + +H + + RQ+ GL ++H +N +H DLK +N
Sbjct: 98 -MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPEN 154
Query: 135 IFVNGNH-GEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 191
I E+K+ D GL + + + + GT EF APE+ E + D++S G+
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERLS 248
+++ P+ +N + + V S + + K FI K L+ + R++
Sbjct: 215 SYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273
Query: 249 AKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 282
L+ P+L N ++P +R
Sbjct: 274 IHQALEHPWLTPGNAP---GRDSQIPSSRYTKIR 304
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-44
Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 21/242 (8%)
Query: 26 EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 85
+VA + + P LQ +EV +L+ + N++ F + + ++T+
Sbjct: 32 DVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ---LAIVTQWCE 86
Query: 86 SGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 144
+L + ++ + + ARQ G+ YLH+ + IIHRDLK +NIF++ + V
Sbjct: 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTV 143
Query: 145 KIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMV 196
KIGD GLA + + + G+ +MAPE+ + Y+ D+Y+FG+ + E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 197 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVND---PQIKGFIEKCLVP-ASERLSAKDL 252
T + PYS N QI V G L+KV +K + +CL ER +
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 253 LK 254
L
Sbjct: 264 LA 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 158 bits (401), Expect = 6e-44
Identities = 54/277 (19%), Positives = 113/277 (40%), Gaps = 18/277 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ ++ G + P D + +E+ ++ L ++ + ++ D +
Sbjct: 46 HRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE- 100
Query: 76 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ +I E + G L + + + N+ RQ GL ++H H+ I+H D+K +N
Sbjct: 101 -MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPEN 157
Query: 135 IFVNGNH-GEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 191
I VKI D GLA + + T EF APE+ + E D+++ G+
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASERLSA 249
+++ P++ + + + A + P+ K FI+ L +RL+
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
Query: 250 KDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMS 286
D L+ P+L+ ++ ++P +R +
Sbjct: 278 HDALEHPWLKGDHSNL----TSRIPSSRYNKIRQKIK 310
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 4e-43
Identities = 54/257 (21%), Positives = 107/257 (41%), Gaps = 15/257 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
A D+ VA +K L G + +E+ +L +K N+V +
Sbjct: 26 ILAEDKRTQKLVA---IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH- 81
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ +I +L + G L + + Q+L + YLH I+HRDLK +N+
Sbjct: 82 -LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENL 138
Query: 136 FVN--GNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAP-ELYEEEYNELVDIYSFGMC 191
++ I D GL+ + + GTP ++AP L ++ Y++ VD +S G+
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERLS 248
++ P+ + +N A++F+++ +D K FI + +R +
Sbjct: 199 AYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT 257
Query: 249 AKDLLKDPFLQVENQKE 265
+ L+ P++ + +
Sbjct: 258 CEQALQHPWIAGDTALD 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-43
Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 27/269 (10%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
A + E A ++ +++ + + E ++ L VK Y ++ DD+K
Sbjct: 25 VLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK- 82
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ +G L +Y +K + D + + +I+ L YLH IIHRDLK +NI
Sbjct: 83 -LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENI 139
Query: 136 FVNGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 190
+N + ++I D G A + +Q A S +GT ++++PE L E+ + D+++ G
Sbjct: 140 LLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 198
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 249
I ++V P+ N IF+K+ + P+ + +EK LV A++RL
Sbjct: 199 IIYQLVAGLPPF-RAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGC 255
Query: 250 K------DLLKDPFLQ------VENQKEP 266
+ L PF + + Q P
Sbjct: 256 EEMEGYGPLKAHPFFESVTWENLHQQTPP 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 1e-42
Identities = 54/261 (20%), Positives = 111/261 (42%), Gaps = 23/261 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVL-----QLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSW 69
+ + E A + + ++ + EV +L+ + N+++ ++
Sbjct: 20 RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79
Query: 70 VDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
+ ++ +L G L Y + + K + R +L + LH N I+HRD
Sbjct: 80 ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRD 135
Query: 130 LKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEE-------YNE 181
LK +NI ++ + +K+ D G + + R V GTP ++APE+ E Y +
Sbjct: 136 LKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 182 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKC 239
VD++S G+ + ++ P+ + + + + SG + +D +K + +
Sbjct: 195 EVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 253
Query: 240 LVP-ASERLSAKDLLKDPFLQ 259
LV +R +A++ L PF Q
Sbjct: 254 LVVQPQKRYTAEEALAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 6e-42
Identities = 52/284 (18%), Positives = 122/284 (42%), Gaps = 19/284 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ + + VK+ D + E+ +L + N++ ++S+ ++
Sbjct: 22 HRCVETSSKKTYMAKFVKVKGT-----DQVLVKKEISILNIARHRNILHLHESFESMEE- 75
Query: 76 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ MI E + ++ + ++ + I ++ Q+ L +LHSHN I H D++ +N
Sbjct: 76 -LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPEN 132
Query: 135 IFV-NGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMC 191
I +KI + G A ++ R + PE+ APE+++ + + D++S G
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
+ +++ P+ + QI + + + K + F+++ LV R++
Sbjct: 193 VYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 249 AKDLLKDPFLQ--VENQKEPICDPLKLPIQSLKMLRLPMSGPSS 290
A + L+ P+L+ +E + LK +++ ++ S
Sbjct: 252 ASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVS 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 3e-40
Identities = 51/243 (20%), Positives = 102/243 (41%), Gaps = 18/243 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ G +VA VK ++ Q +E ++ L+ N+V+ V++K
Sbjct: 24 MLG--DYRGNKVA---VK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75
Query: 76 TVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ ++TE G+L Y + + + ++ + + YL +N +HRDL
Sbjct: 76 -LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAAR 132
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 192
N+ V+ + K+ D GL T + ++ APE L E++++ D++SFG+ +
Sbjct: 133 NVLVSED-NVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 251
E+ +F + +V G K + P + ++ C A+ R S
Sbjct: 191 WEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQ 249
Query: 252 LLK 254
L +
Sbjct: 250 LRE 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-40
Identities = 62/269 (23%), Positives = 122/269 (45%), Gaps = 15/269 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVL--QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
K ++ G++ A +K + + + EV +LK ++ NV+ ++ + +
Sbjct: 27 KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
V +I EL G L + + +++ + + +QIL+G+ YLHS I H DLK +
Sbjct: 87 D--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPE 142
Query: 134 NIFV---NGNHGEVKIGDLGLAIAMQQPTARS-VIGTPEFMAPELYE-EEYNELVDIYSF 188
NI + N +KI D GLA + + GTPEF+APE+ E D++S
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202
Query: 189 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASE 245
G+ +++ P+ + V++ ++ K FI + LV +
Sbjct: 203 GVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 261
Query: 246 RLSAKDLLKDPFLQVENQKEPICDPLKLP 274
R++ +D L+ P+++ ++ ++ + P
Sbjct: 262 RMTIQDSLQHPWIKPKDTQQALSSAWSHP 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 7e-40
Identities = 45/251 (17%), Positives = 101/251 (40%), Gaps = 19/251 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDD--NVVKFYKSWVD 71
Y + VA V+ D + + ++ EV LLK + V++ W +
Sbjct: 21 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL-DWFE 79
Query: 72 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
V ++ +L + + + ++ +++ Q+L + + H+ ++HRD+K
Sbjct: 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIK 137
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFG 189
+NI ++ N GE+K+ D G ++ GT + PE + ++S G
Sbjct: 138 DENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 197
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
+ + +MV + P+ + + + + + I CL S+R +
Sbjct: 198 ILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSECQHLIRWCLALRPSDRPT 248
Query: 249 AKDLLKDPFLQ 259
+++ P++Q
Sbjct: 249 FEEIQNHPWMQ 259
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (358), Expect = 1e-38
Identities = 52/257 (20%), Positives = 97/257 (37%), Gaps = 14/257 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK- 74
+ A D +VA ++ D + + P + E +L +V Y + +
Sbjct: 24 HLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82
Query: 75 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
++ E LR + K L + H + IIHRD+K
Sbjct: 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPA 140
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYS 187
NI ++ + VK+ D G+A A+ +VIGT ++++PE + + D+YS
Sbjct: 141 NIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199
Query: 188 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASE 245
G + E++T E P++ + ++ V P S + + K L
Sbjct: 200 LGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 259
Query: 246 RLSAKDLLKDPFLQVEN 262
R ++ ++V N
Sbjct: 260 RYQTAAEMRADLVRVHN 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 52/256 (20%), Positives = 100/256 (39%), Gaps = 23/256 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ + +VA +K + +E +L+K L+ +V+ Y +
Sbjct: 30 WMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-- 81
Query: 76 TVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ +ITE +G+L + K + I + + A QI G+ ++ N IHRDL+
Sbjct: 82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAA 138
Query: 134 NIFVNGNHGEVKIGDLGLAIAM---QQPTARSVIGTPEFMAP-ELYEEEYNELVDIYSFG 189
NI V+ + KI D GLA + + ++ AP + + D++SFG
Sbjct: 139 NILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
+ + E+VT ++ + + G + ++ + C +R +
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDRPT 256
Query: 249 AKDL---LKDPFLQVE 261
L L+D F E
Sbjct: 257 FDYLRSVLEDFFTATE 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 47/262 (17%), Positives = 103/262 (39%), Gaps = 21/262 (8%)
Query: 16 YKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
K + + VA +K + P +L +E ++++ L + +V+ +
Sbjct: 24 KKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES 81
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
++ E+ G L +Y +++++V K I Q+ G+ YL N +HRDL
Sbjct: 82 ---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR 136
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYS 187
N+ + KI D GL+ A++ ++ APE + +++ D++S
Sbjct: 137 NVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195
Query: 188 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 246
FG+ + E ++ +++ + G + A ++ + C R
Sbjct: 196 FGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVENR 254
Query: 247 LSAKDL---LKDPFLQVENQKE 265
+ L++ + V N+
Sbjct: 255 PGFAAVELRLRNYYYDVVNEGH 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (355), Expect = 6e-38
Identities = 57/251 (22%), Positives = 118/251 (47%), Gaps = 17/251 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ G A +K + V++ ++ E +L + +++ + ++ D ++
Sbjct: 21 HLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ- 78
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ MI + G L +K + V K +A ++ L YLHS + II+RDLK +NI
Sbjct: 79 -IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENI 135
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 194
++ N G +KI D G A + T ++ GTP+++APE + + YN+ +D +SFG+ I E
Sbjct: 136 LLDKN-GHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV------PASERLS 248
M+ P+ + N + ++K+ + + +K + + + + +
Sbjct: 194 MLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 250
Query: 249 AKDLLKDPFLQ 259
+D+ P+ +
Sbjct: 251 TEDVKNHPWFK 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 2e-37
Identities = 44/259 (16%), Positives = 88/259 (33%), Gaps = 18/259 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ G + +K + SE ++ NV+
Sbjct: 43 CSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP- 101
Query: 76 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
V +ITE +G+L + R+ + + R I G+ YL N +HRDL N
Sbjct: 102 -VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARN 158
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARSV-------IGTPEFMAPELYE-EEYNELVDIY 186
I VN N K+ D GL+ ++ T+ + APE + ++ D++
Sbjct: 159 ILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVW 217
Query: 187 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASE 245
S+G+ + E++++ + + + + + C +
Sbjct: 218 SYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNH 276
Query: 246 RLSAKDLLK--DPFLQVEN 262
R ++ D ++ N
Sbjct: 277 RPKFGQIVNTLDKMIRNPN 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 53/261 (20%), Positives = 104/261 (39%), Gaps = 23/261 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ VA +K + + E ++K L+ + +V+ Y ++
Sbjct: 34 WMGTWN-GTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-- 85
Query: 76 TVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ ++TE + G+L + + K + + + + A QI G+ Y+ N +HRDL+
Sbjct: 86 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA 142
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPE-LYEEEYNELVDIYSFG 189
NI V N K+ D GLA ++ + ++ APE + D++SFG
Sbjct: 143 NILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 201
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
+ + E+ T ++ +V G + + + + +C ER +
Sbjct: 202 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDLMCQCWRKEPEERPT 260
Query: 249 AKDL---LKDPFLQVENQKEP 266
+ L L+D F E Q +P
Sbjct: 261 FEYLQAFLEDYFTSTEPQYQP 281
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-37
Identities = 61/293 (20%), Positives = 107/293 (36%), Gaps = 39/293 (13%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YKA D+ VA ++K+ + G + E+ LL+ L N++ ++
Sbjct: 15 YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 74
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
++++ + + + + IK + L GL YLH H I+HRDLK +N
Sbjct: 75 --ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNN 130
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELY--EEEYNELVDIYSFGM 190
+ ++ N G +K+ D GLA + P + T + APEL Y VD+++ G
Sbjct: 131 LLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189
Query: 191 CILEMVTFEYPYS-------------------------ECKNPAQIFKKVTSGIKPASLA 225
+ E++ C P + K GI +
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249
Query: 226 KVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 277
+ I+ + R++A LK + P C LP +
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ---LPRPN 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 5e-37
Identities = 38/245 (15%), Positives = 93/245 (37%), Gaps = 18/245 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ + +VA ++ + + + E ++ L +V+ Y ++
Sbjct: 22 HLGYWL-NKDKVAIKTIREGAMSE-----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP- 74
Query: 76 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ ++ E G L Y R + + + + G+ YL +IHRDL N
Sbjct: 75 -ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARN 131
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYSFGM 190
V + +K+ D G+ + ++ +PE Y+ D++SFG+
Sbjct: 132 CLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 190
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 249
+ E+ + E ++ +++ + +++G + ++ + + C +R +
Sbjct: 191 LMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWKERPEDRPAF 249
Query: 250 KDLLK 254
LL+
Sbjct: 250 SRLLR 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 9e-37
Identities = 51/269 (18%), Positives = 117/269 (43%), Gaps = 18/269 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ G A ++ + ++ ++ +E +L++ + + ++ +
Sbjct: 22 ILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR- 79
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ + E G L + + + + + + +I+ L YLHS + +++RD+K +N+
Sbjct: 80 -LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENL 136
Query: 136 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 192
++ G +KI D GL T ++ GTPE++APE+ E +Y VD + G+ +
Sbjct: 137 MLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS--- 248
EM+ P+ ++ ++F+ + + P+ K + L +RL
Sbjct: 196 YEMMCGRLPF-YNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 249 --AKDLLKDPFLQVENQKEPICDPLKLPI 275
AK++++ F N ++ + L P
Sbjct: 253 SDAKEVMEHRFFLSINWQDVVQKKLLPPF 281
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 40/264 (15%), Positives = 103/264 (39%), Gaps = 23/264 (8%)
Query: 16 YKAFDEFA--GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
+ I+VA +K+ D +++ E ++ L + +V+ +
Sbjct: 26 RQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA 82
Query: 74 KKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ ++ E+ G L ++ K + + + + Q+ G+ YL N +HRDL
Sbjct: 83 ---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAA 137
Query: 133 DNIFVNGNHGEVKIGDLGLAIAM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIY 186
N+ + KI D GL+ A+ + ++ APE + +++ D++
Sbjct: 138 RNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196
Query: 187 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASE 245
S+G+ + E +++ + ++ + G + + P++ + C + +
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMSDCWIYKWED 255
Query: 246 RLSAKDL---LKDPFLQVENQKEP 266
R + ++ + + ++ E
Sbjct: 256 RPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-36
Identities = 52/249 (20%), Positives = 99/249 (39%), Gaps = 19/249 (7%)
Query: 16 YKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
++ E + VA +K +K E ++ ++VK ++
Sbjct: 24 HQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 80
Query: 73 KKKTVNMITELFTSGNLRQYR-KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
V +I EL T G LR + + ++D+ + +A Q+ L YL S +HRD+
Sbjct: 81 P---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIA 135
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYS 187
N+ V+ + VK+GD GL+ M+ T ++MAPE + + D++
Sbjct: 136 ARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194
Query: 188 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 246
FG+C+ E++ + + ++ +G + P + + KC S R
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLMTKCWAYDPSRR 253
Query: 247 LSAKDLLKD 255
+L
Sbjct: 254 PRFTELKAQ 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 58/249 (23%), Positives = 111/249 (44%), Gaps = 13/249 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ A + A +K D VL + + L + + + + ++ +
Sbjct: 19 FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
M E G+L + + D+ +A +I+ GL +LHS I++RDLK DNI
Sbjct: 79 FFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNI 134
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 192
++ G +KI D G+ A+ + GTP+++APE L ++YN VD +SFG+ +
Sbjct: 135 LLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 193
Query: 193 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK- 250
EM+ + P+ ++ ++F + + + + K + K V +RL +
Sbjct: 194 YEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
Query: 251 DLLKDPFLQ 259
D+ + P +
Sbjct: 251 DIRQHPLFR 259
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 4e-36
Identities = 53/314 (16%), Positives = 125/314 (39%), Gaps = 31/314 (9%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVD--D 72
+ F++ + A ++ D K EV ++ + ++V+ + +
Sbjct: 29 LQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRIVDVYENLYA 79
Query: 73 KKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130
+K + ++ E G L + + + + I + YLHS N I HRD+
Sbjct: 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV 137
Query: 131 KCDNIFVN--GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYNELVDIY 186
K +N+ + +K+ D G A + + TP ++APE+ E+Y++ D++
Sbjct: 138 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 197
Query: 187 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------PASLAKVNDPQIKGFIEKCL 240
S G+ + ++ P+ + I + + I+ P ++K I L
Sbjct: 198 SLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 256
Query: 241 VP-ASERLSAKDLLKDPFLQ--VENQKEPICDPLKLPIQSLKMLRLPMSGPSSM-DIDSD 296
++R++ + + P++ + + P+ L + + S++ + D
Sbjct: 257 KTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVD 316
Query: 297 YKQLSLSTCTESNN 310
Y+Q+ + +++N
Sbjct: 317 YEQIKIKKIEDASN 330
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-35
Identities = 47/246 (19%), Positives = 96/246 (39%), Gaps = 18/246 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+VA +K + + + E ++ +L + +V+ Y +
Sbjct: 21 KYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP- 73
Query: 76 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ +ITE +G L Y R+ + + + + + YL S +HRDL N
Sbjct: 74 -IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARN 130
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTARS---VIGTPEFMAPELYE-EEYNELVDIYSFGM 190
VN + G VK+ D GL+ + S + PE+ +++ DI++FG+
Sbjct: 131 CLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 249
+ E+ + E ++ + + G++ + ++ + C A ER +
Sbjct: 190 LMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSCWHEKADERPTF 248
Query: 250 KDLLKD 255
K LL +
Sbjct: 249 KILLSN 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 15/248 (6%)
Query: 16 YKAFDEFAGIEVAWSR-VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
YK G +V +K P +++ E +++ S+ + +V + +
Sbjct: 26 YKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 83
Query: 75 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
TV +IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRDL
Sbjct: 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAAR 140
Query: 134 NIFVNGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 188
N+ V VKI D GLA + ++ A ++MA E + Y D++S+
Sbjct: 141 NVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 199
Query: 189 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL 247
G+ + E++TF + ++I + G + + + KC + A R
Sbjct: 200 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRP 258
Query: 248 SAKDLLKD 255
++L+ +
Sbjct: 259 KFRELIIE 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 3e-35
Identities = 53/246 (21%), Positives = 100/246 (40%), Gaps = 18/246 (7%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y+ + + VA +K D ++++ E ++K +K N+V+ +
Sbjct: 34 YEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88
Query: 76 TVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ E T GNL Y + V V+ A QI + YL N IHRDL
Sbjct: 89 YIIT--EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAAR 144
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT---PEFMAP-ELYEEEYNELVDIYSFG 189
N V N VK+ D GL+ M T + G ++ AP L +++ D+++FG
Sbjct: 145 NCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 190 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 248
+ + E+ T+ + +Q+++ + + ++ + C S+R S
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC-PEKVYELMRACWQWNPSDRPS 262
Query: 249 AKDLLK 254
++ +
Sbjct: 263 FAEIHQ 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (337), Expect = 5e-35
Identities = 54/254 (21%), Positives = 110/254 (43%), Gaps = 15/254 (5%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL--YSEVHLLKSLKDDNVVKFYKSWVDDK 73
Y G A + + G+ L + L+ + +V ++
Sbjct: 21 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
K ++ I +L G+L + +H ++ +A +I+ GL ++H+ +++RDLK
Sbjct: 81 K--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA 136
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMC 191
NI ++ HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G
Sbjct: 137 NILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS-- 248
+ +++ P+ + K + + L P+++ +E L + RL
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL 255
Query: 249 ---AKDLLKDPFLQ 259
A+++ + PF +
Sbjct: 256 GRGAQEVKESPFFR 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 6e-35
Identities = 56/275 (20%), Positives = 102/275 (37%), Gaps = 45/275 (16%)
Query: 16 YKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSW 69
A I+VA VK+ + + L SE+ ++ L +N+V +
Sbjct: 54 MNATAYGISKTGVSIQVA---VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110
Query: 70 VDDKKKTVNMITELFTSGNLRQYRKKHKN-----------------------VDIKVIKN 106
+ +I E G+L Y + + + + +
Sbjct: 111 TLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 168
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARS 162
+A Q+ G+ +L + +HRDL N+ V VKI D GLA + +
Sbjct: 169 FAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGN 225
Query: 163 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK 220
++MAPE L+E Y D++S+G+ + E+ + PY A +K + +G K
Sbjct: 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK 285
Query: 221 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 254
+I ++ C + +R S +L
Sbjct: 286 MDQPFYA-TEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 9e-35
Identities = 59/239 (24%), Positives = 97/239 (40%), Gaps = 15/239 (6%)
Query: 24 GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83
+ VA +K D + Q P + EV+ + SL N+++ Y + + M+TEL
Sbjct: 36 TVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTEL 91
Query: 84 FTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 142
G+L +KH+ + + +A Q+ G+ YL S IHRDL N+ +
Sbjct: 92 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-D 148
Query: 143 EVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 196
VKIGD GL A+ Q + APE L ++ D + FG+ + EM
Sbjct: 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208
Query: 197 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 254
T+ N +QI K+ + + I + +C +R + L
Sbjct: 209 TYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 53/251 (21%), Positives = 99/251 (39%), Gaps = 20/251 (7%)
Query: 16 YKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 72
Y + I A VK + + G++ + +E ++K NV+ +
Sbjct: 44 YHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100
Query: 73 KKKTVNMITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131
+ + ++ G+LR + + + N +K + + Q+ G+ + +HRDL
Sbjct: 101 EGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLA 157
Query: 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARS------VIGTPEFMAPE-LYEEEYNELVD 184
N ++ VK+ D GLA M S ++MA E L +++ D
Sbjct: 158 ARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 216
Query: 185 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-A 243
++SFG+ + E++T P N I + G + DP + + KC P A
Sbjct: 217 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP-LYEVMLKCWHPKA 275
Query: 244 SERLSAKDLLK 254
R S +L+
Sbjct: 276 EMRPSFSELVS 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 49/265 (18%), Positives = 97/265 (36%), Gaps = 19/265 (7%)
Query: 15 TYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
K + VA +K E ++ N+++ K
Sbjct: 27 MLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83
Query: 75 KTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
+ +ITE +G L ++ R+K + + R I G + N +HRDL
Sbjct: 84 --MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG--MKYLANMNYVHRDLAAR 139
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYS 187
NI VN N K+ D GL+ ++ T + APE + ++ D++S
Sbjct: 140 NILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 198
Query: 188 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 246
FG+ + E++T+ + ++ K + G + + I + +C + R
Sbjct: 199 FGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-PSAIYQLMMQCWQQERARR 257
Query: 247 LSAKDLLK--DPFLQVENQKEPICD 269
D++ D ++ + + + D
Sbjct: 258 PKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 53/301 (17%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK-- 73
+KA G +VA +V +++ + G E+ +L+ LK +NVV +
Sbjct: 27 FKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84
Query: 74 ----KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 129
K ++ ++ + + IK + +L+GL Y+H + I+HRD
Sbjct: 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRD 142
Query: 130 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA------RSVIGTPEFMAPE--LYEEEYNE 181
+K N+ + + G +K+ D GLA A + + T + PE L E +Y
Sbjct: 143 MKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 201
Query: 182 LVDIYSFGMCILEMVTFEYPYS-----------------------------ECKNPAQIF 212
+D++ G + EM T E ++
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261
Query: 213 KKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPL 271
K +K A V DP I+K LV ++R+ + D L F +P+ L
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF----WSDPMPSDL 317
Query: 272 K 272
K
Sbjct: 318 K 318
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 7e-34
Identities = 51/259 (19%), Positives = 98/259 (37%), Gaps = 27/259 (10%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
KA + G+ + + +K D + E+ +L L N++ +
Sbjct: 27 LKARIKKDGLRMDAA-IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85
Query: 75 KTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYL 118
+ + E GNL + +K + + + ++A + G+ YL
Sbjct: 86 --LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143
Query: 119 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI-GTPEFMAPE-LYE 176
IHRDL NI V N+ KI D GL+ + +++ +MA E L
Sbjct: 144 SQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY 200
Query: 177 EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236
Y D++S+G+ + E+V+ A++++K+ G + D ++ +
Sbjct: 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC-DDEVYDLM 259
Query: 237 EKCLVP-ASERLSAKDLLK 254
+C ER S +L
Sbjct: 260 RQCWREKPYERPSFAQILV 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 41/286 (14%)
Query: 16 YKAFD-EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD---DNVVKFYKSWVD 71
+KA D + G VA RV++ + G EV +L+ L+ NVV+ +
Sbjct: 24 FKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81
Query: 72 ---DKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 127
D++ + ++ E + V + IK+ Q+L GL +LHSH ++H
Sbjct: 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVH 139
Query: 128 RDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 185
RDLK NI V + G++K+ D GLA I Q SV+ T + APE L + Y VD+
Sbjct: 140 RDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDL 198
Query: 186 YSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---------------------- 223
+S G EM + + + Q+ K + P
Sbjct: 199 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPI 258
Query: 224 --LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ-VENQKE 265
D K + KCL ++R+SA L P+ Q +E KE
Sbjct: 259 EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 66/315 (20%), Positives = 116/315 (36%), Gaps = 57/315 (18%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--- 72
A+D + VA +K + Q+ E+ +L + +N++
Sbjct: 25 CSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81
Query: 73 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
+ K V ++T L + + + +H + I + QIL GL Y+HS N ++HRDLK
Sbjct: 82 QMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKP 137
Query: 133 DNIFVNGNHGEVKIGDLGLAIAM-----QQPTARSVIGTPEFMAPELYEEE--YNELVDI 185
N+ +N ++KI D GLA + T + APE+ Y + +DI
Sbjct: 138 SNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 196
Query: 186 YSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------------------ 221
+S G + EM++ + Q+ + P
Sbjct: 197 WSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 256
Query: 222 ----ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPL--- 271
L D + ++K L +R+ + L P+L+ + EPI +
Sbjct: 257 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKF 316
Query: 272 -----KLPIQSLKML 281
LP + LK L
Sbjct: 317 DMELDDLPKEKLKEL 331
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 51/281 (18%), Positives = 102/281 (36%), Gaps = 47/281 (16%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 71
Y+A +G VA +V D + E+ +++ L N+V+ FY S
Sbjct: 37 YQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEK 88
Query: 72 DKKKTVNMITELFTSGN---LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 128
+ +N++ + R Y + + + + +K + Q+ L Y+HS I HR
Sbjct: 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHR 146
Query: 129 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELY--EEEYNELVDI 185
D+K N+ ++ + +K+ D G A + + S I + + APEL +Y +D+
Sbjct: 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 186 YSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---------------------- 223
+S G + E++ + + Q+ + + P
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 224 ----LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
P+ + L + RL+ + F
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 39/283 (13%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA ++ G VA ++++D + G E+ LLK L N+VK + K
Sbjct: 19 YKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK- 75
Query: 76 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ ++ E + + + +IK++ Q+L GL + HSH ++HRDLK N
Sbjct: 76 -LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQN 132
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFGM 190
+ +N G +K+ D GLA A P + T + APE+ + Y+ VDI+S G
Sbjct: 133 LLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN---------------------- 228
EMVT + Q+F+ + P +
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251
Query: 229 ----DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 266
D + + + L ++R+SAK L PF Q + P
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 2e-33
Identities = 55/251 (21%), Positives = 110/251 (43%), Gaps = 17/251 (6%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+ +G A + V++ ++ +E +L+++ +VK S+ D+
Sbjct: 58 MLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN- 115
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ M+ E G + + ++ + +A QI+ YLHS + +I+RDLK +N+
Sbjct: 116 -LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENL 172
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 194
++ G +++ D G A ++ T ++ GTPE +APE + + YN+ VD ++ G+ I E
Sbjct: 173 LIDQQ-GYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 195 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV------PASERLS 248
M P+ P QI++K+ SG +K + L + +
Sbjct: 231 MAAGYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287
Query: 249 AKDLLKDPFLQ 259
D+ +
Sbjct: 288 VNDIKNHKWFA 298
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (319), Expect = 2e-33
Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 39/275 (14%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
YKA + + G A +++++ + G E+ +LK LK N+VK Y K+
Sbjct: 19 YKAQNNY-GETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR- 74
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
+ ++ E + ++ K++ Q+L+G+ Y H ++HRDLK N+
Sbjct: 75 -LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNL 131
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE--YNELVDIYSFGMC 191
+N GE+KI D GLA A P + I T + AP++ Y+ +DI+S G
Sbjct: 132 LINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 192 ILEMVTFEYPYSECKNPAQIFK--------------------------KVTSGIKPASLA 225
EMV + Q+ + V + S
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 226 KVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
K D + K L ++R++AK L+ + +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (315), Expect = 9e-33
Identities = 45/265 (16%), Positives = 96/265 (36%), Gaps = 30/265 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
Y D AG EVA +K+ + +L+ E + K ++ + + W +
Sbjct: 24 YLGTDIAAGEEVA---IKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIR-WCGAEGD 76
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
M+ EL + + +K + A Q++ + Y+HS N IHRD+K DN
Sbjct: 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNF 134
Query: 136 FV--NGNHGEVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYE-EEYNELV 183
+ V I D GLA + +++ GT + + + E +
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194
Query: 184 DIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSGIKPASLAKVND---PQIKGFIEK 238
D+ S G ++ + + Q +++++ + + + ++
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 254
Query: 239 CLVP-ASERLSA---KDLLKDPFLQ 259
C ++ + L ++ F +
Sbjct: 255 CRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-32
Identities = 60/276 (21%), Positives = 116/276 (42%), Gaps = 39/276 (14%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
+KA + VA RV++DD G E+ LLK LK N+V+ + DKK
Sbjct: 19 FKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
++ E + + + ++D +++K++ Q+L GL + HS N ++HRDLK N+
Sbjct: 77 --TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNL 132
Query: 136 FVNGNHGEVKIGDLGLAIAMQQPTARS--VIGTPEFMAPELY--EEEYNELVDIYSFGMC 191
+N +GE+K+ + GLA A P + T + P++ + Y+ +D++S G
Sbjct: 133 LIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGI---------------------------KPASL 224
E+ P + K++ + ++
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 225 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
+ + ++ L +R+SA++ L+ P+
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 9e-32
Identities = 49/284 (17%), Positives = 109/284 (38%), Gaps = 52/284 (18%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
++A + +V +K P +K+ E+ +L++L+ N++ D
Sbjct: 52 FEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVS 104
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+T ++ E + + +Q ++ + I+ + +IL L Y HS I+HRD+K N
Sbjct: 105 RTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHN 159
Query: 135 IFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMC 191
+ ++ H ++++ D GLA + + F PEL + Y+ +D++S G
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 219
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVT----------------------------------- 216
+ M+ + P+ + ++
Sbjct: 220 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 279
Query: 217 SGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 259
+ + P+ F++K L RL+A++ ++ P+
Sbjct: 280 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-31
Identities = 52/264 (19%), Positives = 104/264 (39%), Gaps = 33/264 (12%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
Y A + VA VK+ + + L SE+ +L L + N+V +
Sbjct: 45 YGLIKSDAAMTVA---VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101
Query: 75 KTVNMITELFTSGNLRQYRKKHKN------------------VDIKVIKNWARQILHGLV 116
+ITE G+L + ++ ++ +D++ + +++ Q+ G+
Sbjct: 102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159
Query: 117 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV----IGTPEFMAP 172
+L S N IHRDL NI + KI D GLA ++ + V ++MAP
Sbjct: 160 FLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 173 E-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 231
E ++ Y D++S+G+ + E+ + F K+ + +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE 276
Query: 232 IKGFIEKCLVP-ASERLSAKDLLK 254
+ ++ C +R + K +++
Sbjct: 277 MYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 57/277 (20%), Positives = 121/277 (43%), Gaps = 23/277 (8%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 74
K G A +K ++Q + +E +L+ ++ +V + ++ + K
Sbjct: 44 RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103
Query: 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 134
+ + + G L + + + ++ + +I+ L +LH II+RD+K +N
Sbjct: 104 LHLIL--DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLEN 159
Query: 135 IFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSF 188
I ++ N G V + D GL+ +A + A GT E+MAP++ + +++ VD +S
Sbjct: 160 ILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
Query: 189 GMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-AS 244
G+ + E++T P+ E + A+I +++ P + K I++ L+
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPK 276
Query: 245 ERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQ 276
+RL A ++ + F Q N + + P +
Sbjct: 277 KRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFK 313
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (305), Expect = 3e-31
Identities = 46/274 (16%), Positives = 87/274 (31%), Gaps = 44/274 (16%)
Query: 16 YKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV 70
++A VA VK+ E L+ + N+VK
Sbjct: 30 FQARAPGLLPYEPFTMVA---VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86
Query: 71 DDKKKTVNMITELFTSGNLRQYRKKHKN------------------------VDIKVIKN 106
K + ++ E G+L ++ + +
Sbjct: 87 VGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 144
Query: 107 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR----S 162
ARQ+ G+ YL +HRDL N V N VKI D GL+ + +
Sbjct: 145 IARQVAAGMAYLSERK--FVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGN 201
Query: 163 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 221
+M PE ++ Y D++++G+ + E+ ++ ++ V G
Sbjct: 202 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL 261
Query: 222 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 254
A ++ + C ++R S + +
Sbjct: 262 ACPENC-PLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 59/280 (21%), Positives = 105/280 (37%), Gaps = 50/280 (17%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ G EVA VKI + ++ +E++ L+ +N++ F + D
Sbjct: 20 WRGKWR--GEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGT 72
Query: 76 TVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIH 127
+ +++ G+L Y ++ V ++ + A GL +LH P I H
Sbjct: 73 WTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131
Query: 128 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEE---- 177
RDLK NI V N G I DLGLA+ T +GT +MAPE+ ++
Sbjct: 132 RDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 178 ---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG------IKPASLAKVN 228
E + DIY+ G+ E+ ++ + + ++ +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 229 DPQIKG-------------FIEKCLVP-ASERLSAKDLLK 254
P I + +C + RL+A + K
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-31
Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 24 GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITE 82
+VA VK+ DL L SE+ ++K + N++ + D + +I E
Sbjct: 45 VTKVA---VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVE 99
Query: 83 LFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPII 126
+ GNLR+Y + + + K + + A Q+ G+ YL S I
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CI 157
Query: 127 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPE-LYEEEYNE 181
HRDL N+ V + +KI D GLA + + ++MAPE L++ Y
Sbjct: 158 HRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 216
Query: 182 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 241
D++SFG+ + E+ T ++FK + G + + ++ + C
Sbjct: 217 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC-TNELYMMMRDCWH 275
Query: 242 P-ASERLSAKDLLKD 255
S+R + K L++D
Sbjct: 276 AVPSQRPTFKQLVED 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 6e-31
Identities = 69/291 (23%), Positives = 113/291 (38%), Gaps = 41/291 (14%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
A D G +VA ++ Q ++ Y E+ LLK ++ +NV+ + D+
Sbjct: 35 CSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92
Query: 76 TVNMITELFTS--GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 133
L G KH+ + I+ Q+L GL Y+H+ HRDLK
Sbjct: 93 DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPG 150
Query: 134 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMC 191
N+ VN + E+KI D GLA + T + APE+ Y + VDI+S G
Sbjct: 151 NLAVNED-CELKILDFGLARQADSEM-TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208
Query: 192 ILEMVTFEYPYSECKNPAQIFKKVTSGIKP----------------------------AS 223
+ EM+T + + + Q+ + + P AS
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 224 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPL 271
+ P +EK LV A +R++A + L P+ + + + EP
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKY 319
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 2e-30
Identities = 50/269 (18%), Positives = 102/269 (37%), Gaps = 28/269 (10%)
Query: 16 YKAFDEFAGIEVAWSRV--KIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 73
Y+ + + +RV K + + + +E ++K +VV+ +
Sbjct: 37 YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96
Query: 74 KKTVNMITELFTSGNLRQYRKKHKNV----------DIKVIKNWARQILHGLVYLHSHNP 123
+I EL T G+L+ Y + + + + A +I G+ YL+++
Sbjct: 97 P--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK- 153
Query: 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPE-LYEEE 178
+HRDL N V + VKIGD G+ + + + +M+PE L +
Sbjct: 154 -FVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 211
Query: 179 YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238
+ D++SFG+ + E+ T + + Q+ + V G + +
Sbjct: 212 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC-PDMLFELMRM 270
Query: 239 CLVP-ASERLSAKDLLKDPFLQVENQKEP 266
C R S +++ ++ + EP
Sbjct: 271 CWQYNPKMRPSFLEIIS----SIKEEMEP 295
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 52/267 (19%), Positives = 100/267 (37%), Gaps = 35/267 (13%)
Query: 16 YKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV 70
+A VA VK+ + + L SE+ +L + V
Sbjct: 30 IEADAFGIDKTATCRTVA---VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86
Query: 71 DDKKKTVNMITELFTSGNLRQYRKKHKN----------------VDIKVIKNWARQILHG 114
+ +I E GNL Y + +N + ++ + ++ Q+ G
Sbjct: 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146
Query: 115 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFM 170
+ +L S IHRDL NI ++ VKI D GLA + + ++M
Sbjct: 147 MEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 203
Query: 171 A-PELYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKVN 228
A +++ Y D++SFG+ + E+ + PY K + +++ G +
Sbjct: 204 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 262
Query: 229 DPQIKGFIEKCLVP-ASERLSAKDLLK 254
P++ + C S+R + +L++
Sbjct: 263 TPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 114 bits (285), Expect = 1e-28
Identities = 32/244 (13%), Positives = 84/244 (34%), Gaps = 28/244 (11%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75
++ + +VA +K D +L E K L + + +
Sbjct: 22 FEGTNLLNNQQVA---IKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75
Query: 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 135
V ++ +L + +K + A+Q+L + +H + +++RD+K DN
Sbjct: 76 NV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNF 132
Query: 136 FVN----GNHGEVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYE-EEYNE 181
+ N + + D G+ + P +++ GT +M+ + E +
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192
Query: 182 LVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSGIKPASLAKVND---PQIKGFI 236
D+ + G + + + + Q ++++ + L ++ + ++
Sbjct: 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
Query: 237 EKCL 240
Sbjct: 253 HYAR 256
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 74/303 (24%), Positives = 119/303 (39%), Gaps = 43/303 (14%)
Query: 16 YKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
AFD G+ VA VK + Q ++ Y E+ LLK +K +NV+ + +
Sbjct: 35 CAAFDTKTGLRVA---VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91
Query: 75 KT--VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 132
++ G K + + ++ QIL GL Y+HS + IIHRDLK
Sbjct: 92 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKP 149
Query: 133 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGM 190
N+ VN E+KI D GLA + T + APE+ YN+ VDI+S G
Sbjct: 150 SNLAVN-EDCELKILDFGLARHTDDEM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207
Query: 191 CILEMVTFEYPYSECKNPAQIFKKVTSGIKP----------------------------A 222
+ E++T + + Q+ + P A
Sbjct: 208 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267
Query: 223 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPLKLPIQSLK 279
++ +P +EK LV + +R++A L + + EP+ DP +S
Sbjct: 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRD 327
Query: 280 MLR 282
+L
Sbjct: 328 LLI 330
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 8e-27
Identities = 68/318 (21%), Positives = 117/318 (36%), Gaps = 57/318 (17%)
Query: 16 YKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 74
A+D VA +K + Q ++ Y E+ L+K + N++ + K
Sbjct: 34 CAAYDAVLDRNVA---IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90
Query: 75 ----KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 130
+ V ++ EL + + + + D + + Q+L G+ +LHS IHRDL
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGI--IHRDL 145
Query: 131 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-VIGTPEFMAPE-LYEEEYNELVDIYSF 188
K NI V + +KI D GLA + + T + APE + Y E VDI+S
Sbjct: 146 KPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 189 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--------------------------- 221
G + EMV + + Q K + P
Sbjct: 205 GCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 264
Query: 222 ------------ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVE-NQKEPI 267
+ K+ Q + + K LV ++R+S D L+ P++ V + E
Sbjct: 265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 324
Query: 268 CDPLKLPIQSLKMLRLPM 285
P ++ + L +
Sbjct: 325 APPPQIYDKQLDEREHTI 342
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.8 bits (229), Expect = 5e-21
Identities = 63/321 (19%), Positives = 112/321 (34%), Gaps = 73/321 (22%)
Query: 16 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----------- 64
+ A D VA V+ D V + E+ LL+ + D + K
Sbjct: 30 WLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVNDADNTKEDSMGANHILK 84
Query: 65 ---FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 121
+ + V + L + + +H+ + + +K ++Q+L GL Y+H
Sbjct: 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-R 143
Query: 122 NPPIIHRDLKCDNIFVN-----GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LY 175
IIH D+K +N+ + N ++KI DLG A + + I T E+ +PE L
Sbjct: 144 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNSIQTREYRSPEVLL 202
Query: 176 EEEYNELVDIYSFGMCILEMVTFEYPY------SECKNPAQIFKKVTSGIKPAS------ 223
+ DI+S I E++T ++ + S K+ I + + + S
Sbjct: 203 GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 262
Query: 224 ---------------------------------LAKVNDPQIKGFIEKCLVP-ASERLSA 249
+K +I F+ L +R A
Sbjct: 263 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322
Query: 250 KDLLKDPFLQVENQKEPICDP 270
L+ P+L+ E I P
Sbjct: 323 GGLVNHPWLKDTLGMEEIRVP 343
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.0 bits (147), Expect = 2e-11
Identities = 26/144 (18%), Positives = 49/144 (34%), Gaps = 17/144 (11%)
Query: 51 VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQ 110
L+ L+ V K Y + ++ EL + L + R ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNA------VLMELIDAKELYRVRVEN-------PDEVLDM 111
Query: 111 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM 170
IL + + I+H DL N+ V+ + I D ++ + + R ++
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRN 167
Query: 171 APELYEEEYNELVDIYSFGMCILE 194
+ Y DI S IL+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 641 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.44 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.34 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=428.15 Aligned_cols=256 Identities=52% Similarity=0.909 Sum_probs=235.1
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC--CCCEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928--9766999
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKKTVNM 79 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~--~~~~l~l 79 (641)
|+-..+|+|+||+||+|.+..++..||+|.+..... .....+.+.+|+++|++++|||||++|++|.+. ....+++
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEE
T ss_conf 851697008284999999999995999999851227--989999999999999857999850699998403345888999
Q ss_pred EECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCCC
Q ss_conf 98057999999999957999999999999999999999982899927303677938992899948995144023215898
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~~ 159 (641)
||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||+++++|+||||||+|||+++.++.+||+|||+|+......
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCCCC
T ss_conf 99578989489997513554699999999999999999997899799687674351166799988980057654236876
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 75445898777732222457843331110100234531567999999979999999729998754567817899999993
Q 006528 160 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
..+.+||+.|||||++.+.|+.++|||||||++|+|++|+.||.+..+..++++.+..+..+..+....++++++||.+|
T Consensus 170 ~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 249 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 249 (270)
T ss_dssp BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 67755381300898847899986711007999999987889998765599999999738998656755789999999997
Q ss_pred CC-CCCCCCCHHHHHCCCCCC
Q ss_conf 49-989998999997293344
Q 006528 240 LV-PASERLSAKDLLKDPFLQ 259 (641)
Q Consensus 240 L~-dP~~RpSa~eLL~Hpfl~ 259 (641)
|. +|.+|||+.|+|+||||+
T Consensus 250 l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 250 IRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp SCSSGGGSCCHHHHHTSGGGC
T ss_pred CCCCHHHCCCHHHHHCCCCCC
T ss_conf 637975892999996775409
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=411.31 Aligned_cols=256 Identities=24% Similarity=0.441 Sum_probs=217.5
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
.+++..+|+|+||+||+|.+..+|..||+|.++... .+....++.+|+.+|++++|||||+++++|.+. ..+++|
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~iV 82 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 82 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CEEEEE
T ss_conf 889789712778099999998999699999987540---978999999999999867999999499999989--999999
Q ss_pred ECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCCC
Q ss_conf 8057999999999957999999999999999999999982-899927303677938992899948995144023215898
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 159 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~~ 159 (641)
|||+++|+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ ..|.+||+|||+|+......
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHT
T ss_pred EECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEC-CCCCEEEEECCCCCCCCCCC
T ss_conf 9767998689987424999999999999999999999998599--97144577994687-89989995487762567886
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHH----------------------------
Q ss_conf 754458987777322224-578433311101002345315679999999799----------------------------
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---------------------------- 210 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~---------------------------- 210 (641)
..+.+||+.|||||++.+ .|+.++||||+||++|||++|+.||........
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 21113771411946875899894888998999999999888998998878999999887517754577421233322111
Q ss_pred -------------HHHHHHCCCCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCCCC
Q ss_conf -------------9999972999875456781789999999349-98999899999729334434478
Q 006528 211 -------------IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 264 (641)
Q Consensus 211 -------------i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~~~ 264 (641)
....+.....+.......++++++||.+||. +|.+||||+|+|+||||+...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCCCC
T ss_conf 12223541347788766502687667644489999999999868994679089999609864769823
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=404.97 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=217.3
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.++.+|..||+|.++.... ...+.+.+|+.+|++++|||||++++++.+. ..+|+||
T Consensus 23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivm 96 (293)
T d1yhwa1 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVM 96 (293)
T ss_dssp CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC--CEEEEEE
T ss_conf 887898128582999999989998999999843017----2799999999999867999880585779889--9989999
Q ss_pred CCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC--C
Q ss_conf 05799999999995799999999999999999999998289992730367793899289994899514402321589--8
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~--~ 159 (641)
|||++|+|.+++.+ +.+++..++.|++||+.||.|||++| |+||||||+|||++ ..|.+||+|||+|+.+... .
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCC
T ss_pred EECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEC-CCCCEEECCCHHHEEECCCCCC
T ss_conf 70379808988641-59999999999999999999999879--72267768886887-8996864251564132136664
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 754458987777322224-5784333111010023453156799999997999999972999875456781789999999
Q 006528 160 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 238 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~k 238 (641)
....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..+......+...++.+++||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
T ss_conf 44444477736826644799880120313729999980488998997999999999857999888855379999999999
Q ss_pred HCC-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 349-98999899999729334434
Q 006528 239 CLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 239 cL~-dP~~RpSa~eLL~Hpfl~~~ 261 (641)
||. +|.+|||+.|+|+||||+..
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 866996689099999649965778
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=404.46 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=221.1
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||+||+|.+..+|..||+|.+..... ......+.+.+|+.+|++|+|||||++++++.+. ..+++|
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~iv 93 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLV 93 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC--CEEEEE
T ss_conf 6762797018880999999989993999999844443-5889999999999999977899982389999989--988999
Q ss_pred ECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCCCC
Q ss_conf 80579999999999579999999999999999999999828999273036779389928999489951440232158987
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~~~ 160 (641)
||||.+|+|..++...+++++..++.+++||+.||.|||++| |+||||||+|||++ ..|.+||+|||+|..... .
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~--~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--A 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS--B
T ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCCCEEEEC-CCCCEEEEECCCCCCCCC--C
T ss_conf 980699945789973799999999999999999999998689--76667884217987-999789844365334677--8
Q ss_pred CCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf 5445898777732222----457843331110100234531567999999979999999729998754567817899999
Q 006528 161 RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
...+||+.|||||++. +.|+.++|||||||++|+|++|..||.+. +..+....+..+..+.......++++++||
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~li 247 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHCCCCCCCCCCCCHHHHHHH
T ss_conf 7313476636889983467888672145455899999998788999997-999999999828999888788899999999
Q ss_pred HHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 99349-989998999997293344344
Q 006528 237 EKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
.+||. +|.+|||+.++|+||||+...
T Consensus 248 ~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 248 DSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf 997737965791899997199753789
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=407.44 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=218.5
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.++.+|..||+|.++.... .+..+.+.+|+.+|++++|||||++++++.+. ..+|+||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~ivm 82 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLFL 82 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC--CEEEEEE
T ss_conf 899897217480999999999997999999845664---12799999999999857998884696540467--4367988
Q ss_pred CCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC---
Q ss_conf 05799999999995799999999999999999999998289992730367793899289994899514402321589---
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~--- 158 (641)
|||++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||+|+.....
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEETTEE
T ss_pred ECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEC-CCCCEEECCCHHHEEECCCCCC
T ss_conf 64589808999753799999999999999999999999759--83575468997887-8998798323142240468865
Q ss_pred -CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf -8754458987777322224-57-84333111010023453156799999997999999972999875456781789999
Q 006528 159 -TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~-~y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
.....+||+.|||||++.+ .| +.++|||||||++|+|+||++||.........+..+.............++++++|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
T ss_conf 31113255747428728618999997101617379999998299788889859999999863888788644699999999
Q ss_pred HHHHCC-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 999349-98999899999729334434
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpfl~~~ 261 (641)
|.+||. +|.+|||++|+|+||||+..
T Consensus 240 i~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 999767996689099999619845859
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=405.20 Aligned_cols=251 Identities=21% Similarity=0.359 Sum_probs=223.4
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
++...+|+|+||+||+|.++.+|..||+|.+...... .......+.+|+.+++.++|||||++++++.+. ..+++||
T Consensus 9 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ivm 85 (263)
T d2j4za1 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVYLIL 85 (263)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC--CEEEEEE
T ss_conf 9988985177858999999899949999998168856-768999999999999856888888599999989--9989998
Q ss_pred CCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCCCCC
Q ss_conf 05799999999995799999999999999999999998289992730367793899289994899514402321589875
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 161 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~~~~ 161 (641)
|||++|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|.........
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCCCCE
T ss_pred EECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECCCCCEEC-CCCCEEECCCCEEEECCCCCCC
T ss_conf 50479858988750489999999999999999999999889--46522023441466-8998711555633544888523
Q ss_pred CCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 4458987777322224-578433311101002345315679999999799999997299987545678178999999934
Q 006528 162 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 240 (641)
Q Consensus 162 ~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL 240 (641)
..+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+++..+..+..+ ++...++++++||.+||
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFT--FPDFVTEGARDLISRLL 239 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC--CCTTSCHHHHHHHHHHT
T ss_pred CCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHHHHHHC
T ss_conf 55788763499997589989314404675999998329999888-9999999999718999--98668999999999976
Q ss_pred C-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 9-98999899999729334434
Q 006528 241 V-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 241 ~-dP~~RpSa~eLL~Hpfl~~~ 261 (641)
. +|.+|||+.|+|+||||+..
T Consensus 240 ~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 240 KHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCCHHHCCCHHHHHCCCCCCCC
T ss_conf 4797689099999719070783
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.68 Aligned_cols=257 Identities=19% Similarity=0.357 Sum_probs=225.9
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||+||+|.++.+|..||+|.+++.... .......+.+|+.+|+.++||||++++++|.+. ..+|+|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~iv 83 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFV 83 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC--CCCCCC
T ss_conf 28988983176849999999899989999998156544-979999999999999867999887787640356--421110
Q ss_pred ECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCC--C
Q ss_conf 80579999999999579999999999999999999999828999273036779389928999489951440232158--9
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--P 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~--~ 158 (641)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+|+.... .
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTC
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEC-CCCCEEEEECCCCCCCCCCCC
T ss_conf 003579860555532567759999999999965211343159--62246477784765-899888820565200356786
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 875445898777732222-4578433311101002345315679999999799999997299987545678178999999
Q 006528 159 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
.....+||+.|+|||++. ..|+.++|||||||++|||++|++||.+ .+..+++..+..+.. .++...++++++||.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLA 237 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCC--CCCCCCCHHHHHHHH
T ss_conf 20551008899666650489888333102230678899878999999-699999999852899--898668999999998
Q ss_pred HHCC-CCCCCCC-----HHHHHCCCCCCCCCCCCC
Q ss_conf 9349-9899989-----999972933443447888
Q 006528 238 KCLV-PASERLS-----AKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 238 kcL~-dP~~RpS-----a~eLL~Hpfl~~~~~~~~ 266 (641)
+||. +|.+|++ +.++++||||+..++...
T Consensus 238 ~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l 272 (337)
T d1o6la_ 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHHHH
T ss_conf 66638934422565234999972915036999999
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.22 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=222.9
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
.+++..+|+|+||+||+|.++.+|..||+|.+..... .+...+.+.+|+++|++++|||||++++++.+.....+|+|
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 7996798308891999999999997999999874657--97999999999999997789998248999991789989999
Q ss_pred ECCCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCCC---CEEEECCCCCCEEEECCCCCEEEEECCHHH
Q ss_conf 805799999999995----7999999999999999999999982899---927303677938992899948995144023
Q 006528 81 TELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNP---PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gp---pIiHrDLKp~NILI~~~~g~IKL~DFGlA~ 153 (641)
||||++|+|.+++.+ .+.+++..++.|+.||+.||.|||++++ +|+||||||+|||++ ..|.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCC-CCCCEEEEECCCEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747-88857980010003
Q ss_pred HCCCC--CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Q ss_conf 21589--8754458987777322224-57843331110100234531567999999979999999729998754567817
Q 006528 154 AMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 230 (641)
Q Consensus 154 ~~~~~--~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~ 230 (641)
.+... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..++...+..+..+. ++...++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~s~ 240 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRR-IPYRYSD 240 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCH
T ss_pred ECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCH
T ss_conf 224577755667788232799998399999389887527899998018899899-89999999997189988-9743599
Q ss_pred HHHHHHHHHCC-CCCCCCCHHHHHCCCCC
Q ss_conf 89999999349-98999899999729334
Q 006528 231 QIKGFIEKCLV-PASERLSAKDLLKDPFL 258 (641)
Q Consensus 231 ~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl 258 (641)
++++||.+||. +|.+|||+.|+|+|||+
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 99999999767995579189999729819
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=396.81 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=220.0
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.++.+|..||+|.+.... ....+.+.+|+.+|++|+|||||++++++.+. ..+++||
T Consensus 29 ~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivm 102 (350)
T d1koaa2 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIY 102 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEEEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CEEEEEE
T ss_conf 89889840768199999988999899999984524----31699999999999867997999299999989--9999999
Q ss_pred CCCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEEC-CCCCEEEEECCHHHHCCCC-
Q ss_conf 05799999999995-79999999999999999999999828999273036779389928-9994899514402321589-
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~-~~g~IKL~DFGlA~~~~~~- 158 (641)
|||+||+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++. ..|.+||+|||+|+.+...
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred ECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC
T ss_conf 857998899999762378999999999999999999997569--760001546736416889869995452104425654
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHH
Q ss_conf 8754458987777322224-5784333111010023453156799999997999999972999--875456781789999
Q 006528 159 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGF 235 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--~~~l~~~~~~~l~~L 235 (641)
......||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+++..+..+.. +.......++++++|
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
T ss_conf 32000686242188997589987267655465999999859899899-79999999998478898942235899999999
Q ss_pred HHHHCC-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 999349-9899989999972933443447
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpfl~~~~~ 263 (641)
|.+||. +|.+|||+.|+|+||||+..+.
T Consensus 260 i~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 99975689667908999862913288988
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.86 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=215.6
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.++.+|..||+|.++... ....+.+.+|+.+|++++|||||++++++.+. ..+++||
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lvm 88 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILI 88 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred EEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC----HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC--CEEEEEE
T ss_conf 98479930778199999999999399999987289----99999999999999867999988498898009--9589999
Q ss_pred CCCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC--
Q ss_conf 05799999999995-799999999999999999999998289992730367793899289994899514402321589--
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~-- 158 (641)
|||++|+|.+++.+ .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECHHHHH
T ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEECCHHHEEEC-CCCCEEEEECHHHHCCCCCCC
T ss_conf 627998188999862899999999999999999999999889--88714070031487-899989971612303577864
Q ss_pred CCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-CCCCCCCHHH
Q ss_conf 875445898777732222------457843331110100234531567999999979999999729998-7545678178
Q 006528 159 TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQ 231 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~-~~l~~~~~~~ 231 (641)
...+.+||+.|||||++. ..|+.++|||||||++|+|+||+.||.+. +..+++..+..+..+ ...+...+++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHCCCCCCCCCCCCCCHH
T ss_conf 10010256264799998320257888880665787899999982088999998-99999999970799877765669999
Q ss_pred HHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 9999999349-989998999997293344344
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 99999997669966891999996292318898
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=397.03 Aligned_cols=253 Identities=20% Similarity=0.302 Sum_probs=220.5
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
++...+|+|+||+||+|.++.+|..||+|.+..... ......+.+|+.+|++++|||||++++++.+. ..+|+||
T Consensus 12 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lvm 86 (307)
T d1a06a_ 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYESG--GHLYLIM 86 (307)
T ss_dssp EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHH---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CEEEEEE
T ss_conf 998899406583999999999998999999815773---12899999999999867998999198999989--9888988
Q ss_pred CCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEEC--CCCCEEEEECCHHHHCCCC-
Q ss_conf 0579999999999579999999999999999999999828999273036779389928--9994899514402321589-
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~--~~g~IKL~DFGlA~~~~~~- 158 (641)
|||+||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+.. ++|.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCE--EEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCCC
T ss_conf 52689848886530367887899999999999987524130--5568704630011046888249983154358725897
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC--CCCCCCHHHHHHH
Q ss_conf 8754458987777322224-578433311101002345315679999999799999997299987--5456781789999
Q 006528 159 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIKGF 235 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~--~l~~~~~~~l~~L 235 (641)
...+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+..++...+..+.... ......++++++|
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf 04400328422591887379998078734515999999859799999-89999999986168777876666789999999
Q ss_pred HHHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 999349-989998999997293344344
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
|.+||. +|.+|||+.|+|+||||+...
T Consensus 244 i~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 9997608975791899986298447997
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=397.90 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=215.5
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC--CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 99999928418648999998689929999998636656--8935699999999999817999811365899928976699
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL--QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 78 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~--~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 78 (641)
++++..+|+|+||+||+|.+..+|..||+|.+...... .......+...++.+++.++|||||++++++.+. ..+|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~~~~ 83 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLS 83 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC--CEEE
T ss_conf 85101884288909999999999979999998458754266799999999999998508998588999999989--9889
Q ss_pred EEECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC
Q ss_conf 99805799999999995799999999999999999999998289992730367793899289994899514402321589
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~ 158 (641)
+|||||++|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|+.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECSSS
T ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCEEEEC-CCCCEEEEEECEEEECCCC
T ss_conf 99991489838999873255327899999999999999999779--62204442216785-8896798220102333788
Q ss_pred CCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCC--HHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 875445898777732222-4-578433311101002345315679999999--799999997299987545678178999
Q 006528 159 TARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~-~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
.....+||+.|||||++. + .|+.++|||||||++|+|+||+.||.+... ...+...+.. .+..++...++++++
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRS 238 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--CCCCCCSSSCHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC--CCCCCCCCCCHHHHH
T ss_conf 643311345542168760389998441046778999999859998888998999999986046--888788778999999
Q ss_pred HHHHHCC-CCCCCCC-----HHHHHCCCCCCCCCCCC
Q ss_conf 9999349-9899989-----99997293344344788
Q 006528 235 FIEKCLV-PASERLS-----AKDLLKDPFLQVENQKE 265 (641)
Q Consensus 235 LI~kcL~-dP~~RpS-----a~eLL~Hpfl~~~~~~~ 265 (641)
||.+||. +|.+||| |+++++||||+..++..
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~ 275 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf 9999856698880887435799997491023789879
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=394.58 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=219.4
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.+..+|..||+|.++... ......+.+|+.+|++|+|||||+++++|.+. ..+++||
T Consensus 32 ~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ivm 105 (352)
T d1koba_ 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLIL 105 (352)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CEEEEEE
T ss_conf 99899931778299999998999799999988726----46799999999999867997989199999989--9999999
Q ss_pred CCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEEC-CCCCEEEEECCHHHHCCCC-
Q ss_conf 057999999999957-9999999999999999999999828999273036779389928-9994899514402321589-
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~-~~g~IKL~DFGlA~~~~~~- 158 (641)
|||+||+|.+++... .++++..++.|+.||+.||.|||++| |+||||||+|||++. ..|.+||+|||+|..+...
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred ECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC
T ss_conf 828998088889863899899999999999999999999779--265131445531134678848995256303437887
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCHHHHHHH
Q ss_conf 8754458987777322224-5784333111010023453156799999997999999972999--875456781789999
Q 006528 159 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGF 235 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--~~~l~~~~~~~l~~L 235 (641)
......||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. +.......++++++|
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
T ss_conf 20100476453489997479989763338989999999968899899-79999999998478898930024799999999
Q ss_pred HHHHCC-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 999349-9899989999972933443447
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpfl~~~~~ 263 (641)
|.+||. +|.+|||+.|+|+||||+....
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 99975699668918999960973488820
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=397.34 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=224.2
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
++++..||+|+||+||+|.++.+|..||+|.+...... .....+.+.+|+.+|+.++|||||++++++.+. ..+++|
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~~v 119 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYMV 119 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCC--CCCCCC
T ss_conf 08988961176808999999899989999998267745-889999999999999974877274034444322--222322
Q ss_pred ECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCCCC
Q ss_conf 80579999999999579999999999999999999999828999273036779389928999489951440232158987
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~~~ 160 (641)
+||+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|+.+... .
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~-~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR-T 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC-B
T ss_pred CCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHCCCC-CCCCEEEEECEEEEECCCC-C
T ss_conf 223346622666751589899999999999999899998599--86176799993607-7897886101033322566-6
Q ss_pred CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 54458987777322224-57843331110100234531567999999979999999729998754567817899999993
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+... .+...++++++||.+|
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNL 272 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHHHHHH
T ss_conf 433676356788997179988533114500789999758899899-5999999998617988--9766899999999998
Q ss_pred CC-CCCCCC-----CHHHHHCCCCCCCCCCCCC
Q ss_conf 49-989998-----9999972933443447888
Q 006528 240 LV-PASERL-----SAKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 240 L~-dP~~Rp-----Sa~eLL~Hpfl~~~~~~~~ 266 (641)
|. +|.+|+ |++++++||||+..++...
T Consensus 273 L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~ 305 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred HHHCHHHCCCCCCCCHHHHHCCCCCCCCCHHHH
T ss_conf 340998606553454999971905158998999
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=393.36 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=224.1
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEE
Q ss_conf 999992841864899999868992999999863665689--356999999999998179998113658999289766999
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 79 (641)
++...+|+|+||+||+|.++.+|..||+|.++....... ....+.+.+|+.+|++++|||||+++++|.+. ..+++
T Consensus 13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~i 90 (293)
T d1jksa_ 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--TDVIL 90 (293)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CEEEE
T ss_conf 9827981178959999999999989999998756632134068999999999999867998999388999979--98999
Q ss_pred EECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCC---CCEEEEECCHHHHCC
Q ss_conf 98057999999999957999999999999999999999982899927303677938992899---948995144023215
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAMQ 156 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~---g~IKL~DFGlA~~~~ 156 (641)
|||||++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++ +.+||+|||+|....
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEEECCCCCCCCEEECCHHHHHHCC
T ss_conf 9986778643100103564215578999999999987666254--22113330127982589866646964334421057
Q ss_pred CC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCHHHH
Q ss_conf 89-8754458987777322224-57843331110100234531567999999979999999729998--75456781789
Q 006528 157 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQI 232 (641)
Q Consensus 157 ~~-~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~--~~l~~~~~~~l 232 (641)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+.+..+..+... .......++.+
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 247 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALA 247 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCCCCHHCCCCCHHH
T ss_conf 77631224777743099998189999766522140999999708899889-99999999998168888701047889999
Q ss_pred HHHHHHHCC-CCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf 999999349-9899989999972933443447888
Q 006528 233 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 233 ~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~~~~~ 266 (641)
++||.+||. +|.+|||+.++|+||||+..++...
T Consensus 248 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred HHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCHHHH
T ss_conf 99999986389668919999961904188870576
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=396.89 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=223.5
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.++.+|..||+|.+...... .....+.+.+|+++|++++||||+++++++.+. ..+|+||
T Consensus 11 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ivm 87 (288)
T d1uu3a_ 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFGL 87 (288)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEEEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC--CEEEEEE
T ss_conf 8988985087909999999899979999998657755-777899999999999876888861799999989--9889999
Q ss_pred CCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC---
Q ss_conf 05799999999995799999999999999999999998289992730367793899289994899514402321589---
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~--- 158 (641)
|||++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC-----
T ss_pred ECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCCCCCCCC-CCCEEEECCCCCCEECCCCCCC
T ss_conf 70489877776531599999999999999999997621650--88476774123668-8853886032102422567764
Q ss_pred -CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf -8754458987777322224-57843331110100234531567999999979999999729998754567817899999
Q 006528 159 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
...+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+++..+..+.. .++...++++++||
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARDLV 241 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHHHH
T ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCC--CCCCCCCHHHHHHH
T ss_conf 333555677552584400268989666230456999998038899899-599999999971899--99854799999999
Q ss_pred HHHCC-CCCCCCCHHH------HHCCCCCCCCCCCCC
Q ss_conf 99349-9899989999------972933443447888
Q 006528 237 EKCLV-PASERLSAKD------LLKDPFLQVENQKEP 266 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~e------LL~Hpfl~~~~~~~~ 266 (641)
.+||. +|.+|||++| +++||||+..++...
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHHHH
T ss_conf 9985579768919789737789876976478998896
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=394.07 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=224.5
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
.+++..+|+|+||+||+|.++.+|..||+|.++..... .....+.+.+|+.+|+.++|||||++++++.+. ..+++|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 82 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMI 82 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEEC--CEEEEE
T ss_conf 08888972076808999999899979999998457754-889999999999999863696753303568528--800567
Q ss_pred ECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCCCC
Q ss_conf 80579999999999579999999999999999999999828999273036779389928999489951440232158987
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 160 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~~~ 160 (641)
||||.||+|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+..... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~-~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV-T 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC-B
T ss_pred EEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCC--EECCCCCCHHEEEC-CCCCEEEECCCCCEEECCC-C
T ss_conf 650378632234322221110079999999987655412476--77055681050386-8998898317521671245-6
Q ss_pred CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 54458987777322224-57843331110100234531567999999979999999729998754567817899999993
Q 006528 161 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 239 (641)
Q Consensus 161 ~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kc 239 (641)
.+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+... ++...+++++++|.+|
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELR--FPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHHHHHH
T ss_conf 434576343599998389998043046533368999759899999-6999999999708988--9977899999999999
Q ss_pred CC-CCCCCC-----CHHHHHCCCCCCCCCCCCC
Q ss_conf 49-989998-----9999972933443447888
Q 006528 240 LV-PASERL-----SAKDLLKDPFLQVENQKEP 266 (641)
Q Consensus 240 L~-dP~~Rp-----Sa~eLL~Hpfl~~~~~~~~ 266 (641)
|. +|.+|+ |++++|+||||+..++...
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l 268 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHHCHHHCCCCCHHHHHHHHCCCCCCCCCHHHH
T ss_conf 544997666431021999981935146798999
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.82 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=219.1
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 999992841864899999868992999999863665689356999999999998-1799981136589992897669999
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK-SLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk-~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
++...+|+|+||+||+|.++.+|..||+|.++...... ....+.+..|..++. .++|||||++++++.+. ..+|+|
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~yiv 81 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLFFV 81 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCC-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC--CCEEEE
T ss_conf 88658940878289999999999899999980555338-489999999999999847999687898897049--831677
Q ss_pred ECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCC--C
Q ss_conf 80579999999999579999999999999999999999828999273036779389928999489951440232158--9
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--P 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~--~ 158 (641)
|||+++|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|+.... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTC
T ss_pred EEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCEEEC-CCCCEECCCCCHHHHCCCCCC
T ss_conf 750379808998640478999999999999999999998689--34034765404444-899630155530232356653
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 8754458987777322224-578433311101002345315679999999799999997299987545678178999999
Q 006528 159 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 237 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~ 237 (641)
......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+++..+..+.. .++...++++++||.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLV 235 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCC--CCCCCCCHHHHHHHH
T ss_conf 34545787776899998279988323201122789898738899999-899999999971899--897567999999999
Q ss_pred HHCC-CCCCCCCHH-HHHCCCCCCCCCCC
Q ss_conf 9349-989998999-99729334434478
Q 006528 238 KCLV-PASERLSAK-DLLKDPFLQVENQK 264 (641)
Q Consensus 238 kcL~-dP~~RpSa~-eLL~Hpfl~~~~~~ 264 (641)
+||. +|.+||++. ++++||||+..++.
T Consensus 236 ~~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp HHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HHCCCCCCCCCCHHHHHHHCCHHCCCCHH
T ss_conf 96544898783889999809013158999
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.99 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=217.4
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.++.+|..||+|.++... .....+.+|+++|+.++|||||+++++|.+. ..+|+||
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~lvm 80 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--EELVMIF 80 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCEEEEEEEEC--CEEEEEE
T ss_conf 88789831778399999998999699999975786-----6599999999999857997989098999889--9889999
Q ss_pred CCCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECC-CCCEEEEECCHHHHCCCC-
Q ss_conf 0579999999999579-9999999999999999999998289992730367793899289-994899514402321589-
Q 006528 82 ELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~-~g~IKL~DFGlA~~~~~~- 158 (641)
|||+||+|.+++...+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCC
T ss_conf 538998088998753899999999999999999999998769--975135544434437885189976441110034677
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHH
Q ss_conf 8754458987777322224-57843331110100234531567999999979999999729998--75456781789999
Q 006528 159 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGF 235 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~--~~l~~~~~~~l~~L 235 (641)
......|++.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+... .......++++++|
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCHHHCCCCCHHHHHH
T ss_conf 53212233222340210487778401130279999999828999999-89999999998389998802236789999999
Q ss_pred HHHHCC-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 999349-98999899999729334434
Q 006528 236 IEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~Hpfl~~~ 261 (641)
|.+||. +|.+|||+.|+|+||||+..
T Consensus 238 i~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 999866996689099999639965667
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.92 Aligned_cols=255 Identities=20% Similarity=0.291 Sum_probs=209.0
Q ss_pred EEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCH-HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 999928418648999998689929999998636656893-5699999999999817999811365899928976699998
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 3 Il~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~-~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
.+..||+|+||+||+|.++.+|..||+|+++........ .....+.+|+.+|++++|||||++++++.+. ..+++||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEE
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC--CCEEEHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258--7402204
Q ss_pred CCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC--C
Q ss_conf 05799999999995799999999999999999999998289992730367793899289994899514402321589--8
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~--~ 159 (641)
||+.+|++..+......+++..++.|++||+.||.|||++| |+||||||+|||++ ..+.+||+|||+|...... .
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCC
T ss_pred HHHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCCEEEEC-CCCCCCCCCCCCCCCCCCCCCC
T ss_conf 55345077655412667789999999999999998863163--55035776258853-7784114657610005787554
Q ss_pred CCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCC--CCC--------------
Q ss_conf 75445898777732222-4-57843331110100234531567999999979999999729--998--------------
Q 006528 160 ARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP-------------- 221 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~-~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~~-------------- 221 (641)
....+||+.|+|||++. . .|+.++|||||||++|+|+||.+||.+. +..+....+... ...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~-~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-SDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCC-CHHHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf 330204733363999726778880564363042899998596999999-9999999999851899725452100021344
Q ss_pred ----------CCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf ----------75456781789999999349-9899989999972933443447
Q 006528 222 ----------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 222 ----------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~~ 263 (641)
.......++++++||.+||+ +|.+||||+|+|+||||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 30347898867856568999999999976389456908999967996578999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.94 Aligned_cols=250 Identities=18% Similarity=0.274 Sum_probs=204.9
Q ss_pred EEEEE-ECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCEEEEEEEE--CCCCEE
Q ss_conf 99999-28418648999998689929999998636656893569999999999981-799981136589992--897669
Q 006528 2 RILIS-SRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS-LKDDNVVKFYKSWVD--DKKKTV 77 (641)
Q Consensus 2 RIl~~-lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~~~~--~~~~~l 77 (641)
+|+.. +|+|+||+||+|.+..+|..||+|.++.. ..+.+|+.++.+ ++|||||+++++|.+ ....++
T Consensus 14 ~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC---------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 98107965454869999998899989999998974---------779999999998669999782989995034689789
Q ss_pred EEEECCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEEC--CCCCEEEEECCHHH
Q ss_conf 9998057999999999957--9999999999999999999999828999273036779389928--99948995144023
Q 006528 78 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAI 153 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~--~~g~IKL~DFGlA~ 153 (641)
|+|||||+||+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+|||++. +.+.+||+|||+|+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
T ss_conf 99997789984999998627877579999999999999999999769--8644410022011355556631135455123
Q ss_pred HCCC-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHH---HHHHHHHCCCC--CCCCCC
Q ss_conf 2158-98754458987777322224-57843331110100234531567999999979---99999972999--875456
Q 006528 154 AMQQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIK--PASLAK 226 (641)
Q Consensus 154 ~~~~-~~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~---~i~~~i~~g~~--~~~l~~ 226 (641)
.... ......+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+..... .+...+..+.. +.....
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHH
T ss_pred ECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 33688864322677563792777489888888887645167788658899889887788999999985388888985434
Q ss_pred CCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 781789999999349-989998999997293344344
Q 006528 227 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 227 ~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
..++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCCC
T ss_conf 6999999999997569965790999997098761788
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=373.51 Aligned_cols=253 Identities=21% Similarity=0.352 Sum_probs=219.1
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCC-----HHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCCC
Q ss_conf 999992841864899999868992999999863665689-----356999999999998179-99811365899928976
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQL-----PGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~-----~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~ 75 (641)
++...||+|+||+||+|.+..+|..||+|.+++...... ....+.+.+|+.++++++ ||||+++++++.+. .
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~ 83 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN--T 83 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred EECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC--C
T ss_conf 88528841768499999999999899999996244641147888999999999999999850799747997621467--6
Q ss_pred EEEEEECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHC
Q ss_conf 69999805799999999995799999999999999999999998289992730367793899289994899514402321
Q 006528 76 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~ 155 (641)
.+|+|||||++|+|.++++..+.+++..++.|+.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+++.+
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred CEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCHHEEEC
T ss_conf 05999976898668999986599999999999999999999998759--94323462548986-8998387124031672
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCC-------CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCC
Q ss_conf 589-8754458987777322224-------5784333111010023453156799999997999999972999--87545
Q 006528 156 QQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLA 225 (641)
Q Consensus 156 ~~~-~~~~~~GTp~ymAPEvl~~-------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--~~~l~ 225 (641)
... ......||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+ .+.......+..+.. +....
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTG
T ss_pred CCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCC-CCHHHHHHHHHHCCCCCCCCCC
T ss_conf 688721345246788898886053445678899233185656023103228889889-9999999999818988898543
Q ss_pred CCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCC
Q ss_conf 6781789999999349-9899989999972933443
Q 006528 226 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 226 ~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~ 260 (641)
...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf 468999999999976589668919999973978797
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.02 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=206.8
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
.+++..+|+|+||+||+|.+..+|..||+|.++.... .....+.+.+|+++|++++|||||+++++|.+. ..+++|
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~iv 79 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 79 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCC--CCEEEE
T ss_conf 7765177237680999999999997999999802225--758999999999999867998388744533224--320378
Q ss_pred ECCCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC-
Q ss_conf 805799999999995-799999999999999999999998289992730367793899289994899514402321589-
Q 006528 81 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~- 158 (641)
|||+.++.+...... .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+|+.....
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCCS
T ss_pred EEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCHHEEEC-CCCCCEECCCCCCEECCCCC
T ss_conf 8623774455544202568888999999999999999865288--99213571140113-46762103578613436886
Q ss_pred -CCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC-------------
Q ss_conf -8754458987777322224-5-78433311101002345315679999999799999997299987-------------
Q 006528 159 -TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA------------- 222 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~~-~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~------------- 222 (641)
......||+.|+|||++.. . ++.++||||||+++|+|++|+.||.+......+...+.....+.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCC
T ss_conf 41001036521541122136657774221033331342796687998988999999999983289833314442224212
Q ss_pred -------------CCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf -------------5456781789999999349-989998999997293344344
Q 006528 223 -------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 223 -------------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 434543222204441667899999999997639955791899996787014699
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.81 Aligned_cols=247 Identities=19% Similarity=0.290 Sum_probs=209.4
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCH--HHHHHHHHHHHHHHHCC--CCCCCEEEEEEEECCCCEE
Q ss_conf 9999928418648999998689929999998636656893--56999999999998179--9981136589992897669
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLP--GDLQKLYSEVHLLKSLK--DDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~--~~~~~l~~Ei~iLk~L~--HpNIVkl~~~~~~~~~~~l 77 (641)
++...+|+|+||+||+|.+..+|..||+|.++........ ....++.+|+.+|++++ |||||++++++.+. ..+
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~--~~~ 84 (273)
T d1xwsa_ 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP--DSF 84 (273)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--SEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC--CEE
T ss_conf 996798408783999999999997999999856884433455679999999999997435898812799998309--968
Q ss_pred EEEECCCCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCC
Q ss_conf 999805799-9999999957999999999999999999999982899927303677938992899948995144023215
Q 006528 78 NMITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~g-GsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~ 156 (641)
++|+||+.+ +++.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||+|....
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEECCCCEEEECCCCCCEECC
T ss_conf 9999833686228999861589999999999999999999998779--75566761114774478848977546535324
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 898754458987777322224-5-78433311101002345315679999999799999997299987545678178999
Q 006528 157 QPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 157 ~~~~~~~~GTp~ymAPEvl~~-~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
.....+..||+.|+|||++.+ . ++.++|||||||++|+|+||+.||.. .. .+..+.. .+....++++++
T Consensus 163 ~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~----~i~~~~~--~~~~~~s~~~~~ 233 (273)
T d1xwsa_ 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DE----EIIRGQV--FFRQRVSSECQH 233 (273)
T ss_dssp SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HH----HHHHCCC--CCSSCCCHHHHH
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCC---CH----HHHHCCC--CCCCCCCHHHHH
T ss_conf 44556656587747999984899788653325540345367568899887---36----7761544--778779999999
Q ss_pred HHHHHCC-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 9999349-98999899999729334434
Q 006528 235 FIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~Hpfl~~~ 261 (641)
||.+||. +|.+|||++|+|+||||+..
T Consensus 234 li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9999760897589399998539866788
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.58 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=202.9
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC----CCCEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928----97669
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----KKKTV 77 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~----~~~~l 77 (641)
+.+..+|+|+||+||+|.+..+|..||+|.+...... ..+|+.+|++++||||++++++|... +..++
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH--------HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 7516982176839999999999979999998816068--------99999999866898987387899744765773189
Q ss_pred EEEECCCCCCCHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHH
Q ss_conf 9998057999999999---9579999999999999999999999828999273036779389928999489951440232
Q 006528 78 NMITELFTSGNLRQYR---KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l---~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~ 154 (641)
++|||||++|.+..+. .....+++..++.|++||+.||+|||++| |+||||||+|||++.+...+||+|||++..
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 999841688607888863103689999999999999999999998668--764578860378735897116733660544
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHC-C------------
Q ss_conf 158-9875445898777732222--45784333111010023453156799999997999999972-9------------
Q 006528 155 MQQ-PTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------ 218 (641)
Q Consensus 155 ~~~-~~~~~~~GTp~ymAPEvl~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g------------ 218 (641)
... ....+.+|++.|+|||++. ..|+.++||||+||++|||++|+.||.......++...+.. +
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp CCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf 04776532002555556827764046888210002465277855028799898799999999999748981776543062
Q ss_pred -----CCC--------CCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf -----998--------75456781789999999349-989998999997293344344
Q 006528 219 -----IKP--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 219 -----~~~--------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
..+ .......++++++||.+||. ||.+||||.|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 1011035544567444431568999999999997658955792999996698452466
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.12 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=209.7
Q ss_pred EEECCCCCEEEEEEEEC--CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEEC
Q ss_conf 99284186489999986--8992999999863665689356999999999998179998113658999289766999980
Q 006528 5 ISSRRIPAVDTYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 82 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~--~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 82 (641)
+.||+|+||+||+|.+. .++..||+|.++... ..+...+.+.+|+.+|++++|||||++++++..+ .+++|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC---CEEEEEE
T ss_conf 7834587829999998169738599999988010--8989999999999999867998985277775059---7799997
Q ss_pred CCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCCC---
Q ss_conf 57999999999957999999999999999999999982899927303677938992899948995144023215898---
Q 006528 83 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 159 (641)
Q Consensus 83 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~~--- 159 (641)
|+++|+|.+++.....+++..+..|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+|+.+....
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEE
T ss_pred CCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCHHHCCC-CCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 4788968999752257899999999999999976687479--55677761131023-56751234134533134323443
Q ss_pred --CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf --75445898777732222-457843331110100234531-56799999997999999972999875456781789999
Q 006528 160 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 160 --~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
.....||+.|||||++. +.|+.++||||||+++|||+| |+.||.+ .+..++...+..+..+. .+...++++++|
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~~~~~~~l 242 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGCPREMYDL 242 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHH
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHH
T ss_conf 2244567784203916653799984344303403132896589999999-89999999998289999-986567999999
Q ss_pred HHHHCC-CCCCCCCHHHH---HCCCCCCCC
Q ss_conf 999349-98999899999---729334434
Q 006528 236 IEKCLV-PASERLSAKDL---LKDPFLQVE 261 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eL---L~Hpfl~~~ 261 (641)
|.+||. +|.+|||+.++ |+|+|++..
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCCHHHCCCHHHHHHHHHCHHHHCC
T ss_conf 999758897689098999998528875047
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.59 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=206.9
Q ss_pred CEEEEEECCCCCEEEEEEEECCCC-----EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCC
Q ss_conf 999999284186489999986899-----299999986366568935699999999999817-99981136589992897
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 74 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG-----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~ 74 (641)
+++...+|+|+||+||+|.+...+ ..||+|.+.... .......+.+|+.+|+++ +|||||++++++.+.
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC--
T ss_conf 39701983078819999998578855420499999966335---8789999999999999715899686877888629--
Q ss_pred CEEEEEECCCCCCCHHHHHHHCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCC
Q ss_conf 66999980579999999999579-----------------------9999999999999999999998289992730367
Q 006528 75 KTVNMITELFTSGNLRQYRKKHK-----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~~-----------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLK 131 (641)
..+++|||||++|+|.+++.... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlK 191 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLA 191 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCS
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCC
T ss_conf 95899997279995999998625777510221000012220012577899999999999999999997399--0505270
Q ss_pred CCCEEEECCCCCEEEEECCHHHHCCCCC----CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCC
Q ss_conf 7938992899948995144023215898----75445898777732222-457843331110100234531-56799999
Q 006528 132 CDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSEC 205 (641)
Q Consensus 132 p~NILI~~~~g~IKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~ 205 (641)
|+|||++ ..+.+||+|||+|+...... ..+..||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.
T Consensus 192 p~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 192 ARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred HHCCCCC-CCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCC
T ss_conf 3214434-598289851422220457786156234357876578388727999963303000399999983899999998
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCC
Q ss_conf 997999999972999875456781789999999349-98999899999729
Q 006528 206 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 206 ~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.....+.+.+..+..+ ..+...++++++||.+||. +|.+|||+++|++|
T Consensus 271 ~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9899999998569989-9887678999999999758896689399999999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.29 Aligned_cols=255 Identities=27% Similarity=0.349 Sum_probs=203.1
Q ss_pred EEEEEECCCCCEEEEEEEECCC-CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEEEC---CC
Q ss_conf 9999928418648999998689-9299999986366568935699999999999817---999811365899928---97
Q 006528 2 RILISSRRIPAVDTYKAFDEFA-GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDD---KK 74 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~t-G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~~~~~---~~ 74 (641)
+++..+|+|+||+||+|.+..+ +..||+|.++..... ......+.+|+.+|+.| +||||+++++++... ..
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred EEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCC--CHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf 98889921558699999998889989999998023245--1679999999999998742589880236632214666667
Q ss_pred CEEEEEECCCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHH
Q ss_conf 669999805799999999995-7999999999999999999999982899927303677938992899948995144023
Q 006528 75 KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~ 153 (641)
..+++++||+.+|.+...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCC
T ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEEC-CCCCEEECCHHHHH
T ss_conf 4699999740587144444303789998999999999999999997588--98357986278985-89975421000101
Q ss_pred HCCC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCC--C----------
Q ss_conf 2158-9875445898777732222-457843331110100234531567999999979999999729--9----------
Q 006528 154 AMQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--I---------- 219 (641)
Q Consensus 154 ~~~~-~~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~---------- 219 (641)
.... .......||+.|+|||++. ..|+.++||||+||++|||++|+.||.+. +..+....+... .
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred HHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHHCCCCHHCCCCCC
T ss_conf 100234577765485114831001798881110003289999998787998998-9899999999840799611053211
Q ss_pred -------------CCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf -------------9875456781789999999349-989998999997293344344
Q 006528 220 -------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 220 -------------~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
....+....++.+++||.+||. +|.+||||.|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCH
T ss_conf 110333022345645440445899999999998748966791899996696340752
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.41 Aligned_cols=251 Identities=20% Similarity=0.333 Sum_probs=208.7
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCCCEEEE
Q ss_conf 9999992841864899999868992999999863665689356999999999998179-998113658999289766999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 79 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~l 79 (641)
.+++..+|+|+||+||+|.+..+|..||+|+++... ..++.+|+.+|+.++ ||||++++++|.......+++
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEE
T ss_conf 189789831748199999988999799999988899-------9999999999985157998767999998168771268
Q ss_pred EECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC-
Q ss_conf 9805799999999995799999999999999999999998289992730367793899289994899514402321589-
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~- 158 (641)
|||||.+|+|..+. +.+++..++.+++||+.||.|||++| |+||||||+|||++.+++.+||+|||+|......
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEEECCCCCHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCC
T ss_conf 88631798589974---68999999999999999998876433--44345644123774899836641565426646887
Q ss_pred CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHC--------------CC---
Q ss_conf 8754458987777322224--5784333111010023453156799999997999999972--------------99---
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--------------GI--- 219 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--------------g~--- 219 (641)
.....++|+.|+|||++.+ .|+.++||||+|+++|+|++|..||............+.. ..
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCCCC
T ss_conf 44432248642476102688888845232335455587604889998876018999999998788415555542254447
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf ------------------9875456781789999999349-9899989999972933443447
Q 006528 220 ------------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 263 (641)
Q Consensus 220 ------------------~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~~ 263 (641)
.+.......++++++||.+||. +|.+||||+|+|+||||+...+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 430000033343311211552112448999999999986699568908999964935588797
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.08 Aligned_cols=253 Identities=27% Similarity=0.364 Sum_probs=208.3
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----CCEE
Q ss_conf 999992841864899999868992999999863665689356999999999998179998113658999289----7669
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTV 77 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l 77 (641)
+++..+|+|+||+||+|.++.+|..||+|.++... ......+.+.+|+.+|++++|||||+++++|.... ...+
T Consensus 21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEE
T ss_conf 99889801778199999999999899999985222--5969999999999999866898754799986357655554159
Q ss_pred EEEECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCC
Q ss_conf 99980579999999999579999999999999999999999828999273036779389928999489951440232158
Q 006528 78 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 157 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~ 157 (641)
++||||+ +++|..+.+. ..+++..++.+++||+.||.|||++| |+||||||+|||++ ..+.+||+|||+|.....
T Consensus 99 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred EEEEECC-CCCHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCHHHCC-CCCCCCCCCCCCEECCCC
T ss_conf 9998405-5218999874-02269999999999999999987378--76456685111121-001221134310220687
Q ss_pred CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHC-CC---------------
Q ss_conf 98754458987777322224--5784333111010023453156799999997999999972-99---------------
Q 006528 158 PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI--------------- 219 (641)
Q Consensus 158 ~~~~~~~GTp~ymAPEvl~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~--------------- 219 (641)
. .....||+.|+|||++.+ .++.++||||+||++|+|++|++||.+......+...... +.
T Consensus 174 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 174 E-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp S-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred C-CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCCHHHH
T ss_conf 6-310245533358899817878996501030038999999786998889768999999850378848888653000344
Q ss_pred ---------C---CCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf ---------9---875456781789999999349-989998999997293344344
Q 006528 220 ---------K---PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 220 ---------~---~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
. ........++.+++||.+||. +|.+||||.|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 33115786665566775568999999999997729955792999996396237587
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=362.51 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=208.4
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.++ +|..||+|+++.... .....+++.+|+.+|++++||||++++++|.+.. .+++++
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i~~ 79 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLVF 79 (286)
T ss_dssp EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEEE
T ss_pred EECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCC--CEEEEE
T ss_conf 34318722778189999968-999999999812326--8589999999999998679986876601204677--315899
Q ss_pred CCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC--C
Q ss_conf 05799999999995799999999999999999999998289992730367793899289994899514402321589--8
Q 006528 82 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~--~ 159 (641)
+++.++.+..+....+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .++.+||+|||.|...... .
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC----
T ss_pred EEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCC--EEECCCCCCEEEEC-CCCCEEECCCCCCEECCCCCCC
T ss_conf 74004567899860477514456899999999999860574--88267877505686-8997873236643011467654
Q ss_pred CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHC--CC----------------
Q ss_conf 754458987777322224--5784333111010023453156799999997999999972--99----------------
Q 006528 160 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GI---------------- 219 (641)
Q Consensus 160 ~~~~~GTp~ymAPEvl~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~---------------- 219 (641)
.....|++.|+|||++.+ .++.++||||||+++|||++|+.||.+.. ..+....+.. +.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-EADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCC-HHHHHHHHHHHHCCCCHHHCCCHHHHHHCC
T ss_conf 1010243110137887178888841002111758999977979989889-899999999863899711042123332214
Q ss_pred ---------CCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCC
Q ss_conf ---------9875456781789999999349-9899989999972933443
Q 006528 220 ---------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 220 ---------~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~ 260 (641)
.........++.+++||.+||+ ||.+||||+|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 333335676466651258999999999986689668909999856922074
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=363.87 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=209.4
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
+++...+|+|+||+||+|.++.+|..||+|.++... ...+.+.+|+.+|++++|||||++++++.+. ..+++|
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 91 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII 91 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-----CHHHHHHHHHHHHHHCCCCCEECCCCCEEEC--CEEEEE
T ss_conf 398659820888089999999999699999977761-----0399999999999867999882677527457--854787
Q ss_pred ECCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC
Q ss_conf 8057999999999957--99999999999999999999998289992730367793899289994899514402321589
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~ 158 (641)
||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+|+.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCCTTTCCSS
T ss_pred EECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCCCEEECCCC
T ss_conf 63146760677753035541579999999999999788898789--30576045768998-9992898324454653788
Q ss_pred CC---CCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 87---5445898777732222-4578433311101002345315679999999799999997299987545678178999
Q 006528 159 TA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 159 ~~---~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
.. ....|++.|+|||++. +.|+.++||||||+++|||+++..||....+..+++..+..+..+. .+...++.+++
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~ 247 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEGCPEKVYE 247 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHHH
T ss_pred CCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC-CCCCCHHHHHH
T ss_conf 72210355665466692787279998104302178999999867998877425999999985588888-87433099999
Q ss_pred HHHHHCC-CCCCCCCHHHHHC
Q ss_conf 9999349-9899989999972
Q 006528 235 FIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~ 254 (641)
||.+||. +|.+|||+.++++
T Consensus 248 li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 248 LMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHH
T ss_conf 999975779768939999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=360.40 Aligned_cols=249 Identities=19% Similarity=0.306 Sum_probs=208.7
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCE---EEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 9999992841864899999868992---9999998636656893569999999999981799981136589992897669
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~---~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 77 (641)
+++...+|+|+||+||+|.++.+|. .||+|.+... ......+.+.+|+.+|++++|||||++++++... ..+
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~ 102 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TPV 102 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred CEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CEE
T ss_conf 27856980278829999999579978899999997844---5989999999999999857998886189999628--877
Q ss_pred EEEECCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCC
Q ss_conf 9998057999999999957-999999999999999999999982899927303677938992899948995144023215
Q 006528 78 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~ 156 (641)
++|||||++|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC-------
T ss_pred EEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCCCCEECC
T ss_conf 9999722798530021045679999999999999999889885279--83576150448988-99919988844315756
Q ss_pred CCC-------CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 898-------75445898777732222-457843331110100234531-567999999979999999729998754567
Q 006528 157 QPT-------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 227 (641)
Q Consensus 157 ~~~-------~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~ 227 (641)
... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ ....++...+..+..+.. +..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~~-~~~ 257 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLPP-PMD 257 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCCC-CTT
T ss_pred CCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCCC-CCC
T ss_conf 777765365025666883003878883699786121445357899998679999999-999999999973788999-742
Q ss_pred CHHHHHHHHHHHCC-CCCCCCCHHHHHCC--CCCC
Q ss_conf 81789999999349-98999899999729--3344
Q 006528 228 NDPQIKGFIEKCLV-PASERLSAKDLLKD--PFLQ 259 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~RpSa~eLL~H--pfl~ 259 (641)
.++.+++||.+||. +|.+|||+.+++++ .+++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 26999999999758797689299999999999841
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.48 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=204.1
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC---CEEE
Q ss_conf 9999928418648999998689929999998636656893569999999999981799981136589992897---6699
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVN 78 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~---~~l~ 78 (641)
+++..+|+|+||+||+|.++.+|..||+|+++... .....+++.+|+.+|++|+||||+++++++..... ..++
T Consensus 11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp EEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 99789940648099999999999499999980310---958999999999999976898988588899505645541499
Q ss_pred EEECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC
Q ss_conf 99805799999999995799999999999999999999998289992730367793899289994899514402321589
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~ 158 (641)
++ +++.+|+|.++++.. ++++..++.++.||+.||.|||++| |+||||||+|||++ +.|.+||+|||+|......
T Consensus 88 l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGG
T ss_pred EE-EEECCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEC-CCCCEEECCCCCEEECCCC
T ss_conf 99-962598656644058-9999999999999999999999789--86777876437887-9997787545705650477
Q ss_pred -----CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-----------
Q ss_conf -----8754458987777322224--5784333111010023453156799999997999999972999-----------
Q 006528 159 -----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK----------- 220 (641)
Q Consensus 159 -----~~~~~~GTp~ymAPEvl~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~----------- 220 (641)
.....+||+.|+|||++.. .|+.++||||+|+++|+|++|+.||............+.....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_conf 76410101102652000387860478887410100467013377669799788888999998765206997566423433
Q ss_pred --------------C---CCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf --------------8---75456781789999999349-989998999997293344344
Q 006528 221 --------------P---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 221 --------------~---~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
. .......++++++||.+||. ||.+||||.++|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 222202446775577877783789999999999997648956790899986198655588
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.85 Aligned_cols=246 Identities=16% Similarity=0.322 Sum_probs=207.6
Q ss_pred EECCCCCEEEEEEEECC--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEECC
Q ss_conf 92841864899999868--9929999998636656893569999999999981799981136589992897669999805
Q 006528 6 SSRRIPAVDTYKAFDEF--AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 83 (641)
Q Consensus 6 ~lG~GafgtVYkA~d~~--tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 83 (641)
+||+|+||+||+|.++. ++..||+|.++... .....+.+.+|+.+|++++|||||++++++..+ .+++||||
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~lvmE~ 89 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEM 89 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEEC
T ss_pred EEECCCCEEEEEEEEECCCCCEEEEEEEECHHC---CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC---EEEEEEEE
T ss_conf 873060809999999608976899999988203---978999999999999867998880686560368---07999980
Q ss_pred CCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC----
Q ss_conf 7999999999957-99999999999999999999998289992730367793899289994899514402321589----
Q 006528 84 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 158 (641)
Q Consensus 84 ~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~---- 158 (641)
|++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+|+.+...
T Consensus 90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEE-TTEEEECCCTTCEECTTCSCEE
T ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEECC-CCCEEECCCHHHHCCCCCCCCC
T ss_conf 7899689975212569999999999999999878998688--105767646604546-8854203313421155434321
Q ss_pred -CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf -875445898777732222-457843331110100234531-56799999997999999972999875456781789999
Q 006528 159 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 159 -~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
......||+.|||||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+..+..+.. +...++++.+|
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~~~-p~~~~~~l~~l 244 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRMEC-PPECPPELYAL 244 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCCCC-CTTCCHHHHHH
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCC-CHHHHHHHHHCCCCCCC-CCCCCHHHHHH
T ss_conf 13562113743358688727999954123220178999993899999997-99999999981899999-97678999999
Q ss_pred HHHHCC-CCCCCCCHHHH---HCCCCCCCCC
Q ss_conf 999349-98999899999---7293344344
Q 006528 236 IEKCLV-PASERLSAKDL---LKDPFLQVEN 262 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eL---L~Hpfl~~~~ 262 (641)
|.+||. +|.+|||+.++ |+|+|+....
T Consensus 245 i~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf 9997577976890999999999999998541
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.16 Aligned_cols=244 Identities=27% Similarity=0.376 Sum_probs=206.7
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
++...+|+|+||+||+|... ..||+|.++.... .+...+.+.+|+.+|++++|||||++++++.. ..+++||
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv~ 82 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIVT 82 (276)
T ss_dssp CCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEE
T ss_pred EEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CEEEEEE
T ss_conf 99889830788589999999---9899999973469--98999999999999984799878645679715---5899999
Q ss_pred CCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC--
Q ss_conf 057999999999957-99999999999999999999998289992730367793899289994899514402321589--
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~-- 158 (641)
|||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC------
T ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCHHHEEEC-CCCCEEECCCCCEEECCCCCC
T ss_conf 658998889998523578999999999999999988875099--95161478997981-899788750022133355677
Q ss_pred --CCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCH
Q ss_conf --875445898777732222----45784333111010023453156799999997999999972999875---456781
Q 006528 159 --TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAKVND 229 (641)
Q Consensus 159 --~~~~~~GTp~ymAPEvl~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~---l~~~~~ 229 (641)
......||+.|||||++. +.|+.++|||||||++|||+||+.||.+.....++...+..+..++. .....+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHHCCCCCH
T ss_conf 63125665574317999995056899995315163599999999788998998969999999965888986000365554
Q ss_pred HHHHHHHHHHCC-CCCCCCCHHHHHCCC
Q ss_conf 789999999349-989998999997293
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLKDP 256 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~Hp 256 (641)
+++++||.+||. +|.+|||+.+++++-
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 9999999997588976892999999999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.62 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=208.1
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC------C
Q ss_conf 9999992841864899999868992999999863665689356999999999998179998113658999289------7
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK------K 74 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~------~ 74 (641)
.+++..+|+|+||+||+|.+..+|..||+|++..... ......++.+|+.+|+.++||||+++++++.... .
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 8899997227482999999989997999999842224--63789999999999998359996606765402465444457
Q ss_pred CEEEEEECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHH
Q ss_conf 66999980579999999999579999999999999999999999828999273036779389928999489951440232
Q 006528 75 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 154 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~ 154 (641)
..+++|+||+.++.+..+......+++..++.+++||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC--EEECCCCCHHEEEC-CCCCEEEEECCEEEE
T ss_conf 638999853578741012220344330899999999999998852299--88567672220366-899687631350022
Q ss_pred CCC------CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHC---CCCCCC
Q ss_conf 158------98754458987777322224--5784333111010023453156799999997999999972---999875
Q 006528 155 MQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPAS 223 (641)
Q Consensus 155 ~~~------~~~~~~~GTp~ymAPEvl~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~---g~~~~~ 223 (641)
... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+ .+.......+.. ...+..
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG-NTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHHHCCCCTTT
T ss_pred CCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCC-CCHHHHHHHHHHHCCCCCHHH
T ss_conf 3554443211356602497874289970799989178700678646617448799899-899999999998418998255
Q ss_pred CC---------------------------CCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 45---------------------------6781789999999349-98999899999729334434
Q 006528 224 LA---------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 224 l~---------------------------~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~ 261 (641)
.. ...++.+++||.+||. +|.+||||+|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 344320344433201334455503340444599899999999873896589099999749501569
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=357.48 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=212.2
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC--CEEEE
Q ss_conf 9999928418648999998689929999998636656893569999999999981799981136589992897--66999
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--KTVNM 79 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~--~~l~l 79 (641)
++...+|+|+||+||+|.+..+|..||+|.++.... ..+...+++.+|+.+|+.++||||+++++++..... ..+|+
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEEE
T ss_conf 986899608992999999999998999999855664-6989999999999999856999887311435432688766999
Q ss_pred EECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC-
Q ss_conf 9805799999999995799999999999999999999998289992730367793899289994899514402321589-
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~- 158 (641)
||||++||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.++|+|||.+......
T Consensus 89 vmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEECC---
T ss_pred EEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCC-CCCCCEEEHHHHHHHHCCCC
T ss_conf 9977889871011203589999999999999999999998579--52763467556657-54320100344432212354
Q ss_pred ----CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHH-HHCCCCC-CCCCCCCHHH
Q ss_conf ----8754458987777322224-5784333111010023453156799999997999999-9729998-7545678178
Q 006528 159 ----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK-VTSGIKP-ASLAKVNDPQ 231 (641)
Q Consensus 159 ----~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~-i~~g~~~-~~l~~~~~~~ 231 (641)
.....+||+.|||||++.+ .|+.++||||||+++|+|+||+.||.+. +..++... +.....+ .......+++
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCC-CHHHHHHHHHHCCCCCCCHHCCCCCHH
T ss_conf 4333346425762436999983999996632026528999997697998996-999999999846999971003478999
Q ss_pred HHHHHHHHCC-CCCCCC-CHHHHHCCCCCCC
Q ss_conf 9999999349-989998-9999972933443
Q 006528 232 IKGFIEKCLV-PASERL-SAKDLLKDPFLQV 260 (641)
Q Consensus 232 l~~LI~kcL~-dP~~Rp-Sa~eLL~Hpfl~~ 260 (641)
+++||.+||. +|.+|| |++++ .|+|++.
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l-~~~l~r~ 274 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEM-RADLVRV 274 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHH-HHHHHHH
T ss_pred HHHHHHHHCCCCHHHCHHHHHHH-HHHHHHH
T ss_conf 99999998667976777399999-9999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.20 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=215.1
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
.+++..+|+|+||+||+|.+..+|..||+|+++.... ......++.+|+.+|+.++||||+++++++.+. ..++++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~iv 79 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCC--CCEEEE
T ss_conf 7862697128681999999999996999999803217--868999999999999856757888213544444--311588
Q ss_pred ECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC--
Q ss_conf 805799999999995799999999999999999999998289992730367793899289994899514402321589--
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~-- 158 (641)
++++.+++|..++...+.+++..++.+++|++.||+|||+++ |+||||||+|||++. .+.+||+|||.|......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECT-TCCEEECCCTTCEECCSCCS
T ss_pred EEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEEECCCCCCCCCCC-CCCEEEEECCHHHCCCCCCC
T ss_conf 630233222112123565403678999999999987743399--860014676121133-78266520460110468875
Q ss_pred CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-----------------
Q ss_conf 8754458987777322224--578433311101002345315679999999799999997299-----------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----------------- 219 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~----------------- 219 (641)
......+++.|+|||++.. .++.++|||||||++|+|++|+.||....+..+.+..+....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCC
T ss_conf 10010344310146675069888804440265418899851899998899999999999861189973551344322211
Q ss_pred ----------CCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCC
Q ss_conf ----------9875456781789999999349-9899989999972933443
Q 006528 220 ----------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 260 (641)
Q Consensus 220 ----------~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~ 260 (641)
.........++.+++||.+||. +|.+||||+|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred CCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 3344454431043306568999999999986499668909999964953407
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.84 Aligned_cols=247 Identities=20% Similarity=0.342 Sum_probs=209.0
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
+++...+|+|+||+||+|.++ ++..||+|+++... ...+.+.+|+.+|++++|||||++++++.+ ..+++|
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv 85 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYII 85 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred EEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCEEEEEEEECC---CCEEEE
T ss_conf 388679810798289999999-99999999986476-----888999999999986799988578731045---976999
Q ss_pred ECCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC
Q ss_conf 8057999999999957--99999999999999999999998289992730367793899289994899514402321589
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~ 158 (641)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECSSS
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEE-CCCCEEECCCCCEEECCCC
T ss_conf 99578982888875147898878899999999999999997489--54675642251562-0244042341014773588
Q ss_pred ---CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf ---875445898777732222-4578433311101002345315679999999799999997299987545678178999
Q 006528 159 ---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 159 ---~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
......|++.|||||++. +.|+.++||||||+++|||+|+..|+....+..++...+..+..+.. +...++++++
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~-p~~~~~~l~~ 241 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQ 241 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-CTTCCHHHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC-CCCCHHHHHH
T ss_conf 644203567744445828983799982456452579999999689888888899999999970688889-6557199999
Q ss_pred HHHHHCC-CCCCCCCHHHHHC--CCCCCC
Q ss_conf 9999349-9899989999972--933443
Q 006528 235 FIEKCLV-PASERLSAKDLLK--DPFLQV 260 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~--Hpfl~~ 260 (641)
||.+||. +|.+|||++++++ |+||..
T Consensus 242 li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 242 LMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99997588976893999999986113213
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.20 Aligned_cols=243 Identities=15% Similarity=0.300 Sum_probs=206.8
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
++++..+|+|+||+||+|.+. ++..||||.++... ...+.+.+|+.++++++|||||++++++... ..+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv 78 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV 78 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred CEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCCCCCEECCC--CCEEEE
T ss_conf 588889820888299999988-99999999987886-----7689999999999966899756535243159--933799
Q ss_pred ECCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC-
Q ss_conf 8057999999999957-99999999999999999999998289992730367793899289994899514402321589-
Q 006528 81 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~- 158 (641)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+|+.....
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC---------
T ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCHHHEEEC-CCCCEEECCCCHHEECCCCC
T ss_conf 9836999189975201347889999999999999877653164--31044315326666-88776865532100236887
Q ss_pred --CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf --875445898777732222-45784333111010023453156799999997999999972999875456781789999
Q 006528 159 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 159 --~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
......||+.|+|||++. ..|+.++||||||+++|||+|+..|+....+..++...+..+..+. .+...++++.+|
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~~l 234 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQI 234 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCHHHHHH
T ss_pred CEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCCCHHHHHH
T ss_conf 3350430017666785786079998403321059999999878988877899999999998068889-954367999999
Q ss_pred HHHHCC-CCCCCCCHHHHHCC
Q ss_conf 999349-98999899999729
Q 006528 236 IEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~H 255 (641)
|.+||. +|.+|||++++++|
T Consensus 235 i~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 235 MNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCHHHCCCHHHHHHH
T ss_conf 999765797689199999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.61 Aligned_cols=258 Identities=20% Similarity=0.312 Sum_probs=214.4
Q ss_pred CEEEEEECCCCCEEEEEEEE---CCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCCCE
Q ss_conf 99999928418648999998---689929999998636656893569999999999981799-98113658999289766
Q 006528 1 MRILISSRRIPAVDTYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d---~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~~~~~~~~~ 76 (641)
.+++..||+|+||+||+|.+ +.+|..||+|.++...........+.+.+|+.+|++++| |||+++++++.+. ..
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~--~~ 103 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE--TK 103 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--TE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC--CC
T ss_conf 5999898328783999999876588794899999836772101689999999999998646798399962000248--73
Q ss_pred EEEEECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCC
Q ss_conf 99998057999999999957999999999999999999999982899927303677938992899948995144023215
Q 006528 77 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~ 156 (641)
+++++||+.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+||+++. .|.+||+|||+|..+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~-~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDS-NGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT-TSCEEESCSSEEEECC
T ss_pred EEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCCCCEEECC-CCCEEEEECCCHHHHC
T ss_conf 0012312341179999873045437888888999999998851499--896547732012469-9988874132022203
Q ss_pred CC---CCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCCCHHHHHHHCCCCCCCC---CCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 89---8754458987777322224---5784333111010023453156799999---9979999999729998754567
Q 006528 157 QP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTSGIKPASLAKV 227 (641)
Q Consensus 157 ~~---~~~~~~GTp~ymAPEvl~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~---~~~~~i~~~i~~g~~~~~l~~~ 227 (641)
.. ...+..|++.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+......... .++..
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~ 258 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQE 258 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTT
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCC--CCCCC
T ss_conf 4444322122233333106876057768871325177779999997689998888777799999983356899--88654
Q ss_pred CHHHHHHHHHHHCC-CCCCCC-----CHHHHHCCCCCCCCCCCC
Q ss_conf 81789999999349-989998-----999997293344344788
Q 006528 228 NDPQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 265 (641)
Q Consensus 228 ~~~~l~~LI~kcL~-dP~~Rp-----Sa~eLL~Hpfl~~~~~~~ 265 (641)
.++++++||.+||. +|.+|| +|+|+|+||||+..++..
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~ 302 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred CCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCHHH
T ss_conf 79999999999744589881999745099997497234899889
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.59 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=205.9
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC----CCCE
Q ss_conf 999999284186489999986899299999986366568935699999999999817999811365899928----9766
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----KKKT 76 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~----~~~~ 76 (641)
.+++..+|+|+||+||+|.|..+|..||+|++..... ......++.+|+.+|++++||||++++++|... ....
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 5998896217585999999999998999999882336--97999999999999986489876489989702564345762
Q ss_pred EEEEECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCC
Q ss_conf 99998057999999999957999999999999999999999982899927303677938992899948995144023215
Q 006528 77 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~ 156 (641)
+|+|||||.++.+.. + ...+++..++.+++||+.||.|||++| |+||||||+|||++. .+.+|++|||++....
T Consensus 97 ~~iv~Ey~~~~l~~~-~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~-~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-I--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS-DCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHHHH-H--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECT-TCCEEECCCCC-----
T ss_pred EEEEEECCCHHHHHH-H--HCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCC-CCCEEEECHHHHHCCC
T ss_conf 699984144677876-5--038999999999999999998865221--124567763211365-4431320102321146
Q ss_pred CC-CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHC-----------------
Q ss_conf 89-875445898777732222-45784333111010023453156799999997999999972-----------------
Q 006528 157 QP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS----------------- 217 (641)
Q Consensus 157 ~~-~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~----------------- 217 (641)
.. .....+||+.|+|||++. ..|+.++||||+||++|+|++|++||.+. +......++..
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR-DYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCC-CHHHHHHHHHHHCCCCCHHHHHHHHHHH
T ss_conf 665533221465555813314777787743335662578986598998889-7788999999720589879998765667
Q ss_pred -----CCCCC------------------CCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCC
Q ss_conf -----99987------------------5456781789999999349-98999899999729334434
Q 006528 218 -----GIKPA------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 261 (641)
Q Consensus 218 -----g~~~~------------------~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~ 261 (641)
..... ......++.+++||.+||. +|.+||||+|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 77764175435666421264333543210133379999999999876994579089999669420878
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.29 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=207.0
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCE----EEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 9999992841864899999868992----999999863665689356999999999998179998113658999289766
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~----~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~ 76 (641)
++++..+|+|+||+||+|.+..+|. .||+|.++... .....+.+.+|+.+|++++|||||++++++.+. .
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~ 84 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 84 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC---C
T ss_conf 9783198208992999999958998898999999965134---979999999999999867998881589999619---8
Q ss_pred EEEEECCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHC
Q ss_conf 99998057999999999957-99999999999999999999998289992730367793899289994899514402321
Q 006528 77 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 155 (641)
Q Consensus 77 l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~ 155 (641)
.+++++++.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|+..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~-~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKT-PQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEE-TTEEEECCCSHHHHT
T ss_pred EEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCHHHCCEECC-CCCEEEECCCCCEEC
T ss_conf 36999842687401011133457999999999999999999998769--504762120311679-987586025522233
Q ss_pred CCCC----CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 5898----75445898777732222-457843331110100234531-56799999997999999972999875456781
Q 006528 156 QQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 156 ~~~~----~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
.... .....||+.|||||++. +.|+.++||||||+++|||+| |..||.+ .+..++...+..+..+.. +...+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~~-p~~~~ 239 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLPQ-PPICT 239 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCCC-CTTBC
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCCC-CCCCC
T ss_conf 5444532236510586446708874699983565440799999999779999999-998999999975998999-85568
Q ss_pred HHHHHHHHHHCC-CCCCCCCHHHHHCCCC
Q ss_conf 789999999349-9899989999972933
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLKDPF 257 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~Hpf 257 (641)
+.+++||.+||. +|.+|||+.+++.|..
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 99999999847899346919999999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.76 Aligned_cols=244 Identities=19% Similarity=0.292 Sum_probs=207.8
Q ss_pred EEEEEECCCCCEEEEEEEECCCC----EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 99999284186489999986899----29999998636656893569999999999981799981136589992897669
Q 006528 2 RILISSRRIPAVDTYKAFDEFAG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG----~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 77 (641)
++...+|+|+||+||+|.++.++ ..||+|.++... .......+.+|+.+|++++|||||++++++.+. ..+
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~~~ 84 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPM 84 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred EEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--CCE
T ss_conf 861598117790999999968998787999999988445---968999999999999856898783236778338--803
Q ss_pred EEEECCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCC
Q ss_conf 9998057999999999957-999999999999999999999982899927303677938992899948995144023215
Q 006528 78 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~ 156 (641)
++|+||+.+|++.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC-----
T ss_pred EEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--CCCCCCCCCEEEEC-CCCEEEECCCCHHHCCC
T ss_conf 8999721357402221023454208999999999998541212123--42576564427888-99849984551030035
Q ss_pred CCC-----CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Q ss_conf 898-----75445898777732222-457843331110100234531567999999979999999729998754567817
Q 006528 157 QPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 230 (641)
Q Consensus 157 ~~~-----~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~ 230 (641)
... .....||+.|||||++. +.|+.++||||||+++|||+++..|+....+..+++..+..+..+.. +...++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-CTTCBH
T ss_pred CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC-CHHHHH
T ss_conf 7876526742677773434888870499997355634489899999679886556899999999863578998-504579
Q ss_pred HHHHHHHHHCC-CCCCCCCHHHHHC
Q ss_conf 89999999349-9899989999972
Q 006528 231 QIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 231 ~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.++++|.+||. +|.+|||+.++++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999999977679768939999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.59 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=205.8
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC---CCEEE
Q ss_conf 999992841864899999868992999999863665689356999999999998179998113658999289---76699
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVN 78 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~---~~~l~ 78 (641)
+++..+|+|+||+||+|.+..+|..||+|+++... ......+++.+|+.+|++++|||||++++++.... ....+
T Consensus 21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEE
T ss_conf 88889831788399999999999799999988200--2868999999999999866898742599999634645668649
Q ss_pred EEECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC
Q ss_conf 99805799999999995799999999999999999999998289992730367793899289994899514402321589
Q 006528 79 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 79 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~ 158 (641)
++++++.+|+|.+++.. +++++..++.+++||+.||.|||++| |+||||||+|||++ ..|.+|++|||+|.....
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD- 173 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----CCTG-
T ss_pred EEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCC-CCCCCCCCCCCHHCCCCC-
T ss_conf 99996258862320022-45309999999999999999997388--76516677633455-432200132100012575-
Q ss_pred CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--C-------------
Q ss_conf 8754458987777322224--5784333111010023453156799999997999999972999--8-------------
Q 006528 159 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--P------------- 221 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--~------------- 221 (641)
...+..|++.|+|||++.+ .++.++||||||+++|+|++|+.||.+. +.......+..... +
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHCCCCCHHHHHHCCCHHHH
T ss_conf 4444345435558355337756785512432058999997688997889-889999999973079975773200102445
Q ss_pred --------------CCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf --------------75456781789999999349-989998999997293344344
Q 006528 222 --------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 262 (641)
Q Consensus 222 --------------~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~Hpfl~~~~ 262 (641)
.......++++++||.+||. +|.+||||.|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 44430355787555662678999999999997758834593899985599548799
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.71 Aligned_cols=241 Identities=20% Similarity=0.331 Sum_probs=207.6
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
+++..+|+|+||+||+|.++ ++..||+|.++.... ..+.+.+|+.++++++||||+++++++.+. ..+++||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~ 78 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIIT 78 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEE
T ss_pred EEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCEEEEEEEEEEC--CCEEEEE
T ss_conf 99689820788399999988-998999999874757-----789999999999966898601588998507--8169999
Q ss_pred CCCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCCC-
Q ss_conf 05799999999995-7999999999999999999999982899927303677938992899948995144023215898-
Q 006528 82 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 159 (641)
Q Consensus 82 Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~~- 159 (641)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||+|+.+....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSC
T ss_pred ECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCEEEEEC-CCCCEEECCCHHHEECCCCCC
T ss_conf 704899388864102467768999999999999999875468--43466541358876-998479886144202357872
Q ss_pred --CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf --75445898777732222-457843331110100234531-56799999997999999972999875456781789999
Q 006528 160 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 235 (641)
Q Consensus 160 --~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~L 235 (641)
.....||+.|+|||++. ..|+.++||||||+++|||+| |+.||.+ .+..++...+..+..+. .+...++++++|
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~~~~l~~l 233 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRLY-RPHLASEKVYTI 233 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHH
T ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCC-CCCCCCHHHHHH
T ss_conf 2524657887757807863799885210336432467397559999889-99999999998079789-965465999999
Q ss_pred HHHHCC-CCCCCCCHHHHHCC
Q ss_conf 999349-98999899999729
Q 006528 236 IEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 236 I~kcL~-dP~~RpSa~eLL~H 255 (641)
|.+||. +|.+|||+.++++|
T Consensus 234 i~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 234 MYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCHHHCCCHHHHHHH
T ss_conf 999766897689399999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.93 Aligned_cols=248 Identities=19% Similarity=0.300 Sum_probs=209.2
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
+++...+|+|+||+||+|.+.. +..||+|.++... ...+.+.+|+.++++++|||||++|+++.+ + .+++|
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~--~~~lv 89 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIYIV 89 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--SCEEE
T ss_pred EEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-C--CEEEE
T ss_conf 7984699307980999999999-9999999988044-----888999999999986666788689999823-9--75999
Q ss_pred ECCCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC
Q ss_conf 805799999999995--799999999999999999999998289992730367793899289994899514402321589
Q 006528 81 TELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~ 158 (641)
|||+++|+|..++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC-----
T ss_pred EEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHH--EECCCCCCEEEEEC-CCCCEEECCCCHHHHCCCC
T ss_conf 99447994354200003553059999999999999999875411--43353123079998-9992998442555425688
Q ss_pred ---CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf ---875445898777732222-4578433311101002345315679999999799999997299987545678178999
Q 006528 159 ---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 234 (641)
Q Consensus 159 ---~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~ 234 (641)
......||+.|+|||++. +.++.++||||||+++|||++|..|+.......+++..+..+..++ .+...++++++
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~ 245 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHHHH
T ss_pred CCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCCCHHHHH
T ss_conf 73352454556654580898379989177413235899999868999998888999999998268999-98323799999
Q ss_pred HHHHHCC-CCCCCCCHHHHHC--CCCCCCC
Q ss_conf 9999349-9899989999972--9334434
Q 006528 235 FIEKCLV-PASERLSAKDLLK--DPFLQVE 261 (641)
Q Consensus 235 LI~kcL~-dP~~RpSa~eLL~--Hpfl~~~ 261 (641)
||.+||. +|.+||++++++. ++||...
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 999975669758919999999876662389
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.70 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=208.4
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEE--EEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCCCEE
Q ss_conf 99999928418648999998689929--9999986366568935699999999999817-99981136589992897669
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIE--VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~--VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l 77 (641)
+++...+|+|+||+||+|.++.+|.. ||+|+++... .....+.+.+|+.+|+++ +|||||++++++.+. ..+
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~ 86 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYL 86 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEE
T ss_pred CEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC--CEE
T ss_conf 68877982078828999999899969999999978233---8579999999999998622899883678888418--736
Q ss_pred EEEECCCCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCC
Q ss_conf 9998057999999999957----------------999999999999999999999982899927303677938992899
Q 006528 78 NMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 141 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~ 141 (641)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~-~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE-N 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG-G
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCCCCCCCEEEECC-C
T ss_conf 9999802898699998640355555123101234578999999999999999987663089--545550520489868-8
Q ss_pred CCEEEEECCHHHHCCCC-CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCC-CCCCCCCHHHHHHHHHCC
Q ss_conf 94899514402321589-875445898777732222-457843331110100234531567-999999979999999729
Q 006528 142 GEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEY-PYSECKNPAQIFKKVTSG 218 (641)
Q Consensus 142 g~IKL~DFGlA~~~~~~-~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~-Pf~~~~~~~~i~~~i~~g 218 (641)
+.+||+|||+|+..... ......||+.|+|||.+. +.|+.++||||||+++|||++|.. ||.+ .+..+++..+..+
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG 242 (309)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGT
T ss_pred CCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHC
T ss_conf 763874344322444223455301377555538752699996221531388999998368999999-9999999999826
Q ss_pred CCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCC
Q ss_conf 99875456781789999999349-98999899999729
Q 006528 219 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 219 ~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
..+. .+...++++++||.+||. +|.+|||+.+++++
T Consensus 243 ~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 8888-876678999999999767896689499999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.11 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=206.4
Q ss_pred CEEEEEECCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCC
Q ss_conf 9999992841864899999868-----99299999986366568935699999999999817-99981136589992897
Q 006528 1 MRILISSRRIPAVDTYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 74 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~-----tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~ 74 (641)
+++...+|+|+||+||+|.+.. +++.||+|.++... .....+.+.+|..++.++ +|+||+.+++++....
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~- 90 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 90 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC---CCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC-
T ss_conf 79844984167839999998677755578399999986001---71789999999999886149984997411540479-
Q ss_pred CEEEEEECCCCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEE
Q ss_conf 6699998057999999999957----------------999999999999999999999982899927303677938992
Q 006528 75 KTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 138 (641)
Q Consensus 75 ~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~ 138 (641)
..+++|||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~ 168 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS 168 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEC
T ss_conf 7579999845899299999853666665322202332146899999999999999999887379--71786773106577
Q ss_pred CCCCCEEEEECCHHHHCCCC----CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHC-CCCCCCCCCHHHHH
Q ss_conf 89994899514402321589----875445898777732222-4578433311101002345315-67999999979999
Q 006528 139 GNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIF 212 (641)
Q Consensus 139 ~~~g~IKL~DFGlA~~~~~~----~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG-~~Pf~~~~~~~~i~ 212 (641)
..+.+||+|||+|+..... ......||+.|||||++. +.|+.++|||||||++|||+|+ ..||.+......+.
T Consensus 169 -~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 169 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp -GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred -CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf -9982898457520011356652224751667210203686468899663221367899999868899998999899999
Q ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCC
Q ss_conf 99972999875456781789999999349-98999899999729
Q 006528 213 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 213 ~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
..+..+..+. .+...++++++||.+||. +|.+|||+.++++|
T Consensus 248 ~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9996389888-886578999999999767796679199999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=342.46 Aligned_cols=244 Identities=19% Similarity=0.264 Sum_probs=207.6
Q ss_pred CEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 999999284186489999986-----899299999986366568935699999999999817999811365899928976
Q 006528 1 MRILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~ 75 (641)
+++...+|+|+||+||+|.++ .++..||+|+++... .....+.+.+|+.+|++++||||+++++++... .
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~ 89 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--K 89 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC---CHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCC--C
T ss_conf 38867982078839999998887657788299999988210---857999999999999966899765524666059--8
Q ss_pred EEEEEECCCCCCCHHHHHHHCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCC
Q ss_conf 6999980579999999999579------------------------9999999999999999999998289992730367
Q 006528 76 TVNMITELFTSGNLRQYRKKHK------------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 131 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~------------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLK 131 (641)
.+++++||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ ++|||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlK 167 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLA 167 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--EEEEEEC
T ss_conf 03899981589929999985275542100001110012103467889899999999999999855413578--6854884
Q ss_pred CCCEEEECCCCCEEEEECCHHHHCCCC----CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCC-CCCCCC
Q ss_conf 793899289994899514402321589----875445898777732222-45784333111010023453156-799999
Q 006528 132 CDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFE-YPYSEC 205 (641)
Q Consensus 132 p~NILI~~~~g~IKL~DFGlA~~~~~~----~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~-~Pf~~~ 205 (641)
|+|||++. .+.+||+|||+|+.+... ...+..|++.|+|||++. ..|+.++|||||||++|||+++. .||.+
T Consensus 168 p~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~- 245 (301)
T d1lufa_ 168 TRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG- 245 (301)
T ss_dssp GGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-
T ss_pred CCCEEECC-CCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCC-
T ss_conf 01168989-9928983314421136776411157777676767989972688980563025236299998068999999-
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHC
Q ss_conf 997999999972999875456781789999999349-9899989999972
Q 006528 206 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 206 ~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+..++...+..+..+. .+...++++.+||.+||. +|.+|||+.++++
T Consensus 246 ~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHCCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 89999999997399788-87325299999999974889657939999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.16 Aligned_cols=244 Identities=22% Similarity=0.349 Sum_probs=206.3
Q ss_pred CEEEEEECCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 99999928418648999998689---929999998636656893569999999999981799981136589992897669
Q 006528 1 MRILISSRRIPAVDTYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 77 (641)
+++...+|+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred EEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CEE
T ss_conf 69877993078829999999369964499999993656---687999999999999986899998569889953---747
Q ss_pred EEEECCCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCC
Q ss_conf 999805799999999995-7999999999999999999999982899927303677938992899948995144023215
Q 006528 78 NMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~ 156 (641)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++. .+.+||+|||+|+...
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~-~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSS-NDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEE-TTEEEECC--------
T ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCHHHEEECC-CCCEEECCCHHHEECC
T ss_conf 9999840698077654224789999999999999987752302267--441410265532067-8967876503421336
Q ss_pred CC---CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Q ss_conf 89---875445898777732222-457843331110100234531-5679999999799999997299987545678178
Q 006528 157 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 231 (641)
Q Consensus 157 ~~---~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~ 231 (641)
.. ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+ .+..+++..+..+..+. .+...++.
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~ 237 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNCPPT 237 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCTTCCHH
T ss_pred CCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHH
T ss_conf 77623305400583103266751699887452444247899998269999888-99999999998189998-98777999
Q ss_pred HHHHHHHHCC-CCCCCCCHHHHHCC
Q ss_conf 9999999349-98999899999729
Q 006528 232 IKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 232 l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
+++||.+||. +|.+|||+.++++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999999768797689299999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.52 Aligned_cols=243 Identities=20% Similarity=0.261 Sum_probs=206.3
Q ss_pred EEECCCCCEEEEEEEECCCC---EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99284186489999986899---299999986366568935699999999999817999811365899928976699998
Q 006528 5 ISSRRIPAVDTYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~tG---~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
..+|+|+||+||+|.+..++ ..||||+++.. ......+++.+|+.+|++++||||+++++++.... ..+++||
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ 108 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVL 108 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEEEEE
T ss_pred EEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-CCEEEEE
T ss_conf 6981368809999999779987999999998843---69789999999999998678999867867898069-9438999
Q ss_pred CCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC--
Q ss_conf 057999999999957-99999999999999999999998289992730367793899289994899514402321589--
Q 006528 82 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~-- 158 (641)
|||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ..+.+||+|||+++.....
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTTTTC
T ss_pred EEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCCCCCCHHHEEEC-CCCCEEEECCCCHHHCCCCCC
T ss_conf 874067414421013454048999999999887652003367--62577668757677-999889910652322556655
Q ss_pred ----CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Q ss_conf ----875445898777732222-457843331110100234531567999999979999999729998754567817899
Q 006528 159 ----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 233 (641)
Q Consensus 159 ----~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~ 233 (641)
......||+.|+|||++. +.++.++||||||+++|||+|+..||....+..++...+..+..+. .+...++.+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~~~l~ 264 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPDPLY 264 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCCHHHH
T ss_pred CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC-CCCCCCHHHH
T ss_conf 531002565556455676887437999745746619999999978999988899999999998089889-9644759999
Q ss_pred HHHHHHCC-CCCCCCCHHHHHCC
Q ss_conf 99999349-98999899999729
Q 006528 234 GFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 234 ~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
+||.+||. +|.+||++.|+++|
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999768897689399999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.20 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=204.6
Q ss_pred CEEEEEECCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 99999928418648999998689---929999998636656893569999999999981799981136589992897669
Q 006528 1 MRILISSRRIPAVDTYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~t---G~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 77 (641)
++++..||+|+||+||+|..... ...||+|.++.... ..+...+.+.+|+.+|++++||||+++|+++.+. .+
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~~ 85 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PM 85 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred EEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC---CH
T ss_conf 1997898038883999999988999079999999983555-7989999999999999868999987898777401---00
Q ss_pred EEEECCCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCC
Q ss_conf 999805799999999995-7999999999999999999999982899927303677938992899948995144023215
Q 006528 78 NMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 156 (641)
Q Consensus 78 ~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~ 156 (641)
++|+||+.+|++.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred HEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECHHHHCCCCC-CCEEECCCHHHHHCC
T ss_conf 1146542386125444212689999999999999999998752178--7520566888156556-543325611555303
Q ss_pred CCC-----CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 898-----754458987777322224-57843331110100234531-56799999997999999972999875456781
Q 006528 157 QPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 229 (641)
Q Consensus 157 ~~~-----~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~ 229 (641)
... .....|++.|+|||++.+ .|+.++||||||+++|||+| |+.||.+ .+..++...+.........+...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 5887526547632573107999983799994215661489999999689999999-699999999984799999854453
Q ss_pred HHHHHHHHHHCC-CCCCCCCHHHHHC
Q ss_conf 789999999349-9899989999972
Q 006528 230 PQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 230 ~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+.+++||.+||. +|.+|||+.+|++
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99999999976889667929999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.23 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=207.2
Q ss_pred EEEEEECCCCCEEEEEEEECCCC-------EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECC
Q ss_conf 99999284186489999986899-------299999986366568935699999999999817-9998113658999289
Q 006528 2 RILISSRRIPAVDTYKAFDEFAG-------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK 73 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG-------~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~ 73 (641)
++...+|+|+||.||+|.+..++ ..||+|.++... .......+.+|...+.++ +|||||++++++.+.
T Consensus 16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~- 91 (299)
T d1fgka_ 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD- 91 (299)
T ss_dssp EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC-
T ss_conf 970098516782899999857875556675499999988112---8688999999999999813999697346522018-
Q ss_pred CCEEEEEECCCCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEE
Q ss_conf 76699998057999999999957----------------99999999999999999999998289992730367793899
Q 006528 74 KKTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137 (641)
Q Consensus 74 ~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI 137 (641)
..+++|||||.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||+
T Consensus 92 -~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 -GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV 168 (299)
T ss_dssp -SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred -CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECCCCEEE
T ss_conf -8689999736999099999860677643222334574346799999999999999998766379--7863022102245
Q ss_pred ECCCCCEEEEECCHHHHCCCC----CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHH
Q ss_conf 289994899514402321589----875445898777732222-457843331110100234531-56799999997999
Q 006528 138 NGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 211 (641)
Q Consensus 138 ~~~~g~IKL~DFGlA~~~~~~----~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i 211 (641)
+ ..+.+||+|||+++..... ......|++.|+|||++. +.|+.++||||||+++|||++ |.+||.+ .+..++
T Consensus 169 ~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~ 246 (299)
T d1fgka_ 169 T-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEEL 246 (299)
T ss_dssp C-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHH
T ss_pred C-CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-CCHHHH
T ss_conf 4-78976762211101135555543146678884663266751798882555477588888740179898999-999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHC
Q ss_conf 999972999875456781789999999349-9899989999972
Q 006528 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 212 ~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+..+..+..+.. +...++.+++||.+||. +|.+|||+.++++
T Consensus 247 ~~~i~~~~~~~~-p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTCCCCC-CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCCCC-CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 999972888898-7435299999999976679767939999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.65 Aligned_cols=244 Identities=21% Similarity=0.308 Sum_probs=204.7
Q ss_pred EEEEEECCCCCEEEEEEEE-----CCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCCC
Q ss_conf 9999928418648999998-----6899299999986366568935699999999999817-999811365899928976
Q 006528 2 RILISSRRIPAVDTYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d-----~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~ 75 (641)
++...+|+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++.+ +|||||++++++.+. .
T Consensus 26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~--~ 100 (311)
T d1t46a_ 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--G 100 (311)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred EEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC--C
T ss_conf 9854982068829999998066447788699999987424---8779999999999987626999887899898319--9
Q ss_pred EEEEEECCCCCCCHHHHHHHCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEE
Q ss_conf 6999980579999999999579------------------9999999999999999999998289992730367793899
Q 006528 76 TVNMITELFTSGNLRQYRKKHK------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 137 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~~------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI 137 (641)
.+++|||||++|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||++
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL 178 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCCCC
T ss_conf 78999973799879999985356654444453322233458899999999999999999887579--2666241021000
Q ss_pred ECCCCCEEEEECCHHHHCCCCC----CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHH
Q ss_conf 2899948995144023215898----75445898777732222-457843331110100234531-56799999997999
Q 006528 138 NGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 211 (641)
Q Consensus 138 ~~~~g~IKL~DFGlA~~~~~~~----~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i 211 (641)
+ ..+.+||+|||+++...... .....||+.|+|||++. +.++.++||||||+++|||+| |.+||........+
T Consensus 179 ~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 T-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp E-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred C-CCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 0-257521023401023367886158620135968767788617999974001025899999985899887789989999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHC
Q ss_conf 999972999875456781789999999349-9899989999972
Q 006528 212 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 212 ~~~i~~g~~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
.+.+..+..+. .+...++.+.+||.+||. +|.+|||+.++++
T Consensus 258 ~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99986689889-85436599999999975779657929999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.34 Aligned_cols=240 Identities=21% Similarity=0.359 Sum_probs=205.5
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 99999928418648999998689929999998636656893569999999999981799981136589992897669999
Q 006528 1 MRILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 80 (641)
+++...+|+|+||+||+|.++ |..||+|.++.. ...+.+.+|+.++++++||||+++++++.+.. ..+++|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv 79 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV 79 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred EEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCH------HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-CCEEEE
T ss_conf 488579820798089999999--909999998857------77999999999998678989854987887238-928999
Q ss_pred ECCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEECCHHHHCCCC
Q ss_conf 8057999999999957--99999999999999999999998289992730367793899289994899514402321589
Q 006528 81 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~~~~~~ 158 (641)
|||+++|+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++ ..|.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-------
T ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCC--EECCCCCHHHHEEC-CCCCEEECCCCCCEECCCC
T ss_conf 96369998999987457888899999999999985232113376--55366656760146-8997763245600344787
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf 875445898777732222-457843331110100234531-567999999979999999729998754567817899999
Q 006528 159 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 236 (641)
Q Consensus 159 ~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~~~~l~~~~~~~l~~LI 236 (641)
.....+++.|+|||++. +.|+.++||||||+++|||+| |++||.. ....++...+..+..+.. +...++++++||
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li 233 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMDA-PDGCPPAVYEVM 233 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCCC-CTTCCHHHHHHH
T ss_pred -CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCCC-CCCCCHHHHHHH
T ss_conf -76556664677817872798885887775799999999789999999-999999999980899999-765799999999
Q ss_pred HHHCC-CCCCCCCHHHHHCC
Q ss_conf 99349-98999899999729
Q 006528 237 EKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 237 ~kcL~-dP~~RpSa~eLL~H 255 (641)
.+||. +|.+|||+.+++++
T Consensus 234 ~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHCCCCHHHCCCHHHHHHH
T ss_conf 99756697689399999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.14 Aligned_cols=245 Identities=20% Similarity=0.314 Sum_probs=206.0
Q ss_pred CEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 999999284186489999986-----899299999986366568935699999999999817999811365899928976
Q 006528 1 MRILISSRRIPAVDTYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 75 (641)
Q Consensus 1 ~RIl~~lG~GafgtVYkA~d~-----~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~ 75 (641)
+++...+|+|+||+||+|.+. .++..||+|+++... .......+.+|+.++++++||||+++++++... .
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~ 96 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--Q 96 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--S
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--C
T ss_conf 18835982078818999998786447789689999987012---868999999999999976999884125478428--8
Q ss_pred EEEEEECCCCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEE
Q ss_conf 699998057999999999957----------9999999999999999999999828999273036779389928999489
Q 006528 76 TVNMITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 145 (641)
Q Consensus 76 ~l~lV~Ey~~gGsL~~~l~~~----------~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IK 145 (641)
.+++|+||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld-~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEE
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECEECCCCEEEC-CCCEEE
T ss_conf 106777604899889998750332113444688799999999999999999876479--65432867754035-996499
Q ss_pred EEECCHHHHCCCC----CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCC-CCCCCCCCHHHHHHHHHCCC
Q ss_conf 9514402321589----875445898777732222-45784333111010023453156-79999999799999997299
Q 006528 146 IGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFE-YPYSECKNPAQIFKKVTSGI 219 (641)
Q Consensus 146 L~DFGlA~~~~~~----~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~-~Pf~~~~~~~~i~~~i~~g~ 219 (641)
|+|||+|+.+... ......|++.|+|||.+. +.|+.++||||||+++|||+|+. .||.+ .+..+++..+..+.
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGG 252 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTC
T ss_pred EEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCC
T ss_conf 94245420235776303134023163237888873699883334443789999999689999999-89999999998088
Q ss_pred CCCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHCC
Q ss_conf 9875456781789999999349-98999899999729
Q 006528 220 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 220 ~~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
.+.. +...++.+.++|.+||. +|.+|||+.+++++
T Consensus 253 ~~~~-p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 253 LLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp CCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 8888-63353999999999757796589399999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=319.92 Aligned_cols=248 Identities=20% Similarity=0.241 Sum_probs=192.5
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99999284186489999986899299999986366568935699999999999817999811365899928976699998
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 81 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 81 (641)
++...+|+|+||+||+|.+..+|..||+|.+...... ..+..|+++++.++|++++..+..+... ....++||
T Consensus 10 ~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~ivm 82 (299)
T d1ckia_ 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVM 82 (299)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred EEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC------HHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCEEEEEE
T ss_conf 9968985078809999999889989999997210058------8899999999970389960179999951-98778999
Q ss_pred CCCCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEEC--CCCCEEEEECCHHHHCCCC
Q ss_conf 0579999999999-579999999999999999999999828999273036779389928--9994899514402321589
Q 006528 82 ELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP 158 (641)
Q Consensus 82 Ey~~gGsL~~~l~-~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~--~~g~IKL~DFGlA~~~~~~ 158 (641)
||+.+ +|.+.+. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++. ....+||+|||+|+.+...
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EECCC-CHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCC
T ss_conf 87387-133324430688768999999999999999999799--442667876606433577761565046751342554
Q ss_pred ---------CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCCCCHHHH--HHHHHC---CCCCCC
Q ss_conf ---------8754458987777322224-5784333111010023453156799999997999--999972---999875
Q 006528 159 ---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI--FKKVTS---GIKPAS 223 (641)
Q Consensus 159 ---------~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i--~~~i~~---g~~~~~ 223 (641)
......||+.|||||++.+ .|+.++||||||+++|||+||+.||......... +..... ......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred CCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH
T ss_conf 45541000135776787353299999189989832188617789999849876655305779999998523567898357
Q ss_pred CCCCCHHHHHHHHHHHCC-CCCCCCCHHH---HHCCCCCC
Q ss_conf 456781789999999349-9899989999---97293344
Q 006528 224 LAKVNDPQIKGFIEKCLV-PASERLSAKD---LLKDPFLQ 259 (641)
Q Consensus 224 l~~~~~~~l~~LI~kcL~-dP~~RpSa~e---LL~Hpfl~ 259 (641)
.....++++.+||.+||. +|.+||++.+ +|+|+|..
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 5347889999999998439955791999999999999997
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.69 Aligned_cols=245 Identities=22% Similarity=0.289 Sum_probs=188.1
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC--CEEEE
Q ss_conf 9999928418648999998689929999998636656893569999999999981799981136589992897--66999
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--KTVNM 79 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~--~~l~l 79 (641)
.+...||+|+||+||+|.. +|..||+|.++... ........|+..+++++|||||++++++.+... ..+++
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC-----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9988982078819999999--99899999987200-----4679999999999627998683268899837986048999
Q ss_pred EECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC------CCCEEEECCCCCCEEEECCCCCEEEEECCHHH
Q ss_conf 980579999999999579999999999999999999999828------99927303677938992899948995144023
Q 006528 80 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 80 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~------gppIiHrDLKp~NILI~~~~g~IKL~DFGlA~ 153 (641)
|||||++|+|.+++++. .+++..+..++.|++.||.|||+. .++|+||||||+|||++ .++.+||+|||++.
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCTTCE
T ss_pred EEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEEC-CCCCEEEEECCCCC
T ss_conf 99646698989998658-99989999999999999999887665204689866153173135786-88776887638662
Q ss_pred HCCCC------CCCCCCCCCCCCCCCCCCCC-------CCCCCCCCCCCCHHHHHHHCCCCCCCC--------------C
Q ss_conf 21589------87544589877773222245-------784333111010023453156799999--------------9
Q 006528 154 AMQQP------TARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTFEYPYSEC--------------K 206 (641)
Q Consensus 154 ~~~~~------~~~~~~GTp~ymAPEvl~~~-------ys~ksDIwSlGiil~ELltG~~Pf~~~--------------~ 206 (641)
..... ......||+.|+|||++.+. ++.++|||||||++|||+||..||... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 34677762001355250354767822105654546777675012201599999996289988766311241012255643
Q ss_pred CHHHHHHHHHCCCCCCCCCCC-----CHHHHHHHHHHHCC-CCCCCCCHHHHHCC
Q ss_conf 979999999729998754567-----81789999999349-98999899999729
Q 006528 207 NPAQIFKKVTSGIKPASLAKV-----NDPQIKGFIEKCLV-PASERLSAKDLLKD 255 (641)
Q Consensus 207 ~~~~i~~~i~~g~~~~~l~~~-----~~~~l~~LI~kcL~-dP~~RpSa~eLL~H 255 (641)
....+...+..+...+.++.. ....+.+++.+||. +|.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 0999999875024688877655776899999999999760698589599999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=315.01 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=193.1
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCC-----------CCCCCEEEEEEE
Q ss_conf 999992841864899999868992999999863665689356999999999998179-----------998113658999
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----------DDNVVKFYKSWV 70 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-----------HpNIVkl~~~~~ 70 (641)
+++..+|+|+||+||+|.+..+|..||+|+++... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 16 ~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-----CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 99899750778189999999999799999983431-----3368999999999984014555554227676478998763
Q ss_pred ECCCCEEEEEECCCCCCC-HHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEEECCCCCCEEEECCCC----
Q ss_conf 289766999980579999-999999--57999999999999999999999982-8999273036779389928999----
Q 006528 71 DDKKKTVNMITELFTSGN-LRQYRK--KHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHG---- 142 (641)
Q Consensus 71 ~~~~~~l~lV~Ey~~gGs-L~~~l~--~~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIiHrDLKp~NILI~~~~g---- 142 (641)
.......+++++++..+. ...... ....+++..++.+++||+.||.|||+ +| |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTE
T ss_pred ECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEECCCCCCCC
T ss_conf 12565202343200035420000012234678689999999999999888764058--6465677057056305765644
Q ss_pred -CEEEEECCHHHHCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCH------HHHHHH
Q ss_conf -4899514402321589875445898777732222-45784333111010023453156799999997------999999
Q 006528 143 -EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP------AQIFKK 214 (641)
Q Consensus 143 -~IKL~DFGlA~~~~~~~~~~~~GTp~ymAPEvl~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~------~~i~~~ 214 (641)
.+|++|||.|..... .....+||+.|+|||++. ..|+.++||||+|+++++|++|+.||...... ..+...
T Consensus 169 ~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred CEEEEEECCCCCCCCC-CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHH
T ss_conf 3056753144212344-542236652105713214667776432012378999998788998987554321026899999
Q ss_pred HH-CCCC--------------------------------------CCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHC
Q ss_conf 97-2999--------------------------------------875456781789999999349-9899989999972
Q 006528 215 VT-SGIK--------------------------------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 215 i~-~g~~--------------------------------------~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+. .+.. ........++++++||.+||. ||.+||||+|+|+
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 99837998788624532200013201220243235776444210001567435899999999987799457908999966
Q ss_pred CCCCCCCC
Q ss_conf 93344344
Q 006528 255 DPFLQVEN 262 (641)
Q Consensus 255 Hpfl~~~~ 262 (641)
||||+...
T Consensus 328 Hp~f~~~~ 335 (362)
T d1q8ya_ 328 HPWLKDTL 335 (362)
T ss_dssp CGGGTTCT
T ss_pred CCCCCCCC
T ss_conf 93407898
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=305.79 Aligned_cols=242 Identities=14% Similarity=0.162 Sum_probs=196.0
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCCCEEEEE
Q ss_conf 9999928418648999998689929999998636656893569999999999981799-981136589992897669999
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~~~~~~~~~l~lV 80 (641)
++...+|+|+||+||+|.+..+|..||+|.+..... ...+.+|++.++.|+| +||+.+++++... ...++|
T Consensus 8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~v 79 (293)
T d1csna_ 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLV 79 (293)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC------CHHHHHHHHHHHHHCCCCCCCEEEEEEECC--CCCEEE
T ss_conf 997998417882999999988997999999750258------299999999999964899987799996018--811799
Q ss_pred ECCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEEC----CCCCEEEEECCHHHHC
Q ss_conf 8057999999999957-9999999999999999999999828999273036779389928----9994899514402321
Q 006528 81 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLGLAIAM 155 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~----~~g~IKL~DFGlA~~~ 155 (641)
|||+ +|+|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||++. ..+.+||+|||+|+..
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf 9964-88879999752031106899999999999999999779--66266771315234754344795687236605771
Q ss_pred CCC---------CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCHHHHHHHCCCCCCCC--CCHHHHHHHHHCC---CC
Q ss_conf 589---------8754458987777322224-5784333111010023453156799999--9979999999729---99
Q 006528 156 QQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSG---IK 220 (641)
Q Consensus 156 ~~~---------~~~~~~GTp~ymAPEvl~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~--~~~~~i~~~i~~g---~~ 220 (641)
... .....+||+.|||||++.+ .|+.++||||||+++|+|+||..||.+. ......+..+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred CCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf 46766541110246762775102679896488888699989831999999869876788530219999999970567999
Q ss_pred CCCCCCCCHHHHHHHHHHHCC-CCCCCCCHHHHHC
Q ss_conf 875456781789999999349-9899989999972
Q 006528 221 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 254 (641)
Q Consensus 221 ~~~l~~~~~~~l~~LI~kcL~-dP~~RpSa~eLL~ 254 (641)
+..+....++++.+++..|+. +|.+||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 58965799899999999984399300859999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3e-25 Score=167.60 Aligned_cols=170 Identities=17% Similarity=0.146 Sum_probs=122.1
Q ss_pred EEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-----C---------CHHHHHHHHHHHHHHHHCCCCCCCEEEEE
Q ss_conf 999928418648999998689929999998636656-----8---------93569999999999981799981136589
Q 006528 3 ILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL-----Q---------LPGDLQKLYSEVHLLKSLKDDNVVKFYKS 68 (641)
Q Consensus 3 Il~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~-----~---------~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 68 (641)
+-..+|.|+||+||+|.+. +|..||+|.++..... . ..........|...+.++.|+++++.+++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 2778024856599999979-999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCCCEEEEEECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCEEEECCCCCEEEEE
Q ss_conf 99289766999980579999999999579999999999999999999999828999273036779389928999489951
Q 006528 69 WVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 148 (641)
Q Consensus 69 ~~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~gppIiHrDLKp~NILI~~~~g~IKL~D 148 (641)
.. .+++|||++++.+.+ ++...+..++.|++.+|.|||++| |+||||||+|||++ + +.++|+|
T Consensus 83 --~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~liD 145 (191)
T d1zara2 83 --EG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWIID 145 (191)
T ss_dssp --ET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEECC
T ss_pred --CC----CEEEEEEECCCCCCC-------HHHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHEEEE-C-CCEEEEE
T ss_conf --28----889999504565420-------015789999999999999982688--89836890361142-8-9899987
Q ss_pred CCHHHHCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 44023215898754458-98777732222457843331110100
Q 006528 149 LGLAIAMQQPTARSVIG-TPEFMAPELYEEEYNELVDIYSFGMC 191 (641)
Q Consensus 149 FGlA~~~~~~~~~~~~G-Tp~ymAPEvl~~~ys~ksDIwSlGii 191 (641)
||.|.....+....+.. ... .-.+.+...|+..+|+||..--
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~-~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVR-NIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHH-HHHHHHHHHHCCCCCHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHH-HHHHHHCCCCCCCCCHHHHHHH
T ss_conf 788430899870999987799-9999975789984468999998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.44 E-value=1.7e-06 Score=54.43 Aligned_cols=81 Identities=9% Similarity=0.001 Sum_probs=53.2
Q ss_pred EEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC---CCHHHHHHHHHHHHHHHHC-CC--CCCCEEEEEEEECCCCEE
Q ss_conf 99928418648999998689929999998636656---8935699999999999817-99--981136589992897669
Q 006528 4 LISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVL---QLPGDLQKLYSEVHLLKSL-KD--DNVVKFYKSWVDDKKKTV 77 (641)
Q Consensus 4 l~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~---~~~~~~~~l~~Ei~iLk~L-~H--pNIVkl~~~~~~~~~~~l 77 (641)
+..+|.|....||++.+...|..|++|+-...-.. ..+....+...|...|+.+ .+ ..+.++|. .+... .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~--~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM--A 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT--T
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECCCC--C
T ss_conf 9980798527689999579984899961771303467778887789999999999865057988552899--85988--7
Q ss_pred EEEECCCCCCC
Q ss_conf 99980579999
Q 006528 78 NMITELFTSGN 88 (641)
Q Consensus 78 ~lV~Ey~~gGs 88 (641)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEECCCCCC
T ss_conf 79871357765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=3e-06 Score=52.98 Aligned_cols=138 Identities=16% Similarity=0.076 Sum_probs=82.5
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCCCEEEEE
Q ss_conf 999992841864899999868992999999863665689356999999999998179-9981136589992897669999
Q 006528 2 RILISSRRIPAVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMI 80 (641)
Q Consensus 2 RIl~~lG~GafgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV 80 (641)
|.+...+.++...||+.. ..+..+++|....... .....+.+|...+..+. +--+.+++.+..+. ...++|
T Consensus 17 ~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv 88 (263)
T d1j7la_ 17 RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLL 88 (263)
T ss_dssp EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEE
T ss_pred EEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCC----CCHHHHHHHHHHHHHHHCCCCCCCEEEEEECC--CCEEEE
T ss_conf 799767899877189999--0898699998488765----32556999999999876069987289997508--964999
Q ss_pred ECCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------------
Q ss_conf 805799999999995799999999999999999999998289--------------------------------------
Q 006528 81 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN-------------------------------------- 122 (641)
Q Consensus 81 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~aL~yLHs~g-------------------------------------- 122 (641)
|++++|.++....... .....++.++...|..||+..
T Consensus 89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEECCCCCCCCCCCCC-----CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 9860433435433440-----26999999899999998556842143576446565557789987765555430332320
Q ss_pred -------------------CCEEEECCCCCCEEEECCCCCEEEEECCHHH
Q ss_conf -------------------9927303677938992899948995144023
Q 006528 123 -------------------PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 123 -------------------ppIiHrDLKp~NILI~~~~g~IKL~DFGlA~ 153 (641)
+.++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred CHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEEC-CCCEEEEEECHHCC
T ss_conf 05799999999844986781789860047642364-99659996023144
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=0.00011 Score=43.62 Aligned_cols=131 Identities=14% Similarity=0.018 Sum_probs=73.1
Q ss_pred CEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCC--CCCCEEEEEEEECCCCEEEEEECCCCCCCH
Q ss_conf 648999998689929999998636656893569999999999981799--981136589992897669999805799999
Q 006528 12 AVDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDKKKTVNMITELFTSGNL 89 (641)
Q Consensus 12 fgtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL 89 (641)
...||+... ..|..+++|...... ...+..|...++.|.. -.+.+++.+..+. ...++|+++++|.++
T Consensus 24 ~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 24 DAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDL 93 (255)
T ss_dssp SCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEET
T ss_pred CCEEEEEEE-CCCCEEEEEECCCCC-------HHHHHHHHHHHHHHHHCCCCCCCEEEECCCC--CCEEEEEEEEECCCC
T ss_conf 775899993-898789999589667-------7689999999999986599988613222456--615999874413554
Q ss_pred HH--------------HHHH-CC------CCC--HHH-HHHHH-------------------HHHHHHHHHHHHCC----
Q ss_conf 99--------------9995-79------999--999-99999-------------------99999999998289----
Q 006528 90 RQ--------------YRKK-HK------NVD--IKV-IKNWA-------------------RQILHGLVYLHSHN---- 122 (641)
Q Consensus 90 ~~--------------~l~~-~~------~l~--e~~-i~~i~-------------------~QIl~aL~yLHs~g---- 122 (641)
.. .+.+ +. ++. ... ...+. ......+..+....
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 32212689999999999998736885448875541246889999998754110113401121379999999987187657
Q ss_pred C-CEEEECCCCCCEEEECCCCCEEEEECCHHH
Q ss_conf 9-927303677938992899948995144023
Q 006528 123 P-PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 123 p-pIiHrDLKp~NILI~~~~g~IKL~DFGlA~ 153 (641)
+ .++|+|+.|.||+++. ++.+-|+||+.+.
T Consensus 174 ~~~liHgD~~~~Nvl~~~-~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG 204 (255)
T ss_dssp CEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred CCEEEECCCCCCCEEEEC-CCEEEEEECHHCC
T ss_conf 956786788876357737-9658999853326
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.76 E-value=0.0023 Score=35.65 Aligned_cols=132 Identities=11% Similarity=0.060 Sum_probs=69.5
Q ss_pred EEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCC--CEEEEE---EEECCCCEEEEEECCCCCC
Q ss_conf 48999998689929999998636656893569999999999981799981--136589---9928976699998057999
Q 006528 13 VDTYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV--VKFYKS---WVDDKKKTVNMITELFTSG 87 (641)
Q Consensus 13 gtVYkA~d~~tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI--Vkl~~~---~~~~~~~~l~lV~Ey~~gG 87 (641)
-.||++.. ++|..|++|..+... ...+.+..|+..+..|....| +..... .........+.+++++.|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~-----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred CEEEEEEC-CCCCEEEEEEECCCC-----CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCC
T ss_conf 02699983-899979999847877-----889999999999999985599878752068980566534799998652776
Q ss_pred CH-----HHHHH---------H----C-----CCCCH-------------------H---HHHHHHHHHHHHHHHHH-HC
Q ss_conf 99-----99999---------5----7-----99999-------------------9---99999999999999998-28
Q 006528 88 NL-----RQYRK---------K----H-----KNVDI-------------------K---VIKNWARQILHGLVYLH-SH 121 (641)
Q Consensus 88 sL-----~~~l~---------~----~-----~~l~e-------------------~---~i~~i~~QIl~aL~yLH-s~ 121 (641)
.+ .++.. . . ...+. . .....+.+++..+.-+- ..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 88999999999989999998863035786556778978876656899987476998898999999999999999845456
Q ss_pred CC-CEEEECCCCCCEEEECCCCCEEEEECCHHH
Q ss_conf 99-927303677938992899948995144023
Q 006528 122 NP-PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 122 gp-pIiHrDLKp~NILI~~~~g~IKL~DFGlA~ 153 (641)
.| .+||+|+.++|||++ + + ..++||+-+.
T Consensus 190 ~p~~liHgDlh~~NvL~~-~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWR-D-G-PMFVDLDDAR 219 (325)
T ss_dssp SCCEECCSSCSGGGEEES-S-S-EEECCCTTCC
T ss_pred CCCEEECCCCCCCCEEEE-C-C-CEEEECHHCC
T ss_conf 871202478880428783-8-9-3588652014
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.60 E-value=0.014 Score=30.80 Aligned_cols=73 Identities=12% Similarity=-0.028 Sum_probs=42.2
Q ss_pred EEECCCCCEEEEEEEECC-------CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCCCE
Q ss_conf 992841864899999868-------992999999863665689356999999999998179-998113658999289766
Q 006528 5 ISSRRIPAVDTYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKT 76 (641)
Q Consensus 5 ~~lG~GafgtVYkA~d~~-------tG~~VAiK~i~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~ 76 (641)
..++.|---.+|++.... .+..|.+...- . ... .....+|..+++.+. +.-..++++++ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~----~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~--~~--- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N----PET-ESHLVAESVIFTLLSERHLGPKLYGIF--SG--- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S----CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C----CCH-HHHHHHHHHHHHHHHHCCCCCEEEEEC--CC---
T ss_conf 991785334348999688775445789817999659-9----611-658999999999997579998089981--89---
Q ss_pred EEEEECCCCCCCH
Q ss_conf 9999805799999
Q 006528 77 VNMITELFTSGNL 89 (641)
Q Consensus 77 l~lV~Ey~~gGsL 89 (641)
.+|+||++|.++
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEECCCCC
T ss_conf -569997345548
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.34 E-value=0.034 Score=28.52 Aligned_cols=29 Identities=34% Similarity=0.426 Sum_probs=24.2
Q ss_pred CEEEECCCCCCEEEECCCCCEEEEECCHHH
Q ss_conf 927303677938992899948995144023
Q 006528 124 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 153 (641)
Q Consensus 124 pIiHrDLKp~NILI~~~~g~IKL~DFGlA~ 153 (641)
++||+|+.++||+++++ ...-+.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred CCCCCCCCHHHHHCCCC-CCEEEECCCCCC
T ss_conf 03337863656402045-412674222123
|